Clustering O 0 0.11576779186725616
of O 0 0.04206257686018944
missense O 0 0.10541513562202454
mutations O 0 0.034095145761966705
in O 0 0.01905280537903309
the O 0 0.04485824331641197
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 0.9999983310699463
gene O 0 0.02953048050403595
in O 0 0.013056915253400803
a O 0 0.024831056594848633
sporadic B-Disease 1 0.9942248463630676
T I-Disease 1 0.9999995231628418
- I-Disease 1 0.9999996423721313
cell I-Disease 1 0.9982160925865173
leukaemia I-Disease 1 0.9999986886978149
. O 0 0.0648983046412468

Ataxia B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999996423721313
telangiectasia I-Disease 1 0.9999997615814209
( O 0 0.18703240156173706
A B-Disease 1 0.9999788999557495
- I-Disease 1 1.0
T I-Disease 1 0.9999923706054688
) O 0 0.013149741105735302
is O 0 0.008408221416175365
a O 0 0.017820006236433983
recessive B-Disease 1 0.9991208910942078
multi I-Disease 1 0.9999995231628418
- I-Disease 1 1.0
system I-Disease 1 0.9999711513519287
disorder I-Disease 1 1.0
caused O 1 0.9888938069343567
by O 0 0.023133326321840286
mutations O 0 0.02196596935391426
in O 0 0.010615606792271137
the O 0 0.016986392438411713
ATM O 0 0.058813709765672684
gene O 0 0.020416000857949257
at O 0 0.023069608956575394
11q22 O 1 0.9977700710296631
- O 1 0.9999774694442749
q23 O 1 0.9998600482940674
( O 0 0.05258732661604881
ref O 1 0.9956523776054382
. O 0 0.022843481972813606
3 O 0 0.034809209406375885
) O 0 0.031558919697999954
. O 0 0.033664271235466

The O 0 0.04622069001197815
risk O 0 0.20817022025585175
of O 0 0.41541606187820435
cancer B-Disease 1 0.9999998807907104
, O 1 0.6788893938064575
especially O 1 0.9445651769638062
lymphoid B-Disease 1 0.9999998807907104
neoplasias I-Disease 1 0.9999886751174927
, O 0 0.02397073060274124
is O 0 0.015298607759177685
substantially O 0 0.025694284588098526
elevated O 1 0.8856642842292786
in O 0 0.01649782992899418
A B-Disease 1 0.9999769926071167
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9999386072158813
and O 0 0.018640153110027313
has O 0 0.01580493152141571
long O 0 0.021791862323880196
been O 0 0.0157767403870821
associated O 0 0.023540953174233437
with O 0 0.0394526943564415
chromosomal O 1 0.9999963045120239
instability O 1 0.9999909400939941
. O 0 0.09395792335271835

By O 0 0.05635751411318779
analysing O 1 0.9059950113296509
tumour B-Disease 1 0.9999996423721313
DNA O 0 0.043111007660627365
from O 0 0.021932607516646385
patients O 0 0.03941597789525986
with O 0 0.01840275153517723
sporadic B-Disease 1 0.9821032285690308
T I-Disease 1 0.9999982118606567
- I-Disease 1 0.9999964237213135
cell I-Disease 1 0.9638255834579468
prolymphocytic I-Disease 1 0.9999886751174927
leukaemia I-Disease 1 1.0
( O 1 0.9758707284927368
T B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999997615814209
PLL I-Disease 1 0.9999964237213135
) O 0 0.022859040647745132
, O 0 0.016400892287492752
a O 0 0.021403487771749496
rare O 0 0.04970506578683853
clonal B-Disease 1 0.9999377727508545
malignancy I-Disease 1 0.9999958276748657
with O 0 0.020658932626247406
similarities O 0 0.020299619063735008
to O 0 0.013058389537036419
a O 0 0.021460039541125298
mature B-Disease 1 0.8425087928771973
T I-Disease 1 0.9999924898147583
- I-Disease 1 0.9999977350234985
cell I-Disease 1 0.989069402217865
leukaemia I-Disease 1 0.9999977350234985
seen O 0 0.022305680438876152
in O 0 0.01674431562423706
A B-Disease 1 0.9999203681945801
- I-Disease 1 1.0
T I-Disease 1 0.9999988079071045
, O 0 0.014348260127007961
we O 0 0.008182939141988754
demonstrate O 0 0.01413723360747099
a O 0 0.013130245730280876
high O 0 0.020274702459573746
frequency O 0 0.0160965658724308
of O 0 0.01870572194457054
ATM O 1 0.7557525634765625
mutations O 0 0.036144062876701355
in O 0 0.03167204186320305
T B-Disease 1 0.9999948740005493
- I-Disease 1 0.9999979734420776
PLL I-Disease 1 0.9998973608016968
. O 0 0.06881728768348694

In O 0 0.03261486068367958
marked O 0 0.04123135283589363
contrast O 0 0.026622073724865913
to O 0 0.015838991850614548
the O 0 0.021772995591163635
ATM O 1 0.6458845734596252
mutation O 0 0.029156053438782692
pattern O 0 0.021139612421393394
in O 0 0.01410385686904192
A B-Disease 1 0.999852180480957
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999855756759644
, O 0 0.013892577029764652
the O 0 0.01266050711274147
most O 0 0.011688826605677605
frequent O 0 0.029224243015050888
nucleotide O 0 0.026866313070058823
changes O 0 0.011376919224858284
in O 0 0.012179598212242126
this O 0 0.020221833139657974
leukaemia B-Disease 1 0.9999995231628418
were O 0 0.03802427276968956
missense O 1 0.9776551723480225
mutations O 0 0.06983397156000137
. O 0 0.04836742579936981

These O 0 0.029823588207364082
clustered O 0 0.05319179967045784
in O 0 0.017170455306768417
the O 0 0.019446760416030884
region O 0 0.023863866925239563
corresponding O 0 0.017993604764342308
to O 0 0.01594664342701435
the O 0 0.028685258701443672
kinase O 1 0.9985054731369019
domain O 0 0.034127745777368546
, O 0 0.01483533438295126
which O 0 0.009439169429242611
is O 0 0.010067787952721119
highly O 0 0.01741429604589939
conserved O 0 0.02154001221060753
in O 0 0.017126092687249184
ATM O 1 0.970231831073761
- O 1 0.998831570148468
related O 0 0.027440274134278297
proteins O 0 0.02229459211230278
in O 0 0.018233278766274452
mouse O 0 0.05014970153570175
, O 0 0.031899355351924896
yeast O 0 0.07428863644599915
and O 0 0.04110923409461975
Drosophila O 0 0.10423366725444794
. O 0 0.05237488076090813

The O 0 0.04595842957496643
resulting O 0 0.05791127309203148
amino O 0 0.2147180736064911
- O 1 0.9999939203262329
acid O 0 0.44979193806648254
substitutions O 0 0.03365835174918175
are O 0 0.008679106831550598
predicted O 0 0.01913602650165558
to O 0 0.015006119385361671
interfere O 0 0.04087289422750473
with O 0 0.02563147433102131
ATP O 1 0.9999184608459473
binding O 0 0.051229339092969894
or O 0 0.030233442783355713
substrate O 0 0.06759633868932724
recognition O 0 0.05328826233744621
. O 0 0.04803602024912834

Two O 0 0.018192501738667488
of O 0 0.024597981944680214
seventeen O 0 0.07308808714151382
mutated O 1 0.9978907704353333
T B-Disease 1 0.9999980926513672
- I-Disease 1 0.9999977350234985
PLL I-Disease 1 0.9998735189437866
samples O 0 0.022124169394373894
had O 0 0.012404143810272217
a O 0 0.013266332447528839
previously O 0 0.017602046951651573
reported O 0 0.025364644825458527
A B-Disease 1 0.9985094666481018
- I-Disease 1 0.9999996423721313
T I-Disease 1 0.9999951124191284
allele O 0 0.13247734308242798
. O 0 0.04720129072666168

In O 0 0.03725028038024902
contrast O 0 0.040805235505104065
, O 0 0.023475026711821556
no O 0 0.018838336691260338
mutations O 0 0.019369198009371758
were O 0 0.009611595422029495
detected O 0 0.017356427386403084
in O 0 0.010132395662367344
the O 0 0.02019084244966507
p53 O 1 0.9878286123275757
gene O 0 0.022733202204108238
, O 0 0.012326987460255623
suggesting O 0 0.016010010614991188
that O 0 0.010469489730894566
this O 0 0.024212870746850967
tumour B-Disease 1 1.0
suppressor O 1 0.9999983310699463
is O 0 0.02460159920156002
not O 0 0.01359325647354126
frequently O 0 0.018633900210261345
altered O 0 0.024784261360764503
in O 0 0.01976136490702629
this O 0 0.028802767395973206
leukaemia B-Disease 1 0.9999984502792358
. O 0 0.06782840192317963

Occasional O 0 0.12544754147529602
missense O 0 0.3559291958808899
mutations O 0 0.05428668484091759
in O 0 0.023588771000504494
ATM O 0 0.13638688623905182
were O 0 0.010772176086902618
also O 0 0.010087715461850166
found O 0 0.011583159677684307
in O 0 0.01721831224858761
tumour B-Disease 1 1.0
DNA O 0 0.026923486962914467
from O 0 0.01627539098262787
patients O 0 0.03867702558636665
with O 0 0.017673010006546974
B B-Disease 1 0.9999867677688599
- I-Disease 1 0.9999616146087646
cell I-Disease 0 0.0948738232254982
non I-Disease 1 0.9955922961235046
- I-Disease 1 1.0
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 1.0
( O 1 0.7890327572822571
B B-Disease 1 0.9999909400939941
- I-Disease 1 0.9999223947525024
NHL I-Disease 0 0.08353667706251144
) O 0 0.014362767338752747
and O 0 0.012785895727574825
a O 0 0.029668642207980156
B B-Disease 1 0.9999518394470215
- I-Disease 1 0.9999651908874512
NHL I-Disease 1 0.941053569316864
cell O 0 0.07045954465866089
line O 0 0.06279869377613068
. O 0 0.04346354678273201

The O 0 0.0325358621776104
evidence O 0 0.01752934604883194
of O 0 0.013361018151044846
a O 0 0.014837468974292278
significant O 0 0.011666731908917427
proportion O 0 0.01699693687260151
of O 0 0.014201883226633072
loss O 1 0.8181442618370056
- O 1 0.9999865293502808
of O 0 0.3988003432750702
- O 1 0.999998927116394
function O 0 0.025493700057268143
mutations O 0 0.019047513604164124
and O 0 0.010559710673987865
a O 0 0.0153115289285779
complete O 0 0.020684869959950447
absence O 0 0.027778761461377144
of O 0 0.0157584547996521
the O 0 0.01885334402322769
normal O 0 0.022200800478458405
copy O 0 0.026419581845402718
of O 0 0.018308889120817184
ATM O 0 0.04196601361036301
in O 0 0.008855788968503475
the O 0 0.010789151303470135
majority O 0 0.01593885011970997
of O 0 0.02795855887234211
mutated O 1 0.9989767074584961
tumours B-Disease 1 0.9999998807907104
establishes O 1 0.9999610185623169
somatic O 1 0.9999004602432251
inactivation O 1 0.9999392032623291
of O 0 0.023470154032111168
this O 0 0.013571783900260925
gene O 0 0.017041299492120743
in O 0 0.00948459841310978
the O 0 0.019849281758069992
pathogenesis O 1 0.9991576671600342
of O 0 0.03467344865202904
sporadic B-Disease 1 0.9999339580535889
T I-Disease 1 0.9999998807907104
- I-Disease 1 0.9999996423721313
PLL I-Disease 1 0.9999740123748779
and O 0 0.023498795926570892
suggests O 0 0.021518642082810402
that O 0 0.01182452030479908
ATM O 0 0.05422751232981682
acts O 0 0.02625430002808571
as O 0 0.024332113564014435
a O 1 0.8729180693626404
tumour B-Disease 1 1.0
suppressor O 1 0.999996542930603
. O 0 0.06777846068143845

As O 0 0.03876129165291786
constitutional O 0 0.048229582607746124
DNA O 0 0.03220535069704056
was O 0 0.023553598672151566
not O 0 0.009918224066495895
available O 0 0.009155315347015858
, O 0 0.010886156931519508
a O 0 0.022656645625829697
putative O 1 0.9570320844650269
hereditary O 1 0.9999942779541016
predisposition O 1 0.9999983310699463
to O 1 0.99411940574646
T B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
PLL I-Disease 1 0.9999918937683105
will O 0 0.026321088895201683
require O 0 0.021545298397541046
further O 0 0.020366137847304344
investigation O 0 0.04127315804362297
. O 0 0.028394479304552078
. O 0 0.039837952703237534

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.9986876845359802
kinase O 1 0.9983686804771423
is O 0 0.01959172450006008
involved O 0 0.01343215350061655
in O 0 0.009405926801264286
the O 0 0.014443264342844486
modulation O 0 0.0281376875936985
of O 0 0.01679757423698902
the O 0 0.03925716131925583
Ca2 O 1 0.9999958276748657
+ O 1 0.9997238516807556
homeostasis O 1 0.9998672008514404
in O 0 0.3955112397670746
skeletal O 1 1.0
muscle O 1 0.9999991655349731
cells O 1 0.8538395166397095
. O 0 0.057594217360019684

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999988317489624
DM B-Disease 1 1.0
) O 0 0.02515420690178871
, O 0 0.0127067556604743
the O 0 0.01387165579944849
most O 0 0.019061317667365074
prevalent O 1 0.9999939203262329
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9298747181892395
adults O 1 0.9570406675338745
, O 0 0.023328673094511032
is O 0 0.014775658957660198
caused O 0 0.028494980186223984
by O 0 0.0194461140781641
( O 0 0.03538759425282478
CTG O 1 0.9999904632568359
) O 0 0.02837304398417473
n O 0 0.07401088625192642
- O 1 0.9551877975463867
repeat O 0 0.035290058702230453
expansion O 0 0.02269519865512848
in O 0 0.009727980010211468
a O 0 0.01570078171789646
gene O 0 0.019063729792833328
encoding O 0 0.018800392746925354
a O 0 0.024158868938684464
protein O 0 0.038363147526979446
kinase O 1 0.8469584584236145
( O 0 0.05896630138158798
DM B-Disease 1 1.0
protein O 0 0.1497511863708496
kinase O 1 0.9951747059822083
; O 0 0.03334066644310951
DMPK O 1 0.9999265670776367
) O 0 0.02281278371810913
and O 0 0.017435310408473015
involves O 0 0.024342766031622887
changes O 0 0.016077926382422447
in O 0 0.0224627498537302
cytoarchitecture O 1 0.9997898936271667
and O 0 0.061673298478126526
ion O 1 0.9986912608146667
homeostasis O 1 0.9978715181350708
. O 0 0.06577577441930771

To O 0 0.04598397761583328
obtain O 0 0.03794284164905548
clues O 0 0.02911706268787384
to O 0 0.014165705069899559
the O 0 0.01646972820162773
normal O 0 0.01917366124689579
biological O 0 0.020523041486740112
role O 0 0.023007651790976524
of O 0 0.021537303924560547
DMPK O 1 0.9999815225601196
in O 0 0.027854064479470253
cellular O 1 0.9923896193504333
ion O 1 0.9998503923416138
homeostasis O 1 0.9996776580810547
, O 0 0.017133334651589394
we O 0 0.009049232117831707
have O 0 0.005259637255221605
compared O 0 0.011055688373744488
the O 0 0.01919850893318653
resting O 1 0.9995669722557068
[ O 1 0.9969269633293152
Ca2 O 1 0.9999966621398926
+ O 1 0.9989302754402161
] O 0 0.051584940403699875
i O 0 0.02185206487774849
, O 0 0.013704139739274979
the O 0 0.015343453735113144
amplitude O 0 0.03024107590317726
and O 0 0.014396300539374352
shape O 0 0.024876508861780167
of O 0 0.02808736078441143
depolarization O 1 0.9999984502792358
- O 1 0.9999998807907104
induced O 1 0.9999998807907104
Ca2 O 1 0.9999994039535522
+ O 1 0.9999046325683594
transients O 1 0.9985711574554443
, O 0 0.017735136672854424
and O 0 0.010789802297949791
the O 0 0.011484176851809025
content O 0 0.011368433013558388
of O 0 0.017461346462368965
ATP O 1 0.9999903440475464
- O 1 0.9999890327453613
driven O 0 0.16812948882579803
ion O 0 0.25824829936027527
pumps O 0 0.05014250427484512
in O 0 0.01974971406161785
cultured O 1 0.9949986934661865
skeletal O 1 0.9999943971633911
muscle O 1 0.9988973140716553
cells O 0 0.02597571350634098
of O 0 0.019901176914572716
wild O 0 0.04294642060995102
- O 1 0.9997836947441101
type O 0 0.031600479036569595
and O 0 0.019133716821670532
DMPK O 1 0.9999234676361084
[ O 1 0.9784528613090515
- O 1 0.999998927116394
/ O 1 0.9999973773956299
- O 1 0.9999964237213135
] O 0 0.3281204104423523
knockout O 1 0.9282673597335815
mice O 0 0.07323632389307022
. O 0 0.044414181262254715

In O 0 0.040158454328775406
vitro O 0 0.10310337692499161
- O 1 0.9962221384048462
differentiated O 0 0.4137788712978363
DMPK O 1 0.9998927116394043
[ O 1 0.9689245820045471
- O 1 0.9999959468841553
/ O 1 0.999956488609314
- O 1 0.9998792409896851
] O 0 0.0679088607430458
myotubes O 0 0.10966577380895615
exhibit O 0 0.03658876195549965
a O 0 0.023167088627815247
higher O 0 0.029817814007401466
resting O 1 0.9998093247413635
[ O 1 0.9860039353370667
Ca2 O 1 0.9999567270278931
+ O 1 0.9908766150474548
] O 0 0.050597645342350006
i O 0 0.019187621772289276
than O 0 0.008709737099707127
do O 0 0.0119215352460742
wild O 0 0.031383443623781204
- O 1 0.9999438524246216
type O 0 0.25551337003707886
myotubes O 1 0.978540301322937
because O 0 0.013732023537158966
of O 0 0.012983530759811401
an O 0 0.01315609086304903
altered O 0 0.018137896433472633
open O 0 0.016724413260817528
probability O 0 0.013211117126047611
of O 0 0.01716306246817112
voltage O 1 0.7741414904594421
- O 1 0.9999366998672485
dependent O 0 0.06290330737829208
l O 1 0.9948008060455322
- O 1 0.9999308586120605
type O 1 0.8209264278411865
Ca2 O 1 0.9997082352638245
+ O 1 0.7629189491271973
and O 0 0.051721133291721344
Na O 1 0.9999810457229614
+ O 0 0.2286759316921234
channels O 0 0.05042458325624466
. O 0 0.04236707463860512

The O 0 0.06705578416585922
mutant O 1 0.712022066116333
myotubes O 1 0.9938048124313354
exhibit O 0 0.06363628804683685
smaller O 0 0.03163621947169304
and O 0 0.030348021537065506
slower O 0 0.07820431143045425
Ca2 O 1 0.9996463060379028
+ O 0 0.1076151579618454
responses O 0 0.02958117425441742
upon O 0 0.027001194655895233
triggering O 0 0.07079489529132843
by O 0 0.03365308418869972
acetylcholine O 1 0.9978808760643005
or O 0 0.035395748913288116
high O 1 0.8420670628547668
external O 1 0.8152145147323608
K O 1 0.9992566704750061
+ O 0 0.25943973660469055
. O 0 0.05412185564637184

In O 0 0.034151364117860794
addition O 0 0.027911586686968803
, O 0 0.016539575532078743
we O 0 0.011137111112475395
observed O 0 0.014123468659818172
that O 0 0.009693218395113945
these O 0 0.01433676015585661
Ca2 O 1 0.9999394416809082
+ O 1 0.9995567202568054
transients O 1 0.9982210993766785
partially O 0 0.04436776414513588
result O 0 0.014285720884799957
from O 0 0.010802813805639744
an O 0 0.014291603118181229
influx O 0 0.04553431272506714
of O 0 0.03407999873161316
extracellular O 1 0.9997772574424744
Ca2 O 1 0.9998944997787476
+ O 0 0.07662129402160645
through O 0 0.017649712041020393
the O 0 0.028398964554071426
l O 1 0.9993688464164734
- O 1 0.9999889135360718
type O 1 0.9851992130279541
Ca2 O 1 0.9999319314956665
+ O 1 0.5266407132148743
channel O 0 0.06166725233197212
. O 0 0.0434100516140461

Neither O 0 0.05522357299923897
the O 0 0.02842455916106701
content O 0 0.019616203382611275
nor O 0 0.019397923722863197
the O 0 0.012415708042681217
activity O 0 0.01788109354674816
of O 0 0.0288024190813303
Na O 1 0.9999995231628418
+ O 1 0.9997872710227966
/ O 1 0.9999231100082397
K O 1 0.9980716109275818
+ O 1 0.9139522314071655
ATPase O 1 0.9468191266059875
and O 0 0.0433049313724041
sarcoplasmic O 1 0.9999693632125854
reticulum O 1 0.9999856948852539
Ca2 O 1 0.9999969005584717
+ O 1 0.9999481439590454
- O 1 0.9999947547912598
ATPase O 1 0.9978870749473572
are O 0 0.015771793201565742
affected O 0 0.031243370845913887
by O 0 0.034587204456329346
DMPK O 1 0.9997815489768982
absence O 1 0.7532053589820862
. O 0 0.06309378892183304

In O 0 0.03625015541911125
conclusion O 0 0.039110660552978516
, O 0 0.021098164841532707
our O 0 0.019028212875127792
data O 0 0.01187897939234972
suggest O 0 0.015872390940785408
that O 0 0.01378527283668518
DMPK O 1 0.9996557235717773
is O 0 0.018281064927577972
involved O 0 0.01718711294233799
in O 0 0.015502184629440308
modulating O 0 0.18082372844219208
the O 0 0.01922188512980938
initial O 0 0.02146722935140133
events O 0 0.014925646595656872
of O 0 0.022327356040477753
excitation O 1 0.9967588782310486
- O 1 0.9999935626983643
contraction O 1 0.9889946579933167
coupling O 1 0.9580910205841064
in O 0 0.0487247072160244
skeletal O 1 0.9999984502792358
muscle O 1 0.9999077320098877
. O 0 0.04443516209721565
. O 0 0.048043616116046906

Constitutional O 0 0.19061177968978882
RB1 O 1 0.9999940395355225
- O 1 0.9999752044677734
gene O 0 0.0642172172665596
mutations O 0 0.03844667971134186
in O 0 0.022716090083122253
patients O 1 0.8242250084877014
with O 0 0.03474067896604538
isolated O 1 0.9849921464920044
unilateral B-Disease 1 0.9991123080253601
retinoblastoma I-Disease 1 0.9999977350234985
. O 0 0.08900147676467896

In O 0 0.03219965845346451
most O 0 0.023581868037581444
patients O 0 0.07383518666028976
with O 0 0.02281653694808483
isolated O 1 0.9210714101791382
unilateral B-Disease 1 0.9998540878295898
retinoblastoma I-Disease 1 1.0
, O 1 0.999546468257904
tumor B-Disease 1 0.9999998807907104
development O 0 0.09830154478549957
is O 0 0.019801821559667587
initiated O 0 0.05014513060450554
by O 0 0.024712566286325455
somatic O 1 0.9048428535461426
inactivation O 1 0.9976213574409485
of O 0 0.023931797593832016
both O 0 0.0188733097165823
alleles O 0 0.03799011558294296
of O 0 0.027078257873654366
the O 0 0.3792477548122406
RB1 O 1 0.9999984502792358
gene O 0 0.07615534216165543
. O 0 0.04763729125261307

However O 0 0.030352327972650528
, O 0 0.01761220023036003
some O 0 0.010095612145960331
of O 0 0.018889013677835464
these O 0 0.018285144120454788
patients O 1 0.9993559718132019
can O 0 0.03278499096632004
transmit O 1 0.9953953623771667
retinoblastoma B-Disease 1 0.9999994039535522
predisposition O 1 0.9999421834945679
to O 0 0.037518493831157684
their O 0 0.034058358520269394
offspring O 0 0.1473556011915207
. O 0 0.050538256764411926

To O 0 0.0324242003262043
determine O 0 0.023045197129249573
the O 0 0.020955286920070648
frequency O 0 0.01963508501648903
and O 0 0.011880535632371902
nature O 0 0.014159593731164932
of O 0 0.0169968418776989
constitutional O 1 0.8403717875480652
RB1 O 1 1.0
- O 1 0.9999979734420776
gene O 0 0.04013233631849289
mutations O 0 0.024468349292874336
in O 0 0.013471176847815514
patients O 0 0.11258549243211746
with O 0 0.01866728439927101
isolated O 1 0.9756118059158325
unilateral B-Disease 1 0.9999521970748901
retinoblastoma I-Disease 1 0.9999998807907104
, O 0 0.02569332905113697
we O 0 0.01368838269263506
analyzed O 0 0.018443109467625618
DNA O 0 0.019741972908377647
from O 0 0.02030685730278492
peripheral O 1 0.9996733665466309
blood O 1 0.990932822227478
and O 0 0.050153907388448715
from O 1 0.986957311630249
tumor B-Disease 1 1.0
tissue O 1 0.9999057054519653
. O 0 0.06096770986914635

The O 0 0.03829735890030861
analysis O 0 0.025132907554507256
of O 0 0.03377944231033325
tumors B-Disease 1 0.9999723434448242
from O 0 0.02678322233259678
54 O 0 0.05270454287528992
( O 0 0.02706035040318966
71 O 0 0.04535846412181854
% O 0 0.01948489621281624
) O 0 0.014030409045517445
of O 0 0.01852838322520256
76 O 0 0.198870450258255
informative O 0 0.3160155117511749
patients O 0 0.43454211950302124
showed O 0 0.02177637815475464
loss O 0 0.027285128831863403
of O 0 0.02537144161760807
constitutional O 1 0.8803253769874573
heterozygosity O 1 0.9999991655349731
( O 1 0.9940670728683472
LOH O 1 1.0
) O 0 0.0478440523147583
at O 0 0.05684639513492584
intragenic O 1 0.998630702495575
loci O 0 0.13494376838207245
. O 0 0.054274968802928925

Three O 0 0.0327407643198967
of O 0 0.03938628360629082
13 O 0 0.08048127591609955
uninformative O 1 0.999954342842102
patients O 1 0.9965037107467651
had O 0 0.04903719946742058
constitutional O 0 0.097098708152771
deletions O 0 0.2800971567630768
. O 0 0.06260174512863159

For O 0 0.03638559207320213
39 O 0 0.04564976319670677
randomly O 0 0.03242814168334007
selected O 0 0.04579984396696091
tumors B-Disease 1 0.9995535016059875
, O 0 0.03257282078266144
SSCP O 1 0.9998371601104736
, O 0 0.049504879862070084
hetero O 1 0.9999991655349731
- O 1 0.9999977350234985
duplex O 1 0.9998716115951538
analysis O 0 0.0212167426943779
, O 0 0.018421005457639694
sequencing O 0 0.025128202512860298
, O 0 0.016368918120861053
and O 0 0.017760099843144417
Southern O 0 0.043912243098020554
blot O 1 0.9686013460159302
analysis O 0 0.01908123306930065
were O 0 0.012177258729934692
used O 0 0.013040782883763313
to O 0 0.02000686712563038
identify O 0 0.03877522423863411
mutations O 0 0.048912230879068375
. O 0 0.039843808859586716

Mutations O 0 0.05933154374361038
were O 0 0.019070176407694817
detected O 0 0.029209835454821587
in O 0 0.014329599216580391
21 O 0 0.027318473905324936
( O 0 0.02079523354768753
91 O 0 0.04174919053912163
% O 0 0.019114315509796143
) O 0 0.014829162508249283
of O 0 0.02310197986662388
23 O 0 0.4721166789531708
tumors B-Disease 1 0.9999994039535522
with O 1 0.9291353821754456
LOH O 1 1.0
. O 0 0.08628204464912415

In O 0 0.0343429259955883
6 O 0 0.04351368173956871
( O 0 0.024020474404096603
38 O 0 0.02889389730989933
% O 0 0.014594643376767635
) O 0 0.011540533974766731
of O 0 0.014796831645071507
16 O 0 0.04843807592988014
tumors B-Disease 1 0.9999995231628418
without O 0 0.3437199294567108
LOH O 1 1.0
, O 0 0.026381757110357285
one O 0 0.02114170975983143
mutation O 0 0.03555271774530411
was O 0 0.02526211366057396
detected O 0 0.02718731015920639
, O 0 0.013645034283399582
and O 0 0.01101784035563469
in O 0 0.011145958676934242
9 O 0 0.024897916242480278
( O 0 0.01662871055305004
56 O 0 0.0241999514400959
% O 0 0.012660471722483635
) O 0 0.010267093777656555
of O 0 0.01312115229666233
the O 0 0.04135719686746597
tumors B-Disease 1 0.9999998807907104
without O 1 0.8864784240722656
LOH O 1 1.0
, O 0 0.03281416743993759
both O 0 0.022382454946637154
mutations O 0 0.030664600431919098
were O 0 0.017501233145594597
found O 0 0.025415003299713135
. O 0 0.03485959395766258

Thus O 0 0.03781290724873543
, O 0 0.02073938027024269
a O 0 0.01864214427769184
total O 0 0.013047848828136921
of O 0 0.01578546315431595
45 O 0 0.026456108316779137
mutations O 0 0.022065093740820885
were O 0 0.010428209789097309
identified O 0 0.021409349516034126
in O 0 0.0203082337975502
tumors B-Disease 1 0.9999765157699585
of O 0 0.06063240393996239
36 O 1 0.7800941467285156
patients O 1 0.9993676543235779
. O 0 0.05944642052054405

Thirty O 0 0.0838012546300888
- O 0 0.08990587294101715
nine O 0 0.01939219795167446
of O 0 0.017544930800795555
the O 0 0.02236698567867279
mutations O 0 0.03828359767794609
- O 1 0.9971169233322144
including O 0 0.013325962238013744
34 O 0 0.023295428603887558
small O 0 0.0169905424118042
mutations O 0 0.021018942818045616
, O 0 0.014051446691155434
2 O 0 0.02068750001490116
large O 0 0.021591652184724808
structural O 1 0.7595719695091248
alterations O 0 0.183965265750885
, O 0 0.019161343574523926
and O 0 0.019860072061419487
hypermethylation O 1 0.9997095465660095
in O 0 0.024172749370336533
3 O 1 0.8946292400360107
tumors O 1 0.9999998807907104
- O 1 0.9999570846557617
were O 0 0.013814306817948818
not O 0 0.010205147787928581
detected O 0 0.018673092126846313
in O 0 0.010577872395515442
the O 0 0.022209351882338524
corresponding O 0 0.06128758564591408
peripheral O 1 0.9999932050704956
blood O 1 0.9988191723823547
DNA O 0 0.07035069167613983
. O 0 0.05121808871626854

In O 0 0.03664906695485115
6 O 0 0.04556868597865105
( O 0 0.027373136952519417
17 O 0 0.026836568489670753
% O 0 0.015263873152434826
) O 0 0.01007687859237194
of O 0 0.010210201144218445
the O 0 0.016760192811489105
36 O 0 0.033937640488147736
patients O 1 0.9414012432098389
, O 0 0.017828963696956635
a O 0 0.023776762187480927
mutation O 0 0.037030987441539764
was O 0 0.022451169788837433
detected O 0 0.020876707509160042
in O 0 0.009916478767991066
constitutional O 0 0.023844648152589798
DNA O 0 0.019713187590241432
, O 0 0.010947509668767452
and O 0 0.008687487803399563
1 O 0 0.014111893251538277
of O 0 0.011687235906720161
these O 0 0.010477842763066292
mutations O 0 0.024003658443689346
is O 0 0.013580085709691048
known O 0 0.01687059924006462
to O 0 0.013181486167013645
be O 0 0.011495846323668957
associated O 0 0.017257513478398323
with O 0 0.020408831536769867
reduced O 0 0.05783836543560028
expressivity O 1 0.9995146989822388
. O 0 0.063475601375103

The O 0 0.039001669734716415
presence O 0 0.032090235501527786
of O 0 0.020610695704817772
a O 0 0.025312189012765884
constitutional O 0 0.049870919436216354
mutation O 0 0.18669262528419495
was O 0 0.022615693509578705
not O 0 0.010277421213686466
associated O 0 0.011615895666182041
with O 0 0.009378448128700256
an O 0 0.014076772145926952
early O 0 0.023580338805913925
age O 0 0.0604286789894104
at O 0 0.13747546076774597
treatment O 1 0.9997044205665588
. O 0 0.05191858857870102

In O 0 0.039374325424432755
1 O 0 0.05647967755794525
patient O 1 0.996026873588562
, O 0 0.04339599609375
somatic O 1 0.9975641965866089
mosaicism O 1 0.9999557733535767
was O 0 0.04212377220392227
demonstrated O 0 0.029048819094896317
by O 0 0.01634671352803707
molecular O 0 0.01817500963807106
analysis O 0 0.008635682985186577
of O 0 0.012651130557060242
DNA O 0 0.022586770355701447
and O 0 0.020411890000104904
RNA O 0 0.06316940486431122
from O 0 0.03856562450528145
peripheral O 1 0.9999183416366577
blood O 1 0.9956088662147522
. O 0 0.05863624066114426

In O 0 0.03714126721024513
2 O 0 0.04666284844279289
patients O 0 0.05319353938102722
without O 0 0.016171494498848915
a O 0 0.027355456724762917
detectable O 1 0.9843506813049316
mutation O 0 0.06244406849145889
in O 0 0.027514230459928513
peripheral O 1 0.9999942779541016
blood O 1 0.9996086955070496
, O 0 0.12592947483062744
mosaicism O 1 0.9999866485595703
was O 0 0.036316391080617905
suggested O 0 0.017582688480615616
because O 0 0.009385419078171253
1 O 0 0.013058813288807869
of O 0 0.01223672553896904
the O 0 0.023133184760808945
patients O 1 0.9999464750289917
showed O 1 0.9998835325241089
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.031450461596250534
the O 0 0.02536846324801445
other O 0 0.01596103049814701
later O 0 0.03118017315864563
developed O 0 0.048680055886507034
bilateral B-Disease 1 0.9298467636108398
retinoblastoma I-Disease 1 0.9999896287918091
. O 0 0.07292790710926056

In O 0 0.035270821303129196
conclusion O 0 0.03761754184961319
, O 0 0.02241065353155136
our O 0 0.021553879603743553
results O 0 0.014094113372266293
emphasize O 0 0.028274355456233025
that O 0 0.010095370002090931
the O 0 0.018955988809466362
manifestation O 1 0.9989911913871765
and O 0 0.030789444223046303
transmissibility O 1 0.9999852180480957
of O 1 0.7357383966445923
retinoblastoma B-Disease 1 0.9999992847442627
depend O 0 0.02317933179438114
on O 0 0.013443784788250923
the O 0 0.012311828322708607
nature O 0 0.012578432448208332
of O 0 0.010786464437842369
the O 0 0.013034701347351074
first O 0 0.020102255046367645
mutation O 0 0.02564140036702156
, O 0 0.011043522506952286
its O 0 0.010884247720241547
time O 0 0.010762292891740799
in O 0 0.00999109074473381
development O 0 0.016236212104558945
, O 0 0.012620201334357262
and O 0 0.010022745467722416
the O 0 0.011264814995229244
number O 0 0.009267278015613556
and O 0 0.011347363702952862
types O 0 0.014721723273396492
of O 0 0.02458999678492546
cells O 0 0.09201889485120773
that O 0 0.013051791116595268
are O 0 0.011837631464004517
affected O 0 0.02915593981742859
. O 0 0.02546081505715847
. O 0 0.038485120981931686

Hereditary B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
of I-Disease 0 0.12858130037784576
the I-Disease 1 0.6165956854820251
fifth I-Disease 1 0.9998534917831421
component I-Disease 1 0.9758982062339783
of I-Disease 0 0.035619549453258514
complement I-Disease 1 0.7403979897499084
in O 0 0.026560230180621147
man O 0 0.1995174139738083
. O 0 0.04168519377708435

I O 0 0.16465555131435394
. O 0 0.0722324550151825

Clinical O 1 0.9961722493171692
, O 0 0.06447349488735199
immunochemical O 1 0.9999096393585205
, O 0 0.037013232707977295
and O 0 0.030243201181292534
family O 0 0.049835123121738434
studies O 0 0.0363045372068882
. O 0 0.04093683883547783

The O 0 0.035496097058057785
first O 0 0.02447136491537094
recognized O 0 0.0323730893433094
human O 0 0.036362215876579285
kindred O 1 0.9999929666519165
with O 1 0.9824564456939697
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9698007702827454
the I-Disease 1 0.9636387228965759
fifth I-Disease 1 0.9999172687530518
component I-Disease 1 0.9730749726295471
of I-Disease 0 0.05384084954857826
complement I-Disease 1 0.998856782913208
( O 1 0.6703829169273376
C5 O 1 0.9999949932098389
) O 0 0.02710779942572117
is O 0 0.02273145318031311
described O 0 0.04005727171897888
. O 0 0.035624582320451736

The O 0 0.05338786914944649
proband O 1 0.9425907731056213
, O 0 0.019904926419258118
a O 0 0.020130371674895287
20 O 0 0.022146878764033318
- O 1 0.9442905783653259
year O 0 0.01879456825554371
- O 1 0.9720630645751953
old O 0 0.04387801140546799
black O 0 0.09558506309986115
female O 1 0.7333018779754639
with O 1 0.9993626475334167
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9998557567596436
age O 1 0.9820623993873596
11 O 0 0.039664264768362045
, O 0 0.030967241153120995
lacked O 1 0.9958237409591675
serum O 1 0.9999997615814209
hemolytic O 1 1.0
complement O 1 0.9996697902679443
activity O 0 0.1525038480758667
, O 0 0.02899942360818386
even O 0 0.026342105120420456
during O 0 0.052002809941768646
remission O 1 0.9999620914459229
. O 0 0.06554213911294937

C5 O 1 0.9997691512107849
was O 0 0.10177344083786011
undetectable O 1 0.9978518486022949
in O 0 0.02654697187244892
her O 0 0.06708502024412155
serum O 1 0.9994215965270996
by O 0 0.026480939239263535
both O 0 0.03190247714519501
immunodiffusion O 1 0.9999744892120361
and O 1 0.7485694289207458
hemolytic O 1 1.0
assays O 1 0.9274366497993469
. O 0 0.06365368515253067

Other O 0 0.03736059367656708
complement O 0 0.059081025421619415
components O 0 0.025329921394586563
were O 0 0.011821412481367588
normal O 0 0.023082144558429718
during O 0 0.03241998702287674
remission O 1 0.9999867677688599
of O 1 0.9965542554855347
lupus O 1 1.0
, O 1 0.7140767574310303
but O 0 0.042638495564460754
C1 O 1 0.9999998807907104
, O 0 0.4437613785266876
C4 O 1 0.9999967813491821
, O 0 0.1203584223985672
C2 O 1 0.9999995231628418
, O 0 0.03154204413294792
and O 0 0.04899650439620018
C3 O 1 0.9999996423721313
levels O 0 0.06836345046758652
fell O 1 0.8525940179824829
during O 0 0.26683875918388367
exacerbations O 1 0.9999929666519165
. O 0 0.07414870709180832

A O 0 0.058078471571207047
younger O 0 0.06090269610285759
half O 0 0.04246070235967636
- O 1 0.9999399185180664
sister O 1 0.7027742862701416
, O 0 0.01771751046180725
who O 0 0.0188448429107666
had O 0 0.01874985545873642
no O 0 0.0359070785343647
underlying O 1 0.9999972581863403
disease O 1 1.0
, O 1 0.9617252349853516
was O 1 0.5386336445808411
also O 0 0.013949674554169178
found O 0 0.012142776511609554
to O 0 0.01714048907160759
lack O 0 0.057534217834472656
immunochemically O 1 0.9999834299087524
detectable O 1 0.9998786449432373
C5 O 1 0.9999479055404663
. O 0 0.06785266846418381

By O 0 0.09856490045785904
hemolytic O 1 1.0
assay O 1 0.9971016049385071
, O 0 0.03659135103225708
she O 0 0.027914946898818016
exhibited O 0 0.041826602071523666
1 O 0 0.03642008453607559
- O 1 0.9942775368690491
2 O 0 0.01834208332002163
% O 0 0.008986877277493477
of O 0 0.010685356333851814
the O 0 0.020441515371203423
normal O 0 0.2512154281139374
serum O 1 0.9999980926513672
C5 O 1 0.9999959468841553
level O 0 0.03254399821162224
and O 0 0.017176320776343346
normal O 0 0.026711449027061462
concentrations O 0 0.03560313954949379
of O 0 0.021008336916565895
other O 0 0.02003176510334015
complement O 0 0.07823394984006882
components O 0 0.051108118146657944
. O 0 0.04133293405175209

C5 O 1 0.9999347925186157
levels O 0 0.0369894914329052
of O 0 0.020654533058404922
other O 0 0.01286914199590683
family O 0 0.022388851270079613
members O 0 0.015153496526181698
were O 0 0.009919414296746254
either O 0 0.014416773803532124
normal O 0 0.014886441640555859
or O 0 0.010779512114822865
approximately O 0 0.015141034498810768
half O 0 0.02364048920571804
- O 1 0.998708963394165
normal O 0 0.02302018739283085
, O 0 0.016532959416508675
consistent O 0 0.025692934170365334
with O 0 0.020971253514289856
autosomal O 1 0.9975383281707764
codominant O 1 0.9998942613601685
inheritance O 0 0.24213199317455292
of O 0 0.026271797716617584
the O 0 0.04710492119193077
gene O 0 0.42461276054382324
determining O 1 0.9776548147201538
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.11684483289718628

Normal O 1 0.8808386921882629
hemolytic O 1 0.9999997615814209
titers O 1 0.9990078806877136
were O 0 0.028535114601254463
restored O 0 0.04577610641717911
to O 0 0.01783389039337635
both O 0 0.02053612470626831
homozygous O 1 0.9014332294464111
C5 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
deficient I-Disease 1 0.9999991655349731
( O 0 0.33914753794670105
C5D B-Disease 1 0.9999991655349731
) O 0 0.0350055955350399
sera O 1 0.8033449053764343
by O 0 0.015830717980861664
addition O 0 0.01563660055398941
of O 0 0.022532356902956963
highly O 0 0.14690174162387848
purified O 1 0.9987586736679077
human O 0 0.4346117675304413
C5 O 1 0.9999619722366333
. O 0 0.061008747667074203

In O 0 0.04305112734436989
specific O 0 0.046541810035705566
C5 O 1 0.9999978542327881
titrations O 1 0.9997404217720032
, O 0 0.026035400107502937
however O 0 0.014876730740070343
, O 0 0.01418505609035492
it O 0 0.009902149438858032
was O 0 0.017830507829785347
noted O 0 0.014618436805903912
that O 0 0.008060634136199951
when O 0 0.011568749323487282
limited O 0 0.01279076561331749
amounts O 0 0.013594810850918293
of O 0 0.024259766563773155
C5 O 1 0.999836802482605
were O 0 0.01930905319750309
assayed O 0 0.04798571392893791
in O 0 0.010929123498499393
the O 0 0.015383538790047169
presence O 0 0.0202071201056242
of O 0 0.017872929573059082
low O 0 0.040644168853759766
dilutions O 1 0.9153822660446167
of O 0 0.029766028746962547
either O 0 0.0565464049577713
C5D B-Disease 1 1.0
serum O 1 0.9999972581863403
, O 0 0.031937941908836365
curving O 0 0.1452840268611908
rather O 0 0.017484670504927635
than O 0 0.013643275946378708
linear O 0 0.03841722011566162
dose O 1 0.9989646673202515
- O 1 0.9998928308486938
response O 0 0.03141919523477554
plots O 0 0.029875412583351135
were O 0 0.01290956698358059
consistently O 0 0.027924152091145515
obtained O 0 0.018782813102006912
, O 0 0.01744798570871353
suggesting O 0 0.025123927742242813
some O 0 0.017930254340171814
inhibitory O 0 0.08320656418800354
effect O 0 0.04588045924901962
. O 0 0.04193877428770065

Further O 0 0.04238215088844299
studies O 0 0.02354273945093155
suggested O 0 0.020894408226013184
that O 0 0.011930941604077816
low O 0 0.03333219885826111
dilutions O 1 0.9417718648910522
of O 0 0.052752941846847534
C5D B-Disease 1 1.0
serum O 1 0.9999858140945435
contain O 0 0.03610647842288017
a O 0 0.07524611800909042
factor O 1 0.9175875186920166
( O 0 0.023208769038319588
or O 0 0.015561557374894619
factors O 0 0.016243107616901398
) O 0 0.014991928823292255
interfering O 0 0.027131834998726845
at O 0 0.012606511823832989
some O 0 0.007035113405436277
step O 0 0.01731611043214798
in O 0 0.011347513645887375
the O 0 0.03167002648115158
hemolytic O 1 1.0
assay O 1 0.998960018157959
of O 1 0.5068216323852539
C5 O 1 0.9999935626983643
, O 0 0.02022252418100834
rather O 0 0.012035009451210499
than O 0 0.01071002334356308
a O 0 0.026814762502908707
true O 0 0.0862160474061966
C5 O 1 0.999998927116394
inhibitor O 1 0.9999924898147583
or O 0 0.06688466668128967
inactivator O 1 0.9976551532745361
. O 0 0.05622333660721779

Of O 0 0.06299442052841187
clinical O 1 0.9912394881248474
interest O 0 0.026840845122933388
are O 0 0.011479640379548073
( O 0 0.017385298386216164
a O 0 0.016910424456000328
) O 0 0.010899730958044529
the O 0 0.01245567575097084
documentation O 0 0.02901703491806984
of O 0 0.042788609862327576
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999978542327881
vasculitis B-Disease 1 1.0
, O 1 0.9999370574951172
and O 1 0.999962329864502
arthritis B-Disease 1 1.0
in O 0 0.1988012194633484
an O 0 0.2910730540752411
individual O 0 0.15305127203464508
lacking O 1 0.9999700784683228
C5 O 1 0.9999997615814209
( O 0 0.02069300040602684
and O 0 0.013242733664810658
its O 0 0.020246487110853195
biologic O 1 0.999954104423523
functions O 0 0.023603426292538643
) O 0 0.017551753669977188
, O 0 0.015762809664011
and O 0 0.016607843339443207
( O 0 0.022486433386802673
b O 0 0.06522643566131592
) O 0 0.01454306859523058
a O 0 0.016426336020231247
remarkable O 0 0.03285147622227669
propensity O 1 0.9984418749809265
to O 1 0.6118432879447937
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.08436661958694458
the O 1 0.7958809733390808
proband O 1 0.9999616146087646
, O 0 0.021571842953562737
even O 0 0.012803477235138416
during O 0 0.013133451342582703
periods O 0 0.020239271223545074
of O 0 0.020631946623325348
low O 1 0.9772633910179138
- O 1 0.999987006187439
dose O 1 0.8742901086807251
or O 0 0.021596573293209076
alternate O 0 0.042084794491529465
- O 1 0.999955415725708
day O 1 0.8020942211151123
corticosteroid O 1 0.9999977350234985
therapy O 1 0.9997476935386658
. O 0 0.06522007286548615

Other O 0 0.030205603688955307
observations O 0 0.029145676642656326
indicate O 0 0.01815863512456417
that O 0 0.009805222973227501
the O 0 0.01963067054748535
C5D B-Disease 1 0.9999500513076782
state O 0 0.01595422439277172
is O 0 0.015191330574452877
compatible O 0 0.031252503395080566
with O 0 0.01987745612859726
normal O 0 0.2744769752025604
coagulation O 1 0.9999994039535522
function O 0 0.02799011766910553
and O 0 0.015519959852099419
the O 0 0.017440784722566605
capacity O 0 0.022017059847712517
to O 0 0.0203412976115942
mount O 1 0.9757822751998901
a O 0 0.18215954303741455
neutrophilic O 1 0.9999992847442627
leukocytosis O 1 0.9999994039535522
during O 1 0.9998396635055542
pyogenic B-Disease 1 0.9999998807907104
infection I-Disease 1 0.9999997615814209
. O 0 0.07055055350065231
. O 0 0.06145293638110161

Susceptibility O 1 0.999053418636322
to O 1 0.9084170460700989
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.2447187453508377
twins O 1 0.9949313998222351
: O 0 0.020121276378631592
the O 0 0.013911408372223377
role O 0 0.02206462062895298
of O 0 0.022919325157999992
genes O 0 0.03692904859781265
, O 1 0.8441078662872314
HLA O 1 1.0
, O 0 0.029530484229326248
and O 0 0.021694596856832504
the O 0 0.03076455369591713
environment O 0 0.0470508374273777
. O 0 0.03836362436413765

OBJECTIVE O 0 0.08814089745283127
To O 0 0.024586422368884087
determine O 0 0.017704203724861145
the O 0 0.018377188593149185
relative O 0 0.02936987765133381
effects O 0 0.02737816795706749
of O 0 0.020714012905955315
genetic O 0 0.028604507446289062
and O 0 0.01970498450100422
environmental O 0 0.03553029149770737
factors O 0 0.018759265542030334
in O 0 0.01907804235816002
susceptibility O 1 0.9999396800994873
to O 1 0.9995157718658447
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999752044677734
AS B-Disease 1 0.9999405145645142
) O 0 0.045867037028074265
. O 0 0.04055652394890785

METHODS O 0 0.0585923008620739
Twins O 0 0.22213111817836761
with O 0 0.02217957377433777
AS B-Disease 0 0.03497907519340515
were O 0 0.009433267638087273
identified O 0 0.011266721412539482
from O 0 0.007012525573372841
the O 0 0.012194586917757988
Royal O 0 0.13991548120975494
National O 1 0.9691369533538818
Hospital O 1 0.9999998807907104
for O 1 0.9999336004257202
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9988627433776855
. O 0 0.07022055983543396

Clinical O 1 0.9831348657608032
and O 0 0.053750935941934586
radiographic O 1 0.998432457447052
examinations O 0 0.3022722005844116
were O 0 0.018163107335567474
performed O 0 0.024752773344516754
to O 0 0.018123626708984375
establish O 0 0.1008632704615593
diagnoses O 1 0.9999982118606567
, O 1 0.5166129469871521
and O 1 0.9947211742401123
disease O 1 1.0
severity O 1 0.9999988079071045
was O 1 0.9925537705421448
assessed O 0 0.03319762647151947
using O 0 0.012511426582932472
a O 0 0.019284334033727646
combination O 0 0.026089584454894066
of O 0 0.02317606285214424
validated O 0 0.06684393435716629
scoring O 0 0.051213812083005905
systems O 0 0.06074683740735054
. O 0 0.04207158088684082

HLA O 1 0.9999666213989258
typing O 0 0.13038606941699982
for O 0 0.0504579171538353
HLA O 1 0.9999998807907104
- O 1 0.9999632835388184
B27 O 1 0.999255359172821
, O 0 0.08220086991786957
HLA O 1 0.9999998807907104
- O 1 0.9999788999557495
B60 O 1 0.9960280656814575
, O 0 0.02666030451655388
and O 0 0.03465249761939049
HLA O 1 1.0
- O 1 0.9999974966049194
DR1 O 1 0.9998117089271545
was O 0 0.03238967806100845
performed O 0 0.026268737390637398
by O 0 0.01918911188840866
polymerase O 0 0.4657750725746155
chain O 0 0.03988633304834366
reaction O 0 0.022280730307102203
with O 0 0.01409266795963049
sequence O 0 0.021853672340512276
- O 1 0.9969646334648132
specific O 0 0.017066199332475662
primers O 0 0.06326590478420258
, O 0 0.01943400129675865
and O 0 0.021432144567370415
zygosity O 1 0.996130108833313
was O 0 0.039062339812517166
assessed O 0 0.04362308606505394
using O 0 0.028836306184530258
microsatellite O 1 0.7445612549781799
markers O 0 0.09079699218273163
. O 0 0.053541507571935654

Genetic O 0 0.06716380268335342
and O 0 0.028910761699080467
environmental O 0 0.04954653978347778
variance O 0 0.034546881914138794
components O 0 0.02178572490811348
were O 0 0.009936793707311153
assessed O 0 0.017709726467728615
with O 0 0.011954223737120628
the O 0 0.019837938249111176
program O 0 0.047438230365514755
Mx O 1 0.9999054670333862
, O 0 0.01610644906759262
using O 0 0.00911287497729063
data O 0 0.00790106225758791
from O 0 0.007733521983027458
this O 0 0.006645266432315111
and O 0 0.008770224638283253
previous O 0 0.01450364850461483
studies O 0 0.014604197815060616
of O 0 0.020142627879977226
twins O 1 0.9743894934654236
with O 0 0.03390717878937721
AS B-Disease 1 0.9826276898384094
. O 0 0.0498427078127861

RESULTS O 0 0.028761999681591988
Six O 0 0.019521547481417656
of O 0 0.02462960034608841
8 O 0 0.049683138728141785
monozygotic O 1 0.9992276430130005
( O 0 0.23726052045822144
MZ O 1 0.9999997615814209
) O 0 0.03891255334019661
twin O 1 0.8540387153625488
pairs O 0 0.029965195804834366
were O 0 0.023861955851316452
disease O 1 0.9999667406082153
concordant O 1 0.9995086193084717
, O 0 0.023512758314609528
compared O 0 0.014530758373439312
with O 0 0.010523047298192978
4 O 0 0.01599288545548916
of O 0 0.013907824642956257
15 O 0 0.02694019116461277
B27 O 1 0.9992749094963074
- O 1 0.9997376799583435
positive O 0 0.0438929907977581
dizygotic O 1 0.998788058757782
( O 0 0.06875637918710709
DZ O 1 0.9999983310699463
) O 0 0.036624129861593246
twin O 0 0.46860623359680176
pairs O 0 0.02988649718463421
( O 0 0.024388495832681656
27 O 0 0.030232099816203117
% O 0 0.019006645306944847
) O 0 0.012039353139698505
and O 0 0.00963883101940155
4 O 0 0.01601572148501873
of O 0 0.01802200824022293
32 O 0 0.0522875115275383
DZ O 1 0.9999991655349731
twin O 1 0.9967679977416992
pairs O 0 0.03225206956267357
overall O 0 0.03729085624217987
( O 0 0.023882903158664703
12 O 0 0.023792117834091187
. O 0 0.01618296094238758
5 O 0 0.027752399444580078
% O 0 0.027568692341446877
) O 0 0.030102616176009178
. O 0 0.033278197050094604

Nonsignificant O 1 0.9985356330871582
increases O 0 0.049417831003665924
in O 0 0.021427350118756294
similarity O 0 0.025958744809031487
with O 0 0.013906986452639103
regard O 0 0.022097621113061905
to O 0 0.016744349151849747
age O 0 0.3407639265060425
at O 1 0.9993689656257629
disease O 1 1.0
onset O 1 0.9999998807907104
and O 0 0.03309789299964905
all O 0 0.015096387825906277
of O 0 0.03121042624115944
the O 1 0.9966810345649719
disease O 1 0.9999998807907104
severity O 1 0.9999936819076538
scores O 0 0.05991804972290993
assessed O 0 0.025495074689388275
were O 0 0.0098339868709445
noted O 0 0.01670287922024727
in O 0 0.019022757187485695
disease O 1 0.999997615814209
- O 1 0.9999996423721313
concordant O 1 0.9999939203262329
MZ O 1 0.9999998807907104
twins O 1 0.7629801630973816
compared O 0 0.03674306347966194
with O 0 0.03892295062541962
concordant O 1 0.9997096657752991
DZ O 1 0.9999971389770508
twins O 1 0.9860936403274536
. O 0 0.07091318815946579

HLA O 1 0.9999998807907104
- O 1 0.999992847442627
B27 O 1 0.9990058541297913
and O 0 0.03303639218211174
B60 O 1 0.892788827419281
were O 0 0.013206268660724163
associated O 0 0.016537200659513474
with O 0 0.015043758787214756
the O 0 0.049830399453639984
disease O 1 0.9999978542327881
in O 0 0.04354943707585335
probands O 1 0.9999949932098389
, O 0 0.017564568668603897
and O 0 0.01106629241257906
the O 0 0.01339177880436182
rate O 0 0.021582281216979027
of O 0 0.0579671710729599
disease O 1 0.9999990463256836
concordance O 1 0.9998180270195007
was O 0 0.05856357142329216
significantly O 0 0.021953430026769638
increased O 0 0.023093190044164658
among O 0 0.050379056483507156
DZ O 1 0.9999996423721313
twin O 1 0.9736962914466858
pairs O 0 0.01984536647796631
in O 0 0.009325273334980011
which O 0 0.009121067821979523
the O 0 0.018408672884106636
co O 1 0.9997325539588928
- O 1 0.9999963045120239
twin O 1 0.9955987930297852
was O 0 0.03164476901292801
positive O 0 0.02278543822467327
for O 0 0.015673687681555748
both O 0 0.025835834443569183
B27 O 1 0.9980112314224243
and O 0 0.05733266845345497
DR1 O 1 0.9994491934776306
. O 0 0.055830176919698715

Additive O 1 0.9420256018638611
genetic O 0 0.062398750334978104
effects O 0 0.039936162531375885
were O 0 0.01511170994490385
estimated O 0 0.019201859831809998
to O 0 0.017683658748865128
contribute O 0 0.028858929872512817
97 O 0 0.04651613160967827
% O 0 0.017667248845100403
of O 0 0.01644052006304264
the O 0 0.023874342441558838
population O 0 0.026297282427549362
variance O 0 0.050689734518527985
. O 0 0.04396628960967064

CONCLUSION O 0 0.33210745453834534
Susceptibility O 1 0.9948326349258423
to O 0 0.028621964156627655
AS B-Disease 0 0.30008673667907715
is O 0 0.017481116577982903
largely O 0 0.021776476874947548
genetically O 0 0.020795980468392372
determined O 0 0.018461575731635094
, O 0 0.012430679053068161
and O 0 0.01084069348871708
the O 0 0.015136504545807838
environmental O 0 0.03650220111012459
trigger O 1 0.6758559942245483
for O 0 0.02121778205037117
the O 1 0.9537774324417114
disease O 1 0.9999997615814209
is O 0 0.10042912513017654
probably O 0 0.05632536858320236
ubiquitous O 1 0.8991866111755371
. O 0 0.04715513810515404

HLA O 1 0.9999998807907104
- O 1 0.9999786615371704
B27 O 1 0.9067171812057495
accounts O 0 0.022536031901836395
for O 0 0.012306389398872852
a O 0 0.016260206699371338
minority O 0 0.02245236560702324
of O 0 0.017656097188591957
the O 0 0.027824372053146362
overall O 1 0.9732836484909058
genetic O 1 0.7961289882659912
susceptibility O 1 0.9996117949485779
to O 0 0.040344055742025375
AS B-Disease 1 0.964970588684082
. O 0 0.04897608235478401

Cell O 0 0.12149563431739807
cycle O 0 0.09422759711742401
- O 1 0.9969947338104248
dependent O 0 0.051626820117235184
colocalization O 0 0.23712174594402313
of O 0 0.038063909858465195
BARD1 O 1 0.9999895095825195
and O 0 0.08345478028059006
BRCA1 O 1 0.9998986721038818
proteins O 0 0.03328116610646248
in O 0 0.020748116075992584
discrete O 0 0.04680371657013893
nuclear O 0 0.06659680604934692
domains O 0 0.07171214371919632
. O 0 0.04387928172945976

Germ O 1 0.9999216794967651
- O 1 0.9996792078018188
line O 0 0.05097753182053566
mutations O 0 0.025878649204969406
of O 0 0.01779911108314991
the O 0 0.03367048501968384
BRCA1 O 1 0.9999475479125977
gene O 0 0.0393761545419693
predispose O 0 0.07747402042150497
women O 0 0.018195578828454018
to O 0 0.013812560588121414
early O 0 0.03432832658290863
- O 1 1.0
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 1 0.7711533308029175
compromising O 1 0.9989687204360962
the O 0 0.029644092544913292
genes O 0 0.030912842601537704
presumptive O 1 0.9999563694000244
function O 0 0.02654462493956089
as O 0 0.024613482877612114
a O 0 0.4537911117076874
tumor B-Disease 1 0.9999996423721313
suppressor O 1 0.9999819993972778
. O 0 0.06302303820848465

Although O 0 0.029541637748479843
the O 0 0.029334265738725662
biochemical O 0 0.050597138702869415
properties O 0 0.03401295095682144
of O 0 0.04455360397696495
BRCA1 O 1 0.9999960660934448
polypeptides O 0 0.42798367142677307
are O 0 0.011860590428113937
not O 0 0.012040902860462666
understood O 0 0.02133975923061371
, O 0 0.013668227940797806
their O 0 0.012770130299031734
expression O 0 0.02689415216445923
pattern O 0 0.03169846162199974
and O 0 0.023668337613344193
subcellular O 0 0.09123338013887405
localization O 0 0.0522075816988945
suggest O 0 0.01702846586704254
a O 0 0.016203124076128006
role O 0 0.027142448350787163
in O 0 0.02298950031399727
cell O 1 0.9739440083503723
- O 1 0.9999691247940063
cycle O 0 0.08042501658201218
regulation O 0 0.0587986595928669
. O 0 0.04266054183244705

When O 0 0.0811736062169075
resting O 1 0.9998904466629028
cells O 0 0.09414784610271454
are O 0 0.01737009547650814
induced O 1 0.9788033366203308
to O 0 0.02383018098771572
proliferate O 0 0.38425642251968384
, O 0 0.01831851340830326
the O 0 0.02021789364516735
steady O 0 0.10767053067684174
- O 1 0.9659297466278076
state O 0 0.013865056447684765
levels O 0 0.018231751397252083
of O 0 0.021185770630836487
BRCA1 O 1 0.9719860553741455
increase O 0 0.016880502924323082
in O 0 0.015310673974454403
late O 0 0.04972507432103157
G1 O 1 0.9999372959136963
and O 0 0.017950953915715218
reach O 0 0.02303469367325306
a O 0 0.019570816308259964
maximum O 0 0.0278487466275692
during O 0 0.04248179867863655
S O 1 0.999451220035553
phase O 0 0.3522861897945404
. O 0 0.05441661179065704

Moreover O 0 0.05180085450410843
, O 0 0.021826913580298424
in O 0 0.021117646247148514
S O 1 0.9999052286148071
phase O 1 0.995309054851532
cells O 0 0.06588274985551834
, O 0 0.03659314289689064
BRCA1 O 1 0.9997681975364685
polypeptides O 0 0.07895942032337189
are O 0 0.017746182158589363
hyperphosphorylated O 1 0.6788473725318909
and O 0 0.026128621771931648
accumulate O 0 0.05392098054289818
into O 0 0.024589743465185165
discrete O 0 0.05163655802607536
subnuclear O 1 0.9962583780288696
foci O 1 0.9976776242256165
termed O 1 0.9805251955986023
" O 0 0.1329561024904251
BRCA1 O 1 0.9989135265350342
nuclear O 0 0.09426289051771164
dots O 0 0.10240703821182251
. O 0 0.05604185909032822

" O 0 0.17660312354564667
BRCA1 O 1 0.9993984699249268
associates O 0 0.1679462194442749
in O 0 0.024877464398741722
vivo O 0 0.06639768928289413
with O 0 0.019378988072276115
a O 0 0.0348796546459198
structurally O 1 0.8799371719360352
related O 0 0.04376664385199547
protein O 0 0.054490141570568085
termed O 1 0.7856018543243408
BARD1 O 1 0.9997583031654358
. O 0 0.0702885240316391

Here O 0 0.03982819616794586
we O 0 0.01669847033917904
show O 0 0.01542646437883377
that O 0 0.007636595983058214
the O 0 0.014189232140779495
steady O 0 0.05286170169711113
- O 1 0.9738837480545044
state O 0 0.013626371510326862
levels O 0 0.017028963193297386
of O 0 0.02132193185389042
BARD1 O 1 0.9999358654022217
, O 0 0.018950223922729492
unlike O 0 0.01791011169552803
those O 0 0.011305073276162148
of O 0 0.028255915269255638
BRCA1 O 1 0.9999901056289673
, O 0 0.02518492005765438
remain O 0 0.027176780626177788
relatively O 0 0.024761945009231567
constant O 0 0.047133393585681915
during O 0 0.06429784744977951
cell O 1 0.9708787798881531
cycle O 1 0.7218597531318665
progression O 1 0.9982507824897766
. O 0 0.06634937226772308

However O 0 0.04298566281795502
, O 0 0.03752222657203674
immunostaining O 1 0.854358971118927
revealed O 0 0.04154757037758827
that O 0 0.019857874140143394
BARD1 O 1 0.9926060438156128
resides O 0 0.0704023540019989
within O 0 0.028874849900603294
BRCA1 O 1 0.998372495174408
nuclear O 0 0.047953493893146515
dots O 0 0.045664772391319275
during O 0 0.02961745671927929
S O 1 0.9671518206596375
phase O 0 0.037258703261613846
of O 0 0.0192889254540205
the O 0 0.03132401779294014
cell O 1 0.8586550951004028
cycle O 0 0.05621965602040291
, O 0 0.015646139159798622
but O 0 0.011178209446370602
not O 0 0.009874864481389523
during O 0 0.021977322176098824
the O 0 0.04036556929349899
G1 O 1 0.9999849796295166
phase O 1 0.8069261908531189
. O 0 0.05354243144392967

Nevertheless O 0 0.10485390573740005
, O 0 0.06526272743940353
BARD1 O 1 0.9998385906219482
polypeptides O 0 0.09026181697845459
are O 0 0.013747005723416805
found O 0 0.01271519809961319
exclusively O 0 0.015471009537577629
in O 0 0.009719944559037685
the O 0 0.013498593121767044
nuclear O 0 0.021605059504508972
fractions O 0 0.02087818831205368
of O 0 0.013270297087728977
both O 0 0.020061153918504715
G1 O 1 0.999991774559021
- O 1 0.9999704360961914
and O 0 0.04158264398574829
S O 1 0.999997615814209
- O 1 0.9999971389770508
phase O 1 0.9821262955665588
cells O 0 0.05529892444610596
. O 0 0.04332423955202103

Therefore O 0 0.0531257726252079
, O 0 0.03689798340201378
progression O 1 0.9017226099967957
to O 0 0.03278772905468941
S O 1 0.9999294281005859
phase O 0 0.3248170018196106
is O 0 0.01711805909872055
accompanied O 0 0.029923254624009132
by O 0 0.012768019922077656
the O 0 0.0175656545907259
aggregation O 0 0.03973815590143204
of O 0 0.0237535759806633
nuclear O 0 0.05899263173341751
BARD1 O 1 0.9995686411857605
polypeptides O 0 0.09070148319005966
into O 0 0.043426014482975006
BRCA1 O 1 0.9894869327545166
nuclear O 0 0.07982759922742844
dots O 0 0.10134954750537872
. O 0 0.049863915890455246

This O 0 0.033376291394233704
cell O 0 0.0638478547334671
cycle O 0 0.07404296100139618
- O 1 0.9956364035606384
dependent O 0 0.044192079454660416
colocalization O 1 0.6614453792572021
of O 0 0.03785288333892822
BARD1 O 1 0.9999834299087524
and O 0 0.040687981992959976
BRCA1 O 1 0.998237133026123
indicates O 0 0.027716640383005142
a O 0 0.017950745299458504
role O 0 0.02243606373667717
for O 0 0.01642776094377041
BARD1 O 1 0.9998419284820557
in O 0 0.03316770866513252
BRCA1 O 1 0.9999966621398926
- O 1 0.9999995231628418
mediated O 1 0.9999939203262329
tumor B-Disease 1 0.9999998807907104
suppression O 1 0.9999954700469971
. O 0 0.07829397171735764

Ethnic O 0 0.059864725917577744
differences O 0 0.03183407709002495
in O 0 0.021487833932042122
the O 0 0.03858230262994766
HFE O 1 0.9998928308486938
codon O 1 0.5104958415031433
282 O 1 0.9127723574638367
( O 0 0.14072775840759277
Cys O 1 0.9999984502792358
/ O 1 0.9999932050704956
Tyr O 1 0.9999938011169434
) O 0 0.06628262251615524
polymorphism O 0 0.10593011975288391
. O 0 0.05115506425499916

Recent O 0 0.03951414301991463
studies O 0 0.019329603761434555
have O 0 0.009202685207128525
shown O 0 0.014761836268007755
that O 0 0.02036193758249283
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999998807907104
HH B-Disease 1 1.0
) O 0 0.3312903344631195
is O 0 0.016826514154672623
likely O 0 0.013118608854711056
to O 0 0.01056225411593914
be O 0 0.009598812088370323
caused O 0 0.018999433144927025
by O 0 0.01714787632226944
homozygosity O 1 0.9102700352668762
for O 0 0.018621277064085007
a O 0 0.02963797189295292
Cys282Tyr O 1 0.9988284707069397
mutation O 0 0.03506793826818466
in O 0 0.015988187864422798
the O 0 0.03290913254022598
HFE O 1 0.9999971389770508
gene O 0 0.05153825506567955
located O 0 0.04731779545545578
4 O 0 0.045851994305849075
. O 0 0.04008280858397484

5 O 0 0.08899962157011032
Mb O 1 0.991574227809906
telomeric O 1 0.9860534071922302
to O 0 0.07273653894662857
HLA O 1 0.9999998807907104
- O 1 0.9999642372131348
A O 0 0.18795178830623627
. O 0 0.052021950483322144

Population O 0 0.032768700271844864
studies O 0 0.020488619804382324
of O 0 0.020379088819026947
this O 0 0.01651928201317787
polymorphism O 0 0.04450960457324982
are O 0 0.009526084177196026
facilitated O 0 0.034145720303058624
by O 0 0.012688708491623402
the O 0 0.013899319805204868
fact O 0 0.012710566632449627
that O 0 0.008454336784780025
the O 0 0.01863802783191204
Cys282Tyr O 1 0.9999231100082397
mutation O 0 0.07974792271852493
creates O 0 0.05007845163345337
a O 0 0.04028768464922905
Rsal O 1 0.9985343217849731
restriction O 0 0.07301374524831772
site O 0 0.05518985912203789
. O 0 0.03949517756700516

We O 0 0.027922553941607475
have O 0 0.011820548214018345
studied O 0 0.01902354322373867
the O 0 0.02201162278652191
codon O 0 0.07398181408643723
282 O 1 0.5626202821731567
( O 0 0.2199602574110031
Cys O 1 0.9999996423721313
/ O 1 0.9999901056289673
Tyr O 1 0.9999779462814331
) O 0 0.04090428352355957
polymorphism O 0 0.049726806581020355
in O 0 0.016314832493662834
different O 0 0.010289778001606464
ethnic O 0 0.03281739726662636
groups O 0 0.03247234225273132
. O 0 0.04057196527719498

In O 0 0.03043467178940773
agreement O 0 0.02902178466320038
with O 0 0.017264921218156815
previous O 0 0.021469639614224434
observations O 0 0.027873970568180084
the O 0 0.03255632519721985
Tyr O 1 0.9999972581863403
allele O 0 0.14625583589076996
appeared O 0 0.026240408420562744
to O 0 0.013394903391599655
be O 0 0.010700428858399391
rare O 0 0.019703714177012444
or O 0 0.016074471175670624
absent O 0 0.0403650663793087
in O 0 0.020085850730538368
Asiatic O 1 0.9999738931655884
( O 0 0.02893197350203991
Indian O 0 0.032513245940208435
, O 0 0.022380683571100235
Chinese O 0 0.034423671662807465
) O 0 0.027421917766332626
populations O 0 0.03397546336054802
. O 0 0.0367460660636425

The O 0 0.04626772925257683
highest O 0 0.1151006668806076
allele O 0 0.11755058914422989
frequency O 0 0.031789831817150116
( O 0 0.021219857037067413
7 O 0 0.022822001948952675
. O 0 0.012560914270579815
5 O 0 0.01986679434776306
% O 0 0.01720520481467247
) O 0 0.015979917719960213
was O 0 0.020751362666487694
found O 0 0.015660863369703293
in O 0 0.01972740702331066
Swedes O 0 0.08758553117513657
. O 0 0.0490562804043293

Saamis O 1 0.9944920539855957
( O 0 0.04703009873628616
2 O 0 0.03501441702246666
% O 0 0.022554047405719757
) O 0 0.01906067691743374
and O 0 0.01998026669025421
Mordvinians O 1 0.9996988773345947
( O 0 0.024220330640673637
1 O 0 0.024354856461286545
. O 0 0.01285374816507101
8 O 0 0.022316254675388336
% O 0 0.01805841363966465
) O 0 0.01522186491638422
had O 0 0.01511302962899208
significantly O 0 0.018639713525772095
lower O 0 0.022318491712212563
frequencies O 0 0.016434233635663986
of O 0 0.02037726901471615
the O 0 0.04301169142127037
Tyr O 1 0.9999908208847046
allele O 0 0.4629618227481842
. O 0 0.05817693471908569

Comparisons O 0 0.0738808885216713
with O 0 0.03260527923703194
allele O 0 0.06234491616487503
frequencies O 0 0.021130681037902832
based O 0 0.015329346992075443
on O 0 0.01740199699997902
prevalence O 1 0.5898870229721069
estimates O 0 0.026362024247646332
of O 0 0.04069741815328598
HH B-Disease 1 1.0
showed O 0 0.031797364354133606
some O 0 0.012852749787271023
disagreements O 0 0.03736063092947006
with O 0 0.01611541397869587
the O 0 0.02802838198840618
RFLP O 1 0.9990122318267822
data O 0 0.018390974029898643
, O 0 0.01984071172773838
particularly O 0 0.023724494501948357
in O 0 0.02293906733393669
Finns O 0 0.13423851132392883
. O 0 0.04865594953298569

The O 0 0.047020815312862396
newly O 0 0.0983390063047409
described O 0 0.09233200550079346
HFE O 1 0.9999922513961792
marker O 1 0.9281127452850342
provides O 0 0.030506256967782974
a O 0 0.01923617534339428
new O 0 0.017818337306380272
approach O 0 0.015348571352660656
to O 0 0.010159117169678211
the O 0 0.014085608534514904
screening O 0 0.06587714701890945
of O 0 0.1384112685918808
HH B-Disease 1 1.0
as O 0 0.024010729044675827
well O 0 0.01309582032263279
as O 0 0.010893573984503746
studies O 0 0.009033579379320145
of O 0 0.010476907715201378
the O 0 0.014707439579069614
relationship O 0 0.024461744353175163
between O 0 0.02055148221552372
the O 0 0.04687123745679855
HFE O 1 0.9999997615814209
Tyr O 1 0.9999990463256836
allele O 1 0.8781221508979797
and O 0 0.03513602167367935
different O 0 0.028329962864518166
disorders O 1 0.9999982118606567
including O 1 0.9827167987823486
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9998195767402649
dominant I-Disease 1 0.9999759197235107
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
associated O 0 0.05103436857461929
with O 0 0.02586241625249386
a O 0 0.03336452320218086
missense O 0 0.09920971095561981
mutation O 0 0.04841148108243942
encoding O 0 0.04214451462030411
Gly23 O 1 0.9997422099113464
- O 1 0.9999957084655762
- O 1 0.9999936819076538
> O 1 0.994575023651123
Val O 1 0.9934612512588501
in O 0 0.043589912354946136
neurophysin O 1 0.9998300075531006
II O 1 0.9999762773513794
. O 0 0.07634621113538742

Autosomal B-Disease 1 0.9994811415672302
dominant I-Disease 1 0.9999392032623291
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9983489513397217
ADNDI B-Disease 1 0.9999994039535522
) O 0 0.021374650299549103
is O 0 0.015450304374098778
an O 0 0.286613792181015
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999942779541016
by O 1 0.9993550181388855
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.9981903433799744
the O 1 0.9992302656173706
magnocellular O 1 0.9999998807907104
neurons O 0 0.08218522369861603
of O 0 0.023993074893951416
the O 0 0.0644688680768013
hypothalamus O 1 0.999632716178894
leading O 0 0.10192626714706421
to O 0 0.02161327749490738
decreased O 0 0.03192400187253952
ability O 0 0.016201114282011986
to O 0 0.011658146977424622
produce O 0 0.01406859327107668
the O 0 0.027677180245518684
hormone O 1 0.9999003410339355
arginine O 1 0.9998664855957031
vasopressin O 1 0.9999772310256958
( O 0 0.39362579584121704
AVP O 1 0.99998939037323
) O 0 0.05148511379957199
. O 0 0.04666442796587944

Affected O 0 0.06831562519073486
individuals O 0 0.022223105654120445
are O 0 0.011588849127292633
not O 0 0.018024595454335213
symptomatic O 1 0.9999971389770508
at O 0 0.12191042304039001
birth O 1 0.8476080298423767
, O 0 0.017817869782447815
but O 0 0.014179389923810959
usually O 0 0.021866852417588234
develop O 1 0.8682699799537659
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
at O 1 0.6602124571800232
1 O 0 0.11721762269735336
- O 1 0.9998555183410645
6 O 0 0.05517583712935448
yr O 1 0.9956570863723755
of O 0 0.0396672748029232
age O 0 0.059192195534706116
. O 0 0.04807543754577637

The O 0 0.04873284697532654
genetic O 0 0.04322359338402748
locus O 0 0.06923655420541763
of O 0 0.02587534673511982
the O 0 0.05259924754500389
disease O 1 0.9999803304672241
is O 0 0.020684048533439636
the O 0 0.03636251017451286
AVP O 1 0.9999998807907104
- O 1 0.9999985694885254
neurophysin O 1 0.9999855756759644
II O 1 0.9999984502792358
( O 0 0.0919366404414177
NPII O 1 0.99998939037323
) O 0 0.022771699354052544
gene O 0 0.019311897456645966
, O 0 0.012694772332906723
and O 0 0.013458242639899254
mutations O 0 0.022022249177098274
that O 0 0.01353954616934061
cause O 1 0.9957306981086731
ADNDI B-Disease 1 0.9999979734420776
have O 0 0.01114384550601244
been O 0 0.010151372291147709
found O 0 0.007272128015756607
in O 0 0.006135733798146248
both O 0 0.007657108828425407
the O 0 0.013870298862457275
signal O 0 0.02621733956038952
peptide O 0 0.0261751227080822
of O 0 0.013041016645729542
the O 0 0.024252209812402725
prepro O 1 0.9999532699584961
- O 1 0.9999991655349731
AVP O 1 0.9999994039535522
- O 1 0.9999958276748657
NPII O 1 0.999983549118042
precursor O 0 0.30977994203567505
and O 0 0.024832816794514656
within O 0 0.030810777097940445
NPII O 1 0.9998095631599426
itself O 0 0.06378170102834702
. O 0 0.043436650186777115

An O 0 0.0511111356317997
affected O 0 0.05747514218091965
girl O 0 0.43916869163513184
who O 0 0.031123250722885132
presented O 0 0.028369572013616562
at O 0 0.020705830305814743
9 O 0 0.0235578790307045
months O 0 0.01599736511707306
of O 0 0.01592971943318844
age O 0 0.024471228942275047
and O 0 0.01469021663069725
her O 0 0.04429281875491142
similarly O 0 0.0412931814789772
affected O 0 0.05057641863822937
younger O 1 0.977286696434021
brother O 1 0.9984267950057983
and O 0 0.023218240588903427
father O 1 0.7315666675567627
were O 0 0.011438515037298203
all O 0 0.010140127502381802
found O 0 0.0096274483948946
to O 0 0.008400297723710537
have O 0 0.006248426157981157
a O 0 0.015232520177960396
novel O 0 0.03341001644730568
missense O 0 0.0794191062450409
mutation O 0 0.043896518647670746
( O 0 0.029145795851945877
G1758 O 1 0.9998118281364441
- O 1 0.9999990463256836
- O 1 0.999998927116394
> O 1 0.9995524287223816
T O 1 0.9661857485771179
) O 0 0.01775568351149559
encoding O 0 0.017665768042206764
the O 0 0.015931041911244392
amino O 0 0.027527328580617905
acid O 0 0.04372269660234451
substitution O 0 0.057211101055145264
Gly23 O 1 0.9997993111610413
- O 1 0.999997615814209
- O 1 0.9999954700469971
> O 1 0.9972655773162842
Val O 1 0.9989332556724548
within O 0 0.055498912930488586
NPII O 1 0.9994661211967468
. O 0 0.06867564469575882

The O 0 0.06544754654169083
mutation O 0 0.06893599778413773
was O 0 0.038048144429922104
confirmed O 0 0.029199639335274696
by O 0 0.027943143621087074
restriction O 0 0.06500290334224701
endonuclease O 1 0.7935301065444946
analysis O 0 0.038369085639715195
. O 0 0.03868057206273079

A O 0 0.3166826367378235
T1 O 1 0.999984622001648
- O 1 0.9994675517082214
weighted O 0 0.06656800210475922
magnetic O 0 0.04484178498387337
resonance O 0 0.040738608688116074
imaging O 0 0.03348984569311142
of O 0 0.015481298789381981
the O 0 0.030760450288653374
fathers O 1 0.9998175501823425
pituitary O 1 0.9999997615814209
gland O 1 0.9999943971633911
demonstrates O 1 0.6790552735328674
an O 0 0.07485251873731613
attenuated O 1 0.9999977350234985
posterior O 1 0.9999964237213135
pituitary O 1 0.9999997615814209
bright O 1 0.999681830406189
spot O 1 0.8330696225166321
. O 0 0.060466453433036804

This O 0 0.04252238571643829
mutation O 0 0.09974973648786545
may O 0 0.017848772928118706
be O 0 0.009446792304515839
valuable O 0 0.015213698148727417
for O 0 0.010698813013732433
developing O 0 0.020693421363830566
models O 0 0.018714718520641327
of O 0 0.029585566371679306
dominantly B-Disease 1 0.9999997615814209
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.04714477062225342
as O 0 0.014748666435480118
the O 0 0.013894503004848957
early O 0 0.015665316954255104
age O 0 0.019430510699748993
of O 0 0.032087985426187515
onset O 1 1.0
of O 1 0.9999364614486694
symptoms O 1 1.0
suggests O 1 0.5091683268547058
that O 0 0.014400461688637733
this O 0 0.015769263729453087
mutation O 0 0.047317344695329666
may O 0 0.01510792225599289
be O 0 0.011218401603400707
particularly O 0 0.01994118094444275
deleterious O 0 0.06839848309755325
to O 0 0.022140542045235634
the O 0 0.046162933111190796
magnocellular O 1 0.9999942779541016
neuron O 1 0.9990729093551636
. O 0 0.036164481192827225
. O 0 0.04116023704409599

Frequent O 0 0.11032120138406754
inactivation O 1 0.9969465136528015
of O 0 0.2291705459356308
PTEN O 1 0.9999996423721313
/ O 1 0.9999932050704956
MMAC1 O 1 0.9999974966049194
in O 0 0.21147209405899048
primary O 1 0.999997615814209
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9032167792320251

Sporadic B-Disease 1 0.9999948740005493
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.0495317243039608
the O 0 0.02121049351990223
most O 0 0.01779695227742195
common O 1 0.7040027379989624
male B-Disease 1 0.9999842643737793
cancer I-Disease 1 0.9999996423721313
in O 0 0.014956804923713207
the O 0 0.01902739889919758
Western O 0 0.02768130600452423
world O 0 0.0244614165276289
, O 0 0.012082170695066452
yet O 0 0.009016239084303379
many O 0 0.005500179249793291
of O 0 0.009395310655236244
the O 0 0.016839617863297462
major O 0 0.040918804705142975
genetic O 0 0.01962774246931076
events O 0 0.010973929427564144
involved O 0 0.01134493574500084
in O 0 0.010046154260635376
the O 0 0.018465228378772736
progression O 1 0.9986615180969238
of O 0 0.024456990882754326
this O 0 0.020726360380649567
often O 0 0.04564444720745087
fatal O 1 0.9999997615814209
cancer B-Disease 1 0.9999998807907104
remain O 0 0.19214831292629242
to O 0 0.03123129904270172
be O 0 0.027229690924286842
elucidated O 1 0.6788807511329651
. O 0 0.04720769822597504

Numerous O 0 0.08602016419172287
cytogenetic O 1 0.9981299042701721
and O 0 0.05130750313401222
allelotype O 1 0.9997331500053406
studies O 0 0.024073204025626183
have O 0 0.012042955495417118
reported O 0 0.02098361775279045
frequent O 0 0.033217448741197586
loss O 0 0.03146093338727951
of O 0 0.03022790513932705
heterozygosity O 1 0.9998916387557983
on O 0 0.042440760880708694
chromosomal O 1 0.9993734955787659
arm O 1 0.9988887906074524
10q O 1 0.999479353427887
in O 0 0.053637247532606125
sporadic B-Disease 1 0.9999988079071045
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9693117141723633

Deletion O 0 0.17697927355766296
mapping O 0 0.06264130026102066
studies O 0 0.02255553938448429
have O 0 0.01192542351782322
unambiguously O 0 0.046990759670734406
identified O 0 0.020680775865912437
a O 0 0.016649365425109863
region O 0 0.02415025793015957
of O 0 0.025005748495459557
chromosome O 0 0.24486269056797028
10q23 O 1 0.9772736430168152
to O 0 0.01706896722316742
be O 0 0.011046168394386768
the O 0 0.015414091758430004
minimal O 0 0.0297078937292099
area O 0 0.025439633056521416
of O 0 0.026852702721953392
loss O 0 0.43566879630088806
. O 0 0.048814453184604645

A O 0 0.05846269056200981
new O 0 0.06016195937991142
tumor B-Disease 1 0.9999994039535522
suppressor O 1 0.9999935626983643
gene O 0 0.05033034458756447
, O 0 0.04199286922812462
PTEN O 1 0.9999984502792358
/ O 1 0.9999915361404419
MMAC1 O 1 0.9999938011169434
, O 0 0.024440424516797066
was O 0 0.02671516127884388
isolated O 0 0.03238929808139801
recently O 0 0.018747922033071518
at O 0 0.011752273887395859
this O 0 0.007371461018919945
region O 0 0.016685189679265022
of O 0 0.02185186930000782
chromosome O 1 0.7492687106132507
10q23 O 1 0.9991723299026489
and O 0 0.017338473349809647
found O 0 0.010972832329571247
to O 0 0.010950236581265926
be O 0 0.010531261563301086
inactivated O 0 0.05000130459666252
by O 0 0.014272713102400303
mutation O 0 0.02532784827053547
in O 0 0.018621724098920822
three O 1 0.5307179093360901
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.999967098236084
lines O 0 0.07496844232082367
. O 0 0.048265598714351654

We O 0 0.03753992170095444
screened O 0 0.11043175309896469
80 O 1 0.9060586094856262
prostate B-Disease 1 1.0
tumors I-Disease 1 0.9999997615814209
by O 0 0.06225867196917534
microsatellite O 1 0.9973015785217285
analysis O 0 0.020677028223872185
and O 0 0.016235733404755592
found O 0 0.02012369967997074
chromosome O 0 0.05537504702806473
10q23 O 1 0.9171431660652161
to O 0 0.01834753528237343
be O 0 0.014858252368867397
deleted O 0 0.03378569334745407
in O 0 0.01729346439242363
23 O 0 0.04059619456529617
cases O 0 0.037848565727472305
. O 0 0.04601168632507324

We O 0 0.03711450472474098
then O 0 0.026942335069179535
proceeded O 0 0.03539484739303589
with O 0 0.014451899565756321
sequence O 0 0.0136356670409441
analysis O 0 0.007818203419446945
of O 0 0.010250488296151161
the O 0 0.01887301541864872
entire O 0 0.08757348358631134
PTEN O 1 0.9999997615814209
/ O 1 0.9999949932098389
MMAC1 O 1 0.9999964237213135
coding O 0 0.0837038978934288
region O 0 0.027791615575551987
and O 0 0.015471024438738823
tested O 0 0.024920744821429253
for O 0 0.014488961547613144
homozygous O 0 0.04822371155023575
deletion O 0 0.04527079313993454
with O 0 0.017489053308963776
new O 0 0.03268434852361679
intragenic O 1 0.9998723268508911
markers O 0 0.04369897022843361
in O 0 0.0124735776335001
these O 0 0.009113900363445282
23 O 0 0.022231604903936386
cases O 0 0.018289286643266678
with O 0 0.023195404559373856
10q23 O 1 0.9995793700218201
loss O 0 0.46796372532844543
of O 0 0.10861751437187195
heterozygosity O 1 0.9999680519104004
. O 0 0.06864778697490692

The O 0 0.036971986293792725
identification O 0 0.027638541534543037
of O 0 0.016028570011258125
the O 0 0.021007463335990906
second O 0 0.048495762050151825
mutational O 1 0.999117910861969
event O 0 0.02734270878136158
in O 0 0.012971925549209118
10 O 0 0.015711046755313873
( O 0 0.015670066699385643
43 O 0 0.028436578810214996
% O 0 0.024188175797462463
) O 0 0.03477801755070686
tumors B-Disease 1 0.9999836683273315
establishes O 1 0.9999387264251709
PTEN O 1 0.9999998807907104
/ O 1 0.9999748468399048
MMAC1 O 1 0.9996851682662964
as O 0 0.022932078689336777
a O 0 0.024759111925959587
main O 0 0.03855958208441734
inactivation O 1 0.9387311935424805
target O 0 0.020876707509160042
of O 0 0.019637489691376686
10q O 1 0.9874956011772156
loss O 0 0.11480402201414108
in O 0 0.03982086852192879
sporadic B-Disease 1 0.9999992847442627
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7747015953063965
. O 0 0.052981939166784286

Risk O 0 0.35193994641304016
reversals O 0 0.13243889808654785
in O 0 0.030081961303949356
predictive O 0 0.10731928050518036
testing O 0 0.08393316715955734
for O 1 0.9086266160011292
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.6381148099899292

The O 0 0.03312951326370239
first O 0 0.027644233778119087
predictive O 0 0.04511492699384689
testing O 0 0.033946692943573
for O 0 0.30119097232818604
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9986802935600281
HD B-Disease 1 0.9999662637710571
) O 0 0.021761292591691017
was O 0 0.0191202349960804
based O 0 0.01390575896948576
on O 0 0.0104862404987216
analysis O 0 0.009954133071005344
of O 0 0.015796981751918793
linked O 0 0.049410078674554825
polymorphic O 1 0.9936017394065857
DNA O 0 0.03828383609652519
markers O 0 0.03354929760098457
to O 0 0.013784482143819332
estimate O 0 0.012994117103517056
the O 0 0.01285227295011282
likelihood O 0 0.024814989417791367
of O 0 0.0226121935993433
inheriting O 1 0.961887001991272
the O 0 0.0427049845457077
mutation O 0 0.08077647536993027
for O 0 0.04123830422759056
HD B-Disease 1 0.9968884587287903
. O 0 0.055530671030282974

Limits O 0 0.05384795740246773
to O 0 0.02451395057141781
accuracy O 0 0.026879211887717247
included O 0 0.022511407732963562
recombination O 0 0.0395437516272068
between O 0 0.015810776501893997
the O 0 0.020942088216543198
DNA O 0 0.025375256314873695
markers O 0 0.027227818965911865
and O 0 0.012704728171229362
the O 0 0.01967019774019718
mutation O 0 0.04995841160416603
, O 0 0.02248811163008213
pedigree O 1 0.5939499139785767
structure O 0 0.027646059170365334
, O 0 0.014909717254340649
and O 0 0.011952241882681847
whether O 0 0.013052312657237053
DNA O 0 0.019889475777745247
samples O 0 0.01499507762491703
were O 0 0.009668809361755848
available O 0 0.011690860614180565
from O 0 0.016144273802638054
family O 0 0.032342568039894104
members O 0 0.03801610693335533
. O 0 0.043280236423015594

With O 0 0.03222779929637909
direct O 0 0.024971861392259598
tests O 0 0.016485219821333885
for O 0 0.015396647155284882
the O 0 0.03105750121176243
HD B-Disease 1 0.9999914169311523
mutation O 0 0.07605472952127457
, O 0 0.017553366720676422
we O 0 0.010683435946702957
have O 0 0.00792341586202383
assessed O 0 0.01706189475953579
the O 0 0.01211249828338623
accuracy O 0 0.015554801560938358
of O 0 0.013152104802429676
results O 0 0.012492929585278034
obtained O 0 0.015620850957930088
by O 0 0.020853405818343163
linkage O 0 0.18772979080677032
approaches O 0 0.03597122058272362
when O 0 0.02170366793870926
requested O 0 0.02689635567367077
to O 0 0.015085275284945965
do O 0 0.012263146229088306
so O 0 0.010133002884685993
by O 0 0.013237139210104942
the O 0 0.02373901754617691
test O 0 0.039293233305215836
individuals O 0 0.029894564300775528
. O 0 0.0423116534948349

For O 0 0.03399406746029854
six O 0 0.02851456217467785
such O 0 0.018672257661819458
individuals O 0 0.018431363627314568
, O 0 0.017686182633042336
there O 0 0.013342662714421749
was O 0 0.024994004517793655
significant O 0 0.02230987325310707
disparity O 0 0.3101341426372528
between O 0 0.024927739053964615
the O 0 0.03244302421808243
tests O 0 0.04182221740484238
. O 0 0.04045335575938225

Three O 0 0.03343430534005165
went O 0 0.034488022327423096
from O 0 0.02298242598772049
a O 0 0.030769789591431618
decreased O 1 0.6651222705841064
risk O 0 0.09010785073041916
to O 0 0.016977127641439438
an O 0 0.021589305251836777
increased O 0 0.2097538262605667
risk O 1 0.959723711013794
, O 0 0.014052562415599823
while O 0 0.010361358523368835
in O 0 0.008611219003796577
another O 0 0.014515920542180538
three O 0 0.013503902591764927
the O 0 0.027165930718183517
risk O 1 0.9498614072799683
was O 0 0.42933374643325806
decreased O 1 0.7245543599128723
. O 0 0.04772533103823662

Knowledge O 0 0.04286450520157814
of O 0 0.023810241371393204
the O 0 0.02658967673778534
potential O 0 0.026700930669903755
reasons O 0 0.017302770167589188
for O 0 0.01147511787712574
these O 0 0.007463998626917601
changes O 0 0.009638375602662563
in O 0 0.009284283965826035
results O 0 0.010643920861184597
and O 0 0.010911602526903152
impact O 0 0.015498816035687923
of O 0 0.014816446229815483
these O 0 0.01276449766010046
risk O 0 0.3256961405277252
reversals O 1 0.9808180332183838
on O 0 0.021621856838464737
both O 0 0.021601993590593338
patients O 1 0.9984527826309204
and O 0 0.02033221907913685
the O 0 0.07483673840761185
counseling O 1 0.9999912977218628
team O 0 0.030539309605956078
can O 0 0.012270789593458176
assist O 0 0.024732688441872597
in O 0 0.010684982873499393
the O 0 0.013190940953791142
development O 0 0.015536149963736534
of O 0 0.014622821472585201
strategies O 0 0.02397698163986206
for O 0 0.013705594465136528
the O 0 0.2319217175245285
prevention O 1 0.9999992847442627
and O 0 0.0557565838098526
, O 0 0.016095563769340515
where O 0 0.014688879251480103
necessary O 0 0.015222572721540928
, O 0 0.01325602550059557
management O 0 0.022972669452428818
of O 0 0.016564568504691124
a O 0 0.03136054798960686
risk O 0 0.27987539768218994
reversal O 0 0.29448097944259644
in O 0 0.01658586598932743
any O 0 0.019929267466068268
predictive O 0 0.06273597478866577
testing O 0 0.03754553571343422
program O 0 0.032615821808576584
. O 0 0.02380383387207985
. O 0 0.03324345871806145

A O 0 0.0815134197473526
novel O 0 0.07601743936538696
common O 0 0.04699099808931351
missense O 0 0.1619042307138443
mutation O 0 0.06117657199501991
G301C O 0 0.11748301237821579
in O 0 0.015621623024344444
the O 0 0.02496231719851494
N O 1 0.9522253274917603
- O 1 0.9995145797729492
acetylgalactosamine O 1 0.9995056390762329
- O 1 0.9998584985733032
6 O 0 0.08674262464046478
- O 1 0.9999773502349854
sulfate O 1 0.9998677968978882
sulfatase O 1 0.9998857975006104
gene O 0 0.05908707529306412
in O 0 0.04395494610071182
mucopolysaccharidosis B-Disease 1 0.999559223651886
IVA I-Disease 1 0.9999912977218628
. O 0 0.08942096680402756

Mucopolysaccharidosis B-Disease 1 0.9999332427978516
IVA I-Disease 1 0.9999992847442627
( O 0 0.483288437128067
MPS B-Disease 1 0.9998863935470581
IVA I-Disease 1 0.9999998807907104
) O 0 0.030577372759580612
is O 0 0.018813004717230797
an O 0 0.026422685012221336
autosomal B-Disease 1 0.9999961853027344
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9997336268424988
by O 0 0.03251572698354721
a O 0 0.15263158082962036
genetic B-Disease 1 0.9579987525939941
defect I-Disease 1 0.999915361404419
in O 0 0.021854769438505173
N O 1 0.9718573093414307
- O 1 0.9996154308319092
acetylgalactosamine O 1 0.999657392501831
- O 1 0.9998774528503418
6 O 0 0.3017278015613556
- O 1 0.9999988079071045
sulfate O 1 0.9999982118606567
sulfatase O 1 0.9999994039535522
( O 0 0.48418548703193665
GALNS O 1 0.9999871253967285
) O 0 0.0524505190551281
. O 0 0.04625348746776581

In O 0 0.03055516444146633
previous O 0 0.02808128111064434
studies O 0 0.022192172706127167
, O 0 0.016571076586842537
we O 0 0.009930425323545933
have O 0 0.0065668304450809956
found O 0 0.007830271497368813
two O 0 0.009340575896203518
common O 0 0.019228242337703705
mutations O 0 0.02737215906381607
in O 0 0.020556753501296043
Caucasians O 1 0.9990518689155579
and O 0 0.028543809428811073
Japanese O 0 0.0816742330789566
, O 0 0.0334249772131443
respectively O 0 0.04173053428530693
. O 0 0.04064422845840454

To O 0 0.046814434230327606
characterize O 0 0.08187682181596756
the O 0 0.04524217173457146
mutational O 1 0.9987599849700928
spectrum O 0 0.04454006254673004
in O 0 0.013333188369870186
various O 0 0.010154605843126774
ethnic O 0 0.02017478086054325
groups O 0 0.014284679666161537
, O 0 0.014639794826507568
mutations O 0 0.016303833574056625
in O 0 0.009273127652704716
the O 0 0.02010916918516159
GALNS O 1 0.9999111890792847
gene O 0 0.02295961230993271
in O 0 0.016076885163784027
Colombian O 1 0.6426445841789246
MPS B-Disease 1 0.9999334812164307
IVA I-Disease 1 1.0
patients O 1 0.9999407529830933
were O 0 0.02373713254928589
investigated O 0 0.07419099658727646
, O 0 0.023793276399374008
and O 0 0.021124014630913734
genetic O 0 0.027937043458223343
backgrounds O 0 0.02447986975312233
were O 0 0.012747311033308506
extensively O 0 0.02362905442714691
analyzed O 0 0.01770562119781971
to O 0 0.01278995256870985
identify O 0 0.019170353189110756
racial O 0 0.0304388590157032
origin O 0 0.013171801343560219
, O 0 0.01252684649080038
based O 0 0.01406760886311531
on O 0 0.017460988834500313
mitochondrial O 0 0.05302344262599945
DNA O 0 0.03905009850859642
( O 0 0.03492949157953262
mtDNA O 0 0.059438638389110565
) O 0 0.03415209427475929
lineages O 0 0.06313610821962357
. O 0 0.04437737539410591

Three O 0 0.040711939334869385
novel O 0 0.08300434052944183
missense O 1 0.7718750834465027
mutations O 0 0.04774465039372444
never O 0 0.02899812161922455
identified O 0 0.019432539120316505
previously O 0 0.01630530133843422
in O 0 0.010350723750889301
other O 0 0.008891846984624863
populations O 0 0.014879722148180008
and O 0 0.011907725594937801
found O 0 0.010479914024472237
in O 0 0.009092092514038086
16 O 0 0.015427086502313614
out O 0 0.012236732058227062
of O 0 0.016476014629006386
19 O 0 0.03526724874973297
Colombian O 1 0.5899366140365601
MPS B-Disease 1 0.9997063279151917
IVA I-Disease 1 0.9999998807907104
unrelated O 1 0.7145102024078369
alleles O 0 0.07010000944137573
account O 0 0.032270267605781555
for O 0 0.029827220365405083
84 O 0 0.0929340124130249
. O 0 0.05224454775452614

2 O 0 0.047269269824028015
% O 0 0.022792203351855278
of O 0 0.02115609683096409
the O 0 0.02782130241394043
alleles O 0 0.0520230196416378
in O 0 0.018543614074587822
this O 0 0.018753010779619217
study O 0 0.03157317265868187
. O 0 0.03621230274438858

The O 0 0.07355818897485733
G301C O 1 0.9853693842887878
and O 0 0.054189130663871765
S162F O 1 0.990949809551239
mutations O 0 0.05527348816394806
account O 0 0.030220361426472664
for O 0 0.028842106461524963
68 O 0 0.08198163658380508
. O 0 0.054709747433662415

4 O 0 0.0773601233959198
% O 0 0.03974967822432518
and O 0 0.031512096524238586
10 O 0 0.03790917620062828
. O 0 0.04400003328919411

5 O 0 0.044837627559900284
% O 0 0.025380698963999748
of O 0 0.02643124759197235
mutations O 0 0.03781266137957573
, O 0 0.02134726755321026
respectively O 0 0.02294585481286049
, O 0 0.015573511831462383
whereas O 0 0.017358282580971718
the O 0 0.01831633597612381
remaining O 0 0.036277275532484055
F69V O 1 0.9999321699142456
is O 0 0.019107647240161896
limited O 0 0.0172861497849226
to O 0 0.01628558710217476
a O 0 0.027657782658934593
single O 0 0.05344075709581375
allele O 0 0.08842345327138901
. O 0 0.045258697122335434

The O 0 0.0577334426343441
skewed O 0 0.09058960527181625
prevalence O 1 0.8824758529663086
of O 0 0.03949378803372383
G301C O 1 0.9981624484062195
in O 0 0.020310688763856888
only O 0 0.020080963149666786
Colombian O 1 0.6426164507865906
patients O 1 0.9850281476974487
and O 0 0.02862275205552578
haplotype O 0 0.25522381067276
analysis O 0 0.01609918661415577
by O 0 0.016745222732424736
restriction O 0 0.03262179344892502
fragment O 0 0.041863732039928436
length O 0 0.02115878276526928
polymorphisms O 0 0.03541417792439461
in O 0 0.0138767771422863
the O 0 0.027677422389388084
GALNS O 1 0.9998685121536255
gene O 0 0.034382935613393784
suggest O 0 0.019932517781853676
that O 0 0.015121621079742908
G301C O 1 0.5054324865341187
originated O 0 0.03379993140697479
from O 0 0.018153462558984756
a O 0 0.030000265687704086
common O 0 0.036788661032915115
ancestor O 0 0.10542453825473785
. O 0 0.05278368294239044

Investigation O 0 0.057986028492450714
of O 0 0.028967736288905144
the O 0 0.02954702638089657
genetic O 0 0.02877526357769966
background O 0 0.02143409289419651
by O 0 0.013827787712216377
means O 0 0.017524337396025658
of O 0 0.020594999194145203
mtDNA O 0 0.03796886280179024
lineages O 0 0.032366592437028885
indicate O 0 0.014706915244460106
that O 0 0.008510943502187729
all O 0 0.012876312248408794
our O 0 0.029345698654651642
patients O 1 0.9925252199172974
are O 0 0.009843254461884499
probably O 0 0.01826021634042263
of O 0 0.020531244575977325
native O 0 0.03801114112138748
American O 0 0.05789817124605179
descent O 0 0.1404511034488678

Low O 0 0.06738933175802231
frequency O 0 0.037307702004909515
of O 0 0.038441263139247894
BRCA1 O 1 0.9992668032646179
germline O 1 0.7655093669891357
mutations O 0 0.029605628922581673
in O 0 0.013115307316184044
45 O 0 0.03752351924777031
German O 1 0.9998107552528381
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9910818338394165
. O 0 0.07523805648088455

In O 0 0.02734491601586342
this O 0 0.014285304583609104
study O 0 0.013590455986559391
we O 0 0.009738982655107975
investigated O 0 0.024417908862233162
45 O 0 0.030239971354603767
German O 1 0.9993165731430054
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.5718012452125549
for O 0 0.04143579676747322
germline O 1 0.999482274055481
mutations O 0 0.03778722137212753
in O 0 0.020434310659766197
the O 0 0.046041421592235565
BRCA1 O 1 0.9999278783798218
gene O 0 0.06475917994976044
. O 0 0.04496954008936882

We O 0 0.02448161132633686
identified O 0 0.021596884354948997
four O 0 0.019005630165338516
germline O 0 0.32092195749282837
mutations O 0 0.025122186169028282
in O 0 0.014931955374777317
three O 0 0.05295524373650551
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.025486407801508904
and O 0 0.012212802655994892
in O 0 0.011527861468493938
one O 0 0.37855279445648193
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9998862743377686
. O 0 0.01526134368032217
among O 0 0.01268843375146389
these O 0 0.005823811981827021
were O 0 0.008275416679680347
one O 0 0.01845628395676613
frameshift O 1 0.9993571639060974
mutation O 0 0.042648378759622574
, O 0 0.01696593314409256
one O 0 0.018621843308210373
nonsense O 0 0.3600988984107971
mutation O 0 0.034155312925577164
, O 0 0.014954417012631893
one O 0 0.016474006697535515
novel O 0 0.04218778759241104
splice O 0 0.14484819769859314
site O 0 0.040085162967443466
mutation O 0 0.036596447229385376
, O 0 0.01742522418498993
and O 0 0.01706426404416561
one O 0 0.02836570516228676
missense O 1 0.8108978867530823
mutation O 0 0.14787189662456512
. O 0 0.04531683400273323

The O 0 0.06200406700372696
missense O 1 0.8792343735694885
mutation O 0 0.08458145707845688
was O 0 0.03703085705637932
also O 0 0.018849745392799377
found O 0 0.01592439040541649
in O 0 0.018010228872299194
2 O 0 0.04245278611779213
. O 0 0.03888110816478729

8 O 0 0.04514665901660919
% O 0 0.017850985750555992
of O 0 0.01474195346236229
the O 0 0.019115710631012917
general O 0 0.027807528153061867
population O 0 0.015308159403502941
, O 0 0.013586800545454025
suggesting O 0 0.015577422454953194
that O 0 0.0075979228131473064
it O 0 0.009050614200532436
is O 0 0.016047606244683266
not O 0 0.02234181948006153
disease O 1 0.9999414682388306
associated O 0 0.0511811301112175
. O 0 0.04798440635204315

The O 0 0.03846929594874382
average O 0 0.03199104592204094
age O 0 0.03728816285729408
of O 1 0.9088342189788818
disease O 1 1.0
onset O 1 1.0
in O 0 0.03498303145170212
those O 0 0.0233966875821352
families O 1 0.6345402598381042
harbouring O 1 0.9999998807907104
causative O 1 0.999998927116394
mutations O 0 0.14093950390815735
was O 0 0.04040147364139557
between O 0 0.032300617545843124
32 O 0 0.05650683492422104
. O 0 0.04423730447888374

3 O 0 0.07250633090734482
and O 0 0.04804598167538643
37 O 0 0.08170116692781448
. O 0 0.05324501171708107

4 O 0 0.05204377695918083
years O 0 0.0263820867985487
, O 0 0.021911976858973503
whereas O 0 0.023372214287519455
the O 0 0.021770929917693138
family O 0 0.04286544770002365
harbouring O 1 0.999727189540863
the O 0 0.04841748997569084
missense O 1 0.9979745745658875
mutation O 0 0.05540541559457779
had O 0 0.018852928653359413
an O 0 0.014093490317463875
average O 0 0.019201042130589485
age O 0 0.023783406242728233
of O 0 0.02767019160091877
onset O 1 0.9999935626983643
of O 0 0.20468690991401672
51 O 1 0.8676586747169495
. O 0 0.05469447001814842

2 O 0 0.08783864229917526
years O 0 0.06004953756928444
. O 0 0.06258716434240341

These O 0 0.022157808765769005
findings O 0 0.024708548560738564
show O 0 0.021758444607257843
that O 0 0.01709178276360035
BRCA1 O 1 0.9992700219154358
is O 0 0.018995916470885277
implicated O 0 0.04354941472411156
in O 0 0.01016740221530199
a O 0 0.011430568061769009
small O 0 0.011286008171737194
fraction O 0 0.024710925295948982
of O 1 0.5288007855415344
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.7824686765670776
suggesting O 0 0.028168348595499992
the O 0 0.017317306250333786
involvement O 0 0.038238655775785446
of O 0 0.024434441700577736
another O 1 0.857123076915741
susceptibility O 1 0.9999916553497314
gene O 0 0.4149012565612793
( O 0 0.055058300495147705
s O 1 0.7980101704597473
) O 0 0.06098258122801781

Paternal O 1 0.9911216497421265
transmission O 1 0.9946757555007935
of O 1 0.9999483823776245
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9996217489242554

We O 0 0.029140103608369827
report O 0 0.02239319309592247
a O 0 0.018907086923718452
rare O 0 0.023258384317159653
case O 0 0.02500663325190544
of O 0 0.037430837750434875
paternally O 1 0.9999934434890747
transmitted O 1 0.9999995231628418
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.10383376479148865
. O 0 0.05715559422969818

The O 0 0.05745784938335419
proband O 1 0.9369930028915405
is O 0 0.020018551498651505
a O 0 0.017862770706415176
23 O 0 0.020096169784665108
year O 0 0.015714000910520554
old O 1 0.6828216910362244
, O 0 0.13533352315425873
mentally B-Disease 1 0.9999998807907104
retarded I-Disease 1 1.0
male O 1 0.9999821186065674
who O 1 0.9999815225601196
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9883119463920593

He O 0 0.042784057557582855
presented O 0 0.06074625626206398
with O 1 0.9282573461532593
respiratory O 1 1.0
and O 1 0.9930991530418396
feeding O 1 0.9997312426567078
difficulties O 1 0.9994778037071228
at O 1 0.9075209498405457
birth O 1 0.995426595211029
. O 0 0.05644669383764267

His O 0 0.06427710503339767
two O 0 0.04868548363447189
sibs O 1 0.9999451637268066
suffer O 1 0.9992786049842834
from O 1 0.6417965292930603
childhood O 1 0.9999998807907104
onset O 1 1.0
DM B-Disease 1 1.0
. O 1 0.9263176918029785

Their O 0 0.02990518882870674
late O 0 0.03891931474208832
father O 0 0.04335477203130722
had O 0 0.018727421760559082
the O 0 0.017969978973269463
adult O 0 0.032436199486255646
type O 0 0.1262253075838089
of O 1 0.8358113169670105
DM B-Disease 1 1.0
, O 0 0.052011989057064056
with O 0 0.03619050234556198
onset O 1 0.9999918937683105
around O 0 0.03456567972898483
30 O 0 0.03533920273184776
years O 0 0.03583967685699463
. O 0 0.04457375779747963

Only O 0 0.022157898172736168
six O 0 0.016957426443696022
other O 0 0.010632378049194813
cases O 0 0.014581877738237381
of O 0 0.01963849924504757
paternal O 1 0.999572217464447
transmission O 1 0.9995174407958984
of O 1 0.9999873638153076
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.1354578584432602
been O 0 0.024034351110458374
reported O 0 0.027905721217393875
recently O 0 0.041673995554447174
. O 0 0.036083973944187164

We O 0 0.027431519702076912
review O 0 0.028965309262275696
the O 0 0.020861655473709106
sex O 0 0.039731115102767944
related O 0 0.023458559066057205
effects O 0 0.03202547878026962
on O 0 0.027366014197468758
transmission O 1 0.9964421391487122
of O 1 0.9997867941856384
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9830873012542725

Decreased O 0 0.12113767862319946
fertility O 0 0.2451200932264328
of O 0 0.02393832616508007
males O 0 0.024004198610782623
with O 0 0.026594070717692375
adult O 1 0.9998026490211487
onset O 1 1.0
DM B-Disease 1 1.0
and O 1 0.8457731604576111
contraction O 1 0.8263787031173706
of O 0 0.024659177288413048
the O 0 0.03191505745053291
repeat O 0 0.3194323480129242
upon O 0 0.03548000007867813
male O 1 0.6394520401954651
transmission O 0 0.05038836970925331
contribute O 0 0.024748744443058968
to O 0 0.013566321693360806
the O 0 0.015447763726115227
almost O 0 0.01614481769502163
absent O 0 0.037745945155620575
occurrence O 0 0.03579358384013176
of O 0 0.0275708120316267
paternal O 1 0.9998569488525391
transmission O 1 0.999691367149353
of O 1 0.9999529123306274
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9780669212341309

Also O 0 0.028894979506731033
the O 0 0.021560657769441605
fathers O 0 0.039531949907541275
of O 0 0.018016207963228226
the O 0 0.024672042578458786
reported O 0 0.09221867471933365
congenitally O 1 0.9999958276748657
affected O 1 0.5416200160980225
children O 0 0.06033380329608917
showed O 0 0.02325519174337387
, O 0 0.014872393570840359
on O 0 0.013494842685759068
average O 0 0.016693757846951485
, O 0 0.018479209393262863
shorter O 0 0.03992365673184395
CTG O 1 0.9998568296432495
repeat O 0 0.08798062056303024
lengths O 0 0.04561927169561386
and O 0 0.02103198878467083
hence O 0 0.03273076191544533
less O 0 0.03100290521979332
severe O 1 0.9999988079071045
clinical O 1 0.9999996423721313
symptoms O 1 0.9999996423721313
than O 0 0.018884073942899704
the O 0 0.029922381043434143
mothers O 1 0.9844033718109131
of O 0 0.04828338697552681
children O 1 0.9993782043457031
with O 1 0.9999750852584839
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9960914254188538

We O 0 0.026088565587997437
conclude O 0 0.035693153738975525
that O 0 0.014271721243858337
paternal O 0 0.11179147660732269
transmission O 1 0.6807674765586853
of O 1 0.9997101426124573
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.992276132106781
rare O 1 0.6830363273620605
and O 0 0.02492276020348072
preferentially O 0 0.09113816171884537
occurs O 0 0.019577478989958763
with O 0 0.018386557698249817
onset O 1 0.9999985694885254
of O 1 0.9988163709640503
DM B-Disease 1 1.0
past O 0 0.04284462705254555
30 O 0 0.02085700072348118
years O 0 0.01492585614323616
in O 0 0.012318462133407593
the O 0 0.023474689573049545
father O 1 0.7831289768218994
. O 0 0.02684248425066471
. O 0 0.03552178665995598

The O 0 0.08707082271575928
RB1 O 1 0.9999743700027466
gene O 0 0.0576113797724247
mutation O 0 0.039602939039468765
in O 0 0.015529039315879345
a O 0 0.031030938029289246
child O 1 0.9731255769729614
with O 1 0.8317391872406006
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999998807907104
. O 1 0.6402413845062256

The O 0 0.08471791446208954
RB1 O 1 0.9999550580978394
gene O 0 0.0634179562330246
mutation O 0 0.04630482941865921
was O 0 0.02422272600233555
investigated O 0 0.02786203660070896
in O 0 0.011716777458786964
a O 0 0.021936312317848206
child O 1 0.9477405548095703
with O 1 0.5492799878120422
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
using O 0 0.02581668645143509
DNA O 0 0.01987346261739731
obtained O 0 0.010481081902980804
from O 0 0.008522424846887589
both O 0 0.010680665262043476
the O 0 0.025363171473145485
pineal B-Disease 1 0.9999996423721313
and I-Disease 1 0.9691019058227539
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 1 0.9576376676559448
the O 1 0.9960546493530273
patient O 1 0.9999959468841553
. O 0 0.07128288596868515

A O 0 0.08213376253843307
nonsense O 0 0.13008318841457367
mutation O 0 0.055097345262765884
in O 0 0.024024780839681625
exon O 0 0.1068117693066597
17 O 0 0.03801993280649185
( O 0 0.030162401497364044
codon O 0 0.061917394399642944
556 O 0 0.07147177308797836
) O 0 0.016373800113797188
of O 0 0.01907557249069214
the O 0 0.038126446306705475
RB1 O 1 0.9999991655349731
gene O 0 0.037656452506780624
was O 0 0.02394998073577881
found O 0 0.01147027313709259
to O 0 0.010526632890105247
be O 0 0.010333116166293621
present O 0 0.019362887367606163
homozygously O 0 0.1799829751253128
in O 0 0.013458901084959507
both O 0 0.015417087823152542
the O 0 0.029518451541662216
retinal B-Disease 1 0.9999861717224121
and I-Disease 0 0.044586993753910065
the I-Disease 1 0.9791972041130066
pineal I-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
. O 0 0.08967281132936478

The O 0 0.03940635919570923
same O 0 0.024563603103160858
mutation O 0 0.04097432270646095
was O 0 0.02678542211651802
present O 0 0.02417471446096897
heterozygously O 1 0.9537681341171265
in O 0 0.01264331117272377
the O 0 0.014230156317353249
DNA O 0 0.014479010365903378
from O 0 0.00843639113008976
the O 0 0.011540827341377735
constitutional O 0 0.02613675221800804
cells O 0 0.01897243596613407
of O 0 0.015943873673677444
the O 0 0.13915354013442993
patient O 1 0.9999854564666748
, O 0 0.026257485151290894
proving O 0 0.0473945215344429
it O 0 0.009526951238512993
to O 0 0.012132108211517334
be O 0 0.011236393824219704
of O 0 0.02313813380897045
germline O 1 0.5339950919151306
origin O 0 0.03693529590964317
. O 0 0.04249060899019241

The O 0 0.04999825730919838
initial O 0 0.05693357437849045
mutation O 0 0.06960789114236832
was O 0 0.028892291709780693
shown O 0 0.016356131061911583
to O 0 0.011803755536675453
have O 0 0.007967826910316944
occurred O 0 0.014924774877727032
in O 0 0.012650937773287296
the O 0 0.027553511783480644
paternally O 1 0.8291757702827454
derived O 0 0.06645850837230682
RB1 O 1 0.9999183416366577
allele O 0 0.13790902495384216
. O 0 0.056414421647787094

The O 0 0.052796944975852966
mutation O 0 0.06197606027126312
is O 0 0.016714105382561684
in O 0 0.011273719370365143
an O 0 0.011956320144236088
area O 0 0.014398329891264439
of O 0 0.011044631712138653
the O 0 0.013787970878183842
gene O 0 0.014441206119954586
that O 0 0.006388308480381966
encodes O 0 0.018925517797470093
the O 0 0.014611468650400639
protein O 0 0.0247636865824461
- O 1 0.961916446685791
binding O 0 0.019430339336395264
region O 0 0.018326086923480034
known O 0 0.016534464433789253
as O 0 0.012762491591274738
the O 0 0.02067052200436592
pocket O 1 0.9935364127159119
region O 0 0.028611771762371063
and O 0 0.014768336899578571
has O 0 0.014151854440569878
been O 0 0.01317382138222456
detected O 0 0.018790461122989655
in O 0 0.009431335143744946
other O 0 0.00991308968514204
cases O 0 0.01998984068632126
of O 0 0.27569779753685
retinoblastoma B-Disease 1 0.9999995231628418
. O 0 0.04917304217815399
. O 0 0.050373028963804245

Low O 0 0.0613555870950222
levels O 0 0.028833823278546333
of O 0 0.024398814886808395
beta O 1 0.5716896653175354
hexosaminidase O 1 0.9946200847625732
A O 0 0.03857436031103134
in O 0 0.018648669123649597
healthy O 0 0.05563061684370041
individuals O 0 0.01603090763092041
with O 0 0.02897048555314541
apparent O 1 0.9999995231628418
deficiency O 1 1.0
of O 1 0.998984158039093
this O 1 0.7457097172737122
enzyme O 1 0.8923507928848267
. O 0 0.04463149607181549

Appreciable O 1 0.6853219270706177
beta O 1 0.60100257396698
hexosaminidase O 1 0.9959853291511536
A O 0 0.14442071318626404
( O 0 0.041148118674755096
hex O 1 0.7217450737953186
A O 0 0.04324037954211235
) O 0 0.018459128215909004
activity O 0 0.015968261286616325
has O 0 0.011064821854233742
been O 0 0.009974600747227669
detected O 0 0.020962703973054886
in O 0 0.016515331342816353
cultured O 1 0.9984183311462402
skin O 1 0.9999978542327881
fibroblasts O 1 0.9999969005584717
and O 1 0.9999103546142578
melanoma B-Disease 1 1.0
tissue O 1 0.9999995231628418
from O 0 0.36950352787971497
healthy O 1 0.9896148443222046
individuals O 0 0.014179115183651447
previously O 0 0.017329487949609756
reported O 0 0.01786789856851101
as O 0 0.018971113488078117
having O 0 0.42289501428604126
deficiency B-Disease 1 1.0
of I-Disease 1 0.7206936478614807
hex I-Disease 1 0.9999237060546875
A I-Disease 0 0.3325859010219574
activity O 0 0.02512020245194435
indistinguishable O 0 0.026228846982121468
from O 0 0.008393587544560432
that O 0 0.006001530680805445
of O 0 0.013375828973948956
patients O 1 0.9002819061279297
with O 1 0.9569819569587708
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9997511506080627
TSD B-Disease 1 0.9999998807907104
) O 0 0.05899927392601967
. O 0 0.046294987201690674

Identification O 0 0.06463022530078888
and O 0 0.03487392142415047
quantitation O 1 0.9476094841957092
of O 0 0.04208936169743538
hex O 1 0.984173059463501
A O 0 0.06609293818473816
, O 0 0.029813997447490692
amounting O 0 0.05074962228536606
to O 0 0.02834431640803814
3 O 0 0.043978095054626465
. O 0 0.03898274898529053

5 O 0 0.06860542297363281
% O 0 0.05813363194465637
- O 1 0.9981288313865662
6 O 0 0.06898470968008041
. O 0 0.04545621946454048

9 O 0 0.04043738916516304
% O 0 0.018891463056206703
of O 0 0.01591895893216133
total O 0 0.025155415758490562
beta O 1 0.9977738261222839
hexosaminidase O 1 0.9998962879180908
activity O 0 0.02980821020901203
, O 0 0.015137692913413048
has O 0 0.011272232048213482
been O 0 0.010069702751934528
obtained O 0 0.014458529651165009
by O 0 0.02258872799575329
cellulose O 1 0.9914393424987793
acetate O 1 0.9999232292175293
gel O 1 0.9985371828079224
electrophoresis O 0 0.10988086462020874
, O 0 0.036910947412252426
DEAE O 1 0.9999523162841797
- O 1 0.9999849796295166
cellulose O 1 0.9993869066238403
ion O 1 0.9947804808616638
- O 1 0.9996858835220337
exchange O 0 0.05130190774798393
chromatography O 1 0.9801464676856995
, O 0 0.0392950177192688
radial O 1 0.996755063533783
immunodiffusion O 1 0.9995170831680298
, O 0 0.04191617667675018
and O 0 0.042733095586299896
radioimmunoassay O 1 0.9966514706611633
. O 0 0.05993875488638878

Previous O 0 0.055414751172065735
family O 0 0.047947607934474945
studies O 0 0.023556062951683998
suggested O 0 0.02130763605237007
that O 0 0.009950505569577217
these O 0 0.008447112515568733
individuals O 0 0.012595522217452526
may O 0 0.013023676350712776
be O 0 0.011948470957577229
compound O 0 0.045906249433755875
heterozygotes O 0 0.06841561198234558
for O 0 0.013473971746861935
the O 0 0.019567586481571198
common O 0 0.033093348145484924
mutant O 1 0.999538779258728
TSD B-Disease 1 0.9999992847442627
gene O 0 0.033874887973070145
and O 0 0.016359860077500343
a O 0 0.024473432451486588
rare O 0 0.04351545497775078
( O 0 0.03669162094593048
allelic O 1 0.996178388595581
) O 0 0.039124853909015656
mutant O 1 0.8914991617202759
gene O 0 0.056184738874435425
. O 0 0.04265671968460083

Thus O 0 0.035660430788993835
, O 0 0.02001684531569481
the O 0 0.021943410858511925
postulated O 0 0.06288377195596695
rate O 0 0.03495436906814575
mutant O 1 0.7156147360801697
gene O 0 0.03179053217172623
appears O 0 0.022079622372984886
to O 0 0.01321420818567276
code O 0 0.015254630707204342
for O 0 0.010594252496957779
the O 0 0.015418109484016895
expression O 0 0.020357957109808922
of O 0 0.017524417489767075
low O 0 0.03117249719798565
amounts O 0 0.019653156399726868
of O 0 0.02825799211859703
hex O 1 0.9070078134536743
A O 0 0.06989873200654984
. O 0 0.04841039702296257

Heterozygotes O 0 0.18385234475135803
for O 0 0.03194474056363106
the O 0 0.03628969192504883
rare O 0 0.10598409175872803
mutant O 1 0.9746984839439392
may O 0 0.024992667138576508
be O 0 0.015327353961765766
indistinguishable O 0 0.04160667210817337
from O 0 0.020344410091638565
heterozygotes O 0 0.08125117421150208
for O 0 0.021589571610093117
the O 0 0.03320051357150078
common O 0 0.16357532143592834
TSD B-Disease 1 0.9999977350234985
mutant O 1 0.9930546879768372
. O 0 0.06922869384288788

However O 0 0.040487390011548996
, O 0 0.031218215823173523
direct O 0 0.03457437455654144
visualization O 0 0.06184164807200432
and O 0 0.025081170722842216
quantitation O 1 0.933232307434082
of O 0 0.03281470015645027
hex O 1 0.8680728673934937
A O 0 0.03245102986693382
by O 0 0.01512348186224699
the O 0 0.016732554882764816
methods O 0 0.014837849885225296
described O 0 0.02140851318836212
may O 0 0.014877361245453358
prevent O 0 0.02987012080848217
false O 0 0.06028982996940613
- O 1 0.9999786615371704
positive O 0 0.08655855804681778
prenatal O 1 0.9999895095825195
diagnosis O 1 0.9999401569366455
of O 1 0.7615989446640015
TSD B-Disease 1 0.9999998807907104
in O 0 0.027601346373558044
fetuses O 0 0.2670697271823883
having O 0 0.017552156001329422
the O 0 0.019663972780108452
incomplete O 0 0.04988906532526016
hex B-Disease 1 0.9995396137237549
A I-Disease 1 0.9991718530654907
deficiency I-Disease 1 1.0
of O 0 0.06956113874912262
the O 1 0.8312160968780518
type O 1 0.9601221084594727
described O 0 0.02211775816977024
in O 0 0.012355088256299496
the O 0 0.019947700202465057
four O 0 0.03087989054620266
healthy O 1 0.8151577115058899
individuals O 0 0.05437614023685455

The O 0 0.08535061031579971
tumor B-Disease 1 0.9999963045120239
suppressor O 1 0.99997878074646
gene O 0 0.31855082511901855
Smad4 O 1 0.9999903440475464
/ O 1 0.9999854564666748
Dpc4 O 1 0.9994934797286987
is O 0 0.020681798458099365
required O 0 0.01631205342710018
for O 0 0.0190444216132164
gastrulation O 1 0.9997765421867371
and O 0 0.022605760022997856
later O 0 0.023872200399637222
for O 0 0.0215330570936203
anterior O 1 0.9995524287223816
development O 0 0.028598587960004807
of O 0 0.02716262824833393
the O 0 0.0595729686319828
mouse O 1 0.950930655002594
embryo O 0 0.14027048647403717
. O 0 0.05153343454003334

Mutations O 0 0.04828982427716255
in O 0 0.017916128039360046
the O 0 0.03457696735858917
SMAD4 O 1 0.9999992847442627
/ O 1 0.9999992847442627
DPC4 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999990463256836
gene O 0 0.037987884134054184
, O 0 0.016383226960897446
a O 0 0.018719065934419632
key O 0 0.027472548186779022
signal O 0 0.029156241565942764
transducer O 0 0.054936520755290985
in O 0 0.011675085872411728
most O 0 0.016974175348877907
TGFbeta O 1 0.9999892711639404
- O 1 0.9999986886978149
related O 0 0.20570853352546692
pathways O 0 0.4978789687156677
, O 0 0.01205470971763134
are O 0 0.005545784253627062
involved O 0 0.008203363977372646
in O 0 0.007625903468579054
50 O 0 0.01576358824968338
% O 0 0.02186599373817444
of O 1 0.9578436613082886
pancreatic B-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
. O 0 0.365451842546463

Homozygous O 0 0.23289591073989868
Smad4 O 1 0.9996798038482666
mutant O 1 0.9992951154708862
mice O 1 0.9032036662101746
die O 1 0.522144079208374
before O 0 0.03511837497353554
day O 0 0.04699355736374855
7 O 0 0.05577515810728073
. O 0 0.042354363948106766

5 O 0 0.07599641382694244
of O 0 0.07056888192892075
embryogenesis O 1 0.9609534740447998
. O 0 0.07694774121046066

Mutant O 0 0.21791186928749084
embryos O 0 0.04572638124227524
have O 0 0.016530588269233704
reduced O 0 0.0269134771078825
size O 0 0.0236187931150198
, O 0 0.021041642874479294
fail O 0 0.039459940046072006
to O 0 0.023282302543520927
gastrulate O 1 0.972926139831543
or O 0 0.0210043266415596
express O 0 0.03815894573926926
a O 0 0.03683381527662277
mesodermal O 1 0.9999290704727173
marker O 1 0.9796767830848694
, O 0 0.02508378215134144
and O 0 0.024114716798067093
show O 0 0.043394166976213455
abnormal O 1 0.9993564486503601
visceral O 1 0.9999885559082031
endoderm O 1 0.9999755620956421
development O 0 0.13530929386615753
. O 0 0.060660164803266525

Growth B-Disease 1 0.8738057017326355
retardation I-Disease 1 0.9997358918190002
of O 0 0.038746628910303116
the O 0 0.17871367931365967
Smad4 O 1 0.9999991655349731
- O 1 0.9999997615814209
deficient O 1 0.999704897403717
embryos O 0 0.026899544522166252
results O 0 0.011547029949724674
from O 0 0.015279111452400684
reduced O 0 0.03737957403063774
cell O 0 0.41866013407707214
proliferation O 1 0.9439424276351929
rather O 0 0.019974367693066597
than O 0 0.01959482952952385
increased O 0 0.04410794749855995
apoptosis O 1 0.9974169731140137
. O 0 0.05512458086013794

Aggregation O 0 0.09785901010036469
of O 0 0.04329594597220421
mutant O 1 0.9849083423614502
Smad4 O 1 0.9999912977218628
ES O 1 0.9999716281890869
cells O 0 0.039714712649583817
with O 0 0.020664222538471222
wild O 0 0.04595287889242172
- O 1 0.9998403787612915
type O 0 0.07775137573480606
tetraploid O 1 0.8895840048789978
morulae O 1 0.9987972974777222
rescues O 1 0.9921091198921204
the O 0 0.11101553589105606
gastrulation B-Disease 1 0.9999904632568359
defect I-Disease 1 0.9999144077301025
. O 0 0.08609765768051147

These O 0 0.02427266724407673
results O 0 0.018982982262969017
indicate O 0 0.021510452032089233
that O 0 0.015545517206192017
Smad4 O 1 0.9921355247497559
is O 0 0.01643858104944229
initially O 0 0.01615334302186966
required O 0 0.008871261961758137
for O 0 0.009125870652496815
the O 0 0.015345443040132523
differentiation O 0 0.041671596467494965
of O 0 0.022854583337903023
the O 0 0.05265917256474495
visceral O 1 0.9999765157699585
endoderm O 1 0.9999704360961914
and O 0 0.019990531727671623
that O 0 0.013151127845048904
the O 0 0.02727389521896839
gastrulation B-Disease 1 0.9999961853027344
defect I-Disease 1 0.9998408555984497
in O 0 0.018990568816661835
the O 0 0.029357772320508957
epiblast O 1 0.9999939203262329
is O 0 0.02317737601697445
secondary O 0 0.08182710409164429
and O 0 0.02632465586066246
non O 1 0.9994950294494629
- O 1 0.9999979734420776
cell O 0 0.21355687081813812
autonomous O 0 0.05952954292297363
. O 0 0.043240927159786224

Rescued O 0 0.1874595731496811
embryos O 0 0.06918994337320328
show O 0 0.0626145601272583
severe O 1 0.9999797344207764
anterior O 1 0.9999986886978149
truncations O 1 0.9999979734420776
, O 0 0.053197141736745834
indicating O 0 0.03140382841229439
a O 0 0.018918488174676895
second O 0 0.02295904979109764
important O 0 0.014842082746326923
role O 0 0.02490978129208088
for O 0 0.02251131646335125
Smad4 O 1 0.9999157190322876
in O 0 0.04080900177359581
anterior O 1 0.9999866485595703
patterning O 1 0.999962329864502
during O 1 0.7663733959197998
embryogenesis O 1 0.9989944100379944
. O 0 0.0717206746339798

Prevalence O 1 0.9867629408836365
of O 0 0.06568054109811783
p16 O 1 0.986865222454071
and O 0 0.05059358850121498
CDK4 O 1 0.9999282360076904
germline O 1 0.9663463234901428
mutations O 0 0.03774189203977585
in O 0 0.021497981622815132
48 O 1 0.8950502872467041
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9999806880950928
families O 0 0.04221753776073456
in O 0 0.028137022629380226
France O 0 0.08535417914390564
. O 0 0.04278853163123131

The O 0 0.06834125518798828
French O 1 0.980530858039856
Familial B-Disease 1 0.9999998807907104
Melanoma I-Disease 1 1.0
Study O 1 0.983738899230957
Group O 1 0.9271628856658936
. O 0 0.05515323579311371

Germline O 1 0.9665379524230957
mutations O 0 0.04743065685033798
in O 0 0.019251590594649315
the O 0 0.031973227858543396
p16 O 1 0.9985039234161377
and O 0 0.03749843314290047
CDK4 O 1 0.9999922513961792
genes O 0 0.020643502473831177
have O 0 0.007489922922104597
been O 0 0.007733071688562632
reported O 0 0.010360820218920708
in O 0 0.007508665323257446
a O 0 0.0168320219963789
subset O 0 0.056632399559020996
of O 0 0.23488537967205048
melanoma B-Disease 1 1.0
pedigrees O 1 0.9995940327644348
, O 0 0.023422889411449432
but O 0 0.013724456541240215
their O 0 0.0182808805257082
prevalence O 1 0.9999737739562988
is O 0 0.019276868551969528
not O 0 0.01424555666744709
well O 0 0.01913178339600563
known O 0 0.03296142444014549
. O 0 0.03505505621433258

We O 0 0.03411436825990677
searched O 0 0.045805033296346664
for O 0 0.017077961936593056
such O 0 0.017180541530251503
germline O 0 0.13207057118415833
mutations O 0 0.023969260975718498
in O 0 0.014134973287582397
48 O 0 0.03703165799379349
French O 1 0.998855710029602
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9999270439147949
families O 0 0.025539526715874672
selected O 0 0.019329983741044998
according O 0 0.010113068856298923
to O 0 0.00907816644757986
two O 0 0.008733433671295643
major O 0 0.019281774759292603
criteria O 0 0.022754456847906113
families O 0 0.014811895787715912
with O 0 0.01080626342445612
at O 0 0.011944401077926159
least O 0 0.008604663424193859
three O 0 0.009894476272165775
affected O 0 0.01863715797662735
members O 0 0.02014787867665291
( O 0 0.025254864245653152
n O 0 0.0616300106048584
= O 0 0.03957857936620712
20 O 0 0.019023312255740166
) O 0 0.01390922348946333
or O 0 0.009548159316182137
families O 0 0.012738164514303207
with O 0 0.009809191338717937
two O 0 0.010236690752208233
affected O 0 0.018153557553887367
members O 0 0.014790402725338936
, O 0 0.011148527264595032
one O 0 0.009967380203306675
of O 0 0.010809052735567093
them O 0 0.009863990359008312
affected O 0 0.014645000919699669
before O 0 0.0113232946023345
the O 0 0.012694492936134338
age O 0 0.01691741868853569
of O 0 0.016326025128364563
50 O 0 0.024462426081299782
( O 0 0.0248294398188591
n O 0 0.05654342472553253
= O 0 0.043254073709249496
28 O 0 0.02914891391992569
) O 0 0.016807688400149345
, O 0 0.011960799805819988
and O 0 0.012293065898120403
one O 0 0.017829671502113342
additional O 0 0.02485072799026966
minor O 1 0.8373204469680786
criterion O 1 0.9992488026618958
. O 0 0.05957455560564995

Sixteen O 0 0.09063015133142471
different O 0 0.032917238771915436
p16 O 1 0.9904782772064209
germline O 1 0.985982358455658
mutations O 0 0.039792053401470184
were O 0 0.013067218475043774
found O 0 0.01277273241430521
in O 0 0.010802580043673515
21 O 0 0.02302137389779091
families O 0 0.01892104372382164
, O 0 0.013784696348011494
while O 0 0.01397673785686493
one O 0 0.02201313152909279
germline O 1 0.9974736571311951
mutation O 0 0.056218214333057404
, O 0 0.02778848260641098
Arg24His O 1 0.9984506368637085
, O 0 0.02206658013164997
was O 0 0.025177447125315666
detected O 0 0.026557570323348045
in O 0 0.01479257084429264
the O 0 0.033305708318948746
CDK4 O 1 0.9999213218688965
gene O 0 0.061445705592632294
. O 0 0.04576414078474045

The O 0 0.03570885956287384
frequency O 0 0.02934412471950054
of O 0 0.0286981463432312
p16 O 1 0.9845816493034363
gene O 0 0.034935396164655685
mutation O 0 0.028153417631983757
in O 0 0.011917440220713615
our O 0 0.01959720253944397
sample O 0 0.02092008851468563
( O 0 0.016994595527648926
44 O 0 0.02613310143351555
% O 0 0.018432697281241417
) O 0 0.013162072747945786
is O 0 0.009299256838858128
among O 0 0.01144615188241005
the O 0 0.013453376479446888
highest O 0 0.0541464164853096
rates O 0 0.02026953361928463
yet O 0 0.013295875862240791
reported O 0 0.013587753288447857
and O 0 0.011913280934095383
the O 0 0.021437525749206543
CDK4 O 1 0.999980092048645
mutation O 0 0.03646228834986687
is O 0 0.012293760664761066
the O 0 0.015207333490252495
second O 0 0.030985379591584206
mutation O 0 0.04270732030272484
detected O 0 0.024370161816477776
in O 0 0.012914867140352726
this O 0 0.016233578324317932
gene O 0 0.03384857997298241
worldwide O 0 0.03531090170145035
. O 0 0.0399734228849411

In O 0 0.03781844303011894
summary O 0 0.04526312276721001
, O 0 0.02100040391087532
our O 0 0.02102893590927124
results O 0 0.014375070109963417
show O 0 0.017255758866667747
frequent O 0 0.026053931564092636
involvement O 0 0.0301987137645483
of O 0 0.018521027639508247
the O 0 0.03186479210853577
p16 O 1 0.9990800619125366
gene O 0 0.03878752514719963
in O 0 0.03091275878250599
familial B-Disease 1 0.9999998807907104
melanoma I-Disease 1 1.0
and O 0 0.03691472113132477
confirm O 0 0.024661222472786903
the O 0 0.014019877649843693
role O 0 0.01789369061589241
of O 0 0.01414848305284977
the O 0 0.021329255774617195
CDK4 O 1 0.9999692440032959
gene O 0 0.025434419512748718
as O 0 0.018170058727264404
a O 0 0.19639834761619568
melanoma B-Disease 1 1.0
- O 1 1.0
predisposing O 1 0.9999881982803345
gene O 0 0.05622520670294762
. O 0 0.02895592898130417
. O 0 0.03544679656624794

Progression O 1 0.849303126335144
of O 0 0.060791172087192535
somatic O 1 0.9965207576751709
CTG O 1 0.9999527931213379
repeat O 0 0.09015591442584991
length O 0 0.030763395130634308
heterogeneity O 0 0.05913245305418968
in O 0 0.016839472576975822
the O 0 0.029017820954322815
blood O 1 0.999283492565155
cells O 1 0.8552252054214478
of O 1 0.9993853569030762
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 1 0.7424095273017883

The O 0 0.03581811860203743
genetic O 0 0.026211809366941452
basis O 0 0.021449686959385872
of O 1 0.8210783004760742
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.027140876278281212
is O 0 0.012204229831695557
the O 0 0.012480709701776505
expansion O 0 0.020979924127459526
of O 0 0.018651356920599937
an O 0 0.04482366517186165
unstable O 1 0.9999935626983643
CTG O 1 0.9999984502792358
repeat O 0 0.05614803731441498
in O 0 0.013438329100608826
the O 0 0.015674076974391937
34 O 0 0.0301308985799551
UTR O 0 0.08825467526912689
of O 0 0.022074319422245026
the O 0 0.07013309001922607
DM B-Disease 1 1.0
protein O 0 0.28934991359710693
kinase O 1 0.887755274772644
gene O 0 0.03524289280176163
on O 0 0.028783371672034264
chromosome O 0 0.06265794485807419
19 O 0 0.055122584104537964
. O 0 0.04273200407624245

One O 0 0.026781657710671425
of O 0 0.019058039411902428
the O 0 0.02087944746017456
principal O 0 0.03679775446653366
features O 0 0.017960775643587112
of O 0 0.018098287284374237
the O 1 0.9419974684715271
DM B-Disease 1 1.0
mutation O 1 0.9071001410484314
is O 0 0.016355156898498535
an O 0 0.014447580091655254
extraordinarily O 0 0.13081716001033783
high O 0 0.027081655338406563
level O 0 0.020934615284204483
of O 0 0.035216886550188065
somatic O 1 0.9999700784683228
mosaicism O 1 0.9999971389770508
, O 0 0.022247126325964928
due O 0 0.017117472365498543
to O 0 0.012885769829154015
an O 0 0.014094020240008831
extremely O 0 0.020715299993753433
high O 0 0.023575320839881897
degree O 0 0.02349415421485901
of O 0 0.042855117470026016
somatic O 1 0.999855637550354
instability O 1 0.9987267851829529
both O 0 0.021279379725456238
within O 0 0.020137187093496323
and O 0 0.021282587200403214
between O 0 0.026227179914712906
different O 0 0.021676812320947647
tissues O 0 0.13969776034355164
. O 0 0.04712577164173126

This O 0 0.0521145723760128
instability O 1 0.962689220905304
appears O 0 0.04470570757985115
to O 0 0.020236795768141747
be O 0 0.014247867278754711
biased O 0 0.03517093136906624
towards O 0 0.025641635060310364
further O 0 0.018027417361736298
expansion O 0 0.027686305344104767
and O 0 0.01607009768486023
continuous O 0 0.026220913976430893
throughout O 0 0.014586416073143482
the O 0 0.015201564878225327
life O 0 0.019506758078932762
of O 0 0.0151259396225214
an O 0 0.017215915024280548
individual O 0 0.015828996896743774
, O 0 0.014552528038620949
features O 0 0.013360804878175259
that O 0 0.006844441872090101
could O 0 0.00754083227366209
be O 0 0.006452236324548721
associated O 0 0.008927907794713974
with O 0 0.00880444049835205
the O 0 0.016652878373861313
progressive O 1 0.9995005130767822
nature O 0 0.043206892907619476
of O 0 0.11908373981714249
the O 1 0.999362051486969
disease O 1 0.9999998807907104
. O 0 0.18104547262191772

Although O 0 0.037773970514535904
increasing O 0 0.03466670960187912
measured O 0 0.036180026829242706
allele O 0 0.05443675071001053
size O 0 0.022352050989866257
between O 0 0.024573663249611855
patients O 1 0.9114242196083069
clearly O 0 0.026161272078752518
correlates O 0 0.03957001119852066
with O 0 0.012719438411295414
an O 0 0.014632971957325935
increased O 0 0.05020194500684738
severity O 1 0.9999932050704956
of O 1 0.9995530247688293
symptoms O 1 0.9999998807907104
and O 0 0.02820664644241333
an O 0 0.015487898141145706
earlier O 0 0.016631465405225754
age O 0 0.023116683587431908
of O 0 0.4468742609024048
onset O 1 1.0
, O 0 0.03952530771493912
this O 0 0.014215427450835705
correlation O 0 0.030061980709433556
is O 0 0.012118959799408913
not O 0 0.009099837392568588
precise O 0 0.015489025972783566
and O 0 0.013042506761848927
measured O 0 0.02552260085940361
allele O 0 0.0412452407181263
length O 0 0.01693519949913025
cannot O 0 0.015250067226588726
be O 0 0.008631234057247639
used O 0 0.007891406305134296
as O 0 0.009312687441706657
an O 0 0.012179724872112274
accurate O 0 0.02293776348233223
predictor O 0 0.3653106987476349
of O 0 0.024625912308692932
age O 0 0.044398825615644455
of O 1 0.5604596138000488
onset O 1 0.9999997615814209
. O 0 0.16514824330806732

In O 0 0.03244919329881668
order O 0 0.028585223481059074
to O 0 0.01763407699763775
further O 0 0.018763603642582893
characterize O 0 0.04245138540863991
the O 0 0.023401444777846336
dynamics O 0 0.042269106954336166
of O 0 0.15296423435211182
DM B-Disease 1 1.0
CTG O 1 0.9999998807907104
repeat O 1 0.9999517202377319
somatic O 1 0.9999676942825317
instability O 1 0.9988654851913452
, O 0 0.02537296526134014
we O 0 0.015493964776396751
have O 0 0.01018514484167099
studied O 0 0.021618027240037918
repeat O 0 0.032610975205898285
length O 0 0.015458132140338421
changes O 0 0.009918383322656155
over O 0 0.011057248339056969
time O 0 0.011910778470337391
in O 0 0.020064951851963997
111 O 1 0.9999891519546509
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999990463256836
with O 0 0.12509874999523163
varying O 0 0.04869166389107704
clinical O 1 0.9999772310256958
severity O 1 0.999996542930603
and O 1 0.9763132929801941
CTG O 1 0.9999992847442627
repeat O 0 0.36467069387435913
size O 0 0.018169859424233437
over O 0 0.013400702737271786
time O 0 0.011340626515448093
intervals O 0 0.01686370186507702
of O 0 0.017356980592012405
1 O 0 0.04580610245466232
- O 1 0.9989748001098633
7 O 0 0.04168833792209625
years O 0 0.029079023748636246
. O 0 0.03606086224317551

We O 0 0.02653818018734455
have O 0 0.011471954174339771
found O 0 0.01337387878447771
a O 0 0.018493469804525375
direct O 0 0.02711307816207409
progression O 0 0.3266981542110443
of O 0 0.019519928842782974
the O 0 0.02386036328971386
size O 0 0.023833055049180984
heterogeneity O 0 0.05466481298208237
over O 0 0.01891118846833706
time O 0 0.015998123213648796
related O 0 0.0157244261354208
to O 0 0.017051933333277702
initial O 0 0.03924405947327614
CTG O 1 0.9999756813049316
repeat O 0 0.07210994511842728
size O 0 0.020989857614040375
and O 0 0.01531129889190197
the O 0 0.01921495608985424
time O 0 0.021649599075317383
interval O 0 0.046075254678726196
and O 0 0.023284783586859703
always O 0 0.03106258437037468
biased O 0 0.04595738276839256
towards O 0 0.03521174564957619
further O 0 0.030591564252972603
expansion O 0 0.05778142437338829
. O 0 0.04705004394054413

Attempts O 0 0.06493230909109116
to O 0 0.02767340838909149
mathematically O 0 0.04262082278728485
model O 0 0.027846021577715874
the O 0 0.0212094746530056
dynamics O 0 0.031500570476055145
have O 0 0.01025170274078846
proved O 0 0.02285677008330822
only O 0 0.013272162526845932
partially O 0 0.03517695516347885
successful O 0 0.02650291472673416
suggesting O 0 0.01831509917974472
that O 0 0.008088702335953712
individual O 0 0.01111894566565752
specific O 0 0.010973541997373104
genetic O 0 0.022203879430890083
and O 0 0.04255758225917816
/ O 1 0.9999971389770508
or O 0 0.023709651082754135
environmental O 0 0.056184299290180206
factors O 0 0.014576975256204605
also O 0 0.009967337362468243
play O 0 0.011204340495169163
a O 0 0.01702706143260002
role O 0 0.031520478427410126
in O 0 0.030148066580295563
somatic O 1 0.999293327331543
mosaicism O 1 0.9999394416809082
. O 0 0.04087105393409729
. O 0 0.045917436480522156

Aspartylglucosaminuria B-Disease 1 0.9993785619735718
among O 0 0.07714973390102386
Palestinian O 0 0.1168309897184372
Arabs O 0 0.12070538848638535
. O 0 0.06697563827037811

Aspartylglucosaminuria B-Disease 1 0.9999967813491821
( O 1 0.9473059177398682
AGU B-Disease 1 0.9999990463256836
) O 0 0.027501599863171577
is O 0 0.016838109120726585
a O 0 0.025558345019817352
rare O 1 0.8782385587692261
disorder B-Disease 1 0.9999997615814209
of I-Disease 1 0.9996318817138672
glycoprotein I-Disease 1 0.9999998807907104
metabolism I-Disease 1 0.9999257326126099
caused O 0 0.2014884203672409
by O 0 0.02255101501941681
the O 0 0.05398721247911453
deficiency B-Disease 1 0.9999997615814209
of I-Disease 0 0.1026020497083664
the I-Disease 1 0.9943763017654419
lysosomal I-Disease 1 1.0
enzyme I-Disease 1 0.9999645948410034
aspartylglucosaminidase I-Disease 1 0.9999988079071045
( O 1 0.8760800361633301
AGA O 1 0.9999970197677612
) O 0 0.05456274002790451
. O 0 0.047593556344509125

AGU B-Disease 1 0.9999960660934448
is O 0 0.050632230937480927
inherited O 1 0.9454389810562134
as O 0 0.02947535552084446
an O 0 0.16563284397125244
autosomal O 1 0.9999995231628418
recessive O 1 0.9999998807907104
trait O 1 0.999982476234436
and O 0 0.22336448729038239
occurs O 0 0.022218065336346626
with O 0 0.013265825808048248
a O 0 0.02040168084204197
high O 0 0.033912330865859985
frequency O 0 0.01660020649433136
in O 0 0.01045896578580141
Finland O 0 0.027818413451313972
because O 0 0.01196811068803072
of O 0 0.015605813823640347
a O 0 0.03507035970687866
founder O 1 0.9990403056144714
effect O 0 0.050216685980558395
. O 0 0.04359103739261627

While O 0 0.035732071846723557
very O 0 0.024208644405007362
few O 0 0.025080911815166473
patients O 1 0.9922646284103394
with O 0 0.05675175413489342
AGU B-Disease 1 1.0
have O 0 0.012792282737791538
been O 0 0.011202956549823284
reported O 0 0.013599518686532974
from O 0 0.012427483685314655
non O 0 0.05962080880999565
- O 1 0.9986369013786316
Finnish O 0 0.056025728583335876
origin O 0 0.013134807348251343
, O 0 0.013679328374564648
we O 0 0.016002170741558075
diagnosed O 1 0.9999958276748657
the O 1 0.8846890926361084
disorder O 1 0.9999998807907104
in O 0 0.028096772730350494
8 O 0 0.3721258342266083
patients O 1 0.9975267052650452
originating O 0 0.03509019315242767
from O 0 0.01620873250067234
3 O 0 0.024409685283899307
unrelated O 0 0.02909446693956852
families O 0 0.019912295043468475
, O 0 0.014302927069365978
all O 0 0.012388043105602264
Palestinian O 0 0.0363655649125576
Arabs O 0 0.03507094457745552
from O 0 0.015994245186448097
the O 0 0.019355952739715576
region O 0 0.027285538613796234
of O 0 0.029980821534991264
Jerusalem O 1 0.8608827590942383
. O 0 0.054241493344306946

The O 0 0.05971264839172363
clinical O 1 0.9994543194770813
diagnosis O 1 0.9999992847442627
of O 1 0.9999051094055176
AGU B-Disease 1 1.0
is O 0 0.3415985703468323
often O 0 0.018251363188028336
difficult O 0 0.019332559779286385
, O 0 0.013184016570448875
in O 0 0.009015362709760666
particular O 0 0.010335447266697884
early O 0 0.010847803205251694
in O 0 0.007119493559002876
the O 0 0.009958899579942226
course O 0 0.016280928626656532
of O 0 0.017260383814573288
the O 1 0.9905258417129517
disease O 1 0.9999998807907104
, O 0 0.018943993374705315
and O 0 0.009866178967058659
most O 0 0.00887549389153719
of O 0 0.013549160212278366
the O 0 0.4377845525741577
patients O 1 0.9999908208847046
are O 0 0.01618369109928608
diagnosed O 1 0.9999978542327881
after O 0 0.03799265995621681
the O 0 0.024925431236624718
age O 0 0.031115597113966942
of O 0 0.02643747068941593
5 O 0 0.03753133490681648
years O 0 0.03358437120914459
. O 0 0.03841675445437431

However O 0 0.0364520400762558
, O 0 0.02816246636211872
since O 0 0.02515415847301483
these O 0 0.020455574616789818
patients O 1 0.9821975231170654
excrete O 1 0.9546169638633728
early O 0 0.023655757308006287
large O 0 0.016816752031445503
amounts O 0 0.013202355243265629
of O 0 0.01847578026354313
aspartylglucosamine O 1 0.9970402121543884
in O 0 0.023651307448744774
urine O 0 0.3198070824146271
, O 0 0.0264948271214962
biochemical O 0 0.49441567063331604
screening O 0 0.15535077452659607
is O 0 0.019890569150447845
easy O 0 0.03379622846841812
by O 0 0.030139660462737083
urine O 1 0.8934268355369568
chromatography O 1 0.9925410747528076
. O 0 0.03684511408209801
. O 0 0.041953492909669876

Detection O 0 0.07733859866857529
of O 0 0.03058275766670704
heterozygous O 0 0.047886449843645096
carriers O 0 0.03267844766378403
of O 0 0.02220800146460533
the O 1 0.5867782831192017
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.11466220766305923
ATM O 1 0.8552067875862122
) O 0 0.018735108897089958
gene O 0 0.022302692756056786
by O 0 0.022302210330963135
G2 O 1 0.9999778270721436
phase O 1 0.880462646484375
chromosomal O 1 0.9978359341621399
radiosensitivity O 1 0.9998282194137573
of O 1 0.9636436700820923
peripheral O 1 0.9999997615814209
blood O 1 0.999996542930603
lymphocytes O 1 0.9999940395355225
. O 0 0.08118104934692383

In O 0 0.05813415348529816
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999996423721313
telangiectasia I-Disease 1 0.9999996423721313
( O 0 0.11779573559761047
A B-Disease 1 0.9999847412109375
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.031936708837747574
patients O 1 0.9327762722969055
, O 0 0.015612801536917686
mutations O 0 0.01651255041360855
in O 0 0.008766279555857182
a O 0 0.01653456501662731
single O 0 0.027370305731892586
gene O 0 0.022475291043519974
, O 0 0.015931975096464157
ATM O 0 0.04715117812156677
, O 0 0.010876940563321114
result O 0 0.009586488828063011
in O 0 0.011787991970777512
an O 0 0.31610023975372314
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.43846243619918823
embraces O 1 0.9996060729026794
a O 0 0.02601347677409649
variety O 0 0.01806851662695408
of O 0 0.023019349202513695
clinical O 1 0.999622106552124
features O 0 0.03372650593519211
and O 0 0.0268629752099514
manifests O 1 0.9989774227142334
extreme O 1 0.9993778467178345
radiosensitivity O 1 0.9999592304229736
and O 0 0.018569501116871834
a O 0 0.02169029600918293
strong O 0 0.03239273279905319
pre O 1 0.9990555644035339
- O 1 0.999993085861206
disposition O 1 0.9990683197975159
to O 0 0.05381011590361595
malignancy B-Disease 1 0.9999951124191284
. O 0 0.057078879326581955

Heterozygotes O 0 0.16300931572914124
for O 0 0.03110707551240921
the O 0 0.033783264458179474
ATM O 1 0.9156287908554077
gene O 0 0.025922633707523346
have O 0 0.008376472629606724
no O 0 0.011634073220193386
clinical O 0 0.02645077556371689
expression O 0 0.017026599496603012
of O 0 0.018425334244966507
A B-Disease 1 0.9999881982803345
- I-Disease 1 1.0
T I-Disease 1 0.9999994039535522
but O 0 0.015471627935767174
may O 0 0.015220614150166512
be O 0 0.016449827700853348
cancer B-Disease 1 0.9999978542327881
prone O 1 0.9997735619544983
with O 0 0.01918250322341919
a O 0 0.02922379970550537
moderate O 1 0.9515169858932495
increase O 0 0.019389914348721504
in O 0 0.016488006338477135
in O 0 0.024434100836515427
vitro O 1 0.7588908672332764
radiosensitivity O 1 0.9978627562522888
. O 0 0.05798458680510521

We O 0 0.03341390937566757
performed O 0 0.04226787015795708
a O 0 0.03577549755573273
blind O 1 0.9930376410484314
chromosomal O 0 0.17183372378349304
analysis O 0 0.01868254318833351
on O 0 0.027227457612752914
G2 O 1 0.9999998807907104
- O 1 0.9999927282333374
phase O 1 0.8598571419715881
lymphocytes O 1 0.9659184813499451
from O 0 0.013689721934497356
7 O 0 0.023165972903370857
unrelated O 0 0.03510502725839615
A B-Disease 1 0.9996218681335449
- I-Disease 1 1.0
T I-Disease 1 0.9999996423721313
patients O 1 0.9288852214813232
, O 0 0.01577742211520672
13 O 0 0.020972777158021927
obligate O 0 0.2865017354488373
A B-Disease 1 0.9997934699058533
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
heterozygotes O 1 0.9997609257698059
( O 0 0.021004091948270798
parents O 0 0.020188115537166595
of O 0 0.017516696825623512
the O 0 0.0633661150932312
patients O 1 0.9999427795410156
) O 0 0.019288990646600723
, O 0 0.013527197763323784
and O 0 0.011032050475478172
14 O 0 0.01688874326646328
normal O 0 0.017578281462192535
controls O 0 0.024560032412409782
following O 0 0.02563389018177986
X O 1 0.9993669390678406
- O 1 0.9999067783355713
irradiation O 0 0.08821558952331543
with O 0 0.020366279408335686
1 O 0 0.038203660398721695
Gy O 1 0.9863870143890381
in O 0 0.0155732911080122
order O 0 0.017614733427762985
to O 0 0.015063443221151829
evaluate O 0 0.03092467412352562
this O 0 0.015267564915120602
cytogenetic O 1 0.5697044134140015
method O 0 0.01925043947994709
as O 0 0.014024307951331139
a O 0 0.019647227600216866
tool O 0 0.03682566434144974
for O 0 0.018648387864232063
detection O 0 0.048871949315071106
of O 0 0.03751423954963684
ATM O 1 0.9937665462493896
carriers O 0 0.08906767517328262
. O 0 0.04909966513514519

Both O 0 0.039192818105220795
A B-Disease 1 0.9969899654388428
- I-Disease 1 0.9999997615814209
T I-Disease 1 0.9999978542327881
homozygotes O 1 0.9990781545639038
and O 0 0.03939250111579895
heterozygotes O 1 0.9854376316070557
showed O 0 0.02885870262980461
significantly O 0 0.02090607024729252
increased O 0 0.016270507127046585
levels O 0 0.018414834514260292
of O 0 0.028706880286335945
radiation O 1 0.9999960660934448
- O 1 0.9999998807907104
induced O 1 0.9999996423721313
chromatid O 1 0.9999995231628418
damage O 1 0.7691276669502258
relative O 0 0.03412575274705887
to O 0 0.016433896496891975
that O 0 0.011393235065042973
of O 0 0.020807065069675446
normal O 0 0.039536360651254654
controls O 0 0.064403235912323
. O 0 0.041990816593170166

These O 0 0.021601587533950806
results O 0 0.015112022869288921
show O 0 0.014785964041948318
that O 0 0.008136271499097347
the O 0 0.02372652105987072
G2 O 1 0.9999995231628418
- O 1 0.9999927282333374
phase O 1 0.997700035572052
chromosomal O 1 0.9998109936714172
radiosensitivity O 1 0.9999887943267822
assay O 1 0.7135224342346191
can O 0 0.011994347907602787
be O 0 0.007622851058840752
used O 0 0.006579248234629631
for O 0 0.007562567945569754
the O 0 0.012145659886300564
detection O 0 0.02932734042406082
of O 0 0.024142974987626076
A B-Disease 1 0.9999380111694336
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999967813491821
heterozygotes O 1 0.9862915873527527
. O 0 0.05594601854681969

In O 0 0.03503983095288277
combination O 0 0.04147050529718399
with O 0 0.025484519079327583
molecular O 0 0.04771701619029045
genetic O 0 0.02926226332783699
analyses O 0 0.021495051681995392
, O 0 0.013319630175828934
this O 0 0.00936982687562704
test O 0 0.018913540989160538
may O 0 0.01047839131206274
be O 0 0.005728725343942642
of O 0 0.00842786394059658
value O 0 0.009027784690260887
in O 0 0.008016527630388737
studies O 0 0.011555230244994164
of O 0 0.02084377221763134
familial B-Disease 1 0.9999966621398926
and I-Disease 1 0.7525432109832764
sporadic I-Disease 1 0.9999885559082031
cancers I-Disease 1 0.9999992847442627
aimed O 0 0.22413790225982666
at O 0 0.022046836093068123
determination O 0 0.030323684215545654
of O 0 0.012855828739702702
the O 0 0.013500581495463848
potential O 0 0.016251444816589355
involvement O 0 0.026947973296046257
of O 0 0.022861085832118988
ATM O 1 0.9996798038482666
mutations O 0 0.06399576365947723
in O 0 0.05955343320965767
tumor B-Disease 1 1.0
risk O 1 0.9995834231376648
or O 0 0.0314597487449646
development O 0 0.04108443856239319
. O 0 0.028347652405500412
. O 0 0.03774601221084595

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
telangiectasia I-Disease 1 0.9999990463256836
: O 0 0.0413345992565155
identification O 0 0.026413246989250183
and O 0 0.014729639515280724
detection O 0 0.030352024361491203
of O 0 0.023737676441669464
founder O 1 0.999981164932251
- O 1 0.9999737739562988
effect O 0 0.02398836798965931
mutations O 0 0.018278125673532486
in O 0 0.01048154104501009
the O 0 0.02089875005185604
ATM O 1 0.9579494595527649
gene O 0 0.02528158202767372
in O 0 0.015946006402373314
ethnic O 0 0.036504242569208145
populations O 0 0.047168467193841934
. O 0 0.04744044691324234

To O 0 0.034425076097249985
facilitate O 0 0.04050886258482933
the O 0 0.02715790458023548
evaluation O 0 0.054186128079891205
of O 0 0.031355131417512894
ATM O 1 0.9975131750106812
heterozygotes O 1 0.9700830578804016
for O 0 0.024354327470064163
susceptibility O 1 0.879277229309082
to O 0 0.020747611299157143
other O 0 0.020708151161670685
diseases O 1 0.9999891519546509
, O 0 0.017126645892858505
such O 0 0.015354681760072708
as O 1 0.9999133348464966
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.656848669052124
we O 0 0.012231685221195221
have O 0 0.006999574601650238
attempted O 0 0.019248992204666138
to O 0 0.011670703068375587
define O 0 0.018421722576022148
the O 0 0.013398300856351852
most O 0 0.012658470310270786
common O 0 0.01652299053966999
mutations O 0 0.016122398898005486
and O 0 0.008675772696733475
their O 0 0.007891080342233181
frequencies O 0 0.013780969195067883
in O 0 0.016508564352989197
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999997615814209
( O 0 0.05295443534851074
A B-Disease 1 0.9999431371688843
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999978542327881
) O 0 0.03258673846721649
homozygotes O 0 0.14949707686901093
from O 0 0.021555142477154732
10 O 0 0.025304540991783142
ethnic O 0 0.03899052366614342
populations O 0 0.04646233841776848
. O 0 0.04738349840044975

Both O 0 0.04717231169342995
genomic O 0 0.09278972446918488
mutations O 0 0.04226430132985115
and O 0 0.021792056038975716
their O 0 0.020082661882042885
effects O 0 0.03520260006189346
on O 0 0.027053609490394592
cDNA O 0 0.08179598301649094
were O 0 0.025027774274349213
characterized O 0 0.06465696543455124
. O 0 0.049414582550525665

Protein O 0 0.10825453698635101
- O 1 0.9505110383033752
truncation O 0 0.09846565872430801
testing O 0 0.028827285394072533
of O 0 0.019050301983952522
the O 0 0.023746751248836517
entire O 0 0.04690389335155487
ATM O 0 0.1158478856086731
cDNA O 0 0.08841200917959213
detected O 0 0.04413314536213875
92 O 0 0.0593690499663353
( O 0 0.02811361476778984
66 O 0 0.04635714739561081
% O 0 0.025555603206157684
) O 0 0.023581301793456078
truncating O 0 0.11348140239715576
mutations O 0 0.03556698188185692
in O 0 0.020438775420188904
140 O 0 0.062088288366794586
mutant O 1 0.769913375377655
alleles O 0 0.11980272084474564
screened O 0 0.12550629675388336
. O 0 0.05796947702765465

The O 0 0.05207252874970436
haplotyping O 1 0.9910803437232971
of O 0 0.039793360978364944
patients O 1 0.9828316569328308
with O 0 0.022359712049365044
identical O 0 0.04073621705174446
mutations O 0 0.04634023830294609
indicates O 0 0.019824709743261337
that O 0 0.007242919411510229
almost O 0 0.00779304001480341
all O 0 0.006671884562820196
of O 0 0.009906071238219738
these O 0 0.006876383908092976
represent O 0 0.013348187319934368
common O 0 0.01880287006497383
ancestry O 0 0.02380313165485859
and O 0 0.012706032022833824
that O 0 0.00977399107068777
very O 0 0.012907538563013077
few O 0 0.018151070922613144
spontaneously O 1 0.8085280656814575
recurring O 1 0.9999275207519531
ATM O 1 0.9997982382774353
mutations O 0 0.06107644364237785
exist O 0 0.03630661219358444
. O 0 0.040292661637067795

Assays O 0 0.09600462764501572
requiring O 0 0.046534303575754166
minimal O 0 0.04339874908328056
amounts O 0 0.021183867007493973
of O 0 0.024701399728655815
genomic O 0 0.047933828085660934
DNA O 0 0.025523582473397255
were O 0 0.012125909328460693
designed O 0 0.021692322567105293
to O 0 0.015101976692676544
allow O 0 0.02136232517659664
rapid O 0 0.0631251409649849
screening O 0 0.0732760801911354
for O 0 0.01959979720413685
common O 0 0.029966194182634354
ethnic O 0 0.05205930396914482
mutations O 0 0.06345481425523758
. O 0 0.045821160078048706

These O 0 0.03746245056390762
rapid O 0 0.09223894774913788
assays O 0 0.0640748143196106
detected O 0 0.04655291512608528
mutations O 0 0.02533908747136593
in O 0 0.012447454035282135
76 O 0 0.035874757915735245
% O 0 0.015524819493293762
of O 0 0.01894517056643963
Costa O 1 0.5147354602813721
Rican O 1 0.999743640422821
patients O 1 0.9998007416725159
( O 0 0.02773771621286869
3 O 0 0.023889830335974693
) O 0 0.013422324322164059
, O 0 0.01024646870791912
50 O 0 0.011724145151674747
% O 0 0.009968635626137257
of O 0 0.014782379381358624
Norwegian O 1 0.7217800617218018
patients O 1 0.9996577501296997
( O 0 0.02526310458779335
1 O 0 0.0251819659024477
) O 0 0.012375365942716599
, O 0 0.010048742406070232
25 O 0 0.010619353502988815
% O 0 0.009882878512144089
of O 0 0.0175566878169775
Polish O 1 0.999937891960144
patients O 1 0.9999886751174927
( O 0 0.05632511153817177
4 O 0 0.028475159779191017
) O 0 0.014284147880971432
, O 0 0.009808645583689213
and O 0 0.00904096756130457
14 O 0 0.01317320205271244
% O 0 0.010363574139773846
of O 0 0.01565328799188137
Italian O 1 0.9998443126678467
patients O 1 0.9999910593032837
( O 0 0.06816677004098892
1 O 0 0.04004320502281189
) O 0 0.015440006740391254
, O 0 0.010577778331935406
as O 0 0.009197407402098179
well O 0 0.008172937668859959
as O 0 0.010095727629959583
in O 0 0.01137615367770195
patients O 0 0.07829558849334717
of O 0 0.03542749211192131
Amish O 1 0.9999841451644897
/ O 1 0.9999551773071289
Mennonite O 1 0.9817367792129517
and O 0 0.03476851433515549
Irish O 0 0.07774985581636429
English O 0 0.04641132801771164
backgrounds O 0 0.05808040499687195
. O 0 0.04830854758620262

Additional O 0 0.04581942781805992
mutations O 0 0.03499877080321312
were O 0 0.013879623264074326
observed O 0 0.017521562054753304
in O 0 0.013276259414851665
Japanese O 0 0.03144931420683861
, O 0 0.02034326083958149
Utah O 0 0.05116066336631775
Mormon O 0 0.07108734548091888
, O 0 0.023699376732110977
and O 0 0.02330615557730198
African O 0 0.060214269906282425
American O 0 0.4597221314907074
patients O 1 0.9961483478546143
. O 0 0.05798778682947159

These O 0 0.03297315910458565
assays O 0 0.04068565368652344
should O 0 0.01945018582046032
facilitate O 0 0.0319962203502655
screening O 0 0.03893299400806427
for O 0 0.022061049938201904
A B-Disease 1 0.9999258518218994
- I-Disease 1 1.0
T I-Disease 1 0.9999973773956299
heterozygotes O 1 0.6104854941368103
in O 0 0.016772085800766945
the O 0 0.022966260090470314
populations O 0 0.028190743178129196
studied O 0 0.0321650430560112
. O 0 0.024574436247348785
. O 0 0.03300252929329872

The O 0 0.05852813273668289
von B-Disease 1 0.9217160940170288
Hippel I-Disease 1 0.9999856948852539
- I-Disease 1 0.9999998807907104
Lindau I-Disease 1 0.9999998807907104
tumor I-Disease 1 1.0
suppressor O 1 0.999996542930603
gene O 0 0.04251229017972946
is O 0 0.01831897720694542
required O 0 0.01583101786673069
for O 0 0.02025747299194336
cell O 0 0.04805658385157585
cycle O 0 0.06084795296192169
exit O 0 0.08407969027757645
upon O 0 0.060404349118471146
serum O 1 0.9994527697563171
withdrawal O 1 0.7150077223777771
. O 0 0.06390716135501862

The O 0 0.05293240025639534
inactivation O 0 0.3307799696922302
of O 0 0.02909906767308712
the O 0 0.03771438077092171
von B-Disease 1 0.9976900815963745
Hippel I-Disease 1 0.9999953508377075
- I-Disease 1 0.999998927116394
Lindau I-Disease 1 0.999995231628418
( I-Disease 0 0.1350112408399582
VHL I-Disease 1 0.9999983310699463
) I-Disease 1 0.5147808790206909
tumor I-Disease 1 0.9999997615814209
suppressor O 1 0.9999995231628418
gene O 1 0.6855537295341492
predisposes O 1 0.9991975426673889
affected O 0 0.023689746856689453
individuals O 0 0.010809828527271748
to O 0 0.011092771776020527
the O 0 0.020197046920657158
human O 1 0.9998661279678345
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.7383407354354858
is O 0 0.018125124275684357
associated O 0 0.015360875055193901
with O 0 0.01796341873705387
sporadic B-Disease 1 0.9999891519546509
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999896287918091
RCC B-Disease 1 1.0
) O 0 0.11351167410612106
and O 0 0.05147882550954819
brain B-Disease 1 0.9974308609962463
hemangioblastomas I-Disease 1 0.9996504783630371
. O 0 0.05997872352600098

VHL O 1 0.9998397827148438
- O 1 0.9978098273277283
negative O 0 0.06620920449495316
786 O 1 0.9996486902236938
- O 1 0.9999939203262329
0 O 1 0.9507496953010559
RCC B-Disease 1 0.9999996423721313
cells O 0 0.03868260979652405
are O 0 0.012597897090017796
tumorigenic O 1 0.9115170240402222
in O 0 0.023912137374281883
nude O 1 0.9986063838005066
mice O 0 0.05189527943730354
which O 0 0.014619473367929459
is O 0 0.015395713970065117
suppressed O 0 0.039966851472854614
by O 0 0.017094137147068977
the O 0 0.025632960721850395
reintroduction O 1 0.9006040692329407
of O 0 0.06738684326410294
VHL B-Disease 1 0.9999786615371704
. O 0 0.0638754740357399

Remarkably O 0 0.20372776687145233
, O 0 0.028419282287359238
this O 0 0.015883618965744972
occurs O 0 0.018156835809350014
without O 0 0.012408069334924221
affecting O 0 0.02262520231306553
the O 0 0.01802934892475605
growth O 0 0.028415026143193245
rate O 0 0.023806221783161163
and O 0 0.019091542810201645
cell O 0 0.07696861028671265
cycle O 0 0.039284829050302505
profile O 0 0.037250883877277374
of O 0 0.020331241190433502
these O 0 0.015714142471551895
cells O 0 0.029761862009763718
in O 0 0.021558061242103577
culture O 0 0.04944511875510216
. O 0 0.04371493309736252

The O 0 0.058409176766872406
786 O 1 0.9989249110221863
- O 1 0.999825656414032
0 O 0 0.054736264050006866
cell O 0 0.040422968566417694
line O 0 0.029070280492305756
, O 0 0.0170619897544384
like O 0 0.018473433330655098
many O 0 0.021688787266612053
cancer B-Disease 1 0.9999996423721313
cells O 0 0.29566776752471924
, O 0 0.025851918384432793
fails O 0 0.04525333270430565
to O 0 0.018041379749774933
exit O 0 0.04175488278269768
the O 0 0.026416491717100143
cell O 0 0.051801521331071854
cycle O 0 0.05730074644088745
upon O 0 0.052346497774124146
serum O 1 0.9993948936462402
withdrawal O 1 0.8309403657913208
. O 0 0.06164805218577385

Here O 0 0.04363791644573212
, O 0 0.024709384888410568
it O 0 0.01282588578760624
is O 0 0.012509364634752274
shown O 0 0.010441646911203861
that O 0 0.008854926563799381
reintroduction O 0 0.03348410874605179
of O 0 0.013917939737439156
the O 0 0.01932138204574585
wild O 0 0.046782396733760834
- O 1 0.9999933242797852
type O 1 0.9470317363739014
VHL B-Disease 1 0.9999630451202393
gene O 0 0.03079555183649063
restores O 0 0.04963817447423935
the O 0 0.014056792482733727
ability O 0 0.013828852213919163
of O 0 0.02447698824107647
VHL O 1 0.9999996423721313
- O 1 0.9999997615814209
negative O 1 0.9998540878295898
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cells O 0 0.035305265337228775
to O 0 0.016634929925203323
exit O 0 0.04082702845335007
the O 0 0.024594709277153015
cell O 0 0.04713521897792816
cycle O 0 0.03921407088637352
and O 0 0.025317728519439697
enter O 0 0.10930880159139633
G0 O 1 0.9999992847442627
/ O 1 0.9999377727508545
quiescence O 1 0.9993446469306946
in O 0 0.04661095142364502
low O 0 0.46385279297828674
serum O 1 0.9968116879463196
. O 0 0.06617451459169388

Both O 0 0.06030650436878204
VHL O 1 0.9999701976776123
- O 1 0.9992901086807251
positive O 0 0.03825923800468445
and O 0 0.03276366367936134
VHL O 1 0.9999982118606567
- O 1 0.9999991655349731
negative O 1 0.9937241673469543
RCC B-Disease 1 0.9999998807907104
cells O 0 0.04779764637351036
exit O 0 0.04764612391591072
the O 0 0.027462366968393326
cell O 0 0.05451004579663277
cycle O 0 0.04685603082180023
by O 0 0.029968535527586937
contact O 0 0.3723613917827606
inhibition O 1 0.9821256399154663
. O 0 0.04979614168405533

The O 0 0.07061684131622314
cyclin O 1 0.9997395873069763
- O 1 0.9998425245285034
dependent O 0 0.4306527376174927
kinase O 1 0.9996726512908936
inhibitor O 1 0.9999417066574097
, O 0 0.044319842010736465
p27 O 1 0.9997239708900452
, O 0 0.03427014499902725
accumulates O 1 0.5818416476249695
upon O 0 0.041627611964941025
serum O 1 0.9999798536300659
withdrawal O 0 0.4192565977573395
, O 0 0.013409914448857307
only O 0 0.007086973171681166
in O 0 0.007008436135947704
the O 0 0.011609424836933613
presence O 0 0.02316497080028057
of O 0 0.03352879360318184
VHL B-Disease 1 0.9999992847442627
, O 0 0.017368802800774574
as O 0 0.013089978136122227
a O 0 0.013964919373393059
result O 0 0.01156624685972929
of O 0 0.013159619644284248
the O 0 0.02231822907924652
stabilization O 1 0.9867817759513855
of O 0 0.027338486164808273
the O 0 0.0434570237994194
protein O 0 0.04534203186631203
. O 0 0.03488766402006149

We O 0 0.03018069453537464
propose O 0 0.03464370593428612
that O 0 0.009622876532375813
the O 0 0.012674272991716862
loss O 0 0.018775835633277893
of O 0 0.017458509653806686
wild O 0 0.3532145023345947
- O 1 0.9999991655349731
type O 1 0.9977321624755859
VHL B-Disease 1 0.9999970197677612
gene O 0 0.02249228022992611
results O 0 0.009077026508748531
in O 0 0.007436589803546667
a O 0 0.013058273121714592
specific O 0 0.01244283840060234
cellular O 0 0.04547511786222458
defect O 1 0.9945212602615356
in O 0 0.025100165978074074
serum O 1 0.9999971389770508
- O 1 0.9999974966049194
dependent O 0 0.043293122202157974
growth O 0 0.02863457426428795
control O 0 0.025900891050696373
, O 0 0.01777210459113121
which O 0 0.015785368159413338
may O 0 0.028241707012057304
initiate O 1 0.9994646906852722
tumor B-Disease 1 0.9999996423721313
formation O 1 0.996904194355011
. O 0 0.05783739313483238

This O 0 0.029460148885846138
is O 0 0.024338405579328537
corrected O 0 0.04358948767185211
by O 0 0.012908108532428741
the O 0 0.01685737818479538
reintroduction O 0 0.050228215754032135
of O 0 0.021590188145637512
wild O 0 0.19178839027881622
- O 1 0.9999988079071045
type O 1 0.9814762473106384
VHL B-Disease 1 0.9999948740005493
, O 0 0.03462746739387512
implicating O 1 0.9998867511749268
VHL B-Disease 1 0.9999619722366333
as O 0 0.01732533983886242
the O 0 0.021208278834819794
first O 1 0.7916521430015564
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9999539852142334
involved O 0 0.017383400350809097
in O 0 0.00878281518816948
the O 0 0.012881718575954437
regulation O 0 0.020816244184970856
of O 0 0.021226389333605766
cell O 1 0.8506331443786621
cycle O 0 0.2316676825284958
exit O 0 0.13822418451309204
, O 0 0.014741586521267891
which O 0 0.00887663196772337
is O 0 0.009043889120221138
consistent O 0 0.01524034608155489
with O 0 0.010872682556509972
its O 0 0.02092563547194004
gatekeeper O 1 0.9999767541885376
function O 0 0.02429017424583435
in O 0 0.019522614777088165
the O 1 0.6920116543769836
kidney O 1 1.0
. O 0 0.04903459548950195
. O 0 0.04598855599761009

Piebaldism B-Disease 1 0.9999701976776123
with O 1 0.8952365517616272
deafness B-Disease 1 1.0
: O 0 0.04793575033545494
molecular O 0 0.027203023433685303
evidence O 0 0.015777334570884705
for O 0 0.015332500450313091
an O 0 0.03393878415226936
expanded O 1 0.9845169186592102
syndrome O 1 1.0
. O 0 0.07655799388885498

In O 0 0.025113346055150032
a O 0 0.023920917883515358
South O 0 0.03670378401875496
African O 0 0.04281531646847725
girl O 1 0.8239754438400269
of O 0 0.03514649346470833
Xhosa O 1 0.9999947547912598
stock O 0 0.48834115266799927
with O 0 0.030603572726249695
severe O 1 0.9999892711639404
piebaldism B-Disease 1 0.9999978542327881
and O 1 0.9889905452728271
profound O 1 0.9999998807907104
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.25519391894340515
identified O 0 0.028737502172589302
a O 0 0.021652327850461006
novel O 0 0.03566718101501465
missense O 0 0.06683540344238281
substitution O 0 0.036771249026060104
at O 0 0.01653965190052986
a O 0 0.01661931723356247
highly O 0 0.022669974714517593
conserved O 0 0.02415747009217739
residue O 0 0.02880491502583027
in O 0 0.010655819438397884
the O 0 0.021231362596154213
intracellular O 1 0.9898307919502258
kinase O 1 0.7101161479949951
domain O 0 0.023104142397642136
of O 0 0.015118866227567196
the O 0 0.028805455192923546
KIT O 1 0.999992847442627
proto O 1 0.9999961853027344
- O 1 0.9999966621398926
oncogene O 1 0.9999325275421143
, O 0 0.05922887474298477
R796G O 1 0.9461899399757385
. O 0 0.05696650594472885

Though O 0 0.08054956793785095
auditory B-Disease 1 0.9961611032485962
anomalies I-Disease 1 0.6781899929046631
have O 0 0.012693931348621845
been O 0 0.013873077929019928
observed O 0 0.015272811986505985
in O 0 0.011953228153288364
mice O 0 0.02334960363805294
with O 0 0.014040597714483738
dominant O 1 0.748094916343689
white O 1 0.9977898597717285
spotting O 1 0.9999901056289673
( O 1 0.6495987772941589
W O 1 0.9999275207519531
) O 0 0.015996210277080536
due O 0 0.01562971994280815
to O 0 0.019942814484238625
KIT O 1 0.9999982118606567
mutations O 1 0.9362099766731262
, O 1 0.9020916223526001
deafness B-Disease 1 1.0
is O 0 0.029612014070153236
not O 0 0.015827219933271408
typical O 0 0.029190409928560257
in O 0 0.020693982020020485
human O 0 0.04524567723274231
piebaldism B-Disease 1 0.9983785152435303
. O 0 0.05902994051575661

Thus O 0 0.0393911711871624
, O 0 0.019415143877267838
the O 0 0.020959697663784027
occurrence O 0 0.05539431422948837
of O 1 0.9369173645973206
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.5209306478500366
this O 0 0.0334632433950901
patient O 1 0.9997661709785461
extends O 0 0.07776984572410583
considerably O 0 0.027490470558404922
the O 0 0.0179786067456007
phenotypic O 0 0.03377121686935425
range O 0 0.018158890306949615
of O 0 0.022593701258301735
piebaldism B-Disease 1 0.9967334270477295
due O 0 0.027199598029255867
to O 0 0.027606753632426262
KIT O 1 0.9999775886535645
gene O 0 0.044043365865945816
mutation O 0 0.03442440554499626
in O 0 0.016331437975168228
humans O 0 0.021286502480506897
and O 0 0.024432476609945297
tightens O 1 0.9733684659004211
the O 0 0.028088673949241638
clinical O 1 0.5886890292167664
similarity O 0 0.03406064957380295
between O 0 0.025744671002030373
piebaldism B-Disease 1 0.9992269277572632
and O 0 0.015785865485668182
the O 0 0.013516701757907867
various O 0 0.010685930959880352
forms O 0 0.02683217264711857
of O 1 0.9998431205749512
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.8281075954437256
. O 0 0.05923737958073616

Cycloheximide O 1 0.9773693680763245
facilitates O 0 0.09565245360136032
the O 0 0.03214012458920479
identification O 0 0.031696271151304245
of O 0 0.027064453810453415
aberrant O 1 0.987825334072113
transcripts O 0 0.03836479038000107
resulting O 0 0.01804014854133129
from O 0 0.012341491878032684
a O 0 0.020185504108667374
novel O 0 0.04289942979812622
splice O 1 0.8375787734985352
- O 1 0.9961795806884766
site O 0 0.034862302243709564
mutation O 0 0.02863985113799572
in O 0 0.01473165862262249
COL17A1 O 1 0.9943244457244873
in O 0 0.01705344207584858
a O 0 0.03033658117055893
patient O 1 0.9996416568756104
with O 1 0.6013854742050171
generalized O 1 0.9999996423721313
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
. O 0 0.20502394437789917

Patients O 1 0.9943109750747681
with O 0 0.07987808436155319
generalized O 1 0.9999934434890747
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.04719230532646179
show O 0 0.029808437451720238
decreased O 0 0.03534311428666115
expression O 0 0.026972809806466103
of O 0 0.032751522958278656
type O 1 0.9999614953994751
XVII O 1 1.0
collagen O 1 0.9999998807907104
, O 0 0.03774658963084221
a O 0 0.04479748010635376
transmembrane O 1 0.9980769157409668
hemidesmosomal O 1 0.9989226460456848
protein O 0 0.036409053951501846
encoded O 0 0.025886889547109604
by O 0 0.03174518421292305
COL17A1 O 1 0.995604395866394
. O 0 0.05562705546617508

This O 0 0.022748490795493126
report O 0 0.019667180255055428
documents O 0 0.015575866214931011
a O 0 0.019824806600809097
novel O 0 0.04550371319055557
splice O 1 0.5819728374481201
- O 1 0.998480498790741
site O 0 0.03551838546991348
mutation O 0 0.028734825551509857
in O 0 0.01481772679835558
COL17A1 O 1 0.9948503375053406
in O 0 0.015991782769560814
a O 0 0.030654696747660637
patient O 1 0.9987010955810547
with O 0 0.045371927320957184
generalized O 1 0.9999960660934448
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.32054728269577026
and O 0 0.02713930793106556
applies O 0 0.029022278264164925
a O 0 0.02209257148206234
new O 0 0.023381760343909264
methodology O 0 0.027504289522767067
to O 0 0.015368704684078693
define O 0 0.028322353959083557
and O 0 0.018955837935209274
characterize O 0 0.048569079488515854
the O 0 0.02847353368997574
resulting O 0 0.04622245579957962
mRNA O 0 0.0765751376748085
splice O 0 0.11839618533849716
variants O 0 0.05437011271715164
. O 0 0.044686540961265564

Mutational O 1 0.5780224204063416
analysis O 0 0.031306229531764984
of O 0 0.03351482376456261
COL17A1 O 1 0.9949016571044922
identified O 0 0.033217985183000565
a O 0 0.02978513017296791
maternally O 0 0.45029231905937195
inherited O 1 0.9991125464439392
G O 1 0.9996234178543091
- O 1 0.9995146989822388
to O 0 0.03376293182373047
- O 1 0.999981164932251
T O 1 0.9984034895896912
transversion O 1 0.6745070219039917
at O 0 0.02008180320262909
the O 0 0.021448496729135513
- O 1 0.995215892791748
1 O 0 0.022288616746664047
position O 0 0.02161724679172039
of O 0 0.02440013363957405
exon O 0 0.12101864814758301
32 O 0 0.06052703037858009
. O 0 0.0463804230093956

This O 0 0.04326567426323891
acceptor O 1 0.7975770831108093
splice O 1 0.9488673806190491
- O 1 0.9992039799690247
site O 0 0.04149417579174042
mutation O 0 0.032626960426568985
led O 0 0.02481243759393692
to O 0 0.013790701515972614
the O 0 0.016412943601608276
formation O 0 0.03148145228624344
of O 0 0.02430763468146324
aberrant O 1 0.9991549253463745
transcripts O 0 0.04419704154133797
present O 0 0.025561554357409477
at O 0 0.028950585052371025
extremely O 0 0.044231195002794266
low O 0 0.08616917580366135
levels O 0 0.050003986805677414
. O 0 0.04393314942717552

Based O 0 0.0401056744158268
on O 0 0.020388351753354073
our O 0 0.022066950798034668
recent O 0 0.01887664571404457
finding O 0 0.025308039039373398
that O 0 0.01749904453754425
cycloheximide O 1 0.9799243211746216
stabilized O 1 0.9930197596549988
mutant O 1 0.7609344124794006
COL17A1 O 1 0.9995713829994202
transcripts O 0 0.05067555606365204
in O 0 0.022653179243206978
keratinocytes O 0 0.42050036787986755
homozygous O 0 0.050964269787073135
for O 0 0.019856993108987808
a O 0 0.0353858508169651
frameshift O 1 0.9991809725761414
mutation O 0 0.04727806895971298
, O 0 0.01589946635067463
the O 0 0.01512167789041996
effects O 0 0.01895541325211525
of O 0 0.014773006550967693
the O 0 0.02900734916329384
splice O 1 0.9980146884918213
- O 1 0.9995983242988586
site O 0 0.030532075092196465
mutation O 0 0.023409172892570496
on O 0 0.012637319043278694
splicing O 0 0.028041057288646698
of O 0 0.02196882851421833
COL17A1 O 1 0.9958445429801941
transcripts O 0 0.036597177386283875
were O 0 0.011640033684670925
determined O 0 0.018280185759067535
using O 0 0.014234148897230625
reverse O 0 0.05016253516077995
transcriptase O 1 0.9391722679138184
polymerase O 0 0.4530869126319885
chain O 0 0.05419096350669861
reaction O 0 0.02703722193837166
of O 0 0.018248271197080612
total O 0 0.02399703487753868
RNA O 0 0.04731268063187599
from O 0 0.02491719275712967
keratinocytes O 1 0.8712676763534546
incubated O 0 0.10765301436185837
for O 0 0.03308036923408508
2 O 0 0.05311790108680725
. O 0 0.04746203497052193

5 O 0 0.07065068185329437
h O 0 0.08233749866485596
in O 0 0.015929384157061577
the O 0 0.020060189068317413
presence O 0 0.029545528814196587
or O 0 0.01838974840939045
absence O 0 0.03222908452153206
of O 0 0.025784630328416824
10 O 0 0.04098956286907196
microg O 1 0.999398946762085
cycloheximide O 1 0.999203622341156
per O 0 0.054363563656806946
ml O 1 0.9707052707672119
. O 0 0.05680404230952263

Using O 0 0.029678748920559883
this O 0 0.01742836833000183
approach O 0 0.02461177110671997
, O 0 0.017678068950772285
an O 0 0.021566910669207573
abnormally O 1 0.9803438186645508
spliced O 0 0.05853432044386864
transcript O 0 0.03791545704007149
was O 0 0.02367808111011982
identified O 0 0.016447734087705612
that O 0 0.008155813440680504
contains O 0 0.013312920928001404
an O 0 0.012878602370619774
extra O 0 0.02274549938738346
264 O 0 0.046985141932964325
bases O 0 0.0277276411652565
upstream O 0 0.03198406100273132
from O 0 0.01977747492492199
exon O 0 0.07109272480010986
32 O 0 0.032166987657547
, O 0 0.01789151318371296
resulting O 0 0.020615840330719948
in O 0 0.014120747335255146
a O 0 0.03161986172199249
premature O 1 0.9964854717254639
termination O 1 0.99562007188797
codon O 0 0.10381011664867401
27 O 0 0.047836776822805405
bp O 0 0.05771496146917343
downstream O 0 0.03495967015624046
from O 0 0.018354373052716255
the O 0 0.030339227989315987
cryptic O 1 0.7019860744476318
splice O 0 0.37894585728645325
site O 0 0.06319468468427658
. O 0 0.04396319016814232

Three O 0 0.03223259001970291
other O 0 0.028130454942584038
splice O 0 0.11577914655208588
variants O 0 0.03215641528367996
, O 0 0.016436709091067314
including O 0 0.012490576133131981
one O 0 0.014902947470545769
derived O 0 0.01372310146689415
from O 0 0.010749158449470997
the O 0 0.01692178100347519
skipping O 0 0.051248740404844284
of O 0 0.030231734737753868
exon O 1 0.7085637450218201
32 O 0 0.04142151027917862
, O 0 0.02150360494852066
were O 0 0.015368934720754623
also O 0 0.020827824249863625
identified O 0 0.03656505048274994
. O 0 0.03533207252621651

These O 0 0.025014465674757957
results O 0 0.01899944432079792
indicate O 0 0.018156137317419052
the O 0 0.017330799251794815
usefulness O 0 0.054629214107990265
of O 0 0.0372706837952137
cycloheximide O 1 0.9999946355819702
treatment O 1 0.9998098015785217
in O 0 0.02025013044476509
evaluating O 0 0.0420491024851799
the O 0 0.024574417620897293
abnormal O 0 0.43786749243736267
processing O 0 0.017757637426257133
of O 0 0.015254409052431583
mRNA O 0 0.026872770860791206
due O 0 0.014068507589399815
to O 0 0.016694312915205956
splice O 0 0.27871912717819214
- O 1 0.9985576272010803
site O 0 0.03105750121176243
mutations O 0 0.022536709904670715
, O 0 0.014294176362454891
because O 0 0.015679391101002693
( O 0 0.02015322633087635
i O 0 0.023496724665164948
) O 0 0.020863017067313194
aberrant O 0 0.10001102089881897
splicing O 0 0.03774670884013176
often O 0 0.012295573018491268
generates O 0 0.021610815078020096
a O 0 0.024010898545384407
premature O 1 0.9662950038909912
termination O 1 0.9985517859458923
codon O 0 0.48207521438598633
, O 0 0.02713656984269619
( O 0 0.027204163372516632
ii O 1 0.9874468445777893
) O 0 0.02030922845005989
transcripts O 0 0.03000623546540737
with O 0 0.02116263471543789
premature O 1 0.9976484179496765
termination O 1 0.9998894929885864
codons O 0 0.48455309867858887
can O 0 0.016105903312563896
occur O 0 0.01435952726751566
at O 0 0.02060600556433201
low O 0 0.0550115667283535
or O 0 0.028151055797934532
undetectable O 1 0.9998065829277039
levels O 0 0.02426895871758461
due O 0 0.01809767074882984
to O 0 0.016726084053516388
nonsense O 1 0.7969277501106262
- O 1 0.9990090131759644
mediated O 0 0.4998914301395416
mRNA O 0 0.049305617809295654
decay O 0 0.08381016552448273
, O 0 0.01783876121044159
and O 0 0.017416441813111305
( O 0 0.02647649124264717
iii O 1 0.9833358526229858
) O 0 0.015875371173024178
the O 0 0.015963023528456688
levels O 0 0.016626372933387756
of O 0 0.013598929159343243
these O 0 0.011231341399252415
transcripts O 0 0.030375076457858086
can O 0 0.011930885724723339
be O 0 0.012108567170798779
increased O 0 0.02217717655003071
by O 0 0.03097698837518692
cycloheximide O 1 0.9970887303352356
. O 0 0.05380554124712944

A O 0 0.09185663610696793
deletion O 0 0.21086114645004272
mutation O 0 0.060848481953144073
in O 0 0.028412487357854843
COL17A1 O 1 0.9955927729606628
in O 0 0.018874436616897583
five O 0 0.022573919966816902
Austrian O 0 0.0817512720823288
families O 0 0.0374709889292717
with O 0 0.04264757037162781
generalized O 1 0.9999890327453613
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
represents O 1 0.9112337231636047
propagation O 0 0.18920768797397614
of O 0 0.03868516534566879
an O 0 0.04265928268432617
ancestral O 1 0.9525516629219055
allele O 0 0.13857626914978027
. O 0 0.057211924344301224

Patients O 1 0.9933445453643799
with O 0 0.07359597086906433
generalized O 1 0.9999984502792358
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.0757409930229187
a O 0 0.03479607775807381
usually O 0 0.02157234586775303
nonlethal O 0 0.06478952616453171
form O 0 0.027737081050872803
of O 0 0.053093697875738144
junctional B-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
, O 0 0.04266595095396042
have O 0 0.018995065242052078
generalized O 1 0.8416442275047302
blistering B-Disease 1 0.999920129776001
, O 1 0.9978938698768616
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9997591376304626
patchy B-Disease 1 0.9999998807907104
alopecia I-Disease 1 1.0
, O 1 0.9960810542106628
and O 1 0.9978139400482178
dental B-Disease 1 1.0
abnormalities I-Disease 1 0.9999994039535522
. O 0 0.2668832540512085

Skin B-Disease 1 0.9999991655349731
fragility I-Disease 1 0.999997615814209
in O 0 0.03185891732573509
most O 0 0.021937234327197075
cases O 0 0.02420417219400406
is O 0 0.016095004975795746
due O 0 0.016721190884709358
to O 0 0.01407049223780632
mutations O 0 0.016117839142680168
in O 0 0.0092234518378973
the O 0 0.016282960772514343
gene O 0 0.0243582371622324
encoding O 0 0.03390217944979668
type O 1 0.9841939806938171
XVII O 1 1.0
collagen O 1 1.0
( O 1 0.963090717792511
COL17A1 O 1 0.9999892711639404
) O 0 0.047730688005685806
. O 0 0.04438387230038643

Recently O 0 0.06935512274503708
, O 0 0.024838373064994812
we O 0 0.012772991321980953
reported O 0 0.01434496883302927
five O 0 0.0157515499740839
Austrian O 0 0.05731229484081268
families O 0 0.032533321529626846
with O 0 0.03739774227142334
generalized O 1 0.9999977350234985
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.48890605568885803
share O 0 0.03443498536944389
the O 0 0.02974976785480976
same O 0 0.03864063322544098
COL17A1 O 1 0.9999629259109497
mutation O 0 0.12346313148736954
. O 0 0.04863240569829941

Affected O 0 0.0640806332230568
individuals O 0 0.020726503804326057
in O 0 0.013968207873404026
three O 0 0.013447193428874016
families O 0 0.01915033534169197
are O 0 0.010348174721002579
homozygous O 0 0.044404536485672
for O 0 0.02547910436987877
4003delTC O 1 0.9996466636657715
, O 0 0.02524184063076973
whereas O 0 0.021764520555734634
those O 0 0.010949192568659782
in O 0 0.011226347647607327
two O 0 0.012751171365380287
others O 0 0.02020411379635334
are O 0 0.016976889222860336
compound O 0 0.121505968272686
heterozygotes O 1 0.9331607818603516
. O 0 0.05769007280468941

To O 0 0.03506904095411301
determine O 0 0.022131329402327538
if O 0 0.013650035485625267
the O 0 0.017187418416142464
occurrence O 0 0.03560279309749603
of O 0 0.025300296023488045
4003delTC O 1 0.9958855509757996
in O 0 0.0165096465498209
these O 0 0.0116005539894104
unrelated O 0 0.03058442659676075
families O 0 0.028616052120923996
signifies O 1 0.8145204782485962
propagation O 0 0.05040067434310913
of O 0 0.020897716283798218
an O 0 0.024174602702260017
ancestral O 1 0.8968384265899658
allele O 0 0.0672936737537384
or O 0 0.019246181473135948
a O 0 0.03239420801401138
mutational O 1 0.9998476505279541
hot O 1 0.9986166954040527
spot O 0 0.2544960677623749
, O 0 0.02633092924952507
haplotypes O 0 0.06184106320142746
were O 0 0.01391081977635622
determined O 0 0.023294363170862198
for O 0 0.01756305620074272
polymorphisms O 0 0.04464361444115639
both O 0 0.016874345019459724
within O 0 0.024107009172439575
and O 0 0.040783997625112534
flanking O 1 0.9995676875114441
COL17A1 O 1 0.9999732971191406
. O 0 0.07600345462560654

Five O 0 0.07368061691522598
intragenic O 1 0.9822599291801453
polymorphisms O 0 0.08645380288362503
were O 0 0.01936081238090992
chosen O 0 0.027469251304864883
based O 0 0.02163722738623619
on O 0 0.019932983443140984
their O 0 0.025950338691473007
informativeness O 1 0.982731282711029
. O 0 0.05443271994590759

One O 0 0.03353200480341911
of O 0 0.021626858040690422
these O 0 0.012424557469785213
, O 0 0.013681444339454174
not O 0 0.008118348196148872
previously O 0 0.013473358005285263
reported O 0 0.014493019320070744
, O 0 0.01484269741922617
was O 0 0.026242952793836594
2988 O 1 0.9939425587654114
A O 0 0.07220336049795151
or O 0 0.02227395586669445
C O 0 0.13728588819503784
that O 0 0.011294972151517868
introduces O 0 0.03465999290347099
a O 0 0.017558136954903603
new O 0 0.022136656567454338
restriction O 0 0.03287982568144798
site O 0 0.03122427500784397
for O 0 0.02632218971848488
Eco0109 O 1 0.9986203908920288
I O 0 0.28673499822616577
. O 0 0.04536792263388634

All O 0 0.034346748143434525
the O 0 0.04512934014201164
4003delTC O 1 0.9946146607398987
alleles O 0 0.059524621814489365
showed O 0 0.027907313778996468
the O 0 0.022813906893134117
same O 0 0.022394215688109398
haplotype O 0 0.0698995590209961
for O 0 0.01712699979543686
these O 0 0.012821346521377563
five O 0 0.03149840608239174
polymorphic O 1 0.9784825444221497
markers O 0 0.09808167070150375
. O 0 0.053388986736536026

Fourteen O 0 0.1589096486568451
microsatellite O 1 0.8182457685470581
polymorphisms O 0 0.0803208276629448
were O 0 0.016292816027998924
selected O 0 0.01962503418326378
based O 0 0.015300346538424492
on O 0 0.011872879229485989
their O 0 0.012991335242986679
high O 0 0.04746332764625549
heterozygosity O 1 0.9948957562446594
and O 0 0.01737791858613491
their O 0 0.011796444654464722
location O 0 0.019544202834367752
within O 0 0.022173089906573296
10q23 O 1 0.9996209144592285
- O 1 0.9999758005142212
q25 O 1 0.9991187453269958
near O 0 0.12065261602401733
COL17A1 O 1 0.9987019300460815
. O 0 0.06024952605366707

Three O 0 0.034509770572185516
families O 0 0.04044654965400696
shared O 0 0.05208515748381615
microsatellite O 1 0.9426765441894531
polymorphisms O 0 0.13135989010334015
covering O 0 0.04745985567569733
at O 0 0.02513827197253704
most O 0 0.01843661069869995
19 O 0 0.0379384346306324
cM O 0 0.04526027664542198
, O 0 0.01861356943845749
whereas O 0 0.019796593114733696
the O 0 0.01588401570916176
others O 0 0.015579630620777607
shared O 0 0.02150285802781582
smaller O 0 0.016449077054858208
regions O 0 0.016462955623865128
consistent O 0 0.02469775453209877
with O 0 0.01882232166826725
cross O 0 0.4813985526561737
- O 1 0.9996706247329712
over O 0 0.019316663965582848
events O 0 0.014105122536420822
during O 0 0.016687050461769104
passage O 0 0.028170807287096977
of O 0 0.018015066161751747
this O 0 0.016625327989459038
mutation O 0 0.03391677886247635
through O 0 0.020836230367422104
several O 0 0.021891383454203606
generations O 0 0.0556965097784996
. O 0 0.0475684218108654

These O 0 0.025177089497447014
results O 0 0.02191592939198017
indicate O 0 0.021798795089125633
that O 0 0.016308452934026718
4003delTC O 1 0.7380850315093994
occurs O 0 0.02024225890636444
on O 0 0.014278040267527103
a O 0 0.02372940443456173
single O 0 0.041428230702877045
ancestral O 1 0.9221853017807007
allele O 0 0.1513117104768753
. O 0 0.030811965465545654
. O 0 0.03693029657006264

The O 0 0.07066988199949265
haptoglobin O 1 0.9991798996925354
- O 1 0.9999053478240967
gene O 0 0.059948209673166275
deletion O 0 0.07246578484773636
responsible O 0 0.050149861723184586
for O 0 0.041498083621263504
anhaptoglobinemia B-Disease 1 0.999314546585083
. O 0 0.058364495635032654

We O 0 0.027253858745098114
have O 0 0.011580286547541618
found O 0 0.011049032211303711
an O 0 0.016042517498135567
allelic O 0 0.07786419242620468
deletion O 0 0.04409274086356163
of O 0 0.021234475076198578
the O 0 0.03632281348109245
haptoglobin O 1 0.999985933303833
( O 0 0.05565493926405907
Hp O 1 0.9893916845321655
) O 0 0.02073748968541622
gene O 0 0.0176346804946661
from O 0 0.012044918723404408
an O 0 0.016649536788463593
individual O 0 0.020733946934342384
with O 0 0.03089716099202633
anhaptoglobinemia B-Disease 1 0.9984837174415588
. O 0 0.0547969751060009

The O 0 0.05316349118947983
Hp O 1 0.917117714881897
gene O 0 0.04372023791074753
cluster O 0 0.04598747938871384
consists O 0 0.023611661046743393
of O 0 0.020789455622434616
coding O 0 0.03385418653488159
regions O 0 0.013779356144368649
of O 0 0.013927973806858063
the O 0 0.020720241591334343
alpha O 1 0.63092041015625
chain O 0 0.04076346382498741
and O 0 0.017593128606677055
beta O 0 0.04843328893184662
chain O 0 0.029302146285772324
of O 0 0.015970448032021523
the O 0 0.02708633989095688
haptoglobin O 1 0.9999529123306274
gene O 0 0.050124641507864
( O 0 0.028093161061406136
Hp O 0 0.26450905203819275
) O 0 0.014095463789999485
and O 0 0.00820189993828535
of O 0 0.01212505716830492
the O 0 0.020310301333665848
alpha O 1 0.9249219298362732
chain O 0 0.03991112485527992
and O 0 0.018192129209637642
beta O 0 0.043625399470329285
chain O 0 0.028180107474327087
of O 0 0.016179341822862625
the O 0 0.02748923748731613
haptoglobin O 1 0.9998854398727417
- O 1 0.9999511241912842
related O 0 0.03279438614845276
gene O 0 0.03824332356452942
( O 0 0.0331578403711319
Hpr O 1 0.9995875954627991
) O 0 0.022056391462683678
, O 0 0.01612897403538227
in O 0 0.014869095757603645
tandem O 0 0.06143192946910858
from O 0 0.017766056582331657
the O 0 0.025816811248660088
5 O 0 0.04023786261677742
side O 0 0.04958316683769226
. O 0 0.046426694840192795

Southern O 0 0.11559544503688812
blot O 1 0.9887076616287231
and O 0 0.04673442617058754
PCR O 0 0.14169904589653015
analyses O 0 0.02803315408527851
have O 0 0.010335613042116165
indicated O 0 0.015191824175417423
that O 0 0.006868359167128801
the O 0 0.010831820778548717
individual O 0 0.011458129622042179
with O 0 0.015033969655632973
anhaptoglobinemia B-Disease 1 0.9987227320671082
was O 0 0.0275596734136343
homozygous O 0 0.030653858557343483
for O 0 0.011976446025073528
the O 0 0.020364757627248764
gene O 0 0.025052711367607117
deletion O 0 0.034536655992269516
and O 0 0.012155389413237572
that O 0 0.008094124495983124
the O 0 0.015217090025544167
gene O 0 0.025646911934018135
deletion O 0 0.0373961515724659
was O 0 0.019701937213540077
included O 0 0.013676869682967663
at O 0 0.013317063450813293
least O 0 0.009948336519300938
from O 0 0.010741353034973145
the O 0 0.018960021436214447
promoter O 0 0.36587920784950256
region O 0 0.025115659460425377
of O 0 0.023165643215179443
Hp O 1 0.7266043424606323
to O 0 0.028953764587640762
Hpr O 1 0.9998013377189636
alpha O 0 0.05442819371819496
but O 0 0.013136406429111958
not O 0 0.010521294549107552
to O 0 0.021849315613508224
Hpr O 1 0.9994869232177734
beta O 1 0.9959161877632141
( O 0 0.06360406428575516
Hpdel O 1 0.9946911931037903
) O 0 0.04498187452554703
. O 0 0.042683299630880356

In O 0 0.03501620516180992
addition O 0 0.027086885645985603
, O 0 0.019538983702659607
we O 0 0.011562095023691654
found O 0 0.009716600179672241
seven O 0 0.013796504586935043
individuals O 0 0.01208631880581379
with O 0 0.016534270718693733
hypohaptoglobinemia B-Disease 1 0.9985176920890808
in O 0 0.015965653583407402
three O 0 0.01477477140724659
families O 0 0.021740984171628952
, O 0 0.015245807357132435
and O 0 0.012669356539845467
the O 0 0.019376011565327644
genotypes O 0 0.08140737563371658
of O 0 0.01525713037699461
six O 0 0.015258575789630413
of O 0 0.015744326636195183
the O 0 0.01845783181488514
seven O 0 0.018504098057746887
individuals O 0 0.012586109340190887
were O 0 0.010169572196900845
found O 0 0.01119003351777792
to O 0 0.015229236334562302
be O 0 0.02298123389482498
Hp2 O 1 0.9999196529388428
/ O 1 0.9998816251754761
Hpdel O 1 0.99885094165802
. O 0 0.05710733309388161

The O 0 0.06553540378808975
phenotypes O 0 0.45423299074172974
and O 0 0.034209851175546646
genotypes O 0 0.2831527590751648
in O 0 0.014793646521866322
one O 0 0.014559668488800526
of O 0 0.01306282076984644
these O 0 0.008401521481573582
three O 0 0.01108371652662754
families O 0 0.017675185576081276
showed O 0 0.017963342368602753
the O 0 0.01855585165321827
father O 0 0.03591052070260048
to O 0 0.016493750736117363
be O 0 0.016395779326558113
hypohaptoglobinemic B-Disease 1 0.9979540109634399
( O 0 0.03087402880191803
Hp2 O 1 0.993961751461029
) O 0 0.02132696658372879
and O 0 0.02617979794740677
Hp2 O 1 0.9999716281890869
/ O 1 0.9999556541442871
Hpdel O 1 0.9989669322967529
, O 0 0.020236967131495476
the O 0 0.017594093456864357
mother O 0 0.03536495566368103
to O 0 0.014915607869625092
be O 0 0.013728187419474125
Hp2 O 1 0.9968365430831909
- O 1 0.9982965588569641
1 O 0 0.028198618441820145
and O 0 0.024627551436424255
Hp1 O 1 0.9999436140060425
/ O 1 0.9999145269393921
Hp2 O 1 0.9959086179733276
, O 0 0.017097294330596924
one O 0 0.01044540200382471
of O 0 0.010046077892184258
the O 0 0.012014072388410568
two O 0 0.009928070940077305
children O 0 0.018162639811635017
to O 0 0.013580878265202045
be O 0 0.014923556707799435
hypohaptoglobinemic B-Disease 1 0.9996172189712524
( O 0 0.029943427070975304
Hp2 O 1 0.9985374212265015
) O 0 0.021360866725444794
and O 0 0.025108905509114265
Hp2 O 1 0.9999816417694092
/ O 1 0.9999878406524658
Hpdel O 1 0.999786913394928
, O 0 0.02098398469388485
and O 0 0.012371630407869816
the O 0 0.013781268149614334
other O 0 0.011161640286445618
child O 0 0.03893078863620758
to O 0 0.015487179160118103
be O 0 0.015872256830334663
Hp1 O 1 0.9908457398414612
and O 0 0.03354715183377266
Hp1 O 1 0.999987006187439
/ O 1 0.999940037727356
Hpdel O 1 0.9962106943130493
, O 0 0.02331368252635002
showing O 0 0.025202281773090363
an O 0 0.01997506432235241
anomalous O 1 0.9019748568534851
inheritance O 0 0.44356223940849304
of O 0 0.05137833580374718
Hp O 1 0.9997238516807556
phenotypes O 0 0.1261519491672516
in O 0 0.019096912816166878
the O 0 0.030497658997774124
child O 1 0.9102790355682373
with O 0 0.04753183200955391
Hp1 O 1 0.9998360872268677
. O 0 0.06429518014192581

The O 0 0.08323942124843597
Hp2 O 1 0.9999841451644897
/ O 1 0.9999945163726807
Hpdel O 1 0.9995920062065125
individuals O 0 0.02314317412674427
had O 0 0.019499408081173897
an O 0 0.017286861315369606
extremely O 0 0.023550471290946007
low O 0 0.02469162456691265
level O 0 0.019747048616409302
of O 0 0.022536618635058403
Hp O 1 0.9482410550117493
( O 0 0.025477280840277672
mean O 0 0.031945522874593735
+ O 1 0.8431200981140137
/ O 1 0.9990166425704956
- O 1 0.9998877048492432
SD O 1 0.9989235997200012
= O 0 0.05622318387031555
0 O 0 0.03493324667215347
. O 0 0.023882847279310226
049 O 1 0.9891202449798584
+ O 1 0.5721647143363953
/ O 1 0.9566519260406494
- O 1 0.8229075074195862
0 O 0 0.03596797585487366
. O 0 0.02136405184864998
043 O 1 0.9945762157440186
mg O 1 0.9998513460159302
/ O 1 0.999842643737793
ml O 1 0.9996708631515503
; O 0 0.03152431547641754
n O 0 0.06646647304296494
= O 0 0.04795509949326515
6 O 0 0.028261462226510048
) O 0 0.014720250852406025
, O 0 0.011837002821266651
compared O 0 0.011873533949255943
with O 0 0.009916342794895172
the O 0 0.01569499261677265
level O 0 0.020400717854499817
( O 0 0.017071565613150597
1 O 0 0.018182268366217613
. O 0 0.011885300278663635
64 O 0 0.03619840741157532
+ O 1 0.818108081817627
/ O 1 0.9961504936218262
- O 1 0.947449803352356
1 O 0 0.02576892450451851
. O 0 0.01943608559668064
07 O 1 0.9947906732559204
mg O 1 0.999983549118042
/ O 1 0.9999680519104004
ml O 1 0.9985927939414978
) O 0 0.01839323714375496
obtained O 0 0.012813865207135677
from O 0 0.014192525297403336
52 O 0 0.04128219559788704
healthy O 0 0.06563127040863037
volunteers O 0 0.05561230331659317
having O 0 0.04348558187484741
phenotype O 1 0.997187077999115
Hp2 O 1 0.999674916267395
, O 0 0.026697847992181778
whereas O 0 0.028611835092306137
the O 0 0.03200700879096985
serum O 1 0.9998216032981873
Hp O 1 0.549645185470581
level O 0 0.023376207798719406
of O 0 0.015673253685235977
an O 0 0.014021572656929493
individual O 0 0.01542576216161251
with O 0 0.026714464649558067
Hp1 O 1 0.9999946355819702
/ O 1 0.9999959468841553
Hpdel O 1 0.9999145269393921
was O 0 0.06130874156951904
0 O 0 0.05977749079465866
. O 0 0.04266073554754257

50 O 0 0.09618964046239853
mg O 1 0.9999580383300781
/ O 1 0.9999876022338867
ml O 1 0.9997566342353821
, O 0 0.027076711878180504
which O 0 0.013012011535465717
was O 0 0.016600223258137703
approximately O 0 0.011012941598892212
half O 0 0.01238707359880209
the O 0 0.014132455922663212
level O 0 0.01758885756134987
of O 0 0.019202973693609238
Hp O 0 0.10385920852422714
in O 0 0.01675187237560749
control O 0 0.035573553293943405
sera O 1 0.9959375858306885
from O 0 0.020473742857575417
the O 0 0.03042239136993885
Hp1 O 1 0.9999630451202393
phenotype O 1 0.9610219597816467
( O 0 0.021805940195918083
1 O 0 0.02164851501584053
. O 0 0.013559616170823574
26 O 0 0.032156653702259064
+ O 1 0.9371431469917297
/ O 1 0.9984000325202942
- O 1 0.9589935541152954
0 O 0 0.027874376624822617
. O 0 0.014047265984117985
33 O 0 0.03757477179169655
mg O 1 0.9988499879837036
/ O 1 0.9995412826538086
ml O 1 0.99905925989151
; O 0 0.03379642963409424
n O 0 0.06122096627950668
= O 0 0.04844073951244354
9 O 0 0.027192197740077972
) O 0 0.015604551881551743
, O 0 0.011972418986260891
showing O 0 0.018685949966311455
a O 0 0.028259864076972008
gene O 0 0.06416100263595581
- O 1 0.9999723434448242
dosage O 1 0.9982969164848328
effect O 0 0.04806246608495712
. O 0 0.04057085141539574

The O 0 0.04467190429568291
other O 0 0.027248289436101913
allele O 0 0.3319649398326874
( O 0 0.03717247396707535
Hp2 O 1 0.9854068756103516
) O 0 0.017399290576577187
of O 0 0.01400956604629755
individuals O 0 0.014895835891366005
with O 0 0.026258116587996483
Hp2 O 1 0.9999995231628418
/ O 1 0.9999988079071045
Hpdel O 1 0.9999901056289673
was O 0 0.038740139454603195
found O 0 0.011764508672058582
to O 0 0.010075055994093418
have O 0 0.006992909591645002
, O 0 0.00903615728020668
in O 0 0.008036764338612556
all O 0 0.012324806302785873
exons O 0 0.03995863348245621
, O 0 0.018295597285032272
no O 0 0.020755615085363388
mutation O 0 0.0360758975148201
, O 0 0.019696936011314392
by O 0 0.023307017982006073
DNA O 0 0.041159097105264664
sequencing O 0 0.05518599599599838
. O 0 0.04053465276956558

On O 0 0.029304198920726776
the O 0 0.01854548044502735
basis O 0 0.012360017746686935
of O 0 0.013105017133057117
the O 0 0.01640748605132103
present O 0 0.018112031742930412
study O 0 0.016259070485830307
, O 0 0.013270577415823936
the O 0 0.016345087438821793
mechanism O 0 0.026930203661322594
of O 0 0.02218637987971306
anhaptoglobinemia B-Disease 1 0.9981762170791626
and O 0 0.01650449074804783
the O 0 0.01727534644305706
mechanism O 0 0.030442506074905396
of O 0 0.022165825590491295
anomalous O 1 0.9955641031265259
inheritance O 1 0.97870934009552
of O 1 0.7812100052833557
Hp O 1 0.9999778270721436
phenotypes O 1 0.8592665791511536
were O 0 0.0219986941665411
well O 0 0.027862010523676872
explained O 0 0.047713108360767365
. O 0 0.037338074296712875

However O 0 0.03801406919956207
, O 0 0.02718539535999298
the O 0 0.02648826502263546
mechanism O 0 0.04862091317772865
of O 0 0.04445646330714226
hypohaptoglobinemia B-Disease 1 0.9999096393585205
remains O 0 0.22221069037914276
unknown O 0 0.08628249168395996

ATM O 0 0.3575364947319031
mutations O 0 0.047836676239967346
and O 0 0.02865675650537014
phenotypes O 0 0.09796463698148727
in O 0 0.04789659380912781
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 0.9999995231628418
families O 0 0.029739022254943848
in O 0 0.013832632452249527
the O 0 0.017504390329122543
British O 0 0.03678656741976738
Isles O 0 0.4895041584968567
: O 0 0.019423916935920715
expression O 0 0.018216878175735474
of O 0 0.017685050144791603
mutant O 1 0.9340258836746216
ATM O 0 0.39049389958381653
and O 0 0.012279924936592579
the O 0 0.015339097008109093
risk O 0 0.04122934862971306
of O 1 0.8578855395317078
leukemia B-Disease 1 1.0
, O 1 0.9999984502792358
lymphoma B-Disease 1 1.0
, O 1 0.9999852180480957
and O 1 0.9999867677688599
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8895028829574585

We O 0 0.02770937979221344
report O 0 0.020272599533200264
the O 0 0.01759152114391327
spectrum O 0 0.027796421200037003
of O 0 0.020499926060438156
59 O 0 0.051762524992227554
ATM O 0 0.13663466274738312
mutations O 0 0.021880879998207092
observed O 0 0.01825489103794098
in O 0 0.020281903445720673
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.11411349475383759
A B-Disease 1 0.9999768733978271
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
) O 0 0.03036607801914215
patients O 0 0.054943256080150604
in O 0 0.01575397327542305
the O 0 0.026219507679343224
British O 0 0.05589548498392105
Isles O 1 0.6558862328529358
. O 0 0.051272742450237274

Of O 0 0.05549159273505211
51 O 0 0.09751861542463303
ATM O 1 0.9244797229766846
mutations O 0 0.041726477444171906
identified O 0 0.02330115996301174
in O 0 0.012649545446038246
families O 0 0.01857757568359375
native O 0 0.015938779339194298
to O 0 0.0121360057964921
the O 0 0.015362817794084549
British O 0 0.030078304931521416
Isles O 0 0.09007353335618973
, O 0 0.01636628247797489
11 O 0 0.017517687752842903
were O 0 0.014184156432747841
founder O 1 0.9994572997093201
mutations O 0 0.03039509803056717
, O 0 0.014949969947338104
and O 0 0.012004908174276352
2 O 0 0.015564843080937862
of O 0 0.010893876664340496
these O 0 0.007368367165327072
11 O 0 0.01790187880396843
conferred O 0 0.06461358815431595
a O 0 0.03737827017903328
milder O 1 0.9992152452468872
clinical O 1 0.9998553991317749
phenotype O 1 0.9875553250312805
with O 0 0.0188370943069458
respect O 0 0.025545015931129456
to O 0 0.023730089887976646
both O 0 0.06493876874446869
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9982706308364868
cellular O 1 0.9862504005432129
features O 0 0.059633705765008926
. O 0 0.04683221876621246

We O 0 0.027793947607278824
report O 0 0.017226722091436386
, O 0 0.010235984809696674
in O 0 0.007458574138581753
two O 0 0.011738752014935017
A B-Disease 1 0.9949867725372314
- I-Disease 1 0.9999997615814209
T I-Disease 1 0.9999774694442749
families O 0 0.019636351615190506
, O 0 0.013160797767341137
an O 0 0.014625987969338894
ATM O 0 0.21970294415950775
mutation O 0 0.030367368832230568
( O 0 0.021958235651254654
7271T O 1 0.9987630844116211
- O 1 0.9999979734420776
- O 1 0.9999991655349731
> O 1 0.9999097585678101
G O 1 0.9988988637924194
) O 0 0.015546136535704136
that O 0 0.008258691988885403
may O 0 0.00911834929138422
be O 0 0.006189844571053982
associated O 0 0.008131904527544975
with O 0 0.00728578632697463
an O 0 0.010111093521118164
increased O 0 0.01736895553767681
risk O 1 0.731800377368927
of O 1 0.998859167098999
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.04098646342754364
both O 0 0.02803828939795494
homozygotes O 1 0.9999247789382935
and O 0 0.04241865500807762
heterozygotes O 1 0.9997439980506897
( O 0 0.02907668612897396
relative O 0 0.036609381437301636
risk O 0 0.030464863404631615
12 O 0 0.0200103297829628
. O 0 0.01362824160605669
7 O 0 0.02578805573284626
; O 0 0.024514533579349518
P O 1 0.9975723624229431
= O 0 0.05644673854112625
. O 0 0.02211609296500683
0025 O 1 0.9996065497398376
) O 0 0.019352233037352562
, O 0 0.010867100208997726
although O 0 0.007920544594526291
there O 0 0.006234605330973864
is O 0 0.007742008194327354
a O 0 0.012719103135168552
less O 0 0.01422277931123972
severe O 1 0.9998651742935181
A B-Disease 1 0.9999992847442627
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
phenotype O 1 0.5108608603477478
in O 0 0.011442018672823906
terms O 0 0.010655425488948822
of O 0 0.012483613565564156
the O 0 0.020038483664393425
degree O 0 0.05320792272686958
of O 1 0.9975085258483887
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9904595613479614

This O 0 0.027943886816501617
mutation O 0 0.045118898153305054
( O 0 0.0341949537396431
7271T O 1 0.9997398257255554
- O 1 0.9999991655349731
- O 1 0.9999996423721313
> O 1 0.9999376535415649
G O 1 0.9906452894210815
) O 0 0.017479395493865013
also O 0 0.010205835103988647
allows O 0 0.010825838893651962
expression O 0 0.011975036934018135
of O 0 0.01146320253610611
full O 0 0.027341734617948532
- O 1 0.9993466734886169
length O 0 0.02813591994345188
ATM O 1 0.5780215263366699
protein O 0 0.018016545102000237
at O 0 0.01379724033176899
a O 0 0.015552678145468235
level O 0 0.01967148669064045
comparable O 0 0.022091390565037727
with O 0 0.013318178243935108
that O 0 0.014350215904414654
in O 0 0.02229125052690506
unaffected O 1 0.889183521270752
individuals O 0 0.03357604146003723
. O 0 0.044983748346567154

In O 0 0.03548252582550049
addition O 0 0.02791779488325119
, O 0 0.016199802979826927
we O 0 0.008320660330355167
have O 0 0.0054416535422205925
studied O 0 0.012104752473533154
18 O 0 0.019931593909859657
A B-Disease 1 0.9998061060905457
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9994949102401733
, O 0 0.014096107333898544
in O 0 0.009513535536825657
15 O 0 0.013918096199631691
families O 0 0.015633899718523026
, O 0 0.014370194636285305
who O 0 0.0237245112657547
developed O 1 0.8090018630027771
leukemia B-Disease 1 1.0
, O 1 0.9995226860046387
lymphoma B-Disease 1 1.0
, O 1 0.992110550403595
preleukemic O 1 0.9999992847442627
T O 1 0.9999990463256836
- O 1 0.9999876022338867
cell O 0 0.3736209571361542
proliferation O 1 0.9757546782493591
, O 0 0.03678309917449951
or O 1 0.9993589520454407
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.9829903841018677
mostly O 0 0.03351587429642677
in O 0 0.03569534793496132
childhood O 1 0.9988518953323364
. O 0 0.05437072366476059

A O 0 0.05730942264199257
wide O 0 0.03438075631856918
variety O 0 0.02178681083023548
of O 0 0.03086479753255844
ATM O 1 0.9996788501739502
mutation O 0 0.06046323850750923
types O 0 0.01851731166243553
, O 0 0.015042643062770367
including O 0 0.017093118280172348
missense O 0 0.2756427228450775
mutations O 0 0.025596914812922478
and O 0 0.014942971058189869
in O 0 0.021254349499940872
- O 1 0.9999960660934448
frame O 1 0.7711031436920166
deletions O 0 0.05439593270421028
, O 0 0.015296639874577522
were O 0 0.010615456849336624
seen O 0 0.02017226815223694
in O 0 0.01645408570766449
these O 0 0.020677249878644943
patients O 1 0.868263840675354
. O 0 0.05179605633020401

We O 0 0.028366772457957268
also O 0 0.017964113503694534
show O 0 0.015333589166402817
that O 0 0.00694698840379715
25 O 0 0.010439528152346611
% O 0 0.007395484019070864
of O 0 0.008963490836322308
all O 0 0.012901014648377895
A B-Disease 1 0.99992835521698
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
patients O 1 0.8861306309700012
carried O 0 0.02254353277385235
in O 0 0.01924334652721882
- O 1 0.9997803568840027
frame O 0 0.055112238973379135
deletions O 0 0.057986773550510406
or O 0 0.02533571980893612
missense O 1 0.8765708804130554
mutations O 0 0.028512831777334213
, O 0 0.012840154580771923
many O 0 0.007883818820118904
of O 0 0.010972170159220695
which O 0 0.00899486429989338
were O 0 0.007852603681385517
also O 0 0.009802229702472687
associated O 0 0.010829516686499119
with O 0 0.0106581412255764
expression O 0 0.020213589072227478
of O 0 0.026826757937669754
mutant O 1 0.9997146725654602
ATM O 1 0.9996029734611511
protein O 0 0.05305019021034241
. O 0 0.03763257712125778

The O 0 0.05306929722428322
DMPK O 1 0.9991322159767151
gene O 0 0.04027736559510231
of O 0 0.038129955530166626
severely O 1 0.9999974966049194
affected O 1 0.9999943971633911
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.9966957569122314
hypermethylated O 1 0.999992847442627
proximal O 1 0.9997534155845642
to O 0 0.02577943727374077
the O 0 0.02683275192975998
largely O 0 0.03914359211921692
expanded O 0 0.06142937391996384
CTG O 1 0.9999041557312012
repeat O 1 0.5428299307823181
. O 0 0.06551352143287659

Using O 0 0.042821768671274185
methylation O 0 0.09701532125473022
- O 1 0.9993352293968201
sensitive O 0 0.06796441227197647
restriction O 0 0.05461695417761803
enzymes O 0 0.03803711757063866
, O 0 0.01755937933921814
we O 0 0.013878760859370232
characterized O 0 0.027277354151010513
the O 0 0.021613415330648422
methylation O 0 0.04139645770192146
pattern O 0 0.025368502363562584
on O 0 0.013729838654398918
the O 0 0.015242007561028004
5 O 0 0.016588633880019188
side O 0 0.01612093113362789
of O 0 0.014565101824700832
the O 0 0.02618170529603958
CTG O 1 0.9999698400497437
repeat O 0 0.04548698291182518
in O 0 0.012870931066572666
the O 0 0.022512339055538177
DMPK O 1 0.9998692274093628
gene O 0 0.02254316583275795
of O 0 0.015238872729241848
normal O 0 0.017761671915650368
individuals O 0 0.01036099623888731
and O 0 0.012279214337468147
of O 0 0.030229708179831505
patients O 1 0.9999926090240479
affected O 1 0.9940383434295654
with O 1 0.9998457431793213
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.6606859564781189
showing O 0 0.04728063941001892
expansions O 0 0.0577627457678318
of O 0 0.0298259649425745
the O 0 0.04636664688587189
repetitive O 1 0.9887098670005798
sequence O 0 0.04588279500603676
. O 0 0.04518348351120949

The O 0 0.06544063985347748
gene O 0 0.05408865585923195
segment O 0 0.049734268337488174
analyzed O 0 0.02758178859949112
corresponds O 0 0.028307566419243813
to O 0 0.01786421611905098
the O 0 0.026008764281868935
genomic O 0 0.07316835969686508
SacI O 1 0.9966750144958496
- O 1 0.9985355138778687
HindIII O 1 0.76945561170578
fragment O 0 0.061788905411958694
carrying O 0 0.04185767471790314
exons O 0 0.06907189637422562
11 O 0 0.0482124425470829
- O 1 0.9724814891815186
15 O 0 0.05031634494662285
. O 0 0.04088107496500015

There O 0 0.039682481437921524
is O 0 0.0325351357460022
constitutive O 0 0.10323260724544525
methylation O 0 0.06012304127216339
in O 0 0.02810194343328476
intron O 1 0.9914733171463013
12 O 0 0.026406588032841682
at O 0 0.020882373675704002
restriction O 0 0.028119346126914024
sites O 0 0.017148571088910103
of O 0 0.019234152510762215
SacII O 1 0.9930219054222107
and O 0 0.028094163164496422
HhaI O 1 0.9987164735794067
, O 0 0.026632394641637802
localized O 0 0.049172308295965195
1 O 0 0.028437646105885506
, O 0 0.01977374218404293
159 O 0 0.15360552072525024
- O 1 0.9978131055831909
1 O 0 0.028565704822540283
, O 0 0.01780935935676098
232 O 0 0.05005141347646713
bp O 0 0.0433771051466465
upstream O 0 0.025034090504050255
of O 0 0.016389744356274605
the O 0 0.02946089208126068
CTG O 1 0.9999966621398926
repeat O 1 0.9566072821617126
, O 0 0.024246951565146446
whereas O 0 0.021357271820306778
most O 0 0.012368054129183292
, O 0 0.012714007869362831
if O 0 0.010089157149195671
not O 0 0.007008831482380629
all O 0 0.008022904396057129
, O 0 0.008750542998313904
of O 0 0.009160680696368217
the O 0 0.011231319978833199
other O 0 0.007164958864450455
sites O 0 0.011956782080233097
of O 0 0.01685212552547455
SacII O 1 0.9997535347938538
, O 0 0.02812068909406662
HhaI O 1 0.9995518326759338
, O 0 0.020442618057131767
and O 0 0.01729273423552513
HpaII O 1 0.9988111257553101
in O 0 0.012035706080496311
this O 0 0.009025813080370426
region O 0 0.017338277772068977
are O 0 0.009652942419052124
unmethylated O 1 0.9986649751663208
, O 0 0.019084200263023376
in O 0 0.014279691502451897
normal O 0 0.022793391719460487
individuals O 0 0.013235948979854584
and O 0 0.01362556405365467
most O 0 0.01328260824084282
of O 0 0.022759873420000076
the O 0 0.27402859926223755
patients O 1 0.9998109936714172
. O 0 0.056367967277765274

In O 0 0.022985775023698807
a O 0 0.017490405589342117
number O 0 0.011511674150824547
of O 0 0.020243991166353226
young O 1 0.9948223829269409
and O 1 0.7923696041107178
severely O 1 0.9999992847442627
affected O 1 0.9995372295379639
patients O 1 0.9999610185623169
, O 0 0.023042501881718636
however O 0 0.014071503654122353
, O 0 0.014176390133798122
complete O 0 0.02123272977769375
methylation O 0 0.03149520605802536
of O 0 0.014434502460062504
these O 0 0.009693315252661705
restriction O 0 0.02291189506649971
sites O 0 0.0164223313331604
was O 0 0.01765015907585621
found O 0 0.011307179927825928
in O 0 0.011682752519845963
the O 0 0.027330929413437843
mutated O 0 0.27052587270736694
allele O 0 0.09729490429162979
. O 0 0.049651894718408585

In O 0 0.02543623559176922
most O 0 0.016684412956237793
of O 0 0.018327783793210983
these O 0 0.014450161717832088
patients O 1 0.8463749885559082
, O 0 0.01640661247074604
the O 0 0.02175316773355007
onset O 1 0.9999970197677612
of O 1 0.9353577494621277
the O 1 0.9999911785125732
disease O 1 1.0
was O 1 0.9999997615814209
congenital O 1 1.0
. O 1 0.9935535192489624

Preliminary O 0 0.05424303933978081
in O 0 0.04029859974980354
vivo O 1 0.5384786128997803
footprinting O 1 0.980985701084137
data O 0 0.015074384398758411
gave O 0 0.015886012464761734
evidence O 0 0.011425030417740345
for O 0 0.015407080762088299
protein O 0 0.02816561982035637
- O 1 0.9954108595848083
DNA O 0 0.022141270339488983
contact O 0 0.020394781604409218
in O 0 0.010571815073490143
normal O 0 0.018240464851260185
genes O 0 0.01567637361586094
at O 0 0.018775975331664085
an O 0 0.02422470599412918
Sp1 O 1 0.9998065829277039
consensus O 0 0.032578639686107635
binding O 0 0.02266116626560688
site O 0 0.019713763147592545
upstream O 0 0.021849697455763817
of O 0 0.014653529971837997
the O 0 0.02774282731115818
CTG O 1 0.9999951124191284
repeat O 0 0.29472896456718445
and O 0 0.016250865533947945
for O 0 0.01197146624326706
a O 0 0.016205472871661186
significant O 0 0.014750974252820015
reduction O 0 0.025117913261055946
of O 0 0.014666017144918442
this O 0 0.011089111678302288
interaction O 0 0.018012048676609993
in O 0 0.012041809968650341
cells O 0 0.017774969339370728
with O 0 0.014255496673285961
a O 0 0.03361693024635315
hypermethylated O 1 0.9999768733978271
DMPK O 1 0.9999954700469971
gene O 0 0.062416087836027145
. O 0 0.029964832589030266
. O 0 0.03613578900694847

The O 0 0.16282610595226288
hemochromatosis B-Disease 1 0.9999998807907104
gene O 0 0.07465846836566925
product O 0 0.03941117227077484
complexes O 0 0.05033685266971588
with O 0 0.0210706926882267
the O 0 0.03789905086159706
transferrin O 1 0.9999915361404419
receptor O 1 0.9266364574432373
and O 0 0.030478110536932945
lowers O 1 0.8828207850456238
its O 0 0.02596260793507099
affinity O 0 0.050778862088918686
for O 0 0.028732720762491226
ligand O 1 0.7405104041099548
binding O 0 0.04701565206050873
. O 0 0.03741622343659401

We O 0 0.03893908113241196
recently O 0 0.03564298525452614
reported O 0 0.023847617208957672
the O 0 0.023442158475518227
positional O 0 0.049838460981845856
cloning O 0 0.030315574258565903
of O 0 0.01761547662317753
a O 0 0.0227328073233366
candidate O 0 0.041210003197193146
gene O 0 0.03722023591399193
for O 0 0.041484981775283813
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999905824661255
HFE O 1 0.999997615814209
. O 0 0.09098856151103973

The O 0 0.04647769033908844
gene O 0 0.03784980997443199
product O 0 0.023371998220682144
, O 0 0.013406900689005852
a O 0 0.013970269821584225
member O 0 0.018478550016880035
of O 0 0.012500442564487457
the O 0 0.018562566488981247
major O 0 0.40874969959259033
histocompatibility O 1 1.0
complex O 1 0.9859218001365662
class O 1 0.9899076223373413
I O 1 0.9967457056045532
- O 1 0.9999483823776245
like O 0 0.020584896206855774
family O 0 0.022437818348407745
, O 0 0.012936403043568134
was O 0 0.015113633126020432
found O 0 0.00773409241810441
to O 0 0.00716351717710495
have O 0 0.005849855020642281
a O 0 0.013681869022548199
mutation O 0 0.027029985561966896
, O 0 0.02308218739926815
Cys O 1 0.9999775886535645
- O 1 0.9995437264442444
282 O 1 0.9161328673362732
- O 1 0.9999916553497314
- O 1 0.999996542930603
> O 1 0.9995977282524109
Tyr O 1 0.9999935626983643
( O 0 0.04430050402879715
C282Y O 1 0.9980250597000122
) O 0 0.019619692116975784
, O 0 0.01296523492783308
in O 0 0.010665100999176502
85 O 0 0.031933531165122986
% O 0 0.022955697029829025
of O 0 0.03273855894804001
patient O 1 0.9998295307159424
chromosomes O 0 0.08364333212375641
. O 0 0.05849430337548256

This O 0 0.044859517365694046
mutation O 0 0.06842344999313354
eliminates O 0 0.06871011853218079
the O 0 0.023758182302117348
ability O 0 0.023558806627988815
of O 0 0.02879202738404274
HFE O 1 0.9990585446357727
to O 0 0.020358098670840263
associate O 0 0.03503796085715294
with O 0 0.022622661665081978
beta2 O 1 0.9999904632568359
- O 1 0.9999991655349731
microglobulin O 1 0.9999798536300659
( O 0 0.03871258720755577
beta2m O 1 0.996059775352478
) O 0 0.021166659891605377
and O 0 0.02005179412662983
prevents O 1 0.9850767254829407
cell O 1 0.9961926937103271
- O 1 0.9999685287475586
surface O 0 0.053892601281404495
expression O 0 0.045031532645225525
. O 0 0.037788890302181244

A O 0 0.06438488513231277
second O 0 0.05383974313735962
mutation O 0 0.04392033815383911
that O 0 0.011302079074084759
has O 0 0.011468385346233845
no O 0 0.011326082982122898
effect O 0 0.01389803271740675
on O 0 0.016794731840491295
beta2m O 1 0.999470055103302
association O 0 0.04676621034741402
, O 0 0.02658492513000965
H63D O 1 0.9999923706054688
, O 0 0.020505690947175026
was O 0 0.01853913627564907
found O 0 0.00914389081299305
in O 0 0.007565832231193781
eight O 0 0.011357339099049568
out O 0 0.011674602515995502
of O 0 0.015399270690977573
nine O 0 0.028565922752022743
patients O 1 0.9881721138954163
heterozygous O 0 0.05008711665868759
for O 0 0.022717174142599106
the O 0 0.04220620170235634
C282Y O 1 0.9998953342437744
mutant O 1 0.9904007315635681
. O 0 0.06406480073928833

In O 0 0.030900252982974052
this O 0 0.017950113862752914
report O 0 0.020098939538002014
, O 0 0.015058978460729122
we O 0 0.010698101483285427
demonstrate O 0 0.02004450373351574
in O 0 0.014305501244962215
cultured O 0 0.06355156004428864
293 O 0 0.3845115602016449
cells O 0 0.04562361538410187
overexpressing O 1 0.9507341384887695
wild O 0 0.05706663802266121
- O 1 0.9998950958251953
type O 0 0.08519580215215683
or O 0 0.02664271742105484
mutant O 1 0.9969605803489685
HFE O 1 0.9999946355819702
proteins O 0 0.021600553765892982
that O 0 0.007053828798234463
both O 0 0.007618246134370565
the O 0 0.014134986326098442
wild O 0 0.03185448795557022
- O 1 0.9998239874839783
type O 0 0.04122542589902878
and O 0 0.029501980170607567
H63D O 1 0.9999970197677612
HFE O 1 0.9999984502792358
proteins O 0 0.038947563618421555
form O 0 0.026530852541327477
stable O 0 0.07334519177675247
complexes O 0 0.04779274761676788
with O 0 0.01767440140247345
the O 0 0.04089779406785965
transferrin O 1 0.9999974966049194
receptor O 1 0.9996951818466187
( O 0 0.0825931653380394
TfR O 1 0.9998973608016968
) O 0 0.04766952618956566
. O 0 0.0433192253112793

The O 0 0.0635075643658638
C282Y O 1 0.992973804473877
mutation O 0 0.05875781178474426
nearly O 0 0.02867126278579235
completely O 0 0.037746965885162354
prevents O 0 0.03913018852472305
the O 0 0.016364850103855133
association O 0 0.0193807240575552
of O 0 0.016569990664720535
the O 0 0.029831165447831154
mutant O 1 0.9994950294494629
HFE O 1 0.9999974966049194
protein O 0 0.04262269660830498
with O 0 0.024204859510064125
the O 0 0.04642845690250397
TfR O 1 0.9993621706962585
. O 0 0.05868421122431755

Studies O 0 0.03854953870177269
on O 0 0.030548594892024994
cell O 0 0.2741979956626892
- O 1 0.9995695948600769
associated O 0 0.03766646236181259
transferrin O 1 0.9919658899307251
at O 0 0.030699510127305984
37 O 0 0.0394638255238533
degrees O 0 0.032125961035490036
C O 0 0.05730700120329857
suggest O 0 0.015197309665381908
that O 0 0.008108086884021759
the O 0 0.01679154299199581
overexpressed O 0 0.12235613167285919
wild O 0 0.047282010316848755
- O 1 0.9999864101409912
type O 1 0.9894900918006897
HFE O 1 0.9999980926513672
protein O 0 0.03473243862390518
decreases O 0 0.033840227872133255
the O 0 0.02106834203004837
affinity O 0 0.03591040521860123
of O 0 0.022582270205020905
the O 0 0.04461871087551117
TfR O 1 0.9999508857727051
for O 0 0.05682449787855148
transferrin O 1 0.999437153339386
. O 0 0.06997689604759216

The O 0 0.07327642291784286
overexpressed O 1 0.9998989105224609
H63D O 1 0.9999967813491821
protein O 0 0.047174058854579926
does O 0 0.016197772696614265
not O 0 0.008619960397481918
have O 0 0.0066507006995379925
this O 0 0.008751437067985535
effect O 0 0.014599842019379139
, O 0 0.01212929654866457
providing O 0 0.014100885018706322
the O 0 0.011991793289780617
first O 0 0.013908453285694122
direct O 0 0.01511666551232338
evidence O 0 0.010968376882374287
for O 0 0.011775185354053974
a O 0 0.020617902278900146
functional O 0 0.032036907970905304
consequence O 0 0.03519538789987564
of O 0 0.024492181837558746
the O 0 0.08948758244514465
H63D O 1 0.9999974966049194
mutation O 1 0.5121611952781677
. O 0 0.048499565571546555

Addition O 0 0.03536638990044594
of O 0 0.03775377944111824
soluble O 1 0.9268450140953064
wild O 0 0.07807569205760956
- O 1 0.9999911785125732
type O 1 0.9865878224372864
HFE O 1 0.9999974966049194
/ O 1 0.9999464750289917
beta2m O 1 0.9997970461845398
heterodimers O 1 0.9997614026069641
to O 0 0.04147413745522499
cultured O 1 0.9970268607139587
cells O 0 0.04146166518330574
also O 0 0.01729249209165573
decreased O 0 0.03181232139468193
the O 0 0.02239609695971012
apparent O 0 0.05669626221060753
affinity O 0 0.03674554079771042
of O 0 0.02010207623243332
the O 0 0.028535770252346992
TfR O 1 0.9996033310890198
for O 0 0.01664523407816887
its O 0 0.019703324884176254
ligand O 0 0.06388942152261734
under O 0 0.026344161480665207
steady O 0 0.3903989791870117
- O 1 0.9983835220336914
state O 0 0.016714684665203094
conditions O 0 0.020776133984327316
, O 0 0.011068077757954597
both O 0 0.009269795380532742
in O 0 0.01576489768922329
293 O 1 0.9976812601089478
cells O 0 0.03815940394997597
and O 0 0.02337370626628399
in O 0 0.03576131910085678
HeLa O 1 0.9999833106994629
cells O 0 0.07877972722053528
. O 0 0.0516732893884182

Furthermore O 0 0.06683801114559174
, O 0 0.02667079120874405
at O 0 0.02507827803492546
4 O 0 0.03262172266840935
degrees O 0 0.035510942339897156
C O 1 0.5151911377906799
, O 0 0.01816496066749096
the O 0 0.019475650042295456
added O 0 0.030088726431131363
soluble O 0 0.08529238402843475
complex O 0 0.03254368528723717
of O 0 0.0438053235411644
HFE O 1 0.9999991655349731
/ O 1 0.9999837875366211
beta2m O 1 0.999482274055481
inhibited O 0 0.1514281928539276
binding O 0 0.03203778341412544
of O 0 0.027817253023386
transferrin O 1 0.9752174615859985
to O 0 0.04173247888684273
HeLa O 1 0.9999927282333374
cell O 0 0.16287870705127716
TfR O 1 0.9826931953430176
in O 0 0.018682776018977165
a O 0 0.03480268269777298
concentration O 1 0.9999109506607056
- O 1 0.9999920129776001
dependent O 0 0.06172153353691101
manner O 0 0.049811866134405136
. O 0 0.04319564998149872

Scatchard O 0 0.2563234865665436
plots O 0 0.05324529856443405
of O 0 0.024580219760537148
these O 0 0.012027084827423096
data O 0 0.011361172422766685
indicate O 0 0.01370569970458746
that O 0 0.007828175090253353
the O 0 0.017155516892671585
added O 0 0.03236672654747963
heterodimer O 1 0.9923143982887268
substantially O 0 0.03639271482825279
reduced O 0 0.02339775115251541
the O 0 0.022358363494277
affinity O 0 0.045940324664115906
of O 0 0.04064997285604477
TfR O 1 0.9999666213989258
for O 0 0.06324303895235062
transferrin O 1 0.9997550845146179
. O 0 0.06582179665565491

These O 0 0.02193913608789444
results O 0 0.017869271337985992
establish O 0 0.02818027324974537
a O 0 0.024522334337234497
molecular O 0 0.032618895173072815
link O 0 0.035674646496772766
between O 0 0.027974067255854607
HFE O 1 0.9999572038650513
and O 0 0.019046835601329803
a O 0 0.022313162684440613
key O 0 0.03426463156938553
protein O 0 0.019342511892318726
involved O 0 0.013586437329649925
in O 0 0.014661361463367939
iron O 1 0.9993632435798645
transport O 0 0.11019817739725113
, O 0 0.019775543361902237
the O 0 0.03049365058541298
TfR O 1 0.9999845027923584
, O 0 0.020907578989863396
and O 0 0.015156158246099949
raise O 0 0.020391276106238365
the O 0 0.013870487920939922
possibility O 0 0.017814824357628822
that O 0 0.01138684619218111
alterations O 0 0.027183400467038155
in O 0 0.011628866195678711
this O 0 0.013732125982642174
regulatory O 0 0.2070397585630417
mechanism O 0 0.05861884728074074
may O 0 0.014220566488802433
play O 0 0.012018783017992973
a O 0 0.014004467986524105
role O 0 0.01949332468211651
in O 0 0.011714309453964233
the O 0 0.024154243990778923
pathogenesis O 1 0.999997615814209
of O 1 0.9998958110809326
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9993312358856201
. O 0 0.07756730169057846

Genomic O 0 0.07945545017719269
organization O 0 0.033809173852205276
of O 0 0.026065092533826828
the O 0 0.04270422086119652
UBE3A O 1 0.9999991655349731
/ O 1 0.9999892711639404
E6 O 1 0.9999940395355225
- O 1 0.9999947547912598
AP O 1 0.849080502986908
gene O 0 0.037540074437856674
and O 0 0.024592982605099678
related O 0 0.04196770489215851
pseudogenes O 0 0.4359956383705139
. O 0 0.051281217485666275

The O 0 0.06747042387723923
UBE3A O 1 0.9990346431732178
gene O 0 0.04425029084086418
encodes O 0 0.041046030819416046
the O 0 0.02862771786749363
E6 O 1 0.9994346499443054
- O 1 0.9997885823249817
AP O 1 0.7391694188117981
ubiquitin O 1 0.9973763227462769
- O 1 0.9999408721923828
protein O 0 0.036831606179475784
ligase O 0 0.04811912775039673
and O 0 0.015106260776519775
has O 0 0.014669525437057018
recently O 0 0.019215185195207596
been O 0 0.010285289958119392
shown O 0 0.009679271839559078
to O 0 0.009403626434504986
be O 0 0.011048044078052044
mutated O 0 0.12778234481811523
in O 1 0.9300192594528198
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999997615814209
who O 1 0.985045850276947
lack O 1 0.9965929388999939
15q11 O 1 0.9999967813491821
- O 1 0.9999969005584717
q13 O 1 0.9996503591537476
deletions O 0 0.10643753409385681
or O 0 0.03503710776567459
chromosome O 0 0.06537534296512604
15 O 0 0.05753549933433533
paternal O 1 0.9984946250915527
uniparental B-Disease 1 0.9999985694885254
disomy I-Disease 1 0.9999171495437622
. O 0 0.08540671318769455

Previous O 0 0.09473853558301926
UBE3A O 1 0.9996888637542725
cDNA O 0 0.12776952981948853
analysis O 0 0.027112096548080444
has O 0 0.019554628059267998
shown O 0 0.016886921599507332
a O 0 0.025565702468156815
coding O 0 0.04527939110994339
region O 0 0.026203017681837082
of O 0 0.023777930065989494
approximately O 0 0.030767571181058884
2 O 0 0.04996404051780701
. O 0 0.04372496157884598

6 O 0 0.07131313532590866
kb O 0 0.10178632289171219
and O 0 0.021934496238827705
a O 0 0.02802230417728424
3 O 0 0.04225197434425354
- O 1 0.9996919631958008
untranslated O 1 0.9234994053840637
region O 0 0.0354660265147686
( O 0 0.029974358156323433
UTR O 1 0.8467812538146973
) O 0 0.019685881212353706
of O 0 0.02415570430457592
< O 1 0.6993141770362854
50 O 0 0.03201373666524887
bp O 0 0.04936745762825012
, O 0 0.01876310259103775
whereas O 0 0.020773300901055336
Northern O 0 0.02170032449066639
analysis O 0 0.01386471651494503
has O 0 0.012623343616724014
indicated O 0 0.017536228522658348
mRNA O 0 0.022855542600154877
sizes O 0 0.01457772683352232
of O 0 0.017151610925793648
5 O 0 0.041976410895586014
- O 1 0.9983966946601868
8 O 0 0.06383772939443588
kb O 0 0.17166833579540253
. O 0 0.05713284760713577

We O 0 0.03277447074651718
have O 0 0.016314027830958366
analyzed O 0 0.02598932757973671
additional O 0 0.02370748668909073
cDNA O 0 0.09667614102363586
clones O 0 0.07797717303037643
and O 0 0.023060820996761322
provide O 0 0.01986481249332428
evidence O 0 0.015081295743584633
for O 0 0.014851770363748074
an O 0 0.01956876739859581
additional O 0 0.02847432717680931
0 O 0 0.05770373344421387
. O 0 0.04409779608249664

5 O 0 0.04673370346426964
kb O 0 0.08450127393007278
of O 0 0.03086472488939762
5 O 0 0.04917263984680176
- O 1 0.9997811913490295
UTR O 1 0.9928717017173767
and O 0 0.027574559673666954
> O 0 0.09660477936267853
2 O 0 0.02945953607559204
kb O 0 0.06794321537017822
of O 0 0.02990688383579254
3 O 0 0.0577409453690052
- O 1 0.999771773815155
UTR O 1 0.98069167137146
. O 0 0.05117784067988396

We O 0 0.027882514521479607
have O 0 0.012792566791176796
established O 0 0.024902744218707085
the O 0 0.020753491669893265
genomic O 0 0.04001425579190254
organization O 0 0.0324326753616333
of O 0 0.03229639679193497
UBE3A O 1 0.9999568462371826
and O 0 0.020786022767424583
the O 0 0.018178287893533707
sequence O 0 0.01899578608572483
of O 0 0.03283761814236641
intron O 1 0.9999986886978149
- O 1 0.9999929666519165
exon O 1 0.8845325708389282
borders O 0 0.06872650235891342
. O 0 0.04600346460938454

We O 0 0.03168094903230667
have O 0 0.01382807269692421
also O 0 0.01484912633895874
mapped O 0 0.025913327932357788
two O 0 0.012377127073705196
highly O 0 0.03180501237511635
homologous O 0 0.05444616451859474
processed O 0 0.037373073399066925
pseudogenes O 0 0.07843486964702606
, O 0 0.03465370461344719
UBE3AP1 O 1 0.9999208450317383
and O 0 0.033067286014556885
UBE3AP2 O 1 0.9999324083328247
, O 0 0.020362168550491333
to O 0 0.016825072467327118
chromosomes O 0 0.02840709127485752
2 O 0 0.021611986681818962
and O 0 0.01468320656567812
21 O 0 0.02496877685189247
, O 0 0.0172682236880064
respectively O 0 0.018685495480895042
, O 0 0.016309315338730812
and O 0 0.013220518827438354
determined O 0 0.021888114511966705
their O 0 0.017995553091168404
genomic O 0 0.057424817234277725
organization O 0 0.04510704427957535
. O 0 0.04155103489756584

These O 0 0.025033945217728615
results O 0 0.019175373017787933
will O 0 0.014151555486023426
form O 0 0.01372738741338253
the O 0 0.012889749370515347
basis O 0 0.012501236982643604
for O 0 0.012280578725039959
studies O 0 0.014106282964348793
of O 0 0.022172512486577034
mutation O 0 0.05049639940261841
and O 0 0.029155122116208076
imprinting O 1 0.9973306655883789
of O 0 0.22571727633476257
UBE3A O 1 0.9999898672103882
. O 0 0.07694631069898605

Mutation O 0 0.10731350630521774
spectrum O 0 0.06667379289865494
and O 0 0.04192211478948593
genotype O 1 0.9981576800346375
- O 1 0.9998854398727417
phenotype O 0 0.1579854041337967
analyses O 0 0.030133889988064766
in O 0 0.024752674624323845
Cowden B-Disease 1 0.9999994039535522
disease I-Disease 1 0.9999902248382568
and O 1 0.713639497756958
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.05487564951181412
two O 0 0.05250587314367294
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 1 0.9996278285980225
germline O 1 0.9999995231628418
PTEN O 1 0.9999995231628418
mutation O 1 0.9480599761009216
. O 0 0.06766831129789352

The O 0 0.2730313837528229
tumour B-Disease 1 1.0
suppressor O 1 0.999998927116394
gene O 1 0.9676859378814697
PTEN O 1 0.9999208450317383
, O 0 0.03651709482073784
which O 0 0.02165854722261429
maps O 0 0.030104011297225952
to O 0 0.03333598002791405
10q23 O 1 0.9002516865730286
. O 0 0.054018475115299225

3 O 0 0.04688607528805733
and O 0 0.025992006063461304
encodes O 0 0.04191864654421806
a O 0 0.030064217746257782
403 O 0 0.08297832310199738
amino O 0 0.04171331971883774
acid O 0 0.05366411432623863
dual O 0 0.0603744238615036
specificity O 0 0.25806447863578796
phosphatase O 1 0.9997676014900208
( O 0 0.037170104682445526
protein O 0 0.0436856634914875
tyrosine O 1 0.8920734524726868
phosphatase O 1 0.9993908405303955
; O 0 0.033133137971162796
PTPase O 1 0.9992390871047974
) O 0 0.021926861256361008
, O 0 0.01633598282933235
was O 0 0.021338345482945442
shown O 0 0.014419234357774258
recently O 0 0.017886443063616753
to O 0 0.01145131140947342
play O 0 0.01322538498789072
a O 0 0.019020847976207733
broad O 0 0.03696395084261894
role O 0 0.04638413339853287
in O 0 0.028742749243974686
human O 1 0.669601321220398
malignancy B-Disease 1 0.9999990463256836
. O 0 0.07047022134065628

Somatic O 1 0.9989697933197021
PTEN O 1 0.9999357461929321
deletions O 0 0.11857662349939346
and O 0 0.030466653406620026
mutations O 0 0.025374596938490868
were O 0 0.009541509672999382
observed O 0 0.013074316084384918
in O 0 0.012821781449019909
sporadic B-Disease 1 0.9848448634147644
breast I-Disease 1 0.9999998807907104
, I-Disease 1 0.8352366089820862
brain I-Disease 1 0.9999802112579346
, I-Disease 1 0.9970188140869141
prostate I-Disease 1 1.0
and I-Disease 1 0.9999996423721313
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999954700469971
lines O 0 0.025666123256087303
and O 0 0.011595039628446102
in O 0 0.00938977301120758
several O 0 0.009999532252550125
primary O 0 0.06774641573429108
tumours B-Disease 1 0.9999964237213135
such O 0 0.018918653950095177
as O 1 0.9659903645515442
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9999997615814209
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9983420372009277

In O 0 0.03370348736643791
addition O 0 0.0363163948059082
, O 0 0.04010912775993347
PTEN O 1 0.9999164342880249
was O 0 0.032564423978328705
identified O 0 0.022511696442961693
as O 0 0.015138688497245312
the O 0 0.020435690879821777
susceptibility O 0 0.36044472455978394
gene O 0 0.022777626290917397
for O 0 0.016159003600478172
two O 0 0.03106071799993515
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9980124235153198
CD B-Disease 1 0.99988853931427
; O 0 0.04344620555639267
MIM O 1 0.9999984502792358
158350 O 1 0.9994004964828491
) O 0 0.02330656349658966
and O 0 0.02281852625310421
Bannayan B-Disease 1 0.9999381303787231
- I-Disease 1 0.999996542930603
Zonana I-Disease 1 0.999915599822998
( I-Disease 0 0.04876025393605232
BZS I-Disease 1 0.9981946349143982
) I-Disease 0 0.02384074777364731
or I-Disease 0 0.020603124052286148
Ruvalcaba I-Disease 1 0.9998201727867126
- I-Disease 1 0.9999700784683228
Riley I-Disease 1 0.9997377991676331
- I-Disease 1 0.9999996423721313
Smith I-Disease 1 0.9999958276748657
syndrome I-Disease 1 1.0
( O 1 0.9995675683021545
MIM O 1 0.9999998807907104
153480 O 1 0.9999760389328003
) O 0 0.06067200377583504
. O 0 0.0483706034719944

Constitutive O 1 0.7021964192390442
DNA O 0 0.04682911932468414
from O 0 0.023409249261021614
37 O 0 0.04887494072318077
CD B-Disease 0 0.07656797766685486
families O 0 0.028772691264748573
and O 0 0.020402222871780396
seven O 0 0.036201369017362595
BZS B-Disease 1 0.998623251914978
families O 0 0.03723623976111412
was O 0 0.03780308738350868
screened O 0 0.08072331547737122
for O 0 0.04266932234168053
germline O 1 0.999944806098938
PTEN O 1 0.9999971389770508
mutations O 0 0.09476679563522339
. O 0 0.05625525116920471

PTEN O 1 0.999942421913147
mutations O 0 0.05704620108008385
were O 0 0.015666060149669647
identified O 0 0.01770700514316559
in O 0 0.009278534911572933
30 O 0 0.013910055160522461
of O 0 0.01571180298924446
37 O 0 0.03413723409175873
( O 0 0.02326459251344204
81 O 0 0.05257698893547058
% O 0 0.023889854550361633
) O 0 0.02205784246325493
CD B-Disease 0 0.05467597395181656
families O 0 0.022261420264840126
, O 0 0.016522085294127464
including O 0 0.016218416392803192
missense O 0 0.07393403351306915
and O 0 0.024938397109508514
nonsense O 1 0.8155440092086792
point O 0 0.03158478066325188
mutations O 0 0.033051785081624985
, O 0 0.021160544827580452
deletions O 0 0.04630992189049721
, O 0 0.02216343767940998
insertions O 0 0.057152677327394485
, O 0 0.019022373482584953
a O 0 0.031890593469142914
deletion O 1 0.9940511584281921
/ O 1 0.9998207688331604
insertion O 0 0.455886572599411
and O 0 0.03990364447236061
splice O 1 0.5088746547698975
site O 0 0.059322796761989594
mutations O 0 0.04930851235985756
. O 0 0.03931375965476036

These O 0 0.029037145897746086
mutations O 0 0.030408205464482307
were O 0 0.011590885929763317
scattered O 0 0.018640955910086632
over O 0 0.013755031861364841
the O 0 0.014773436821997166
entire O 0 0.022857695817947388
length O 0 0.01859479770064354
of O 0 0.032030217349529266
PTEN O 1 0.9999985694885254
, O 0 0.018707463517785072
with O 0 0.012077538296580315
the O 0 0.013454969972372055
exception O 0 0.018025541678071022
of O 0 0.01286529190838337
the O 0 0.016368288546800613
first O 0 0.019686106592416763
, O 0 0.018378056585788727
fourth O 0 0.04086073487997055
and O 0 0.02328881435096264
last O 0 0.03996477276086807
exons O 0 0.08730914443731308
. O 0 0.043348345905542374

A O 0 0.08081141114234924
hot O 0 0.18060605227947235
spot O 0 0.06539864838123322
for O 0 0.03702563792467117
PTEN O 1 0.9999867677688599
mutation O 0 0.049329955130815506
in O 0 0.01893954537808895
CD B-Disease 0 0.2259095460176468
was O 0 0.022895261645317078
identified O 0 0.017361339181661606
in O 0 0.012437541037797928
exon O 0 0.0481426827609539
5 O 0 0.017578216269612312
that O 0 0.007710160221904516
contains O 0 0.013655833899974823
the O 0 0.0199884045869112
PTPase O 1 0.9991196990013123
core O 1 0.8135551810264587
motif O 0 0.08981108665466309
, O 0 0.012588351033627987
with O 0 0.00926060788333416
13 O 0 0.01580263115465641
of O 0 0.014516890048980713
30 O 0 0.02079438976943493
( O 0 0.01979921944439411
43 O 0 0.03134395554661751
% O 0 0.023115145042538643
) O 0 0.025322625413537025
CD B-Disease 0 0.0962018296122551
mutations O 0 0.03150346875190735
identified O 0 0.020737124606966972
in O 0 0.015324749052524567
this O 0 0.022119147703051567
exon O 0 0.11919711530208588
. O 0 0.05041380599141121

Seven O 0 0.035665787756443024
of O 0 0.030168317258358
30 O 0 0.03254537656903267
( O 0 0.026092341169714928
23 O 0 0.02810528874397278
% O 0 0.01815800741314888
) O 0 0.011134275235235691
were O 0 0.006496801506727934
within O 0 0.009504243731498718
the O 0 0.017440572381019592
core O 0 0.2029092013835907
motif O 0 0.07405228912830353
, O 0 0.014294566586613655
the O 0 0.014629156328737736
majority O 0 0.01875440590083599
( O 0 0.013136852532625198
five O 0 0.009160386398434639
of O 0 0.011792786419391632
seven O 0 0.015556209720671177
) O 0 0.01238584890961647
of O 0 0.011494162492454052
which O 0 0.011162029579281807
were O 0 0.014957992359995842
missense O 1 0.8805621266365051
mutations O 0 0.03808700665831566
, O 0 0.02025465853512287
possibly O 0 0.02198578603565693
pointing O 0 0.023725079372525215
to O 0 0.014411896467208862
the O 0 0.01870833896100521
functional O 0 0.030726520344614983
significance O 0 0.02426910400390625
of O 0 0.0213007852435112
this O 0 0.02048684097826481
region O 0 0.04634512960910797
. O 0 0.04475384205579758

Germline O 1 0.999929666519165
PTEN O 1 0.9999831914901733
mutations O 0 0.05394452065229416
were O 0 0.015501486137509346
identified O 0 0.017342640087008476
in O 0 0.009051207453012466
four O 0 0.010577362962067127
of O 0 0.015842655673623085
seven O 0 0.027389459311962128
( O 0 0.030559072270989418
57 O 0 0.05881360545754433
% O 0 0.03801354765892029
) O 0 0.04264245182275772
BZS B-Disease 1 0.9930478930473328
families O 0 0.05483492463827133
studied O 0 0.05718337744474411
. O 0 0.049110207706689835

Interestingly O 0 0.11182213574647903
, O 0 0.028104066848754883
none O 0 0.020041704177856445
of O 0 0.016806507483124733
these O 0 0.012950219213962555
mutations O 0 0.025386666879057884
was O 0 0.021828414872288704
observed O 0 0.01650535687804222
in O 0 0.01460316963493824
the O 0 0.029942667111754417
PTPase O 1 0.9997923970222473
core O 1 0.906063437461853
motif O 0 0.325912743806839
. O 0 0.048996634781360626

It O 0 0.027845609933137894
is O 0 0.0201253741979599
also O 0 0.015295550227165222
worthy O 0 0.04201200231909752
of O 0 0.018449464812874794
note O 0 0.018774818629026413
that O 0 0.007636592723429203
a O 0 0.015065792948007584
single O 0 0.024587389081716537
nonsense O 0 0.059270765632390976
point O 0 0.026326043531298637
mutation O 0 0.03810783475637436
, O 0 0.022254537791013718
R233X O 1 0.9934752583503723
, O 0 0.018332993611693382
was O 0 0.01889795809984207
observed O 0 0.014032619073987007
in O 0 0.009779109619557858
the O 0 0.01975650154054165
germline O 1 0.5909516215324402
DNA O 0 0.022452417761087418
from O 0 0.01118576992303133
two O 0 0.013675655238330364
unrelated O 0 0.04321872442960739
CD B-Disease 0 0.25645193457603455
families O 0 0.029218018054962158
and O 0 0.02623787894845009
one O 0 0.04113772511482239
BZS B-Disease 1 0.9997957348823547
family O 0 0.07819737493991852
. O 0 0.052267689257860184

Genotype O 1 0.9997921586036682
- O 1 0.9999961853027344
phenotype O 1 0.9584652781486511
studies O 0 0.019671576097607613
were O 0 0.011302611790597439
not O 0 0.009301097132265568
performed O 0 0.019020777195692062
on O 0 0.011423900723457336
this O 0 0.008236316964030266
small O 0 0.01582294888794422
group O 0 0.03225862979888916
of O 0 0.039102282375097275
BZS B-Disease 1 0.9999029636383057
families O 0 0.06386754661798477
. O 0 0.052923232316970825

However O 0 0.039435699582099915
, O 0 0.040667660534381866
genotype O 1 0.9841523766517639
- O 1 0.9998941421508789
phenotype O 0 0.0801222175359726
analysis O 0 0.023302827030420303
inthe O 0 0.3377251923084259
group O 0 0.03186647593975067
of O 0 0.027458004653453827
CD B-Disease 1 0.808230459690094
families O 0 0.026847008615732193
revealed O 0 0.02495616115629673
two O 0 0.011930863372981548
possible O 0 0.017048314213752747
associations O 0 0.024878056719899178
worthy O 0 0.05196582153439522
of O 0 0.023329365998506546
follow O 0 0.03878628835082054
- O 1 0.9994142055511475
up O 0 0.025664255023002625
in O 0 0.01791965961456299
independent O 0 0.034213799983263016
analyses O 0 0.04072495922446251
. O 0 0.03369700163602829

The O 0 0.0354267954826355
first O 0 0.027713030576705933
was O 0 0.02802094630897045
an O 0 0.015391138382256031
association O 0 0.021011721342802048
noted O 0 0.01275143027305603
in O 0 0.008179434575140476
the O 0 0.011540176346898079
group O 0 0.02029639482498169
of O 0 0.018087204545736313
CD B-Disease 1 0.9305605888366699
families O 0 0.0446278378367424
with O 1 0.9845453500747681
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9011538624763489

A O 0 0.0714300274848938
correlation O 0 0.04716332256793976
was O 0 0.025594880804419518
observed O 0 0.015375401824712753
between O 0 0.01275140605866909
the O 0 0.017570601776242256
presence O 0 0.03638539835810661
/ O 1 0.9837734699249268
absence O 0 0.03064858727157116
of O 0 0.022602522745728493
a O 0 0.16927118599414825
PTEN O 1 0.9999985694885254
mutation O 0 0.03663891181349754
and O 0 0.013252905569970608
the O 0 0.01695478893816471
type O 0 0.037972718477249146
of O 0 0.09817289561033249
breast O 1 1.0
involvement O 1 0.9999698400497437
( O 0 0.45302778482437134
unaffected O 1 0.9994223117828369
versus O 1 0.9994284510612488
benign O 1 0.9999998807907104
versus O 1 0.9999949932098389
malignant O 1 1.0
) O 0 0.07458245754241943
. O 0 0.05141597241163254

Specifically O 0 0.04356028512120247
and O 0 0.020157787948846817
more O 0 0.011747954413294792
directly O 0 0.017126580700278282
, O 0 0.014006602577865124
an O 0 0.014395453967154026
association O 0 0.027506981045007706
was O 0 0.02128301002085209
also O 0 0.01016535796225071
observed O 0 0.009666919708251953
between O 0 0.008499191142618656
the O 0 0.009820225648581982
presence O 0 0.014914039522409439
of O 0 0.014012070372700691
a O 0 0.03814568743109703
PTEN O 1 0.9999986886978149
mutation O 1 0.9987278580665588
and O 1 0.9996975660324097
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9949095845222473

Secondly O 1 0.9887791872024536
, O 0 0.030178459361195564
there O 0 0.014752076007425785
appeared O 0 0.018696988001465797
to O 0 0.012309380806982517
be O 0 0.010268005542457104
an O 0 0.017998063936829567
interdependent O 1 0.9287170767784119
association O 0 0.033256933093070984
between O 0 0.02367456629872322
mutations O 0 0.031182242557406425
upstream O 0 0.029801303520798683
and O 0 0.012015420943498611
within O 0 0.011757735162973404
the O 0 0.023562591522932053
PTPase O 1 0.9999263286590576
core O 1 0.9345194101333618
motif O 0 0.22636574506759644
, O 0 0.015549938194453716
the O 0 0.01842176541686058
core O 0 0.05221015587449074
motif O 0 0.03943365067243576
containing O 0 0.013828229159116745
the O 0 0.01163626741617918
majority O 0 0.015672659501433372
of O 0 0.022389894351363182
missense O 1 0.9970405697822571
mutations O 0 0.03095102123916149
, O 0 0.014094503596425056
and O 0 0.010580063797533512
the O 0 0.013244347646832466
involvement O 0 0.022012393921613693
of O 0 0.010721620172262192
all O 0 0.011407971382141113
major O 1 0.5441411137580872
organ O 1 0.9999912977218628
systems O 0 0.38149890303611755
( O 0 0.01954171434044838
central O 0 0.02781166322529316
nervous O 1 0.9811557531356812
system O 0 0.03886295482516289
, O 0 0.3566202223300934
thyroid O 1 1.0
, O 1 0.9959971904754639
breast O 1 1.0
, O 1 0.9999784231185913
skin O 1 1.0
and O 1 0.9999990463256836
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9825000762939453
. O 0 0.056404855102300644

However O 0 0.03783638775348663
, O 0 0.022452061995863914
these O 0 0.01108239870518446
observations O 0 0.019474703818559647
would O 0 0.011925602331757545
need O 0 0.013388223946094513
to O 0 0.010880870744585991
be O 0 0.00854787789285183
confirmed O 0 0.012347003445029259
by O 0 0.009955242276191711
studying O 0 0.013683908618986607
a O 0 0.015341565944254398
larger O 0 0.016051197424530983
number O 0 0.012766114436089993
of O 0 0.026561416685581207
CD B-Disease 1 0.8717161417007446
families O 0 0.05114402249455452
. O 0 0.047275204211473465

Molecular O 0 0.26942506432533264
defects O 1 0.984744131565094
leading O 0 0.042226746678352356
to O 0 0.02077813260257244
human O 0 0.03351254761219025
complement B-Disease 1 0.9995899796485901
component I-Disease 1 0.9999995231628418
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.024479258805513382
an O 0 0.027055654674768448
African O 1 0.9524424076080322
- O 1 0.9999669790267944
American O 0 0.05184229835867882
family O 0 0.051647718995809555
. O 0 0.04282386600971222

Complement B-Disease 1 0.9848397374153137
component I-Disease 1 0.9999958276748657
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.999500036239624
C6D B-Disease 1 0.9999998807907104
) O 0 0.035045091062784195
was O 0 0.06071830913424492
diagnosed O 1 0.9999071359634399
in O 0 0.012867052108049393
a O 0 0.018141742795705795
16 O 0 0.02542918734252453
- O 1 0.9993196725845337
year O 0 0.01916041225194931
- O 1 0.9483195543289185
old O 0 0.0371653214097023
African O 0 0.036010295152664185
- O 1 0.9976065158843994
American O 0 0.03602244332432747
male O 1 0.8189520239830017
with O 1 0.963606595993042
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9884824156761169

The O 0 0.08044645935297012
patients O 1 0.9967713952064514
father O 0 0.31137970089912415
and O 0 0.02230324223637581
two O 0 0.017866292968392372
brothers O 1 0.6184929609298706
also O 0 0.017926929518580437
had O 0 0.025832710787653923
C6D B-Disease 1 0.9999690055847168
, O 0 0.0164055023342371
but O 0 0.00987967848777771
gave O 0 0.01449250802397728
no O 0 0.009743141010403633
history O 0 0.01670634001493454
of O 0 0.22315528988838196
meningitis B-Disease 1 1.0
or O 1 0.5735228061676025
other O 0 0.16548927128314972
neisserial B-Disease 1 0.9999998807907104
infection I-Disease 1 0.9999998807907104
. O 0 0.08871784806251526

By O 0 0.031850267201662064
using O 0 0.02472480945289135
exon O 0 0.1461610198020935
- O 1 0.8421580195426941
specific O 0 0.022490505129098892
polymerase O 0 0.12942416965961456
chain O 0 0.061213716864585876
reaction O 0 0.039778951555490494
( O 0 0.028830181807279587
PCR O 0 0.07060907781124115
) O 0 0.025844894349575043
/ O 0 0.1659630835056305
single O 0 0.03826923295855522
- O 1 0.9953950047492981
strand O 0 0.07133790105581284
conformation O 0 0.05197601392865181
polymorphism O 0 0.04029659926891327
as O 0 0.014751855283975601
a O 0 0.021320000290870667
screening O 0 0.04029805585741997
step O 0 0.027456127107143402
and O 0 0.015393609181046486
nucleotide O 0 0.026012161746621132
sequencing O 0 0.019153714179992676
of O 0 0.014495791867375374
target O 0 0.027312951162457466
exons O 0 0.03992994502186775
, O 0 0.014000045135617256
we O 0 0.009684515185654163
determined O 0 0.013442924246191978
that O 0 0.007257673889398575
the O 0 0.0160833727568388
proband O 1 0.9693547487258911
was O 0 0.025746135041117668
a O 0 0.027187947183847427
compound O 0 0.05693739280104637
heterozygote O 0 0.10292963683605194
for O 0 0.020446056500077248
two O 0 0.03194597736001015
C6 O 1 0.9999988079071045
gene O 0 0.07456640899181366
mutations O 0 0.061531148850917816
. O 0 0.044812947511672974

The O 0 0.04299168661236763
first O 0 0.03075350821018219
, O 0 0.029476480558514595
1195delC O 1 0.6370273232460022
located O 0 0.03532499447464943
in O 0 0.018814118579030037
exon O 0 0.0819753035902977
7 O 0 0.028288325294852257
, O 0 0.015326173976063728
is O 0 0.012733331881463528
a O 0 0.01953640766441822
novel O 0 0.03834819048643112
mutation O 0 0.029886458069086075
, O 0 0.012940154410898685
while O 0 0.011121021583676338
the O 0 0.014655527658760548
second O 0 0.0246738214045763
, O 0 0.020196860656142235
1936delG O 1 0.8527557849884033
in O 0 0.018218591809272766
exon O 0 0.21734793484210968
12 O 0 0.023836925625801086
, O 0 0.01590043492615223
has O 0 0.012591218575835228
been O 0 0.011331139132380486
described O 0 0.018086180090904236
before O 0 0.016694124788045883
to O 0 0.01966742053627968
cause O 0 0.4900514781475067
C6D B-Disease 1 0.9997957348823547
in O 0 0.016984840855002403
an O 0 0.018665971234440804
unrelated O 0 0.039271362125873566
African O 1 0.9012580513954163
- O 1 0.9999709129333496
American O 0 0.0533149354159832
individual O 0 0.03294408321380615
. O 0 0.038982000201940536

Both O 0 0.046652231365442276
mutations O 0 0.04725540056824684
result O 0 0.02279757894575596
in O 0 0.02555755339562893
premature O 1 0.9981415271759033
termination O 1 0.9998156428337097
codons O 1 0.9245773553848267
and O 0 0.13416539132595062
C6 O 1 0.9999988079071045
null O 1 0.9850603938102722
alleles O 0 0.11746813356876373
. O 0 0.05447651445865631

Allele O 1 0.9338251352310181
- O 1 0.9983555674552917
specific O 0 0.030118674039840698
PCR O 0 0.060266200453042984
indicated O 0 0.022356605157256126
that O 0 0.009111255407333374
the O 0 0.017473360523581505
probands O 1 0.5966329574584961
two O 0 0.01518534030765295
brothers O 0 0.04568888992071152
also O 0 0.01915118284523487
inherited O 1 0.808479905128479
the O 0 0.03467044606804848
1195delC O 1 0.9998558759689331
mutation O 0 0.042003434151411057
from O 0 0.014019896276295185
their O 0 0.01583632081747055
heterozygous O 0 0.04461539536714554
mother O 0 0.04744037985801697
and O 0 0.018681900575757027
the O 0 0.026858385652303696
1936delG O 1 0.9996609687805176
mutation O 0 0.03963723033666611
from O 0 0.015264898538589478
their O 0 0.01875312440097332
homozygous O 0 0.09521656483411789
father O 1 0.5699134469032288
. O 0 0.03186646103858948
. O 0 0.039615482091903687

PAX6 O 1 0.9999215602874756
mutations O 0 0.13656556606292725
reviewed O 0 0.09466882795095444
. O 0 0.0632525309920311

Mutations O 0 0.07392481714487076
in O 0 0.03359142318367958
PAX6 O 1 0.9999363422393799
are O 0 0.013468079268932343
responsible O 0 0.026641950011253357
for O 0 0.01874825358390808
human O 1 0.6531175374984741
aniridia B-Disease 1 0.9999997615814209
and O 0 0.019173752516508102
have O 0 0.009032486006617546
also O 0 0.008727067150175571
been O 0 0.00791502371430397
found O 0 0.007833920419216156
in O 0 0.009785233996808529
patients O 0 0.25988152623176575
with O 0 0.023349884897470474
Peters B-Disease 1 0.9999978542327881
anomaly I-Disease 1 0.9999972581863403
, O 0 0.16857968270778656
with O 1 0.9998400211334229
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9997492432594299
with O 1 0.9994787573814392
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999998807907104
keratitis I-Disease 1 1.0
, O 1 0.7406235933303833
and O 0 0.03208259120583534
with O 0 0.2292616069316864
isolated B-Disease 1 0.9999798536300659
foveal I-Disease 1 0.9999997615814209
hypoplasia I-Disease 1 0.9999997615814209
. O 0 0.11397295445203781

No O 0 0.045982081443071365
locus O 0 0.071797214448452
other O 0 0.014001689851284027
than O 0 0.01703387126326561
chromosome O 0 0.05667416751384735
11p13 O 1 0.9634354114532471
has O 0 0.01793018728494644
been O 0 0.014902856200933456
implicated O 0 0.1597822904586792
in O 0 0.021819980815052986
aniridia B-Disease 1 0.9999984502792358
, O 0 0.027445711195468903
and O 0 0.03013991191983223
PAX6 O 1 0.9999995231628418
is O 0 0.022065207362174988
clearly O 0 0.018863296136260033
the O 0 0.016821255907416344
major O 0 0.025039207190275192
, O 0 0.014874957501888275
if O 0 0.010594229213893414
not O 0 0.008122879080474377
only O 0 0.011095638386905193
, O 0 0.021163666620850563
gene O 0 0.03246400132775307
responsible O 0 0.04484779015183449
. O 0 0.04149483144283295

Twenty O 0 0.08951295912265778
- O 0 0.21862976253032684
eight O 0 0.021670369431376457
percent O 0 0.017739297822117805
of O 0 0.019395699724555016
identified O 0 0.03898271545767784
PAX6 O 1 0.9999873638153076
mutations O 0 0.039340633898973465
are O 0 0.01602349244058132
C O 1 0.9995939135551453
- O 1 0.9999855756759644
T O 1 0.9861071109771729
changes O 0 0.018755730241537094
at O 0 0.026352526620030403
CpG O 1 0.9629727602005005
dinucleotides O 1 0.9905684590339661
, O 0 0.020845143124461174
20 O 0 0.017671767622232437
% O 0 0.013836685568094254
are O 0 0.00873707514256239
splicing O 0 0.030771367251873016
errors O 0 0.023255430161952972
, O 0 0.013783548027276993
and O 0 0.010704537853598595
more O 0 0.007527661509811878
than O 0 0.009057172574102879
30 O 0 0.018540548160672188
% O 0 0.017817560583353043
are O 0 0.011441905051469803
deletion O 0 0.06196166202425957
or O 0 0.03256121277809143
insertion O 1 0.5070570111274719
events O 0 0.0433666817843914
. O 0 0.04313303530216217

There O 0 0.030125118792057037
is O 0 0.021169481799006462
a O 0 0.02831476926803589
noticeably O 0 0.20973660051822662
elevated O 1 0.9993126392364502
level O 0 0.02983740344643593
of O 0 0.021626289933919907
mutation O 0 0.032352667301893234
in O 0 0.012859988026320934
the O 0 0.021395068615674973
paired O 0 0.21238954365253448
domain O 0 0.02639954350888729
compared O 0 0.015061774291098118
with O 0 0.01168197114020586
the O 0 0.01622372679412365
rest O 0 0.023170122876763344
of O 0 0.021568570286035538
the O 0 0.035054877400398254
gene O 0 0.04819178581237793
. O 0 0.040283940732479095

Increased O 0 0.06043422967195511
mutation O 0 0.05173596739768982
in O 0 0.02024983800947666
the O 0 0.030538378283381462
homeodomain O 1 0.998824417591095
is O 0 0.023153124377131462
accounted O 0 0.025178829208016396
for O 0 0.0133743891492486
by O 0 0.018064484000205994
the O 0 0.03452502191066742
hypermutable O 1 0.9995163679122925
CpG O 1 0.9986088871955872
dinucleotide O 1 0.9813061356544495
in O 0 0.0441410131752491
codon O 0 0.10755381733179092
240 O 0 0.08603278547525406
. O 0 0.05228973552584648

Very O 0 0.033961400389671326
nearly O 0 0.027577964588999748
all O 0 0.020483119413256645
mutations O 0 0.027667518705129623
appear O 0 0.016885584220290184
to O 0 0.01579766906797886
cause O 0 0.12403498589992523
loss O 0 0.03125024959445
of O 0 0.017013156786561012
function O 0 0.016173185780644417
of O 0 0.014680128544569016
the O 0 0.028384316712617874
mutant O 1 0.9995933175086975
allele O 0 0.43502047657966614
, O 0 0.01588372327387333
and O 0 0.010780512355268002
more O 0 0.0066487547010183334
than O 0 0.008830220438539982
80 O 0 0.019455354660749435
% O 0 0.017050879076123238
of O 0 0.023158220574259758
exonic O 1 0.9826865196228027
substitutions O 0 0.05250464007258415
result O 0 0.024676287546753883
in O 0 0.0264822319149971
nonsense O 1 0.6008509993553162
codons O 0 0.1115771234035492
. O 0 0.05295594409108162

In O 0 0.028093453496694565
a O 0 0.03226488083600998
gene O 0 0.028492391109466553
with O 0 0.01565045677125454
such O 0 0.01582525111734867
extraordinarily O 1 0.7735210061073303
high O 0 0.04714300110936165
sequence O 0 0.021594438701868057
conservation O 0 0.028661461547017097
throughout O 0 0.016187623143196106
evolution O 0 0.01999075710773468
, O 0 0.013677448965609074
there O 0 0.009304063394665718
are O 0 0.009323813952505589
presumed O 0 0.05360126122832298
undiscovered O 1 0.9989666938781738
missense O 1 0.9893202781677246
mutations O 0 0.03982234001159668
, O 0 0.016150115057826042
these O 0 0.008421414531767368
are O 0 0.00795290432870388
hypothesized O 0 0.026402605697512627
to O 0 0.011462305672466755
exist O 0 0.011537079699337482
in O 0 0.011946848593652248
as O 0 0.02239137515425682
- O 1 0.9996095299720764
yet O 0 0.03079579398036003
unidentified O 0 0.08642613142728806
phenotypes O 0 0.08543629944324493
. O 0 0.030168931931257248
. O 0 0.04023650288581848

Genetic O 0 0.09149427711963654
heterogeneity O 0 0.14273932576179504
and O 0 0.03668894246220589
penetrance O 1 0.7451547384262085
analysis O 0 0.015215548686683178
of O 0 0.016040554270148277
the O 0 0.027086472138762474
BRCA1 O 1 0.9998096823692322
and O 0 0.03552016243338585
BRCA2 O 1 0.999894380569458
genes O 0 0.040129177272319794
in O 1 0.5565153360366821
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9399696588516235
. O 0 0.05863695591688156

The O 1 0.996855616569519
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999678134918213
Consortium O 1 0.8777180910110474
. O 0 0.07167994230985641

The O 0 0.0383424237370491
contribution O 0 0.04444160684943199
of O 0 0.03746424987912178
BRCA1 O 1 0.9982818365097046
and O 0 0.03500412032008171
BRCA2 O 1 0.9997519850730896
to O 1 0.7053810954093933
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9998518228530884
assessed O 0 0.1402459293603897
by O 0 0.022804496809840202
linkage O 0 0.2654957175254822
and O 0 0.019370533525943756
mutation O 0 0.029617026448249817
analysis O 0 0.011438211426138878
in O 0 0.011385821737349033
237 O 0 0.0556974858045578
families O 0 0.020322686061263084
, O 0 0.011932100169360638
each O 0 0.0066427006386220455
with O 0 0.00789905060082674
at O 0 0.009432110004127026
least O 0 0.007078248076140881
four O 0 0.008270327001810074
cases O 0 0.01560104452073574
of O 1 0.9416210055351257
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.02186799980700016
collected O 0 0.014463122934103012
by O 0 0.01671285182237625
the O 1 0.9933649301528931
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999935626983643
Consortium O 1 0.9042940735816956
. O 0 0.05230807512998581

Families O 0 0.05107421427965164
were O 0 0.018086843192577362
included O 0 0.01939750462770462
without O 0 0.01317166443914175
regard O 0 0.019238831475377083
to O 0 0.011291314847767353
the O 0 0.016843102872371674
occurrence O 0 0.35052290558815
of O 1 0.9969930648803711
ovarian B-Disease 1 1.0
or I-Disease 1 0.9985163807868958
other I-Disease 0 0.2727307081222534
cancers I-Disease 1 0.9999884366989136
. O 0 0.061883363872766495

Overall O 1 0.6512898206710815
, O 0 0.4687071442604065
disease O 1 0.9999923706054688
was O 0 0.48231688141822815
linked O 0 0.42737847566604614
to O 0 0.02666233293712139
BRCA1 O 1 0.9980961680412292
in O 0 0.013049271889030933
an O 0 0.012834654189646244
estimated O 0 0.01490730233490467
52 O 0 0.02482280135154724
% O 0 0.012203976511955261
of O 0 0.013441578485071659
families O 0 0.018804505467414856
, O 0 0.016462013125419617
to O 0 0.019195714965462685
BRCA2 O 1 0.9064852595329285
in O 0 0.01359493937343359
32 O 0 0.025049205869436264
% O 0 0.015130884014070034
of O 0 0.015774771571159363
families O 0 0.021536607295274734
, O 0 0.015216875821352005
and O 0 0.012467551976442337
to O 0 0.012988204136490822
neither O 0 0.01972990483045578
gene O 0 0.01645238883793354
in O 0 0.010060371831059456
16 O 0 0.018508082255721092
% O 0 0.01685134321451187
( O 0 0.016161398962140083
95 O 0 0.025981631129980087
% O 0 0.01810293272137642
confidence O 0 0.03915083780884743
interval O 0 0.08091401308774948
[ O 0 0.30335408449172974
CI O 1 0.999991774559021
] O 0 0.04665881767868996
6 O 0 0.030138462781906128
% O 0 0.025211092084646225
- O 1 0.9861248135566711
28 O 0 0.0330217070877552
% O 0 0.02070208080112934
) O 0 0.017341846600174904
, O 0 0.01796933077275753
suggesting O 0 0.03187539428472519
other O 0 0.025353293865919113
predisposition O 1 0.9994744658470154
genes O 0 0.04808157682418823
. O 0 0.04108358174562454

The O 0 0.040636107325553894
majority O 0 0.0341598279774189
( O 0 0.02613687328994274
81 O 0 0.03685490041971207
% O 0 0.012656789273023605
) O 0 0.008997299708425999
of O 0 0.012616671621799469
the O 0 0.4695005416870117
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.6423611044883728
were O 0 0.014182748273015022
due O 0 0.02028706856071949
to O 0 0.021840013563632965
BRCA1 O 1 0.9996873140335083
, O 0 0.01655479148030281
with O 0 0.012307259254157543
most O 0 0.01276521384716034
others O 0 0.01652497425675392
( O 0 0.01821514591574669
14 O 0 0.024481862783432007
% O 0 0.02199440635740757
) O 0 0.01947094313800335
due O 0 0.028310902416706085
to O 0 0.041564423590898514
BRCA2 O 1 0.9993414282798767
. O 0 0.05144258961081505

Conversely O 0 0.09421174973249435
, O 0 0.022150853648781776
the O 0 0.015973761677742004
majority O 0 0.01615794189274311
of O 0 0.01427977904677391
families O 0 0.017739813774824142
with O 0 0.013699551112949848
male B-Disease 0 0.4477110207080841
and I-Disease 0 0.2963556945323944
female I-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.025963855907320976
due O 0 0.04398975148797035
to O 0 0.045902807265520096
BRCA2 O 1 0.9999803304672241
( O 0 0.042463116347789764
76 O 0 0.38805291056632996
% O 0 0.03790558874607086
) O 0 0.037407878786325455
. O 0 0.04043500870466232

The O 0 0.03903532400727272
largest O 0 0.056363072246313095
proportion O 0 0.04808038845658302
( O 0 0.02851456217467785
67 O 0 0.0425250306725502
% O 0 0.019429033622145653
) O 0 0.013853233307600021
of O 0 0.013449232093989849
families O 0 0.017248570919036865
due O 0 0.016120387241244316
to O 0 0.012660329230129719
other O 0 0.010883014649152756
genes O 0 0.014097764156758785
was O 0 0.014727160334587097
found O 0 0.008984400890767574
in O 0 0.008422506973147392
families O 0 0.011916717514395714
with O 0 0.008550929836928844
four O 0 0.009601808153092861
or O 0 0.00890855398029089
five O 0 0.009054305963218212
cases O 0 0.015067248605191708
of O 0 0.07811036705970764
female O 1 0.9999997615814209
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.16333435475826263
. O 0 0.05193032696843147

These O 0 0.02452559769153595
estimates O 0 0.022973617538809776
were O 0 0.012253043241798878
not O 0 0.01291284803301096
substantially O 0 0.026220662519335747
affected O 0 0.01856154389679432
either O 0 0.011840169318020344
by O 0 0.011890637688338757
changing O 0 0.016117218881845474
the O 0 0.017736589536070824
assumed O 0 0.04476908594369888
penetrance O 1 0.999019980430603
model O 0 0.031986676156520844
for O 0 0.022406935691833496
BRCA1 O 1 0.9997833371162415
or O 0 0.015308108180761337
by O 0 0.013445233926177025
including O 0 0.016722947359085083
or O 0 0.024935470893979073
excluding O 0 0.41665440797805786
BRCA1 O 1 0.9999798536300659
mutation O 0 0.23118805885314941
data O 0 0.029288848862051964
. O 0 0.03526432439684868

Among O 0 0.037891924381256104
those O 0 0.020275574177503586
families O 0 0.03349459543824196
with O 0 0.044346924871206284
disease O 1 0.9999977350234985
due O 1 0.5001130700111389
to O 0 0.2213890701532364
BRCA1 O 1 0.9999927282333374
that O 0 0.011861646547913551
were O 0 0.009977058507502079
tested O 0 0.016919655725359917
by O 0 0.008315015584230423
one O 0 0.008577018976211548
of O 0 0.01040849182754755
the O 0 0.01776244305074215
standard O 0 0.03083253651857376
screening O 0 0.05499639734625816
methods O 0 0.01756519451737404
, O 0 0.016235733404755592
mutations O 0 0.017472952604293823
were O 0 0.00975259579718113
detected O 0 0.01880163513123989
in O 0 0.01005026139318943
the O 0 0.018941018730401993
coding O 0 0.03768226131796837
sequence O 0 0.017880572006106377
or O 0 0.016430063173174858
splice O 0 0.04655012860894203
sites O 0 0.01268699485808611
in O 0 0.008701573126018047
an O 0 0.012326517142355442
estimated O 0 0.01890990510582924
63 O 0 0.03627237677574158
% O 0 0.02145731821656227
( O 0 0.020196426659822464
95 O 0 0.03332514688372612
% O 0 0.03187015280127525
CI O 1 0.998921275138855
51 O 0 0.0560152493417263
% O 0 0.04175828397274017
- O 1 0.9992693066596985
77 O 0 0.08786003291606903
% O 0 0.03867447003722191
) O 0 0.03567711263895035
. O 0 0.03682854399085045

The O 0 0.050893623381853104
estimated O 0 0.04288526996970177
sensitivity O 0 0.055530842393636703
was O 0 0.031011776998639107
identical O 0 0.022275827825069427
for O 0 0.01756463572382927
direct O 0 0.029995648190379143
sequencing O 0 0.03495510667562485
and O 0 0.02207157202064991
other O 0 0.020059818401932716
techniques O 0 0.03622569143772125
. O 0 0.0385296456515789

The O 0 0.05837130546569824
penetrance O 1 0.9894058108329773
of O 0 0.06108686327934265
BRCA2 O 1 0.999729335308075
was O 0 0.037695784121751785
estimated O 0 0.022491736337542534
by O 0 0.019091660156846046
maximizing O 0 0.05654586851596832
the O 0 0.02604622393846512
LOD O 1 0.9992448091506958
score O 0 0.025592327117919922
in O 0 0.022919336333870888
BRCA2 O 1 0.9999641180038452
- O 1 0.9999932050704956
mutation O 0 0.05904984846711159
families O 0 0.021177303045988083
, O 0 0.014011160470545292
over O 0 0.014899363741278648
all O 0 0.017828520387411118
possible O 0 0.03553828224539757
penetrance O 1 0.9990898370742798
functions O 0 0.04780992865562439
. O 0 0.04495270177721977

The O 0 0.034400053322315216
estimated O 0 0.029716484248638153
cumulative O 0 0.06454404443502426
risk O 1 0.6497189402580261
of O 1 0.9938722848892212
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 1 0.8809266090393066
28 O 0 0.04115655645728111
% O 0 0.018882429227232933
( O 0 0.017644306644797325
95 O 0 0.028329413384199142
% O 0 0.02614898979663849
CI O 1 0.9993904829025269
9 O 0 0.036660339683294296
% O 0 0.02992980182170868
- O 1 0.9771332740783691
44 O 0 0.034224167466163635
% O 0 0.017507966607809067
) O 0 0.012339184992015362
by O 0 0.01161186583340168
age O 0 0.019717497751116753
50 O 0 0.01860884018242359
years O 0 0.01602337136864662
and O 0 0.017631277441978455
84 O 0 0.0439908467233181
% O 0 0.021327046677470207
( O 0 0.021276485174894333
95 O 0 0.03173695132136345
% O 0 0.028064679354429245
CI O 1 0.999685525894165
43 O 0 0.042363669723272324
% O 0 0.02726893685758114
- O 1 0.9905099272727966
95 O 0 0.036163367331027985
% O 0 0.020194295793771744
) O 0 0.015418426133692265
by O 0 0.016259344294667244
age O 0 0.03226185962557793
70 O 0 0.04155564680695534
years O 0 0.0393318347632885
. O 0 0.04762093722820282

The O 0 0.07946761697530746
corresponding O 1 0.9998962879180908
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999929666519165
were O 0 0.04418925195932388
0 O 0 0.07496707886457443
. O 0 0.04691595956683159

4 O 0 0.060354363173246384
% O 0 0.0327673964202404
( O 0 0.026976415887475014
95 O 0 0.03760036826133728
% O 0 0.03465345501899719
CI O 1 0.9998099207878113
0 O 0 0.04536862298846245
% O 0 0.03281869739294052
- O 1 0.9966272115707397
1 O 0 0.02754903770983219
% O 0 0.015992216765880585
) O 0 0.011624547652900219
by O 0 0.01147761195898056
age O 0 0.0184478759765625
50 O 0 0.018023202195763588
years O 0 0.014974203892052174
and O 0 0.014726212248206139
27 O 0 0.02824402041733265
% O 0 0.01947304792702198
( O 0 0.01900479756295681
95 O 0 0.03384704515337944
% O 0 0.030170200392603874
CI O 1 0.9994706511497498
0 O 0 0.04519753158092499
% O 0 0.030029671266674995
- O 1 0.9526529312133789
47 O 0 0.04006701707839966
% O 0 0.020144924521446228
) O 0 0.01493488997220993
by O 0 0.01544289942830801
age O 0 0.027855150401592255
70 O 0 0.03828643634915352
years O 0 0.03406261280179024
. O 0 0.044071778655052185

The O 0 0.04220243915915489
lifetime O 0 0.10229364782571793
risk O 1 0.9893544912338257
of O 1 0.9998648166656494
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 1 0.9217821955680847
similar O 0 0.01450760755687952
to O 0 0.012976137921214104
the O 0 0.01754455268383026
risk O 0 0.2779132127761841
in O 0 0.02598937414586544
BRCA1 O 1 0.9999991655349731
carriers O 1 0.8981702923774719
, O 0 0.015480085276067257
but O 0 0.009054305963218212
there O 0 0.007768956944346428
was O 0 0.013277510181069374
some O 0 0.007499261759221554
suggestion O 0 0.02224588207900524
of O 0 0.01308596134185791
a O 0 0.023696795105934143
lower O 0 0.06901246309280396
risk O 0 0.22040490806102753
in O 0 0.03058234602212906
BRCA2 O 1 0.9999445676803589
carriers O 1 0.5813859701156616
< O 1 0.8589745759963989
50 O 0 0.028874075040221214
years O 0 0.02200143225491047
of O 0 0.029646191745996475
age O 0 0.05733383819460869
. O 0 0.04958454892039299

Eye B-Disease 1 0.9999489784240723
movement I-Disease 1 0.9896995425224304
abnormalities I-Disease 1 0.9987247586250305
correlate O 0 0.06312962621450424
with O 0 0.02710973657667637
genotype O 1 0.8931506276130676
in O 0 0.03040745109319687
autosomal O 1 0.9999880790710449
dominant O 1 0.9999995231628418
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999977350234985
I I-Disease 1 0.9996863603591919
. O 0 0.05653459206223488

We O 0 0.035653214901685715
compared O 0 0.04067505896091461
horizontal O 1 0.8506559729576111
eye O 1 0.999423623085022
movements O 0 0.052782826125621796
( O 0 0.03339683637022972
visually O 0 0.07768616825342178
guided O 0 0.45739322900772095
saccades O 1 0.9999899864196777
, O 0 0.040477436035871506
antisaccades O 1 0.9996813535690308
, O 0 0.023934535682201385
and O 0 0.019403083249926567
smooth O 0 0.1994991898536682
pursuit O 1 0.7755510210990906
) O 0 0.01564803346991539
in O 0 0.011227322742342949
control O 0 0.023615682497620583
subjects O 0 0.027204833924770355
( O 0 0.022979028522968292
n O 0 0.06357558071613312
= O 0 0.04275057837367058
14 O 0 0.025947533547878265
) O 0 0.01743714138865471
and O 0 0.015407218597829342
patients O 0 0.041081398725509644
with O 0 0.011316176503896713
three O 0 0.012576774694025517
forms O 0 0.01788434013724327
of O 0 0.03004506416618824
autosomal O 1 0.9999853372573853
dominant O 1 0.9999858140945435
cerebellar B-Disease 1 0.9999998807907104
ataxias I-Disease 1 0.9999996423721313
type I-Disease 1 0.999927282333374
I I-Disease 1 0.9998053908348083
spinocerebellar B-Disease 1 0.9999996423721313
ataxias I-Disease 1 0.9998444318771362
1 I-Disease 0 0.03403369337320328
and I-Disease 0 0.019818292930722237
2 I-Disease 0 0.02836526744067669
( O 0 0.02716403268277645
SCA1 B-Disease 1 0.9970324039459229
, O 0 0.026490923017263412
n O 0 0.05384450405836105
= O 0 0.0396803580224514
11 O 0 0.025271857157349586
; O 0 0.022501662373542786
SCA2 B-Disease 1 0.9975700974464417
, O 0 0.027214275673031807
n O 0 0.04989367350935936
= O 0 0.03210265189409256
10 O 0 0.013525719754397869
) O 0 0.014389056712388992
and O 0 0.020879775285720825
SCA3 B-Disease 1 0.9999990463256836
/ O 1 0.9999518394470215
Machado B-Disease 1 0.9999583959579468
- I-Disease 1 0.9999955892562866
Joseph I-Disease 1 0.999955415725708
disease I-Disease 1 0.9999988079071045
( O 1 0.9109743237495422
MJD B-Disease 1 1.0
) O 0 0.04735174402594566
( O 0 0.03911185637116432
n O 0 0.07969494163990021
= O 0 0.06641463190317154
16 O 0 0.0394505113363266
) O 0 0.036546703428030014
. O 0 0.04038812592625618

In O 0 0.060482826083898544
SCA1 B-Disease 1 0.9994951486587524
, O 0 0.05908558890223503
saccade O 1 0.9995720982551575
amplitude O 0 0.27647432684898376
was O 0 0.040673624724149704
significantly O 0 0.02838148921728134
increased O 0 0.02772054448723793
, O 0 0.023614006116986275
resulting O 0 0.033364105969667435
in O 0 0.03412935510277748
hypermetria B-Disease 1 0.9990893602371216
. O 0 0.053881801664829254

The O 0 0.0746069923043251
smooth O 0 0.25287485122680664
pursuit O 0 0.48460909724235535
gain O 0 0.07328778505325317
was O 0 0.08335558325052261
decreased O 0 0.1970568299293518
. O 0 0.05693201720714569

In O 0 0.06005673483014107
SCA2 B-Disease 1 0.9994487166404724
, O 0 0.05746462568640709
saccade O 1 0.9989551305770874
velocity O 0 0.0950099378824234
was O 0 0.07400061935186386
markedly O 0 0.33589494228363037
decreased O 0 0.0923478901386261
. O 0 0.053026214241981506

The O 0 0.04060141369700432
percentage O 0 0.0306033156812191
of O 0 0.023838698863983154
errors O 0 0.037804022431373596
in O 0 0.02397017553448677
antisaccades O 1 0.999891996383667
was O 0 0.06129005551338196
greatly O 0 0.03150230646133423
increased O 0 0.021170098334550858
and O 0 0.014611411839723587
was O 0 0.02190803736448288
significantly O 0 0.024645475670695305
correlated O 0 0.03327229991555214
with O 0 0.019908005371689796
age O 0 0.350032240152359
at O 1 0.9978904128074646
disease O 1 1.0
onset O 1 0.9999998807907104
. O 1 0.5528203845024109

In O 0 0.035796869546175
addition O 0 0.02848614752292633
, O 0 0.02189227193593979
a O 0 0.02644757367670536
correlation O 0 0.039480093866586685
between O 0 0.026345834136009216
smooth O 0 0.38282468914985657
pursuit O 1 0.5758761763572693
gain O 0 0.027234548702836037
and O 0 0.014030315913259983
the O 0 0.015034603886306286
number O 0 0.015270003117620945
of O 0 0.030103357508778572
trinucleotide O 1 0.9999188184738159
repeats O 0 0.09955666959285736
was O 0 0.050429731607437134
found O 0 0.03398065268993378
. O 0 0.03958320617675781

In O 0 0.05946923419833183
SCA3 B-Disease 1 0.9999102354049683
, O 0 0.05533773452043533
gaze B-Disease 1 0.9997723698616028
- I-Disease 1 0.9999954700469971
evoked I-Disease 1 0.9998425245285034
nystagmus I-Disease 1 0.9999942779541016
was O 0 0.04650792479515076
often O 0 0.01630743406713009
present O 0 0.017120851203799248
as O 0 0.018903037533164024
was O 0 0.04970943555235863
saccade O 1 0.9999268054962158
hypometria O 1 0.999534010887146
and O 0 0.03295411169528961
smooth O 0 0.343631386756897
pursuit O 1 0.7941122055053711
gain O 0 0.05490389093756676
was O 0 0.14424347877502441
markedly O 1 0.5452628135681152
decreased O 0 0.1865362524986267
. O 0 0.055390700697898865

Three O 0 0.03929450362920761
major O 0 0.047870051115751266
criteria O 0 0.049010373651981354
, O 0 0.03965415805578232
saccade O 1 0.998397171497345
amplitude O 0 0.10881292074918747
, O 0 0.037178754806518555
saccade O 1 0.9967970252037048
velocity O 0 0.041359223425388336
, O 0 0.016362063586711884
and O 0 0.012742344290018082
presence O 0 0.020944278687238693
of O 0 0.026807161048054695
gaze B-Disease 1 0.9999779462814331
- I-Disease 1 0.9999991655349731
evoked I-Disease 1 0.9997031092643738
nystagmus I-Disease 1 0.9999667406082153
, O 0 0.023205704987049103
permitted O 0 0.021368544548749924
the O 0 0.018485743552446365
correct O 0 0.028488602489233017
assignment O 0 0.03151008114218712
of O 0 0.015324345789849758
90 O 0 0.020677315071225166
% O 0 0.012134416960179806
of O 0 0.01480109989643097
the O 0 0.027190478518605232
SCA1 B-Disease 1 0.9999792575836182
, O 0 0.019063271582126617
90 O 0 0.016683021560311317
% O 0 0.010244355536997318
of O 0 0.013689091429114342
the O 0 0.026563391089439392
SCA2 B-Disease 1 0.999976634979248
, O 0 0.02064322680234909
and O 0 0.013470017351210117
93 O 0 0.029414702206850052
% O 0 0.012734243646264076
of O 0 0.014137180522084236
the O 0 0.024901146069169044
patients O 1 0.9989116191864014
with O 0 0.026815297082066536
SCA3 B-Disease 1 0.9999992847442627
to O 0 0.0162520632147789
their O 0 0.01188291423022747
genetically O 0 0.021683434024453163
confirmed O 0 0.025882666930556297
patient O 1 0.9989148378372192
group O 0 0.04478390887379646
and O 0 0.017450952902436256
, O 0 0.0158267579972744
therefore O 0 0.014799250289797783
, O 0 0.013896986842155457
may O 0 0.013380353339016438
help O 0 0.024415137246251106
orient O 1 0.971713662147522
diagnoses O 1 0.999504566192627
of O 0 0.05194031074643135
SCA1 B-Disease 1 0.9999991655349731
, O 0 0.08560101687908173
SCA2 B-Disease 1 0.9999864101409912
, O 0 0.02697126194834709
and O 0 0.02728170156478882
SCA3 B-Disease 1 0.9999936819076538
at O 0 0.027035435661673546
early O 0 0.026583457365632057
clinical O 0 0.20886273682117462
stages O 0 0.042588334530591965
of O 0 0.07479718327522278
the O 1 0.999263346195221
diseases O 1 1.0
. O 0 0.12304053455591202
. O 0 0.05009626969695091

Genetic O 0 0.048205312341451645
basis O 0 0.023318441584706306
and O 0 0.025147469714283943
molecular O 0 0.048524875193834305
mechanism O 1 0.9147826433181763
for O 1 0.9987905621528625
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9982836246490479

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.9997283816337585
more O 0 0.017286038026213646
than O 0 0.013050280511379242
300 O 0 0.024299170821905136
, O 0 0.020627716556191444
000 O 0 0.04664735496044159
sudden O 1 0.9411444664001465
deaths O 0 0.0347227081656456
each O 0 0.012006762437522411
year O 0 0.01432931050658226
in O 0 0.014694282785058022
the O 0 0.028908349573612213
USA O 1 0.5761348009109497
alone O 0 0.04906077682971954
. O 0 0.0392785482108593

In O 0 0.025254536420106888
approximately O 0 0.023695020005106926
5 O 0 0.033039726316928864
- O 1 0.9483127593994141
12 O 0 0.020082267001271248
% O 0 0.012262983247637749
of O 0 0.011758111417293549
these O 0 0.008425310254096985
cases O 0 0.014237233437597752
, O 0 0.011913483031094074
there O 0 0.007718551438301802
are O 0 0.006249557249248028
no O 0 0.016780942678451538
demonstrable O 1 0.9999936819076538
cardiac O 1 0.9999998807907104
or O 1 0.8991569876670837
non O 1 0.9999986886978149
- O 1 1.0
cardiac O 1 1.0
causes O 1 0.9944623112678528
to O 0 0.016464978456497192
account O 0 0.013301570899784565
for O 0 0.009537716396152973
the O 0 0.014921283349394798
episode O 0 0.0340874083340168
, O 0 0.012838981114327908
which O 0 0.008532018400728703
is O 0 0.010172403417527676
therefore O 0 0.013734735548496246
classified O 0 0.036199286580085754
as O 1 0.8246224522590637
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999963045120239
IVF B-Disease 1 0.9999998807907104
) O 0 0.07268483936786652
. O 0 0.05459314212203026

A O 0 0.04240797460079193
distinct O 0 0.026781369000673294
group O 0 0.034797634929418564
of O 1 0.5806647539138794
IVF B-Disease 1 1.0
patients O 1 0.9999904632568359
has O 0 0.02415291965007782
been O 0 0.014346708543598652
found O 0 0.010647245682775974
to O 0 0.010348339565098286
present O 0 0.013257683254778385
with O 0 0.014150976203382015
a O 0 0.032557837665081024
characteristic O 1 0.9661524295806885
electrocardiographic O 1 0.9999464750289917
pattern O 0 0.38364526629447937
. O 0 0.052352175116539

Because O 0 0.0315341092646122
of O 0 0.02157360315322876
the O 0 0.020054876804351807
small O 0 0.016307448968291283
size O 0 0.014020134694874287
of O 0 0.014036083593964577
most O 0 0.014679674059152603
pedigrees O 0 0.04524921625852585
and O 0 0.014826486818492413
the O 0 0.018062859773635864
high O 1 0.6544338464736938
incidence O 1 0.999816358089447
of O 1 0.8426348567008972
sudden B-Disease 1 0.9999980926513672
death I-Disease 1 0.999941349029541
, O 0 0.02008053846657276
however O 0 0.012629966251552105
, O 0 0.01323823630809784
molecular O 0 0.016668424010276794
genetic O 0 0.015727054327726364
studies O 0 0.012564598582684994
of O 0 0.02766668237745762
IVF B-Disease 1 0.9999995231628418
have O 0 0.015053675509989262
not O 0 0.014145382679998875
yet O 0 0.021269451826810837
been O 0 0.02091079019010067
done O 0 0.029776757583022118
. O 0 0.037386681884527206

Because O 0 0.3340758979320526
IVF B-Disease 1 0.9999997615814209
causes O 1 0.9999991655349731
cardiac O 1 1.0
rhythm O 1 0.9999998807907104
disturbance O 1 0.9999992847442627
, O 0 0.034261949360370636
we O 0 0.014673784375190735
investigated O 0 0.02874824032187462
whether O 0 0.01936209946870804
malfunction O 1 0.9976724982261658
of O 0 0.025432536378502846
ion O 1 0.987912118434906
channels O 0 0.021988723427057266
could O 0 0.014713323675096035
cause O 0 0.036338455975055695
the O 0 0.02736903540790081
disorder O 1 0.9999924898147583
by O 0 0.021450107917189598
studying O 0 0.024696702137589455
mutations O 0 0.02187085896730423
in O 0 0.01501277182251215
the O 0 0.051506634801626205
cardiac O 1 1.0
sodium O 1 0.9995434880256653
channel O 0 0.0719313845038414
gene O 0 0.06523744761943817
SCN5A O 1 0.9880889058113098
. O 0 0.05449535325169563

We O 0 0.02867230214178562
have O 0 0.013177759014070034
now O 0 0.017663506790995598
identified O 0 0.018772566691040993
a O 0 0.02216598391532898
missense O 0 0.07736027240753174
mutation O 0 0.03281230106949806
, O 0 0.0159809198230505
a O 0 0.02600860223174095
splice O 1 0.9946411848068237
- O 1 0.9999920129776001
donor O 1 0.9078499674797058
mutation O 0 0.034672074019908905
, O 0 0.013385088182985783
and O 0 0.012878365814685822
a O 0 0.027396803721785545
frameshift O 1 0.9977268576622009
mutation O 0 0.03318169713020325
in O 0 0.01330716721713543
the O 0 0.01974724419414997
coding O 0 0.036629363894462585
region O 0 0.02358451671898365
of O 0 0.02798517420887947
SCN5A O 1 0.9996715784072876
in O 0 0.027270760387182236
three O 0 0.03780214861035347
IVF B-Disease 1 0.9999244213104248
families O 0 0.06794188171625137
. O 0 0.05582771077752113

We O 0 0.03679213672876358
show O 0 0.028526630252599716
that O 0 0.015229571610689163
sodium O 0 0.03592982143163681
channels O 0 0.013673880137503147
with O 0 0.0102173937484622
the O 0 0.021963156759738922
missense O 1 0.9477903246879578
mutation O 0 0.06892380863428116
recover O 0 0.17383036017417908
from O 0 0.025047414004802704
inactivation O 1 0.9999327659606934
more O 0 0.015287377871572971
rapidly O 0 0.028883367776870728
than O 0 0.011850948445498943
normal O 0 0.01595316268503666
and O 0 0.010770072229206562
that O 0 0.009375568479299545
the O 0 0.023323489353060722
frameshift O 1 0.9999299049377441
mutation O 1 0.5652697086334229
causes O 1 0.5577123761177063
the O 0 0.03597988560795784
sodium O 1 0.7167807817459106
channel O 0 0.02185124345123768
to O 0 0.013024999760091305
be O 0 0.01381285022944212
non O 0 0.16273678839206696
- O 1 0.9999334812164307
functional O 0 0.06668475270271301
. O 0 0.0411209873855114

Our O 0 0.04106253385543823
results O 0 0.01856430061161518
indicate O 0 0.016719307750463486
that O 0 0.010446683503687382
mutations O 0 0.023854045197367668
in O 0 0.02203952521085739
cardiac O 1 1.0
ion O 1 0.9999935626983643
- O 1 0.9999959468841553
channel O 0 0.03738488629460335
genes O 0 0.01752142235636711
contribute O 0 0.01618652231991291
to O 0 0.012340051122009754
the O 0 0.017412077635526657
risk O 0 0.03993434086441994
of O 0 0.035644255578517914
developing O 1 0.9990369081497192
IVF B-Disease 1 0.9999992847442627
. O 0 0.04643692448735237
. O 0 0.046583812683820724

Molecular O 0 0.08980052918195724
heterogeneity O 0 0.11934705823659897
in O 0 0.04050862789154053
mucopolysaccharidosis B-Disease 1 0.9997432827949524
IVA I-Disease 1 0.9999924898147583
in O 0 0.026512544602155685
Australia O 0 0.027255147695541382
and O 0 0.01689128391444683
Northern O 0 0.026593897491693497
Ireland O 0 0.03141004592180252
: O 0 0.01800348237156868
nine O 0 0.0221671424806118
novel O 0 0.03807768598198891
mutations O 0 0.027212342247366905
including O 0 0.01955990493297577
T312S O 1 0.9978471994400024
, O 0 0.02028138004243374
a O 0 0.023887762799859047
common O 0 0.02692711539566517
allele O 0 0.06255416572093964
that O 0 0.017735328525304794
confers O 1 0.9519183039665222
a O 0 0.20093020796775818
mild O 1 0.9999587535858154
phenotype O 1 0.9994235038757324
. O 0 0.06154201924800873

Mucopolysaccharidosis B-Disease 1 0.9996680021286011
IVA I-Disease 1 0.9999982118606567
( O 0 0.30446115136146545
MPS B-Disease 1 0.999798595905304
IVA I-Disease 1 0.9999998807907104
) O 0 0.02834606170654297
is O 0 0.018041711300611496
an O 0 0.028274429962038994
autosomal B-Disease 1 0.9999969005584717
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9996745586395264
by O 0 0.03188752010464668
a O 0 0.22968454658985138
genetic B-Disease 1 0.8836175203323364
defect I-Disease 1 0.999909520149231
in O 0 0.021445799618959427
N O 1 0.9884533286094666
- O 1 0.9997695088386536
acetylgalactosamine O 1 0.9996851682662964
- O 1 0.9999101161956787
6 O 0 0.2902292311191559
- O 1 0.9999974966049194
sulfate O 1 0.9999985694885254
sulfatase O 1 0.9999991655349731
( O 0 0.49351441860198975
GALNS O 1 0.9999784231185913
) O 0 0.048004183918237686
. O 0 0.04197002202272415

Previous O 0 0.04058856889605522
studies O 0 0.024609412997961044
of O 0 0.024742869660258293
patients O 0 0.22564250230789185
from O 0 0.0156742911785841
a O 0 0.023077629506587982
British O 0 0.14554128050804138
- O 1 0.9999052286148071
Irish O 0 0.03689832240343094
population O 0 0.01381121575832367
showed O 0 0.013795402832329273
that O 0 0.008805505931377411
the O 0 0.01873934268951416
I113F O 1 0.9993571639060974
mutation O 0 0.03580731898546219
is O 0 0.011531360447406769
the O 0 0.011536133475601673
most O 0 0.009610813111066818
common O 0 0.014224451966583729
single O 0 0.023874035105109215
mutation O 0 0.03135567530989647
among O 0 0.029453380033373833
MPS B-Disease 1 0.9999949932098389
IVA I-Disease 1 1.0
patients O 1 0.9999991655349731
and O 0 0.18796448409557343
produces O 0 0.2343214601278305
a O 1 0.908180296421051
severe O 1 0.9999996423721313
clinical O 1 0.9999994039535522
phenotype O 1 0.9999767541885376
. O 0 0.07199051231145859

We O 0 0.03407362475991249
studied O 0 0.03497304767370224
mutations O 0 0.02525896020233631
in O 0 0.013697502203285694
the O 0 0.02454228140413761
GALNS O 1 0.999927282333374
gene O 0 0.02465078979730606
from O 0 0.01224775705486536
23 O 0 0.022197216749191284
additional O 0 0.023182427510619164
MPS B-Disease 1 0.9999234676361084
IVA I-Disease 1 1.0
patients O 1 0.9999943971633911
( O 0 0.030377397313714027
15 O 0 0.019276699051260948
from O 0 0.013140494003891945
Australia O 0 0.02019336260855198
, O 0 0.013413669541478157
8 O 0 0.015147763304412365
from O 0 0.010098042897880077
Northern O 0 0.01719883643090725
Ireland O 0 0.02384238876402378
) O 0 0.012942190282046795
, O 0 0.00944423582404852
with O 0 0.009656025096774101
various O 0 0.013628371059894562
clinical O 1 0.9999455213546753
phenotypes O 1 0.9999967813491821
( O 1 0.988167941570282
severe O 1 0.9999905824661255
, O 0 0.033351361751556396
16 O 0 0.029040751978754997
cases O 0 0.02363341860473156
; O 0 0.02050202153623104
intermediate O 0 0.15627025067806244
, O 0 0.01902850717306137
4 O 0 0.026357531547546387
cases O 0 0.026973269879817963
; O 0 0.02944880910217762
mild O 1 0.9991626739501953
, O 0 0.03359023481607437
3 O 0 0.03871608525514603
cases O 0 0.0327155776321888
) O 0 0.0355694554746151
. O 0 0.038599252700805664

We O 0 0.02719947136938572
found O 0 0.0172161553055048
two O 0 0.013624378480017185
common O 0 0.02291494607925415
mutations O 0 0.023257507011294365
that O 0 0.010469846427440643
together O 0 0.014416259713470936
accounted O 0 0.02244783379137516
for O 0 0.01221441850066185
32 O 0 0.020776912569999695
% O 0 0.012209450826048851
of O 0 0.01375708170235157
the O 0 0.020767657086253166
44 O 0 0.04429088160395622
unrelated O 0 0.05566982924938202
alleles O 0 0.06112871691584587
in O 0 0.024807121604681015
these O 0 0.027375927194952965
patients O 1 0.9883941411972046
. O 0 0.05348213389515877

One O 0 0.03251626342535019
is O 0 0.023260246962308884
the O 0 0.03038027510046959
T312S O 1 0.9980271458625793
mutation O 0 0.048668764531612396
, O 0 0.01946285180747509
a O 0 0.024512508884072304
novel O 0 0.04338262602686882
mutation O 0 0.03620850294828415
found O 0 0.017259487882256508
exclusively O 0 0.027334969490766525
in O 0 0.02712375856935978
milder O 1 0.9975411891937256
patients O 1 0.9992849230766296
. O 0 0.059359051287174225

The O 0 0.03581347316503525
other O 0 0.015986235812306404
is O 0 0.014004646800458431
the O 0 0.015217012725770473
previously O 0 0.019980674609541893
described O 0 0.030294079333543777
I113F O 1 0.994245707988739
that O 0 0.01812000945210457
produces O 0 0.0366494245827198
a O 0 0.06396903842687607
severe O 1 0.9999866485595703
phenotype O 1 0.9998852014541626
. O 0 0.06897325813770294

The O 0 0.06671041995286942
I113F O 1 0.9417701959609985
and O 0 0.040406450629234314
T312S O 1 0.9971615076065063
mutations O 0 0.03789559006690979
accounted O 0 0.02872542478144169
for O 0 0.01628604531288147
8 O 0 0.02847212553024292
( O 0 0.018383866176009178
18 O 0 0.02021954394876957
% O 0 0.01695799082517624
) O 0 0.014700517058372498
and O 0 0.013497158885002136
6 O 0 0.027649756520986557
( O 0 0.01763242669403553
14 O 0 0.019319159910082817
% O 0 0.0145346038043499
) O 0 0.013279883190989494
of O 0 0.018407629802823067
44 O 0 0.04999685660004616
unrelated O 0 0.1033858209848404
alleles O 0 0.09937571734189987
, O 0 0.041498664766550064
respectively O 0 0.050727467983961105
. O 0 0.05077686160802841

The O 0 0.04391982778906822
relatively O 0 0.04200717806816101
high O 0 0.0979297012090683
residual O 1 0.9994869232177734
GALNS O 1 0.9999949932098389
activity O 0 0.031655870378017426
seen O 0 0.01955024152994156
when O 0 0.01404144149273634
the O 0 0.019860323518514633
T312S O 1 0.7662423253059387
mutant O 0 0.08981670439243317
cDNA O 0 0.07435870170593262
is O 0 0.02581925131380558
overexpressed O 0 0.08768920600414276
in O 0 0.02412840723991394
mutant O 1 0.6251949071884155
cells O 0 0.03219670057296753
provides O 0 0.02144392766058445
an O 0 0.012795890681445599
explanation O 0 0.01995811052620411
for O 0 0.014027412980794907
the O 0 0.028389986604452133
mild O 1 0.9999802112579346
phenotype O 1 0.9999045133590698
in O 0 0.036319710314273834
patients O 1 0.9995403289794922
with O 0 0.027233906090259552
this O 0 0.028264161199331284
mutation O 0 0.07878284156322479
. O 0 0.04119351506233215

The O 0 0.0479096956551075
distribution O 0 0.03532857075333595
and O 0 0.021275173872709274
relative O 0 0.028538234531879425
frequencies O 0 0.017995713278651237
of O 0 0.01730080135166645
the O 0 0.02932259812951088
I113F O 1 0.9945882558822632
and O 0 0.03442889079451561
T312S O 1 0.998314619064331
mutations O 0 0.032216038554906845
in O 0 0.015065424144268036
Australia O 0 0.023884259164333344
corresponded O 0 0.0300292931497097
to O 0 0.013251373544335365
those O 0 0.009349929168820381
observed O 0 0.013220003806054592
in O 0 0.010173252783715725
Northern O 0 0.022368572652339935
Ireland O 0 0.026063615456223488
and O 0 0.013334003277122974
are O 0 0.006676412187516689
unique O 0 0.010256744921207428
to O 0 0.008795198053121567
these O 0 0.006007996853441
two O 0 0.008726361207664013
populations O 0 0.014625342562794685
, O 0 0.01325481478124857
suggesting O 0 0.017215648666024208
that O 0 0.008536683395504951
both O 0 0.012300199829041958
mutations O 0 0.019073082134127617
were O 0 0.01068198960274458
probably O 0 0.015349853783845901
introduced O 0 0.01407330296933651
to O 0 0.011104677803814411
Australia O 0 0.017154954373836517
by O 0 0.014195101335644722
Irish O 0 0.038496363908052444
migrants O 0 0.028479447588324547
during O 0 0.02198699861764908
the O 0 0.025293441489338875
19th O 0 0.06304706633090973
century O 0 0.07428112626075745
. O 0 0.051678404211997986

Haplotype O 0 0.17449267208576202
analysis O 0 0.03220437839627266
using O 0 0.021413136273622513
6 O 0 0.04751044511795044
RFLPs O 0 0.34728771448135376
provides O 0 0.027204910293221474
additional O 0 0.015003116801381111
data O 0 0.010163111612200737
that O 0 0.008714192546904087
the O 0 0.022567544132471085
I113F O 1 0.9882985353469849
mutation O 0 0.05149833485484123
originated O 0 0.031465448439121246
from O 0 0.01897229254245758
a O 0 0.030283350497484207
common O 0 0.0390150249004364
ancestor O 0 0.10920722037553787
. O 0 0.04742860794067383

The O 0 0.036751680076122284
other O 0 0.0188404880464077
9 O 0 0.03473266586661339
novel O 0 0.04322873055934906
mutations O 0 0.03052002377808094
identified O 0 0.02054104395210743
in O 0 0.011364794336259365
these O 0 0.01047247089445591
23 O 0 0.03462653607130051
patients O 1 0.757089376449585
were O 0 0.011184198781847954
each O 0 0.00873653870075941
limited O 0 0.013735278509557247
to O 0 0.014074613340198994
a O 0 0.024078136309981346
single O 0 0.03803562372922897
family O 0 0.04969978705048561
. O 0 0.04353973641991615

These O 0 0.028219182044267654
data O 0 0.018636656925082207
provide O 0 0.01743757352232933
further O 0 0.013875595293939114
evidence O 0 0.013804072514176369
for O 0 0.014991550706326962
extensive O 0 0.03360569849610329
allelic O 1 0.8193569183349609
heterogeneity O 1 0.7165224552154541
in O 0 0.02531026490032673
MPS B-Disease 1 0.9962783455848694
IVA I-Disease 1 0.9999980926513672
in O 0 0.025345759466290474
British O 1 0.7510086894035339
- O 1 0.999998927116394
Irish O 1 0.9996223449707031
patients O 1 0.9997056126594543
and O 0 0.01677652820944786
provide O 0 0.01619337871670723
evidence O 0 0.012093797326087952
for O 0 0.011203336529433727
their O 0 0.01373301725834608
transmission O 0 0.025339825078845024
to O 0 0.012135765515267849
Australia O 0 0.01792706362903118
by O 0 0.016230585053563118
British O 0 0.04667205736041069
- O 1 0.999636173248291
Irish O 0 0.06366103142499924
migrants O 0 0.05117100849747658
. O 0 0.027090057730674744
. O 0 0.03656287491321564

Identification O 0 0.04461456462740898
of O 0 0.031027566641569138
constitutional O 0 0.35764363408088684
WT1 O 1 0.9999991655349731
mutations O 0 0.051878154277801514
, O 0 0.01786191761493683
in O 0 0.013905300758779049
patients O 1 0.6261624097824097
with O 0 0.02795609086751938
isolated O 1 0.999984622001648
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.09752486646175385
and O 0 0.021034259349107742
analysis O 0 0.01665302738547325
of O 0 0.030720653012394905
genotype O 1 0.9999285936355591
/ O 1 0.9999606609344482
phenotype O 0 0.4063575267791748
correlations O 0 0.03560846671462059
by O 0 0.014447295106947422
use O 0 0.010306072421371937
of O 0 0.016005728393793106
a O 0 0.03675016015768051
computerized O 1 0.9883868098258972
mutation O 0 0.08425775915384293
database O 0 0.04809360206127167
. O 0 0.039680253714323044

Constitutional O 0 0.06145332381129265
mutations O 0 0.03468633443117142
of O 0 0.023094436153769493
the O 0 0.03873678296804428
WT1 O 1 0.9999973773956299
gene O 0 0.030319703742861748
, O 0 0.0164461862295866
encoding O 0 0.022115463390946388
a O 0 0.02988647297024727
zinc O 1 0.9999186992645264
- O 1 0.9999212026596069
finger O 1 0.9528489708900452
transcription O 0 0.05460626631975174
factor O 0 0.029199952259659767
involved O 0 0.018590882420539856
in O 0 0.028949327766895294
renal O 1 1.0
and O 1 0.9997500777244568
gonadal O 1 1.0
development O 1 0.9958337545394897
, O 0 0.01843724399805069
are O 0 0.006495964713394642
found O 0 0.007088469807058573
in O 0 0.007068438921123743
most O 0 0.009872921742498875
patients O 0 0.031997039914131165
with O 0 0.02548331767320633
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997017979621887
DDS B-Disease 1 1.0
) O 0 0.030323326587677002
, O 0 0.024302268400788307
or O 0 0.05055571720004082
diffuse B-Disease 1 0.9999997615814209
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999655485153198
DMS B-Disease 1 1.0
) O 0 0.025037646293640137
associated O 0 0.016684960573911667
with O 0 0.01837778277695179
pseudohermaphroditism B-Disease 1 0.9999943971633911
and O 0 0.22348861396312714
/ O 1 0.9999954700469971
or O 1 0.996344268321991
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 1 0.9995049238204956
WT B-Disease 1 0.999998927116394
) O 0 0.04843444004654884
. O 0 0.04254978895187378

Most O 0 0.04851264879107475
mutations O 0 0.06977099925279617
in O 0 0.046483319252729416
DDS B-Disease 1 0.9999995231628418
patients O 1 0.9983755350112915
lie O 0 0.08641811460256577
in O 0 0.025126401335000992
exon O 0 0.1075107529759407
8 O 0 0.03305564075708389
or O 0 0.01978529989719391
exon O 0 0.06795281171798706
9 O 0 0.029224632307887077
, O 0 0.020966941490769386
encoding O 0 0.040904417634010315
zinc O 1 0.9995511174201965
finger O 1 0.9474421143531799
2 O 0 0.04276959225535393
or O 0 0.03498487547039986
zinc O 1 0.9999738931655884
finger O 1 0.985055685043335
3 O 0 0.02637610025703907
, O 0 0.016463974490761757
respectively O 0 0.016651496291160583
, O 0 0.01150873489677906
with O 0 0.011799118481576443
a O 0 0.024659866467118263
hot O 1 0.9811867475509644
spot O 0 0.43734878301620483
( O 0 0.033868249505758286
R394W O 1 0.990211546421051
) O 0 0.023543186485767365
in O 0 0.021436329931020737
exon O 0 0.10166335850954056
9 O 0 0.05920020490884781
. O 0 0.04339544102549553

We O 0 0.02772366628050804
analyzed O 0 0.02096339501440525
a O 0 0.015350228175520897
series O 0 0.016493240371346474
of O 0 0.018487971276044846
24 O 0 0.03312205895781517
patients O 1 0.8521198034286499
, O 0 0.015644464641809464
10 O 0 0.016607830300927162
with O 0 0.020361362025141716
isolated B-Disease 1 0.998965859413147
DMS I-Disease 1 0.9999998807907104
( O 1 0.9523463845252991
IDMS B-Disease 1 0.9999997615814209
) O 0 0.02360805869102478
, O 0 0.015579520724713802
10 O 0 0.017447086051106453
with O 0 0.024247482419013977
DDS B-Disease 1 0.9999983310699463
, O 0 0.021119238808751106
and O 0 0.016313815489411354
4 O 0 0.029926722869277
with O 0 0.035580363124608994
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 0.9999998807907104
and O 1 0.9996059536933899
/ O 1 0.9999995231628418
or O 1 0.9213273525238037
WT B-Disease 1 0.9999887943267822
. O 0 0.059826429933309555

We O 0 0.03560439497232437
report O 0 0.04386909306049347
WT1 O 1 0.9989467263221741
heterozygous O 0 0.07652084529399872
mutations O 0 0.035121895372867584
in O 0 0.019057270139455795
16 O 0 0.033874139189720154
patients O 1 0.9915647506713867
, O 0 0.01873285509645939
4 O 0 0.02167082391679287
of O 0 0.020438916981220245
whom O 0 0.036412984132766724
presented O 0 0.043528515845537186
with O 0 0.04781143739819527
IDMS B-Disease 1 0.9999921321868896
. O 0 0.06413155049085617

One O 0 0.039997123181819916
male O 0 0.040925972163677216
and O 0 0.016570845618844032
two O 0 0.019199863076210022
female O 1 0.9984129667282104
IDMS B-Disease 1 0.9999998807907104
patients O 1 0.9999662637710571
with O 1 0.9883791208267212
WT1 O 1 1.0
mutations O 1 0.9986555576324463
underwent O 1 0.9999878406524658
normal O 1 0.977571427822113
puberty O 1 0.9998705387115479
. O 0 0.07260352373123169

Two O 0 0.03753194212913513
mutations O 0 0.05023285001516342
associated O 0 0.03243245184421539
with O 0 0.03307795524597168
IDMS B-Disease 1 0.9999963045120239
are O 0 0.010715358890593052
different O 0 0.0060843005776405334
from O 0 0.010282864794135094
those O 0 0.014390508644282818
described O 0 0.04038568586111069
in O 0 0.05653134733438492
DDS B-Disease 1 1.0
patients O 1 0.9998435974121094
. O 0 0.07253681123256683

No O 0 0.0852767825126648
WT1 O 1 0.9999518394470215
mutations O 0 0.04617610201239586
were O 0 0.015251615084707737
detected O 0 0.021893838420510292
in O 0 0.009345226921141148
the O 0 0.013859320431947708
six O 0 0.022876126691699028
other O 0 0.0291574839502573
IDMS B-Disease 1 0.9999998807907104
patients O 1 0.9998776912689209
, O 0 0.030181461945176125
suggesting O 0 0.037063561379909515
genetic O 0 0.03462764620780945
heterogeneity O 1 0.8150697946548462
of O 0 0.044816624373197556
this O 0 0.06003367155790329
disease O 1 0.9999972581863403
. O 0 0.06494183838367462

We O 0 0.0450315922498703
analyzed O 0 0.07208958268165588
genotype O 1 0.9984373450279236
/ O 1 0.9998921155929565
phenotype O 1 0.8857412934303284
correlations O 0 0.0591769777238369
, O 0 0.018715020269155502
on O 0 0.012260512448847294
the O 0 0.011479988694190979
basis O 0 0.009109043516218662
of O 0 0.01084358710795641
the O 0 0.013362576253712177
constitution O 0 0.01897476240992546
of O 0 0.01786073110997677
a O 0 0.037517741322517395
WT1 O 1 0.9999849796295166
mutation O 0 0.036063052713871
database O 0 0.017882397398352623
of O 0 0.01833322085440159
84 O 1 0.7848427295684814
germ O 1 0.9999995231628418
- O 1 0.9999958276748657
line O 0 0.05265878513455391
mutations O 0 0.024362705647945404
, O 0 0.01262935996055603
to O 0 0.0096916938200593
compare O 0 0.016789305955171585
the O 0 0.012949013151228428
distribution O 0 0.016221048310399055
and O 0 0.015989890322089195
type O 0 0.042537108063697815
of O 0 0.02313329465687275
mutations O 0 0.029500698670744896
, O 0 0.015111029148101807
according O 0 0.01228240504860878
to O 0 0.01386281382292509
the O 0 0.020239394158124924
different O 0 0.021522993221879005
symptoms O 1 0.9998911619186401
. O 0 0.05814296379685402

This O 0 0.031188327819108963
demonstrated O 0 0.04472758248448372
( O 0 0.025904396548867226
1 O 0 0.02534426562488079
) O 0 0.014009947888553143
the O 0 0.014851197600364685
association O 0 0.02119537442922592
between O 0 0.016333308070898056
mutations O 0 0.02093309722840786
in O 0 0.014025515876710415
exons O 0 0.04019135981798172
8 O 0 0.022945843636989594
and O 0 0.015804797410964966
9 O 0 0.030933275818824768
and O 0 0.03050212934613228
DMS B-Disease 1 0.9999995231628418
; O 0 0.025437967851758003
( O 0 0.020978931337594986
2 O 0 0.023130351677536964
) O 0 0.01624138467013836
among O 0 0.021716628223657608
patients O 1 0.9288595914840698
with O 0 0.04203818738460541
DMS B-Disease 1 0.9999998807907104
, O 0 0.019683493301272392
a O 0 0.01739245094358921
higher O 0 0.013689952902495861
frequency O 0 0.013425178825855255
of O 0 0.014581824652850628
exon O 0 0.06674088537693024
8 O 0 0.027328243479132652
mutations O 0 0.02199624478816986
among O 0 0.01683844067156315
46 O 0 0.03596404194831848
, O 0 0.035347793251276016
XY O 1 0.999994158744812
patients O 1 0.976751446723938
with O 0 0.025593379512429237
female O 1 0.9025129675865173
phenotype O 0 0.41632792353630066
than O 0 0.011891237460076809
among O 0 0.01947716251015663
46 O 0 0.04208751395344734
, O 0 0.03957416117191315
XY O 1 0.9999940395355225
patients O 1 0.9345251321792603
with O 0 0.021591251716017723
sexual O 0 0.2967369258403778
ambiguity O 1 0.9070541262626648
or O 0 0.06744252145290375
male O 1 0.9993140697479248
phenotype O 1 0.9998300075531006
; O 0 0.022291656583547592
and O 0 0.019176090136170387
( O 0 0.02094549685716629
3 O 0 0.02106936275959015
) O 0 0.012645496055483818
statistically O 0 0.012846913188695908
significant O 0 0.010728125460445881
evidence O 0 0.010242504067718983
that O 0 0.009398479014635086
mutations O 0 0.017312146723270416
in O 0 0.012677207589149475
exons O 0 0.0406917966902256
8 O 0 0.0250925961881876
and O 0 0.017385926097631454
9 O 0 0.031751036643981934
preferentially O 0 0.05706444010138512
affect O 0 0.03220668062567711
amino O 0 0.033636413514614105
acids O 0 0.02392834611237049
with O 0 0.013963009230792522
different O 0 0.010181226767599583
functions O 0 0.023665569722652435
. O 0 0.02390516921877861
. O 0 0.038484618067741394

The O 0 0.07822722941637039
185delAG O 1 0.9996984004974365
BRCA1 O 1 0.9999287128448486
mutation O 0 0.06564833968877792
originated O 0 0.030258195474743843
before O 0 0.017079858109354973
the O 0 0.01748017407953739
dispersion O 0 0.0415223203599453
of O 0 0.017667554318904877
Jews O 0 0.028297143056988716
in O 0 0.013464639894664288
the O 0 0.020640328526496887
diaspora O 0 0.048019807785749435
and O 0 0.018921976909041405
is O 0 0.015978634357452393
not O 0 0.012992759235203266
limited O 0 0.02204219065606594
to O 0 0.03261403366923332
Ashkenazim O 1 0.9959518909454346
. O 0 0.0564778633415699

The O 0 0.062426358461380005
185delAG O 1 0.9857186675071716
mutation O 0 0.0698956549167633
in O 0 0.03142241761088371
BRCA1 O 1 0.9982149600982666
is O 0 0.02236320450901985
detected O 0 0.02573886513710022
in O 0 0.012949170544743538
Ashkenazi O 0 0.053076617419719696
Jews O 0 0.02501680701971054
both O 0 0.011920826509594917
in O 0 0.020644929260015488
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9161166548728943
in O 0 0.021075380966067314
the O 0 0.02450660429894924
general O 0 0.045590102672576904
population O 0 0.028980080038309097
. O 0 0.03762734681367874

All O 0 0.04698177054524422
tested O 0 0.08453083038330078
Ashkenazi O 1 0.9980668425559998
mutation O 0 0.07603050768375397
carriers O 0 0.04090014100074768
share O 0 0.017178760841488838
the O 0 0.016650840640068054
same O 0 0.018089497461915016
allelic O 0 0.3963657319545746
pattern O 0 0.036360420286655426
at O 0 0.027099022641777992
the O 0 0.0459013432264328
BRCA1 O 1 0.9999717473983765
locus O 1 0.9767338037490845
. O 0 0.05651291087269783

Our O 0 0.04481895640492439
previous O 0 0.029402904212474823
study O 0 0.01907883770763874
showed O 0 0.01774522289633751
that O 0 0.009510457515716553
this O 0 0.013798842206597328
Ashkenazi O 1 0.992849588394165
mutation O 0 0.056434448808431625
also O 0 0.01817571558058262
occurs O 0 0.016842789947986603
in O 0 0.011719048023223877
Iraqi O 0 0.02629808709025383
Jews O 0 0.0299620870500803
with O 0 0.017631707713007927
a O 0 0.028211239725351334
similar O 0 0.030555613338947296
allelic O 1 0.9901055693626404
pattern O 0 0.09807590395212173
. O 0 0.05654378607869148

We O 0 0.03646097332239151
extended O 0 0.03744859993457794
our O 0 0.02197243459522724
analysis O 0 0.012190515175461769
to O 0 0.010432442650198936
other O 0 0.010828975588083267
non O 0 0.05163059011101723
- O 1 0.9995360374450684
Ashkenazi O 1 0.9173995852470398
subsets O 0 0.07833680510520935
354 O 0 0.07161989063024521
of O 0 0.030760204419493675
Moroccan O 0 0.07138486206531525
origin O 0 0.020813720300793648
, O 0 0.022275200113654137
200 O 0 0.03480591997504234
Yemenites O 1 0.8368463516235352
and O 0 0.028229176998138428
150 O 0 0.036341145634651184
Iranian O 0 0.04912763088941574
Jews O 0 0.060015518218278885
. O 0 0.04658167436718941

Heteroduplex O 1 0.667374849319458
analysis O 0 0.039543475955724716
complemented O 0 0.0586702860891819
by O 0 0.021908802911639214
direct O 0 0.027065737172961235
DNA O 0 0.030861269682645798
sequencing O 0 0.03458544611930847
of O 0 0.032747697085142136
abnormally O 1 0.9839285612106323
migrating O 0 0.0757259801030159
bands O 0 0.05914856493473053
were O 0 0.02716309390962124
employed O 0 0.05404245853424072
. O 0 0.04330364242196083

Four O 0 0.025329746305942535
of O 0 0.025105053558945656
Moroccan O 0 0.13512474298477173
origin O 0 0.01870737411081791
( O 0 0.018430976197123528
1 O 0 0.020296042785048485
. O 0 0.012186472304165363
1 O 0 0.020440788939595222
% O 0 0.0157536119222641
) O 0 0.012060095556080341
and O 0 0.009502367116510868
none O 0 0.01199023425579071
of O 0 0.014775215648114681
the O 0 0.028233306482434273
Yemenites O 1 0.9999414682388306
or O 0 0.023327402770519257
Iranians O 0 0.030353303998708725
was O 0 0.022798487916588783
a O 0 0.022685982286930084
carrier O 0 0.05435729771852493
of O 0 0.023697229102253914
the O 0 0.0403362475335598
185delAG O 1 0.999599039554596
mutation O 0 0.09699245542287827
. O 0 0.04738422855734825

BRCA1 O 1 0.9996683597564697
allelic O 1 0.9700440168380737
patterns O 0 0.03733573108911514
were O 0 0.013698597438633442
determined O 0 0.018456822261214256
for O 0 0.010733338072896004
four O 0 0.011303378269076347
of O 0 0.013334210962057114
these O 0 0.008632037788629532
individuals O 0 0.010397774167358875
and O 0 0.009693657048046589
for O 0 0.01074264943599701
12 O 0 0.016430765390396118
additional O 0 0.015259717591106892
non O 0 0.06796160340309143
- O 1 0.9998389482498169
Ashkenazi O 1 0.9959522485733032
185delAG O 1 0.9983389377593994
mutation O 0 0.053745534271001816
carriers O 0 0.04194679483771324
who O 0 0.033213820308446884
had O 1 0.8542967438697815
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9076409935951233

Six O 0 0.055624499917030334
non O 1 0.7834235429763794
- O 1 0.9999397993087769
Ashkenazi O 1 0.9653621315956116
individuals O 0 0.021324239671230316
shared O 0 0.024641873314976692
the O 0 0.02228301577270031
common O 0 0.03645530715584755
Ashkenazi O 1 0.9999585151672363
haplotype O 1 0.994070827960968
, O 0 0.017292890697717667
four O 0 0.012292000465095043
had O 0 0.014321109279990196
a O 0 0.016332251951098442
closely O 0 0.018865203484892845
related O 0 0.020634576678276062
pattern O 0 0.02488282509148121
, O 0 0.014601612463593483
and O 0 0.012444091029465199
the O 0 0.017351143062114716
rest O 0 0.03451425954699516
( O 0 0.029529733583331108
n O 0 0.06611534208059311
= O 0 0.04916146770119667
6 O 0 0.030915655195713043
) O 0 0.018149089068174362
displayed O 0 0.02499040775001049
a O 0 0.029507450759410858
distinct O 0 0.045451242476701736
BRCA1 O 1 0.9992265701293945
allelic O 1 0.9969770908355713
pattern O 0 0.22179025411605835
. O 0 0.05847529321908951

We O 0 0.02844337560236454
conclude O 0 0.032375216484069824
that O 0 0.012498777359724045
the O 0 0.028004314750432968
185delAG O 1 0.9999285936355591
BRCA1 O 1 0.9999576807022095
mutation O 0 0.0537913516163826
occurs O 0 0.016660211607813835
in O 0 0.009755372069776058
some O 0 0.01060887798666954
non O 1 0.6066145300865173
- O 1 0.9999731779098511
Ashkenazi O 1 0.9967214465141296
populations O 0 0.024500329047441483
at O 0 0.020742954686284065
rates O 0 0.02339249849319458
comparable O 0 0.024317288771271706
with O 0 0.01494902279227972
that O 0 0.015652257949113846
of O 0 0.03381495550274849
Ashkenazim O 1 0.9987986087799072
. O 0 0.0597103014588356

The O 0 0.03510083630681038
majority O 0 0.028848519548773766
of O 0 0.030180849134922028
Jewish O 0 0.09215911477804184
185delAG O 1 0.9997492432594299
mutation O 0 0.10066624730825424
carriers O 0 0.03589342534542084
have O 0 0.009826524183154106
a O 0 0.018844058737158775
common O 0 0.026850448921322823
allelic O 1 0.9935384392738342
pattern O 0 0.08260534703731537
, O 0 0.018434306606650352
supporting O 0 0.02549220807850361
the O 0 0.02179061621427536
founder O 1 0.998467743396759
effect O 0 0.023826995864510536
notion O 0 0.027776453644037247
, O 0 0.014329040423035622
but O 0 0.010945893824100494
dating O 0 0.02217748574912548
the O 0 0.016040893271565437
mutations O 0 0.017505595460534096
origin O 0 0.008636686019599438
to O 0 0.009505966678261757
an O 0 0.010433677583932877
earlier O 0 0.014770807698369026
date O 0 0.015843911096453667
than O 0 0.011813844554126263
currently O 0 0.021772043779492378
estimated O 0 0.030645132064819336
. O 0 0.03724725916981697

However O 0 0.03375673666596413
, O 0 0.02084936760365963
the O 0 0.01770620234310627
different O 0 0.011374291963875294
allelic O 0 0.07395893335342407
pattern O 0 0.03137313947081566
at O 0 0.02282419241964817
the O 0 0.03410337492823601
BRCA1 O 1 0.9999544620513916
locus O 0 0.3864648938179016
even O 0 0.012265133671462536
in O 0 0.0084686903283
some O 0 0.00959761906415224
Jewish O 0 0.06825795769691467
mutation O 1 0.7471398711204529
carriers O 0 0.05210709571838379
, O 0 0.018148556351661682
might O 0 0.014200065284967422
suggest O 0 0.012308649718761444
that O 0 0.009023682214319706
the O 0 0.01902647316455841
mutation O 0 0.04015357792377472
arose O 0 0.03865547105669975
independently O 0 0.02874695137143135
. O 0 0.023864246904850006
. O 0 0.0366261824965477

Crystal O 0 0.10813310742378235
structure O 0 0.03977658972144127
of O 0 0.03219427913427353
the O 1 0.6663403511047363
hemochromatosis B-Disease 1 1.0
protein O 1 0.9844846725463867
HFE O 1 0.9999881982803345
and O 0 0.030101493000984192
characterization O 0 0.04823571443557739
of O 0 0.021402491256594658
its O 0 0.024047059938311577
interaction O 0 0.035630855709314346
with O 0 0.040414128452539444
transferrin O 1 0.9999855756759644
receptor O 1 0.5338332653045654
. O 0 0.053310491144657135

HFE O 1 0.9996022582054138
is O 0 0.03715779632329941
an O 0 0.04377002641558647
MHC O 1 0.9999990463256836
- O 1 0.9999865293502808
related O 0 0.02692861668765545
protein O 0 0.018204884603619576
that O 0 0.006867022253572941
is O 0 0.009294926188886166
mutated O 0 0.022941643372178078
in O 0 0.009876077994704247
the O 0 0.027689769864082336
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999037981033325

HFE O 1 0.9987340569496155
binds O 0 0.14840292930603027
to O 0 0.052928704768419266
transferrin O 1 0.9999732971191406
receptor O 1 0.9975525736808777
( O 0 0.06042131409049034
TfR O 1 0.9998863935470581
) O 0 0.025574522092938423
and O 0 0.018565980717539787
reduces O 0 0.0354267954826355
its O 0 0.016874276101589203
affinity O 0 0.03521106764674187
for O 0 0.022234506905078888
iron O 1 0.9998757839202881
- O 1 0.9998906850814819
loaded O 0 0.07119834423065186
transferrin O 1 0.9931908249855042
, O 0 0.04289143905043602
implicating O 1 0.9998619556427002
HFE O 1 0.999997615814209
in O 0 0.19908255338668823
iron O 1 0.9999972581863403
metabolism O 1 0.9994268417358398
. O 0 0.0657871812582016

The O 0 0.08184505999088287
2 O 0 0.08238143473863602
. O 0 0.05971241742372513

6 O 0 0.061871033161878586
A O 0 0.053436342626810074
crystal O 0 0.1790311485528946
structure O 0 0.038201190531253815
of O 0 0.031443946063518524
HFE O 1 0.9999825954437256
reveals O 0 0.045973457396030426
the O 0 0.018153298646211624
locations O 0 0.017867814749479294
of O 0 0.1187528744339943
hemochromatosis B-Disease 1 1.0
mutations O 0 0.4583984613418579
and O 0 0.02157689444720745
a O 0 0.07843134552240372
patch O 1 0.9999874830245972
of O 0 0.07912112027406693
histidines O 1 0.9999293088912964
that O 0 0.012023369781672955
could O 0 0.01038679014891386
be O 0 0.00792660191655159
involved O 0 0.013767657801508904
in O 0 0.023798389360308647
pH O 1 0.9999942779541016
- O 1 0.9999920129776001
dependent O 0 0.07840951532125473
interactions O 0 0.05101143941283226
. O 0 0.04262445867061615

We O 0 0.03257438912987709
also O 0 0.02231166511774063
demonstrate O 0 0.03423284366726875
that O 0 0.023527804762125015
soluble O 1 0.9862470626831055
TfR O 1 0.9999034404754639
and O 0 0.0523008368909359
HFE O 1 0.9999963045120239
bind O 0 0.22034123539924622
tightly O 0 0.045119863003492355
at O 0 0.017922228202223778
the O 0 0.018244614824652672
basic O 0 0.030346719548106194
pH O 1 0.9158381819725037
of O 0 0.01868787407875061
the O 0 0.1674572080373764
cell O 1 0.9647825956344604
surface O 0 0.024699030444025993
, O 0 0.012479029595851898
but O 0 0.0077628642320632935
not O 0 0.00738943787291646
at O 0 0.01454220712184906
the O 0 0.026835281401872635
acidic O 1 0.9994646906852722
pH O 1 0.9998028874397278
of O 0 0.39795395731925964
intracellular O 1 0.999980092048645
vesicles O 1 0.999652624130249
. O 0 0.05856366083025932

TfR O 1 0.9999032020568848
HFE O 1 0.9999926090240479
stoichiometry O 1 0.9988558292388916
( O 0 0.04352055490016937
2 O 0 0.035856060683727264
1 O 0 0.0271995197981596
) O 0 0.01657956652343273
differs O 0 0.022067105397582054
from O 0 0.024638477712869644
TfR O 1 0.9997681975364685
transferrin O 1 0.9999468326568604
stoichiometry O 1 0.9955645799636841
( O 0 0.03247024491429329
2 O 0 0.0293340552598238
2 O 0 0.0272392425686121
) O 0 0.01638626866042614
, O 0 0.013911841437220573
implying O 0 0.02485569752752781
a O 0 0.01295367069542408
different O 0 0.007132262457162142
mode O 0 0.022062182426452637
of O 0 0.015423010103404522
binding O 0 0.027132000774145126
for O 0 0.02378062903881073
HFE O 1 0.9999830722808838
and O 0 0.03873251751065254
transferrin O 1 0.9999125003814697
to O 0 0.03950447961688042
TfR O 1 0.9999421834945679
, O 0 0.020739547908306122
consistent O 0 0.02138669416308403
with O 0 0.011982553638517857
our O 0 0.018622586503624916
demonstration O 0 0.03912580758333206
that O 0 0.017055338248610497
HFE O 1 0.9999880790710449
, O 0 0.03728081285953522
transferrin O 1 0.9993222951889038
, O 0 0.03038976900279522
and O 0 0.029512371867895126
TfR O 1 0.9999361038208008
form O 0 0.03633244335651398
a O 0 0.050364308059215546
ternary O 1 0.9926676154136658
complex O 0 0.0746798887848854
. O 0 0.048263128846883774

Identification O 0 0.04384888336062431
of O 0 0.02297382615506649
three O 0 0.02058103121817112
novel O 0 0.048093054443597794
mutations O 0 0.028187096118927002
and O 0 0.015063653700053692
a O 0 0.019055921584367752
high O 0 0.023759786039590836
frequency O 0 0.014265308156609535
of O 0 0.012894190847873688
the O 0 0.02136373333632946
Arg778Leu O 1 0.999605119228363
mutation O 0 0.04493628814816475
in O 0 0.019567886367440224
Korean O 1 0.999220609664917
patients O 1 0.999772846698761
with O 1 0.6923484206199646
Wilson B-Disease 1 0.9999960660934448
disease I-Disease 1 0.9999996423721313
. O 0 0.08663530647754669

Four O 0 0.045197002589702606
mutations O 0 0.07362409681081772
- O 1 0.9999183416366577
- O 1 0.9999580383300781
R778L O 1 0.999237060546875
, O 0 0.03560812026262283
A874V O 1 0.992021381855011
, O 0 0.026479316875338554
L1083F O 1 0.82450932264328
, O 0 0.018892111256718636
and O 0 0.019526032730937004
2304delC O 1 0.9995935559272766
- O 1 0.9999799728393555
- O 1 0.9657081961631775
in O 0 0.010698642581701279
the O 0 0.014743795618414879
copper O 0 0.28209757804870605
- O 1 0.9974396228790283
transporting O 0 0.04706567898392677
enzyme O 0 0.033108700066804886
, O 0 0.021050067618489265
P O 1 0.9998550415039062
- O 1 0.9999923706054688
type O 1 0.9940449595451355
ATPase O 1 0.9999504089355469
( O 0 0.03847533091902733
ATP7B O 1 0.9998134970664978
) O 0 0.020042022690176964
, O 0 0.010657396167516708
were O 0 0.008441210724413395
identified O 0 0.014998436905443668
in O 0 0.014275940135121346
Korean O 1 0.9913700819015503
Patients O 1 0.9996371269226074
with O 1 0.8051791787147522
Wilson B-Disease 1 0.9999953508377075
disease I-Disease 1 0.9999994039535522
. O 0 0.08723284304141998

Arg778Leu O 1 0.9983080625534058
, O 0 0.030662624165415764
the O 0 0.019481699913740158
most O 0 0.013546247966587543
frequently O 0 0.01542204711586237
reported O 0 0.017142143100500107
mutation O 0 0.023734577000141144
of O 0 0.014316256158053875
this O 0 0.015433542430400848
enzyme O 0 0.10410024970769882
, O 0 0.014562569558620453
was O 0 0.014728191308677197
found O 0 0.007627714425325394
in O 0 0.006968674249947071
six O 0 0.010216129012405872
of O 0 0.013428948819637299
eight O 0 0.025719420984387398
unrelated O 1 0.9036787748336792
patients O 1 0.9996474981307983
studied O 0 0.031806908547878265
, O 0 0.020583849400281906
an O 0 0.02239593304693699
allele O 0 0.05255654826760292
frequency O 0 0.02478879876434803
of O 0 0.02739604003727436
37 O 0 0.06117527186870575
. O 0 0.050254326313734055

5 O 0 0.05773845687508583
% O 0 0.033328842371702194
, O 0 0.021883968263864517
which O 0 0.014141726307570934
is O 0 0.013956976123154163
considerably O 0 0.01979699172079563
higher O 0 0.014646686613559723
than O 0 0.009093484841287136
those O 0 0.010114300064742565
in O 0 0.013572768308222294
other O 0 0.016292806714773178
Asian O 0 0.04600054398179054
populations O 0 0.043881308287382126
. O 0 0.042678117752075195

The O 0 0.04270457476377487
novel O 0 0.05501007288694382
single O 0 0.04722455143928528
nucleotide O 0 0.06354217976331711
deletion O 0 0.08583124727010727
, O 0 0.030197327956557274
2304delC O 1 0.9916597008705139
, O 0 0.024776341393589973
was O 0 0.024693932384252548
found O 0 0.015926891937851906
in O 0 0.017481286078691483
one O 0 0.03186781331896782
patient O 1 0.9732334017753601
. O 0 0.05254381150007248

Since O 0 0.04458373785018921
a O 0 0.03781639784574509
mutation O 0 0.043292924761772156
at O 0 0.030930060893297195
cDNA O 0 0.1003340557217598
nucleotide O 0 0.08586225658655167
2302 O 1 0.9997772574424744
( O 0 0.04359648376703262
2302insC O 1 0.9896494150161743
) O 0 0.021357376128435135
had O 0 0.01643875055015087
been O 0 0.011873613111674786
previously O 0 0.01672075130045414
described O 0 0.019568748772144318
, O 0 0.011383400298655033
this O 0 0.006541067268699408
region O 0 0.013375986367464066
of O 0 0.012834920547902584
the O 0 0.02848602831363678
ATP7B O 1 0.9999992847442627
gene O 0 0.042844031006097794
may O 0 0.016941377893090248
be O 0 0.012638519518077374
susceptible O 0 0.048559848219156265
to O 0 0.024754872545599937
gene O 0 0.059270892292261124
rearrangements O 1 0.9994810223579407
causing O 1 0.9999270439147949
Wilson B-Disease 1 0.9999938011169434
disease I-Disease 1 0.9999994039535522
. O 0 0.10137046128511429

Disruption O 0 0.11864612251520157
of O 0 0.0402853786945343
splicing O 0 0.04980843514204025
regulated O 0 0.025849083438515663
by O 0 0.015330607071518898
a O 0 0.030998818576335907
CUG O 1 0.999980092048645
- O 1 0.9999533891677856
binding O 0 0.05292968451976776
protein O 0 0.04349863901734352
in O 0 0.045794710516929626
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
. O 0 0.33249521255493164

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999982118606567
DM B-Disease 1 1.0
) O 0 0.05002126470208168
is O 0 0.02085009217262268
caused O 0 0.028505248948931694
by O 0 0.016965320333838463
a O 0 0.0347137376666069
CTG O 1 0.9999713897705078
expansion O 0 0.03059699572622776
in O 0 0.012445767410099506
the O 0 0.01761859841644764
3 O 0 0.026283659040927887
untranslated O 0 0.07953569293022156
region O 0 0.026478026062250137
of O 0 0.026183772832155228
the O 1 0.7471978068351746
DM B-Disease 1 1.0
gene O 0 0.1284617781639099
. O 0 0.054008353501558304

One O 0 0.03954169154167175
model O 0 0.04944440349936485
of O 0 0.08150604367256165
DM B-Disease 1 1.0
pathogenesis O 1 0.9999995231628418
suggests O 0 0.04777783155441284
that O 0 0.01838078908622265
RNAs O 0 0.048688486218452454
from O 0 0.011305169202387333
the O 0 0.013800153508782387
expanded O 0 0.02314356528222561
allele O 0 0.030149037018418312
create O 0 0.014763308688998222
a O 0 0.016423802822828293
gain O 0 0.025959087535738945
- O 1 0.9995355606079102
of O 0 0.03029594011604786
- O 1 0.999984860420227
function O 0 0.021697286516427994
mutation O 0 0.021348673850297928
by O 0 0.012665784917771816
the O 0 0.01649489626288414
inappropriate O 0 0.03610866144299507
binding O 0 0.022360948845744133
of O 0 0.017697421833872795
proteins O 0 0.018182743340730667
to O 0 0.01826745644211769
the O 0 0.03552011772990227
CUG O 1 0.9998849630355835
repeats O 0 0.09811142832040787
. O 0 0.05070602521300316

Data O 0 0.03518562391400337
presented O 0 0.030418267473578453
here O 0 0.018112316727638245
indicate O 0 0.01630009151995182
that O 0 0.009118507616221905
the O 0 0.01750630885362625
conserved O 0 0.03567390888929367
heterogeneous O 0 0.07171902805566788
nuclear O 0 0.06059173494577408
ribonucleoprotein O 1 0.9824085831642151
, O 0 0.03658987209200859
CUG O 1 0.9993446469306946
- O 1 0.9981959462165833
binding O 0 0.036156244575977325
protein O 0 0.028934935107827187
( O 0 0.02656700648367405
CUG O 1 0.9999715089797974
- O 1 0.9999902248382568
BP O 1 0.9294151067733765
) O 0 0.01911286823451519
, O 0 0.01348880585283041
may O 0 0.0128093296661973
mediate O 0 0.04030044004321098
the O 0 0.025312211364507675
trans O 1 0.9989676475524902
- O 1 0.9998972415924072
dominant O 0 0.07257592678070068
effect O 0 0.020858682692050934
of O 0 0.020404115319252014
the O 0 0.03699823096394539
RNA O 0 0.07031475752592087
. O 0 0.03849473595619202

CUG O 1 0.9999853372573853
- O 1 0.9999803304672241
BP O 1 0.5782095193862915
was O 0 0.0296800397336483
found O 0 0.013247046619653702
to O 0 0.01172072533518076
bind O 0 0.021013513207435608
to O 0 0.011806320399045944
the O 0 0.017967823892831802
human O 0 0.4690359830856323
cardiac O 1 1.0
troponin O 1 1.0
T O 1 0.9999991655349731
( O 0 0.043742213398218155
cTNT O 1 0.9951689839363098
) O 0 0.02723238803446293
pre O 1 0.6556219458580017
- O 1 0.9999285936355591
messenger O 1 0.5734185576438904
RNA O 0 0.04357496649026871
and O 0 0.018206963315606117
regulate O 0 0.032371677458286285
its O 0 0.023618686944246292
alternative O 0 0.05148349702358246
splicing O 0 0.07066630572080612
. O 0 0.0410732664167881

Splicing O 0 0.0698627233505249
of O 0 0.03166917711496353
cTNT O 1 0.9765501618385315
was O 0 0.04439498484134674
disrupted O 1 0.7332649827003479
in O 0 0.11921707540750504
DM B-Disease 1 1.0
striated O 1 0.9999998807907104
muscle O 1 0.9999605417251587
and O 0 0.027092760428786278
in O 0 0.019106252118945122
normal O 0 0.038394272327423096
cells O 0 0.031150564551353455
expressing O 0 0.03839538246393204
transcripts O 0 0.03997166454792023
that O 0 0.018032656982541084
contain O 0 0.04293873533606529
CUG O 1 0.9997432827949524
repeats O 0 0.09372019022703171
. O 0 0.051567550748586655

Altered O 0 0.06900763511657715
expression O 0 0.03430982306599617
of O 0 0.023999588564038277
genes O 0 0.02540350705385208
regulated O 0 0.03544725477695465
posttranscriptionally O 0 0.23857800662517548
by O 0 0.03373480960726738
CUG O 1 0.9999951124191284
- O 1 0.9999948740005493
BP O 1 0.8318362832069397
therefore O 0 0.022759882733225822
may O 0 0.018563471734523773
contribute O 0 0.03400537744164467
to O 0 0.05897404998540878
DM B-Disease 1 1.0
pathogenesis O 1 0.9999997615814209
. O 0 0.04795725271105766
. O 0 0.04663640260696411

Identification O 0 0.04058830812573433
of O 0 0.024863049387931824
a O 0 0.033619146794080734
novel O 0 0.060266248881816864
nonsense O 1 0.9473045468330383
mutation O 0 0.04052719101309776
and O 0 0.01625276356935501
a O 0 0.022705575451254845
missense O 0 0.06495746225118637
substitution O 0 0.03182647004723549
in O 0 0.012016801163554192
the O 0 0.023949969559907913
vasopressin O 1 0.9999251365661621
- O 1 0.9999977350234985
neurophysin O 1 0.9999767541885376
II O 1 0.9999816417694092
gene O 0 0.025374889373779297
in O 0 0.009996878914535046
two O 0 0.011431544087827206
Spanish O 0 0.032728005200624466
kindreds O 1 0.8649255037307739
with O 0 0.052355632185935974
familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
. O 1 0.634859561920166

Familial B-Disease 1 0.9999966621398926
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9990083575248718
FNDI B-Disease 1 0.9999998807907104
) O 0 0.02499495819211006
is O 0 0.015455004759132862
an O 0 0.02116040140390396
autosomal B-Disease 1 0.9999978542327881
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
caused O 1 0.9999992847442627
by O 1 0.999890923500061
deficiency O 1 1.0
in O 0 0.04647400230169296
the O 1 0.994787335395813
antidiuretic O 1 1.0
hormone O 1 0.999997615814209
arginine O 1 0.9999828338623047
vasopressin O 1 0.9999605417251587
( O 0 0.05889784172177315
AVP O 1 0.99959796667099
) O 0 0.01849597692489624
encoded O 0 0.012113138101994991
by O 0 0.010931293480098248
the O 0 0.022296354174613953
AVP O 1 0.9999927282333374
- O 1 0.9999814033508301
neurophysin O 1 0.9999098777770996
II O 1 0.9999948740005493
( O 0 0.24041405320167542
AVP O 1 0.9999994039535522
- O 1 0.9999963045120239
NPII O 1 0.9999767541885376
) O 0 0.032746754586696625
gene O 0 0.03331732004880905
on O 0 0.030875882133841515
chromosome O 0 0.08217065781354904
20p13 O 1 0.7632426619529724
. O 0 0.05561387911438942

In O 0 0.02862531691789627
this O 0 0.017668811604380608
study O 0 0.021950148046016693
, O 0 0.0157680194824934
we O 0 0.010515563189983368
analyzed O 0 0.013797893188893795
two O 0 0.009240255691111088
families O 0 0.017758827656507492
with O 0 0.02065611444413662
FNDI B-Disease 1 0.999970555305481
using O 0 0.018909258767962456
direct O 0 0.027097618207335472
automated O 0 0.05634727329015732
fluorescent O 0 0.12106373906135559
, O 0 0.020795390009880066
solid O 0 0.032058581709861755
phase O 0 0.03893785923719406
, O 0 0.019338510930538177
single O 0 0.03288836032152176
- O 1 0.9497119188308716
stranded O 0 0.05454182252287865
DNA O 0 0.020878737792372704
sequencing O 0 0.021710459142923355
of O 0 0.02327532321214676
PCR O 0 0.12314219772815704
- O 1 0.9994458556175232
amplified O 1 0.9038403034210205
AVP O 1 0.9999927282333374
- O 1 0.9999511241912842
NPII O 1 0.9996274709701538
DNA O 0 0.07337722182273865
. O 0 0.04487853869795799

In O 0 0.02445651963353157
one O 0 0.017477478832006454
of O 0 0.017740197479724884
the O 0 0.022203344851732254
families O 0 0.027921171858906746
, O 0 0.022030765190720558
affected O 0 0.02369328774511814
individuals O 0 0.01340598613023758
presented O 0 0.021472331136465073
a O 0 0.021619364619255066
novel O 0 0.039776768535375595
nonsense O 0 0.2024780511856079
mutation O 0 0.03163799270987511
in O 0 0.014667678624391556
exon O 0 0.054472677409648895
3 O 0 0.016554730013012886
of O 0 0.012990191578865051
the O 0 0.017682282254099846
gene O 0 0.020080914720892906
, O 0 0.011349846608936787
consisting O 0 0.016359584406018257
in O 0 0.011138539761304855
a O 0 0.024797923862934113
G O 1 0.772484302520752
to O 0 0.02660354971885681
T O 1 0.9453188180923462
transition O 0 0.042519643902778625
at O 0 0.03192361444234848
nucleotide O 0 0.06049760431051254
2101 O 1 0.9984126091003418
, O 0 0.01971770077943802
which O 0 0.012484276667237282
produces O 0 0.01947908289730549
a O 0 0.018628157675266266
stop O 0 0.033539243042469025
signal O 0 0.030466388911008835
in O 0 0.019254598766565323
codon O 0 0.07106926292181015
82 O 0 0.0811719000339508
( O 0 0.056465014815330505
Glu O 1 0.9999517202377319
) O 0 0.03637039661407471
of O 0 0.05085305869579315
NPII O 1 0.9977251887321472
. O 0 0.0700540542602539

The O 0 0.0637107565999031
premature O 1 0.9881911277770996
termination O 1 0.9694128036499023
eliminates O 0 0.11145244538784027
part O 0 0.022803455591201782
of O 0 0.017561040818691254
the O 0 0.03405914083123207
C O 1 0.9999916553497314
- O 1 0.9999963045120239
terminal O 1 0.898298978805542
domain O 0 0.026879802346229553
of O 0 0.021865209564566612
NPII O 1 0.99954754114151
, O 0 0.016807476058602333
including O 0 0.012614966370165348
a O 0 0.021578393876552582
cysteine O 0 0.06974591314792633
residue O 0 0.04978102445602417
in O 0 0.012473823502659798
position O 0 0.02096744440495968
85 O 0 0.03217640146613121
, O 0 0.015630217269062996
which O 0 0.010316325351595879
could O 0 0.009405652992427349
be O 0 0.007787209004163742
involved O 0 0.010594586841762066
in O 0 0.009879790246486664
the O 0 0.020185161381959915
correct O 0 0.041841987520456314
folding O 0 0.09563957899808884
of O 0 0.033498406410217285
the O 0 0.06921787559986115
prohormone O 1 0.9999849796295166
. O 0 0.0690922737121582

In O 0 0.02531272917985916
the O 0 0.024820897728204727
second O 0 0.03657190501689911
family O 0 0.03187287971377373
, O 0 0.01910116896033287
a O 0 0.02674091048538685
G279A O 1 0.9563533067703247
substitution O 0 0.03849618509411812
at O 0 0.019165975973010063
position O 0 0.02568165771663189
- O 1 0.8959999680519104
1 O 0 0.015735957771539688
of O 0 0.011428721249103546
the O 0 0.018607445061206818
signal O 0 0.044927239418029785
peptide O 0 0.04438678175210953
was O 0 0.021575238555669785
observed O 0 0.015507105737924576
in O 0 0.012556727975606918
all O 0 0.01742546260356903
affected O 0 0.035299766808748245
individuals O 0 0.03261036053299904
. O 0 0.04566428065299988

This O 0 0.04235915094614029
missense O 0 0.12830157577991486
mutation O 0 0.05489525571465492
, O 0 0.02108641527593136
which O 0 0.019545596092939377
replaces O 1 0.9957072734832764
Ala O 1 0.9999896287918091
with O 0 0.040360793471336365
Thr O 1 0.9999939203262329
, O 0 0.025767382234334946
is O 0 0.01939745992422104
frequent O 0 0.04451337456703186
among O 1 0.9029340147972107
FNDI B-Disease 1 1.0
patients O 1 0.9999967813491821
and O 0 0.034443099051713943
is O 0 0.01713889092206955
thought O 0 0.015622992068529129
to O 0 0.012374416925013065
reduce O 0 0.0197612214833498
the O 0 0.01535889320075512
efficiency O 0 0.033170584589242935
of O 0 0.02804560586810112
cleavage O 1 0.9989795088768005
by O 0 0.03281385824084282
signal O 0 0.10219718515872955
peptidases O 1 0.9874365329742432
. O 0 0.034913986921310425
. O 0 0.040098775178194046

Genetic O 0 0.054401129484176636
heterogeneity O 0 0.08739909529685974
of O 0 0.053285833448171616
Saethre B-Disease 1 0.9999995231628418
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.04249278083443642
due O 0 0.03432759270071983
to O 0 0.032148342579603195
TWIST O 1 0.9977554678916931
and O 0 0.06026480346918106
FGFR O 1 0.9999963045120239
mutations O 0 0.08347101509571075
. O 0 0.049111660569906235

Thirty O 0 0.09780451655387878
- O 1 0.9925508499145508
two O 0 0.02097688801586628
unrelated O 0 0.04088062793016434
patients O 0 0.05995482951402664
with O 0 0.013391911052167416
features O 0 0.017800386995077133
of O 0 0.028345614671707153
Saethre B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.02553948387503624
a O 0 0.028114084154367447
common O 0 0.1805572509765625
autosomal B-Disease 1 0.9999533891677856
dominant I-Disease 1 0.9999140501022339
condition I-Disease 1 0.9999716281890869
of O 1 0.9998397827148438
craniosynostosis B-Disease 1 1.0
and O 1 0.9999706745147705
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999885559082031
, O 0 0.024124611169099808
were O 0 0.01461801864206791
screened O 0 0.03580627590417862
for O 0 0.015773845836520195
mutations O 0 0.024948548525571823
in O 0 0.017204074189066887
TWIST O 1 0.9828311204910278
, O 0 0.04396812245249748
FGFR2 O 1 0.9999914169311523
, O 0 0.041071146726608276
and O 0 0.04399614408612251
FGFR3 O 1 0.9999074935913086
. O 0 0.06018702685832977

Nine O 0 0.051502976566553116
novel O 0 0.054350223392248154
and O 0 0.025502603501081467
three O 0 0.031585901975631714
recurrent O 1 0.9999957084655762
TWIST O 1 0.999990701675415
mutations O 0 0.061927326023578644
were O 0 0.015412500128149986
found O 0 0.014689803123474121
in O 0 0.016269201412796974
12 O 0 0.03205373138189316
families O 0 0.040449731051921844
. O 0 0.04668717831373215

Seven O 0 0.046846549957990646
families O 0 0.0331561379134655
were O 0 0.014358284883201122
found O 0 0.01201221626251936
to O 0 0.01029513031244278
have O 0 0.008205167949199677
the O 0 0.02185595966875553
FGFR3 O 1 0.9999955892562866
P250R O 1 0.9999955892562866
mutation O 0 0.14913704991340637
, O 0 0.0165040735155344
and O 0 0.012776688672602177
one O 0 0.011821746826171875
individual O 0 0.01203918270766735
was O 0 0.016604216769337654
found O 0 0.009357379749417305
to O 0 0.008700425736606121
have O 0 0.007153800688683987
an O 0 0.01865413226187229
FGFR2 O 1 0.9999762773513794
VV269 O 1 0.9999661445617676
- O 1 0.9999219179153442
270 O 0 0.10020720958709717
deletion O 0 0.09942041337490082
. O 0 0.05093595013022423

To O 0 0.03639209643006325
date O 0 0.03104814887046814
, O 0 0.02026587724685669
our O 0 0.02330460213124752
detection O 0 0.03561434894800186
rate O 0 0.018831362947821617
for O 0 0.01864595338702202
TWIST O 1 0.8870506286621094
or O 0 0.032295532524585724
FGFR O 1 0.9999513626098633
mutations O 0 0.037260089069604874
is O 0 0.015882277861237526
68 O 0 0.025358041748404503
% O 0 0.012621644884347916
in O 0 0.010513865388929844
our O 0 0.026387054473161697
Saethre B-Disease 1 0.9999947547912598
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999978542327881
, O 0 0.02548227831721306
including O 0 0.016029274091124535
our O 0 0.025002919137477875
five O 0 0.02722860686480999
patients O 1 0.9971701502799988
elsewhere O 0 0.02556447498500347
reported O 0 0.027994146570563316
with O 0 0.02954411320388317
TWIST O 1 0.9976568222045898
mutations O 0 0.0673580914735794
. O 0 0.045250531286001205

More O 0 0.02053481712937355
than O 0 0.014484372921288013
35 O 0 0.0251319520175457
different O 0 0.01349136233329773
TWIST O 0 0.3846641778945923
mutations O 0 0.031254734843969345
are O 0 0.00982347596436739
now O 0 0.018446076661348343
known O 0 0.02030622400343418
in O 0 0.014459534548223019
the O 0 0.02740202285349369
literature O 0 0.03965543210506439
. O 0 0.040570978075265884

The O 0 0.03806550055742264
most O 0 0.02121788077056408
common O 0 0.026798740029335022
phenotypic O 0 0.0616675466299057
features O 0 0.02823236584663391
, O 0 0.01623951829969883
present O 0 0.013281184248626232
in O 0 0.008146394044160843
more O 0 0.006339605897665024
than O 0 0.006371152121573687
a O 0 0.011720787733793259
third O 0 0.019080478698015213
of O 0 0.01581515558063984
our O 0 0.029247622936964035
patients O 1 0.9922898411750793
with O 0 0.024669747799634933
TWIST O 1 0.9999234676361084
mutations O 0 0.03839075192809105
, O 0 0.01895725540816784
are O 0 0.012573541142046452
coronal B-Disease 1 0.9989251494407654
synostosis I-Disease 1 0.9990082383155823
, O 0 0.03245186433196068
brachycephaly B-Disease 1 0.9954541921615601
, O 0 0.03270309418439865
low B-Disease 1 0.9769549369812012
frontal I-Disease 1 0.9999996423721313
hairline I-Disease 1 1.0
, O 1 0.9994016885757446
facial B-Disease 1 0.9999994039535522
asymmetry I-Disease 1 0.9999986886978149
, O 1 0.9991004467010498
ptosis B-Disease 1 1.0
, O 1 0.9747589826583862
hypertelorism B-Disease 1 0.9999992847442627
, O 0 0.039066702127456665
broad B-Disease 1 0.7681115865707397
great I-Disease 1 0.9967834949493408
toes I-Disease 1 0.9999545812606812
, O 0 0.0453503392636776
and O 0 0.04422758147120476
clinodactyly B-Disease 1 0.9988914132118225
. O 0 0.056922849267721176

Significant O 0 0.06814789772033691
intra O 1 0.9999096393585205
- O 1 0.9998855590820312
and O 0 0.04352660849690437
interfamilial O 1 0.9972782731056213
phenotypic O 0 0.08789536356925964
variability O 0 0.056670647114515305
is O 0 0.017698315903544426
present O 0 0.01662154123187065
for O 0 0.01596623845398426
either O 0 0.026889778673648834
TWIST O 1 0.9533453583717346
mutations O 0 0.060711849480867386
or O 0 0.04598948732018471
FGFR O 1 0.9999741315841675
mutations O 0 0.08501104265451431
. O 0 0.05082742124795914

The O 0 0.05196066573262215
overlap O 0 0.043593503534793854
in O 0 0.026200680062174797
clinical O 1 0.8919562697410583
features O 0 0.028172088786959648
and O 0 0.01638907566666603
the O 0 0.01894921436905861
presence O 0 0.025101277977228165
, O 0 0.01219670008867979
in O 0 0.008412675932049751
the O 0 0.011840332299470901
same O 0 0.012375191785395145
genes O 0 0.012896873988211155
, O 0 0.0104645024985075
of O 0 0.013920608907938004
mutations O 0 0.01752077415585518
for O 0 0.008795523084700108
more O 0 0.007121455390006304
than O 0 0.0084784971550107
one O 0 0.018048031255602837
craniosynostotic B-Disease 1 0.9976704716682434
condition I-Disease 1 0.5875693559646606
- O 1 0.9721100926399231
such O 0 0.011162999086081982
as O 0 0.01881284825503826
Saethre B-Disease 1 0.9997768998146057
- I-Disease 1 0.9999648332595825
Chotzen I-Disease 1 0.9981648325920105
, I-Disease 0 0.025004876777529716
Crouzon I-Disease 1 0.9918638467788696
, I-Disease 0 0.022216862067580223
and I-Disease 0 0.037240102887153625
Pfeiffer I-Disease 1 1.0
syndromes I-Disease 1 1.0
- O 1 0.9999991655349731
support O 0 0.037110041826963425
the O 0 0.022346964105963707
hypothesis O 0 0.030917534604668617
that O 0 0.012469255365431309
TWIST O 1 0.6016370058059692
and O 0 0.020411908626556396
FGFRs O 1 0.9529894590377808
are O 0 0.007522120140492916
components O 0 0.013274735771119595
of O 0 0.010966763831675053
the O 0 0.014786338433623314
same O 0 0.014732960611581802
molecular O 0 0.02987629547715187
pathway O 0 0.03620026633143425
involved O 0 0.011753044091165066
in O 0 0.009204237721860409
the O 0 0.017170686274766922
modulation O 0 0.19342461228370667
of O 1 0.8568785786628723
craniofacial O 1 1.0
and O 1 0.9999411106109619
limb O 1 1.0
development O 1 0.9524216651916504
in O 0 0.02954544499516487
humans O 0 0.03180597722530365
. O 0 0.025657836347818375
. O 0 0.03693917766213417

Mutation O 0 0.06896016746759415
analysis O 0 0.024142151698470116
of O 0 0.03882898390293121
UBE3A O 1 0.9999997615814209
in O 1 0.9999600648880005
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9816181063652039

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9996383190155029
AS B-Disease 1 0.9998922348022461
) O 0 0.02639319933950901
is O 0 0.015816260129213333
caused O 0 0.024597328156232834
by O 0 0.020134422928094864
chromosome O 0 0.22029505670070648
15q11 O 1 0.9996337890625
- O 1 0.9998937845230103
q13 O 1 0.9424635767936707
deletions O 0 0.05799573287367821
of O 0 0.025120669975876808
maternal O 1 0.7423175573348999
origin O 0 0.01654006354510784
, O 0 0.016133401542901993
by O 0 0.023310009390115738
paternal O 1 0.9998127818107605
uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 0.9999992847442627
( O 1 0.9788672924041748
UPD B-Disease 1 0.9999998807907104
) O 0 0.02515094168484211
15 O 0 0.01995161548256874
, O 0 0.016432801261544228
by O 0 0.02652723714709282
imprinting O 1 0.9999938011169434
defects O 1 0.9999840259552002
, O 0 0.021656500175595284
and O 0 0.015766916796565056
by O 0 0.016856178641319275
mutations O 0 0.024772416800260544
in O 0 0.01561080850660801
the O 0 0.04110413044691086
UBE3A O 1 0.9999980926513672
gene O 0 0.07446377724409103
. O 0 0.04361184313893318

UBE3A O 1 0.9921063184738159
encodes O 0 0.08348491042852402
a O 0 0.05082958936691284
ubiquitin O 1 0.9981247782707214
- O 1 0.9999761581420898
protein O 0 0.041413575410842896
ligase O 0 0.05665738135576248
and O 0 0.02227003313601017
shows O 0 0.036228347569704056
brain O 1 0.9958813190460205
- O 1 0.9995926022529602
specific O 0 0.039615992456674576
imprinting O 1 0.9485935568809509
. O 0 0.04804201424121857

Here O 0 0.03998420014977455
we O 0 0.0234482754021883
describe O 0 0.052985016256570816
UBE3A O 1 0.999700665473938
coding O 0 0.30007418990135193
- O 1 0.996672511100769
region O 0 0.041702091693878174
mutations O 0 0.03399093821644783
detected O 0 0.02903604693710804
by O 0 0.021788589656352997
SSCP O 1 0.9989157915115356
analysis O 0 0.016585471108555794
in O 0 0.014329686760902405
13 O 0 0.030799511820077896
AS B-Disease 0 0.18795470893383026
individuals O 0 0.02578350342810154
or O 0 0.026704849675297737
families O 0 0.04637463763356209
. O 0 0.04687652736902237

Two O 0 0.02603091485798359
identical O 0 0.034680914133787155
de O 0 0.08125907182693481
novo O 1 0.5898236632347107
5 O 0 0.050551872700452805
- O 1 0.9778727293014526
bp O 0 0.0756269097328186
duplications O 0 0.07327940315008163
in O 0 0.02621135301887989
exon O 0 0.09997588396072388
16 O 0 0.03235883265733719
were O 0 0.021714642643928528
found O 0 0.029388437047600746
. O 0 0.037093330174684525

Among O 0 0.040010180324316025
the O 0 0.023082701489329338
other O 0 0.015232246369123459
11 O 0 0.025035051628947258
unique O 0 0.022972697392106056
mutations O 0 0.02803993970155716
, O 0 0.015539467334747314
8 O 0 0.018969250842928886
were O 0 0.011134344153106213
small O 0 0.01740979216992855
deletions O 0 0.050004590302705765
or O 0 0.022308185696601868
insertions O 0 0.11122361570596695
predicted O 0 0.0314035564661026
to O 0 0.022382527589797974
cause O 0 0.4435063302516937
frameshifts O 1 0.9993508458137512
, O 0 0.021929116919636726
1 O 0 0.023256802931427956
was O 0 0.020487798377871513
a O 0 0.019884398207068443
mutation O 0 0.023115914314985275
to O 0 0.011936102993786335
a O 0 0.01799142360687256
stop O 0 0.030182793736457825
codon O 0 0.04403718560934067
, O 0 0.014096260070800781
1 O 0 0.01688745804131031
was O 0 0.017932815477252007
a O 0 0.022230971604585648
missense O 0 0.2864815294742584
mutation O 0 0.03757517412304878
, O 0 0.014946122653782368
and O 0 0.013661518692970276
1 O 0 0.021850798279047012
was O 0 0.021874021738767624
predicted O 0 0.023193996399641037
to O 0 0.017214348539710045
cause O 0 0.04317079484462738
insertion O 0 0.05295219644904137
of O 0 0.021395958960056305
an O 0 0.02608024887740612
isoleucine O 1 0.9980350136756897
in O 0 0.015009135007858276
the O 0 0.020556606352329254
hect O 1 0.8176112174987793
domain O 0 0.024781133979558945
of O 0 0.016715068370103836
the O 0 0.03290960192680359
UBE3A O 1 0.9999984502792358
protein O 0 0.03398352861404419
, O 0 0.014981899410486221
which O 0 0.010080641135573387
functions O 0 0.015553639270365238
in O 0 0.020572269335389137
E2 O 1 0.9997242093086243
binding O 0 0.04435720294713974
and O 0 0.035499341785907745
ubiquitin O 0 0.1937771588563919
transfer O 0 0.05281910300254822
. O 0 0.04869847744703293

Eight O 0 0.03317657485604286
of O 0 0.022701259702444077
the O 0 0.0248179379850626
cases O 0 0.025892356410622597
were O 0 0.024667466059327126
familial O 1 0.9999970197677612
, O 0 0.03608720004558563
and O 0 0.018991243094205856
five O 0 0.01903030276298523
were O 0 0.019217832013964653
sporadic O 0 0.07968027144670486
. O 0 0.04419682174921036

In O 0 0.034253668040037155
two O 0 0.02946077659726143
familial O 1 0.999921441078186
cases O 0 0.03836137428879738
and O 0 0.021222585812211037
one O 0 0.02098488062620163
sporadic O 0 0.1596260517835617
case O 0 0.030108606442809105
, O 0 0.02494223043322563
mosaicism O 1 0.9990919828414917
for O 0 0.034237928688526154
UBE3A O 1 0.9999998807907104
mutations O 0 0.09570028632879257
was O 0 0.028130505234003067
detected O 0 0.021416055038571358
in O 0 0.009157063439488411
the O 0 0.012664979323744774
mother O 0 0.03039534017443657
of O 0 0.013083130121231079
three O 0 0.014001434668898582
AS B-Disease 1 0.9425628781318665
sons O 1 0.9946168065071106
, O 0 0.015208689495921135
in O 0 0.010513066314160824
the O 0 0.0183468796312809
maternal O 1 0.9995245933532715
grandfather O 1 0.9828757047653198
of O 0 0.01851014234125614
two O 0 0.013563955202698708
AS B-Disease 0 0.33050355315208435
first O 0 0.027533622458577156
cousins O 0 0.18207401037216187
, O 0 0.015298193320631981
and O 0 0.01123859267681837
in O 0 0.010176043957471848
the O 0 0.016519946977496147
mother O 0 0.11803967505693436
of O 0 0.023196956142783165
an O 0 0.03679325059056282
AS B-Disease 1 0.9989426732063293
daughter O 1 0.9999061822891235
. O 0 0.05777739733457565

The O 0 0.04081904515624046
frequencies O 0 0.025334889069199562
with O 0 0.014378334395587444
which O 0 0.011127348057925701
we O 0 0.0127356993034482
detected O 0 0.02630126103758812
mutations O 0 0.017666412517428398
were O 0 0.010046477429568768
5 O 0 0.019302813336253166
( O 0 0.015437991358339787
14 O 0 0.018909577280282974
% O 0 0.0145390210673213
) O 0 0.011444726027548313
of O 0 0.011924637481570244
35 O 0 0.02041694149374962
in O 0 0.014023608528077602
sporadic O 0 0.03811262175440788
cases O 0 0.02160029113292694
and O 0 0.018412386998534203
8 O 0 0.03238070756196976
( O 0 0.01924693025648594
80 O 0 0.021496698260307312
% O 0 0.014921389520168304
) O 0 0.011602281592786312
of O 0 0.013495877385139465
10 O 0 0.020994337275624275
in O 0 0.024631381034851074
familial O 1 0.999983549118042
cases O 0 0.325926274061203
. O 0 0.03463386371731758
. O 0 0.042457010596990585

The O 0 0.09061174839735031
hemochromatosis B-Disease 1 0.9999997615814209
845 O 1 0.9999816417694092
G O 1 0.9999961853027344
- O 1 0.9999992847442627
- O 1 0.9999839067459106
> O 0 0.23693528771400452
A O 0 0.024032870307564735
and O 0 0.01533446554094553
187 O 0 0.057138893753290176
C O 1 0.992550253868103
- O 1 0.9999896287918091
- O 1 0.9999796152114868
> O 1 0.9973157048225403
G O 1 0.9521979689598083
mutations O 0 0.03877661004662514
: O 0 0.02697029523551464
prevalence O 1 0.8942079544067383
in O 0 0.02503134496510029
non O 1 0.987476646900177
- O 1 0.9999949932098389
Caucasian O 1 0.997869610786438
populations O 0 0.057803429663181305
. O 0 0.05146491900086403

Hemochromatosis B-Disease 1 0.9999958276748657
, O 0 0.04256657138466835
the O 1 0.5303795337677002
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 0.9999977350234985
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 1 0.9137728810310364
leads O 1 0.9900190830230713
, O 0 0.0253871139138937
if O 0 0.020891591906547546
untreated O 1 0.9999693632125854
, O 0 0.020232880488038063
to O 0 0.024830063804984093
progressive O 1 0.9999990463256836
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 1 0.9845235347747803
premature B-Disease 1 0.9999903440475464
death I-Disease 1 0.999152660369873
. O 0 0.05672154948115349

The O 0 0.11721663177013397
hemochromatosis B-Disease 1 1.0
gene O 0 0.3954017460346222
, O 0 0.048202693462371826
HFE O 1 0.9999970197677612
, O 0 0.02762112021446228
recently O 0 0.02803763933479786
has O 0 0.013790654949843884
been O 0 0.010771308094263077
identified O 0 0.016191329807043076
, O 0 0.010054304264485836
and O 0 0.010078695602715015
characterization O 0 0.02645275369286537
of O 0 0.013048535212874413
this O 0 0.012323267757892609
gene O 0 0.01922471635043621
has O 0 0.011104254052042961
shown O 0 0.009139756672084332
that O 0 0.005836653523147106
it O 0 0.006365575827658176
contains O 0 0.010967261157929897
two O 0 0.008450092747807503
mutations O 0 0.016159458085894585
that O 0 0.007503326050937176
result O 0 0.011044417507946491
in O 0 0.012988859787583351
amino O 0 0.028596729040145874
acid O 0 0.04020508751273155
substitutions O 0 0.04563760757446289
- O 1 0.5744274854660034
cDNA O 0 0.06740354746580124
nucleotides O 0 0.040866345167160034
845 O 0 0.43082988262176514
G O 1 0.9977656602859497
- O 1 0.9999768733978271
- O 1 0.9999508857727051
> O 1 0.697740375995636
A O 0 0.04066827893257141
( O 0 0.02897239662706852
C282Y O 0 0.21730197966098785
) O 0 0.014538091607391834
and O 0 0.013865974731743336
187 O 0 0.05924149602651596
C O 1 0.9974948167800903
- O 1 0.9999966621398926
- O 1 0.9999960660934448
> O 1 0.9995236396789551
G O 1 0.997911274433136
( O 0 0.0571218878030777
H63D O 1 0.9997003078460693
) O 0 0.04782295972108841
. O 0 0.04307840019464493

Although O 0 0.09466405212879181
hemochromatosis B-Disease 1 0.9999997615814209
is O 0 0.03321833908557892
common O 0 0.026676131412386894
in O 0 0.021367210894823074
Caucasians O 1 0.9986353516578674
, O 0 0.02829090878367424
affecting O 1 0.6318675875663757
> O 1 0.9996963739395142
= O 0 0.3461352586746216
1 O 0 0.04286137968301773
/ O 1 0.9307248592376709
300 O 0 0.018262218683958054
individuals O 0 0.009113766252994537
of O 0 0.011234821751713753
northern O 0 0.019636884331703186
European O 0 0.01510524656623602
origin O 0 0.01103251799941063
, O 0 0.010921965353190899
it O 0 0.007025537546724081
has O 0 0.008624210953712463
not O 0 0.00742625305429101
been O 0 0.009959595277905464
recognized O 0 0.018872475251555443
in O 0 0.01251949928700924
other O 0 0.01620130054652691
populations O 0 0.03215235471725464
. O 0 0.039610885083675385

The O 0 0.04146096110343933
present O 0 0.02981644496321678
study O 0 0.02263295277953148
used O 0 0.017658619210124016
PCR O 0 0.053884584456682205
and O 0 0.02148524299263954
restriction O 0 0.36319592595100403
- O 1 0.9999984502792358
enzyme O 1 0.5010008811950684
digestion O 0 0.23680374026298523
to O 0 0.017680048942565918
analyze O 0 0.020794739946722984
the O 0 0.012319774366915226
frequency O 0 0.012253048829734325
of O 0 0.010710680857300758
the O 0 0.019763190299272537
845 O 1 0.9997500777244568
G O 1 0.9999678134918213
- O 1 0.9999982118606567
- O 1 0.9999719858169556
> O 0 0.0632006824016571
A O 0 0.022018922492861748
and O 0 0.01294601522386074
187 O 0 0.04920387268066406
C O 1 0.9842509031295776
- O 1 0.999987006187439
- O 1 0.9999855756759644
> O 1 0.9669674634933472
G O 0 0.27245137095451355
mutations O 0 0.03012537769973278
in O 0 0.02424672432243824
HLA O 1 0.9999997615814209
- O 1 0.9978660941123962
typed O 0 0.034237731248140335
samples O 0 0.013781468383967876
from O 0 0.011470532976090908
non O 0 0.20798853039741516
- O 1 0.9999886751174927
Caucasian O 1 0.9973779916763306
populations O 0 0.024101540446281433
, O 0 0.015618188306689262
comprising O 0 0.028848467394709587
Australian O 0 0.03928887099027634
Aboriginal O 0 0.287389874458313
, O 0 0.024340232834219933
Chinese O 0 0.031683165580034256
, O 0 0.02348444052040577
and O 0 0.025662297382950783
Pacific O 0 0.06290438026189804
Islanders O 0 0.09524932503700256
. O 0 0.04955541342496872

Results O 0 0.02494492568075657
showed O 0 0.018303120508790016
that O 0 0.008673747070133686
the O 0 0.01742394082248211
845 O 1 0.997533917427063
G O 1 0.9999730587005615
- O 1 0.999998927116394
- O 1 0.9999959468841553
> O 1 0.8753459453582764
A O 0 0.034894704818725586
mutation O 0 0.03131502494215965
was O 0 0.017815785482525826
present O 0 0.013319224119186401
in O 0 0.00889528077095747
these O 0 0.008045005612075329
populations O 0 0.018109984695911407
( O 0 0.022275008261203766
allele O 0 0.04019094631075859
frequency O 0 0.019554371014237404
0 O 0 0.022723769769072533
. O 0 0.010375479236245155
32 O 0 0.020670607686042786
% O 0 0.018531139940023422
) O 0 0.015969114378094673
, O 0 0.014609470032155514
and O 0 0.013213703408837318
, O 0 0.015919549390673637
furthermore O 0 0.021455084905028343
, O 0 0.013474580831825733
it O 0 0.009374589659273624
was O 0 0.017050784081220627
always O 0 0.016494901850819588
seen O 0 0.013866933062672615
in O 0 0.01089831255376339
conjunction O 0 0.03525679558515549
with O 0 0.03963359072804451
HLA O 1 1.0
haplotypes O 1 0.9967207312583923
common O 0 0.02630631811916828
in O 0 0.018820930272340775
Caucasians O 1 0.9650426506996155
, O 0 0.015553303062915802
suggesting O 0 0.014647498726844788
that O 0 0.010007371194660664
845 O 1 0.9987200498580933
G O 1 0.9999839067459106
- O 1 0.9999995231628418
- O 1 0.9999988079071045
> O 1 0.9977439641952515
A O 0 0.036816999316215515
may O 0 0.014604603871703148
have O 0 0.007549331057816744
been O 0 0.009603826329112053
introduced O 0 0.014642985537648201
into O 0 0.012160977348685265
these O 0 0.008532777428627014
populations O 0 0.021579990163445473
by O 0 0.03148423880338669
Caucasian O 1 0.9991629123687744
admixture O 1 0.9913724660873413
. O 0 0.06475654989480972

187 O 0 0.1286444067955017
C O 1 0.9968063831329346
- O 1 0.999996542930603
- O 1 0.9999982118606567
> O 1 0.9991247057914734
G O 1 0.7243332266807556
was O 0 0.02306705340743065
present O 0 0.015816951170563698
at O 0 0.01677987165749073
an O 0 0.01838732697069645
allele O 0 0.04804476350545883
frequency O 0 0.022534675896167755
of O 0 0.023174017667770386
2 O 0 0.04468070715665817
. O 0 0.039688803255558014

68 O 0 0.07515682280063629
% O 0 0.024145051836967468
in O 0 0.01291500125080347
the O 0 0.014981688000261784
two O 0 0.013560127466917038
populations O 0 0.021870054304599762
analyzed O 0 0.025267332792282104
( O 0 0.021588465198874474
Australian O 0 0.03762426599860191
Aboriginal O 0 0.08082503825426102
and O 0 0.030594438314437866
Chinese O 0 0.05231543630361557
) O 0 0.037951912730932236
. O 0 0.03881046548485756

In O 0 0.030137067660689354
the O 0 0.025570832192897797
Australian O 0 0.0370783731341362
Aboriginal O 0 0.048567406833171844
samples O 0 0.022255992516875267
, O 0 0.01641358993947506
187 O 0 0.05505440756678581
C O 1 0.9980829954147339
- O 1 0.9999977350234985
- O 1 0.9999978542327881
> O 1 0.9987082481384277
G O 0 0.3605489432811737
was O 0 0.022502200677990913
found O 0 0.009925570338964462
to O 0 0.008490877225995064
be O 0 0.008534826338291168
associated O 0 0.01601257175207138
with O 0 0.026844728738069534
HLA O 1 1.0
haplotypes O 1 0.9973874688148499
common O 0 0.030568255111575127
in O 0 0.02168748714029789
Caucasians O 1 0.9991014003753662
, O 0 0.020724721252918243
suggesting O 0 0.01949608512222767
that O 0 0.009100676514208317
it O 0 0.008379471488296986
was O 0 0.01873372495174408
introduced O 0 0.020645255222916603
by O 0 0.020697083324193954
recent O 0 0.038280222564935684
admixture O 0 0.14788074791431427
. O 0 0.05582990497350693

In O 0 0.02912212535738945
the O 0 0.02579876035451889
Chinese O 0 0.03038022480905056
samples O 0 0.018016882240772247
analyzed O 0 0.016139434650540352
, O 0 0.013988648541271687
187 O 0 0.046717800199985504
C O 1 0.9918409585952759
- O 1 0.9999946355819702
- O 1 0.9999940395355225
> O 1 0.9989250302314758
G O 1 0.9352281093597412
was O 0 0.022310569882392883
present O 0 0.013823560439050198
in O 0 0.010953716933727264
association O 0 0.017411261796951294
with O 0 0.010957509279251099
a O 0 0.014845081605017185
wide O 0 0.018797531723976135
variety O 0 0.016977954655885696
of O 0 0.24083630740642548
HLA O 1 1.0
haplotypes O 1 0.9994016885757446
, O 0 0.022798864170908928
showing O 0 0.02362314984202385
this O 0 0.012485754676163197
mutation O 0 0.023429149761795998
to O 0 0.012001581490039825
be O 0 0.01113005168735981
widespread O 0 0.025038350373506546
and O 0 0.01526592206209898
likely O 0 0.01748921535909176
to O 0 0.015558166429400444
predate O 0 0.03961990028619766
the O 0 0.014253812842071056
more O 0 0.008559458889067173
genetically O 0 0.017239699140191078
restricted O 0 0.024413956329226494
845 O 1 0.9980480670928955
G O 1 0.9999865293502808
- O 1 0.9999994039535522
- O 1 0.9999963045120239
> O 1 0.9950862526893616
A O 0 0.0639745369553566
mutation O 0 0.06913650035858154
. O 0 0.03886488080024719

Genotype O 1 0.9847954511642456
- O 1 0.9989681243896484
phenotype O 0 0.21069899201393127
correlations O 0 0.09263460338115692
in O 0 0.05849470570683479
attenuated B-Disease 1 0.9999972581863403
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 1 0.7055343985557556

Germ O 1 0.9999407529830933
- O 1 0.998399555683136
line O 0 0.04488972947001457
mutations O 0 0.025080764666199684
of O 0 0.02033505029976368
the O 0 0.3988572061061859
tumor B-Disease 1 1.0
suppressor O 1 0.9999996423721313
APC O 1 0.999982476234436
are O 0 0.015331167727708817
implicated O 0 0.05772995203733444
in O 0 0.0356498658657074
attenuated B-Disease 1 0.9999959468841553
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999027252197266
AAPC B-Disease 1 0.9999998807907104
) O 0 0.027810869738459587
, O 0 0.015595787204802036
a O 0 0.0212941262871027
variant O 0 0.04066893085837364
of O 0 0.050420988351106644
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999988079071045
FAP B-Disease 1 1.0
) O 0 0.08735431730747223
. O 0 0.052404288202524185

AAPC B-Disease 1 0.9999587535858154
is O 0 0.035820718854665756
recognized O 0 0.028727132827043533
by O 0 0.015034577809274197
the O 0 0.0200003981590271
occurrence O 0 0.043307021260261536
of O 0 0.034929607063531876
< O 1 0.9999184608459473
100 O 0 0.06255589425563812
colonic B-Disease 1 0.9999991655349731
adenomas I-Disease 1 0.9999890327453613
and O 0 0.01957647316157818
a O 0 0.01995980367064476
later O 0 0.027920683845877647
onset O 1 0.9999982118606567
of O 1 0.999996542930603
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999489784240723
age O 1 0.9992208480834961
> O 1 0.9993579983711243
40 O 0 0.038737617433071136
years O 0 0.031481072306632996
) O 0 0.03490922600030899
. O 0 0.038891926407814026

The O 0 0.04158252850174904
aim O 0 0.041818756610155106
of O 0 0.018398001790046692
this O 0 0.011101741343736649
study O 0 0.015465476550161839
was O 0 0.019815655425190926
to O 0 0.0192851759493351
assess O 0 0.07033776491880417
genotype O 1 0.9993512034416199
- O 1 0.9999892711639404
phenotype O 1 0.9593712687492371
correlations O 0 0.08660441637039185
in O 0 0.046234630048274994
AAPC B-Disease 1 0.999991774559021
families O 0 0.07494243234395981
. O 0 0.06001387536525726

By O 0 0.05059877783060074
protein O 0 0.059236712753772736
- O 1 0.9829565286636353
truncation O 0 0.32243746519088745
test O 0 0.0444861464202404
( O 0 0.03569721058011055
PTT O 1 0.8464110493659973
) O 0 0.02587653510272503
assay O 0 0.03929620981216431
, O 0 0.013365437276661396
the O 0 0.01466649305075407
entire O 0 0.026475800201296806
coding O 0 0.03252227231860161
region O 0 0.017770692706108093
of O 0 0.015577670186758041
the O 0 0.027354646474123
APC B-Disease 1 0.9999964237213135
gene O 0 0.035893961787223816
was O 0 0.02943454310297966
screened O 0 0.04262678697705269
in O 0 0.015023191459476948
affected O 0 0.020419858396053314
individuals O 0 0.014811699278652668
from O 0 0.021698208525776863
11 O 0 0.2801136076450348
AAPC B-Disease 1 0.9999998807907104
kindreds O 1 0.9999512434005737
, O 0 0.031622227281332016
and O 0 0.01899927482008934
their O 0 0.016916325315833092
phenotypic O 0 0.044038500636816025
differences O 0 0.027817824855446815
were O 0 0.02426329255104065
examined O 0 0.06273165345191956
. O 0 0.046768274158239365

Five O 0 0.04420438036322594
novel O 0 0.08737015724182129
germ O 1 0.9999324083328247
- O 1 0.9999794960021973
line O 1 0.8186798691749573
APC B-Disease 1 0.9999674558639526
mutations O 0 0.03566687926650047
were O 0 0.013846252113580704
identified O 0 0.0196938868612051
in O 0 0.016225378960371017
seven O 0 0.040318749845027924
kindreds O 1 0.9795745015144348
. O 0 0.06130783632397652

Mutations O 0 0.06027103587985039
were O 0 0.017736947163939476
located O 0 0.023946324363350868
in O 0 0.009167664684355259
three O 0 0.007743788417428732
different O 0 0.00454484298825264
regions O 0 0.008472460322082043
of O 0 0.012519416399300098
the O 0 0.0340784452855587
APC B-Disease 1 0.9999995231628418
gene O 0 0.041861239820718765
( O 0 0.019872859120368958
1 O 0 0.020461304113268852
) O 0 0.0120184775441885
at O 0 0.01042079646140337
the O 0 0.012866363860666752
5 O 0 0.016911853104829788
end O 0 0.020533185452222824
spanning O 0 0.03130694106221199
exons O 0 0.04949967563152313
4 O 0 0.024466652423143387
and O 0 0.0161631740629673
5 O 0 0.02350611425936222
, O 0 0.01821628212928772
( O 0 0.017457978799939156
2 O 0 0.019777733832597733
) O 0 0.013219636864960194
within O 0 0.013959103263914585
exon O 0 0.07171338051557541
9 O 0 0.03228498995304108
, O 0 0.01693331077694893
and O 0 0.01538934651762247
( O 0 0.01776188611984253
3 O 0 0.019954822957515717
) O 0 0.012343201786279678
at O 0 0.012855568900704384
the O 0 0.01693897135555744
3 O 0 0.02861778624355793
distal O 1 0.9848055243492126
end O 0 0.03300366923213005
of O 0 0.027083974331617355
the O 0 0.04061152786016464
gene O 0 0.05231069400906563
. O 0 0.04166915640234947

Variability O 0 0.06587814539670944
in O 0 0.014937428757548332
the O 0 0.01579432748258114
number O 0 0.01839943788945675
of O 1 0.9945911169052124
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9972934126853943
most O 0 0.021477749571204185
apparent O 1 0.5555765628814697
in O 0 0.013628545217216015
individuals O 0 0.012585262767970562
with O 0 0.01319881435483694
mutations O 0 0.018877554684877396
in O 0 0.01024840772151947
region O 0 0.01760273240506649
1 O 0 0.017879551276564598
, O 0 0.012320109643042088
and O 0 0.01670687273144722
upper O 1 0.9999903440475464
- O 1 1.0
gastrointestinal O 1 1.0
manifestations O 1 0.9999992847442627
were O 0 0.03224180266261101
more O 0 0.022048544138669968
severe O 1 0.999889612197876
in O 0 0.02961660362780094
them O 0 0.033132798969745636
. O 0 0.04268478974699974

In O 0 0.03218105807900429
individuals O 0 0.021434396505355835
with O 0 0.019415054470300674
mutations O 0 0.02608184888958931
in O 0 0.01291582640260458
either O 0 0.01618698053061962
region O 0 0.025470610707998276
2 O 0 0.025418587028980255
or O 0 0.015660472214221954
region O 0 0.021540453657507896
3 O 0 0.01802026852965355
, O 0 0.01120341569185257
the O 0 0.011716623790562153
average O 0 0.013930875808000565
number O 0 0.012630757875740528
of O 0 0.029691603034734726
adenomas B-Disease 1 0.9999986886978149
tended O 0 0.051198478788137436
to O 0 0.01750798150897026
be O 0 0.01042604073882103
lower O 0 0.014226596802473068
than O 0 0.007508185692131519
those O 0 0.007427869364619255
in O 0 0.00923776812851429
individuals O 0 0.012293830513954163
with O 0 0.013657323084771633
mutations O 0 0.021449517458677292
in O 0 0.012725823558866978
region O 0 0.0225442573428154
1 O 0 0.022157831117510796
, O 0 0.013766136951744556
although O 0 0.013137000612914562
age O 0 0.029805336147546768
at O 0 0.3934732973575592
diagnosis O 1 0.9999933242797852
was O 0 0.1258189082145691
similar O 0 0.03015054762363434
. O 0 0.03890476003289223

In O 0 0.04003021493554115
all O 0 0.044766563922166824
AAPC B-Disease 1 0.999996542930603
kindreds O 1 0.9872642755508423
, O 0 0.026790184900164604
a O 0 0.025407226756215096
predominance O 0 0.44247135519981384
of O 0 0.031409356743097305
right O 1 0.9931882619857788
- O 1 1.0
sided O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.999994158744812
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999991655349731
was O 1 0.9844793677330017
observed O 0 0.05534105375409126
. O 0 0.045419104397296906

No O 0 0.10203530639410019
desmoid B-Disease 1 0.9999924898147583
tumors I-Disease 1 0.9999957084655762
were O 0 0.025050850585103035
found O 0 0.020559968426823616
in O 0 0.02131926268339157
these O 0 0.02459210529923439
kindreds O 1 0.9865987300872803
. O 0 0.05494385585188866

Our O 0 0.049172841012477875
data O 0 0.019289646297693253
suggest O 0 0.015968335792422295
that O 0 0.009582827799022198
, O 0 0.015713034197688103
in O 0 0.022273210808634758
AAPC B-Disease 1 0.9999984502792358
families O 0 0.025860091671347618
, O 0 0.013316635973751545
the O 0 0.013040021061897278
location O 0 0.014675839804112911
of O 0 0.014117402024567127
the O 0 0.0756208747625351
APC B-Disease 1 0.9999998807907104
mutation O 1 0.9976297616958618
may O 0 0.02907716855406761
partially O 0 0.05175812542438507
predict O 0 0.036481793969869614
specific O 0 0.0223231241106987
phenotypic O 0 0.06700942665338516
expression O 0 0.05469346418976784
. O 0 0.045878566801548004

This O 0 0.029243655502796173
should O 0 0.02099139615893364
help O 0 0.02089511975646019
in O 0 0.010660333558917046
the O 0 0.013511603698134422
design O 0 0.02112518437206745
of O 0 0.019729914143681526
tailored O 1 0.6908602714538574
clinical O 1 0.9999626874923706
- O 1 0.9999998807907104
management O 1 0.9473897814750671
protocols O 0 0.04467751830816269
in O 0 0.011642860248684883
this O 0 0.01282558310776949
subset O 0 0.0719226598739624
of O 1 0.8981884121894836
FAP B-Disease 1 1.0
patients O 1 0.9999957084655762
. O 0 0.04251675307750702
. O 0 0.04622439295053482

Wilms B-Disease 1 0.9999991655349731
' I-Disease 1 0.9998574256896973
tumor I-Disease 1 0.9999884366989136
1 O 0 0.04604673758149147
and O 0 0.03204092010855675
Dax O 1 0.9999737739562988
- O 1 0.9986910223960876
1 O 0 0.03289947286248207
modulate O 0 0.05087187513709068
the O 0 0.022997908294200897
orphan O 1 0.9998120665550232
nuclear O 0 0.1239652931690216
receptor O 1 0.9870720505714417
SF O 1 0.9999974966049194
- O 1 0.9916115403175354
1 O 0 0.024859881028532982
in O 0 0.016291195526719093
sex O 0 0.049819573760032654
- O 1 0.998690664768219
specific O 0 0.026236144825816154
gene O 0 0.041083551943302155
expression O 0 0.044028785079717636
. O 0 0.04008260741829872

Products O 0 0.04677831754088402
of O 0 0.037369903177022934
steroidogenic O 1 0.999948263168335
factor O 0 0.40621063113212585
1 O 0 0.04503421112895012
( O 0 0.0389416329562664
SF O 1 0.9999991655349731
- O 1 0.9993011951446533
1 O 0 0.028218373656272888
) O 0 0.01585485227406025
and O 0 0.023762188851833344
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9999996423721313
1 O 1 0.7246278524398804
( O 0 0.19217197597026825
WT1 O 1 0.9999967813491821
) O 0 0.026074450463056564
genes O 0 0.015843506902456284
are O 0 0.007111570332199335
essential O 0 0.02241923287510872
for O 0 0.018379606306552887
mammalian O 0 0.07137052714824677
gonadogenesis O 1 0.9690264463424683
prior O 0 0.0402756929397583
to O 0 0.03402135893702507
sexual O 0 0.18116939067840576
differentiation O 1 0.8824089169502258
. O 0 0.06102089583873749

In O 0 0.029285989701747894
males O 0 0.03181557357311249
, O 0 0.0431329607963562
SF O 1 0.9999998807907104
- O 1 0.9999923706054688
1 O 0 0.03513343259692192
participates O 0 0.03598727285861969
in O 0 0.013367373496294022
sexual O 0 0.027423430234193802
development O 0 0.020618624985218048
by O 0 0.01557742990553379
regulating O 0 0.029366569593548775
expression O 0 0.018851175904273987
of O 0 0.017058560624718666
the O 0 0.031099418178200722
polypeptide O 1 0.9999257326126099
hormone O 1 0.9999407529830933
Mullerian O 1 0.9999998807907104
inhibiting O 1 0.9999963045120239
substance O 1 0.9999879598617554
( O 1 0.9420026540756226
MIS O 1 0.9999955892562866
) O 0 0.04677513986825943
. O 0 0.04049426317214966

Here O 0 0.0408051423728466
, O 0 0.02133771777153015
we O 0 0.01456046849489212
show O 0 0.02160836011171341
that O 0 0.02215881645679474
WT1 O 1 0.999975323677063
- O 1 0.9999809265136719
KTS O 1 0.9997873902320862
isoforms O 0 0.046925898641347885
associate O 0 0.04891756549477577
and O 0 0.026700804010033607
synergize O 1 0.998871386051178
with O 0 0.05827551335096359
SF O 1 0.9999998807907104
- O 1 0.9999492168426514
1 O 0 0.0377369150519371
to O 0 0.027585603296756744
promote O 0 0.07720385491847992
MIS O 1 0.9999828338623047
expression O 0 0.06037810072302818
. O 0 0.042230986058712006

In O 0 0.0375652015209198
contrast O 0 0.052637916058301926
, O 0 0.04635879024863243
WT1 O 1 0.9999608993530273
missense O 1 0.9600289463996887
mutations O 0 0.04373395815491676
, O 0 0.01870274730026722
associated O 0 0.01675460673868656
with O 0 0.014881444163620472
male B-Disease 0 0.057765718549489975
pseudohermaphroditism I-Disease 1 0.9999425411224365
in O 0 0.03750750422477722
Denys B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.04955480620265007
fail O 0 0.07290979474782944
to O 0 0.0323021300137043
synergize O 1 0.9997093081474304
with O 0 0.16104401648044586
SF O 1 0.9999998807907104
- O 1 0.9999855756759644
1 O 0 0.06456949561834335
. O 0 0.044691771268844604

Additionally O 0 0.04945271834731102
, O 0 0.02260361611843109
the O 0 0.02810679003596306
X O 1 0.9994150400161743
- O 1 0.9999550580978394
linked O 0 0.041712190955877304
, O 0 0.019077837467193604
candidate O 0 0.03813580051064491
dosage O 1 0.9684099555015564
- O 1 0.9988835453987122
sensitive O 0 0.047680433839559555
sex O 0 0.051248520612716675
- O 1 0.9986850619316101
reversal O 0 0.11841396242380142
gene O 0 0.029603563249111176
, O 0 0.02614426426589489
Dax O 1 0.9999639987945557
- O 1 0.9991703033447266
1 O 0 0.02841155230998993
, O 0 0.02011520229279995
antagonizes O 1 0.8355051875114441
synergy O 1 0.5520787239074707
between O 0 0.03815297782421112
SF O 1 0.9999998807907104
- O 1 0.9999876022338867
1 O 0 0.0394376777112484
and O 0 0.029616443440318108
WT1 O 1 0.9999762773513794
, O 0 0.01841142028570175
most O 0 0.011604195460677147
likely O 0 0.012583977542817593
through O 0 0.011229264549911022
a O 0 0.015694215893745422
direct O 0 0.020582392811775208
interaction O 0 0.026955818757414818
with O 0 0.03735514357686043
SF O 1 1.0
- O 1 0.9999943971633911
1 O 0 0.05876130983233452
. O 0 0.03864951804280281

We O 0 0.03356111794710159
propose O 0 0.0460268072783947
that O 0 0.02438363991677761
WT1 O 1 0.9991185069084167
and O 0 0.043279267847537994
Dax O 1 0.9999979734420776
- O 1 0.9999879598617554
1 O 0 0.04460990056395531
functionally O 0 0.050143953412771225
oppose O 0 0.025216858834028244
each O 0 0.008727672509849072
other O 0 0.009157274849712849
in O 0 0.014768733642995358
testis O 1 0.9953889846801758
development O 0 0.027844887226819992
by O 0 0.029809610918164253
modulating O 1 0.9999856948852539
SF O 1 1.0
- O 1 0.9999934434890747
1 O 0 0.1281975656747818
- O 1 0.9997194409370422
mediated O 1 0.8313225507736206
transactivation O 1 0.9986053109169006
. O 0 0.03801899403333664
. O 0 0.04314199090003967

A O 0 0.06543952226638794
mouse O 0 0.0608275830745697
model O 0 0.03541504964232445
for O 0 0.041180308908224106
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 1.0
centre O 1 0.9995884299278259
mutations O 0 0.08181975036859512
. O 0 0.04510281980037689

Imprinting O 0 0.13579240441322327
in O 0 0.023393994197249413
the O 0 0.03506065160036087
15q11 O 1 0.9999154806137085
- O 1 0.9999598264694214
q13 O 1 0.9676293134689331
region O 0 0.02510746382176876
involves O 0 0.021989502012729645
an O 0 0.020365983247756958
imprinting O 1 0.9999368190765381
centre O 1 0.9997043013572693
( O 1 0.8298134207725525
IC O 1 0.9999964237213135
) O 0 0.020926062017679214
, O 0 0.015294386073946953
mapping O 0 0.020191531628370285
in O 0 0.009638620540499687
part O 0 0.015921492129564285
to O 0 0.013168168254196644
the O 0 0.022104837000370026
promoter O 1 0.5586631894111633
and O 0 0.020172519609332085
first O 0 0.028567910194396973
exon O 0 0.15040697157382965
of O 0 0.048869259655475616
SNRPN O 1 0.9999130964279175
. O 0 0.0671822652220726

Deletion O 0 0.10290679335594177
of O 0 0.03649904578924179
this O 0 0.0317423939704895
IC O 1 0.9997907280921936
abolishes O 1 0.9986808896064758
local O 0 0.037881698459386826
paternally O 0 0.10435666143894196
derived O 0 0.027481142431497574
gene O 0 0.022057492285966873
expression O 0 0.015610558912158012
and O 0 0.010656080208718777
results O 0 0.01315287221223116
in O 0 0.02786971814930439
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999984502792358
PWS B-Disease 1 1.0
) O 0 0.10649918019771576
. O 0 0.05402768403291702

We O 0 0.025882774963974953
have O 0 0.011114804074168205
created O 0 0.01938238926231861
two O 0 0.015083052217960358
deletion O 0 0.17063425481319427
mutations O 0 0.03343723714351654
in O 0 0.017756463959813118
mice O 0 0.03598310053348541
to O 0 0.02281777188181877
understand O 0 0.05592166259884834
PWS B-Disease 1 1.0
and O 0 0.023796958848834038
the O 0 0.02571575529873371
mechanism O 0 0.04143569990992546
of O 0 0.025811493396759033
this O 0 0.03116176277399063
IC O 1 0.9999167919158936
. O 0 0.04916428029537201

Mice O 0 0.17046937346458435
harbouring O 1 0.994293212890625
an O 0 0.048099663108587265
intragenic O 1 0.9994210004806519
deletion O 0 0.14788027107715607
in O 0 0.029025770723819733
Snrpn O 1 0.9997469782829285
are O 0 0.01729481853544712
phenotypically O 1 0.6033715009689331
normal O 0 0.029750511050224304
, O 0 0.01797635853290558
suggesting O 0 0.020940575748682022
that O 0 0.012182260863482952
mutations O 0 0.025517771020531654
of O 0 0.02530171163380146
SNRPN O 1 0.9999780654907227
are O 0 0.0136627908796072
not O 0 0.014756760559976101
sufficient O 0 0.031082652509212494
to O 0 0.04082711786031723
induce O 1 0.9995635151863098
PWS B-Disease 1 0.9999994039535522
. O 0 0.08446011692285538

Mice O 0 0.07257422804832458
with O 0 0.02201484702527523
a O 0 0.025348523631691933
larger O 0 0.02568286657333374
deletion O 0 0.04734325408935547
involving O 0 0.025170456618070602
both O 0 0.018571756780147552
Snrpn O 1 0.9851683378219604
and O 0 0.018284613266587257
the O 0 0.031542304903268814
putative O 1 0.9999899864196777
PWS O 1 1.0
- O 1 1.0
IC O 1 0.999981164932251
lack O 0 0.03609519079327583
expression O 0 0.020593037828803062
of O 0 0.016381504014134407
the O 0 0.025598620995879173
imprinted O 1 0.9979946613311768
genes O 0 0.03461962938308716
Zfp127 O 1 0.9991819262504578
( O 0 0.031233567744493484
mouse O 0 0.04591142013669014
homologue O 0 0.09149536490440369
of O 0 0.037107110023498535
ZNF127 O 1 0.9999668598175049
) O 0 0.03249233961105347
, O 0 0.034465763717889786
Ndn O 1 0.9999229907989502
and O 0 0.03595791384577751
Ipw O 1 0.9941189289093018
, O 0 0.023907380178570747
and O 0 0.019167503342032433
manifest O 0 0.06048499420285225
several O 0 0.020558826625347137
phenotypes O 1 0.5219095945358276
common O 0 0.04702254384756088
to O 1 0.8776421546936035
PWS B-Disease 1 1.0
infants O 1 0.9999895095825195
. O 0 0.07683124393224716

These O 0 0.0265938900411129
data O 0 0.016698714345693588
demonstrate O 0 0.020486069843173027
that O 0 0.008136107586324215
both O 0 0.008182351477444172
the O 0 0.012295323424041271
position O 0 0.017254037782549858
of O 0 0.015981903299689293
the O 0 0.030679024755954742
IC O 1 0.9998869895935059
and O 0 0.014394568279385567
its O 0 0.012469378300011158
role O 0 0.017873330041766167
in O 0 0.009582415223121643
the O 0 0.014789609238505363
coordinate O 0 0.031105514615774155
expression O 0 0.019599037244915962
of O 0 0.015141298994421959
genes O 0 0.014168602414429188
is O 0 0.010930350050330162
conserved O 0 0.020493311807513237
between O 0 0.018023261800408363
mouse O 0 0.07362504303455353
and O 0 0.016927095130085945
human O 0 0.02218782901763916
, O 0 0.014473062939941883
and O 0 0.01234887633472681
indicate O 0 0.01358568761497736
that O 0 0.007697799243032932
the O 0 0.016312582418322563
mouse O 0 0.035478439182043076
is O 0 0.013373230583965778
a O 0 0.019744880497455597
suitable O 0 0.03138251230120659
model O 0 0.024449899792671204
system O 0 0.01652606949210167
in O 0 0.009411371313035488
which O 0 0.008153868839144707
to O 0 0.010547647252678871
investigate O 0 0.027311664074659348
the O 0 0.018494315445423126
molecular O 0 0.022898094728589058
mechanisms O 0 0.020823700353503227
of O 0 0.02102084457874298
imprinting O 1 0.9742627739906311
in O 0 0.014037606306374073
this O 0 0.010051826946437359
region O 0 0.01969524845480919
of O 0 0.016715914011001587
the O 0 0.02935895137488842
genome O 0 0.04511573538184166
. O 0 0.02604784443974495
. O 0 0.034960683435201645

Mutations O 0 0.05175270885229111
of O 0 0.025369631126523018
the O 0 0.03189026936888695
ATM O 0 0.43306729197502136
gene O 0 0.028074409812688828
detected O 0 0.022247064858675003
in O 0 0.014779184013605118
Japanese O 1 0.6399430632591248
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999330043792725
: O 0 0.031389620155096054
possible O 0 0.022682461887598038
preponderance O 1 0.6560025811195374
of O 0 0.018402529880404472
the O 0 0.02124229446053505
two O 0 0.02292455919086933
founder O 1 0.9988710284233093
mutations O 0 0.0770086720585823
4612del165 O 1 0.9941787719726562
and O 0 0.05819407477974892
7883del5 O 1 0.9923741221427917
. O 0 0.06382209062576294

The O 0 0.04845372959971428
ATM O 0 0.456451416015625
( O 0 0.032420456409454346
A O 1 0.9979148507118225
- O 1 0.9999997615814209
T O 1 0.9999978542327881
, O 0 0.027383306995034218
mutated O 0 0.07314302772283554
) O 0 0.01913158781826496
gene O 0 0.021354077383875847
on O 0 0.01894102804362774
human O 0 0.03804925084114075
chromosome O 0 0.09610626846551895
11q22 O 1 0.974763810634613
. O 0 0.058942683041095734

3 O 0 0.04847149923443794
has O 0 0.025453299283981323
recently O 0 0.025811342522501945
been O 0 0.012775433249771595
identified O 0 0.014683826826512814
as O 0 0.009966740384697914
the O 0 0.013621911406517029
gene O 0 0.015543704852461815
responsible O 0 0.014116066507995129
for O 0 0.008793435990810394
the O 0 0.01552850753068924
human O 0 0.48415887355804443
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9711489677429199
A B-Disease 1 0.9999927282333374
- I-Disease 1 1.0
T I-Disease 1 0.9999972581863403
) O 0 0.040709055960178375
. O 0 0.03715997189283371

In O 0 0.027310682460665703
order O 0 0.022006936371326447
to O 0 0.015557931736111641
define O 0 0.022209584712982178
the O 0 0.014660168439149857
types O 0 0.016195325180888176
of O 0 0.254397988319397
disease O 1 1.0
- O 1 1.0
causing O 1 0.999931812286377
ATM O 1 0.9843988418579102
mutations O 0 0.018610510975122452
in O 0 0.009719843044877052
Japanese O 0 0.033611178398132324
A B-Disease 1 0.9999285936355591
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9981472492218018
as O 0 0.01815749704837799
well O 0 0.0132597042247653
as O 0 0.013393516652286053
to O 0 0.013204424642026424
look O 0 0.017937956377863884
for O 0 0.014153578318655491
possible O 0 0.027299141511321068
mutational O 1 0.9984466433525085
hotspots O 1 0.959952712059021
, O 0 0.025416169315576553
reverse O 0 0.05438666418194771
- O 1 0.999321699142456
transcribed O 0 0.047052204608917236
RNA O 0 0.033605001866817474
derived O 0 0.013711654581129551
from O 0 0.012083751149475574
ten O 0 0.02602076530456543
patients O 0 0.09281889349222183
belonging O 0 0.027235591784119606
to O 0 0.01365447137504816
eight O 0 0.016912732273340225
unrelated O 0 0.028958696871995926
Japanese O 0 0.04165248945355415
A B-Disease 1 0.99979168176651
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999951124191284
families O 0 0.024870680645108223
was O 0 0.023931104689836502
analyzed O 0 0.01966995932161808
for O 0 0.014016550034284592
mutations O 0 0.019450901076197624
by O 0 0.015981221571564674
the O 0 0.030157389119267464
restriction O 0 0.07084452360868454
endonuclease O 1 0.9903301000595093
fingerprinting O 0 0.10593496263027191
method O 0 0.04810614511370659
. O 0 0.043325379490852356

As O 0 0.037350211292505264
has O 0 0.020138535648584366
been O 0 0.013943536207079887
reported O 0 0.016750333830714226
by O 0 0.013506824150681496
others O 0 0.017075760290026665
, O 0 0.016303976997733116
mutations O 0 0.017411423847079277
that O 0 0.008844365365803242
lead O 0 0.019989481195807457
to O 0 0.01848018541932106
exon O 1 0.5630297064781189
skipping O 0 0.32001203298568726
or O 0 0.029325447976589203
premature O 1 0.9995280504226685
protein O 0 0.03482194244861603
truncation O 0 0.06873007118701935
were O 0 0.014357460662722588
also O 0 0.017004571855068207
predominant O 0 0.04273296520113945
in O 0 0.01941606029868126
our O 0 0.037469569593667984
mutants O 1 0.5105070471763611
. O 0 0.05101710930466652

Six O 0 0.03953908383846283
different O 0 0.017826208844780922
mutations O 0 0.028585422784090042
were O 0 0.01224049087613821
identified O 0 0.016638312488794327
on O 0 0.011250383220613003
12 O 0 0.014655236154794693
of O 0 0.015265285037457943
the O 0 0.027526991441845894
16 O 0 0.04516254737973213
alleles O 0 0.07260513305664062
examined O 0 0.07736686617136002
. O 0 0.05204667150974274

Four O 0 0.03531164303421974
were O 0 0.02352014183998108
deletions O 0 0.05435130372643471
involving O 0 0.028151385486125946
a O 0 0.023458778858184814
loss O 0 0.02745184302330017
of O 0 0.018584879115223885
a O 0 0.028180433437228203
single O 0 0.04700857028365135
exon O 1 0.8586843013763428
exon O 0 0.10265227407217026
7 O 0 0.03565129265189171
, O 0 0.025091037154197693
exon O 0 0.07472427189350128
16 O 0 0.029693497344851494
, O 0 0.02618834562599659
exon O 0 0.08705057948827744
33 O 0 0.052794575691223145
or O 0 0.033674728125333786
exon O 0 0.11608175933361053
35 O 0 0.06740055233240128
. O 0 0.05204842984676361

The O 0 0.0439787395298481
others O 0 0.024988362565636635
were O 0 0.01634949818253517
minute O 0 0.03818759322166443
deletions O 0 0.062267471104860306
, O 0 0.02769496850669384
4649delA O 0 0.26903125643730164
in O 0 0.02391776442527771
exon O 0 0.09741677343845367
33 O 0 0.04683167114853859
and O 0 0.03165622055530548
7883del5 O 1 0.7258857488632202
in O 0 0.03250688314437866
exon O 0 0.1454721838235855
55 O 0 0.07322249561548233
. O 0 0.05209852755069733

The O 0 0.06043403968214989
mutations O 0 0.0788172259926796
4612del165 O 1 0.9984631538391113
and O 0 0.03405344858765602
7883del5 O 1 0.9979220032691956
were O 0 0.013209053315222263
found O 0 0.010519462637603283
in O 0 0.007594536989927292
more O 0 0.006381483748555183
than O 0 0.006744906306266785
two O 0 0.009143773466348648
unrelated O 0 0.02571314387023449
families O 0 0.021166305989027023
; O 0 0.018421299755573273
44 O 0 0.02957852929830551
% O 0 0.018890928477048874
( O 0 0.016296355053782463
7 O 0 0.018493639305233955
of O 0 0.013531332835555077
16 O 0 0.017013326287269592
) O 0 0.01122894138097763
of O 0 0.011849970556795597
the O 0 0.023111816495656967
mutant O 1 0.922254741191864
alleles O 0 0.04208436608314514
had O 0 0.017339441925287247
one O 0 0.012680849060416222
of O 0 0.015343669801950455
the O 0 0.022995058447122574
two O 0 0.025353264063596725
mutations O 0 0.04758552834391594
. O 0 0.04034603759646416

The O 0 0.07278921455144882
4612del165 O 1 0.998893678188324
mutations O 0 0.04135556146502495
in O 0 0.01421450637280941
three O 0 0.011189990676939487
different O 0 0.007287641987204552
families O 0 0.0131477490067482
were O 0 0.008908528834581375
all O 0 0.010477803647518158
ascribed O 0 0.029239052906632423
to O 0 0.0106144854798913
the O 0 0.013810331001877785
same O 0 0.017350882291793823
T O 1 0.999985933303833
- O 1 0.9999982118606567
- O 1 0.9999769926071167
> O 0 0.1879393756389618
A O 0 0.02646855264902115
substitution O 0 0.029333429411053658
at O 0 0.017509467899799347
the O 0 0.023484354838728905
splice O 0 0.13117483258247375
donor O 0 0.06140587106347084
site O 0 0.03788067772984505
in O 0 0.027753785252571106
intron O 1 0.9945603013038635
33 O 0 0.07586626708507538
. O 0 0.05036667734384537

Microsatellite O 1 0.9278947114944458
genotyping O 0 0.278109610080719
around O 0 0.03212564438581467
the O 0 0.034812118858098984
ATM O 1 0.9920861124992371
locus O 0 0.25054213404655457
also O 0 0.016681497916579247
indicated O 0 0.016797291114926338
that O 0 0.008363108150660992
a O 0 0.01711561344563961
common O 0 0.02338653989136219
haplotype O 1 0.5162190198898315
was O 0 0.02360098622739315
shared O 0 0.019814712926745415
by O 0 0.014287566766142845
the O 0 0.024626387283205986
mutant O 1 0.6831789612770081
alleles O 0 0.0516095794737339
in O 0 0.02231670171022415
both O 0 0.031027313321828842
mutations O 0 0.05908874422311783
. O 0 0.045160699635744095

This O 0 0.029715420678257942
suggests O 0 0.02591537870466709
that O 0 0.01019149087369442
these O 0 0.007381128612905741
two O 0 0.014912947081029415
founder O 1 0.9986893534660339
mutations O 0 0.0424206405878067
may O 0 0.018763769418001175
be O 0 0.013149518519639969
predominant O 0 0.03973865136504173
among O 0 0.02704218588769436
Japanese O 0 0.0685797855257988
ATM O 1 0.9853876233100891
mutant O 1 0.8469676971435547
alleles O 0 0.10341725498437881
. O 0 0.05225221812725067

W474C O 1 0.9845573902130127
amino O 0 0.09700408577919006
acid O 0 0.12553702294826508
substitution O 0 0.0613529309630394
affects O 0 0.039489734917879105
early O 0 0.016775798052549362
processing O 0 0.011601445265114307
of O 0 0.01000920869410038
the O 0 0.014478275552392006
alpha O 0 0.059403013437986374
- O 1 0.6083928346633911
subunit O 0 0.03046436794102192
of O 0 0.017658842727541924
beta O 1 0.8035226464271545
- O 1 0.9997764229774475
hexosaminidase O 1 0.9959104061126709
A O 0 0.02789059281349182
and O 0 0.013480615802109241
is O 0 0.01230083778500557
associated O 0 0.01844378188252449
with O 0 0.034334924072027206
subacute O 1 1.0
G B-Disease 1 0.9999997615814209
( I-Disease 1 0.963034451007843
M2 I-Disease 1 0.999980092048645
) I-Disease 0 0.05316658318042755
gangliosidosis I-Disease 1 0.9797034859657288
. O 0 0.05227699875831604

Mutations O 0 0.05734386295080185
in O 0 0.02149241231381893
the O 0 0.038252200931310654
HEXA O 1 0.9999974966049194
gene O 0 0.029675479978322983
, O 0 0.014649867080152035
encoding O 0 0.01523001678287983
the O 0 0.014880835078656673
alpha O 0 0.050601836293935776
- O 0 0.11085991561412811
subunit O 0 0.034254442900419235
of O 0 0.018811659887433052
beta O 0 0.17870590090751648
- O 1 0.9996508359909058
hexosaminidase O 1 0.9990122318267822
A O 0 0.04903722181916237
( O 0 0.03037448227405548
Hex O 1 0.8015117049217224
A O 0 0.03405504673719406
) O 0 0.015956073999404907
, O 0 0.010665584355592728
that O 0 0.00864978227764368
abolish O 0 0.043580323457717896
Hex O 0 0.08032528311014175
A O 0 0.0338447205722332
enzyme O 0 0.038663242012262344
activity O 0 0.02738884463906288
cause O 1 0.9984183311462402
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9858065843582153
TSD B-Disease 1 0.9999998807907104
) O 0 0.021862566471099854
, O 0 0.014599827118217945
the O 0 0.02133522741496563
fatal O 1 0.999975323677063
infantile B-Disease 1 0.9999998807907104
form I-Disease 1 0.7010780572891235
of I-Disease 1 0.9981181621551514
G I-Disease 1 0.9999991655349731
( I-Disease 1 0.5027528405189514
M2 I-Disease 1 0.9999384880065918
) I-Disease 0 0.03559534624218941
gangliosidosis I-Disease 1 0.9869248867034912
, I-Disease 0 0.03857296332716942
Type I-Disease 0 0.06567246466875076
1 I-Disease 0 0.05083377659320831
. O 0 0.042732223868370056

Less O 0 0.05153694748878479
severe O 1 0.9989033937454224
, O 0 0.3681737184524536
subacute O 1 1.0
( O 1 0.9822747707366943
juvenile O 1 0.9999998807907104
- O 1 1.0
onset O 1 1.0
) O 0 0.16749127209186554
and O 1 0.5119322538375854
chronic O 1 1.0
( O 1 0.9616445302963257
adult O 1 0.999903678894043
- O 1 1.0
onset O 1 1.0
) O 0 0.03238028287887573
variants O 0 0.021715249866247177
are O 0 0.0075363945215940475
characterized O 0 0.019452067092061043
by O 0 0.01272867526859045
a O 0 0.019761452451348305
broad O 0 0.042303312569856644
spectrum O 0 0.04159850254654884
of O 0 0.043903034180402756
clinical O 1 0.9999897480010986
manifestations O 1 0.9999988079071045
and O 0 0.08891397714614868
are O 0 0.009303219616413116
associated O 0 0.01590474136173725
with O 0 0.015097239054739475
residual O 1 0.958218514919281
levels O 0 0.024113936349749565
of O 0 0.02709737792611122
Hex O 1 0.9992284774780273
A O 1 0.904356062412262
enzyme O 0 0.3471759557723999
activity O 0 0.048221156001091
. O 0 0.040600910782814026

We O 0 0.0249717328697443
identified O 0 0.026591304689645767
a O 0 0.032968226820230484
1422 O 1 0.9995597004890442
G O 1 0.9998202919960022
- O 1 0.9999953508377075
- O 1 0.99998939037323
> O 1 0.9976294636726379
C O 1 0.9465057849884033
( O 0 0.03810417652130127
amino O 0 0.04767691344022751
acid O 0 0.0921279564499855
W474C O 1 0.9299846887588501
) O 0 0.022301722317934036
substitution O 0 0.026591850444674492
in O 0 0.00966440886259079
the O 0 0.01210442278534174
first O 0 0.014791521243751049
position O 0 0.017264574766159058
of O 0 0.017568502575159073
exon O 0 0.05966833606362343
13 O 0 0.024379737675189972
of O 0 0.026174703612923622
HEXA O 1 0.9998643398284912
of O 0 0.022934259846806526
a O 0 0.028342951089143753
non O 0 0.2535097897052765
- O 1 0.9992119073867798
Jewish O 0 0.05743446946144104
proband O 1 0.9873800277709961
who O 0 0.03270835429430008
manifested O 1 0.9313496947288513
a O 0 0.07761769741773605
subacute O 1 0.9999998807907104
variant O 1 0.9802021384239197
of O 1 0.8017262816429138
G B-Disease 1 0.9999977350234985
( I-Disease 0 0.351138710975647
M2 I-Disease 1 0.9998573064804077
) I-Disease 0 0.05188889428973198
gangliosidosis I-Disease 1 0.543185830116272
. O 0 0.05390986427664757

On O 0 0.028631754219532013
the O 0 0.02639828622341156
second O 0 0.053416602313518524
maternally O 1 0.9970418810844421
inherited O 1 0.999847412109375
allele O 0 0.15272659063339233
, O 0 0.016756350174546242
we O 0 0.008915510959923267
identified O 0 0.013136184774339199
the O 0 0.01563715748488903
common O 0 0.16392239928245544
infantile O 1 1.0
disease O 1 1.0
- O 1 1.0
causing O 1 0.9999063014984131
4 O 1 0.6773015856742859
- O 1 0.9999227523803711
bp O 0 0.07127408683300018
insertion O 0 0.06920477747917175
, O 0 0.03648120537400246
+ O 1 0.9042426943778992
TATC O 1 0.9998960494995117
1278 O 1 0.9989305138587952
, O 0 0.031705934554338455
in O 0 0.026022743433713913
exon O 0 0.11039602011442184
11 O 0 0.05361122265458107
. O 0 0.04575967416167259

Pulse O 1 0.9974651336669922
- O 1 0.9986966252326965
chase O 0 0.07594674080610275
analysis O 0 0.023909173905849457
using O 0 0.023345138877630234
proband O 1 0.9852576851844788
fibroblasts O 0 0.3404107987880707
revealed O 0 0.02832689881324768
that O 0 0.00965457409620285
the O 0 0.0188596248626709
W474C O 1 0.988416850566864
- O 1 0.9611724019050598
containing O 0 0.02802409417927265
alpha O 0 0.0763820931315422
- O 1 0.9922818541526794
subunit O 0 0.06932573020458221
precursor O 0 0.0532236248254776
was O 0 0.02678358182311058
normally O 0 0.02204381674528122
synthesized O 0 0.03209826350212097
, O 0 0.013458585366606712
but O 0 0.009080312214791775
not O 0 0.012258837930858135
phosphorylated O 1 0.7499156594276428
or O 0 0.01818217895925045
secreted O 0 0.036987531930208206
, O 0 0.011929676868021488
and O 0 0.010270104743540287
the O 0 0.016662413254380226
mature O 0 0.2130441516637802
lysosomal O 1 0.9999970197677612
alpha O 1 0.9998584985733032
- O 1 0.9999881982803345
subunit O 0 0.21177037060260773
was O 0 0.037147391587495804
not O 0 0.021214313805103302
detected O 0 0.049682799726724625
. O 0 0.0362994559109211

When O 0 0.031640201807022095
the O 0 0.02803153358399868
W474C O 1 0.9901112914085388
- O 1 0.9929141998291016
containing O 0 0.028416870161890984
alpha O 0 0.12885639071464539
- O 1 0.9854347705841064
subunit O 0 0.05613606050610542
was O 0 0.03439788520336151
transiently O 1 0.8647412061691284
co O 1 0.8452443480491638
- O 1 0.7902854084968567
expressed O 0 0.017401637509465218
with O 0 0.010877135209739208
the O 0 0.01776428334414959
beta O 1 0.8474547266960144
- O 1 0.9901238083839417
subunit O 0 0.04346618056297302
to O 0 0.013600043021142483
produce O 0 0.01686330884695053
Hex O 0 0.07483995705842972
A O 0 0.03443819656968117
( O 0 0.025363247841596603
alphabeta O 1 0.5432613492012024
) O 0 0.018333300948143005
in O 0 0.020333558320999146
COS O 1 0.9999990463256836
- O 1 0.9999831914901733
7 O 0 0.03464566916227341
cells O 0 0.017576636746525764
, O 0 0.009719324298202991
the O 0 0.012685487978160381
mature O 0 0.03564581647515297
alpha O 1 0.8645856976509094
- O 1 0.999749481678009
subunit O 0 0.06118074804544449
was O 0 0.022836854681372643
present O 0 0.015613052062690258
, O 0 0.011510927230119705
but O 0 0.00836759340018034
its O 0 0.011465602554380894
level O 0 0.017505785450339317
was O 0 0.017942341044545174
much O 0 0.010783483274281025
lower O 0 0.013845914043486118
than O 0 0.006022856570780277
that O 0 0.005391799379140139
from O 0 0.008002578280866146
normal O 0 0.020379669964313507
alpha O 1 0.7462878227233887
- O 1 0.9998387098312378
subunit O 0 0.20579734444618225
transfections O 1 0.8706227540969849
, O 0 0.016166655346751213
although O 0 0.010497858747839928
higher O 0 0.01018159743398428
than O 0 0.0066259922459721565
in O 0 0.008400503545999527
those O 0 0.011560465209186077
cells O 0 0.02366841584444046
transfected O 0 0.0881766825914383
with O 0 0.012310897931456566
an O 0 0.01763182133436203
alpha O 1 0.9520502686500549
- O 1 0.9996198415756226
subunit O 0 0.07208860665559769
associated O 0 0.027681225910782814
with O 0 0.03744979947805405
infantile O 1 0.9999996423721313
TSD B-Disease 1 0.9999994039535522
. O 0 0.09213364869356155

Furthermore O 0 0.06251874566078186
, O 0 0.022929493337869644
the O 0 0.021270018070936203
precursor O 0 0.037788018584251404
level O 0 0.01651396043598652
of O 0 0.013292749412357807
the O 0 0.02247806079685688
W474C O 1 0.9998855590820312
alpha O 1 0.9963576197624207
- O 1 0.9997937083244324
subunit O 0 0.06116464361548424
was O 0 0.024250267073512077
found O 0 0.011873533949255943
to O 0 0.013767147436738014
accumulate O 0 0.031163014471530914
in O 0 0.009785660542547703
comparison O 0 0.013246559537947178
to O 0 0.009724295698106289
the O 0 0.014892310835421085
normal O 0 0.029021477326750755
alpha O 1 0.8411394357681274
- O 1 0.9998227953910828
subunit O 0 0.1946428269147873
precursor O 0 0.09519775211811066
levels O 0 0.050429295748472214
. O 0 0.044717855751514435

We O 0 0.02750840224325657
conclude O 0 0.031970810145139694
that O 0 0.010541621595621109
the O 0 0.02236335724592209
1422 O 1 0.9995827078819275
G O 1 0.9999465942382812
- O 1 0.9999984502792358
- O 1 0.9999986886978149
> O 1 0.9996131062507629
C O 1 0.9917861819267273
mutation O 0 0.03577549755573273
is O 0 0.011962022632360458
the O 0 0.013782888650894165
cause O 0 0.024523144587874413
of O 0 0.025338079780340195
Hex B-Disease 1 0.9997977614402771
A I-Disease 1 0.9999212026596069
enzyme I-Disease 1 0.9999985694885254
deficiency I-Disease 1 1.0
in O 0 0.037264157086610794
the O 0 0.10625846683979034
proband O 1 0.9998267292976379
. O 0 0.06258968263864517

The O 0 0.05901884287595749
resulting O 0 0.060933273285627365
W474C O 1 0.9248318672180176
substitution O 0 0.06572126597166061
clearly O 0 0.030009593814611435
interferes O 0 0.05638747289776802
with O 0 0.02048799768090248
alpha O 1 0.9826595783233643
- O 1 0.9999173879623413
subunit O 0 0.07222104072570801
processing O 0 0.02204545959830284
, O 0 0.01281525194644928
but O 0 0.009753636084496975
because O 0 0.009962049312889576
the O 0 0.01569690741598606
base O 0 0.03714970126748085
substitution O 0 0.043062418699264526
falls O 0 0.05577854812145233
at O 0 0.015732236206531525
the O 0 0.011774031445384026
first O 0 0.014209995977580547
position O 0 0.01785275898873806
of O 0 0.017446070909500122
exon O 0 0.07589328289031982
13 O 0 0.02819606103003025
, O 0 0.026738421991467476
aberrant O 1 0.9948369264602661
splicing O 0 0.048335280269384384
may O 0 0.013947679661214352
also O 0 0.01071733608841896
contribute O 0 0.01779741235077381
to O 0 0.01944565214216709
Hex B-Disease 1 0.9996545314788818
A I-Disease 1 0.9998602867126465
deficiency I-Disease 1 1.0
in O 0 0.027901606634259224
this O 0 0.026050612330436707
proband O 1 0.9992177486419678
. O 0 0.033994272351264954
. O 0 0.04059849679470062

Two O 0 0.03443369269371033
frequent O 0 0.07791844010353088
missense O 1 0.8705111742019653
mutations O 0 0.09902313351631165
in O 0 0.16162839531898499
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.8986426591873169

Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
is O 0 0.13800598680973053
an O 1 0.9980756044387817
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999995231628418
by O 1 0.99854576587677
early O 1 0.9999806880950928
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999994039535522
goiter B-Disease 1 1.0
. O 1 0.995421826839447

A O 0 0.05405838415026665
century O 0 0.04213785380125046
after O 0 0.023502623662352562
its O 0 0.014971897006034851
recognition O 0 0.021938184276223183
as O 0 0.019802555441856384
a O 0 0.26316630840301514
syndrome O 1 0.9999997615814209
by O 0 0.029991179704666138
Vaughan O 1 0.9999473094940186
Pendred O 1 0.999977707862854
, O 0 0.027587400749325752
the O 0 0.23042896389961243
disease O 1 0.9999997615814209
gene O 1 0.9646489024162292
( O 0 0.29389163851737976
PDS O 1 0.9999970197677612
) O 0 0.025128202512860298
was O 0 0.025514017790555954
mapped O 0 0.03412841260433197
to O 0 0.02633330039680004
chromosome O 0 0.08306504786014557
7q22 O 1 0.9987626075744629
- O 1 0.9998747110366821
q31 O 1 0.9816569089889526
. O 0 0.0648585855960846

1 O 0 0.06287776678800583
and O 0 0.02924000844359398
, O 0 0.023985708132386208
recently O 0 0.02931881695985794
, O 0 0.015409511514008045
found O 0 0.011757053434848785
to O 0 0.014414009638130665
encode O 0 0.029874060302972794
a O 0 0.04446900635957718
putative O 1 0.997954249382019
sulfate O 1 0.9999402761459351
transporter O 1 0.9979263544082642
. O 0 0.06722314655780792

We O 0 0.03906949982047081
performed O 0 0.04315675050020218
mutation O 0 0.032278165221214294
analysis O 0 0.011180334724485874
of O 0 0.015388834290206432
the O 0 0.031053723767399788
PDS B-Disease 1 0.9999997615814209
gene O 0 0.03478771820664406
in O 0 0.01700994372367859
patients O 0 0.17793454229831696
from O 0 0.01942969299852848
14 O 0 0.03601403161883354
Pendred B-Disease 1 0.9986467957496643
families O 0 0.027674566954374313
originating O 0 0.028287068009376526
from O 0 0.01167840976268053
seven O 0 0.014000486582517624
countries O 0 0.010865690186619759
and O 0 0.015094077214598656
identified O 0 0.02492406778037548
all O 0 0.021822361275553703
mutations O 0 0.04507379233837128
. O 0 0.04051456227898598

The O 0 0.05034179985523224
mutations O 0 0.03962833061814308
include O 0 0.01851065643131733
three O 0 0.01517447642982006
single O 0 0.031171446666121483
base O 0 0.039462488144636154
deletions O 0 0.04750644043087959
, O 0 0.01886484958231449
one O 0 0.020565127953886986
splice O 0 0.07886697351932526
site O 0 0.038281962275505066
mutation O 0 0.0375581718981266
and O 0 0.021931717172265053
10 O 0 0.035179365426301956
missense O 0 0.2199726551771164
mutations O 0 0.06849564611911774
. O 0 0.047761328518390656

One O 0 0.05400238186120987
missense O 1 0.5431037545204163
mutation O 0 0.14774949848651886
( O 0 0.04471487179398537
L236P O 1 0.9982554316520691
) O 0 0.02275269292294979
was O 0 0.019277755171060562
found O 0 0.009351872839033604
in O 0 0.008566196076571941
a O 0 0.01527852937579155
homozygous O 0 0.029169566929340363
state O 0 0.01135013997554779
in O 0 0.011348669417202473
two O 0 0.016262348741292953
consanguineous O 1 0.9949228167533875
families O 0 0.025458307936787605
and O 0 0.014969329349696636
in O 0 0.012956949882209301
a O 0 0.018197443336248398
heterozygous O 0 0.02819633111357689
state O 0 0.009090250357985497
in O 0 0.008947464637458324
five O 0 0.012892055325210094
additional O 0 0.020542031154036522
non O 1 0.6856710314750671
- O 1 0.9999768733978271
consanguineous O 1 0.9993956089019775
families O 0 0.06154076009988785
. O 0 0.05179718881845474

Another O 0 0.06663812696933746
missense O 1 0.9000683426856995
mutation O 1 0.7373621463775635
( O 0 0.04786955192685127
T416P O 1 0.9996564388275146
) O 0 0.02072681300342083
was O 0 0.01834067516028881
found O 0 0.009268372319638729
in O 0 0.008330254815518856
a O 0 0.015190012753009796
homozygous O 0 0.029048113152384758
state O 0 0.010070255026221275
in O 0 0.01046692207455635
one O 0 0.014169854111969471
family O 0 0.021393591538071632
and O 0 0.012536359019577503
in O 0 0.011326951906085014
a O 0 0.019623862579464912
heterozygous O 0 0.03231995180249214
state O 0 0.01396679226309061
in O 0 0.015112888999283314
four O 0 0.021900171414017677
families O 0 0.041057225316762924
. O 0 0.045325953513383865

Pendred B-Disease 1 0.998958945274353
patients O 0 0.23422332108020782
in O 0 0.022450154647231102
three O 0 0.027110157534480095
non O 1 0.9805797934532166
- O 1 0.9999958276748657
consanguineous O 1 0.999382495880127
families O 0 0.03427503630518913
were O 0 0.015343237668275833
shown O 0 0.016076084226369858
to O 0 0.015224561095237732
be O 0 0.018063824623823166
compound O 0 0.05846269056200981
heterozygotes O 0 0.26393362879753113
for O 0 0.0370747335255146
L236P O 1 0.9986280202865601
and O 0 0.05475644767284393
T416P O 1 0.9923127293586731
. O 0 0.061969343572854996

In O 0 0.026138046756386757
total O 0 0.02262027934193611
, O 0 0.01804911345243454
one O 0 0.014779394492506981
or O 0 0.011145963333547115
both O 0 0.009263460524380207
of O 0 0.013958368450403214
these O 0 0.011157683096826077
mutations O 0 0.01851513423025608
were O 0 0.008341684937477112
found O 0 0.008916017599403858
in O 0 0.007482036016881466
nine O 0 0.013501528650522232
of O 0 0.014608446508646011
the O 0 0.022494442760944366
14 O 0 0.03646641969680786
families O 0 0.0364118330180645
analyzed O 0 0.04552832618355751
. O 0 0.04006337374448776

The O 0 0.03527483716607094
identification O 0 0.027079865336418152
of O 0 0.017946431413292885
two O 0 0.019637886434793472
frequent O 1 0.6343008279800415
PDS B-Disease 1 0.9999995231628418
mutations O 0 0.04385220631957054
will O 0 0.01793719083070755
facilitate O 0 0.029506461694836617
the O 0 0.026667917147278786
molecular O 0 0.05902301147580147
diagnosis O 1 0.9999810457229614
of O 1 0.9998014569282532
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.823879599571228

Insertional O 1 0.9748767614364624
mutation O 0 0.07332860678434372
by O 0 0.03722936660051346
transposable O 1 0.9994454979896545
element O 0 0.19456008076667786
, O 0 0.032977763563394547
L1 O 1 0.9989142417907715
, O 0 0.016705015674233437
in O 0 0.012242152355611324
the O 0 0.024787643924355507
DMD B-Disease 1 0.9999996423721313
gene O 0 0.026626186445355415
results O 0 0.014127719216048717
in O 0 0.019480424001812935
X B-Disease 1 0.9997214674949646
- I-Disease 1 0.9999994039535522
linked I-Disease 1 0.9999330043792725
dilated I-Disease 1 0.9999997615814209
cardiomyopathy I-Disease 1 1.0
. O 1 0.5213110446929932

X B-Disease 1 0.9979984164237976
- I-Disease 1 0.9999945163726807
linked I-Disease 1 0.9998626708984375
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 1 0.9990293979644775
XLDCM B-Disease 1 0.9999997615814209
) O 0 0.03157687559723854
is O 0 0.01787102222442627
a O 0 0.025281935930252075
clinical O 1 0.8692363500595093
phenotype O 1 0.8945465087890625
of O 0 0.03636859357357025
dystrophinopathy B-Disease 1 0.9999856948852539
which O 0 0.01966528594493866
is O 0 0.01668635569512844
characterized O 0 0.0314372293651104
by O 0 0.030044175684452057
preferential O 1 0.9999880790710449
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.999618649482727
without O 0 0.02229558862745762
any O 0 0.01971564069390297
overt O 1 0.9937757253646851
clinical O 1 0.9995691180229187
signs O 1 0.9987732768058777
of O 1 0.9999545812606812
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9437748789787292

To O 0 0.030855854973196983
date O 0 0.02384600229561329
, O 0 0.013014668598771095
several O 0 0.008528849110007286
mutations O 0 0.017367621883749962
in O 0 0.012179942801594734
the O 0 0.0925866961479187
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999899864196777
, O 1 0.9998406171798706
DMD O 1 1.0
, O 0 0.025937987491488457
have O 0 0.00972802098840475
been O 0 0.011274149641394615
identified O 0 0.015566598623991013
in O 0 0.01429628673940897
patients O 1 0.6088137030601501
with O 0 0.02616763487458229
XLDCM B-Disease 1 0.9999978542327881
, O 0 0.019899597391486168
but O 0 0.0119440583512187
a O 0 0.017747167497873306
pathogenic O 0 0.042490407824516296
correlation O 0 0.023970702663064003
of O 0 0.015011554583907127
these O 0 0.012550946325063705
cardiospecific O 1 0.9743955135345459
mutations O 0 0.035426292568445206
in O 0 0.023937588557600975
DMD O 1 0.9999996423721313
with O 0 0.02662796340882778
the O 1 0.6289363503456116
XLDCM B-Disease 1 0.9999998807907104
phenotype O 1 0.9999085664749146
has O 0 0.025810640305280685
remained O 0 0.03945082798600197
to O 0 0.023973893374204636
be O 0 0.025099022313952446
elucidated O 0 0.170829176902771
. O 0 0.050227463245391846

We O 0 0.029693854972720146
report O 0 0.02048339694738388
here O 0 0.01444152556359768
the O 0 0.014198584482073784
identification O 0 0.016334548592567444
of O 0 0.013081640005111694
a O 0 0.018954001367092133
unique O 0 0.022057585418224335
de O 0 0.09144990891218185
novo O 1 0.9981460571289062
L1 O 1 0.9994474053382874
insertion O 0 0.07299904525279999
in O 0 0.01793021894991398
the O 0 0.02723837085068226
muscle O 1 0.9647122621536255
exon O 1 0.6735778450965881
1 O 0 0.036189477890729904
in O 0 0.025969957932829857
DMD O 1 0.9999915361404419
in O 0 0.02249227464199066
three O 0 0.0323350727558136
XLDCM B-Disease 1 0.9999991655349731
patients O 1 0.998174786567688
from O 0 0.024027304723858833
two O 0 0.021039605140686035
unrelated O 0 0.04838060587644577
Japanese O 0 0.06767101585865021
families O 0 0.054206207394599915
. O 0 0.05038896203041077

The O 0 0.045034632086753845
insertion O 0 0.0691213384270668
was O 0 0.02773440256714821
a O 0 0.023400157690048218
5 O 0 0.03106117621064186
- O 1 0.9926586747169495
truncated O 0 0.050262633711099625
form O 0 0.017064718529582024
of O 0 0.01931455172598362
human O 0 0.036825068295001984
L1 O 1 0.9999121427536011
inversely O 0 0.06573359668254852
integrated O 0 0.03610517829656601
in O 0 0.011282401159405708
the O 0 0.016982903704047203
5 O 0 0.028239358216524124
- O 1 0.9985880255699158
untranslated O 0 0.3394974172115326
region O 0 0.021617691963911057
in O 0 0.01267195213586092
the O 0 0.024023106321692467
muscle O 1 0.999247670173645
exon O 1 0.9890449047088623
1 O 0 0.028798319399356842
, O 0 0.013615499250590801
which O 0 0.009566823951900005
affected O 0 0.01606352999806404
the O 0 0.018393591046333313
transcription O 0 0.04640788957476616
or O 0 0.011756992898881435
the O 0 0.014520198106765747
stability O 0 0.029727287590503693
of O 0 0.018302373588085175
the O 0 0.031065301969647408
muscle O 1 0.9947443008422852
form O 0 0.02420806512236595
of O 0 0.05395185574889183
dystrophin O 1 0.9999802112579346
transcripts O 0 0.03564845025539398
but O 0 0.00880410335958004
not O 0 0.005238140933215618
that O 0 0.004638900980353355
of O 0 0.009439543820917606
the O 0 0.020558251067996025
brain O 1 0.9973375201225281
or O 0 0.24974308907985687
Purkinje O 1 0.9999991655349731
cell O 1 0.9706317186355591
form O 0 0.027274517342448235
, O 0 0.01828751340508461
probably O 0 0.01600208878517151
due O 0 0.013321098871529102
to O 0 0.010786912404000759
its O 0 0.013532771728932858
unique O 0 0.019060712307691574
site O 0 0.02673373743891716
of O 0 0.028832627460360527
integration O 0 0.07355891913175583
. O 0 0.04405990242958069

We O 0 0.03486993908882141
speculate O 0 0.034554317593574524
that O 0 0.010391765274107456
this O 0 0.008578295819461346
insertion O 0 0.030589254572987556
of O 0 0.016352670267224312
an O 0 0.021190684288740158
L1 O 1 0.9996067881584167
sequence O 0 0.02501637674868107
in O 0 0.02568596415221691
DMD O 1 1.0
is O 0 0.02114591747522354
responsible O 0 0.02197400853037834
for O 0 0.009861513040959835
some O 0 0.006354505196213722
of O 0 0.009666727855801582
the O 0 0.01149724517017603
population O 0 0.010255429893732071
of O 0 0.017033696174621582
Japanese O 1 0.8885164260864258
patients O 1 0.999687671661377
with O 0 0.27690744400024414
XLDCM B-Disease 1 0.9999996423721313
. O 0 0.03753702715039253
. O 0 0.03804541006684303

Severe O 1 0.9828314781188965
early O 1 0.6026678085327148
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999998807907104
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999430179595947
red O 1 0.9999997615814209
hair O 1 0.9999986886978149
pigmentation O 1 0.9999998807907104
caused O 1 0.9999152421951294
by O 1 0.9970076680183411
POMC O 1 1.0
mutations O 0 0.1335754245519638
in O 0 0.028466135263442993
humans O 0 0.03747546672821045
. O 0 0.03732745721936226

Sequential O 0 0.1021512970328331
cleavage O 0 0.10984013229608536
of O 0 0.024311134591698647
the O 0 0.025855956599116325
precursor O 0 0.07090602070093155
protein O 0 0.025847941637039185
pre O 0 0.07649370282888412
- O 1 0.9998350143432617
pro O 1 0.9727662801742554
- O 1 0.999974250793457
opiomelanocortin O 1 0.9993675351142883
( O 0 0.0554756224155426
POMC O 1 0.9999597072601318
) O 0 0.023885225877165794
generates O 0 0.027411792427301407
the O 0 0.026175469160079956
melanocortin O 1 0.9998306035995483
peptides O 0 0.10063914954662323
adrenocorticotrophin O 1 0.9995813965797424
( O 0 0.05875026434659958
ACTH O 1 0.9999127388000488
) O 0 0.027813948690891266
, O 0 0.030526118353009224
melanocyte O 1 0.9999974966049194
- O 1 0.9999978542327881
stimulating O 1 0.9999104738235474
hormones O 1 0.9921889305114746
( O 0 0.055452294647693634
MSH O 1 0.999998927116394
) O 0 0.02812311425805092
alpha O 0 0.06355120241641998
, O 0 0.020216885954141617
beta O 0 0.052842143923044205
and O 0 0.017723985016345978
gamma O 0 0.05284174159169197
as O 0 0.01247126329690218
well O 0 0.00882387813180685
as O 0 0.011429199948906898
the O 0 0.020928237587213516
opioid O 1 0.9999828338623047
- O 1 0.9999970197677612
receptor O 1 0.9823181629180908
ligand O 1 0.9809119701385498
beta O 1 0.9940792322158813
- O 1 0.9999227523803711
endorphin O 1 0.9981461763381958
. O 0 0.06628644466400146

While O 0 0.0308085847645998
a O 0 0.020748009905219078
few O 0 0.014034722000360489
cases O 0 0.01896732486784458
of O 0 0.05526338145136833
isolated O 1 0.9999995231628418
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.01929868943989277
been O 0 0.017623335123062134
reported O 0 0.027238711714744568
( O 0 0.03752574324607849
OMIM O 1 0.9999916553497314
201400 O 1 0.998660683631897
) O 0 0.020795302465558052
, O 0 0.017430881038308144
an O 0 0.027881531044840813
inherited O 1 0.9999996423721313
POMC O 1 1.0
defect O 1 0.9999992847442627
has O 0 0.029202723875641823
not O 0 0.015298241749405861
been O 0 0.01737559214234352
described O 0 0.026476122438907623
so O 0 0.01912599429488182
far O 0 0.0239128228276968
. O 0 0.03334331512451172

Recent O 0 0.04878386855125427
studies O 0 0.025613706558942795
in O 0 0.01892554946243763
animal O 0 0.030307456851005554
models O 0 0.023847417905926704
elucidated O 0 0.05219966918230057
a O 0 0.017065763473510742
central O 0 0.01726454123854637
role O 0 0.021425530314445496
of O 0 0.023210648447275162
alpha O 1 0.9998283386230469
- O 1 0.999997615814209
MSH O 1 0.9999750852584839
in O 0 0.014455228112637997
the O 0 0.014976426027715206
regulation O 0 0.02052347920835018
of O 0 0.01697571761906147
food O 0 0.03290598839521408
intake O 0 0.08856935054063797
by O 0 0.014691542834043503
activation O 0 0.027578620240092278
of O 0 0.014167257584631443
the O 0 0.024252237752079964
brain O 1 0.9968331456184387
melanocortin O 1 0.999998927116394
- O 1 0.9999651908874512
4 O 0 0.04695679619908333
- O 1 0.999402642250061
receptor O 0 0.06449383497238159
( O 0 0.034502409398555756
MC4 O 1 0.9999911785125732
- O 1 0.9999562501907349
R O 1 0.9788482189178467
; O 0 0.024297432973980904
refs O 0 0.06709349900484085
3 O 0 0.03461749106645584
- O 1 0.9950056672096252
5 O 0 0.021436922252178192
) O 0 0.012053982354700565
and O 0 0.00920200627297163
the O 0 0.014615422114729881
linkage O 0 0.04631936177611351
of O 0 0.024121299386024475
human O 1 0.8720611333847046
obesity B-Disease 1 1.0
to O 0 0.044337205588817596
chromosome O 0 0.08579334616661072
2 O 0 0.020358193665742874
in O 0 0.010201940312981606
close O 0 0.01802189089357853
proximity O 0 0.02548903226852417
to O 0 0.016447242349386215
the O 0 0.03443272411823273
POMC O 1 0.9999984502792358
locus O 1 0.9376366138458252
, O 0 0.022027239203453064
led O 0 0.024052439257502556
to O 0 0.012675980105996132
the O 0 0.013188670389354229
proposal O 0 0.015912577509880066
of O 0 0.010406801477074623
an O 0 0.013066867366433144
association O 0 0.023221148177981377
of O 0 0.05119013413786888
POMC O 1 0.9999998807907104
with O 1 0.519641637802124
human O 1 0.9972524046897888
obesity B-Disease 1 1.0
. O 0 0.14778617024421692

The O 0 0.03923334553837776
dual O 0 0.04608885943889618
role O 0 0.03222722187638283
of O 0 0.028943834826350212
alpha O 1 0.9996302127838135
- O 1 0.9999957084655762
MSH O 1 0.9999880790710449
in O 0 0.02337576448917389
regulating O 0 0.054361701011657715
food O 0 0.04330884665250778
intake O 1 0.5499547123908997
and O 0 0.027299217879772186
influencing O 1 0.9666578769683838
hair O 1 0.9995812773704529
pigmentation O 1 0.9999948740005493
predicts O 1 0.7575744390487671
that O 0 0.012358343228697777
the O 0 0.02149629406630993
phenotype O 0 0.2217182070016861
associated O 0 0.01680242456495762
with O 0 0.013786797411739826
a O 0 0.029060766100883484
defect O 1 0.9995817542076111
in O 0 0.02932206727564335
POMC O 1 0.9999918937683105
function O 0 0.025684092193841934
would O 0 0.017330536618828773
include O 0 0.033079326152801514
obesity B-Disease 1 0.9999998807907104
, O 0 0.11083273589611053
alteration O 1 0.9997928738594055
in O 0 0.22138488292694092
pigmentation O 1 0.9999998807907104
and O 1 0.9999632835388184
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.579818069934845

The O 0 0.04814739152789116
observation O 0 0.07390569895505905
of O 0 0.033223941922187805
these O 0 0.02149643748998642
symptoms O 1 0.9998158812522888
in O 0 0.01924499124288559
two O 0 0.024140387773513794
probands O 1 0.9996883869171143
prompted O 0 0.07636917382478714
us O 0 0.024181963875889778
to O 0 0.015305858105421066
search O 0 0.02340393327176571
for O 0 0.015428051352500916
mutations O 0 0.024253519251942635
within O 0 0.01884150318801403
their O 0 0.03295386955142021
POMC O 1 0.9999862909317017
genes O 0 0.05674673616886139
. O 0 0.04705178365111351

Patient O 1 0.9993844032287598
1 O 0 0.04585767537355423
was O 0 0.027131447568535805
found O 0 0.012057526968419552
to O 0 0.009692134335637093
be O 0 0.009574404917657375
a O 0 0.01858041062951088
compound O 0 0.0476670116186142
heterozygote O 0 0.19438563287258148
for O 0 0.013429253362119198
two O 0 0.011464153416454792
mutations O 0 0.020251473411917686
in O 0 0.013692105188965797
exon O 0 0.19772349298000336
3 O 0 0.032494738698005676
( O 0 0.031115124002099037
G7013T O 1 0.9937906861305237
, O 0 0.036424264311790466
C7133delta O 1 0.9996190071105957
) O 0 0.022533608600497246
which O 0 0.012253683060407639
interfere O 0 0.027940085157752037
with O 0 0.014621563255786896
appropriate O 0 0.02333085425198078
synthesis O 0 0.03252147138118744
of O 0 0.031232409179210663
ACTH O 1 0.9999954700469971
and O 0 0.055921878665685654
alpha O 1 0.999596893787384
- O 1 0.9999923706054688
MSH O 1 0.999884843826294
. O 0 0.06426438689231873

Patient O 1 0.9852471351623535
2 O 0 0.04550233483314514
was O 0 0.03395184129476547
homozygous O 0 0.041713517159223557
for O 0 0.015477999113500118
a O 0 0.02212175913155079
mutation O 0 0.03122597560286522
in O 0 0.017863750457763672
exon O 1 0.7277333736419678
2 O 0 0.04326646402478218
( O 0 0.03761916607618332
C3804A O 1 0.9875051975250244
) O 0 0.030963869765400887
which O 0 0.03100985661149025
abolishes O 1 0.9973942041397095
POMC O 1 0.9999468326568604
translation O 0 0.08534113317728043
. O 0 0.05530858412384987

These O 0 0.02580324560403824
findings O 0 0.023068498820066452
represent O 0 0.015007034875452518
the O 0 0.015042233280837536
first O 0 0.016124818474054337
examples O 0 0.01639045961201191
of O 0 0.017116166651248932
a O 0 0.037341710180044174
genetic B-Disease 1 0.9278148412704468
defect I-Disease 1 0.9999639987945557
within O 0 0.022869685664772987
the O 0 0.038651447743177414
POMC O 1 0.9999973773956299
gene O 0 0.024921149015426636
and O 0 0.011266699992120266
define O 0 0.019980082288384438
a O 0 0.020568881183862686
new O 0 0.30179932713508606
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
resulting O 0 0.13550405204296112
in O 0 0.019317669793963432
early O 1 0.8581129312515259
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999997615814209
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999903440475464
red O 1 1.0
hair O 1 0.9999996423721313
pigmentation O 1 0.9999994039535522
. O 0 0.06076589226722717
. O 0 0.05012727901339531

A O 0 0.06030894070863724
European O 0 0.03855360299348831
multicenter O 1 0.938563883304596
study O 0 0.03340534865856171
of O 0 0.1381949931383133
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.2252572774887085
classification O 0 0.08890063315629959
of O 0 0.025945156812667847
105 O 0 0.33458858728408813
mutations O 0 0.027631457895040512
and O 0 0.012612258084118366
a O 0 0.01662493869662285
general O 0 0.024609321728348732
system O 0 0.01907208375632763
for O 0 0.02063264697790146
genotype O 1 0.869373083114624
- O 1 0.9945359230041504
based O 0 0.024878161028027534
prediction O 0 0.045752741396427155
of O 0 0.04904276505112648
metabolic O 1 0.9999735355377197
phenotype O 1 0.9956179857254028
. O 0 0.05978758633136749

Phenylketonuria B-Disease 1 0.999998927116394
( O 1 0.9944037199020386
PKU B-Disease 1 0.9999998807907104
) O 0 0.039636462926864624
and O 0 0.034355998039245605
mild B-Disease 1 0.9999951124191284
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.999805748462677
MHP B-Disease 1 1.0
) O 0 0.04626923426985741
are O 0 0.021529050543904305
allelic B-Disease 1 0.9999977350234985
disorders I-Disease 1 1.0
caused O 1 0.9990096092224121
by O 0 0.029379233717918396
mutations O 0 0.02323232591152191
in O 0 0.011746139265596867
the O 0 0.019850125536322594
gene O 0 0.031936582177877426
encoding O 0 0.044624634087085724
phenylalanine O 1 0.9999241828918457
hydroxylase O 1 0.9999958276748657
( O 1 0.992160975933075
PAH O 1 1.0
) O 0 0.062484826892614365
. O 0 0.046707186847925186

Previous O 0 0.051190298050642014
studies O 0 0.02460506372153759
have O 0 0.011201024055480957
suggested O 0 0.014682048000395298
that O 0 0.008106212131679058
the O 0 0.013931773602962494
highly O 0 0.030910499393939972
variable O 0 0.048143476247787476
metabolic O 1 0.9979968667030334
phenotypes O 1 0.9968580007553101
of O 1 0.9999697208404541
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9999797344207764
with O 1 0.9998513460159302
PAH O 1 1.0
genotypes O 1 0.9998162388801575
. O 0 0.07894966751337051

We O 0 0.03232134133577347
identified O 0 0.030946435406804085
both O 0 0.026156675070524216
causative O 1 0.9923957586288452
mutations O 0 0.0424819253385067
in O 0 0.029195411130785942
686 O 1 0.9999889135360718
patients O 1 0.9908208250999451
from O 0 0.024895410984754562
seven O 0 0.03245191648602486
European O 0 0.037304140627384186
centers O 0 0.06354889273643494
. O 0 0.047713976353406906

On O 0 0.0294895451515913
the O 0 0.0192765723913908
basis O 0 0.013586845248937607
of O 0 0.015109297819435596
the O 0 0.021404216066002846
phenotypic O 0 0.0431075356900692
characteristics O 0 0.027585523203015327
of O 0 0.028091369196772575
297 O 1 0.9990230798721313
functionally O 1 0.9995819926261902
hemizygous O 1 0.9999849796295166
patients O 1 0.9719760417938232
, O 0 0.02143385075032711
105 O 0 0.039458416402339935
of O 0 0.01842469535768032
the O 0 0.022993361577391624
mutations O 0 0.022280212491750717
were O 0 0.010298365727066994
assigned O 0 0.023233352228999138
to O 0 0.01099065225571394
one O 0 0.011630585417151451
of O 0 0.014590549282729626
four O 0 0.02423691190779209
arbitrary O 0 0.04891202598810196
phenotype O 1 0.9165484309196472
categories O 0 0.05718633532524109
. O 0 0.048755794763565063

We O 0 0.030296223238110542
proposed O 0 0.03195091336965561
and O 0 0.021191131323575974
tested O 0 0.032701194286346436
a O 0 0.024482501670718193
simple O 0 0.025432944297790527
model O 0 0.025880752131342888
for O 0 0.017933938652276993
correlation O 0 0.04110557585954666
between O 0 0.03482196480035782
genotype O 0 0.4660482406616211
and O 0 0.031142065301537514
phenotypic O 0 0.07061442732810974
outcome O 0 0.05792625620961189
. O 0 0.05076342448592186

The O 0 0.05076999217271805
observed O 0 0.0452132448554039
phenotype O 0 0.07058720290660858
matched O 0 0.03493739664554596
the O 0 0.02539733424782753
predicted O 0 0.04035147652029991
phenotype O 0 0.05492423102259636
in O 0 0.014945273287594318
79 O 0 0.04131319746375084
% O 0 0.01608058251440525
of O 0 0.014785698615014553
the O 0 0.019162744283676147
cases O 0 0.019208988174796104
, O 0 0.014677067287266254
and O 0 0.010466271080076694
in O 0 0.007872511632740498
only O 0 0.007984813302755356
5 O 0 0.014229037798941135
of O 0 0.017228683456778526
184 O 1 0.9744346737861633
patients O 1 0.9769129753112793
was O 0 0.029209023341536522
the O 0 0.023223960772156715
observed O 0 0.025477049872279167
phenotype O 0 0.03770138695836067
more O 0 0.00835928414016962
than O 0 0.0092889703810215
one O 0 0.014328326098620892
category O 0 0.024976585060358047
away O 0 0.019077874720096588
from O 0 0.014820944517850876
that O 0 0.013342204503715038
expected O 0 0.03015950135886669
. O 0 0.03504987061023712

Among O 0 0.03718236833810806
the O 0 0.0249161496758461
seven O 0 0.02595210261642933
contributing O 0 0.0422615185379982
centers O 0 0.030265195295214653
, O 0 0.01496349461376667
the O 0 0.016703350469470024
proportion O 0 0.026002109050750732
of O 0 0.02463775873184204
patients O 1 0.9995614886283875
for O 0 0.01893131621181965
whom O 0 0.048099733889102936
the O 0 0.02580220066010952
observed O 0 0.030824529007077217
phenotype O 0 0.05870530381798744
did O 0 0.013196665793657303
not O 0 0.007730163633823395
match O 0 0.014605056494474411
the O 0 0.015969039872288704
predicted O 0 0.03139248862862587
phenotype O 0 0.05123812332749367
was O 0 0.02299695648252964
4 O 0 0.023348603397607803
% O 0 0.019341133534908295
- O 0 0.4117167294025421
23 O 0 0.028116941452026367
% O 0 0.021669378504157066
( O 0 0.031768202781677246
P O 1 0.9997484087944031
< O 1 0.9982819557189941
. O 0 0.027717165648937225
0001 O 1 0.9990566372871399
) O 0 0.021447256207466125
, O 0 0.016019374132156372
suggesting O 0 0.01746472716331482
that O 0 0.007802019361406565
differences O 0 0.012007102370262146
in O 0 0.009489580988883972
methods O 0 0.01038696151226759
used O 0 0.008767248131334782
for O 0 0.01567908562719822
mutation O 0 0.205929234623909
detection O 1 0.9378272891044617
or O 0 0.053033389151096344
phenotype O 1 0.9936861395835876
classification O 0 0.33045318722724915
may O 0 0.015467524528503418
account O 0 0.012257874011993408
for O 0 0.009748488664627075
a O 0 0.014415046200156212
considerable O 0 0.021038908511400223
proportion O 0 0.032318416982889175
of O 0 0.041247691959142685
genotype O 1 0.9999185800552368
- O 1 0.9999977350234985
phenotype O 1 0.9803324937820435
inconsistencies O 0 0.09144959598779678
. O 0 0.05014438554644585

Our O 0 0.036426790058612823
data O 0 0.01410092692822218
indicate O 0 0.012908406555652618
that O 0 0.01005447469651699
the O 0 0.03612494841217995
PAH O 1 1.0
- O 1 0.9999988079071045
mutation O 0 0.2857508957386017
genotype O 0 0.061464399099349976
is O 0 0.012211156077682972
the O 0 0.013472691178321838
main O 0 0.03179498761892319
determinant O 1 0.9904122948646545
of O 0 0.05007302016019821
metabolic O 1 0.999992847442627
phenotype O 1 0.9681000113487244
in O 0 0.017650572583079338
most O 0 0.02724018506705761
patients O 1 0.9999963045120239
with O 1 0.9999947547912598
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9344790577888489

In O 0 0.029283085837960243
the O 0 0.02376830019056797
present O 0 0.020694609731435776
study O 0 0.014844258315861225
, O 0 0.012366719543933868
the O 0 0.014354425482451916
classification O 0 0.03358219936490059
of O 0 0.032115209847688675
105 O 1 0.999977707862854
PAH O 1 1.0
mutations O 0 0.09079620242118835
may O 0 0.016182202845811844
allow O 0 0.013497164472937584
the O 0 0.013445902615785599
prediction O 0 0.024291258305311203
of O 0 0.014148161746561527
the O 0 0.025478286668658257
biochemical O 0 0.21962827444076538
phenotype O 0 0.3519331216812134
in O 0 0.02115652896463871
> O 1 0.5489699840545654
10 O 0 0.02063106559216976
, O 0 0.020286329090595245
000 O 0 0.05056280270218849
genotypes O 1 0.8241274356842041
, O 0 0.02293577417731285
which O 0 0.013618586584925652
may O 0 0.013708528131246567
be O 0 0.008423469960689545
useful O 0 0.010774957947432995
for O 0 0.009295575320720673
the O 0 0.016174955293536186
management O 0 0.034736547619104385
of O 0 0.03781434893608093
hyperphenylalaninemia B-Disease 1 0.9999996423721313
in O 0 0.07286673039197922
newborns O 1 0.9997226595878601
. O 0 0.06299357116222382

Somatic O 1 0.8051167726516724
instability O 0 0.11222414672374725
of O 0 0.03554065525531769
the O 0 0.05104789510369301
CTG O 1 0.9999886751174927
repeat O 0 0.07959369570016861
in O 0 0.018722044304013252
mice O 0 0.03206837177276611
transgenic O 0 0.041388653218746185
for O 0 0.019543377682566643
the O 1 0.9707334041595459
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9993035793304443
is O 0 0.08719207346439362
age O 0 0.049122340977191925
dependent O 0 0.0316491574048996
but O 0 0.013223325833678246
not O 0 0.010870006866753101
correlated O 0 0.02288476563990116
to O 0 0.012496729381382465
the O 0 0.01917695440351963
relative O 0 0.04452276974916458
intertissue O 1 0.9995483756065369
transcription O 1 0.6150458455085754
levels O 0 0.04710066318511963
and O 0 0.051979705691337585
proliferative O 1 0.9999988079071045
capacities O 1 0.8586803674697876
. O 0 0.06279735267162323

A O 0 0.1077461987733841
( O 0 0.06276512145996094
CTG O 1 0.9989609718322754
) O 0 0.032800085842609406
nexpansion O 0 0.07544736564159393
in O 0 0.01373243611305952
the O 0 0.017742421478033066
3 O 0 0.03442267328500748
- O 1 0.9996726512908936
untranslated O 1 0.9093216061592102
region O 0 0.03193534165620804
( O 0 0.022462690249085426
UTR O 0 0.10317579656839371
) O 0 0.011341003701090813
of O 0 0.013588686473667622
the O 0 0.03405401110649109
DM O 1 1.0
protein O 0 0.4293751120567322
kinase O 1 0.9978806972503662
gene O 0 0.03538285568356514
( O 0 0.02840406447649002
DMPK O 1 0.9992111921310425
) O 0 0.016216346994042397
is O 0 0.011356149800121784
responsible O 0 0.0236609298735857
for O 0 0.025639250874519348
causing O 1 0.9999978542327881
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999991655349731
DM B-Disease 1 1.0
) O 0 0.07281941920518875
. O 0 0.047306083142757416

Major O 1 0.8163533806800842
instability O 1 0.994257926940918
, O 0 0.02704334631562233
with O 0 0.016692498698830605
very O 0 0.016342781484127045
large O 0 0.0189785435795784
expansions O 0 0.03789352998137474
between O 0 0.01784839667379856
generations O 0 0.02767173759639263
and O 0 0.015732059255242348
high O 0 0.02924521453678608
levels O 0 0.025328779593110085
of O 0 0.03313407674431801
somatic O 1 0.9999761581420898
mosaicism O 1 0.9999959468841553
, O 0 0.03376128524541855
is O 0 0.02380206622183323
observed O 0 0.02753537707030773
in O 0 0.026710715144872665
patients O 1 0.8684460520744324
. O 0 0.04880158603191376

There O 0 0.032288361340761185
is O 0 0.022844014689326286
a O 0 0.023944633081555367
good O 0 0.027108006179332733
correlation O 0 0.02904175966978073
between O 0 0.01954243704676628
repeat O 0 0.05657600983977318
size O 0 0.019926754757761955
( O 0 0.014793968759477139
at O 0 0.012092669494450092
least O 0 0.009255328215658665
in O 0 0.01402122899889946
leucocytes O 1 0.9990888833999634
) O 0 0.02534608729183674
, O 0 0.024136630818247795
clinical O 1 0.9973822236061096
severity O 1 0.9997161030769348
and O 0 0.03940783441066742
age O 1 0.6581940650939941
of O 1 0.9236467480659485
onset O 1 0.9999996423721313
. O 0 0.24001435935497284

The O 0 0.07905090600252151
trinucleotide O 1 0.9997867941856384
repeat O 1 0.9899137020111084
instability O 1 0.9973307847976685
mechanisms O 0 0.05885481834411621
involved O 0 0.02805151976644993
in O 0 0.0361623540520668
DM B-Disease 1 1.0
and O 0 0.02910587377846241
other O 0 0.019741714000701904
human O 1 0.9947952628135681
genetic B-Disease 1 0.9999862909317017
diseases I-Disease 1 1.0
are O 0 0.024885866791009903
unknown O 0 0.05064120143651962
. O 0 0.04253684729337692

We O 0 0.03958230838179588
studied O 0 0.052814241498708725
somatic O 0 0.3652181923389435
instability O 0 0.14697255194187164
by O 0 0.029092561453580856
measuring O 0 0.05300333350896835
the O 0 0.04075034335255623
CTG O 1 0.9999936819076538
repeat O 0 0.09668838232755661
length O 0 0.020931480452418327
at O 0 0.015367483720183372
several O 0 0.009587028063833714
ages O 0 0.018063724040985107
in O 0 0.009881721809506416
various O 0 0.011196080595254898
tissues O 0 0.03415103629231453
of O 0 0.027122460305690765
transgenic O 1 0.9923732876777649
mice O 0 0.03927226364612579
carrying O 0 0.03175833076238632
a O 0 0.028976699337363243
( O 0 0.036984797567129135
CTG O 1 0.9998953342437744
) O 0 0.03128097951412201
55expansion O 0 0.2638010084629059
surrounded O 0 0.04432574287056923
by O 0 0.016741853207349777
45 O 0 0.02476176992058754
kb O 0 0.059882525354623795
of O 0 0.021255185827612877
the O 0 0.030888020992279053
human O 1 0.9376985430717468
DM B-Disease 1 1.0
region O 0 0.04375283420085907
, O 0 0.01927381567656994
using O 0 0.01520705409348011
small O 0 0.029207143932580948
- O 1 0.9998346567153931
pool O 0 0.4924616813659668
PCR O 0 0.13129563629627228
. O 0 0.04438719525933266

These O 0 0.03925866261124611
mice O 0 0.045981813222169876
have O 0 0.012503840029239655
been O 0 0.012905995361506939
shown O 0 0.01225358434021473
to O 0 0.014480282552540302
reproduce O 0 0.027689140290021896
the O 0 0.026603443548083305
intergenerational O 1 0.999752938747406
and O 0 0.03778136521577835
somatic O 1 0.9713765978813171
instability O 0 0.3441462218761444
of O 0 0.02533211000263691
the O 0 0.03375330567359924
55 O 0 0.113447405397892
CTG O 1 0.9999868869781494
repeat O 0 0.07365552335977554
suggesting O 0 0.027605000883340836
that O 0 0.011288302950561047
surrounding O 0 0.022738514468073845
sequences O 0 0.013154624029994011
and O 0 0.011558616533875465
the O 0 0.02005925215780735
chromatin O 1 0.9256381988525391
environment O 0 0.02800610661506653
are O 0 0.010513806715607643
involved O 0 0.022364504635334015
in O 0 0.026246732100844383
instability O 1 0.9954314231872559
mechanisms O 0 0.17801909148693085
. O 0 0.05422326177358627

As O 0 0.03337753936648369
observed O 0 0.019853288307785988
in O 0 0.008492892608046532
some O 0 0.006606623996049166
of O 0 0.011577662080526352
the O 0 0.020620329305529594
tissues O 1 0.9905434250831604
of O 1 0.9999406337738037
DM B-Disease 1 1.0
patients O 1 0.9999997615814209
, O 0 0.026580611243844032
there O 0 0.012700350023806095
is O 0 0.014082740992307663
a O 0 0.020369626581668854
tendency O 0 0.03889000043272972
for O 0 0.01933932490646839
repeat O 0 0.049999795854091644
length O 0 0.028718266636133194
and O 0 0.028401173651218414
somatic O 1 0.9490687251091003
mosaicism O 1 0.9989035129547119
to O 0 0.019714217633008957
increase O 0 0.014814511872828007
with O 0 0.011684051714837551
the O 0 0.016003400087356567
age O 0 0.023400908336043358
of O 0 0.02374211512506008
the O 0 0.046226222068071365
mouse O 1 0.611083447933197
. O 0 0.04615846648812294

Furthermore O 0 0.07399989664554596
, O 0 0.027598632499575615
we O 0 0.015686124563217163
observed O 0 0.017316073179244995
no O 0 0.013779019005596638
correlation O 0 0.02135702595114708
between O 0 0.01447245106101036
the O 0 0.023686449974775314
somatic O 1 0.8774992227554321
mutation O 0 0.1642748862504959
rate O 0 0.03829433023929596
and O 0 0.06720705330371857
tissue O 1 0.9997971653938293
proliferation O 1 0.9997836947441101
capacity O 0 0.07264489680528641
. O 0 0.04839980602264404

The O 0 0.06559057533740997
somatic O 1 0.9870007038116455
mutation O 0 0.07020258903503418
rates O 0 0.026220571249723434
in O 0 0.014019758440554142
different O 0 0.010621588677167892
tissues O 0 0.040323883295059204
were O 0 0.011475886218249798
also O 0 0.01070496253669262
not O 0 0.008291195146739483
correlated O 0 0.018792198970913887
to O 0 0.009466803632676601
the O 0 0.013620764948427677
relative O 0 0.037057992070913315
inter O 1 0.9999474287033081
- O 1 0.9999973773956299
tissue O 0 0.342227578163147
difference O 0 0.0187136922031641
in O 0 0.012830790132284164
transcriptional O 0 0.03751613199710846
levels O 0 0.012738564983010292
of O 0 0.010592867620289326
the O 0 0.011878542602062225
three O 0 0.013407336547970772
genes O 0 0.020859384909272194
( O 0 0.026722580194473267
DMAHP O 1 0.9999258518218994
, O 0 0.031073054298758507
DMPK O 1 0.9999486207962036
and O 0 0.02270158752799034
59 O 0 0.05264034867286682
) O 0 0.019576463848352432
surrounding O 0 0.02929050289094448
the O 0 0.027856117114424706
repeat O 0 0.3130093514919281
. O 0 0.029349256306886673
. O 0 0.03778280317783356

A O 0 0.07090454548597336
novel O 0 0.08108235895633698
missense O 1 0.8986679911613464
mutation O 0 0.05769958719611168
in O 0 0.0215409304946661
patients O 1 0.6952041983604431
from O 0 0.021270165219902992
a O 0 0.40170052647590637
retinoblastoma B-Disease 1 0.9999994039535522
pedigree O 1 0.9786370992660522
showing O 0 0.03405715897679329
only O 0 0.01830182410776615
mild O 1 0.5534904599189758
expression O 0 0.029142964631319046
of O 0 0.027875443920493126
the O 1 0.9912540316581726
tumor B-Disease 1 0.9999998807907104
phenotype O 1 0.9994090795516968
. O 0 0.057314347475767136

We O 0 0.031777460128068924
have O 0 0.016325917094945908
used O 0 0.017761938273906708
single O 0 0.0415952242910862
strand O 0 0.0786656066775322
conformation O 0 0.06823261082172394
polymorphism O 0 0.04901539534330368
analysis O 0 0.013452603481709957
to O 0 0.010098801925778389
study O 0 0.010746035724878311
the O 0 0.013240041211247444
27 O 0 0.02244403399527073
exons O 0 0.0342363566160202
of O 0 0.01879608817398548
the O 0 0.03454063832759857
RB1 O 1 0.9999988079071045
gene O 0 0.027926534414291382
in O 0 0.01176182460039854
individuals O 0 0.010709922760725021
from O 0 0.012079688720405102
a O 0 0.02105693146586418
family O 0 0.038270629942417145
showing O 0 0.04347526654601097
mild O 1 0.9717980027198792
expression O 0 0.033726807683706284
of O 0 0.03114939294755459
the O 1 0.8838152885437012
retinoblastoma B-Disease 1 0.9999997615814209
phenotype O 1 0.9996758699417114
. O 0 0.06356357783079147

In O 0 0.026341963559389114
this O 0 0.018642980605363846
family O 0 0.03320719301700592
affected O 0 0.030154509469866753
individuals O 0 0.019235076382756233
developed O 0 0.18801221251487732
unilateral B-Disease 1 0.9999972581863403
tumors I-Disease 1 1.0
and O 0 0.4263031780719757
, O 0 0.019877813756465912
as O 0 0.013324383646249771
a O 0 0.014855531044304371
result O 0 0.0130258584395051
of O 0 0.018218019977211952
linkage O 1 0.6191810369491577
analysis O 0 0.018166644498705864
, O 0 0.02296239696443081
unaffected O 1 0.9962181448936462
mutation O 0 0.11990588903427124
carriers O 0 0.03616652637720108
were O 0 0.011831508949398994
also O 0 0.013001006096601486
identified O 0 0.01790306158363819
within O 0 0.017329653725028038
the O 0 0.03173142299056053
pedigree O 0 0.30835917592048645
. O 0 0.047206517308950424

A O 0 0.06798949092626572
single O 0 0.048281844705343246
band O 0 0.05057390779256821
shift O 0 0.03549496829509735
using O 0 0.018770582973957062
SSCP O 1 0.9900656938552856
was O 0 0.028495611622929573
identified O 0 0.019980715587735176
in O 0 0.014308042824268341
exon O 0 0.06502140313386917
21 O 0 0.023723704740405083
which O 0 0.01058887504041195
resulted O 0 0.016420189291238785
in O 0 0.011699910275638103
a O 0 0.021020706743001938
missense O 0 0.061607714742422104
mutation O 0 0.030287325382232666
converting O 0 0.03233768045902252
a O 0 0.038992613554000854
cys O 1 0.9999985694885254
- O 1 0.9999994039535522
- O 1 0.9999978542327881
> O 1 0.997565507888794
arg O 1 0.9988716244697571
at O 0 0.028803149238228798
nucleotide O 0 0.0352395735681057
position O 0 0.025403473526239395
28 O 0 0.025349630042910576
in O 0 0.01621241308748722
the O 0 0.035146381705999374
exon O 0 0.19327059388160706
. O 0 0.05348293110728264

The O 0 0.0553298145532608
mutation O 0 0.06867539882659912
destroyed O 0 0.06467531621456146
an O 0 0.03953591734170914
NdeI O 1 0.999795138835907
restriction O 1 0.5925979614257812
enzyme O 0 0.1086222305893898
site O 0 0.05816268548369408
. O 0 0.042564116418361664

Analysis O 0 0.0281645730137825
of O 0 0.02066640742123127
all O 0 0.015500861220061779
family O 0 0.024347346276044846
members O 0 0.016262274235486984
demonstrated O 0 0.015371762216091156
that O 0 0.007126835640519857
the O 0 0.013902808539569378
missense O 0 0.12551598250865936
mutation O 0 0.05216490849852562
co O 1 0.9960404634475708
- O 1 0.999963641166687
segregated O 1 0.9872717261314392
with O 0 0.028045592829585075
patients O 1 0.9999568462371826
with O 1 0.9932681918144226
tumors B-Disease 1 1.0
or O 0 0.1560496836900711
who O 0 0.03392035514116287
, O 0 0.01483568362891674
as O 0 0.010965139605104923
a O 0 0.01367531530559063
result O 0 0.014795316383242607
of O 0 0.019985700026154518
linkage O 1 0.8489493131637573
analysis O 0 0.015764320269227028
had O 0 0.015458110719919205
been O 0 0.013556727208197117
predicted O 0 0.01999014988541603
to O 0 0.015250097028911114
carry O 0 0.02574421651661396
the O 0 0.03884286433458328
predisposing O 1 0.9965259432792664
mutation O 0 0.0964081734418869
. O 0 0.05341796204447746

These O 0 0.027431651949882507
observations O 0 0.02657327987253666
point O 0 0.017287040129303932
to O 0 0.012316872365772724
another O 0 0.015600567683577538
region O 0 0.018055761232972145
of O 0 0.015375833958387375
the O 0 0.03562585264444351
RB1 O 1 0.9999996423721313
gene O 0 0.037421874701976776
where O 0 0.01893753372132778
mutations O 0 0.0188303180038929
only O 0 0.008753667585551739
modify O 0 0.021562080830335617
the O 0 0.014476941898465157
function O 0 0.013293838128447533
of O 0 0.011984665878117085
the O 0 0.018312769010663033
gene O 0 0.020183663815259933
and O 0 0.012697665952146053
raise O 0 0.019653858616948128
important O 0 0.013314231298863888
questions O 0 0.015679627656936646
for O 0 0.014407623559236526
genetic O 0 0.030070310458540916
counseling O 1 0.992634117603302
in O 0 0.015315455384552479
families O 0 0.020485466346144676
with O 0 0.016891174018383026
these O 0 0.016186658293008804
distinctive O 1 0.6776339411735535
phenotypes O 1 0.9635865688323975
. O 0 0.03571698069572449
. O 0 0.04476136714220047

Maternal B-Disease 1 0.9896135926246643
disomy I-Disease 1 0.998978853225708
and O 1 0.9763553738594055
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9967445135116577
with O 0 0.43263310194015503
gamete O 1 0.9999901056289673
complementation O 1 0.9999969005584717
in O 0 0.020964009687304497
a O 0 0.022018911316990852
case O 0 0.023248646408319473
of O 0 0.03035062737762928
familial O 1 0.9999986886978149
translocation O 1 0.9999691247940063
( O 0 0.03297959268093109
3 O 0 0.026517760008573532
; O 0 0.01546095497906208
15 O 0 0.020866243168711662
) O 0 0.021216493099927902
( O 0 0.02859698422253132
p25 O 1 0.9941924214363098
; O 0 0.03663792833685875
q11 O 1 0.9929972290992737
. O 0 0.02571188472211361
2 O 0 0.03806034475564957
) O 0 0.030867666006088257
. O 0 0.034585706889629364

Maternal B-Disease 1 0.9998362064361572
uniparental I-Disease 1 0.9999986886978149
disomy I-Disease 1 0.9999978542327881
( I-Disease 1 0.9801857471466064
UPD I-Disease 1 0.9999998807907104
) I-Disease 0 0.03127457946538925
for I-Disease 0 0.02160879410803318
chromosome I-Disease 0 0.04588916897773743
15 I-Disease 0 0.019583577290177345
is O 0 0.013685287907719612
responsible O 0 0.01869235187768936
for O 0 0.011633574031293392
an O 0 0.012629365548491478
estimated O 0 0.014031094498932362
30 O 0 0.01135710347443819
% O 0 0.008252578787505627
of O 0 0.009761909954249859
cases O 0 0.017019258812069893
of O 1 0.9066257476806641
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999978542327881
PWS B-Disease 1 1.0
) O 0 0.09332016110420227
. O 0 0.05292598530650139

We O 0 0.029216594994068146
report O 0 0.01805221661925316
on O 0 0.013179536908864975
an O 0 0.012844433076679707
unusual O 0 0.016756625846028328
case O 0 0.01970263570547104
of O 0 0.02216595597565174
maternal B-Disease 1 0.9999219179153442
disomy I-Disease 1 0.9999408721923828
15 I-Disease 0 0.03925022482872009
in O 0 0.033056437969207764
PWS B-Disease 1 1.0
that O 0 0.0173238143324852
is O 0 0.014792395755648613
most O 0 0.011241507716476917
consistent O 0 0.020209677517414093
with O 0 0.014001702889800072
adjacent O 0 0.0409715473651886
- O 1 0.9622830152511597
1 O 0 0.024532541632652283
segregation O 0 0.0451938770711422
of O 0 0.018023008480668068
a O 0 0.0374024324119091
paternal O 1 0.9998621940612793
t O 1 0.998993456363678
( O 0 0.02338639833033085
3 O 0 0.02260514721274376
; O 0 0.014287102967500687
15 O 0 0.019654201343655586
) O 0 0.01963021047413349
( O 0 0.02792409621179104
p25 O 1 0.9941317439079285
; O 0 0.029514677822589874
q11 O 1 0.9070814847946167
. O 0 0.016941457986831665
2 O 0 0.02237320877611637
) O 0 0.013630037195980549
with O 0 0.014185361564159393
simultaneous O 0 0.037930846214294434
maternal O 1 0.9972679615020752
meiotic O 1 0.9999922513961792
nondisjunction O 1 0.9999752044677734
for O 0 0.06203392893075943
chromosome O 0 0.10909895598888397
15 O 0 0.05588777735829353
. O 0 0.05026790499687195

The O 0 0.06676770001649857
patient O 1 0.9997995495796204
( O 0 0.25328579545021057
J O 1 0.9999949932098389
. O 0 0.031766388565301895
B O 1 0.9994829893112183
. O 0 0.01464956533163786
) O 0 0.011385219171643257
, O 0 0.00898048747330904
a O 0 0.013538374565541744
17 O 0 0.024804450571537018
- O 1 0.9672511219978333
year O 0 0.018061431124806404
- O 1 0.9942861199378967
old O 0 0.06674104183912277
white O 0 0.12831461429595947
male O 0 0.43907395005226135
with O 0 0.25098761916160583
PWS B-Disease 1 1.0
, O 0 0.029831839725375175
was O 0 0.02252720110118389
found O 0 0.009853703901171684
to O 0 0.008357801474630833
have O 0 0.006388329900801182
47 O 0 0.02058013528585434
chromosomes O 0 0.01839303970336914
with O 0 0.011433306150138378
a O 0 0.026767313480377197
supernumerary O 1 0.9999487400054932
, O 0 0.03954919055104256
paternal O 1 0.9996724128723145
der O 1 0.9997053742408752
( O 0 0.024268969893455505
15 O 0 0.019247116521000862
) O 0 0.01200372539460659
consisting O 0 0.014625622890889645
of O 0 0.013674497604370117
the O 0 0.021023878827691078
short O 0 0.027680642902851105
arm O 1 0.6131574511528015
and O 0 0.017137974500656128
the O 0 0.029169229790568352
proximal O 1 0.9999916553497314
long O 0 0.2539895176887512
arm O 1 0.979540228843689
of O 0 0.031577058136463165
chromosome O 0 0.1610899716615677
15 O 0 0.02593860775232315
, O 0 0.02227010205388069
and O 0 0.03153150528669357
distal O 1 0.9999942779541016
chromosome O 1 0.9992101192474365
arm O 1 0.9997798800468445
3p O 1 0.9997805953025818
. O 0 0.06492442637681961

The O 0 0.07421885430812836
t O 1 0.9954264760017395
( O 0 0.032503191381692886
3 O 0 0.02869051694869995
; O 0 0.01839619129896164
15 O 0 0.02039015293121338
) O 0 0.014837181195616722
was O 0 0.01537397876381874
present O 0 0.011827652342617512
in O 0 0.00868422444909811
the O 0 0.013293799944221973
balanced O 0 0.020948348566889763
state O 0 0.009829998947679996
in O 0 0.011411107145249844
the O 0 0.024530045688152313
patients O 1 0.9998629093170166
father O 1 0.9972544312477112
and O 0 0.03277045115828514
a O 0 0.08711709082126617
sister O 1 0.9807479381561279
. O 0 0.051516804844141006

Fluorescent O 1 0.5352871417999268
in O 0 0.04208217188715935
situ O 1 0.5117122530937195
hybridization O 0 0.049860354512929916
analysis O 0 0.016553392633795738
demonstrated O 0 0.02102697268128395
that O 0 0.011503263376653194
the O 0 0.03087853640317917
PWS B-Disease 1 0.9999998807907104
critical O 0 0.05542147904634476
region O 0 0.0344797819852829
resided O 0 0.048673421144485474
on O 0 0.016186127439141273
the O 0 0.02312992326915264
derivative O 1 0.9085779786109924
chromosome O 0 0.04370737448334694
3 O 0 0.0188366137444973
and O 0 0.010670098476111889
that O 0 0.0073536960408091545
there O 0 0.007842665538191795
was O 0 0.015160872600972652
no O 0 0.012860968708992004
deletion O 0 0.031592320650815964
of O 0 0.01957944594323635
the O 0 0.12654557824134827
PWS B-Disease 1 1.0
region O 0 0.03654787689447403
on O 0 0.017420310527086258
the O 0 0.01788518577814102
normal O 0 0.02122345380485058
pair O 0 0.026822421699762344
of O 0 0.026760026812553406
15s O 1 0.9994795918464661
present O 0 0.04215183109045029
in O 0 0.04123862460255623
J O 1 0.9999619722366333
. O 0 0.06007051840424538

B O 1 0.9920341372489929
. O 0 0.09135807305574417

Methylation O 0 0.09129127860069275
analysis O 0 0.02267208881676197
at O 0 0.024237222969532013
exon O 0 0.06843283772468567
alpha O 0 0.04117970913648605
of O 0 0.014412201941013336
the O 0 0.015883484855294228
small O 0 0.019061317667365074
nuclear O 0 0.04634051024913788
ribonucleoprotein O 1 0.9994935989379883
- O 1 0.9981207251548767
associated O 0 0.038817260414361954
polypeptide O 1 0.9924314022064209
N O 1 0.9673056602478027
( O 0 0.040543075650930405
SNRPN O 1 0.9998716115951538
) O 0 0.025785842910408974
gene O 0 0.020849961787462234
showed O 0 0.01789863407611847
a O 0 0.01961560733616352
pattern O 0 0.026442717760801315
characteristic O 0 0.0237906351685524
of O 0 0.015178979374468327
only O 0 0.014933990314602852
the O 0 0.024083929136395454
maternal O 1 0.999715268611908
chromosome O 0 0.16799569129943848
15 O 0 0.036956895142793655
in O 0 0.0342465303838253
J O 1 0.9999455213546753
. O 0 0.05639122426509857

B O 1 0.9862880706787109
. O 0 0.09435906261205673

Maternal B-Disease 1 0.9976970553398132
disomy I-Disease 1 0.9962538480758667
was O 0 0.05337229371070862
confirmed O 0 0.03255274146795273
by O 0 0.024939924478530884
polymerase O 0 0.4142250120639801
chain O 0 0.05695885419845581
reaction O 0 0.03247959539294243
analysis O 0 0.013453623279929161
of O 0 0.020052706822752953
microsatellite O 0 0.09201276302337646
repeats O 0 0.03337452933192253
at O 0 0.01650453731417656
the O 0 0.019985143095254898
gamma O 1 0.9699317216873169
- O 1 0.999863862991333
aminobutyric O 1 0.9981870055198669
acid O 0 0.4749661386013031
receptor O 0 0.09819869697093964
beta3 O 1 0.9840982556343079
subunit O 0 0.2187104970216751
( O 0 0.05623890832066536
GABRB3 O 1 0.9997960925102234
) O 0 0.05469399318099022
locus O 0 0.13379231095314026
. O 0 0.04799157753586769

A O 0 0.11776279658079147
niece O 1 0.9998828172683716
( O 0 0.07500642538070679
B O 1 0.9990578293800354
. O 0 0.03163788467645645
B O 1 0.9984074234962463
. O 0 0.016669150441884995
) O 0 0.012622441165149212
with O 0 0.011604131199419498
45 O 0 0.02214887924492359
chromosomes O 0 0.024223584681749344
and O 0 0.012776894494891167
the O 0 0.01877426542341709
derivative O 0 0.037543751299381256
3 O 0 0.01759161986410618
but O 0 0.009699426591396332
without O 0 0.010158844292163849
the O 0 0.020542463287711143
der O 1 0.9977861642837524
( O 0 0.02074313536286354
15 O 0 0.019276203587651253
) O 0 0.016232207417488098
demonstrated O 0 0.023807106539607048
a O 0 0.02643163688480854
phenotype O 0 0.18257594108581543
consistent O 0 0.024459481239318848
with O 0 0.011878514662384987
that O 0 0.008794991299510002
reported O 0 0.015124249272048473
for O 0 0.016479771584272385
haploinsufficiency O 1 0.987790584564209
of O 0 0.045789461582899094
distal O 1 0.9999781847000122
3 O 0 0.16474592685699463
p O 1 0.9207283854484558
. O 0 0.05377013608813286

Uniparental B-Disease 1 0.9999929666519165
disomy I-Disease 1 0.9997871518135071
associated O 0 0.04439201578497887
with O 0 0.026008550077676773
unbalanced O 1 0.8987212777137756
segregation O 1 0.8366233110427856
of O 0 0.03604445606470108
non O 1 0.9993202686309814
- O 1 0.9999995231628418
Robertsonian O 1 0.9999970197677612
translocations O 1 0.979115903377533
has O 0 0.016531502828001976
been O 0 0.011848563328385353
reported O 0 0.014054354280233383
previously O 0 0.014365830458700657
but O 0 0.009248899295926094
has O 0 0.009912054985761642
not O 0 0.008482907898724079
, O 0 0.00990661047399044
to O 0 0.01016202848404646
our O 0 0.015661412850022316
knowledge O 0 0.016669033095240593
, O 0 0.011962168850004673
been O 0 0.010073758661746979
observed O 0 0.011999603360891342
in O 0 0.010243572294712067
a O 0 0.02098427340388298
case O 0 0.03398946672677994
of O 0 0.05661940574645996
PWS B-Disease 1 0.9999997615814209
. O 0 0.07843691110610962

Furthermore O 0 0.07464653253555298
, O 0 0.02889706939458847
our O 0 0.02436383254826069
findings O 0 0.02180168777704239
are O 0 0.00782004278153181
best O 0 0.015345717780292034
interpreted O 0 0.017025068402290344
as O 0 0.018254807218909264
true O 0 0.041172463446855545
gamete O 1 0.997581958770752
complementation O 1 0.9999814033508301
resulting O 0 0.06027580052614212
in O 0 0.04321994259953499
maternal B-Disease 1 0.9999916553497314
UPD I-Disease 1 0.9999998807907104
15 I-Disease 0 0.1401013880968094
and O 0 0.12913377583026886
PWS B-Disease 1 0.999997615814209

Schwartz B-Disease 1 0.999032735824585
- I-Disease 1 0.9999992847442627
Jampel I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
type I-Disease 1 0.8258157968521118
2 I-Disease 0 0.03560963645577431
and O 0 0.02954249270260334
Stuve B-Disease 1 0.9999990463256836
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.035486675798892975
a O 0 0.026189500465989113
case O 0 0.02764539234340191
for O 0 0.023244036361575127
" O 0 0.05327752232551575
lumping O 1 0.940129816532135
" O 0 0.060733452439308167
. O 0 0.04822966083884239

Recent O 0 0.05013807490468025
studies O 0 0.025044376030564308
demonstrated O 0 0.023729635402560234
the O 0 0.015465302392840385
existence O 0 0.01820743829011917
of O 0 0.015023543499410152
a O 0 0.02239406108856201
genetically O 0 0.02575320564210415
distinct O 0 0.017347266897559166
, O 0 0.014674559235572815
usually O 0 0.011686641722917557
lethal O 0 0.02189640700817108
form O 0 0.011255359277129173
of O 0 0.013154451735317707
the O 0 0.023472389206290245
Schwartz B-Disease 1 0.999988317489624
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9995662569999695
SJS B-Disease 1 1.0
) O 0 0.027039701119065285
of O 0 0.03528094291687012
myotonia B-Disease 1 0.9999998807907104
and O 1 0.9993108510971069
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.14123179018497467
which O 0 0.015573511831462383
we O 0 0.016882022842764854
called O 1 0.9222995042800903
SJS B-Disease 1 1.0
type I-Disease 0 0.29351258277893066
2 I-Disease 0 0.053514864295721054
. O 0 0.041508108377456665

This O 0 0.061255306005477905
disorder O 1 0.9999958276748657
is O 0 0.03015349805355072
reminiscent O 0 0.4551902711391449
of O 0 0.023744691163301468
another O 0 0.037569209933280945
rare O 0 0.040624622255563736
condition O 0 0.037413328886032104
, O 0 0.014564583078026772
the O 0 0.02647778019309044
Stuve B-Disease 1 0.9999995231628418
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9994452595710754
SWS B-Disease 1 0.9999996423721313
) O 0 0.025838229805231094
, O 0 0.014308447018265724
which O 0 0.010041175410151482
comprises O 0 0.02916819043457508
campomelia B-Disease 0 0.1571984440088272
at O 0 0.02365477941930294
birth O 1 0.6819332242012024
with O 1 0.7840362787246704
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9998667240142822
contractures B-Disease 1 0.9999998807907104
, O 0 0.05256145820021629
and O 0 0.025341831147670746
early B-Disease 0 0.037715353071689606
death I-Disease 1 0.8476285934448242
. O 0 0.048500906676054

To O 0 0.03452595695853233
test O 0 0.028322000056505203
for O 0 0.016883106902241707
possible O 0 0.025522105395793915
nosologic O 1 0.9708994626998901
identity O 0 0.03409024327993393
between O 0 0.024731801822781563
these O 0 0.02376999333500862
disorders O 1 0.9999996423721313
, O 0 0.025008654221892357
we O 0 0.014483228325843811
reviewed O 0 0.021645598113536835
the O 0 0.01506108045578003
literature O 0 0.013684649951756
and O 0 0.010917902924120426
obtained O 0 0.01294335350394249
a O 0 0.017211921513080597
follow O 0 0.027763433754444122
- O 1 0.9571312069892883
up O 0 0.015178568661212921
of O 0 0.01039609219878912
the O 0 0.011329575441777706
only O 0 0.008143968880176544
two O 0 0.011090721935033798
surviving O 1 0.8567669987678528
patients O 1 0.9078629016876221
, O 0 0.015462436713278294
one O 0 0.016087530180811882
with O 0 0.21642030775547028
SJS B-Disease 1 1.0
type I-Disease 1 0.630904495716095
2 I-Disease 0 0.02209879644215107
at O 0 0.016379084438085556
age O 0 0.015505845658481121
10 O 0 0.012259403243660927
years O 0 0.011059622280299664
and O 0 0.010291709564626217
another O 0 0.01796984300017357
with O 0 0.023420462384819984
SWS B-Disease 1 0.9999982118606567
at O 0 0.042881306260824203
age O 0 0.03596419095993042
7 O 0 0.03707451373338699
years O 0 0.03205849602818489
. O 0 0.03814471885561943

Patients O 1 0.7568708062171936
reported O 0 0.027867691591382027
as O 0 0.018698275089263916
having O 0 0.02533577010035515
either O 0 0.3536399006843567
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.4704088270664215
SWS B-Disease 1 0.9999841451644897
presented O 0 0.025472234934568405
a O 0 0.01645434834063053
combination O 0 0.019018622115254402
of O 0 0.013278128579258919
a O 0 0.02309356816112995
severe O 1 0.9999592304229736
, O 1 0.9396103024482727
prenatal O 1 1.0
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9998959302902222
with O 1 0.9999815225601196
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9999502897262573
feeding O 1 0.999994158744812
difficulties O 1 0.9999725818634033
, O 0 0.39179733395576477
tendency O 1 0.9960041642189026
to O 0 0.22312629222869873
hyperthermia B-Disease 1 1.0
, O 0 0.023855583742260933
and O 0 0.017724640667438507
frequent O 0 0.12727485597133636
death O 1 0.9683735966682434
in O 0 0.020440788939595222
infancy O 1 0.9933086633682251
) O 0 0.014552789740264416
with O 0 0.010103393346071243
a O 0 0.019688187167048454
distinct O 0 0.031193366274237633
campomelic B-Disease 1 0.999995231628418
- I-Disease 1 0.9999998807907104
metaphyseal I-Disease 1 0.9999991655349731
skeletal I-Disease 1 0.9999997615814209
dysplasia I-Disease 1 0.9999998807907104
. O 0 0.10194455087184906

The O 0 0.041511766612529755
similarity O 0 0.03512047231197357
of O 0 0.025538986548781395
the O 0 0.0320272296667099
clinical O 1 0.9922981858253479
and O 0 0.03346283361315727
radiographic O 1 0.9999401569366455
findings O 0 0.032399844378232956
is O 0 0.015747305005788803
so O 0 0.012455364689230919
extensive O 0 0.020078204572200775
that O 0 0.011997140012681484
these O 0 0.016893653199076653
disorders O 1 0.9999972581863403
appear O 0 0.02346736751496792
to O 0 0.016153091564774513
be O 0 0.011909302324056625
a O 0 0.02240161783993244
single O 0 0.04100942239165306
entity O 0 0.06594021618366241
. O 0 0.042639970779418945

The O 0 0.0458005852997303
follow O 0 0.05012224614620209
- O 1 0.9360830187797546
up O 0 0.02501707524061203
observation O 0 0.035963274538517
of O 0 0.013657149858772755
an O 0 0.01269802451133728
identical O 0 0.013181882910430431
and O 0 0.009674830362200737
unique O 0 0.01328945904970169
pattern O 0 0.0239131860435009
of O 1 0.723654568195343
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.02208751067519188
the O 0 0.0220359954982996
two O 0 0.01593451015651226
patients O 1 0.9988135099411011
( O 0 0.016222966834902763
one O 0 0.015451716259121895
with O 0 0.1842425912618637
SJS B-Disease 1 1.0
type I-Disease 0 0.3457474708557129
2 I-Disease 0 0.02148592285811901
, O 0 0.012434501200914383
one O 0 0.012454619631171227
with O 0 0.019246166571974754
SWS B-Disease 1 0.9999922513961792
) O 0 0.027211584150791168
surviving O 0 0.06419089436531067
beyond O 0 0.04329536855220795
infancy O 1 0.7279950380325317
adds O 0 0.03433595597743988
to O 0 0.014790479093790054
the O 0 0.014359250664710999
evidence O 0 0.013432021252810955
in O 0 0.011217232793569565
favor O 0 0.020963767543435097
of O 0 0.026838215067982674
identity O 0 0.051580529659986496
. O 0 0.04340382292866707

The O 0 0.04165008291602135
hypothesis O 0 0.05057468265295029
that O 0 0.024518141523003578
SWS B-Disease 1 0.999987006187439
and O 0 0.29444390535354614
SJS B-Disease 1 1.0
type I-Disease 0 0.27416589856147766
2 I-Disease 0 0.023789096623659134
are O 0 0.007840909995138645
the O 0 0.017100147902965546
same O 0 0.026090195402503014
disorder O 1 0.9999971389770508
should O 0 0.02213837206363678
be O 0 0.01478741504251957
testable O 0 0.04602600634098053
by O 0 0.020264243707060814
molecular O 0 0.03211484104394913
methods O 0 0.02378815971314907
. O 0 0.02269575744867325
. O 0 0.032169196754693985

A O 0 0.06826378405094147
mouse O 0 0.0663541927933693
model O 0 0.03406568244099617
of O 0 0.035462021827697754
severe O 1 0.9999986886978149
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999973773956299
defects O 1 0.9999997615814209
in O 1 0.9841924905776978
hemostasis O 1 1.0
and O 1 0.9999189376831055
thrombosis B-Disease 1 1.0
. O 1 0.8384526371955872

von B-Disease 1 0.9981995820999146
Willebrand I-Disease 1 0.9999996423721313
factor I-Disease 1 0.9995589852333069
( I-Disease 1 0.9257083535194397
vWf I-Disease 1 0.9999990463256836
) I-Disease 1 0.9984669089317322
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9957499504089355
humans O 0 0.21108365058898926
. O 0 0.05463852360844612

We O 0 0.031300172209739685
generated O 0 0.027898384258151054
a O 0 0.028582783415913582
mouse O 0 0.048615824431180954
model O 0 0.026021450757980347
for O 0 0.015777168795466423
this O 0 0.018239781260490417
disease O 1 0.9985132813453674
by O 0 0.02344987913966179
using O 0 0.02410685457289219
gene O 0 0.04071033000946045
targeting O 0 0.053877636790275574
. O 0 0.04248956963419914

vWf B-Disease 1 0.9999784231185913
- I-Disease 1 0.9999991655349731
deficient I-Disease 1 0.9999516010284424
mice O 0 0.06375702470541
appeared O 0 0.033730871975421906
normal O 0 0.02718677930533886
at O 0 0.027025824412703514
birth O 0 0.3667904734611511
; O 0 0.016969338059425354
they O 0 0.009449134580790997
were O 0 0.013165902346372604
viable O 0 0.04450579360127449
and O 0 0.02991768904030323
fertile O 0 0.28197741508483887
. O 0 0.04980527609586716

Neither O 0 0.12549737095832825
vWf O 1 0.8452535271644592
nor O 0 0.09750815480947495
vWf O 1 0.9771273732185364
propolypeptide O 1 0.9931455850601196
( O 0 0.06765861809253693
von B-Disease 1 0.9998507499694824
Willebrand I-Disease 1 1.0
antigen O 1 0.9999995231628418
II O 1 0.9999961853027344
) O 0 0.0236988365650177
were O 0 0.013058008626103401
detectable O 0 0.04442181810736656
in O 0 0.017291788011789322
plasma O 1 0.9324188828468323
, O 0 0.03552660346031189
platelets O 1 0.9999703168869019
, O 0 0.034974269568920135
or O 0 0.03714701533317566
endothelial O 1 0.9998483657836914
cells O 0 0.02708190307021141
of O 0 0.02043253183364868
the O 0 0.0350610688328743
homozygous O 0 0.38993921875953674
mutant O 1 0.9855323433876038
mice O 0 0.10467986762523651
. O 0 0.05706494301557541

The O 0 0.06240939721465111
mutant O 1 0.9916529059410095
mice O 1 0.8634006977081299
exhibited O 1 0.9858420491218567
defects O 1 0.9999269247055054
in O 0 0.030634071677923203
hemostasis O 1 0.9999964237213135
with O 0 0.02596898563206196
a O 0 0.07503917068243027
highly O 1 0.9870309233665466
prolonged O 1 0.9999997615814209
bleeding O 1 1.0
time O 0 0.23353615403175354
and O 1 0.8813422918319702
spontaneous O 1 0.9999951124191284
bleeding O 1 0.9999998807907104
events O 0 0.022055912762880325
in O 0 0.014069643802940845
approximately O 0 0.016538310796022415
10 O 0 0.020360982045531273
% O 0 0.025514688342809677
of O 0 0.03776680305600166
neonates O 1 0.9984174966812134
. O 0 0.06283324956893921

As O 0 0.027582479640841484
in O 0 0.01642872393131256
the O 0 0.02379986271262169
human O 1 0.7419515252113342
disease O 1 0.9999924898147583
, O 0 0.020895129069685936
the O 0 0.031976450234651566
factor O 1 0.9923542737960815
VIII O 1 0.9999996423721313
level O 0 0.03540103882551193
in O 0 0.01277178805321455
these O 0 0.010818974114954472
mice O 0 0.026554042473435402
was O 0 0.019106583669781685
reduced O 0 0.018094753846526146
strongly O 0 0.01626264862716198
as O 0 0.01127677597105503
a O 0 0.01321543287485838
result O 0 0.011199629865586758
of O 0 0.011659146286547184
the O 0 0.017146844416856766
lack O 0 0.030763879418373108
of O 0 0.028356198221445084
protection O 1 0.9817574620246887
provided O 0 0.03642900288105011
by O 0 0.044187143445014954
vWf O 1 0.9974594712257385
. O 0 0.05439179018139839

Defective O 1 0.9999949932098389
thrombosis B-Disease 1 1.0
in O 1 0.5582413673400879
mutant O 1 0.9999909400939941
mice O 1 0.9600498080253601
was O 0 0.036073897033929825
also O 0 0.014834693633019924
evident O 0 0.02176818810403347
in O 0 0.009389468468725681
an O 0 0.011269633658230305
in O 0 0.014158228412270546
vivo O 1 0.8881633877754211
model O 0 0.04216654226183891
of O 1 0.8938332200050354
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999988079071045
. O 0 0.27768179774284363

In O 0 0.030160613358020782
this O 0 0.01676999405026436
model O 0 0.026426929980516434
, O 0 0.016013851389288902
the O 0 0.024555930867791176
exteriorized O 1 0.9981651902198792
mesentery O 1 0.9997988343238831
was O 0 0.0916050598025322
superfused O 1 0.9996798038482666
with O 1 0.5150159597396851
ferric O 1 1.0
chloride O 1 0.9999605417251587
and O 0 0.022757936269044876
the O 0 0.026118556037545204
accumulation O 1 0.9808321595191956
of O 0 0.053804609924554825
fluorescently O 1 0.9999951124191284
labeled O 1 0.9994644522666931
platelets O 1 0.9998873472213745
was O 0 0.04511193558573723
observed O 0 0.03139108419418335
by O 0 0.0353795662522316
intravital O 1 0.9981076717376709
microscopy O 0 0.11623124778270721
. O 0 0.04815276712179184

We O 0 0.032227110117673874
conclude O 0 0.04091290757060051
that O 0 0.012574334628880024
these O 0 0.011378421448171139
mice O 0 0.02519470453262329
very O 0 0.014027046039700508
closely O 0 0.0236482173204422
mimic O 1 0.8507118225097656
severe O 1 0.9999490976333618
human O 1 0.9999773502349854
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9974679946899414
will O 0 0.029328826814889908
be O 0 0.011362872086465359
very O 0 0.011249026283621788
useful O 0 0.010700378566980362
for O 0 0.008328324183821678
investigating O 0 0.017835041508078575
the O 0 0.014691142365336418
role O 0 0.027009690180420876
of O 0 0.027800561860203743
vWf O 1 0.9997770190238953
in O 0 0.021566106006503105
normal O 0 0.04048803821206093
physiology O 1 0.9656341671943665
and O 0 0.029276883229613304
in O 0 0.09124947339296341
disease O 1 0.9999994039535522
models O 0 0.05099402740597725
. O 0 0.027992814779281616
. O 0 0.03847435861825943

Oral O 1 0.9675769805908203
contraceptives O 1 0.995061457157135
and O 0 0.02378668822348118
the O 0 0.02600492350757122
risk O 1 0.9750619530677795
of O 1 0.999800980091095
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.999852180480957

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999992847442627
Study O 1 0.8712234497070312
Group O 1 0.5642803907394409
. O 0 0.049748025834560394

BACKGROUND O 0 0.10554710775613785
Women O 0 0.040927473455667496
with O 0 0.01980043388903141
mutations O 0 0.022598952054977417
in O 0 0.011113028973340988
either O 0 0.015329239889979362
the O 0 0.02360605262219906
BRCA1 O 1 0.999589741230011
or O 0 0.02104293368756771
the O 0 0.03401593863964081
BRCA2 O 1 0.9998735189437866
gene O 0 0.022370770573616028
have O 0 0.008118193596601486
a O 0 0.01551046222448349
high O 0 0.03398461267352104
lifetime O 1 0.900658130645752
risk O 1 0.9991368651390076
of O 1 0.9999872446060181
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9831063747406006

Oral O 1 0.7838484644889832
contraceptives O 1 0.9995393753051758
protect O 1 0.9994723200798035
against O 1 0.9999997615814209
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.9296846985816956
general O 1 0.9988349080085754
, O 0 0.0194677896797657
but O 0 0.009751111268997192
it O 0 0.007687789853662252
is O 0 0.009054613299667835
not O 0 0.007010566536337137
known O 0 0.01293192245066166
whether O 0 0.008648186922073364
they O 0 0.005766197573393583
also O 0 0.008227474987506866
protect O 0 0.021433977410197258
against O 0 0.02736184000968933
hereditary B-Disease 1 0.9999960660934448
forms I-Disease 1 0.9960414171218872
of I-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9977657794952393

METHODS O 0 0.04764213413000107
We O 0 0.021283913403749466
enrolled O 0 0.04656432196497917
207 O 0 0.07670073211193085
women O 0 0.044567130506038666
with O 1 0.9021878838539124
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9917884469032288
161 O 1 0.9948843121528625
of O 0 0.024910368025302887
their O 0 0.017514610663056374
sisters O 1 0.8927702903747559
as O 0 0.017652714625000954
controls O 0 0.02206426113843918
in O 0 0.010525009594857693
a O 0 0.021258248016238213
case O 0 0.17538033425807953
- O 1 0.9999392032623291
control O 0 0.04639170318841934
study O 0 0.030537467449903488
. O 0 0.034525997936725616

All O 0 0.03255084156990051
the O 0 0.0375513881444931
patients O 0 0.2889103293418884
carried O 0 0.029714109376072884
a O 0 0.030843358486890793
pathogenic O 0 0.12058798223733902
mutation O 0 0.03194378688931465
in O 0 0.015969714149832726
either O 0 0.02462649531662464
BRCA1 O 1 0.9996635913848877
( O 0 0.02688881941139698
179 O 0 0.223885640501976
women O 0 0.047533027827739716
) O 0 0.028584972023963928
or O 0 0.03114554099738598
BRCA2 O 1 0.9998934268951416
( O 0 0.03727851063013077
28 O 0 0.04882238805294037
women O 0 0.05508648231625557
) O 0 0.036654289811849594
. O 0 0.03931714594364166

The O 0 0.049199532717466354
control O 0 0.04366239905357361
women O 0 0.03273981437087059
were O 0 0.01718520186841488
enrolled O 0 0.04674999788403511
regardless O 0 0.023663077503442764
of O 0 0.018740588799118996
whether O 0 0.01930706575512886
or O 0 0.013483807444572449
not O 0 0.01095674466341734
they O 0 0.009260419756174088
had O 0 0.019180389121174812
either O 0 0.026420973241329193
mutation O 0 0.05860842764377594
. O 0 0.0371360257267952

Lifetime O 0 0.0848132073879242
histories O 0 0.0587700679898262
of O 0 0.04036853462457657
oral O 1 0.9999885559082031
- O 1 1.0
contraceptive O 1 0.9999990463256836
use O 0 0.015513732098042965
were O 0 0.00877379160374403
obtained O 0 0.01200714148581028
by O 0 0.011349882930517197
interview O 0 0.02113211899995804
or O 0 0.010095573961734772
by O 0 0.010618573054671288
written O 0 0.014791909605264664
questionnaire O 0 0.030299942940473557
and O 0 0.009978114627301693
were O 0 0.009574372321367264
compared O 0 0.01641802489757538
between O 0 0.022213464602828026
patients O 1 0.999568521976471
and O 0 0.02323552779853344
control O 1 0.5980410575866699
women O 0 0.16494248807430267
, O 0 0.018936462700366974
after O 0 0.02394716627895832
adjustment O 0 0.146833136677742
for O 0 0.013908961787819862
year O 0 0.017813721671700478
of O 0 0.025204617530107498
birth O 1 0.9070114493370056
and O 0 0.038529880344867706
parity O 1 0.9715327024459839
. O 0 0.054277125746011734

RESULTS O 0 0.0330042690038681
The O 0 0.026023179292678833
adjusted O 0 0.03679032623767853
odds O 0 0.0498613640666008
ratio O 0 0.09635532647371292
for O 1 0.9925493001937866
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.4531081020832062
with O 0 0.015876643359661102
any O 0 0.012681011110544205
past O 0 0.015566574409604073
use O 0 0.012044946663081646
of O 0 0.021136796101927757
oral O 1 0.9995338916778564
contraceptives O 1 0.9999932050704956
was O 1 0.7785340547561646
0 O 0 0.06520766764879227
. O 0 0.04122575744986534

5 O 0 0.06057337298989296
( O 0 0.03396187722682953
95 O 0 0.03618009015917778
percent O 0 0.024881841614842415
confidence O 0 0.04746384546160698
interval O 0 0.04746180772781372
, O 0 0.02131747268140316
0 O 0 0.027517875656485558
. O 0 0.011110613122582436
3 O 0 0.017177529633045197
to O 0 0.015163655392825603
0 O 0 0.035022661089897156
. O 0 0.01926335133612156
8 O 0 0.03689173609018326
) O 0 0.030080555006861687
. O 0 0.033320799469947815

The O 0 0.0705665722489357
risk O 1 0.6891522407531738
decreased O 0 0.04969283565878868
with O 0 0.020250994712114334
increasing O 0 0.025403613224625587
duration O 0 0.04060836136341095
of O 0 0.02134016714990139
use O 0 0.019926540553569794
( O 0 0.026146378368139267
P O 0 0.44982072710990906
for O 0 0.01828688196837902
trend O 0 0.03612678125500679
, O 0 0.025380568578839302
< O 1 0.8293141722679138
0 O 0 0.04000267758965492
. O 0 0.023868722841143608
001 O 1 0.9976605176925659
) O 0 0.019352911040186882
; O 0 0.01116830576211214
use O 0 0.007454940117895603
for O 0 0.009062741883099079
six O 0 0.01239025965332985
or O 0 0.010351437143981457
more O 0 0.007523191627115011
years O 0 0.013174552470445633
was O 0 0.018127044662833214
associated O 0 0.012251137755811214
with O 0 0.010379190556704998
a O 0 0.01898762583732605
60 O 0 0.023614797741174698
percent O 0 0.025658847764134407
reduction O 0 0.051334407180547714
in O 0 0.028237592428922653
risk O 0 0.3857223689556122
. O 0 0.05082722753286362

Oral O 1 0.9961347579956055
- O 1 0.9999057054519653
contraceptive O 1 0.9993921518325806
use O 0 0.02452177368104458
protected O 1 0.5655576586723328
against O 1 0.999948263168335
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.02123391442000866
for O 0 0.015299196355044842
carriers O 0 0.024149436503648758
of O 0 0.015058888122439384
the O 0 0.038455020636320114
BRCA1 O 1 0.9999964237213135
mutation O 1 0.6246732473373413
( O 0 0.02396443672478199
odds O 0 0.04589971527457237
ratio O 0 0.03799620270729065
, O 0 0.01791880652308464
0 O 0 0.024726925417780876
. O 0 0.01260063610970974
5 O 0 0.017605939880013466
; O 0 0.012821877375245094
95 O 0 0.023111194372177124
percent O 0 0.019813569262623787
confidence O 0 0.03976089134812355
interval O 0 0.03958550840616226
, O 0 0.019220376387238503
0 O 0 0.026550952345132828
. O 0 0.011115076951682568
3 O 0 0.01438151765614748
to O 0 0.012563173659145832
0 O 0 0.025592025369405746
. O 0 0.012312928214669228
9 O 0 0.021019646897912025
) O 0 0.010768945328891277
and O 0 0.009230348281562328
for O 0 0.010179055854678154
carriers O 0 0.021747760474681854
of O 0 0.01692211627960205
the O 0 0.03430921956896782
BRCA2 O 1 0.9999849796295166
mutation O 1 0.673907995223999
( O 0 0.026950005441904068
odds O 0 0.055085767060518265
ratio O 0 0.03771313279867172
, O 0 0.017952492460608482
0 O 0 0.024694209918379784
. O 0 0.012807568535208702
4 O 0 0.019058506935834885
; O 0 0.013456320390105247
95 O 0 0.022958356887102127
percent O 0 0.0203607976436615
confidence O 0 0.040553707629442215
interval O 0 0.044596944004297256
, O 0 0.018624860793352127
0 O 0 0.02514394000172615
. O 0 0.010727260261774063
2 O 0 0.01657339371740818
to O 0 0.01465759240090847
1 O 0 0.025795776396989822
. O 0 0.017493961378932
1 O 0 0.0342361256480217
) O 0 0.027865998446941376
. O 0 0.0326642207801342

CONCLUSIONS O 0 0.09043368697166443
Oral O 1 0.9995046854019165
- O 1 0.9999988079071045
contraceptive O 1 0.9999845027923584
use O 0 0.017870837822556496
may O 0 0.012797771021723747
reduce O 0 0.01640390045940876
the O 0 0.014875941909849644
risk O 1 0.9926491379737854
of O 1 0.9999874830245972
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.4298342764377594
women O 1 0.5895916819572449
with O 0 0.025343021377921104
pathogenic O 1 0.990231454372406
mutations O 0 0.026094647124409676
in O 0 0.016679517924785614
the O 0 0.044315725564956665
BRCA1 O 1 0.9999959468841553
or O 0 0.16814610362052917
BRCA2 O 1 0.99985671043396
gene O 0 0.10717833042144775

A O 0 0.06450426578521729
Japanese O 0 0.06116786599159241
family O 0 0.04524992033839226
with O 0 0.03193151205778122
adrenoleukodystrophy B-Disease 1 0.9999992847442627
with O 0 0.026997098699212074
a O 0 0.03501008078455925
codon O 0 0.08778219670057297
291 O 0 0.35446637868881226
deletion O 0 0.07599183171987534
: O 0 0.02428838610649109
a O 0 0.026022961363196373
clinical O 1 0.97567218542099
, O 0 0.034396205097436905
biochemical O 1 0.9567026495933533
, O 0 0.048033203929662704
pathological O 1 0.999935507774353
, O 0 0.03698715567588806
and O 0 0.0301361046731472
genetic O 0 0.04128102585673332
report O 0 0.03009605035185814
. O 0 0.03566392883658409

We O 0 0.02290990948677063
report O 0 0.0163639597594738
a O 0 0.017000114545226097
Japanese O 0 0.031577836722135544
family O 0 0.0344778336584568
with O 0 0.3321211338043213
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.999996542930603
ALD B-Disease 1 1.0
) O 0 0.023808542639017105
with O 0 0.012143873609602451
a O 0 0.014788667671382427
three O 0 0.013353483751416206
base O 0 0.032939523458480835
pair O 0 0.036685116589069366
deletion O 0 0.06829887628555298
( O 0 0.03411801531910896
delGAG O 1 0.996124804019928
291 O 0 0.35718315839767456
) O 0 0.020160701125860214
in O 0 0.018106643110513687
the O 0 0.05592803284525871
ALD B-Disease 1 1.0
gene O 0 0.08993051201105118
. O 0 0.05358473211526871

A O 0 0.05965800583362579
variety O 0 0.029992546886205673
of O 0 0.03224523365497589
phenotypes O 0 0.23966899514198303
were O 0 0.016846563667058945
observed O 0 0.022241177037358284
within O 0 0.019489770755171776
this O 0 0.019153693690896034
family O 0 0.04884204640984535
. O 0 0.04536870867013931

While O 0 0.03764719516038895
the O 0 0.042788371443748474
proband O 1 0.9998016953468323
( O 0 0.05029032751917839
patient O 1 0.9973012804985046
1 O 0 0.0337335541844368
) O 0 0.017136327922344208
was O 0 0.019929733127355576
classified O 0 0.01838604174554348
as O 0 0.011645023711025715
having O 0 0.014055020175874233
a O 0 0.01743638701736927
rare O 0 0.029907062649726868
intermediate O 1 0.546838641166687
type O 0 0.026694225147366524
of O 0 0.02157316915690899
adult O 1 0.9335533380508423
cerebral O 1 0.999996542930603
and O 1 0.9717028737068176
cerebello O 1 1.0
- O 1 1.0
brain O 1 0.9999103546142578
stem O 0 0.10846986621618271
forms O 0 0.016508949920535088
, O 0 0.014423639513552189
his O 0 0.03059295192360878
younger O 1 0.9899016618728638
brother O 1 0.9996739625930786
( O 0 0.04009624570608139
patient O 1 0.9988290667533875
2 O 0 0.02851114608347416
) O 0 0.01819748803973198
and O 0 0.019281800836324692
nephew O 1 0.9999823570251465
( O 0 0.04032255709171295
patient O 1 0.9962168335914612
3 O 0 0.026390038430690765
) O 0 0.01697416789829731
had O 0 0.02075347676873207
a O 0 0.05523918569087982
childhood O 1 0.9999994039535522
ALD B-Disease 1 1.0
type O 1 0.9998959302902222
. O 0 0.07108508050441742

Another O 0 0.0990983322262764
nephew O 1 0.999962329864502
( O 0 0.05758923664689064
patient O 1 0.9960877895355225
4 O 0 0.030935127288103104
) O 0 0.016439368948340416
of O 0 0.01856883056461811
patient O 1 0.9995798468589783
1 O 0 0.030267557129263878
was O 0 0.02192995883524418
classified O 0 0.02175593189895153
as O 0 0.013666936196386814
having O 0 0.020134836435317993
an O 0 0.029163433238863945
adolescent O 1 0.9999955892562866
form O 0 0.3658910393714905
. O 0 0.05078708752989769

The O 0 0.050328221172094345
tau O 1 0.8035188913345337
level O 0 0.029964812099933624
in O 0 0.01958002895116806
the O 0 0.042993608862161636
cerebrospinal O 1 0.9999986886978149
fluid O 1 0.9997411370277405
( O 1 0.554907500743866
CSF O 1 0.999997615814209
) O 0 0.02186322771012783
in O 0 0.016761545091867447
patient O 1 0.9901217818260193
1 O 0 0.023850707337260246
was O 0 0.018401548266410828
as O 0 0.011456537060439587
high O 0 0.01573782041668892
as O 0 0.008838051930069923
that O 0 0.006156705319881439
of O 0 0.016601335257291794
patients O 1 0.9999376535415649
with O 1 0.9999727010726929
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9994551539421082
AD B-Disease 1 0.9990347623825073
) O 0 0.041227858513593674
. O 0 0.03839024901390076

His O 0 0.2837029695510864
brain O 1 0.991375744342804
magnetic O 0 0.07052410393953323
resonance O 1 0.5820187926292419
image O 1 0.9745357632637024
( O 0 0.04404815286397934
MRI O 1 0.9936462640762329
) O 0 0.02387790009379387
showed O 0 0.025956885889172554
abnormalities B-Disease 0 0.322283536195755
in I-Disease 0 0.012139035388827324
the I-Disease 0 0.022865338250994682
bilateral I-Disease 1 0.9977972507476807
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.999968409538269
and O 1 0.9990430474281311
brain O 1 0.9999985694885254
stem O 1 0.9948711395263672
, O 0 0.01708723045885563
but O 0 0.009890478104352951
not O 0 0.007513925898820162
in O 0 0.010171962901949883
the O 0 0.026327092200517654
cerebral O 1 0.9999971389770508
white O 1 0.9924675822257996
matter O 0 0.023351509124040604
, O 0 0.01513885147869587
where O 0 0.01377153117209673
marked O 0 0.021472599357366562
reductions O 0 0.02540290728211403
of O 0 0.01860588788986206
the O 1 0.7774428129196167
cerebral O 1 1.0
blood O 1 0.9999972581863403
flow O 1 0.9443460702896118
and O 0 0.3107184171676636
oxygen O 1 0.9988071918487549
metabolism O 0 0.46148815751075745
were O 0 0.013290535658597946
clearly O 0 0.01903507113456726
demonstrated O 0 0.023792002350091934
by O 0 0.025589872151613235
positron O 1 0.9882273077964783
emission O 0 0.3583807349205017
tomography O 1 0.9070031046867371
( O 0 0.05656828358769417
PET O 1 0.9380192756652832
) O 0 0.04100124165415764
. O 0 0.040507201105356216

In O 0 0.04970988631248474
patients O 1 0.9618738889694214
2 O 0 0.033949416130781174
and O 0 0.018665526062250137
3 O 0 0.022206053137779236
, O 0 0.014601865783333778
the O 0 0.017145801335573196
autopsy O 0 0.3037545680999756
findings O 0 0.02015136368572712
showed O 0 0.023682139813899994
massive O 1 0.954056978225708
demyelination B-Disease 1 0.9999998807907104
of I-Disease 1 0.808113694190979
the I-Disease 1 0.9987726807594299
cerebral I-Disease 1 0.9999998807907104
white I-Disease 1 0.9907016754150391
matter I-Disease 0 0.018566064536571503
with O 0 0.012569060549139977
sparing O 0 0.08904719352722168
of O 0 0.01754121482372284
the O 1 0.7832814455032349
U O 1 1.0
- O 1 0.9999997615814209
fibers O 1 0.9762060642242432
, O 0 0.01967586949467659
compatible O 0 0.026450783014297485
with O 0 0.011751133017241955
the O 0 0.017798636108636856
findings O 0 0.028279675170779228
of O 0 0.053422603756189346
childhood O 1 0.9999992847442627
ALD B-Disease 1 1.0
. O 1 0.5593584179878235

Oleic O 1 0.9966222047805786
and O 0 0.08278075605630875
erucic O 1 0.9999469518661499
acids O 0 0.09897292405366898
( O 0 0.05001721531152725
Lorenzos O 1 0.999158501625061
Oil O 0 0.0383656844496727
) O 0 0.01614091917872429
were O 0 0.010778779163956642
administered O 0 0.03726635500788689
to O 0 0.02103138528764248
patients O 1 0.973361074924469
1 O 0 0.028412604704499245
and O 0 0.017501259222626686
4 O 0 0.024856621399521828
, O 0 0.015636779367923737
but O 0 0.011904731392860413
sufficient O 0 0.02544182352721691
effectiveness O 0 0.03957883641123772
was O 0 0.030752647668123245
not O 0 0.01795097067952156
obtained O 0 0.027323182672262192
. O 0 0.03841373696923256

The O 0 0.04219900444149971
findings O 0 0.027222508564591408
in O 0 0.014555906876921654
this O 0 0.013242715038359165
family O 0 0.025913147255778313
suggest O 0 0.01688534766435623
that O 0 0.01235626358538866
delGAG291 O 1 0.9218035936355591
is O 0 0.013182328082621098
part O 0 0.013920255936682224
of O 0 0.012766577303409576
the O 0 0.019159642979502678
cause O 0 0.49082398414611816
of O 0 0.04045117273926735
Japanese O 1 0.9996709823608398
ALD B-Disease 1 1.0
with O 0 0.05320082604885101
phenotypic O 0 0.2911933958530426
variations O 0 0.04971633106470108
. O 0 0.04376060515642166

Moreover O 0 0.0664711520075798
, O 0 0.02185152843594551
although O 0 0.011643009260296822
the O 0 0.014053897000849247
scale O 0 0.018511084839701653
of O 0 0.013017726130783558
the O 0 0.016910774633288383
study O 0 0.016307244077324867
is O 0 0.012827999889850616
limited O 0 0.014107377268373966
, O 0 0.010907490737736225
there O 0 0.00773212406784296
is O 0 0.009759998880326748
a O 0 0.01384566631168127
possibility O 0 0.01987520046532154
that O 0 0.014421693980693817
PET O 1 0.9556296467781067
can O 0 0.013705955818295479
detect O 0 0.03590328246355057
an O 0 0.02545998804271221
insidious B-Disease 1 0.999998927116394
lesion I-Disease 1 0.9999985694885254
which O 0 0.019299546256661415
is O 0 0.019168291240930557
undetectable O 1 0.9271636605262756
by O 0 0.02094578929245472
computed O 0 0.045431092381477356
tomogram O 1 0.9999668598175049
( O 1 0.6591787934303284
CT O 1 0.9999979734420776
) O 0 0.02707388810813427
or O 0 0.02215481363236904
MRI O 1 0.9495061635971069
analysis O 0 0.014969948679208755
, O 0 0.01226598210632801
and O 0 0.008892637677490711
that O 0 0.006378010846674442
the O 0 0.010357956402003765
higher O 0 0.011639601550996304
level O 0 0.0154741695150733
of O 0 0.018910974264144897
tau O 1 0.9917851686477661
reflects O 0 0.033453017473220825
the O 0 0.01789248362183571
process O 0 0.021245839074254036
of O 0 0.04081649333238602
neuronal B-Disease 1 0.9999309778213501
degeneration I-Disease 1 1.0
in O 1 0.99669349193573
ALD B-Disease 1 1.0
. O 0 0.10880874842405319

Lorenzos O 1 0.9981529116630554
Oil O 0 0.0642792358994484
should O 0 0.02011311613023281
be O 0 0.010789955966174603
given O 0 0.011730717495083809
in O 0 0.01165787223726511
the O 0 0.01841268315911293
early O 0 0.030352678149938583
stage O 0 0.11336537450551987
. O 0 0.030080977827310562
. O 0 0.036851394921541214

Nonsense O 0 0.16560789942741394
mutation O 0 0.06326572597026825
in O 0 0.024555526673793793
exon O 0 0.07358534634113312
4 O 0 0.025486407801508904
of O 0 0.019049901515245438
human O 0 0.03193553537130356
complement O 1 0.9284722805023193
C9 O 1 0.9999994039535522
gene O 0 0.036695726215839386
is O 0 0.014834324829280376
the O 0 0.016234315931797028
major O 0 0.0275302454829216
cause O 0 0.041554130613803864
of O 0 0.031039239838719368
Japanese O 1 0.9917628765106201
complement B-Disease 1 0.9999723434448242
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.22920621931552887

Deficiency B-Disease 1 0.9999983310699463
of I-Disease 0 0.03495841845870018
the I-Disease 0 0.04223158583045006
ninth I-Disease 1 0.9997068047523499
component I-Disease 1 0.7198942303657532
of I-Disease 0 0.02298814058303833
human I-Disease 0 0.2828468382358551
complement I-Disease 1 0.9971035122871399
( O 0 0.3101065456867218
C9 O 1 0.9999991655349731
) O 0 0.018855268135666847
is O 0 0.010176888667047024
the O 0 0.011555698700249195
most O 0 0.014370011165738106
common O 0 0.4887399673461914
complement B-Disease 1 0.9999996423721313
deficiency I-Disease 1 1.0
in O 0 0.17016065120697021
Japan O 1 0.9516190886497498
but O 0 0.01639379747211933
is O 0 0.016198737546801567
rare O 0 0.022578787058591843
in O 0 0.013660753145813942
other O 0 0.013607093133032322
countries O 0 0.019991550594568253
. O 0 0.03683450445532799

We O 0 0.028113504871726036
studied O 0 0.024279460310935974
the O 0 0.017884565517306328
molecular O 0 0.020134611055254936
basis O 0 0.01586781069636345
of O 0 0.09366051852703094
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.020824378356337547
four O 0 0.022866996005177498
Japanese O 1 0.9878267645835876
C9 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999994039535522
patients O 1 0.9978633522987366
who O 0 0.04123348370194435
had O 0 0.07531256973743439
suffered O 1 0.9999978542327881
from O 1 0.9999403953552246
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9981558918952942

Direct O 0 0.05764775350689888
sequencing O 0 0.04839908704161644
of O 0 0.04030897840857506
amplified O 0 0.48575127124786377
C9 O 1 0.9999170303344727
cDNA O 0 0.10304661840200424
and O 0 0.02594901993870735
DNA O 0 0.026894651353359222
revealed O 0 0.024412523955106735
a O 0 0.023523105308413506
nonsense O 0 0.06101483479142189
substitution O 0 0.044716741889715195
( O 0 0.029177339747548103
CGA O 1 0.8741082549095154
- O 1 0.9999926090240479
- O 1 0.999996542930603
> O 1 0.9983422756195068
TGA O 1 0.9992153644561768
) O 0 0.024168139323592186
at O 0 0.022623000666499138
codon O 0 0.04878730699419975
95 O 0 0.02726462297141552
in O 0 0.015089817345142365
exon O 0 0.051601193845272064
4 O 0 0.019621191546320915
in O 0 0.009700548835098743
the O 0 0.017359746620059013
four O 0 0.03713830187916756
C9 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
deficient I-Disease 1 0.999985933303833
individuals O 0 0.049333665519952774
. O 0 0.04661606624722481

An O 0 0.05196382477879524
allele O 0 0.1073671281337738
- O 1 0.9783727526664734
specific O 0 0.0289712306112051
polymerase O 1 0.7732465863227844
chain O 0 0.14244011044502258
reaction O 0 0.045534905046224594
system O 0 0.029812734574079514
designed O 0 0.031940437853336334
to O 0 0.018661094829440117
detect O 0 0.02867709845304489
exclusively O 0 0.014935743995010853
only O 0 0.0069889468140900135
one O 0 0.008126990869641304
of O 0 0.009872522205114365
the O 0 0.015874259173870087
normal O 0 0.021967310458421707
and O 0 0.0216833483427763
mutant O 1 0.8987056016921997
alleles O 0 0.044041913002729416
indicated O 0 0.01959182508289814
that O 0 0.008424589410424232
all O 0 0.008364811539649963
the O 0 0.013887063600122929
four O 0 0.01713324710726738
patients O 0 0.1191948801279068
were O 0 0.013189222663640976
homozygous O 0 0.03377143666148186
for O 0 0.013869386166334152
the O 0 0.020813826471567154
mutation O 0 0.03293255344033241
in O 0 0.016974851489067078
exon O 0 0.34862539172172546
4 O 0 0.021645989269018173
and O 0 0.010844667442142963
that O 0 0.007291268557310104
the O 0 0.013989359140396118
parents O 0 0.02397480234503746
of O 0 0.026962650939822197
patient O 1 0.9998618364334106
2 O 0 0.04119473695755005
were O 0 0.025800343602895737
heterozygous O 0 0.07116025686264038
. O 0 0.04313642904162407

The O 0 0.05134901776909828
common O 0 0.04183203727006912
mutation O 0 0.047194190323352814
at O 0 0.028934216126799583
codon O 0 0.05620088428258896
95 O 0 0.030289748683571815
in O 0 0.01705601066350937
exon O 0 0.07364003360271454
4 O 0 0.027640219777822495
might O 0 0.014646646566689014
be O 0 0.009145751595497131
responsible O 0 0.01746250130236149
for O 0 0.013741222210228443
most O 0 0.023535966873168945
Japanese O 1 0.9995545744895935
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.07829983532428741
. O 0 0.062203243374824524

BRCA1 O 1 0.7876415252685547
required O 0 0.027381980791687965
for O 0 0.02742639370262623
transcription O 1 0.9082127213478088
- O 1 0.9999803304672241
coupled O 1 0.8727179765701294
repair O 1 0.9909623265266418
of O 0 0.06126315891742706
oxidative O 1 0.99996018409729
DNA O 0 0.28739675879478455
damage O 0 0.33684003353118896
. O 0 0.052651599049568176

The O 0 0.07919026911258698
breast B-Disease 1 0.9999997615814209
and I-Disease 1 0.9999809265136719
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 1 0.9998182654380798
BRCA1 O 1 0.9999898672103882
encodes O 0 0.060974277555942535
a O 0 0.04903920367360115
zinc O 1 0.9999842643737793
finger O 1 0.9965057373046875
protein O 0 0.03119686059653759
of O 0 0.024107560515403748
unknown O 0 0.039514705538749695
function O 0 0.038287144154310226
. O 0 0.03927312418818474

Association O 0 0.04561043903231621
of O 0 0.025598689913749695
the O 0 0.03574176877737045
BRCA1 O 1 0.9995817542076111
protein O 0 0.021048452705144882
with O 0 0.01122372318059206
the O 0 0.01985255256295204
DNA O 0 0.051799893379211426
repair O 1 0.9995552897453308
protein O 0 0.04656407982110977
Rad51 O 1 0.9971020817756653
and O 0 0.01786942034959793
changes O 0 0.012370886281132698
in O 0 0.009710658341646194
the O 0 0.016796132549643517
phosphorylation O 0 0.035498034209012985
and O 0 0.017107168212532997
cellular O 0 0.029965773224830627
localization O 0 0.03536276891827583
of O 0 0.01452114712446928
the O 0 0.019485313445329666
protein O 0 0.020466608926653862
after O 0 0.018676824867725372
exposure O 0 0.03141011670231819
to O 0 0.01757996529340744
DNA O 0 0.04047296568751335
- O 1 0.9997166991233826
damaging O 0 0.06223592907190323
agents O 0 0.019508037716150284
are O 0 0.006761397235095501
consistent O 0 0.014554524794220924
with O 0 0.009157678112387657
a O 0 0.01631811633706093
role O 0 0.030596280470490456
for O 0 0.025212062522768974
BRCA1 O 1 0.999821126461029
in O 0 0.030312513932585716
DNA O 0 0.06544722616672516
repair O 1 0.9795486927032471
. O 0 0.04725039005279541

Here O 0 0.03781696408987045
, O 0 0.019805118441581726
it O 0 0.010096370242536068
is O 0 0.010533904656767845
shown O 0 0.00952101033180952
that O 0 0.010071528144180775
mouse O 0 0.03615777939558029
embryonic O 0 0.061492860317230225
stem O 0 0.4441596269607544
cells O 0 0.17472442984580994
deficient B-Disease 1 0.9998074173927307
in I-Disease 0 0.028891073539853096
BRCA1 I-Disease 1 0.9998718500137329
are O 0 0.017006611451506615
defective O 1 0.9519637227058411
in O 0 0.015347611159086227
the O 0 0.01671176217496395
ability O 0 0.015162126161158085
to O 0 0.010615301318466663
carry O 0 0.013203535228967667
out O 0 0.018465980887413025
transcription O 0 0.17114213109016418
- O 1 0.9998375177383423
coupled O 0 0.49685555696487427
repair O 1 0.9736441969871521
of O 0 0.03555335849523544
oxidative O 1 0.9999699592590332
DNA O 0 0.12699460983276367
damage O 0 0.1849288046360016
, O 0 0.016811983659863472
and O 0 0.014184067957103252
are O 0 0.012342439964413643
hypersensitive O 1 0.9999163150787354
to O 0 0.04649069532752037
ionizing O 1 0.9999979734420776
radiation O 1 0.9997064471244812
and O 0 0.03936942666769028
hydrogen O 0 0.2187003344297409
peroxide O 1 0.9073648452758789
. O 0 0.04902754724025726

These O 0 0.022294115275144577
results O 0 0.019522620365023613
suggest O 0 0.021259909495711327
that O 0 0.020259516313672066
BRCA1 O 1 0.999894380569458
participates O 0 0.39871886372566223
, O 0 0.021170534193515778
directly O 0 0.017132095992565155
or O 0 0.01378436665982008
indirectly O 0 0.023040419444441795
, O 0 0.012839931063354015
in O 0 0.014191444963216782
transcription O 1 0.561453104019165
- O 1 0.9999059438705444
coupled O 0 0.3861980736255646
repair O 1 0.9875941872596741
of O 0 0.046986617147922516
oxidative O 1 0.9999759197235107
DNA O 1 0.5894481539726257
damage O 0 0.30245333909988403
. O 0 0.03043188899755478
. O 0 0.039395734667778015

Truncation O 1 0.7843602895736694
mutations O 0 0.04941600188612938
in O 0 0.018870791420340538
the O 0 0.03004046529531479
transactivation O 1 0.9981764554977417
region O 0 0.0376482792198658
of O 0 0.035945940762758255
PAX6 O 1 0.999996542930603
result O 0 0.03171267732977867
in O 0 0.023820053786039352
dominant O 1 0.9982853531837463
- O 1 0.999975323677063
negative O 0 0.061744097620248795
mutants O 1 0.5927278995513916
. O 0 0.050198692828416824

PAX6 O 1 0.9998434782028198
is O 0 0.0417557992041111
a O 0 0.036379169672727585
transcription O 0 0.05061976984143257
factor O 0 0.024391604587435722
with O 0 0.010355423204600811
two O 0 0.010899700224399567
DNA O 0 0.028804950416088104
- O 1 0.9987209439277649
binding O 0 0.03088410198688507
domains O 0 0.03353620693087578
( O 0 0.023088736459612846
paired O 0 0.04415242001414299
box O 0 0.045167773962020874
and O 0 0.025584666058421135
homeobox O 1 0.997342050075531
) O 0 0.01688767969608307
and O 0 0.012621377594769001
a O 0 0.02413690648972988
proline O 1 0.9989076852798462
- O 1 0.999981164932251
serine O 1 0.9996416568756104
- O 1 0.9999778270721436
threonine O 1 0.9968430995941162
( O 0 0.041654154658317566
PST O 1 0.9990621209144592
) O 0 0.03690135106444359
- O 1 0.9969629645347595
rich O 0 0.06930124759674072
transactivation O 1 0.9989179372787476
domain O 0 0.0747983306646347
. O 0 0.04568685218691826

PAX6 O 1 0.9999983310699463
regulates O 1 0.9994896650314331
eye O 1 0.9994547963142395
development O 0 0.040340669453144073
in O 0 0.02098001167178154
animals O 0 0.01939365454018116
ranging O 0 0.02657337673008442
from O 0 0.02410726621747017
jellyfish O 0 0.08954375237226486
to O 0 0.028682386502623558
Drosophila O 0 0.067357137799263
to O 0 0.030595185235142708
humans O 0 0.03703281283378601
. O 0 0.03900698944926262

Heterozygous O 0 0.10595230758190155
mutations O 0 0.035914137959480286
in O 0 0.014996283687651157
the O 0 0.02337578870356083
human O 0 0.1062549576163292
PAX6 O 1 0.9999997615814209
gene O 0 0.03940807282924652
result O 0 0.015578653663396835
in O 0 0.011670096777379513
various O 0 0.013628884218633175
phenotypes O 0 0.05702715739607811
, O 0 0.020281819626688957
including O 0 0.02398279495537281
aniridia B-Disease 1 0.9999945163726807
, O 0 0.0836562067270279
Peters B-Disease 1 0.9999847412109375
anomaly I-Disease 1 0.9999831914901733
, O 0 0.08689087629318237
autosomal B-Disease 1 0.9999878406524658
dominant I-Disease 1 0.9999949932098389
keratitis I-Disease 1 1.0
, O 1 0.9705520868301392
and O 1 0.9549550414085388
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.48309624195098877

It O 0 0.028030402958393097
is O 0 0.019667737185955048
believed O 0 0.01717163622379303
that O 0 0.007984216324985027
the O 0 0.015385122038424015
mutated O 0 0.04552581533789635
allele O 0 0.04548570141196251
of O 0 0.028238985687494278
PAX6 O 1 0.9999986886978149
produces O 0 0.034772392362356186
an O 0 0.022013476118445396
inactive O 1 0.9971213936805725
protein O 0 0.032145727425813675
and O 0 0.024530285969376564
aniridia B-Disease 1 0.9999980926513672
is O 0 0.02789454534649849
caused O 0 0.18551082909107208
due O 0 0.03298313170671463
to O 0 0.03386802226305008
genetic O 0 0.0645250603556633
haploinsufficiency O 1 0.9990984201431274
. O 0 0.0526433028280735

However O 0 0.031133271753787994
, O 0 0.021721459925174713
several O 0 0.019857188686728477
truncation O 1 0.9727872610092163
mutations O 0 0.03199248015880585
have O 0 0.01097419299185276
been O 0 0.012211325578391552
found O 0 0.00866736564785242
to O 0 0.008949154987931252
occur O 0 0.007777142804116011
in O 0 0.008325311355292797
the O 0 0.0181416142731905
C O 1 0.9996140599250793
- O 1 0.9998536109924316
terminal O 0 0.0715014785528183
half O 0 0.016461804509162903
of O 0 0.02460673451423645
PAX6 O 1 0.9999984502792358
in O 0 0.024245021864771843
patients O 1 0.930092990398407
with O 0 0.030205506831407547
Aniridia B-Disease 1 0.9999996423721313
resulting O 0 0.05095265805721283
in O 0 0.01950920931994915
mutant O 0 0.46748921275138855
proteins O 0 0.017132949084043503
that O 0 0.008563284762203693
retain O 0 0.02235238440334797
the O 0 0.018897920846939087
DNA O 0 0.039326537400484085
- O 1 0.9994915723800659
binding O 0 0.03204291686415672
domains O 0 0.026330342516303062
but O 0 0.009499521926045418
have O 0 0.006859180051833391
lost O 0 0.0179501473903656
most O 0 0.011536388657987118
of O 0 0.02007145993411541
the O 0 0.04059508815407753
transactivation O 1 0.9997691512107849
domain O 0 0.08115463703870773
. O 0 0.047661133110523224

It O 0 0.02752242423593998
is O 0 0.01894664391875267
not O 0 0.01199857983738184
clear O 0 0.016830064356327057
whether O 0 0.01377645879983902
such O 0 0.013959333300590515
mutants O 1 0.7098508477210999
really O 0 0.029322993010282516
behave O 0 0.022627249360084534
as O 0 0.014068970456719398
loss O 0 0.036778002977371216
- O 1 0.999671220779419
of O 0 0.03372742608189583
- O 1 0.9999886751174927
function O 0 0.03246806561946869
mutants O 0 0.15725207328796387
as O 0 0.023742668330669403
predicted O 0 0.040427111089229584
by O 0 0.038669515401124954
haploinsufficiency O 1 0.9756556153297424
. O 0 0.05495677515864372

Contrary O 0 0.059987619519233704
to O 0 0.02268555760383606
this O 0 0.015495317056775093
theory O 0 0.0199437215924263
, O 0 0.01436492707580328
our O 0 0.014465844258666039
data O 0 0.009478261694312096
showed O 0 0.011144113726913929
that O 0 0.007046641781926155
these O 0 0.00752252945676446
mutants O 0 0.042295146733522415
are O 0 0.010543044656515121
dominant O 0 0.2211531400680542
- O 1 0.9984521865844727
negative O 0 0.02944696694612503
in O 0 0.024099308997392654
transient O 1 0.9995013475418091
transfection O 1 0.9998835325241089
assays O 0 0.04410354420542717
when O 0 0.017469841986894608
they O 0 0.008432484231889248
are O 0 0.008096498437225819
coexpressed O 0 0.0681784600019455
with O 0 0.020710578188300133
wild O 0 0.0611305870115757
- O 1 0.9999898672103882
type O 1 0.9857848286628723
PAX6 O 1 0.9999858140945435
. O 0 0.06625544279813766

We O 0 0.02503509819507599
found O 0 0.01289164274930954
that O 0 0.009046932682394981
the O 0 0.01737915724515915
dominant O 1 0.9936085939407349
- O 1 0.9999964237213135
negative O 0 0.04197939857840538
effects O 0 0.028670698404312134
result O 0 0.014046426862478256
from O 0 0.012353233061730862
the O 0 0.018709028139710426
enhanced O 0 0.04855429008603096
DNA O 0 0.02892894297838211
binding O 0 0.02242669276893139
ability O 0 0.016163766384124756
of O 0 0.01880064234137535
these O 0 0.020372720435261726
mutants O 0 0.4541056156158447
. O 0 0.05240486189723015

Kinetic O 0 0.09371581673622131
studies O 0 0.026803774759173393
of O 0 0.026792986318469048
binding O 0 0.03829849511384964
and O 0 0.025163186714053154
dissociation O 1 0.6605805158615112
revealed O 0 0.02525239996612072
that O 0 0.009862937964498997
various O 0 0.01168824266642332
truncation O 0 0.12340394407510757
mutants O 0 0.1838202327489853
have O 0 0.012099758721888065
3 O 0 0.029354671016335487
- O 1 0.9959312081336975
5 O 0 0.03280575945973396
- O 1 0.9953493475914001
fold O 0 0.03978150337934494
higher O 0 0.017369363456964493
affinity O 0 0.022850455716252327
to O 0 0.010425237938761711
various O 0 0.009812253527343273
DNA O 0 0.025595922023057938
- O 1 0.9693268537521362
binding O 0 0.020123464986681938
sites O 0 0.012416638433933258
when O 0 0.009021183475852013
compared O 0 0.008598710410296917
with O 0 0.009036806412041187
the O 0 0.018310334533452988
wild O 0 0.14697644114494324
- O 1 0.9999961853027344
type O 1 0.9918203353881836
PAX6 O 1 0.9999772310256958
. O 0 0.06183779612183571

These O 0 0.024248259142041206
results O 0 0.01847051829099655
provide O 0 0.018725354224443436
a O 0 0.020299116149544716
new O 0 0.022791631519794464
insight O 0 0.03014473430812359
into O 0 0.013347622938454151
the O 0 0.014953250996768475
role O 0 0.023722467944025993
of O 0 0.02780875749886036
mutant O 1 0.9996079802513123
PAX6 O 1 0.9999997615814209
in O 0 0.057687245309352875
causing O 1 0.999177873134613
aniridia B-Disease 1 0.9999974966049194
. O 0 0.04816167429089546
. O 0 0.04842005670070648

Reversal O 0 0.49697738885879517
of O 1 0.9319974780082703
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9997825026512146
excellent O 1 0.9994741082191467
neuropsychologic O 1 0.9999347925186157
outcome O 0 0.025521136820316315
in O 0 0.012771278619766235
very B-Disease 0 0.017058249562978745
- I-Disease 1 0.9934495091438293
long I-Disease 0 0.03453805297613144
- I-Disease 1 0.9998824596405029
chain I-Disease 1 0.6812506318092346
acyl I-Disease 1 0.9998546838760376
- I-Disease 1 0.9999949932098389
coenzyme I-Disease 1 0.9999136924743652
A I-Disease 1 0.9999760389328003
dehydrogenase I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
. O 0 0.09248414635658264

Very B-Disease 0 0.051464080810546875
- I-Disease 1 0.9961523413658142
long I-Disease 0 0.051012374460697174
- I-Disease 1 0.9994542002677917
chain I-Disease 0 0.2653644382953644
acyl I-Disease 1 0.999461829662323
- I-Disease 1 0.9998599290847778
coenzyme I-Disease 1 0.9730685353279114
A I-Disease 1 0.7506915330886841
dehydrogenase I-Disease 1 0.9998522996902466
( I-Disease 0 0.10082528740167618
VLCAD I-Disease 1 0.9999994039535522
) I-Disease 1 0.7983630299568176
deficiency I-Disease 1 0.9999998807907104
is O 0 0.02145041711628437
a O 0 0.15682624280452728
disorder O 1 0.9999998807907104
of O 1 0.999594509601593
fatty O 1 1.0
acid O 1 0.9999958276748657
beta O 1 0.9998413324356079
oxidation O 0 0.4190272390842438
that O 0 0.01289657037705183
reportedly O 0 0.02689412236213684
has O 0 0.014107038266956806
high O 0 0.02684827335178852
rates O 0 0.025260722264647484
of O 0 0.037597961723804474
morbidity O 1 0.999998927116394
and O 1 0.7799937129020691
mortality O 1 0.9999734163284302
. O 0 0.06980422884225845

We O 0 0.02971539832651615
describe O 0 0.025108864530920982
the O 0 0.014247417449951172
outcome O 0 0.01613209955394268
of O 0 0.012773004360496998
a O 0 0.017356818541884422
5 O 0 0.0247636865824461
- O 1 0.9656149744987488
year O 0 0.017564404755830765
- O 1 0.9827637672424316
old O 0 0.13223019242286682
girl O 1 0.9852825403213501
with O 1 0.7612726092338562
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 1 0.9743676781654358
was O 0 0.17541468143463135
first O 0 0.017145035788416862
seen O 0 0.015036795288324356
at O 0 0.011811889708042145
5 O 0 0.011182326823472977
months O 0 0.00903963390737772
of O 0 0.011168490163981915
age O 0 0.025946978479623795
with O 1 0.6575967669487
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999998807907104
encephalopathy B-Disease 1 1.0
, O 1 0.9970541000366211
and O 1 0.9336714148521423
hypotonia B-Disease 1 0.9999940395355225
. O 0 0.07610729336738586

Biochemical O 0 0.12076562643051147
studies O 0 0.053487155586481094
indicated O 1 0.9563518762588501
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9994381070137024
by O 0 0.036135703325271606
a O 0 0.056970980018377304
stable O 1 0.9251914024353027
yet O 0 0.04644324630498886
inactive O 1 0.9982213377952576
enzyme O 0 0.11618853360414505
. O 0 0.04764147475361824

Molecular O 0 0.06723079830408096
genetic O 0 0.03046470880508423
analysis O 0 0.012695652432739735
of O 0 0.017873842269182205
her O 0 0.08628707379102707
VLCAD O 1 0.9999946355819702
gene O 0 0.03444996103644371
revealed O 0 0.03218276798725128
a O 0 0.034348487854003906
T1372C O 1 0.9964733719825745
( O 0 0.041757795959711075
F458L O 1 0.9789907932281494
) O 0 0.03452519327402115
missense O 0 0.0954468697309494
mutation O 0 0.04832617565989494
and O 0 0.023890022188425064
a O 0 0.04814798757433891
1668 O 1 0.9996629953384399
ACAG O 1 0.9999696016311646
1669 O 1 0.9997050166130066
splice O 1 0.919372022151947
site O 0 0.08322262018918991
mutation O 0 0.07691559195518494
. O 0 0.044810641556978226

After O 0 0.047518178820610046
initial O 0 0.04729278013110161
treatment O 1 0.9962771534919739
with O 0 0.1418020874261856
intravenous O 1 1.0
glucose O 1 0.9999966621398926
and O 1 0.9203448295593262
carnitine O 1 0.9999996423721313
, O 0 0.03010016866028309
the O 0 0.02942548133432865
patient O 1 0.9988731741905212
has O 0 0.016877328976988792
thrived O 0 0.03865750879049301
on O 0 0.013300618156790733
a O 0 0.020085738971829414
low O 1 0.7733380198478699
- O 1 0.9999920129776001
fat O 1 0.5305669903755188
diet O 0 0.04587114602327347
supplemented O 0 0.030059898272156715
with O 0 0.017733009532094002
medium O 0 0.08253113925457001
- O 1 0.9998893737792969
chain O 0 0.3248338997364044
triglyceride O 1 0.9901623725891113
oil O 0 0.04428979009389877
and O 0 0.035738538950681686
carnitine O 1 0.9999808073043823
and O 0 0.04761599749326706
avoidance O 1 0.9999746084213257
of O 1 0.7970790863037109
fasting O 1 0.999839186668396
. O 0 0.06988102197647095

Her O 1 0.99986732006073
ventricular O 1 1.0
hypertrophy O 1 1.0
resolved O 1 0.9216848611831665
significantly O 0 0.03536613658070564
over O 0 0.022175408899784088
1 O 0 0.025803517550230026
year O 0 0.017656801268458366
, O 0 0.017542531713843346
and O 0 0.022632384672760963
cognitively O 1 0.9998738765716553
, O 0 0.023091597482562065
she O 0 0.021522773429751396
is O 0 0.012120774947106838
in O 0 0.009936376474797726
the O 0 0.01791098527610302
superior O 0 0.045996226370334625
range O 0 0.02786351926624775
for O 0 0.025842059403657913
age O 0 0.052416764199733734
. O 0 0.049286384135484695

Clinical O 0 0.2111159712076187
recognition O 0 0.06528423726558685
of O 1 0.9998717308044434
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 1 0.9951314926147461
important O 0 0.03376735374331474
because O 0 0.012916435487568378
it O 0 0.007628827355802059
is O 0 0.007310484070330858
one O 0 0.006717215292155743
of O 0 0.008378218859434128
the O 0 0.012641065753996372
few O 0 0.01603669300675392
directly O 0 0.03158270940184593
treatable O 1 0.9999998807907104
causes O 1 0.9999734163284302
of O 1 0.9999791383743286
cardiomyopathy B-Disease 1 1.0
in O 1 0.9973989725112915
children O 1 0.9983365535736084
. O 0 0.03608628362417221
. O 0 0.03862475976347923

Cloning O 0 0.062236182391643524
of O 0 0.024633264169096947
a O 0 0.024771172553300858
novel O 0 0.03144839033484459
member O 0 0.020742150023579597
of O 0 0.01491642091423273
the O 0 0.022592442110180855
low O 1 0.9780634045600891
- O 1 0.9999991655349731
density O 1 0.9970842003822327
lipoprotein O 1 0.9999997615814209
receptor O 1 0.9797471761703491
family O 0 0.06421615928411484
. O 0 0.04896789416670799

A O 0 0.05859650671482086
gene O 0 0.03366423770785332
encoding O 0 0.02403387427330017
a O 0 0.02439606562256813
novel O 0 0.05817659571766853
transmembrane O 1 0.9967572093009949
protein O 0 0.028550129383802414
was O 0 0.020279135555028915
identified O 0 0.016895504668354988
by O 0 0.011699839495122433
DNA O 0 0.013573290780186653
sequence O 0 0.00940791331231594
analysis O 0 0.006624787580221891
within O 0 0.008270232938230038
the O 0 0.019438978284597397
insulin B-Disease 1 0.9999616146087646
- I-Disease 1 0.9999996423721313
dependent I-Disease 1 0.9999595880508423
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9990008473396301
IDDM B-Disease 1 0.9999948740005493
) O 0 0.052186813205480576
locus O 1 0.5666459202766418
IDDM4 O 1 0.9993102550506592
on O 0 0.052625417709350586
chromosome O 0 0.23990431427955627
11q13 O 1 0.9779812693595886
. O 0 0.05765785649418831

Based O 0 0.035235386341810226
on O 0 0.02145763672888279
its O 0 0.025476746261119843
chromosomal O 0 0.21642085909843445
position O 0 0.029681382700800896
, O 0 0.016877779737114906
this O 0 0.011614305898547173
gene O 0 0.017210785299539566
is O 0 0.011619310826063156
a O 0 0.018080998212099075
candidate O 0 0.02756611444056034
for O 0 0.02405649609863758
conferring O 1 0.9873599410057068
susceptibility O 1 0.9999717473983765
to O 1 0.8963667750358582
diabetes B-Disease 1 1.0
. O 0 0.18821623921394348

The O 0 0.03958563506603241
gene O 0 0.03060726635158062
, O 0 0.017753055319190025
termed O 0 0.04665752500295639
low O 0 0.06811784207820892
- O 1 0.9999415874481201
density O 0 0.4039780795574188
lipoprotein O 1 0.9999983310699463
receptor O 1 0.9792744517326355
related O 0 0.023747270926833153
protein O 0 0.02253158949315548
5 O 0 0.02151622623205185
( O 0 0.025538131594657898
LRP5 O 1 0.9996151924133301
) O 0 0.018086522817611694
, O 0 0.01519559696316719
encodes O 0 0.026216499507427216
a O 0 0.018139652907848358
protein O 0 0.019458701834082603
of O 0 0.02126312255859375
1615 O 1 0.7168202996253967
amino O 0 0.034480269998311996
acids O 0 0.020789315924048424
that O 0 0.009739203378558159
contains O 0 0.018844781443476677
conserved O 0 0.02655627392232418
modules O 0 0.026522252708673477
which O 0 0.008512364700436592
are O 0 0.005070230457931757
characteristic O 0 0.014321014285087585
of O 0 0.01125049963593483
the O 0 0.019282948225736618
low O 1 0.9625990390777588
- O 1 0.9999990463256836
density O 1 0.9984704852104187
lipoprotein O 1 1.0
( O 1 0.9904993176460266
LDL O 1 1.0
) O 0 0.05874839797616005
receptor O 0 0.14864306151866913
family O 0 0.06156030669808388
. O 0 0.046184297651052475

These O 0 0.02580713853240013
modules O 0 0.04617774114012718
include O 0 0.02263428457081318
a O 0 0.03227590024471283
putative O 1 0.9277877807617188
signal O 0 0.05108213797211647
peptide O 0 0.04918023943901062
for O 0 0.016403378918766975
protein O 0 0.016975846141576767
export O 0 0.016515284776687622
, O 0 0.012585090473294258
four O 0 0.01998320035636425
epidermal O 1 0.9999686479568481
growth O 1 0.5451636910438538
factor O 1 0.9924397468566895
( O 0 0.2740323543548584
EGF O 1 0.9999934434890747
) O 0 0.02666996605694294
repeats O 0 0.03704243525862694
with O 0 0.0170048326253891
associated O 0 0.02664044126868248
spacer O 0 0.08964012563228607
domains O 0 0.031607531011104584
, O 0 0.01838035322725773
three O 0 0.0272620040923357
LDL O 1 1.0
- O 1 0.9999998807907104
receptor O 1 0.9982258677482605
( O 0 0.03488916903734207
LDLR O 1 0.9995763897895813
) O 0 0.022632189095020294
repeats O 0 0.02789227105677128
, O 0 0.013605166226625443
a O 0 0.020260052755475044
single O 0 0.04077407345175743
transmembrane O 1 0.965522825717926
spanning O 0 0.04706690087914467
domain O 0 0.037565018981695175
, O 0 0.02028823085129261
and O 0 0.018557529896497726
a O 0 0.03748708963394165
cytoplasmic O 1 0.9200042486190796
domain O 0 0.0616069957613945
. O 0 0.04574605077505112

The O 0 0.04724343493580818
encoded O 0 0.040983401238918304
protein O 0 0.02269596979022026
has O 0 0.011590826325118542
a O 0 0.014631817117333412
unique O 0 0.015342099592089653
organization O 0 0.025481542572379112
of O 0 0.029374200850725174
EGF O 1 0.9999988079071045
and O 0 0.05760980397462845
LDLR O 1 0.9999980926513672
repeats O 0 0.2740449011325836
; O 0 0.02210165187716484
therefore O 0 0.01867360807955265
, O 0 0.02107533998787403
LRP5 O 1 0.9967781901359558
likely O 0 0.02214517444372177
represents O 0 0.023503312841057777
a O 0 0.018943728879094124
new O 0 0.019781185314059258
category O 0 0.024798840284347534
of O 0 0.019815977662801743
the O 0 0.04105650261044502
LDLR O 1 0.9999918937683105
family O 0 0.13686400651931763
. O 0 0.05348331481218338

Both O 0 0.0361185185611248
human O 0 0.036704566329717636
and O 0 0.035560157150030136
mouse O 1 0.9603442549705505
LRP5 O 1 0.9999936819076538
cDNAs O 1 0.9982509016990662
have O 0 0.01430373266339302
been O 0 0.013622078113257885
isolated O 0 0.027306098490953445
and O 0 0.013845367357134819
the O 0 0.020167676731944084
encoded O 0 0.02718094177544117
mature O 0 0.03636598214507103
proteins O 0 0.016209052875638008
are O 0 0.006782905664294958
95 O 0 0.023600446060299873
% O 0 0.016856882721185684
identical O 0 0.018960298970341682
, O 0 0.016495872288942337
indicating O 0 0.020651381462812424
a O 0 0.019180577248334885
high O 0 0.02973753586411476
degree O 0 0.02638779766857624
of O 0 0.027608610689640045
evolutionary O 0 0.045306768268346786
conservation O 0 0.05644821748137474
. O 0 0.028564851731061935
. O 0 0.036398690193891525

The O 0 0.07021026313304901
APC B-Disease 1 0.9973452687263489
variants O 0 0.050971440970897675
I1307K O 1 0.7305064797401428
and O 0 0.02503589540719986
E1317Q O 1 0.8244962692260742
are O 0 0.010793911293148994
associated O 0 0.029428033158183098
with O 1 0.9999206066131592
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.9956991672515869
but O 0 0.0164461862295866
not O 0 0.011611045338213444
always O 0 0.014649792574346066
with O 0 0.01187835168093443
a O 0 0.02270723693072796
family O 0 0.03424076735973358
history O 0 0.038569893687963486
. O 0 0.043341442942619324

Classical O 0 0.2627846300601959
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999809265136719
FAP B-Disease 1 1.0
) O 0 0.025781244039535522
is O 0 0.013492741622030735
a O 0 0.017550108954310417
high O 1 0.5987484455108643
- O 1 0.9999994039535522
penetrance O 1 0.999998927116394
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 0.9999995231628418
disease I-Disease 1 0.9999998807907104
that O 0 0.03289935365319252
predisposes O 1 0.9998667240142822
to O 0 0.01622956618666649
hundreds O 0 0.01632741093635559
or O 0 0.011992358602583408
thousands O 0 0.022919511422514915
of O 1 0.9986396431922913
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
carcinoma I-Disease 1 1.0
and O 0 0.38425496220588684
that O 0 0.014539364725351334
results O 0 0.012616042047739029
from O 0 0.016091659665107727
truncating O 1 0.9004883170127869
mutations O 0 0.02949199266731739
in O 0 0.017446080222725868
the O 0 0.03932230547070503
APC B-Disease 1 0.9999899864196777
gene O 0 0.060771115124225616
. O 0 0.043408408761024475

A O 0 0.06213155388832092
variant O 0 0.05974163860082626
of O 0 0.04531842842698097
FAP B-Disease 1 0.9999995231628418
is O 1 0.7116996049880981
attenuated B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.036966029554605484
which O 0 0.013134095817804337
results O 0 0.012857802212238312
from O 0 0.01911478117108345
germ O 1 0.9999986886978149
- O 1 0.9999951124191284
line O 0 0.03905480355024338
mutations O 0 0.018957486376166344
in O 0 0.009304586797952652
the O 0 0.014328507706522942
5 O 0 0.0175981055945158
and O 0 0.013389106839895248
3 O 0 0.01715513877570629
regions O 0 0.01385997049510479
of O 0 0.018867013975977898
the O 0 0.041406020522117615
APC B-Disease 1 0.9999874830245972
gene O 0 0.06909055262804031
. O 0 0.04493026062846184

Attenuated B-Disease 1 0.9999854564666748
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999603033065796
have O 0 0.02269084006547928
" O 0 0.041430599987506866
multiple O 0 0.051734719425439835
" O 1 0.9999815225601196
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 1 0.600651741027832
typically O 0 0.020296428352594376
fewer O 0 0.013654664158821106
than O 0 0.009867166168987751
100 O 0 0.019220953807234764
) O 0 0.013884485699236393
without O 0 0.011904124170541763
the O 0 0.023442791774868965
florid O 1 0.9982900023460388
phenotype O 1 0.6016376614570618
of O 0 0.05332573875784874
classical O 1 0.9074372053146362
FAP B-Disease 1 0.9999996423721313
. O 0 0.07459051162004471

Another O 0 0.05054274573922157
group O 0 0.036664851009845734
of O 0 0.028299450874328613
patients O 1 0.9981486797332764
with O 0 0.03514554724097252
multiple O 1 0.9504005908966064
adenomas B-Disease 1 0.9999997615814209
has O 0 0.024557912722229958
no O 0 0.016890380531549454
mutations O 0 0.017727671191096306
in O 0 0.009617364965379238
the O 0 0.026039065793156624
APC B-Disease 1 0.9999994039535522
gene O 0 0.03130929544568062
, O 0 0.014820708893239498
and O 0 0.01271023228764534
their O 0 0.01527843065559864
phenotype O 1 0.5284411907196045
probably O 0 0.015714989975094795
results O 0 0.009287227876484394
from O 0 0.008804048411548138
variation O 0 0.015290865674614906
at O 0 0.016204209998250008
a O 0 0.025088371708989143
locus O 1 0.9221819639205933
, O 0 0.025466252118349075
or O 0 0.022948559373617172
loci O 0 0.053493548184633255
, O 0 0.01740184985101223
elsewhere O 0 0.020520467311143875
in O 0 0.01438314002007246
the O 0 0.027272744104266167
genome O 0 0.04695312678813934
. O 0 0.038588523864746094

Recently O 0 0.06211576238274574
, O 0 0.023748746141791344
however O 0 0.012927236966788769
, O 0 0.01290173176676035
a O 0 0.019636370241642
missense O 0 0.06522630155086517
variant O 0 0.03931860998272896
of O 0 0.03318663313984871
APC B-Disease 1 0.9999988079071045
( O 0 0.1324971616268158
I1307K O 1 0.9998705387115479
) O 0 0.019364535808563232
was O 0 0.018682662397623062
described O 0 0.01712115667760372
that O 0 0.008495877496898174
confers O 0 0.030322736129164696
an O 0 0.01170800719410181
increased O 0 0.01961280219256878
risk O 1 0.9926996827125549
of O 1 0.9999926090240479
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.994454562664032
including O 0 0.17594611644744873
multiple O 1 0.9709805846214294
adenomas B-Disease 1 0.9999995231628418
, O 0 0.05061712488532066
in O 0 0.040609344840049744
Ashkenazim O 1 0.9973746538162231
. O 0 0.058607067912817

We O 0 0.02767890691757202
have O 0 0.012150712311267853
studied O 0 0.01595018059015274
a O 0 0.013460280373692513
set O 0 0.012463266961276531
of O 0 0.014440236613154411
164 O 0 0.2654082179069519
patients O 1 0.859006404876709
with O 0 0.03223798796534538
multiple O 1 0.9998574256896973
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999895095825195
/ I-Disease 1 1.0
or I-Disease 1 0.9992696642875671
carcinoma I-Disease 1 1.0
and O 0 0.03222603350877762
analyzed O 0 0.035571981221437454
codons O 0 0.0889916643500328
1263 O 1 0.9998177886009216
- O 1 0.9999849796295166
1377 O 1 0.9992477893829346
( O 0 0.0461413599550724
exon O 0 0.4155270457267761
15G O 1 0.7187833786010742
) O 0 0.015849430114030838
of O 0 0.014074990525841713
the O 0 0.024740690365433693
APC B-Disease 1 0.9998205304145813
gene O 0 0.03453754633665085
for O 0 0.031464945524930954
germ O 1 0.9999911785125732
- O 1 0.9999493360519409
line O 0 0.07198860496282578
variants O 0 0.05150670185685158
. O 0 0.039483241736888885

Three O 0 0.041718754917383194
patients O 0 0.06780494004487991
with O 0 0.02203863486647606
the O 0 0.03639459237456322
I1307K O 1 0.9999558925628662
allele O 0 0.09701569378376007
were O 0 0.018724730238318443
detected O 0 0.027732642367482185
, O 0 0.013800542801618576
each O 0 0.010789928957819939
of O 0 0.02878706529736519
Ashkenazi O 1 0.9967086315155029
descent O 0 0.1178867444396019
. O 0 0.05598823353648186

Four O 0 0.04753260686993599
patients O 0 0.14004100859165192
had O 0 0.0253700353205204
a O 0 0.04032661393284798
germ O 1 0.999991774559021
- O 1 0.9999339580535889
line O 0 0.054612498730421066
E1317Q O 1 0.9563552737236023
missense O 0 0.19624440371990204
variant O 0 0.04215965047478676
of O 0 0.02892819605767727
APC O 1 0.9999579191207886
that O 0 0.013256791979074478
was O 0 0.01789945736527443
not O 0 0.008219381794333458
present O 0 0.011491400189697742
in O 0 0.011710915714502335
controls O 0 0.024851739406585693
; O 0 0.012093131430447102
one O 0 0.010586529970169067
of O 0 0.01197852473706007
these O 0 0.008181042969226837
individuals O 0 0.010852491483092308
had O 0 0.012962793931365013
an O 0 0.013843882828950882
unusually O 0 0.028518611565232277
large O 0 0.01408448163419962
number O 0 0.011925091966986656
of O 0 0.027932561933994293
metaplastic B-Disease 1 0.9999854564666748
polyps I-Disease 1 0.9999619722366333
of I-Disease 0 0.04966532811522484
the I-Disease 0 0.22046835720539093
colorectum I-Disease 1 0.9999104738235474
. O 0 0.06182709336280823

There O 0 0.03291167691349983
is O 0 0.020964806899428368
increasing O 0 0.018742969259619713
evidence O 0 0.013397852890193462
that O 0 0.008311429992318153
there O 0 0.010849547572433949
exist O 0 0.01982985995709896
germ O 1 0.999894380569458
- O 1 0.9994938373565674
line O 0 0.02984887734055519
variants O 0 0.015181618742644787
of O 0 0.01361266989260912
the O 0 0.02842296101152897
APC B-Disease 1 0.9999942779541016
gene O 0 0.0299687422811985
that O 0 0.011538706719875336
predispose O 0 0.042886484414339066
to O 0 0.010630642995238304
the O 0 0.011886066757142544
development O 0 0.016319777816534042
of O 0 0.02536173164844513
multiple O 1 0.9997897744178772
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
, O 0 0.18222306668758392
but O 0 0.014498659409582615
without O 0 0.012206867337226868
the O 0 0.02161325514316559
florid O 1 0.9998003840446472
phenotype O 1 0.7222674489021301
of O 0 0.03262840211391449
classical O 1 0.9649905562400818
FAP B-Disease 1 1.0
, O 0 0.02184865064918995
and O 0 0.01423008181154728
possibly O 0 0.015334933996200562
with O 0 0.011793024837970734
importance O 0 0.0376933291554451
for O 1 0.9997277855873108
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9999982118606567
in O 0 0.024310505017638206
the O 0 0.03168632462620735
general O 0 0.3192485570907593
population O 0 0.02345566265285015
. O 0 0.02349347062408924
. O 0 0.03370245173573494

Genomic O 0 0.07294405251741409
structure O 0 0.02854248881340027
of O 0 0.021507997065782547
the O 0 0.11038327217102051
human O 1 0.9999969005584717
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999997615814209
CLD B-Disease 1 1.0
) O 0 0.3032515048980713
gene O 0 0.061024259775877
. O 0 0.0438116155564785

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999998807907104
CLD B-Disease 1 1.0
) O 1 0.5568307638168335
is O 0 0.023117341101169586
caused O 0 0.026801126077771187
by O 0 0.01411429699510336
mutations O 0 0.017281509935855865
in O 0 0.009135503321886063
a O 0 0.017363283783197403
gene O 0 0.01920178532600403
which O 0 0.014517202973365784
encodes O 0 0.04496737942099571
an O 0 0.2600008547306061
intestinal O 1 1.0
anion O 1 0.9999997615814209
transporter O 1 0.9999641180038452
. O 0 0.06590420752763748

We O 0 0.029042957350611687
report O 0 0.019697966054081917
here O 0 0.012941202148795128
the O 0 0.014031529426574707
complete O 0 0.022333769127726555
genomic O 0 0.028461290523409843
organization O 0 0.020692426711320877
of O 0 0.01581469550728798
the O 0 0.02457626350224018
human O 0 0.16202381253242493
CLD B-Disease 1 0.9999998807907104
gene O 0 0.04062354937195778
which O 0 0.017704345285892487
spans O 0 0.04186781123280525
approximately O 0 0.027148179709911346
39kb O 1 0.933376669883728
, O 0 0.02588864043354988
and O 0 0.024838656187057495
comprises O 0 0.05595281720161438
21 O 0 0.060352567583322525
exons O 0 0.09621456265449524
. O 0 0.051013197749853134

All O 0 0.06650634109973907
exon O 1 0.9564407467842102
/ O 1 0.993303120136261
intron O 0 0.4693189859390259
boundaries O 0 0.033331554383039474
conform O 0 0.04067809879779816
to O 0 0.020725537091493607
the O 0 0.04062489792704582
GT O 1 0.9999864101409912
/ O 1 0.9999786615371704
AG O 1 0.9999183416366577
rule O 0 0.07959513366222382
. O 0 0.05190802738070488

An O 0 0.029893217608332634
analysis O 0 0.01574980467557907
of O 0 0.017455946654081345
the O 0 0.029634414240717888
putative O 1 0.977430522441864
promoter O 1 0.7594396471977234
region O 0 0.030152849853038788
sequence O 0 0.01722233183681965
shows O 0 0.017197109758853912
a O 0 0.02901112660765648
putative O 1 0.9962651133537292
TATA O 1 0.999996542930603
box O 0 0.20272311568260193
and O 0 0.03095056302845478
predicts O 0 0.07499144226312637
multiple O 0 0.03876262530684471
transcription O 0 0.09359467029571533
factor O 0 0.05639234185218811
binding O 0 0.04308149218559265
sites O 0 0.03683888912200928
. O 0 0.03491324558854103

The O 0 0.05772647261619568
genomic O 0 0.07526668906211853
structure O 0 0.038159340620040894
was O 0 0.02907288260757923
determined O 0 0.02280273102223873
using O 0 0.011942368932068348
DNA O 0 0.015035226941108704
from O 0 0.008960843086242676
several O 0 0.007505791261792183
sources O 0 0.010407798923552036
including O 0 0.009899475611746311
multiple O 0 0.017296770587563515
large O 0 0.02959396131336689
- O 1 0.9999301433563232
insert O 1 0.9110820889472961
libaries O 1 0.9318376779556274
and O 0 0.023694036528468132
genomic O 0 0.04241618514060974
DNA O 0 0.02697732113301754
from O 0 0.028715267777442932
Finnish O 1 0.9999228715896606
CLD B-Disease 1 1.0
patients O 1 0.9999537467956543
and O 0 0.057032227516174316
controls O 0 0.10906337201595306
. O 0 0.058551546186208725

Exon O 1 0.9944471120834351
- O 1 0.99954754114151
specific O 0 0.030665576457977295
primers O 0 0.30131641030311584
developed O 0 0.025776367634534836
in O 0 0.011505676433444023
this O 0 0.009697498753666878
study O 0 0.012992197647690773
will O 0 0.012201442383229733
facilitate O 0 0.031853605061769485
mutation O 0 0.04788237437605858
screening O 0 0.04574849456548691
studies O 0 0.016509506851434708
of O 0 0.023991471156477928
patients O 1 0.9994519352912903
with O 0 0.0376955047249794
the O 1 0.9852812886238098
disease O 1 0.9999995231628418
. O 0 0.1211702898144722

Genomic O 0 0.08587925881147385
sequencing O 0 0.038873620331287384
of O 0 0.025786930695176125
a O 0 0.047845013439655304
BAC O 1 0.9999822378158569
clone O 1 0.9997230172157288
H O 1 0.9999926090240479
_ O 0 0.047641411423683167
RG364P16 O 1 0.7217817306518555
revealed O 0 0.02604863792657852
the O 0 0.015133912675082684
presence O 0 0.01903598941862583
of O 0 0.013612521812319756
another O 0 0.020039044320583344
, O 0 0.015668479725718498
highly O 0 0.024296004325151443
homologous O 0 0.0366465300321579
gene O 0 0.016281669959425926
3 O 0 0.013344107195734978
of O 0 0.013069504871964455
the O 0 0.03147507831454277
CLD B-Disease 1 0.9999998807907104
gene O 0 0.03255587816238403
, O 0 0.012551561929285526
with O 0 0.009636146016418934
a O 0 0.014005996286869049
similar O 0 0.013229809701442719
genomic O 0 0.029267683625221252
structure O 0 0.019985152408480644
, O 0 0.011780173517763615
recently O 0 0.015147506259381771
identified O 0 0.013296576216816902
as O 0 0.01265146303921938
the O 0 0.04508324712514877
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9998925924301147
( O 1 0.9901898503303528
PDS B-Disease 1 0.9999991655349731
) O 0 0.04132067412137985
. O 0 0.027731722220778465
. O 0 0.038952045142650604

The O 0 0.07609526067972183
APCI1307K O 1 0.9999798536300659
allele O 1 0.9820162653923035
and O 0 0.4146007299423218
cancer B-Disease 1 0.9999991655349731
risk O 1 0.8639523983001709
in O 0 0.016773125156760216
a O 0 0.0259186252951622
community O 0 0.04086386039853096
- O 1 0.9958588480949402
based O 0 0.018559301272034645
study O 0 0.015360306017100811
of O 0 0.024285120889544487
Ashkenazi O 1 0.9974645376205444
Jews O 0 0.14080731570720673
. O 0 0.049340344965457916

Mutations O 0 0.07527695596218109
in O 0 0.03599156066775322
APC O 1 0.9981145858764648
are O 0 0.020197900012135506
classically O 1 0.8167611360549927
associated O 0 0.031182022765278816
with O 0 0.04143878072500229
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999984502792358
FAP B-Disease 1 1.0
) O 0 0.027279142290353775
, O 0 0.015910951420664787
a O 0 0.02277347818017006
highly O 0 0.2303415685892105
penetrant O 1 0.9999990463256836
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
characterized O 1 0.9999909400939941
by O 1 0.9996529817581177
multiple O 1 0.999997615814209
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.9940248131752014
, O 0 0.049556758254766464
without O 0 0.02617494948208332
surgical O 1 0.9999983310699463
intervention O 1 0.9794341921806335
, O 0 0.014396489597856998
the O 0 0.013661536388099194
development O 0 0.029888175427913666
of O 1 0.9999175071716309
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999990463256836
CRC B-Disease 1 1.0
) O 0 0.049924787133932114
. O 0 0.03867097944021225

APC B-Disease 1 0.9870781898498535
is O 0 0.03588147088885307
a O 0 0.06991612911224365
tumour O 1 1.0
- O 1 0.9999998807907104
suppressor O 1 0.9999984502792358
gene O 0 0.04398936405777931
, O 0 0.021740345284342766
and O 0 0.025302566587924957
somatic O 1 0.9284114837646484
loss O 1 0.7372267246246338
occurs O 0 0.050536904484033585
in O 0 0.04898921027779579
tumours B-Disease 1 0.9999980926513672
. O 0 0.07796195894479752

The O 0 0.06735017895698547
germline O 1 0.9998620748519897
T O 1 0.9999698400497437
- O 1 0.9992375373840332
to O 0 0.02954755909740925
- O 1 0.9985609650611877
A O 0 0.04158315807580948
transversion O 1 0.6803810000419617
responsible O 0 0.0262314360588789
for O 0 0.015583067201077938
the O 0 0.028438299894332886
APC O 1 0.999934196472168
I1307K O 1 0.9982497096061707
allele O 0 0.06035550683736801
converts O 0 0.03207338601350784
the O 0 0.019835088402032852
wild O 0 0.03455657884478569
- O 1 0.9976531863212585
type O 0 0.02391904778778553
sequence O 0 0.010088548995554447
to O 0 0.01011393778026104
a O 0 0.02600090205669403
homopolymer O 1 0.999992847442627
tract O 1 0.9999998807907104
( O 1 0.9980279803276062
A8 O 1 0.9999998807907104
) O 0 0.021851548925042152
that O 0 0.011768044903874397
is O 0 0.02064482681453228
genetically O 0 0.039531152695417404
unstable O 1 0.9599746465682983
and O 0 0.03455618768930435
prone O 1 0.9968920350074768
to O 0 0.051391538232564926
somatic O 1 0.9919009804725647
mutation O 0 0.13035251200199127
. O 0 0.054210856556892395

The O 0 0.06999446451663971
I1307K O 1 0.9987142086029053
allele O 0 0.3962469696998596
was O 0 0.04201896861195564
found O 0 0.021031109616160393
in O 0 0.02234947495162487
6 O 0 0.05202367529273033
. O 0 0.04349244013428688

1 O 0 0.05206239968538284
% O 0 0.029503876343369484
of O 0 0.03353191167116165
unselected O 1 0.9978431463241577
Ashkenazi O 1 0.9916999936103821
Jews O 0 0.043548669666051865
and O 0 0.01916588842868805
higher O 0 0.020379677414894104
proportions O 0 0.04793519526720047
of O 0 0.029212865978479385
Ashkenazim O 1 0.9999034404754639
with O 0 0.02589721791446209
family O 0 0.04081324115395546
or O 0 0.014138615690171719
personal O 0 0.02452901564538479
histories O 0 0.0440250039100647
of O 1 0.5377069711685181
CRC B-Disease 1 1.0
( O 1 0.5155665278434753
ref O 1 0.9996838569641113
. O 0 0.021955152973532677
2 O 0 0.03512072190642357
) O 0 0.029815498739480972
. O 0 0.03324698656797409

To O 0 0.03280794993042946
evaluate O 0 0.039211664348840714
the O 0 0.018090222030878067
role O 0 0.02997012995183468
of O 0 0.028724312782287598
I1307K O 1 0.999981164932251
in O 0 0.08176794648170471
cancer B-Disease 1 0.9999992847442627
, O 0 0.026722252368927002
we O 0 0.01959666982293129
genotyped O 1 0.9890885949134827
5 O 0 0.03184521570801735
, O 0 0.03140151500701904
081 O 1 0.9963521957397461
Ashkenazi O 1 0.7487638592720032
volunteers O 0 0.05448254942893982
in O 0 0.021495606750249863
a O 0 0.031234879046678543
community O 0 0.044980186969041824
survey O 0 0.04744499549269676
. O 0 0.04259474575519562

Risk O 0 0.06973051279783249
of O 0 0.04928233101963997
developing O 1 0.9998189806938171
colorectal B-Disease 1 1.0
, I-Disease 1 0.9999709129333496
breast I-Disease 1 1.0
and I-Disease 1 0.7635200619697571
other I-Disease 0 0.05171065032482147
cancers I-Disease 1 0.9999836683273315
were O 0 0.014751105569303036
compared O 0 0.018047472462058067
between O 0 0.02394956909120083
genotyped O 1 0.9996637105941772
I1307K O 1 0.9990893602371216
carriers O 0 0.047803618013858795
and O 0 0.021308904513716698
non O 1 0.9146350026130676
- O 1 0.9999147653579712
carriers O 0 0.03357277810573578
and O 0 0.010960961692035198
their O 0 0.011044830083847046
first O 0 0.03002781607210636
- O 1 0.9999374151229858
degree O 0 0.0427795872092247
relatives O 0 0.07170478999614716
. O 0 0.042169805616140366

Sperm O 0 0.07904787361621857
DNA O 0 0.03440442681312561
analysis O 0 0.017155123874545097
in O 0 0.01709751784801483
a O 0 0.04955723136663437
Friedreich B-Disease 1 0.999992847442627
ataxia I-Disease 1 0.9999971389770508
premutation O 1 0.999945878982544
carrier O 1 0.994796097278595
suggests O 0 0.046711258590221405
both O 0 0.02936168573796749
meiotic O 1 0.9996503591537476
and O 0 0.039249688386917114
mitotic O 1 0.9942986965179443
expansion O 0 0.048773158341646194
in O 0 0.026325421407818794
the O 0 0.04547523334622383
FRDA B-Disease 1 0.9998617172241211
gene O 0 0.06746374815702438
. O 0 0.05109522119164467

Friedreich B-Disease 1 0.9999997615814209
ataxia I-Disease 1 0.9999996423721313
is O 0 0.08287560194730759
usually O 0 0.028855279088020325
caused O 0 0.03268011286854744
by O 0 0.01510063000023365
an O 0 0.01431460864841938
expansion O 0 0.026705488562583923
of O 0 0.018970487639307976
a O 0 0.03253079205751419
GAA O 1 0.8431997299194336
trinucleotide O 1 0.9970384836196899
repeat O 0 0.06546006351709366
in O 0 0.026717351749539375
intron O 1 0.9879944324493408
1 O 0 0.031624890863895416
of O 0 0.023782329633831978
the O 0 0.04179287329316139
FRDA B-Disease 1 0.9999622106552124
gene O 0 0.06859562546014786
. O 0 0.043866802006959915

Occasionally O 0 0.05524744838476181
, O 0 0.02545635960996151
a O 0 0.024084040895104408
fully O 0 0.032721519470214844
expanded O 0 0.03648645803332329
allele O 0 0.05365128070116043
has O 0 0.016349205747246742
been O 0 0.013293198309838772
found O 0 0.011493891477584839
to O 0 0.01287605706602335
arise O 0 0.020512061193585396
from O 0 0.013745708391070366
a O 0 0.023384373635053635
premutation O 1 0.9969971179962158
of O 0 0.024852918460965157
100 O 0 0.029849277809262276
or O 0 0.021819155663251877
less O 0 0.028908656910061836
triplet O 1 0.9965975880622864
repeats O 0 0.09008679538965225
. O 0 0.05286979302763939

We O 0 0.030177973210811615
have O 0 0.014623802155256271
examined O 0 0.029146209359169006
the O 0 0.019194576889276505
sperm O 0 0.032030172646045685
DNA O 0 0.020651686936616898
of O 0 0.02185048721730709
a O 0 0.043403398245573044
premutation O 1 0.999174177646637
carrier O 1 0.9423209428787231
. O 0 0.05404672771692276

This O 0 0.038922592997550964
mans O 0 0.15021257102489471
leucocyte O 1 0.9215645790100098
DNA O 0 0.03805922344326973
showed O 0 0.023880256339907646
one O 0 0.019177401438355446
normal O 0 0.0292268767952919
allele O 0 0.04475805163383484
and O 0 0.015679558739066124
one O 0 0.01722056232392788
allele O 0 0.036087002605199814
of O 0 0.018173953518271446
approximately O 0 0.024334579706192017
100 O 0 0.0396946556866169
repeats O 0 0.06356891244649887
. O 0 0.040669359266757965

His O 0 0.0632372722029686
sperm O 0 0.051519911736249924
showed O 0 0.026596972718834877
an O 0 0.019120080396533012
expanded O 0 0.03348439931869507
allele O 0 0.04829711839556694
in O 0 0.016685424372553825
a O 0 0.027736904099583626
tight O 0 0.044686220586299896
range O 0 0.02679583616554737
centering O 0 0.06072093918919563
on O 0 0.0160074345767498
a O 0 0.01874137856066227
size O 0 0.017531752586364746
of O 0 0.020744789391756058
approximately O 0 0.03356941044330597
320 O 0 0.1004357859492302
trinucleotide O 1 0.9938014149665833
repeats O 0 0.10806038230657578
. O 0 0.06169838085770607

His O 0 0.07790353149175644
affected O 0 0.07204541563987732
son O 1 0.9967492818832397
has O 0 0.03213576227426529
repeat O 0 0.06043507158756256
sizes O 0 0.030666960403323174
of O 0 0.03670815750956535
1040 O 1 0.9971475005149841
and O 0 0.04626256227493286
540 O 0 0.40152662992477417
. O 0 0.05747155100107193

These O 0 0.027179526165127754
data O 0 0.018274368718266487
suggest O 0 0.017411720007658005
that O 0 0.010546000674366951
expansion O 0 0.026415683329105377
occurs O 0 0.015186438336968422
in O 0 0.009988576173782349
two O 0 0.011470808647572994
stages O 0 0.025326931849122047
, O 0 0.014294411987066269
the O 0 0.015049159526824951
first O 0 0.022045431658625603
during O 0 0.031042326241731644
meiosis O 0 0.24956229329109192
followed O 0 0.02903839200735092
by O 0 0.019794955849647522
a O 0 0.03057447448372841
second O 0 0.05630860477685928
mitotic O 1 0.979586660861969
expansion O 0 0.08979421108961105
. O 0 0.05973569303750992

We O 0 0.032648034393787384
also O 0 0.02012655697762966
show O 0 0.01753922738134861
that O 0 0.007473821751773357
in O 0 0.008721965365111828
all O 0 0.01075480692088604
informative O 0 0.03984805569052696
carrier O 0 0.419130802154541
father O 0 0.04629144072532654
to O 0 0.017800552770495415
affected O 0 0.03896324709057808
child O 1 0.9979640245437622
transmissions O 0 0.05314789339900017
, O 0 0.013492194935679436
with O 0 0.009469482116401196
the O 0 0.012995866127312183
notable O 0 0.016856210306286812
exception O 0 0.020131397992372513
of O 0 0.01622632145881653
the O 0 0.031353410333395004
premutation O 1 0.9999592304229736
carrier O 1 0.9598414301872253
, O 0 0.020225416868925095
the O 0 0.019360167905688286
expansion O 0 0.03829282894730568
size O 0 0.03131883963942528
decreases O 0 0.05201445147395134
. O 0 0.025976356118917465
. O 0 0.0378529317677021

The O 0 0.05819700285792351
R496H O 1 0.9823456406593323
mutation O 0 0.057572271674871445
of O 0 0.03699712082743645
arylsulfatase O 1 0.9999531507492065
A O 1 0.5870938301086426
does O 0 0.027002817019820213
not O 0 0.027112813666462898
cause O 1 0.9876269698143005
metachromatic B-Disease 1 0.9999979734420776
leukodystrophy I-Disease 1 0.9999992847442627
. O 0 0.0905391275882721

Deficiency B-Disease 1 0.9999974966049194
of I-Disease 0 0.07115020602941513
arylsulfatase I-Disease 1 0.9999455213546753
A I-Disease 1 0.9941493272781372
( O 1 0.5198743343353271
ARSA O 1 0.9999990463256836
) O 0 0.04412238672375679
enzyme O 0 0.07268345355987549
activity O 0 0.046411946415901184
causes O 1 0.9987982511520386
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 1.0
( O 1 0.9995675683021545
MLD B-Disease 1 0.9999996423721313
) O 0 0.06656678020954132
. O 0 0.051963306963443756

A O 0 0.042521968483924866
number O 0 0.020418822765350342
of O 0 0.03590377792716026
ARSA O 1 0.9999951124191284
gene O 0 0.05716656893491745
mutations O 0 0.03831153362989426
responsible O 0 0.04172857850790024
for O 0 0.04110000282526016
MLD B-Disease 1 0.9999997615814209
have O 0 0.02331053651869297
been O 0 0.025672633200883865
identified O 0 0.034710593521595
. O 0 0.03603968396782875

Recently O 0 0.0573420524597168
, O 0 0.02412181720137596
the O 0 0.026066754013299942
R496H O 1 0.9796578288078308
mutation O 0 0.05230908840894699
of O 0 0.03593018651008606
ARSA O 1 0.9999974966049194
was O 0 0.031000714749097824
proposed O 0 0.016120562329888344
to O 0 0.010406683199107647
be O 0 0.007632910273969173
a O 0 0.015444653108716011
cause O 0 0.03028571605682373
of O 0 0.044103655964136124
MLD B-Disease 1 1.0
( O 0 0.4505590498447418
Draghia O 1 0.9999853372573853
et O 1 0.7642742395401001
al O 1 0.8140597939491272
. O 0 0.019191667437553406
, O 0 0.021770047023892403
1997 O 0 0.04394108057022095
) O 0 0.03238081932067871
. O 0 0.0382440946996212

We O 0 0.027126824483275414
have O 0 0.012707897461950779
investigated O 0 0.0356316901743412
the O 0 0.027913236990571022
R496H O 1 0.9998937845230103
mutation O 0 0.05159744247794151
and O 0 0.01499952282756567
found O 0 0.011456807143986225
this O 0 0.00976807065308094
mutation O 0 0.022570321336388588
at O 0 0.014853479340672493
a O 0 0.015871109440922737
relatively O 0 0.01681511290371418
high O 0 0.022571105509996414
frequency O 0 0.013490253128111362
in O 0 0.008107438683509827
an O 0 0.010041119530797005
African O 0 0.022345837205648422
American O 0 0.021828526630997658
population O 0 0.016911828890442848
( O 0 0.02429714985191822
f O 0 0.06170229986310005
= O 0 0.041770316660404205
0 O 0 0.030815310776233673
. O 0 0.018383489921689034
09 O 0 0.08238831907510757
, O 0 0.028528185561299324
n O 0 0.06714708358049393
= O 0 0.062134407460689545
61 O 0 0.06363917142152786
subjects O 0 0.047560106962919235
) O 0 0.03567318618297577
. O 0 0.037439096719026566

The O 0 0.10927097499370575
ARSA O 1 0.9999977350234985
enzyme O 1 0.509986400604248
activity O 0 0.03292887285351753
in O 0 0.016313111409544945
subjects O 0 0.020544001832604408
with O 0 0.011988922953605652
and O 0 0.01219493243843317
without O 0 0.011989831924438477
the O 0 0.022839495912194252
R496H O 1 0.9999808073043823
mutation O 0 0.4387752413749695
was O 0 0.028624922037124634
determined O 0 0.02313709817826748
and O 0 0.015369070693850517
found O 0 0.013364311307668686
to O 0 0.015210583806037903
be O 0 0.01631806790828705
normal O 0 0.03694413602352142
. O 0 0.03823183849453926

It O 0 0.02864689752459526
is O 0 0.019888419657945633
therefore O 0 0.01678023487329483
concluded O 0 0.01946333423256874
that O 0 0.008726261556148529
the O 0 0.019123248755931854
R496H O 1 0.9951283931732178
mutation O 0 0.05353011563420296
of O 0 0.037300266325473785
ARSA O 1 0.9999967813491821
does O 0 0.02335234545171261
not O 0 0.01153308991342783
negatively O 0 0.019205164164304733
influence O 0 0.017355093732476234
the O 0 0.015045610256493092
activity O 0 0.022117527201771736
of O 0 0.02935817837715149
ARSA O 1 0.999997615814209
and O 0 0.0267411470413208
is O 0 0.017728682607412338
not O 0 0.013693735003471375
a O 0 0.02915063314139843
cause O 0 0.13049158453941345
of O 0 0.12642090022563934
MLD B-Disease 1 0.9999994039535522

Down O 0 0.09008431434631348
- O 1 0.7765217423439026
regulation O 0 0.032575204968452454
of O 0 0.026614438742399216
transmembrane O 1 0.9200159311294556
carbonic O 1 0.9997268319129944
anhydrases O 1 0.9999088048934937
in O 1 0.9198302626609802
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9698989987373352
lines O 0 0.025802049785852432
by O 0 0.01665232516825199
wild O 0 0.036705538630485535
- O 1 0.9999165534973145
type O 0 0.2809831202030182
von B-Disease 1 0.998690664768219
Hippel I-Disease 1 0.9999920129776001
- I-Disease 1 0.9999939203262329
Lindau I-Disease 1 0.9998481273651123
transgenes O 1 0.9551332592964172
. O 0 0.07505205273628235

To O 0 0.04628748074173927
discover O 0 0.055916767567396164
genes O 0 0.0201818086206913
involved O 0 0.01743415929377079
in O 0 0.01976543478667736
von B-Disease 1 0.7910681962966919
Hippel I-Disease 1 0.9999805688858032
- I-Disease 1 0.9999985694885254
Lindau I-Disease 1 0.9999955892562866
( O 0 0.07338714599609375
VHL B-Disease 1 0.9999725818634033
) O 0 0.0419965460896492
- O 1 0.9998121857643127
mediated O 1 0.9154264330863953
carcinogenesis O 1 0.9997108578681946
, O 0 0.02099226787686348
we O 0 0.01891392096877098
used O 0 0.034954510629177094
renal B-Disease 1 1.0
cell I-Disease 1 0.9999994039535522
carcinoma I-Disease 1 1.0
cell O 1 0.9915938377380371
lines O 0 0.0518338643014431
stably O 1 0.7112646698951721
transfected O 0 0.2634757459163666
with O 0 0.02471444196999073
wild O 0 0.05809272825717926
- O 1 0.999996542930603
type O 1 0.9963208436965942
VHL O 1 0.9999971389770508
- O 1 0.9999372959136963
expressing O 0 0.19385787844657898
transgenes O 1 0.7851302623748779
. O 0 0.06306608021259308

Large O 0 0.06432925164699554
- O 1 0.9987855553627014
scale O 0 0.060276784002780914
RNA O 0 0.06340014189481735
differential O 0 0.0468188039958477
display O 0 0.03356758505105972
technology O 0 0.02504264935851097
applied O 0 0.014035170897841454
to O 0 0.011015482246875763
these O 0 0.009011494927108288
cell O 0 0.021713025867938995
lines O 0 0.016384687274694443
identified O 0 0.0137409633025527
several O 0 0.010993006639182568
differentially O 0 0.05558014288544655
expressed O 0 0.02261272631585598
genes O 0 0.0152647839859128
, O 0 0.010470578446984291
including O 0 0.010370530188083649
an O 0 0.02033894509077072
alpha O 1 0.9710248708724976
carbonic O 1 0.999915599822998
anhydrase O 1 0.9999911785125732
gene O 0 0.06044820323586464
, O 0 0.039192527532577515
termed O 1 0.6664584875106812
CA12 O 1 0.9997122883796692
. O 0 0.06345247477293015

The O 0 0.05799882113933563
deduced O 0 0.08180157840251923
protein O 0 0.0331864207983017
sequence O 0 0.016834499314427376
was O 0 0.020439254119992256
classified O 0 0.020450729876756668
as O 0 0.012136634439229965
a O 0 0.01700274646282196
one O 0 0.02524552121758461
- O 1 0.999866247177124
pass O 0 0.06122712418437004
transmembrane O 1 0.996384859085083
CA O 0 0.061670154333114624
possessing O 0 0.030683457851409912
an O 0 0.018376456573605537
apparently O 0 0.03230022266507149
intact O 0 0.05153980851173401
catalytic O 0 0.07025252282619476
domain O 0 0.030186736956238747
in O 0 0.016930000856518745
the O 0 0.03369012475013733
extracellular O 1 0.9943781495094299
CA O 1 0.9458149671554565
module O 0 0.42151832580566406
. O 0 0.04948705807328224

Reintroduced O 0 0.12469679862260818
wild O 0 0.09219954907894135
- O 1 0.9999693632125854
type O 1 0.9565397500991821
VHL B-Disease 1 0.9998730421066284
strongly O 0 0.04336172714829445
inhibited O 0 0.08853834122419357
the O 0 0.023847030475735664
overexpression O 0 0.07165777683258057
of O 0 0.019132474437355995
the O 0 0.024629171937704086
CA12 O 1 0.9999264478683472
gene O 0 0.021082261577248573
in O 0 0.011467823758721352
the O 0 0.028546499088406563
parental O 1 0.9999991655349731
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999630451202393
lines O 0 0.06866877526044846
. O 0 0.047027263790369034

Similar O 0 0.03012099489569664
results O 0 0.01605498604476452
were O 0 0.011319920420646667
obtained O 0 0.01909412257373333
with O 0 0.022369416430592537
CA9 O 1 0.9998799562454224
, O 0 0.027020037174224854
encoding O 0 0.03323279693722725
another O 0 0.035003140568733215
transmembrane O 1 0.9051605463027954
CA O 0 0.046687204390764236
with O 0 0.019073545932769775
an O 0 0.027568964287638664
intact O 1 0.5802700519561768
catalytic O 1 0.7804885506629944
domain O 0 0.06175379455089569
. O 0 0.04458091780543327

Although O 0 0.02927631326019764
both O 0 0.0188351571559906
domains O 0 0.03211574628949165
of O 0 0.02461731806397438
the O 0 0.2473028302192688
VHL B-Disease 1 0.9999995231628418
protein O 0 0.033795859664678574
contribute O 0 0.023060370236635208
to O 0 0.013699743896722794
regulation O 0 0.022215010598301888
of O 0 0.026230834424495697
CA12 O 1 0.9999855756759644
expression O 0 0.0340721495449543
, O 0 0.0206143781542778
the O 0 0.025898467749357224
elongin O 1 0.9960330128669739
binding O 0 0.03715695068240166
domain O 0 0.03656938299536705
alone O 0 0.029070604592561722
could O 0 0.020026901736855507
effectively O 0 0.05118333175778389
regulate O 0 0.0974464938044548
CA9 O 1 0.9997896552085876
expression O 0 0.08387275785207748
. O 0 0.0558469220995903

We O 0 0.04369351267814636
mapped O 0 0.09141912311315536
CA12 O 1 0.9978477954864502
and O 0 0.0560406856238842
CA9 O 1 0.9999474287033081
loci O 0 0.1185021698474884
to O 0 0.04728033393621445
chromosome O 0 0.09200596809387207
bands O 0 0.08534067124128342
15q22 O 1 0.99843829870224
and O 0 0.05901401489973068
17q21 O 1 0.9933602213859558
. O 0 0.0643230527639389

2 O 0 0.06265432387590408
respectively O 0 0.042232390493154526
, O 0 0.026999106630682945
regions O 0 0.032715439796447754
prone O 1 0.671260416507721
to O 0 0.028698742389678955
amplification O 0 0.10724972933530807
in O 0 0.017491772770881653
some O 0 0.020799653604626656
human O 0 0.1787252426147461
cancers B-Disease 1 0.999964714050293
. O 0 0.062117356806993484

Additional O 0 0.046795573085546494
experiments O 0 0.037449803203344345
are O 0 0.011009198613464832
needed O 0 0.01681593991816044
to O 0 0.01174051035195589
define O 0 0.02029639482498169
the O 0 0.015122330747544765
role O 0 0.024738337844610214
of O 0 0.026507345959544182
CA O 1 0.9986981153488159
IX O 1 0.9999997615814209
and O 0 0.26229116320610046
CA O 1 0.9989877343177795
XII O 1 0.9999992847442627
enzymes O 0 0.044626761227846146
in O 0 0.01386761199682951
the O 0 0.017133614048361778
regulation O 0 0.024463683366775513
of O 0 0.023770054802298546
pH O 1 0.9945923686027527
in O 0 0.014958322048187256
the O 0 0.028233975172042847
extracellular O 1 0.9989476799964905
microenvironment O 1 0.9993522763252258
and O 0 0.015487179160118103
its O 0 0.014058939181268215
potential O 0 0.020702654495835304
impact O 0 0.02577565237879753
on O 0 0.14171408116817474
cancer B-Disease 1 0.9999998807907104
cell O 1 0.9915351867675781
growth O 0 0.07065268605947495
. O 0 0.044651180505752563

A O 0 0.060757312923669815
gene O 0 0.03676332160830498
encoding O 0 0.02642340399324894
a O 0 0.028624586760997772
transmembrane O 1 0.7471824288368225
protein O 0 0.02386903390288353
is O 0 0.013645765371620655
mutated O 0 0.03237491101026535
in O 0 0.014845526777207851
patients O 1 0.9720132946968079
with O 1 0.9965757727622986
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999998807907104
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 1 0.6078489422798157
. O 0 0.057357411831617355

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9986492991447449
WFS B-Disease 1 0.9999996423721313
; O 0 0.4310669004917145
OMIM O 1 0.9999982118606567
222300 O 1 0.9993906021118164
) O 0 0.02480580098927021
is O 0 0.017907001078128815
an O 0 0.031169140711426735
autosomal B-Disease 1 0.9999984502792358
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 0.4117382764816284
by O 0 0.03893287107348442
young O 1 0.9999213218688965
- O 1 0.9999994039535522
onset O 1 0.9999994039535522
non O 1 0.9999939203262329
- O 1 1.0
immune O 1 0.9999998807907104
insulin B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
dependent I-Disease 1 0.999964714050293
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999518394470215
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999997615814209
. O 0 0.38883456587791443

Linkage O 0 0.13027966022491455
to O 0 0.0376216359436512
markers O 0 0.059351373463869095
on O 0 0.03193388134241104
chromosome O 0 0.17936180531978607
4p O 1 0.9999552965164185
was O 0 0.03868464007973671
confirmed O 0 0.027831491082906723
in O 0 0.015799598768353462
five O 0 0.02358335070312023
families O 0 0.041165102273225784
. O 0 0.042254120111465454

On O 0 0.02566126175224781
the O 0 0.017745861783623695
basis O 0 0.01642400212585926
of O 0 0.026525963097810745
meiotic O 1 0.9999927282333374
recombinants O 1 0.9999982118606567
and O 1 0.986125648021698
disease O 1 1.0
- O 1 0.9999997615814209
associated O 0 0.057149533182382584
haplotypes O 1 0.6711716651916504
, O 0 0.021079977974295616
the O 0 0.03171173110604286
WFS B-Disease 1 0.9999980926513672
gene O 0 0.03678003326058388
was O 0 0.02636585384607315
localized O 0 0.04005039483308792
to O 0 0.019480669870972633
a O 0 0.04452838376164436
BAC O 1 0.9999992847442627
/ O 1 0.9999690055847168
P1 O 1 0.9995214939117432
contig O 1 0.828069806098938
of O 0 0.027968179434537888
less O 0 0.02103755809366703
than O 0 0.019502166658639908
250 O 0 0.0521971769630909
kb O 0 0.15486116707324982
. O 0 0.05773148313164711

Mutations O 0 0.05321291834115982
in O 0 0.017762530595064163
a O 0 0.02791622094810009
novel O 0 0.0539865680038929
gene O 0 0.04230722784996033
( O 0 0.033871956169605255
WFS1 O 1 0.9969854950904846
) O 0 0.018869120627641678
encoding O 0 0.019066987559199333
a O 0 0.025318492203950882
putative O 1 0.9942565560340881
transmembrane O 1 0.9976323843002319
protein O 0 0.023005882278084755
were O 0 0.009079042822122574
found O 0 0.009659585542976856
in O 0 0.008916346356272697
all O 0 0.01051141507923603
affected O 0 0.017481591552495956
individuals O 0 0.011776776984333992
in O 0 0.012767358683049679
six O 0 0.03168076276779175
WFS B-Disease 1 0.9999995231628418
families O 0 0.03225536271929741
, O 0 0.018344787880778313
and O 0 0.013057633303105831
these O 0 0.00930080283433199
mutations O 0 0.01771264709532261
were O 0 0.009043504483997822
associated O 0 0.015381582081317902
with O 0 0.01964496448636055
the O 1 0.9761325716972351
disease O 1 0.9999998807907104
phenotype O 1 0.9999711513519287
. O 0 0.06993194669485092

WFS1 O 1 0.9996131062507629
appears O 0 0.046826355159282684
to O 0 0.018592197448015213
function O 0 0.016699660569429398
in O 0 0.011267200112342834
survival O 0 0.03106624446809292
of O 0 0.023435896262526512
islet O 1 0.9999842643737793
beta O 1 0.9999955892562866
- O 1 0.9999992847442627
cells O 0 0.139953151345253
and O 0 0.03379954770207405
neurons O 0 0.053236886858940125
. O 0 0.02780052088201046
. O 0 0.03867688402533531

Stable O 0 0.33377978205680847
interaction O 0 0.03357769548892975
between O 0 0.016541490331292152
the O 0 0.014987636357545853
products O 0 0.01480763778090477
of O 0 0.014693115837872028
the O 0 0.03053625300526619
BRCA1 O 1 0.9999886751174927
and O 1 0.9220486879348755
BRCA2 O 1 0.9999998807907104
tumor B-Disease 1 1.0
suppressor O 1 0.999992847442627
genes O 0 0.03435785323381424
in O 0 0.025939397513866425
mitotic O 1 0.9903818964958191
and O 0 0.0594690665602684
meiotic O 1 0.9999736547470093
cells O 0 0.18148137629032135
. O 0 0.05723856762051582

BRCA1 O 1 0.9997735619544983
and O 0 0.06324626505374908
BRCA2 O 1 0.9852112531661987
account O 0 0.024500638246536255
for O 0 0.014329775236546993
most O 0 0.011097501963376999
cases O 0 0.014678873121738434
of O 0 0.020119639113545418
familial O 1 0.9999904632568359
, O 0 0.02907465398311615
early O 1 0.7167183756828308
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999728202819824
/ I-Disease 1 1.0
or I-Disease 1 0.9999983310699463
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9702221751213074
encode O 0 0.03504980355501175
products O 0 0.01952950470149517
that O 0 0.009192169643938541
each O 0 0.011284934356808662
interact O 0 0.027036180719733238
with O 0 0.02651524543762207
hRAD51 O 1 0.9856385588645935
. O 0 0.047613464295864105

Results O 0 0.033880896866321564
presented O 0 0.03158881142735481
here O 0 0.01961423270404339
show O 0 0.02187541127204895
that O 0 0.01865881122648716
BRCA1 O 1 0.9995740056037903
and O 0 0.030904345214366913
BRCA2 O 1 0.9997333884239197
coexist O 0 0.0513838455080986
in O 0 0.018051547929644585
a O 0 0.029720311984419823
biochemical O 0 0.058315325528383255
complex O 0 0.027683567255735397
and O 0 0.021324479952454567
colocalize O 1 0.9786659479141235
in O 0 0.02323906682431698
subnuclear O 1 0.9994809031486511
foci O 1 0.9997043013572693
in O 0 0.03478342667222023
somatic O 1 0.9981978535652161
cells O 0 0.034193821251392365
and O 0 0.015834346413612366
on O 0 0.01673787273466587
the O 0 0.02157067507505417
axial O 0 0.05413950979709625
elements O 0 0.027471737936139107
of O 0 0.028634067624807358
developing O 0 0.4436377286911011
synaptonemal O 1 0.9999709129333496
complexes O 1 0.9764528870582581
. O 0 0.055413588881492615

Like O 0 0.08907051384449005
BRCA1 O 1 0.997127115726471
and O 0 0.060645826160907745
RAD51 O 1 0.9999912977218628
, O 0 0.0673351138830185
BRCA2 O 1 0.9989868998527527
relocates O 1 0.9937763214111328
to O 0 0.056064803153276443
PCNA O 1 0.999976396560669
+ O 1 0.6408059597015381
replication O 0 0.059191688895225525
sites O 0 0.021810486912727356
following O 0 0.021439509466290474
exposure O 0 0.04286449775099754
of O 0 0.032928623259067535
S O 1 0.9999805688858032
phase O 1 0.9890549182891846
cells O 0 0.05453566461801529
to O 0 0.044623956084251404
hydroxyurea O 1 0.9999300241470337
or O 0 0.2063644975423813
UV O 1 0.9999967813491821
irradiation O 1 0.9665175676345825
. O 0 0.06743685156106949

Thus O 0 0.056204769760370255
, O 0 0.049381155520677567
BRCA1 O 1 0.9994310736656189
and O 0 0.042189814150333405
BRCA2 O 1 0.9993467926979065
participate O 0 0.03124980442225933
, O 0 0.017409058287739754
together O 0 0.01390411052852869
, O 0 0.01171006541699171
in O 0 0.011196186766028404
a O 0 0.02942522056400776
pathway O 1 0.9992014765739441
( O 0 0.04309777915477753
s O 1 0.9951586127281189
) O 0 0.01593686081469059
associated O 0 0.011405142024159431
with O 0 0.009013948030769825
the O 0 0.015521634370088577
activation O 0 0.029719943180680275
of O 0 0.019190583378076553
double O 0 0.4153527021408081
- O 1 0.9999806880950928
strand O 1 0.5376759767532349
break O 0 0.08412110805511475
repair O 1 0.9995007514953613
and O 0 0.05124557763338089
/ O 1 0.9998006224632263
or O 0 0.04227275401353836
homologous O 0 0.1934729367494583
recombination O 0 0.13211293518543243
. O 0 0.05447839945554733

Dysfunction O 1 0.9999927282333374
of O 0 0.048494499176740646
this O 0 0.03841434046626091
pathway O 1 0.999026894569397
may O 0 0.017166681587696075
be O 0 0.009416859596967697
a O 0 0.014873726293444633
general O 0 0.023014459758996964
phenomenon O 0 0.023197252303361893
in O 0 0.007641110103577375
the O 0 0.009320749901235104
majority O 0 0.009757496416568756
of O 0 0.009917564690113068
cases O 0 0.014219357632100582
of O 0 0.4221026599407196
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999992847442627
/ I-Disease 1 1.0
or I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.6886571645736694
. O 0 0.052276983857154846

A O 0 0.083641417324543
novel O 0 0.09667734056711197
Arg362Ser O 1 0.9814401268959045
mutation O 0 0.04317939281463623
in O 0 0.014330514706671238
the O 0 0.021962076425552368
sterol O 1 0.7989444732666016
27 O 0 0.05835011973977089
- O 1 0.9999881982803345
hydroxylase O 1 0.9999760389328003
gene O 0 0.04658994451165199
( O 0 0.03230495750904083
CYP27 O 1 0.9999618530273438
) O 0 0.018877433612942696
: O 0 0.01402049046009779
its O 0 0.011687257327139378
effects O 0 0.018286436796188354
on O 0 0.016505248844623566
pre O 0 0.48023220896720886
- O 1 0.999599277973175
mRNA O 0 0.05435030534863472
splicing O 0 0.04867088422179222
and O 0 0.02813011035323143
enzyme O 0 0.05800371989607811
activity O 0 0.04206570237874985
. O 0 0.03907802328467369

A O 0 0.07694579660892487
novel O 0 0.07665321230888367
C O 0 0.0924096554517746
to O 0 0.020372625440359116
A O 0 0.031515683978796005
mutation O 0 0.02314434014260769
in O 0 0.009180768392980099
the O 0 0.01633641868829727
sterol O 1 0.7878237366676331
27 O 0 0.049428582191467285
- O 1 0.999993085861206
hydroxylase O 1 0.9999295473098755
gene O 0 0.043499723076820374
( O 0 0.028058424592018127
CYP27 O 1 0.9994885921478271
) O 0 0.01778508722782135
was O 0 0.019948067143559456
identified O 0 0.01649095118045807
by O 0 0.014509742148220539
sequencing O 0 0.031151587143540382
amplified O 0 0.06551861763000488
CYP27 O 1 0.9994845390319824
gene O 0 0.033168550580739975
products O 0 0.01902179792523384
from O 0 0.012994222342967987
a O 0 0.024998001754283905
patient O 1 0.9876606464385986
with O 0 0.045907001942396164
cerebrotendinous B-Disease 1 0.999998927116394
xanthomatosis I-Disease 1 0.9999990463256836
( O 1 0.9601938724517822
CTX B-Disease 1 0.9999973773956299
) O 0 0.06514695286750793
. O 0 0.050664272159338

The O 0 0.056618668138980865
mutation O 0 0.059658974409103394
changed O 0 0.03324376791715622
the O 0 0.0402960442006588
adrenodoxin O 1 0.9994856119155884
cofactor O 1 0.998737633228302
binding O 0 0.055057309567928314
residue O 0 0.07836437225341797
362Arg O 0 0.18080633878707886
to O 0 0.0290574561804533
362Ser O 1 0.959940493106842
( O 0 0.04140890762209892
CGT O 1 0.999083399772644
362Arg O 1 0.9941354990005493
to O 0 0.05252540111541748
AGT O 1 1.0
362Ser O 1 0.999985933303833
) O 0 0.023344578221440315
, O 0 0.014266690239310265
and O 0 0.01101746130734682
was O 0 0.02010324038565159
responsible O 0 0.032505545765161514
for O 0 0.026926064863801003
deficiency O 1 0.9999998807907104
in O 0 0.019273729994893074
the O 0 0.03421813249588013
sterol O 1 0.9999186992645264
27 O 1 0.7584792971611023
- O 1 0.9999974966049194
hydroxylase O 1 0.9998660087585449
activity O 0 0.024675220251083374
, O 0 0.013238945975899696
as O 0 0.010044323280453682
confirmed O 0 0.012546384707093239
by O 0 0.009624467231333256
expression O 0 0.01504953857511282
of O 0 0.015794549137353897
mutant O 0 0.06934338063001633
cDNA O 0 0.0745590329170227
into O 0 0.04372500628232956
COS O 1 0.9999881982803345
- O 1 0.9999366998672485
1 O 0 0.06466957181692123
cells O 0 0.0498950332403183
. O 0 0.042935483157634735

Quantitative O 0 0.05546849966049194
analysis O 0 0.020548135042190552
showed O 0 0.017061574384570122
that O 0 0.00803259015083313
the O 0 0.011999694630503654
expression O 0 0.01922713592648506
of O 0 0.021339790895581245
CYP27 O 1 0.999991774559021
gene O 0 0.033072106540203094
mRNA O 0 0.03129008039832115
in O 0 0.013689677231013775
the O 0 0.02486843429505825
patient O 1 0.7916759848594666
represented O 0 0.03779475390911102
52 O 0 0.07256511598825455
. O 0 0.05045454576611519

5 O 0 0.04780736565589905
% O 0 0.025797635316848755
of O 0 0.02399299480021
the O 0 0.03139057382941246
normal O 0 0.047616492956876755
level O 0 0.05237389728426933
. O 0 0.04775342345237732

As O 0 0.03736836463212967
the O 0 0.03218485414981842
mutation O 0 0.04110002890229225
occurred O 0 0.022462178021669388
at O 0 0.017061255872249603
the O 0 0.02000863291323185
penultimate O 1 0.8339634537696838
nucleotide O 0 0.03302346169948578
of O 0 0.02138112485408783
exon O 0 0.18004851043224335
6 O 0 0.03933386132121086
( O 0 0.02762131206691265
- O 0 0.274684876203537
2 O 0 0.0192938894033432
position O 0 0.018160056322813034
of O 0 0.01848466694355011
exon O 0 0.07846025377511978
6 O 0 0.04766438156366348
- O 1 0.9996125102043152
intron O 1 0.9985747337341309
6 O 0 0.04445415362715721
splice O 0 0.06908448785543442
site O 0 0.023927263915538788
) O 0 0.011217117309570312
of O 0 0.011796360835433006
the O 0 0.017766503617167473
gene O 0 0.021225523203611374
, O 0 0.013016996905207634
we O 0 0.010770799592137337
hypothesized O 0 0.026142358779907227
that O 0 0.008601491339504719
the O 0 0.01906418241560459
mutation O 0 0.05617569014430046
may O 0 0.017872076481580734
partially O 0 0.030558442696928978
affect O 0 0.016841154545545578
the O 0 0.016312116757035255
normal O 0 0.022979088127613068
splicing O 0 0.033765505999326706
efficiency O 0 0.02572638913989067
in O 0 0.01394555065780878
exon O 0 0.08071988821029663
6 O 0 0.029021142050623894
and O 0 0.019873183220624924
cause O 0 0.0393187515437603
alternative O 0 0.037796784192323685
splicing O 0 0.03861875459551811
elsewhere O 0 0.016636410728096962
, O 0 0.012434332631528378
which O 0 0.010325141251087189
resulted O 0 0.02049541287124157
in O 0 0.015269807539880276
decreased O 0 0.04564068838953972
transcript O 0 0.04443427920341492
in O 0 0.018092121928930283
the O 0 0.033548787236213684
patient O 1 0.999464213848114
. O 0 0.048515498638153076

Transfection O 1 0.9773475527763367
of O 0 0.047908902168273926
constructed O 0 0.38981133699417114
minigenes O 1 0.9998618364334106
, O 0 0.02498178742825985
with O 0 0.014457285404205322
or O 0 0.01160731352865696
without O 0 0.009581230580806732
the O 0 0.014549600891768932
mutation O 0 0.02504713647067547
, O 0 0.014563924632966518
into O 0 0.023296937346458435
COS O 1 0.9999998807907104
- O 1 0.9999947547912598
1 O 0 0.03080754168331623
cells O 0 0.018217632547020912
confirmed O 0 0.01199988555163145
that O 0 0.006749082822352648
the O 0 0.015116467140614986
mutant O 0 0.09008622914552689
minigene O 1 0.9966166615486145
was O 0 0.02940506301820278
responsible O 0 0.026176180690526962
for O 0 0.013669275678694248
a O 0 0.019904620945453644
mRNA O 0 0.0317106731235981
species O 0 0.011647075414657593
alternatively O 0 0.027303677052259445
spliced O 0 0.03095780313014984
at O 0 0.01789441891014576
an O 0 0.021427465602755547
activated O 1 0.934688925743103
cryptic O 0 0.08076148480176926
5 O 0 0.035310279577970505
splice O 0 0.07697031646966934
site O 0 0.03211626783013344
88 O 0 0.04965020343661308
bp O 0 0.053995005786418915
upstream O 0 0.02953348122537136
from O 0 0.012291323393583298
the O 0 0.015993814915418625
3 O 0 0.024532031267881393
end O 0 0.028018087148666382
of O 0 0.03250877931714058
exon O 1 0.5985109210014343
6 O 0 0.06551238149404526
. O 0 0.05011516436934471

Our O 0 0.048229966312646866
data O 0 0.018904978409409523
suggest O 0 0.015506129711866379
that O 0 0.008857124485075474
the O 0 0.017029793933033943
C O 0 0.07646450400352478
to O 0 0.01565202884376049
A O 0 0.028695208951830864
mutation O 0 0.027952753007411957
at O 0 0.01606081984937191
the O 0 0.02018030732870102
penultimate O 1 0.9208551049232483
nucleotide O 0 0.02984938770532608
of O 0 0.01805841363966465
exon O 0 0.05582714080810547
6 O 0 0.019021907821297646
of O 0 0.014268126338720322
the O 0 0.02363158017396927
CYP27 O 1 0.9999895095825195
gene O 0 0.025730740278959274
not O 0 0.0098872734233737
only O 0 0.01309447642415762
causes O 0 0.15824735164642334
the O 0 0.06874415278434753
deficiency B-Disease 1 0.9999995231628418
in I-Disease 0 0.01694495789706707
the I-Disease 0 0.02715536765754223
sterol I-Disease 1 0.9994344115257263
27 I-Disease 1 0.5019629597663879
- I-Disease 1 0.9999983310699463
hydroxylase I-Disease 1 0.9999052286148071
activity I-Disease 0 0.028405603021383286
, O 0 0.01603396236896515
but O 0 0.011108915321528912
also O 0 0.012856271117925644
partially O 0 0.030146770179271698
leads O 0 0.025137081742286682
to O 0 0.014137126505374908
alternative O 0 0.024390356615185738
pre O 0 0.08369189500808716
- O 1 0.9837771654129028
mRNA O 0 0.03581683337688446
splicing O 0 0.02877417951822281
of O 0 0.015878209844231606
the O 0 0.028824450448155403
gene O 0 0.04590702801942825
. O 0 0.039141833782196045

To O 0 0.03610105440020561
our O 0 0.030015770345926285
knowledge O 0 0.02474449947476387
, O 0 0.014362860471010208
this O 0 0.008245879784226418
is O 0 0.009718474932014942
the O 0 0.011677012778818607
first O 0 0.014850201085209846
report O 0 0.01335372868925333
regarding O 0 0.017131270840764046
effects O 0 0.018065329641103745
on O 0 0.01603972539305687
pre O 1 0.5522430539131165
- O 1 0.9987267851829529
mRNA O 0 0.03168526664376259
splicing O 0 0.020012205466628075
of O 0 0.010434228926897049
a O 0 0.015653548762202263
mutation O 0 0.024980857968330383
at O 0 0.01630525290966034
the O 0 0.020926203578710556
- O 1 0.9978589415550232
2 O 0 0.020488237962126732
position O 0 0.017562298104166985
of O 0 0.015120584517717361
a O 0 0.02567720226943493
5 O 0 0.041320137679576874
splice O 0 0.10186057537794113
site O 0 0.049147456884384155
. O 0 0.03768739849328995

ATM O 0 0.3098452389240265
germline O 0 0.15196636319160461
mutations O 0 0.04284939542412758
in O 0 0.02598540112376213
classical O 1 0.6740928888320923
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9998327493667603
in O 0 0.025148270651698112
the O 0 0.02975444681942463
Dutch O 0 0.07505202293395996
population O 0 0.033529672771692276
. O 0 0.03965115547180176

Germline O 1 0.9891737699508667
mutations O 0 0.04786216840147972
in O 0 0.015877757221460342
the O 0 0.025606472045183182
ATM O 1 0.8588575720787048
gene O 0 0.018793098628520966
are O 0 0.0052187638357281685
responsible O 0 0.01260351575911045
for O 0 0.01150079071521759
the O 0 0.05433197692036629
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.998794674873352
A B-Disease 1 0.9999977350234985
- I-Disease 1 1.0
T I-Disease 1 0.9999983310699463
) O 0 0.04363192617893219
. O 0 0.033847834914922714

In O 0 0.0333264097571373
our O 0 0.030951164662837982
study O 0 0.023231104016304016
, O 0 0.015797855332493782
we O 0 0.009690266102552414
have O 0 0.006434651091694832
determined O 0 0.014748181216418743
the O 0 0.019587548449635506
ATM O 1 0.6976613998413086
mutation O 0 0.030986811965703964
spectrum O 0 0.021011730656027794
in O 0 0.009193242527544498
19 O 0 0.019716382026672363
classical O 0 0.02708607167005539
A B-Disease 1 0.9998218417167664
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9942730069160461
, O 0 0.015323554165661335
including O 0 0.010525429621338844
some O 0 0.010603143833577633
immigrant O 0 0.06401706486940384
populations O 0 0.0196993388235569
, O 0 0.013378781266510487
as O 0 0.012507184408605099
well O 0 0.010453739203512669
as O 0 0.010824833996593952
12 O 0 0.01535506546497345
of O 0 0.017256835475564003
Dutch O 0 0.04929891601204872
ethnic O 0 0.04092934727668762
origin O 0 0.03320762887597084
. O 0 0.036663226783275604

Both O 0 0.029768120497465134
the O 0 0.0347343347966671
protein O 0 0.043153345584869385
truncation O 0 0.31879085302352905
test O 0 0.045604780316352844
( O 0 0.03523653373122215
PTT O 1 0.9257490038871765
) O 0 0.016491616144776344
and O 0 0.010872313752770424
the O 0 0.017609883099794388
restriction O 0 0.04175523295998573
endonuclease O 1 0.9983550906181335
fingerprinting O 1 0.9647051095962524
( O 0 0.055652912706136703
REF O 1 0.9999505281448364
) O 0 0.02071443200111389
method O 0 0.014865519478917122
were O 0 0.008682820945978165
used O 0 0.009290535002946854
and O 0 0.01043796632438898
compared O 0 0.011586462147533894
for O 0 0.010784617625176907
their O 0 0.013532784767448902
detection O 0 0.05988503247499466
efficiency O 0 0.040482670068740845
, O 0 0.01774420030415058
identifying O 0 0.027175821363925934
76 O 0 0.04548746719956398
% O 0 0.016861481592059135
and O 0 0.012273568660020828
60 O 0 0.015950730070471764
% O 0 0.01327547337859869
of O 0 0.017353955656290054
the O 0 0.0307652298361063
mutations O 0 0.04643484205007553
, O 0 0.03083585575222969
respectively O 0 0.04277613013982773
. O 0 0.043461304157972336

Most O 0 0.05669744685292244
patients O 1 0.8633846640586853
were O 0 0.01917756348848343
found O 0 0.01655423827469349
to O 0 0.019110605120658875
be O 0 0.02329033426940441
compound O 0 0.25171512365341187
heterozygote O 1 0.9558766484260559
. O 0 0.05304621532559395

Seventeen O 0 0.11555476486682892
mutations O 0 0.04483399912714958
were O 0 0.01573316752910614
distinct O 0 0.018882157281041145
, O 0 0.016167186200618744
of O 0 0.014787048101425171
which O 0 0.01296032965183258
10 O 0 0.013643032871186733
were O 0 0.009637045674026012
not O 0 0.011771684512495995
reported O 0 0.02200900949537754
previously O 0 0.03343643993139267
. O 0 0.035016488283872604

Mutations O 0 0.06930171698331833
are O 0 0.01744324527680874
small O 0 0.02674439176917076
deletions O 0 0.06127393618226051
or O 0 0.026354612782597542
point O 0 0.03812205791473389
mutations O 0 0.04118895158171654
frequently O 0 0.0350211039185524
affecting O 0 0.06036939099431038
splice O 0 0.15274079144001007
sites O 0 0.04921731352806091
. O 0 0.040589120239019394

Moreover O 0 0.09200190752744675
, O 0 0.039118725806474686
a O 0 0.04343743622303009
16 O 0 0.05615131929516792
. O 0 0.049555111676454544

7 O 0 0.09574081748723984
- O 1 0.9990975856781006
kb O 1 0.5351323485374451
genomic O 0 0.06140410155057907
deletion O 0 0.04688315466046333
of O 0 0.01824791170656681
the O 0 0.018577011302113533
3 O 0 0.02002956159412861
end O 0 0.01825789175927639
of O 0 0.013943267054855824
the O 0 0.020031433552503586
gene O 0 0.020631494000554085
, O 0 0.01269760075956583
most O 0 0.0103727076202631
likely O 0 0.013773557730019093
a O 0 0.0137663958594203
result O 0 0.012944868765771389
of O 0 0.01863883249461651
recombination O 0 0.04337482154369354
between O 0 0.017028868198394775
two O 0 0.015070589259266853
LINE O 0 0.055606771260499954
elements O 0 0.02716226503252983
, O 0 0.02153739333152771
was O 0 0.03456806764006615
identified O 0 0.038613565266132355
. O 0 0.035960886627435684

The O 0 0.04176371544599533
most O 0 0.02328827977180481
frequently O 0 0.022503461688756943
found O 0 0.0187701229006052
mutation O 0 0.030395474284887314
, O 0 0.01355417724698782
identified O 0 0.012403587810695171
in O 0 0.006140090525150299
three O 0 0.007381049450486898
unrelated O 0 0.019490718841552734
Turkish O 0 0.03449048474431038
A B-Disease 1 0.9999841451644897
- I-Disease 1 1.0
T I-Disease 1 0.9999997615814209
individuals O 0 0.01701798290014267
, O 0 0.013831350952386856
was O 0 0.01754065603017807
previously O 0 0.013706999830901623
described O 0 0.015003637410700321
to O 0 0.008584471419453621
be O 0 0.006623491644859314
a O 0 0.012935039587318897
Turkish O 0 0.03297349438071251
A B-Disease 1 0.9906982779502869
- I-Disease 1 0.9999996423721313
T I-Disease 1 0.9999967813491821
founder O 1 0.9993908405303955
mutation O 0 0.0893969014286995
. O 0 0.047192420810461044

The O 0 0.03304621949791908
presence O 0 0.027580274268984795
of O 0 0.020075934007763863
a O 0 0.03362678736448288
founder O 1 0.9999328851699829
mutation O 0 0.061856549233198166
among O 0 0.019648941233754158
relatively O 0 0.015223709866404533
small O 0 0.013058636337518692
ethnic O 0 0.017722057178616524
population O 0 0.012629002332687378
groups O 0 0.0110703743994236
in O 0 0.009839829057455063
Western O 0 0.018609873950481415
Europe O 0 0.0195248294621706
could O 0 0.01060642022639513
indicate O 0 0.013675184920430183
a O 0 0.01871565729379654
high O 0 0.0441589392721653
carrier O 1 0.8258363008499146
frequency O 0 0.024167325347661972
in O 0 0.014712457545101643
such O 0 0.017283393070101738
communities O 0 0.03468652814626694
. O 0 0.04421752318739891

In O 0 0.03905908390879631
patients O 0 0.06951435655355453
of O 0 0.025759242475032806
Dutch O 0 0.055400315672159195
ethnic O 0 0.03087431937456131
origin O 0 0.0176021046936512
, O 0 0.014372408390045166
however O 0 0.01136432308703661
, O 0 0.012089809402823448
no O 0 0.012045014649629593
significant O 0 0.01886633224785328
founder O 1 0.998898983001709
effect O 0 0.030449150130152702
could O 0 0.017763301730155945
be O 0 0.016646733507514
identified O 0 0.0317390076816082
. O 0 0.033346597105264664

The O 0 0.05451058968901634
observed O 0 0.046187303960323334
genetic O 0 0.04101591184735298
heterogeneity O 0 0.06181786581873894
including O 0 0.016354834660887718
the O 0 0.020360572263598442
relative O 0 0.027011454105377197
high O 0 0.025100670754909515
percentage O 0 0.02117720991373062
of O 0 0.02447398379445076
splice O 1 0.9871768355369568
- O 1 0.9998030066490173
site O 0 0.03769909217953682
mutations O 0 0.02539345808327198
had O 0 0.019322743639349937
no O 0 0.01851101964712143
reflection O 0 0.04208547621965408
on O 0 0.023897038772702217
the O 0 0.04084187000989914
phenotype O 1 0.7069055438041687
. O 0 0.05220549553632736

All O 0 0.04392025247216225
patients O 0 0.2949856221675873
manifested O 1 0.81955486536026
classical O 0 0.07911226898431778
A B-Disease 1 0.9999743700027466
- I-Disease 1 1.0
T I-Disease 1 0.9999929666519165
and O 0 0.025663599371910095
increased O 0 0.036025334149599075
cellular O 0 0.16104808449745178
radioresistant O 1 0.9985602498054504
DNA O 0 0.06582646816968918
synthesis O 0 0.06511405855417252
. O 0 0.039821162819862366

Determination O 0 0.07479752600193024
of O 0 0.029314419254660606
the O 0 0.025941677391529083
genomic O 0 0.04090070724487305
structure O 0 0.022337161004543304
of O 0 0.016823699697852135
the O 0 0.028457125648856163
COL4A4 O 1 0.9999918937683105
gene O 0 0.021961091086268425
and O 0 0.011528127826750278
of O 0 0.018412727862596512
novel O 0 0.08137976378202438
mutations O 0 0.42003729939460754
causing O 1 0.999936580657959
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9995518326759338

Autosomal B-Disease 1 0.9999988079071045
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.7869358658790588
a O 1 0.9527934789657593
progressive O 1 0.9999994039535522
hematuric B-Disease 1 0.9999998807907104
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9995262622833252
by O 1 0.9582881331443787
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.9999995231628418
abnormalities I-Disease 1 0.9999972581863403
and O 0 0.023402195423841476
associated O 0 0.01931157335639
with O 0 0.014963381923735142
mutations O 0 0.019894825294613838
in O 0 0.009642919525504112
either O 0 0.012893765233457088
the O 0 0.018809909000992775
COL4A3 O 1 0.9999570846557617
or O 0 0.01821204274892807
the O 0 0.02761266753077507
COL4A4 O 1 0.9999963045120239
gene O 0 0.028919674456119537
, O 0 0.013329674489796162
which O 0 0.008792995475232601
encode O 0 0.01606394723057747
the O 0 0.01742510125041008
alpha3 O 0 0.3242347538471222
and O 0 0.02913776971399784
alpha4 O 1 0.9999555349349976
type O 1 0.9998645782470703
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.9963655471801758
, O 0 0.0476972833275795
respectively O 0 0.050651680678129196
. O 0 0.04703377187252045

To O 0 0.03376414254307747
date O 0 0.032263513654470444
, O 0 0.02399423159658909
mutation O 0 0.039291512221097946
screening O 0 0.031934939324855804
in O 0 0.009998063556849957
the O 0 0.013099036179482937
two O 0 0.012190721929073334
genes O 0 0.01613849587738514
has O 0 0.013408887200057507
been O 0 0.013542603701353073
hampered O 0 0.05427788570523262
by O 0 0.014185309410095215
the O 0 0.019221624359488487
lack O 0 0.03095807321369648
of O 0 0.0339517667889595
genomic O 1 0.5912603735923767
structure O 0 0.053935445845127106
information O 0 0.030194278806447983
. O 0 0.037562839686870575

We O 0 0.03200765699148178
report O 0 0.022113308310508728
here O 0 0.014959340915083885
the O 0 0.015557713806629181
complete O 0 0.023998089134693146
characterization O 0 0.032799653708934784
of O 0 0.014527405612170696
the O 0 0.01779702864587307
48 O 0 0.02645597606897354
exons O 0 0.03414706513285637
of O 0 0.01717192865908146
the O 0 0.028912192210555077
COL4A4 O 1 0.9999892711639404
gene O 0 0.028724979609251022
, O 0 0.01438120100647211
a O 0 0.01957843266427517
comprehensive O 0 0.054429300129413605
gene O 0 0.02899826690554619
screen O 0 0.027368320152163506
, O 0 0.013267580419778824
and O 0 0.011143982410430908
the O 0 0.014109352603554726
subsequent O 0 0.022719455882906914
detection O 0 0.027855796739459038
of O 0 0.014133964665234089
10 O 0 0.017056258395314217
novel O 0 0.027834149077534676
mutations O 0 0.018483465537428856
in O 0 0.011570756323635578
eight O 0 0.03027411550283432
patients O 1 0.9999909400939941
diagnosed O 1 1.0
with O 1 0.9997768998146057
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9998817443847656

Furthermore O 0 0.07165054976940155
, O 0 0.02738376520574093
we O 0 0.0167962908744812
identified O 0 0.021489107981324196
a O 0 0.024797454476356506
glycine O 0 0.06199636310338974
to O 0 0.021141085773706436
alanine O 0 0.07361870259046555
substitution O 0 0.03363969549536705
in O 0 0.014955723658204079
the O 0 0.028548894450068474
collagenous O 1 0.9999967813491821
domain O 0 0.04110408201813698
that O 0 0.011639239266514778
is O 0 0.012722725979983807
apparently O 0 0.018787885084748268
silent O 0 0.03655141964554787
in O 0 0.011678328737616539
the O 0 0.02089686505496502
heterozygous O 0 0.07420915365219116
carriers O 0 0.051491495221853256
, O 0 0.02219386026263237
in O 0 0.01966696046292782
11 O 0 0.04111146554350853
. O 0 0.04140005260705948

5 O 0 0.04350047558546066
% O 0 0.020247964188456535
of O 0 0.018318161368370056
all O 0 0.016993558034300804
control O 0 0.041659992188215256
individuals O 0 0.016994459554553032
, O 0 0.015121009200811386
and O 0 0.012273905798792839
in O 0 0.011214694008231163
one O 0 0.014567238278687
control O 0 0.026452796533703804
individual O 0 0.01690671592950821
homozygous O 0 0.04101618006825447
for O 0 0.02072068676352501
this O 0 0.023228928446769714
glycine O 0 0.1620665043592453
substitution O 0 0.07254896312952042
. O 0 0.04595530405640602

There O 0 0.033664099872112274
has O 0 0.020457495003938675
been O 0 0.013957665301859379
no O 0 0.01117327343672514
previous O 0 0.012280005030333996
finding O 0 0.016449546441435814
of O 0 0.014270566403865814
a O 0 0.026662874966859818
glycine O 1 0.9704394936561584
substitution O 0 0.042665183544158936
that O 0 0.010334023274481297
is O 0 0.01087066251784563
not O 0 0.008495602756738663
associated O 0 0.012243869714438915
with O 0 0.011140704154968262
any O 0 0.01806778460741043
obvious O 0 0.12273958325386047
phenotype O 1 0.95917809009552
in O 0 0.029693350195884705
homozygous O 0 0.10694294422864914
individuals O 0 0.04196823015809059
. O 0 0.049762483686208725

Founder O 1 0.9992110729217529
BRCA1 O 1 0.9996354579925537
and O 0 0.05076088756322861
BRCA2 O 1 0.9976776242256165
mutations O 0 0.029535353183746338
in O 0 0.015786057338118553
French O 0 0.04911045357584953
Canadian O 1 0.9893454909324646
breast B-Disease 1 1.0
and I-Disease 1 0.9999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.999832272529602
. O 0 0.11501816660165787

We O 0 0.027108084410429
have O 0 0.012363866902887821
identified O 0 0.017769325524568558
four O 0 0.012467728927731514
mutations O 0 0.014627101831138134
in O 0 0.006841213908046484
each O 0 0.0054628849029541016
of O 0 0.01199279259890318
the O 0 0.16285660862922668
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 1.0
susceptibility O 1 0.9999994039535522
genes O 0 0.032021645456552505
, O 0 0.02772044949233532
BRCA1 O 1 0.9996211528778076
and O 0 0.02412891574203968
BRCA2 O 1 0.9770128726959229
, O 0 0.014081636443734169
in O 0 0.010961096733808517
French O 0 0.037826646119356155
Canadian O 1 0.9722056984901428
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999986886978149
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9914940595626831
from O 0 0.05608787015080452
Quebec O 1 0.9529983401298523
. O 0 0.049965064972639084

To O 0 0.04021231830120087
identify O 0 0.05701955780386925
founder O 1 0.9993971586227417
effects O 0 0.08742180466651917
, O 0 0.02084338106215
we O 0 0.01417169813066721
examined O 0 0.026573020964860916
independently O 0 0.01666775345802307
ascertained O 0 0.04557134211063385
French O 0 0.05075004696846008
Canadian O 0 0.25167474150657654
cancer B-Disease 1 0.9999359846115112
families O 0 0.022010432556271553
for O 0 0.014064011164009571
the O 0 0.017944179475307465
distribution O 0 0.018292590975761414
of O 0 0.016529951244592667
these O 0 0.013849216513335705
eight O 0 0.033921029418706894
mutations O 0 0.05334862321615219
. O 0 0.04367873817682266

Mutations O 0 0.06500101834535599
were O 0 0.017678532749414444
found O 0 0.014749430119991302
in O 0 0.014110183343291283
41 O 0 0.03579020872712135
of O 0 0.030246738344430923
97 O 0 0.17691504955291748
families O 0 0.05404386296868324
. O 0 0.04839429631829262

Six O 0 0.03445391356945038
of O 0 0.030033741146326065
eight O 0 0.03429853916168213
mutations O 0 0.03582509979605675
were O 0 0.01684059388935566
observed O 0 0.023991484194993973
at O 0 0.023842385038733482
least O 0 0.020844150334596634
twice O 0 0.03852327540516853
. O 0 0.040722914040088654

The O 0 0.07762550562620163
BRCA1 O 1 0.9998119473457336
C4446T O 1 0.9993460774421692
mutation O 0 0.05868294835090637
was O 0 0.026672041043639183
the O 0 0.017999714240431786
most O 0 0.015738744288682938
common O 0 0.02408456988632679
mutation O 0 0.03841060772538185
found O 0 0.011478396132588387
, O 0 0.012482034042477608
followed O 0 0.01729583740234375
by O 0 0.016985779628157616
the O 0 0.04071278125047684
BRCA2 O 1 0.9999499320983887
8765delAG O 1 0.9999498128890991
mutation O 0 0.22981832921504974
. O 0 0.04850360378623009

Together O 0 0.04888836666941643
, O 0 0.025938203558325768
these O 0 0.013292411342263222
mutations O 0 0.018800873309373856
were O 0 0.009179739281535149
found O 0 0.008971546776592731
in O 0 0.009916792623698711
28 O 0 0.01826908439397812
of O 0 0.016003785654902458
41 O 0 0.03340674191713333
families O 0 0.022638577967882156
identified O 0 0.02177020162343979
to O 0 0.013997136615216732
have O 0 0.012778445146977901
a O 0 0.03226112946867943
mutation O 0 0.06327678263187408
. O 0 0.04005730524659157

The O 0 0.04910321906208992
odds O 0 0.06166762858629227
of O 0 0.027525918558239937
detection O 0 0.03681398928165436
of O 0 0.014767469838261604
any O 0 0.010307745076715946
of O 0 0.013371608220040798
the O 0 0.019755247980356216
four O 0 0.03295503929257393
BRCA1 O 1 0.9999897480010986
mutations O 0 0.05670366808772087
was O 0 0.04144889488816261
18 O 0 0.045501936227083206
. O 0 0.041009679436683655

7x O 1 0.9983885288238525
greater O 0 0.04697669669985771
if O 0 0.01899273693561554
one O 0 0.01271766610443592
or O 0 0.008836151100695133
more O 0 0.006574687082320452
cases O 0 0.019039656966924667
of O 1 0.9999750852584839
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.05222896486520767
also O 0 0.017115572467446327
present O 0 0.016165129840373993
in O 0 0.013912416994571686
the O 0 0.026709914207458496
family O 0 0.04989331588149071
. O 0 0.041544463485479355

The O 0 0.05380232259631157
odds O 0 0.06756102293729782
of O 0 0.03167678043246269
detection O 0 0.040843214839696884
of O 0 0.017255865037441254
any O 0 0.012343516573309898
of O 0 0.014329055324196815
the O 0 0.02242284268140793
four O 0 0.03209042549133301
BRCA2 O 1 0.9999239444732666
mutations O 0 0.05460793524980545
was O 0 0.047095056623220444
5 O 0 0.04630792513489723
. O 0 0.043523769825696945

3x O 1 0.9897079467773438
greater O 0 0.052344582974910736
if O 0 0.019682705402374268
there O 0 0.010714469477534294
were O 0 0.007573519833385944
at O 0 0.010088605806231499
least O 0 0.0069051263853907585
five O 0 0.009368976578116417
cases O 0 0.0188238974660635
of O 1 0.9901933073997498
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.06031402200460434
the O 0 0.12021966278553009
family O 0 0.20178495347499847
. O 0 0.04595566168427467

Interestingly O 0 0.08044733852148056
, O 0 0.02032247744500637
the O 0 0.014560073614120483
presence O 0 0.019171275198459625
of O 0 0.020426958799362183
a O 1 0.9963305592536926
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 1 0.9986553192138672
< O 1 0.999258816242218
36 O 0 0.02401738055050373
years O 0 0.01321591716259718
of O 0 0.0161516685038805
age O 0 0.02571178786456585
was O 0 0.023310916498303413
strongly O 0 0.02046484686434269
predictive O 0 0.025189563632011414
of O 0 0.01265793852508068
the O 0 0.014551468193531036
presence O 0 0.017062900587916374
of O 0 0.011929210275411606
any O 0 0.01012076623737812
of O 0 0.013839111663401127
the O 0 0.022079123184084892
eight O 0 0.03640208765864372
mutations O 0 0.053102388978004456
screened O 0 0.09726321697235107
. O 0 0.050194285809993744

Carriers O 0 0.060682512819767
of O 0 0.024651743471622467
the O 0 0.025074908509850502
same O 0 0.022879071533679962
mutation O 0 0.03802021965384483
, O 0 0.013578718528151512
from O 0 0.009605396538972855
different O 0 0.0062879230827093124
families O 0 0.015796255320310593
, O 0 0.014280887320637703
shared O 0 0.023171374574303627
similar O 0 0.017684636637568474
haplotypes O 0 0.11513655632734299
, O 0 0.015919901430606842
indicating O 0 0.017494739964604378
that O 0 0.00855060201138258
the O 0 0.017647281289100647
mutant O 1 0.892325758934021
alleles O 0 0.04163243994116783
were O 0 0.01212729699909687
likely O 0 0.014475771225988865
to O 0 0.0106705566868186
be O 0 0.007983393035829067
identical O 0 0.01193373091518879
by O 0 0.010553725063800812
descent O 0 0.0227110143750906
for O 0 0.011734061874449253
a O 0 0.02120276354253292
mutation O 0 0.027492711320519447
in O 0 0.013310111127793789
the O 0 0.02638227865099907
founder O 1 0.9973031282424927
population O 0 0.033976487815380096
. O 0 0.04118076711893082

The O 0 0.03828946873545647
identification O 0 0.0330783911049366
of O 0 0.02775922417640686
common O 0 0.12921573221683502
BRCA1 O 1 0.9999964237213135
and O 1 0.5084370374679565
BRCA2 O 1 0.9999942779541016
mutations O 0 0.04063505306839943
will O 0 0.019017448648810387
facilitate O 0 0.035532962530851364
carrier O 0 0.0609254315495491
detection O 0 0.02616018056869507
in O 0 0.009860371239483356
French O 0 0.03322760760784149
Canadian O 1 0.8833416700363159
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999988079071045
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9984545707702637
. O 0 0.07466740161180496

Are O 0 0.03203845024108887
Dp71 O 1 0.9762212634086609
and O 0 0.04885369911789894
Dp140 O 1 0.9999923706054688
brain O 1 0.9999104738235474
dystrophin O 1 0.9999762773513794
isoforms O 0 0.051098037511110306
related O 0 0.02721119485795498
to O 0 0.026357248425483704
cognitive B-Disease 1 0.7998577952384949
impairment I-Disease 1 0.9999953508377075
in O 1 0.9992254972457886
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999039173126221

Molecular O 0 0.08369908481836319
study O 0 0.03772687911987305
and O 0 0.03335576131939888
neuropsychological O 1 0.6840513348579407
analysis O 0 0.016733361408114433
were O 0 0.011527339927852154
performed O 0 0.021016091108322144
concurrently O 0 0.024075036868453026
on O 0 0.014325659722089767
49 O 0 0.039847854524850845
patients O 1 0.9773070812225342
with O 1 0.9907882809638977
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DMD B-Disease 1 1.0
) O 0 0.02858605794608593
in O 0 0.014726890251040459
order O 0 0.01634378358721733
to O 0 0.013738973066210747
find O 0 0.017897168174386024
a O 0 0.016842544078826904
molecular O 0 0.019048519432544708
explanation O 0 0.017161138355731964
for O 0 0.013166503049433231
the O 0 0.02790803462266922
cognitive B-Disease 1 0.995262861251831
impairment I-Disease 1 0.9999785423278809
observed O 0 0.032910529524087906
in O 0 0.025908393785357475
most O 0 0.4958680272102356
DMD B-Disease 1 1.0
patients O 1 0.9999440908432007
. O 0 0.06786833703517914

Complete O 0 0.04941706359386444
analysis O 0 0.01808764971792698
of O 0 0.019765041768550873
the O 0 0.03359047323465347
dystrophin O 1 0.9997463822364807
gene O 0 0.03969947621226311
was O 0 0.029077360406517982
performed O 0 0.027494587004184723
to O 0 0.013780341483652592
define O 0 0.02237561158835888
the O 0 0.018383074551820755
localization O 0 0.046936340630054474
of O 0 0.0241654422134161
deletions O 0 0.06018240377306938
and O 0 0.024667298421263695
duplications O 0 0.061401668936014175
in O 0 0.017405355349183083
relation O 0 0.027425726875662804
to O 0 0.01919279620051384
the O 0 0.027037283405661583
different O 0 0.02762250043451786
DMD B-Disease 1 0.9999997615814209
promoters O 1 0.9976129531860352
. O 0 0.05669749900698662

Qualitative O 0 0.05712102726101875
analysis O 0 0.018289722502231598
of O 0 0.018388086929917336
the O 0 0.028911536559462547
Dp71 O 1 0.9994661211967468
transcript O 0 0.049443621188402176
and O 0 0.01779894530773163
testing O 0 0.017079193145036697
for O 0 0.010353176854550838
the O 0 0.011960409581661224
specific O 0 0.009419572539627552
first O 0 0.01610574685037136
exon O 0 0.07419779151678085
of O 0 0.027842381969094276
Dp140 O 1 0.9905741810798645
were O 0 0.017767664045095444
also O 0 0.01819228194653988
carried O 0 0.027514686807990074
out O 0 0.03181320056319237
. O 0 0.038780491799116135

Neuropsychological O 1 0.9619123935699463
analysis O 0 0.04328256472945213
assessed O 0 0.054742198437452316
verbal O 0 0.06919101625680923
and O 0 0.043817926198244095
visuospatial O 1 0.999909520149231
intelligence O 0 0.04949373006820679
, O 0 0.03152700141072273
verbal O 1 0.8681239485740662
memory O 1 0.9972910284996033
, O 0 0.034195225685834885
and O 0 0.030694466084241867
reading O 0 0.05988406389951706
skills O 0 0.0604882687330246
. O 0 0.046749841421842575

Comparison O 0 0.06130867823958397
of O 0 0.04016491770744324
molecular O 0 0.045362070202827454
and O 0 0.029925314709544182
psychometric O 1 0.7154657244682312
findings O 0 0.028192948549985886
demonstrated O 0 0.028962504118680954
that O 0 0.014618800953030586
deletions O 0 0.04322480782866478
and O 0 0.019258255138993263
duplications O 0 0.10736899822950363
that O 0 0.011977755464613438
were O 0 0.012073351070284843
localized O 0 0.03599448874592781
in O 0 0.012491323985159397
the O 0 0.022598087787628174
distal O 1 0.9983043670654297
part O 0 0.026435211300849915
of O 0 0.02162359282374382
the O 0 0.027864942327141762
gene O 0 0.025421306490898132
seemed O 0 0.021578364074230194
to O 0 0.01383365411311388
be O 0 0.013340020552277565
preferentially O 0 0.0489940382540226
associated O 0 0.02604992687702179
with O 0 0.035493653267621994
cognitive B-Disease 1 0.998491644859314
impairment I-Disease 1 0.9999885559082031
. O 0 0.07494525611400604

Two O 0 0.043370407074689865
altered O 0 0.06335660815238953
Dp71 O 0 0.3828239440917969
transcripts O 0 0.0480504184961319
and O 0 0.01774667762219906
two O 0 0.01620488427579403
deleted O 0 0.04971878603100777
Dp140 O 1 0.5123811364173889
DNA O 0 0.0249437615275383
sequences O 0 0.011164836585521698
were O 0 0.007019056472927332
found O 0 0.007531784474849701
in O 0 0.009399527683854103
four O 0 0.02049226686358452
patients O 1 0.9999130964279175
with O 1 0.9994356036186218
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9983870983123779

These O 0 0.02585759200155735
findings O 0 0.026395613327622414
suggest O 0 0.0166974775493145
that O 0 0.007956852205097675
some O 0 0.007280911784619093
sequences O 0 0.011134245432913303
located O 0 0.017258914187550545
in O 0 0.010406301356852055
the O 0 0.017825765535235405
distal O 1 0.9906594753265381
part O 0 0.022049257531762123
of O 0 0.01791524700820446
the O 0 0.02687247097492218
gene O 0 0.02362559176981449
and O 0 0.012193133123219013
, O 0 0.011260805651545525
in O 0 0.00852606724947691
particular O 0 0.011130401864647865
, O 0 0.012243269942700863
some O 0 0.014475309289991856
DMD B-Disease 1 0.9999996423721313
isoforms O 0 0.028685441240668297
expressed O 0 0.017396355047822
in O 0 0.015513111837208271
the O 1 0.6490902900695801
brain O 1 0.9997407793998718
may O 0 0.015215441584587097
be O 0 0.008413956500589848
related O 0 0.011237988248467445
to O 0 0.012042313814163208
the O 0 0.024501081556081772
cognitive B-Disease 1 0.9996237754821777
impairment I-Disease 1 0.9999998807907104
associated O 1 0.979072630405426
with O 1 0.9974547028541565
DMD B-Disease 1 1.0
. O 0 0.05155935138463974
. O 0 0.04448975250124931

I1307K O 1 0.9994829893112183
APC O 1 0.9996588230133057
and O 0 0.0491645373404026
hMLH1 O 1 0.990048885345459
mutations O 0 0.0309913270175457
in O 0 0.01211902778595686
a O 0 0.020303819328546524
non O 0 0.053880736231803894
- O 1 0.9845839738845825
Jewish O 0 0.030274391174316406
family O 0 0.022002648562192917
with O 0 0.017814867198467255
hereditary B-Disease 1 0.9999990463256836
non I-Disease 1 0.9999998807907104
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9968721270561218

We O 0 0.02943049743771553
describe O 0 0.027214830741286278
a O 0 0.02033291384577751
French O 0 0.034855809062719345
Canadian O 0 0.03942163288593292
hereditary B-Disease 1 0.9999494552612305
non I-Disease 1 0.999997615814209
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999995231628418
HNPCC B-Disease 1 1.0
) O 1 0.6098992824554443
kindred O 1 0.999749481678009
which O 0 0.01791750267148018
carries O 0 0.02551988512277603
a O 0 0.025769643485546112
novel O 0 0.058585960417985916
truncating O 1 0.9985207915306091
mutation O 0 0.11209751665592194
in O 0 0.040142640471458435
hMLH1 O 1 0.9946787357330322
. O 0 0.05787532404065132

Interestingly O 0 0.10687717795372009
, O 0 0.03340243548154831
the O 0 0.04224590212106705
I1307K O 1 0.9995349645614624
APC O 1 0.9999854564666748
polymorphism O 0 0.08507109433412552
, O 0 0.018747517839074135
associated O 0 0.011662197299301624
with O 0 0.007753661368042231
an O 0 0.010043896734714508
increased O 0 0.019890066236257553
risk O 1 0.9989870190620422
of O 1 0.9999971389770508
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9999052286148071
is O 0 0.039542365819215775
also O 0 0.012614551931619644
present O 0 0.015285755507647991
in O 0 0.014082151465117931
this O 0 0.015986213460564613
family O 0 0.043451692909002304
. O 0 0.03942205756902695

The O 0 0.06690121442079544
I1307K O 1 0.9976435303688049
polymorphism O 0 0.09107919782400131
has O 0 0.02038515731692314
previously O 0 0.01764029823243618
only O 0 0.009174896404147148
been O 0 0.010342695750296116
identified O 0 0.012528580613434315
in O 0 0.0077211130410432816
individuals O 0 0.009380712173879147
of O 0 0.018745863810181618
self O 1 0.99985671043396
- O 1 0.9999933242797852
reported O 0 0.039507992565631866
Ashkenazi O 1 0.8773905038833618
Jewish O 0 0.07077300548553467
origins O 0 0.06796829402446747
. O 0 0.04600577801465988

In O 0 0.028530079871416092
addition O 0 0.02356388233602047
, O 0 0.016418859362602234
in O 0 0.01184130273759365
this O 0 0.011834882199764252
family O 0 0.027063528075814247
, O 0 0.016250452026724815
there O 0 0.012218515388667583
appears O 0 0.020102648064494133
to O 0 0.011755275540053844
be O 0 0.008940083906054497
no O 0 0.011347887106239796
relationship O 0 0.019189665094017982
between O 0 0.015489820390939713
the O 0 0.024706052616238594
I1307K O 1 0.9990543723106384
polymorphism O 0 0.0549192912876606
and O 0 0.01686580665409565
the O 0 0.0168906282633543
presence O 0 0.027945712208747864
or O 0 0.020191418007016182
absence O 1 0.9060157537460327
of O 1 0.9871895909309387
cancer B-Disease 1 1.0
. O 0 0.04591136798262596
. O 0 0.04877724498510361

Identification O 0 0.04443211853504181
of O 0 0.025659194216132164
a O 0 0.029805438593029976
novel O 0 0.04213811829686165
mutation O 0 0.030576607212424278
of O 0 0.019742105156183243
the O 0 0.031169338151812553
CPO O 1 0.9995803236961365
gene O 0 0.02389588952064514
in O 0 0.011572539806365967
a O 0 0.02470412291586399
Japanese O 0 0.12000882625579834
hereditary B-Disease 1 0.9999980926513672
coproporphyria I-Disease 1 0.9999964237213135
family O 1 0.7315007448196411
. O 0 0.05998552590608597

Hereditary B-Disease 1 0.9999890327453613
coproporphyria I-Disease 1 0.9999949932098389
( O 1 0.9156859517097473
HCP B-Disease 1 0.9999955892562866
) O 0 0.022469544783234596
is O 0 0.014880302362143993
an O 0 0.021773628890514374
autosomal B-Disease 1 0.9999936819076538
dominant I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
characterized O 1 0.999679446220398
by O 0 0.09838217496871948
a O 1 0.9946534633636475
deficiency B-Disease 1 1.0
of I-Disease 1 0.9999603033065796
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 1.0
( O 1 0.9167026281356812
CPO O 1 0.9999574422836304
) O 0 0.02332892455160618
caused O 0 0.024617381393909454
by O 0 0.016060296446084976
a O 0 0.025441478937864304
mutation O 0 0.03330957517027855
in O 0 0.016622133553028107
the O 0 0.03421247377991676
CPO O 1 0.9994773268699646
gene O 0 0.05980337783694267
. O 0 0.0452883318066597

Only O 0 0.027932917699217796
11 O 0 0.028704088181257248
mutations O 0 0.02429988421499729
of O 0 0.016455428674817085
the O 0 0.021815303713083267
gene O 0 0.022587547078728676
have O 0 0.008766291663050652
been O 0 0.012905648909509182
reported O 0 0.024171698838472366
in O 0 0.03675668314099312
HCP B-Disease 1 0.999998927116394
patients O 1 0.9996071457862854
. O 0 0.0631076842546463

We O 0 0.032676614820957184
report O 0 0.02742559090256691
another O 0 0.03233679383993149
mutation O 0 0.03537027910351753
in O 0 0.01590212993323803
a O 0 0.02819751761853695
Japanese O 0 0.0653742104768753
family O 0 0.05933135375380516
. O 0 0.04893989861011505

Polymerase O 0 0.4884029030799866
chain O 0 0.09660256654024124
reaction O 0 0.07509826123714447
- O 1 0.9985191226005554
single O 0 0.05926142632961273
strand O 0 0.08848095685243607
conformational O 0 0.07221561670303345
polymorphism O 0 0.055185716599226
and O 0 0.02018166519701481
direct O 0 0.020323455333709717
sequence O 0 0.017815448343753815
analyses O 0 0.019066045060753822
demonstrated O 0 0.022557154297828674
a O 0 0.02437003143131733
C O 0 0.4683012366294861
to O 0 0.025808069854974747
T O 1 0.963455855846405
substitution O 0 0.03360171243548393
in O 0 0.014266623184084892
exon O 0 0.050807736814022064
1 O 0 0.017926106229424477
of O 0 0.014701581560075283
the O 0 0.02496347948908806
CPO O 1 0.9978736639022827
gene O 0 0.027260905131697655
at O 0 0.019247738644480705
nucleotide O 0 0.03170860558748245
position O 0 0.023031914606690407
85 O 0 0.03086182475090027
, O 0 0.015273896045982838
which O 0 0.01188885048031807
lies O 0 0.024747824296355247
in O 0 0.01125490851700306
the O 0 0.023884758353233337
putative O 1 0.9695576429367065
presequence O 1 0.9928165674209595
for O 0 0.02708272635936737
targeting O 0 0.04756626486778259
to O 0 0.03563021495938301
mitochondria O 0 0.09783999621868134
. O 0 0.04767662286758423

This O 0 0.037077102810144424
mutation O 0 0.049395058304071426
changes O 0 0.018475299701094627
the O 0 0.023251790553331375
codon O 0 0.05631212890148163
for O 0 0.019998326897621155
glutamine O 0 0.0489811971783638
to O 0 0.017207607626914978
a O 0 0.027569809928536415
termination O 1 0.9076153039932251
codon O 0 0.19976478815078735
at O 0 0.03934568166732788
amino O 0 0.05127575621008873
acid O 0 0.06038994342088699
position O 0 0.04301196709275246
29 O 0 0.059671152383089066
. O 0 0.04531304910778999

MaeI O 1 0.9945477843284607
restriction O 0 0.07038900256156921
analysis O 0 0.021308312192559242
showed O 0 0.017381926998496056
two O 0 0.01126585528254509
other O 0 0.011244963854551315
carriers O 0 0.02884945459663868
in O 0 0.015034393407404423
the O 0 0.028793081641197205
family O 0 0.055033646523952484
. O 0 0.04473978653550148

The O 0 0.06569921225309372
C O 1 0.999955415725708
- O 1 0.9999996423721313
T O 1 0.9999852180480957
mutation O 0 0.04995032027363777
is O 0 0.01560726948082447
located O 0 0.019886590540409088
within O 0 0.01097229402512312
a O 0 0.016255194321274757
recently O 0 0.021985601633787155
proposed O 0 0.02004803530871868
putative O 0 0.055583786219358444
alternative O 0 0.026484603062272072
translation O 0 0.02745901234447956
initiation O 0 0.4676980972290039
codon O 0 0.38940003514289856
( O 0 0.05556178838014603
TIC O 1 0.9999988079071045
- O 1 0.9998581409454346
1 O 0 0.027377517893910408
) O 0 0.014007246121764183
, O 0 0.010662234388291836
supporting O 0 0.02052859403192997
that O 0 0.016647594049572945
TIC O 1 0.9999998807907104
- O 1 0.9999629259109497
1 O 0 0.021906130015850067
is O 0 0.011399976909160614
the O 0 0.015630614012479782
real O 0 0.0367748886346817
TIC O 1 0.9994854927062988
rather O 0 0.020518872886896133
than O 0 0.025449451059103012
TIC O 1 0.9999995231628418
- O 1 0.999975323677063
2 O 0 0.04110610857605934
. O 0 0.02444070763885975
. O 0 0.03366142883896828

Human B-Disease 0 0.06125625967979431
complement I-Disease 0 0.38042396306991577
factor I-Disease 1 0.9995737671852112
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.9991123080253601
with O 1 0.9999973773956299
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9998296499252319

This O 0 0.023771243169903755
study O 0 0.019589975476264954
reports O 0 0.013307004235684872
on O 0 0.010569051839411259
six O 0 0.013832027092576027
cases O 0 0.02013370767235756
of O 1 0.880132794380188
deficiency B-Disease 1 1.0
in I-Disease 0 0.021061891689896584
the I-Disease 0 0.02409517765045166
human I-Disease 0 0.02404964528977871
complement I-Disease 0 0.043699879199266434
regulatory I-Disease 0 0.059751685708761215
protein I-Disease 0 0.03724794089794159
Factor I-Disease 1 0.957099974155426
H I-Disease 1 0.9999990463256836
( O 0 0.13893239200115204
FH O 1 0.9999841451644897
) O 0 0.014482656493782997
in O 0 0.008208660408854485
the O 0 0.010579658672213554
context O 0 0.016163401305675507
of O 0 0.02664881944656372
an O 1 0.9999819993972778
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999524354934692

Five O 0 0.026980960741639137
of O 0 0.022826766595244408
the O 0 0.02065626159310341
cases O 0 0.016415869817137718
were O 0 0.009667618200182915
observed O 0 0.010775210335850716
in O 0 0.009319842793047428
children O 0 0.02071496844291687
presenting O 0 0.13773995637893677
with O 1 0.9993008375167847
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.9925716519355774
. O 0 0.06740644574165344

Two O 0 0.01910504698753357
of O 0 0.020278558135032654
the O 0 0.023418227210640907
children O 0 0.0383976548910141
exhibited O 0 0.3191216289997101
a O 1 0.9975014328956604
homozygous O 1 0.9999994039535522
deficiency O 1 1.0
characterized O 1 0.9985330104827881
by O 0 0.021840637549757957
the O 0 0.019275741651654243
absence O 0 0.030620044097304344
of O 0 0.015524868853390217
the O 0 0.020748339593410492
150 O 0 0.036709945648908615
- O 1 0.9995391368865967
kD O 1 0.9874520897865295
form O 0 0.021177172660827637
of O 0 0.02814876101911068
Factor O 1 0.9984166622161865
H O 1 0.9999916553497314
and O 0 0.01856425777077675
the O 0 0.018902448937296867
presence O 0 0.024943407624959946
, O 0 0.014832532964646816
upon O 0 0.020559778437018394
immunoblotting O 1 0.9646204710006714
, O 0 0.01174105890095234
of O 0 0.011522890999913216
the O 0 0.016498269513249397
42 O 0 0.04274518042802811
- O 1 0.9996596574783325
kD O 1 0.9998641014099121
Factor O 1 0.5140089392662048
H O 1 0.9999793767929077
- O 1 0.9946626424789429
like O 0 0.019192833453416824
protein O 0 0.019145874306559563
1 O 0 0.021956700831651688
( O 0 0.024867702275514603
FHL O 1 0.9999254941940308
- O 1 0.9996240139007568
1 O 0 0.024903051555156708
) O 0 0.011947501450777054
and O 0 0.009795686230063438
other O 0 0.013069775886833668
FH O 1 0.9999992847442627
- O 1 0.999988317489624
related O 0 0.0562579482793808
protein O 0 0.041807856410741806
( O 0 0.03842782601714134
FHR O 1 0.9995467066764832
) O 0 0.04128624126315117
bands O 0 0.06217404082417488
. O 0 0.04256715998053551

Southern O 0 0.11725354939699173
blot O 1 0.8659140467643738
and O 0 0.038608893752098083
PCR O 0 0.06467978656291962
analysis O 0 0.012826248072087765
of O 0 0.0119169307872653
DNA O 0 0.015812119469046593
of O 0 0.013510879129171371
one O 0 0.018775423988699913
patient O 1 0.9969785213470459
with O 0 0.09460578858852386
homozygous O 1 0.9999897480010986
deficiency O 1 1.0
ruled O 1 0.7809626460075378
out O 0 0.01899159513413906
the O 0 0.016169309616088867
presence O 0 0.016826286911964417
of O 0 0.010744144208729267
a O 0 0.013205349445343018
large O 0 0.013579613529145718
deletion O 0 0.02824244275689125
of O 0 0.015310071408748627
the O 0 0.07497311383485794
FH O 1 0.9999998807907104
gene O 0 0.025938216596841812
as O 0 0.016138093546032906
the O 0 0.023042980581521988
underlying O 1 0.9942641854286194
defect O 1 0.9999865293502808
for O 0 0.17851296067237854
the O 1 0.9995439648628235
deficiency O 1 1.0
. O 0 0.4468737244606018

The O 0 0.03231261670589447
other O 0 0.013650272972881794
four O 0 0.0137953395023942
children O 0 0.024444321170449257
presented O 0 0.030813949182629585
with O 0 0.16713939607143402
heterozygous O 1 0.9999938011169434
deficiency O 1 1.0
and O 1 0.5957531332969666
exhibited O 1 0.9462187886238098
a O 0 0.05842471867799759
normal O 0 0.04126736521720886
immunoblotting O 1 0.9919309020042419
pattern O 0 0.03428104519844055
of O 0 0.02258334681391716
proteins O 0 0.022822747007012367
of O 0 0.02182978019118309
the O 0 0.1666869968175888
FH O 1 0.9999991655349731
family O 0 0.12593576312065125
. O 0 0.051127027720212936

Factor B-Disease 1 0.9999629259109497
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.029811616986989975
the O 0 0.029085926711559296
only O 0 0.03575996309518814
complement B-Disease 1 0.9999955892562866
deficiency I-Disease 1 1.0
associated O 1 0.9722469449043274
with O 1 0.9671317934989929
HUS B-Disease 1 1.0
. O 0 0.1270509660243988

These O 0 0.024263685569167137
observations O 0 0.026357537135481834
suggest O 0 0.016157956793904305
a O 0 0.016501085832715034
role O 0 0.02693256363272667
for O 0 0.02703176438808441
FH O 1 0.9999985694885254
and O 0 0.2691292464733124
/ O 1 0.9999873638153076
or O 0 0.1284339874982834
FH O 1 0.9999974966049194
receptors O 0 0.0345495343208313
in O 0 0.014347828924655914
the O 0 0.028044812381267548
pathogenesis O 1 0.9999982118606567
of O 1 0.9998624324798584
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.90320885181427
. O 0 0.06812585145235062

Further O 0 0.0348166860640049
evidence O 0 0.02034917101264
for O 0 0.013160995207726955
a O 0 0.022506922483444214
major O 0 0.0313163585960865
ancient O 0 0.05471649393439293
mutation O 1 0.9956396818161011
underlying O 1 0.9999961853027344
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9865842461585999
linkage O 1 0.9999539852142334
disequilibrium O 1 0.9994934797286987
studies O 0 0.02645402029156685
in O 0 0.016569865867495537
the O 0 0.024012496694922447
Japanese O 0 0.04796040058135986
population O 0 0.02979821339249611
. O 0 0.03637513518333435

The O 1 0.9338095188140869
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999920129776001
DM B-Disease 1 1.0
) O 0 0.04323061555624008
mutation O 0 0.038294725120067596
is O 0 0.015916403383016586
an O 0 0.022596273571252823
unstable O 1 0.9999390840530396
( O 0 0.13819195330142975
CTG O 1 0.9999973773956299
) O 0 0.028703734278678894
n O 0 0.04857943579554558
repeat O 0 0.03697480633854866
, O 0 0.013579173944890499
present O 0 0.013047338463366032
at O 0 0.012393650598824024
a O 0 0.012489845976233482
copy O 0 0.017563845962285995
number O 0 0.0069694132544100285
of O 0 0.013377510011196136
5 O 0 0.028701135888695717
- O 1 0.9792360663414001
37 O 0 0.03227602690458298
repeats O 0 0.031132610514760017
on O 0 0.015081819146871567
normal O 0 0.02347029559314251
chromosomes O 0 0.025526979938149452
but O 0 0.012735549360513687
amplified O 0 0.031537044793367386
to O 0 0.014890672639012337
50 O 0 0.02635118179023266
- O 1 0.7191197276115417
3000 O 0 0.05345594882965088
copies O 0 0.030011039227247238
on O 0 0.04367898777127266
DM B-Disease 1 0.9999996423721313
chromosomes O 0 0.09739909321069717
. O 0 0.05649670958518982

Previous O 0 0.04262426495552063
findings O 0 0.02906889282166958
in O 0 0.017673149704933167
Caucasian O 0 0.07960058003664017
populations O 0 0.02214590460062027
of O 0 0.024386033415794373
a O 1 0.9796231389045715
DM B-Disease 1 1.0
founder O 1 0.9999986886978149
chromosome O 0 0.3830084204673767
raise O 0 0.029176298528909683
a O 0 0.0178733728826046
question O 0 0.016145654022693634
about O 0 0.011530105955898762
the O 0 0.01777650974690914
molecular O 0 0.02007068507373333
events O 0 0.01420864649116993
involved O 0 0.014570645056664944
in O 0 0.013098283670842648
the O 0 0.028454415500164032
expansion O 0 0.08285238593816757
mutation O 0 0.08900415897369385
. O 0 0.04911888763308525

To O 0 0.028480833396315575
investigate O 0 0.038825586438179016
whether O 0 0.017560390755534172
a O 0 0.02242881804704666
founder O 1 0.8702645301818848
chromosome O 0 0.039439134299755096
for O 0 0.018797626718878746
the O 1 0.7310375571250916
DM B-Disease 1 1.0
mutation O 1 0.7179281711578369
exists O 0 0.023315073922276497
in O 0 0.012138361111283302
the O 0 0.016425589099526405
Japanese O 0 0.03264180198311806
population O 0 0.016163188964128494
, O 0 0.01828368939459324
we O 0 0.016847679391503334
genotyped O 0 0.08823413401842117
families O 0 0.023604413494467735
using O 0 0.019267631694674492
polymorphic O 0 0.0993122011423111
markers O 0 0.04627693444490433
near O 0 0.03430060297250748
the O 0 0.02927047200500965
( O 0 0.042576491832733154
CTG O 1 0.9999164342880249
) O 0 0.041141610592603683
n O 0 0.07089515030384064
repeat O 0 0.06494123488664627
region O 0 0.04497934505343437
and O 0 0.03575795888900757
constructed O 0 0.0861494317650795
haplotypes O 0 0.2130192518234253
. O 0 0.05948832258582115

Six O 0 0.03988693654537201
different O 0 0.01794169284403324
haplotypes O 0 0.06670912355184555
were O 0 0.017210494726896286
found O 0 0.021584587171673775
and O 0 0.04256690293550491
DM B-Disease 1 1.0
alleles O 0 0.16084422171115875
were O 0 0.02501373551785946
always O 0 0.047286130487918854
haplotype O 1 0.6437689661979675
A O 0 0.06316829472780228
. O 0 0.046299271285533905

To O 0 0.03334403038024902
find O 0 0.022611495107412338
an O 0 0.012962494976818562
origin O 0 0.010399461723864079
of O 0 0.013141193427145481
the O 0 0.022046057507395744
( O 0 0.038944486528635025
CTG O 1 0.9999814033508301
) O 0 0.03267230466008186
n O 0 0.05880097672343254
repeat O 0 0.06621265411376953
mutation O 0 0.03546641021966934
and O 0 0.013437026180326939
to O 0 0.012509728781878948
investigate O 0 0.028012972325086594
the O 0 0.0176098495721817
mechanism O 0 0.023354027420282364
of O 0 0.014783629216253757
the O 0 0.01966019533574581
expansion O 0 0.037991177290678024
mutation O 0 0.02940133772790432
in O 0 0.011606077663600445
the O 0 0.01604006253182888
Japanese O 0 0.028554439544677734
population O 0 0.013684701174497604
we O 0 0.010354348458349705
have O 0 0.007447322830557823
studied O 0 0.01800093799829483
90 O 0 0.02743661403656006
Japanese O 0 0.08819972723722458
DM B-Disease 1 0.9999997615814209
families O 0 0.042192354798316956
comprising O 0 0.052571091800928116
190 O 0 0.0631025955080986
affected O 0 0.040913090109825134
and O 0 0.02968556061387062
130 O 0 0.06642758101224899
unaffected O 1 0.5755576491355896
members O 0 0.0501180998980999
. O 0 0.05002492293715477

The O 0 0.04448419809341431
results O 0 0.021868659183382988
suggest O 0 0.016115374863147736
that O 0 0.00810252409428358
a O 0 0.01400789339095354
few O 0 0.013695139437913895
common O 0 0.02154451422393322
ancestral O 1 0.9291549921035767
mutations O 0 0.02799978479743004
in O 0 0.013219884596765041
both O 0 0.018984951078891754
Caucasian O 1 0.9962788224220276
and O 0 0.021364031359553337
Japanese O 0 0.038087937980890274
populations O 0 0.018680619075894356
have O 0 0.007951026782393456
originated O 0 0.015364541672170162
by O 0 0.010237570852041245
expansion O 0 0.019085094332695007
of O 0 0.015250477939844131
an O 0 0.022169729694724083
ancestral O 1 0.9846278429031372
n O 0 0.17672710120677948
= O 0 0.040949948132038116
5 O 0 0.022936351597309113
repeat O 0 0.03651127591729164
to O 0 0.02073829434812069
n O 0 0.05858603119850159
= O 0 0.05182240903377533
19 O 0 0.04219789803028107
- O 1 0.5995963215827942
37 O 0 0.050730619579553604
copies O 0 0.03772944584488869
. O 0 0.03731527552008629

These O 0 0.02603783831000328
data O 0 0.020055629312992096
support O 0 0.02776365913450718
multistep O 0 0.06969554722309113
models O 0 0.02316577173769474
of O 0 0.0259871669113636
triplet O 1 0.9999103546142578
repeat O 1 0.6564937829971313
expansion O 0 0.03658142313361168
that O 0 0.011141880415380001
have O 0 0.007682716939598322
been O 0 0.009133605286478996
proposed O 0 0.014143694192171097
for O 0 0.01543646864593029
both O 0 0.03142855316400528
DM B-Disease 1 1.0
and O 1 0.8972050547599792
Friedreichs B-Disease 1 0.9999996423721313
ataxia I-Disease 1 0.9999995231628418
. O 0 0.04871462285518646
. O 0 0.0497710146009922

The O 0 0.03749270737171173
molecular O 0 0.03362182527780533
basis O 0 0.025644659996032715
of O 1 0.9865173101425171
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.030710898339748383
the O 0 0.028936823830008507
western O 0 0.04337109997868538
Cape O 1 0.5876686573028564
, O 0 0.03253781422972679
South O 0 0.053605251014232635
Africa O 0 0.06783895939588547
. O 0 0.046841319650411606

Deficiency B-Disease 1 0.9999988079071045
of I-Disease 0 0.036848075687885284
the I-Disease 0 0.03426355868577957
sixth I-Disease 1 0.9985066056251526
component I-Disease 0 0.2976831793785095
of I-Disease 0 0.020527664572000504
human I-Disease 0 0.06268366426229477
complement I-Disease 1 0.9990359544754028
( O 1 0.9177013635635376
C6 O 1 0.9999998807907104
) O 0 0.01810498535633087
has O 0 0.011848557740449905
been O 0 0.008823448792099953
reported O 0 0.010907779447734356
in O 0 0.007185918744653463
a O 0 0.010576454922556877
number O 0 0.008750490844249725
of O 0 0.01217019371688366
families O 0 0.017000684514641762
from O 0 0.011922726407647133
the O 0 0.01765263080596924
western O 0 0.030413595959544182
Cape O 0 0.42947813868522644
, O 0 0.029167909175157547
South O 0 0.046963874250650406
Africa O 0 0.06346645951271057
. O 0 0.046301111578941345

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 1 0.841116189956665
endemic O 1 0.9994970560073853
in O 0 0.01942140981554985
the O 0 0.02681082859635353
Cape O 1 0.8276441693305969
and O 0 0.013396302238106728
almost O 0 0.0091249393299222
all O 0 0.009252946823835373
pedigrees O 0 0.03227585554122925
of O 0 0.02242092415690422
total O 1 0.9930878281593323
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9999649524688721
C6Q0 O 1 0.9999997615814209
) O 0 0.022208884358406067
have O 0 0.009200268425047398
been O 0 0.013263248838484287
ascertained O 0 0.04374980926513672
because O 0 0.020790204405784607
of O 0 0.4813663363456726
recurrent O 1 1.0
disease O 1 1.0
. O 1 0.7969660758972168

We O 0 0.02843448892235756
have O 0 0.013605429790914059
sequenced O 0 0.028869695961475372
the O 0 0.016309482976794243
expressed O 0 0.02153926156461239
exons O 0 0.03538305312395096
of O 0 0.02001607045531273
the O 0 0.03840254247188568
C6 O 1 0.9999997615814209
gene O 0 0.03253990039229393
from O 0 0.01611589640378952
selected O 0 0.019390249624848366
cases O 0 0.015345918945968151
and O 0 0.011020787991583347
have O 0 0.007772423326969147
found O 0 0.008895072154700756
three O 0 0.012735742144286633
molecular O 0 0.03882895037531853
defects O 1 0.989507257938385
leading O 0 0.03965504840016365
to O 0 0.02433624677360058
total O 1 0.8469685912132263
deficiency O 1 1.0
879delG O 1 0.9999995231628418
, O 0 0.027614902704954147
which O 0 0.012513547204434872
is O 0 0.012372225522994995
the O 0 0.017612820491194725
common O 0 0.026402784511446953
defect O 1 0.997261643409729
in O 0 0.01409412082284689
the O 0 0.022871118038892746
Cape O 1 0.6030346751213074
and O 0 0.022764023393392563
hitherto O 1 0.6404120326042175
unreported O 0 0.1521092653274536
, O 0 0.02122734859585762
and O 0 0.022379640489816666
1195delC O 1 0.9999228715896606
and O 0 0.03316498175263405
1936delG O 1 0.9999173879623413
, O 0 0.018503554165363312
which O 0 0.009159624576568604
have O 0 0.0064696380868554115
been O 0 0.008897943422198296
previously O 0 0.01334837730973959
reported O 0 0.015684571117162704
in O 0 0.016340205445885658
African O 0 0.24344408512115479
- O 1 0.9996869564056396
Americans O 0 0.0539732426404953
. O 0 0.043872393667697906

We O 0 0.030342204496264458
also O 0 0.017683567479252815
show O 0 0.015838997438549995
that O 0 0.00873643159866333
the O 0 0.01878083497285843
879delG O 1 0.9982746839523315
and O 0 0.05149027332663536
1195delC O 1 0.9999967813491821
defects O 1 0.9989352822303772
are O 0 0.00999849196523428
associated O 0 0.018723616376519203
with O 0 0.024054862558841705
characteristic O 1 0.9997088313102722
C6 O 1 1.0
/ O 1 0.9999994039535522
C7 O 1 0.9999983310699463
region O 0 0.06776740401983261
DNA O 0 0.04828076809644699
marker O 1 0.7905974388122559
haplotypes O 0 0.13229046761989594
, O 0 0.021738935261964798
although O 0 0.016895482316613197
small O 0 0.018449489027261734
variations O 0 0.020696312189102173
were O 0 0.017102085053920746
observed O 0 0.033495306968688965
. O 0 0.03740096092224121

The O 0 0.0888783261179924
1936delG O 1 0.9999803304672241
defect O 1 0.9999549388885498
was O 0 0.040444232523441315
observed O 0 0.0198725126683712
only O 0 0.011480127461254597
once O 0 0.017397789284586906
in O 0 0.010516221635043621
the O 0 0.01815617084503174
Cape O 0 0.15206487476825714
, O 0 0.015494066290557384
but O 0 0.010903668589890003
its O 0 0.01743539236485958
associated O 0 0.03032914362847805
haplotype O 1 0.5325307250022888
could O 0 0.023228982463479042
be O 0 0.022511262446641922
deduced O 0 0.06538847833871841
. O 0 0.04172847419977188

The O 0 0.037735916674137115
data O 0 0.01740160584449768
from O 0 0.014899691566824913
the O 0 0.02244732901453972
haplotypes O 0 0.06665468961000443
indicate O 0 0.018707919865846634
that O 0 0.0075161210261285305
these O 0 0.007105411030352116
three O 0 0.01404185127466917
molecular O 0 0.03966158255934715
defects O 1 0.8872298002243042
account O 0 0.018238568678498268
for O 0 0.014875571243464947
the O 0 0.034574512392282486
defects O 1 0.9994133710861206
in O 0 0.012383958324790001
all O 0 0.010210495442152023
the O 0 0.017957478761672974
38 O 0 0.05029992014169693
unrelated O 1 0.7184617519378662
C6Q0 O 1 0.9999973773956299
individuals O 0 0.020917391404509544
we O 0 0.013820387423038483
have O 0 0.00927947461605072
studied O 0 0.017566939815878868
from O 0 0.015225660987198353
the O 0 0.03031986951828003
Cape O 1 0.6575945019721985
. O 0 0.05021248757839203

We O 0 0.02901819720864296
have O 0 0.012984886765480042
also O 0 0.013192394748330116
observed O 0 0.01580909825861454
the O 0 0.02250596135854721
879delG O 1 0.998263418674469
defect O 1 0.9466761350631714
in O 0 0.013504614122211933
two O 0 0.016474440693855286
Dutch O 1 0.9909900426864624
C6 B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
deficient I-Disease 1 0.9999985694885254
kindreds O 1 0.9987084865570068
, O 0 0.021831713616847992
but O 0 0.014493442140519619
the O 0 0.025555409491062164
879delG O 1 0.9999815225601196
defect O 1 0.999792754650116
in O 0 0.017851805314421654
the O 0 0.025793861597776413
Cape O 1 0.9794765114784241
probably O 0 0.023531168699264526
did O 0 0.01492713950574398
not O 0 0.009105208329856396
come O 0 0.012976021505892277
from O 0 0.013866718858480453
The O 0 0.023487815633416176
Netherlands O 0 0.06038111075758934
. O 0 0.028161246329545975
. O 0 0.03667232766747475

Complement B-Disease 1 0.9999613761901855
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.04588022828102112
seven O 0 0.03166310861706734
further O 0 0.037032660096883774
molecular O 1 0.9733790755271912
defects O 1 0.9997825026512146
and O 0 0.021410329267382622
their O 0 0.024759788066148758
associated O 0 0.04833220690488815
marker O 1 0.9981335997581482
haplotypes O 1 0.7658272981643677
. O 0 0.04978172481060028

Seven O 0 0.03540708124637604
further O 0 0.02557947114109993
molecular O 0 0.03302423283457756
bases O 0 0.042645685374736786
of O 1 0.9982765913009644
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.0425579659640789
described O 0 0.09047766029834747
. O 0 0.050279442220926285

All O 0 0.024813465774059296
these O 0 0.013914666138589382
new O 0 0.03035614639520645
molecular O 0 0.05425316467881203
defects O 1 0.9953556060791016
involve O 0 0.030900945886969566
single O 1 0.5522288680076599
- O 1 0.9999788999557495
nucleotide O 0 0.04211842268705368
events O 0 0.017262432724237442
, O 0 0.01834372617304325
deletions O 0 0.04216904938220978
and O 0 0.016476649791002274
substitutions O 0 0.02939876914024353
, O 0 0.012156723998486996
some O 0 0.007148167584091425
of O 0 0.014182962477207184
which O 0 0.0144759276881814
alter O 0 0.045800723135471344
splice O 0 0.09420821070671082
sites O 0 0.025719093158841133
, O 0 0.019917573779821396
and O 0 0.021348025649785995
others O 0 0.03257225453853607
codons O 0 0.08512626588344574
. O 0 0.046780072152614594

They O 0 0.021429769694805145
are O 0 0.009616971015930176
distributed O 0 0.01728304848074913
along O 0 0.022911563515663147
the O 0 0.03475743159651756
C7 O 1 0.9999995231628418
gene O 0 0.04475951939821243
, O 0 0.018249157816171646
but O 0 0.012820755131542683
predominantly O 0 0.02394171804189682
towards O 0 0.02777092531323433
the O 0 0.027559608221054077
3 O 0 0.03995248302817345
end O 0 0.05257667601108551
. O 0 0.04470526799559593

All O 0 0.028930889442563057
were O 0 0.019204415380954742
found O 0 0.020528189837932587
in O 0 0.024739786982536316
compound O 0 0.20937499403953552
heterozygous O 0 0.08443158119916916
individuals O 0 0.03985279053449631
. O 0 0.052576757967472076

The O 0 0.1743292510509491
C6 O 1 0.9999997615814209
/ O 1 0.9999945163726807
C7 O 1 0.9999971389770508
marker O 1 0.9982845187187195
haplotypes O 0 0.37622272968292236
associated O 0 0.02708466351032257
with O 0 0.02369418740272522
most O 0 0.48474863171577454
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999969005584717
are O 0 0.023647602647542953
tabulated O 0 0.047894805669784546
. O 0 0.026317080482840538
. O 0 0.03710271790623665

A O 0 0.0811242014169693
genome O 0 0.06504418700933456
- O 0 0.2431594431400299
wide O 0 0.02721414901316166
search O 0 0.029689960181713104
for O 0 0.02395104244351387
chromosomal O 1 0.9813743233680725
loci O 0 0.4064936935901642
linked O 0 0.13303519785404205
to O 0 0.03796730190515518
mental O 1 0.9999998807907104
health O 1 0.9999971389770508
wellness O 1 0.9999990463256836
in O 0 0.022434379905462265
relatives O 0 0.043742585927248
at O 0 0.02162995934486389
high O 1 0.818759024143219
risk O 1 0.9989064931869507
for O 1 0.9997854828834534
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9891017079353333
the O 1 0.7332491874694824
Old O 1 0.9989732503890991
Order O 0 0.07215050607919693
Amish O 1 0.8633374571800232
. O 0 0.05249422788619995

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9992926120758057
BPAD B-Disease 1 1.0
; O 1 0.9996805191040039
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 1 0.7638158798217773
is O 0 0.015821317210793495
characterized O 0 0.023191198706626892
by O 0 0.01243453100323677
episodes O 0 0.02569090947508812
of O 0 0.13671596348285675
mania B-Disease 1 1.0
and O 1 0.9985445737838745
/ O 1 0.9999995231628418
or O 1 0.7606989741325378
hypomania B-Disease 1 0.9999997615814209
interspersed O 0 0.45825591683387756
with O 0 0.025585222989320755
periods O 0 0.04696790874004364
of O 1 0.6605007648468018
depression B-Disease 1 0.9999998807907104
. O 0 0.29539451003074646

Compelling O 0 0.07225406914949417
evidence O 0 0.02936640754342079
supports O 0 0.03887180984020233
a O 0 0.02603212371468544
significant O 0 0.02693680301308632
genetic O 0 0.03284148499369621
component O 0 0.03937412425875664
in O 0 0.017337342724204063
the O 0 0.03164039924740791
susceptibility O 1 0.9911704063415527
to O 0 0.045027896761894226
develop O 1 0.8768180012702942
BPAD B-Disease 1 0.9999974966049194
. O 0 0.06485615670681

To O 0 0.03754051402211189
date O 0 0.033694684505462646
, O 0 0.02204401046037674
however O 0 0.018351417034864426
, O 0 0.023633042350411415
linkage O 0 0.06412460654973984
studies O 0 0.01692988909780979
have O 0 0.009114786051213741
attempted O 0 0.02442312240600586
only O 0 0.012092276476323605
to O 0 0.017932942137122154
identify O 0 0.03618067502975464
chromosomal O 1 0.9983106851577759
loci O 1 0.9111496806144714
that O 0 0.018356982618570328
cause O 0 0.4434789717197418
or O 0 0.015142171643674374
increase O 0 0.015823040157556534
the O 0 0.021784575656056404
risk O 0 0.16051222383975983
of O 0 0.046025872230529785
developing O 1 0.9967633485794067
BPAD B-Disease 1 0.9999995231628418
. O 0 0.0739540085196495

To O 0 0.03285155072808266
determine O 0 0.022113114595413208
whether O 0 0.014059514738619328
there O 0 0.012054902501404285
could O 0 0.012565284967422485
be O 0 0.014864019118249416
protective O 1 0.9947958588600159
alleles O 0 0.0490744486451149
that O 0 0.015070730820298195
prevent O 0 0.03832597658038139
or O 0 0.016605984419584274
reduce O 0 0.02641269564628601
the O 0 0.019664909690618515
risk O 0 0.03358759731054306
of O 0 0.026683956384658813
developing O 1 0.9943665862083435
BPAD B-Disease 1 1.0
, O 0 0.019691981375217438
similar O 0 0.010100445710122585
to O 0 0.009447203017771244
what O 0 0.00841343030333519
is O 0 0.008065707050263882
observed O 0 0.009325141087174416
in O 0 0.00887625478208065
other O 0 0.01471928134560585
genetic B-Disease 1 0.9999067783355713
disorders I-Disease 1 1.0
, O 0 0.047355350106954575
we O 0 0.016320757567882538
used O 0 0.02258724346756935
mental O 1 0.9999997615814209
health O 1 0.9999995231628418
wellness O 1 1.0
( O 0 0.03352417051792145
absence O 0 0.03925977647304535
of O 0 0.02891196310520172
any O 1 0.9407652616500854
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.05460650101304054
as O 0 0.01630108617246151
the O 0 0.0196584053337574
phenotype O 0 0.06536061316728592
in O 0 0.011995465494692326
our O 0 0.02136337384581566
genome O 0 0.04031877964735031
- O 1 0.999200165271759
wide O 0 0.03179938346147537
linkage O 0 0.0778183564543724
scan O 0 0.0346614308655262
of O 0 0.013779698871076107
several O 0 0.011379403062164783
large O 0 0.01955491304397583
multigeneration O 1 0.7926071286201477
Old O 0 0.06738414615392685
Order O 0 0.04353969171643257
Amish O 1 0.7684507369995117
pedigrees O 0 0.14681701362133026
exhibiting O 0 0.0587332546710968
an O 0 0.026427768170833588
extremely O 0 0.06850206851959229
high O 1 0.9267332553863525
incidence O 1 0.9999688863754272
of O 1 0.9959604144096375
BPAD B-Disease 1 1.0
. O 0 0.09057614207267761

We O 0 0.0315471850335598
have O 0 0.013504690490663052
found O 0 0.012449060566723347
strong O 0 0.0158831886947155
evidence O 0 0.0128158088773489
for O 0 0.01238905731588602
a O 0 0.02389177493751049
locus O 0 0.06460153311491013
on O 0 0.02858838625252247
chromosome O 0 0.0720096156001091
4p O 1 0.9994644522666931
at O 0 0.041893281042575836
D4S2949 O 1 0.906968891620636
( O 0 0.029574083164334297
maximum O 0 0.04401874914765358
GENEHUNTER O 1 0.9998553991317749
- O 1 0.9994818568229675
PLUS O 0 0.07404099404811859
nonparametric O 0 0.11014353483915329
linkage O 0 0.06509304791688919
score O 0 0.029133561998605728
= O 0 0.03961233049631119
4 O 0 0.022111957892775536
. O 0 0.015601410530507565
05 O 0 0.2322985678911209
, O 0 0.028097672387957573
P O 1 0.9917395114898682
= O 0 0.03829282894730568
5 O 0 0.016234885901212692
. O 0 0.00940717477351427
22 O 0 0.017685672268271446
x O 0 0.031016862019896507
10 O 0 0.01882987655699253
( O 0 0.022405190393328667
- O 1 0.9808956980705261
4 O 0 0.027263017371296883
) O 0 0.015798619017004967
; O 0 0.017977621406316757
SIBPAL O 1 0.9753292798995972
Pempirical O 1 0.8120030164718628
value O 0 0.024990560486912727
< O 0 0.17209970951080322
3 O 0 0.0248967707157135
x O 0 0.03237733617424965
10 O 0 0.019932275637984276
( O 0 0.025155087932944298
- O 1 0.9975247979164124
5 O 0 0.028374331071972847
) O 0 0.018464164808392525
) O 0 0.013494206592440605
and O 0 0.013754851184785366
suggestive O 0 0.039399128407239914
evidence O 0 0.012670203112065792
for O 0 0.012353669852018356
a O 0 0.02341485396027565
locus O 0 0.06773363053798676
on O 0 0.029232120141386986
chromosome O 0 0.08288142830133438
4q O 1 0.998809814453125
at O 0 0.03536257520318031
D4S397 O 1 0.9434847831726074
( O 0 0.028110945597290993
maximum O 0 0.037695448845624924
GENEHUNTER O 1 0.9999103546142578
- O 1 0.9996336698532104
PLUS O 0 0.0727773904800415
nonparametric O 0 0.1430550515651703
linkage O 0 0.06693197041749954
score O 0 0.029047340154647827
= O 0 0.03514828532934189
3 O 0 0.017834249883890152
. O 0 0.011577445082366467
29 O 0 0.025205055251717567
, O 0 0.021450519561767578
P O 1 0.983539342880249
= O 0 0.03555094450712204
2 O 0 0.018672676756978035
. O 0 0.010030810721218586
57 O 0 0.029585566371679306
x O 0 0.03479336202144623
10 O 0 0.021004805341362953
( O 0 0.027224501594901085
- O 1 0.9411032795906067
3 O 0 0.027187952771782875
) O 0 0.0177241750061512
; O 0 0.018844226375222206
SIBPAL O 1 0.9273130297660828
Pempirical O 1 0.688646137714386
value O 0 0.02577236481010914
< O 0 0.15214191377162933
1 O 0 0.0256610456854105
x O 0 0.03233189880847931
10 O 0 0.01876949518918991
( O 0 0.02643456868827343
- O 1 0.9984708428382874
3 O 0 0.025415729731321335
) O 0 0.016213176771998405
) O 0 0.01063673198223114
that O 0 0.007115665357559919
are O 0 0.00768788019195199
linked O 0 0.03260412812232971
to O 0 0.03422842547297478
mental O 1 0.9999995231628418
health O 1 0.9999995231628418
wellness O 1 0.9999998807907104
. O 0 0.1847289502620697

These O 0 0.029468847438693047
findings O 0 0.02658575214445591
are O 0 0.009972364641726017
consistent O 0 0.020482029765844345
with O 0 0.013229899108409882
the O 0 0.018934257328510284
hypothesis O 0 0.029350245371460915
that O 0 0.010370162315666676
certain O 0 0.013516905717551708
alleles O 0 0.03443191945552826
could O 0 0.016361931338906288
prevent O 0 0.03180979937314987
or O 0 0.015711627900600433
modify O 0 0.032271478325128555
the O 0 0.0222806166857481
clinical O 1 0.9531276226043701
manifestations O 1 0.9999606609344482
of O 1 0.9992460012435913
BPAD B-Disease 1 1.0
and O 0 0.09279525279998779
perhaps O 0 0.03588566184043884
other O 0 0.025628352537751198
related O 1 0.9971206784248352
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.8702283501625061

Segregation O 1 0.9981957077980042
distortion O 1 0.9998704195022583
in O 1 0.9845036268234253
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.48131105303764343

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999361038208008
DM B-Disease 1 1.0
) O 0 0.032121263444423676
is O 0 0.018964111804962158
an O 0 0.03017888404428959
autosomal B-Disease 1 0.9999982118606567
dominant I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
which O 0 0.021109264343976974
, O 0 0.014576604589819908
in O 0 0.011122355237603188
the O 0 0.017698051407933235
typical O 0 0.03874850273132324
pedigree O 0 0.09378280490636826
, O 0 0.015640733763575554
shows O 0 0.015187385492026806
a O 0 0.01709464192390442
three O 0 0.022972259670495987
generation O 0 0.4304034411907196
anticipation O 1 0.5843569040298462
cascade O 1 0.9814316034317017
. O 0 0.06375047564506531

This O 0 0.020602772012352943
results O 0 0.01825779490172863
in O 0 0.024238526821136475
infertility B-Disease 1 0.9999992847442627
and O 1 0.999994158744812
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999992847442627
CDM B-Disease 1 1.0
) O 0 0.022797320038080215
with O 0 0.014093820936977863
the O 0 0.020212076604366302
disappearance O 1 0.5725852847099304
of O 1 0.6377342939376831
DM B-Disease 1 1.0
in O 0 0.032138075679540634
that O 0 0.026654696092009544
pedigree O 0 0.11466317623853683
. O 0 0.04339161887764931

The O 0 0.039213668555021286
concept O 0 0.037443194538354874
of O 0 0.03515719994902611
segregation O 1 0.9998180270195007
distortion O 1 0.9998661279678345
, O 0 0.02522132731974125
where O 0 0.018396837636828423
there O 0 0.011150205507874489
is O 0 0.014233761467039585
preferential O 0 0.10317398607730865
transmission O 0 0.024851594120264053
of O 0 0.013568631373345852
the O 0 0.016197651624679565
larger O 0 0.01861378736793995
allele O 0 0.035816024988889694
at O 0 0.021501770243048668
the O 0 0.08983607590198517
DM B-Disease 1 1.0
locus O 1 0.999683141708374
, O 0 0.023401714861392975
has O 0 0.015144020318984985
been O 0 0.01157691515982151
put O 0 0.018254635855555534
forward O 0 0.016623876988887787
to O 0 0.013022426515817642
explain O 0 0.01958559826016426
partially O 0 0.03128388524055481
the O 0 0.019793733954429626
maintenance O 1 0.9257228374481201
of O 1 0.5043201446533203
DM B-Disease 1 1.0
in O 0 0.027112126350402832
the O 0 0.031606897711753845
population O 0 0.031925614923238754
. O 0 0.042580705136060715

In O 0 0.025705795735120773
a O 0 0.028538990765810013
survey O 0 0.03134671971201897
of O 0 0.040358833968639374
DM B-Disease 1 0.9999998807907104
in O 0 0.024615561589598656
Northern O 0 0.03566468879580498
Ireland O 0 0.04127645865082741
, O 0 0.028548838570713997
59 O 0 0.060976337641477585
pedigrees O 0 0.08896028995513916
were O 0 0.032217320054769516
ascertained O 0 0.10419494658708572
. O 0 0.05183519795536995

Sibships O 1 0.9472651481628418
where O 0 0.030679162591695786
the O 0 0.02006908506155014
status O 0 0.025589516386389732
of O 0 0.013493690639734268
all O 0 0.010556583292782307
the O 0 0.014287909492850304
members O 0 0.01672501675784588
had O 0 0.014454114250838757
been O 0 0.011538146063685417
identified O 0 0.014329161494970322
were O 0 0.008319247514009476
examined O 0 0.019559282809495926
to O 0 0.009912917390465736
determine O 0 0.010474283248186111
the O 0 0.013019651174545288
transmission O 0 0.023243622854351997
of O 0 0.01808052882552147
the O 0 0.21850815415382385
DM B-Disease 1 1.0
expansion O 1 0.7931214570999146
from O 0 0.025275448337197304
affected O 0 0.034757789224386215
parents O 0 0.02801690064370632
to O 0 0.019504902884364128
their O 0 0.024899495765566826
offspring O 0 0.09582922607660294
. O 0 0.04748743399977684

Where O 0 0.040880437940359116
the O 0 0.037573013454675674
transmitting O 1 0.5029512047767639
parent O 1 0.7063286304473877
was O 0 0.05176428332924843
male O 0 0.11852725595235825
, O 0 0.03643286973237991
58 O 0 0.07298097759485245
. O 0 0.04822362959384918

3 O 0 0.0397377572953701
% O 0 0.0197475366294384
of O 0 0.017541537061333656
the O 0 0.025432530790567398
offspring O 0 0.31620410084724426
were O 0 0.01556213479489088
affected O 0 0.024313701316714287
, O 0 0.013829841278493404
and O 0 0.01025083102285862
in O 0 0.00818375963717699
the O 0 0.01247953437268734
case O 0 0.015531592071056366
of O 0 0.014039263129234314
a O 0 0.026595916599035263
female O 1 0.9325637817382812
transmitting O 1 0.9980918765068054
parent O 1 0.9650469422340393
, O 0 0.03603946790099144
68 O 0 0.0765245258808136
. O 0 0.05296064540743828

7 O 0 0.07885176688432693
% O 0 0.04252302646636963
were O 0 0.02815130352973938
affected O 0 0.06127796322107315
. O 0 0.05392169952392578

Studies O 0 0.04199546203017235
on O 0 0.03423953056335449
meiotic O 1 0.99921715259552
drive O 0 0.24328695237636566
in O 0 0.05255015566945076
DM B-Disease 1 1.0
have O 0 0.015597815625369549
shown O 0 0.016984084621071815
increased O 0 0.019596368074417114
transmission O 0 0.021734079346060753
of O 0 0.012135491706430912
the O 0 0.0145866135135293
larger O 0 0.015610367991030216
allele O 0 0.03137776255607605
at O 0 0.01828004978597164
the O 0 0.029730793088674545
DM B-Disease 1 1.0
locus O 1 0.5547876358032227
in O 0 0.024947578087449074
non O 1 0.9995438456535339
- O 1 0.9999998807907104
DM O 1 1.0
heterozygotes O 1 0.999570906162262
for O 0 0.06039457395672798
CTGn O 1 0.9990295171737671
. O 0 0.06056084483861923

This O 0 0.03207535296678543
study O 0 0.028325330466032028
provides O 0 0.020372740924358368
further O 0 0.012650308199226856
evidence O 0 0.013665597885847092
that O 0 0.01263438630849123
the O 0 0.03770463541150093
DM B-Disease 1 1.0
expansion O 0 0.39180922508239746
tends O 0 0.05142651125788689
to O 0 0.02334420196712017
be O 0 0.02324635721743107
transmitted O 0 0.07181937992572784
preferentially O 0 0.09116365760564804
. O 0 0.04727112874388695

Diagnosis O 1 0.9999711513519287
of O 1 0.9912746548652649
hemochromatosis B-Disease 1 1.0
. O 1 0.6242901682853699

If O 0 0.08212736248970032
untreated O 1 0.9999990463256836
, O 1 0.9996377229690552
hemochromatosis B-Disease 1 1.0
can O 1 0.8811394572257996
cause O 1 0.9999955892562866
serious O 1 0.9999984502792358
illness O 1 0.9999998807907104
and O 0 0.1988646239042282
early B-Disease 0 0.24885284900665283
death I-Disease 1 0.999103307723999
, O 0 0.017189964652061462
but O 0 0.012780503369867802
the O 0 0.4242550730705261
disease O 1 0.9999961853027344
is O 0 0.01811685599386692
still O 0 0.019577402621507645
substantially O 0 0.03625145182013512
under O 1 0.8726323843002319
- O 1 1.0
diagnosed O 1 0.9999996423721313
. O 0 0.063478484749794

The O 0 0.0527578629553318
cornerstone O 1 0.9952998161315918
of O 0 0.04138581082224846
screening O 1 0.9066064357757568
and O 0 0.023234672844409943
case O 0 0.03169384226202965
detection O 0 0.03773941844701767
is O 0 0.014213623479008675
the O 0 0.017685281112790108
measurement O 0 0.03332897275686264
of O 0 0.03652353957295418
serum O 1 0.9999918937683105
transferrin O 1 0.9999678134918213
saturation O 1 0.9473875761032104
and O 0 0.03284960612654686
the O 0 0.05236966535449028
serum O 1 0.9999583959579468
ferritin O 1 0.9999314546585083
level O 0 0.0805097222328186
. O 0 0.05432577803730965

Once O 0 0.06452626734972
the O 0 0.04800114035606384
diagnosis O 1 0.9999411106109619
is O 0 0.02997612953186035
suspected O 0 0.4967689514160156
, O 0 0.02371610701084137
physicians O 0 0.1128637045621872
must O 0 0.021669946610927582
use O 0 0.02507399022579193
serum O 1 0.9999731779098511
ferritin O 1 0.9999898672103882
levels O 0 0.05552462860941887
and O 0 0.04841603711247444
hepatic O 1 1.0
iron O 1 0.9999932050704956
stores O 0 0.07338493317365646
on O 1 0.756087064743042
liver O 1 1.0
biopsy O 1 0.9999992847442627
specimens O 0 0.037677206099033356
to O 0 0.022176606580615044
assess O 0 0.10697650909423828
patients O 0 0.20830442011356354
for O 0 0.015510454773902893
the O 0 0.02295631356537342
presence O 0 0.05313051864504814
of O 1 0.5484212040901184
iron B-Disease 1 0.9999991655349731
overload I-Disease 1 0.9999988079071045
. O 0 0.0774274617433548

Liver O 1 1.0
biopsy O 1 0.9999991655349731
is O 0 0.037271324545145035
also O 0 0.01725430227816105
used O 0 0.010012034326791763
to O 0 0.01003329735249281
establish O 0 0.018848512321710587
the O 0 0.013198429718613625
presence O 0 0.018871327862143517
or O 0 0.013132463209331036
absence O 0 0.04257003590464592
of O 1 0.9839953780174255
cirrhosis B-Disease 1 1.0
, O 1 0.9629656076431274
which O 0 0.020876476541161537
can O 0 0.018016207963228226
affect O 0 0.09426558762788773
prognosis O 1 0.9999994039535522
and O 0 0.050478797405958176
management O 1 0.6857579350471497
. O 0 0.04626091197133064

A O 0 0.06766890734434128
DNA O 0 0.05012330040335655
- O 1 0.7270447015762329
based O 0 0.01665319874882698
test O 0 0.015478172339498997
for O 0 0.011233337223529816
the O 0 0.025829611346125603
HFE O 1 0.9999986886978149
gene O 0 0.037121307104825974
is O 0 0.0184183269739151
commercially O 0 0.02554432861506939
available O 0 0.010395649820566177
, O 0 0.009440463036298752
but O 0 0.00621936796233058
its O 0 0.008986533619463444
place O 0 0.012615418061614037
in O 0 0.010487299412488937
the O 0 0.02202882245182991
diagnosis O 1 0.999991774559021
of O 1 0.9988865256309509
hemochromatosis B-Disease 1 1.0
is O 1 0.7956331968307495
still O 0 0.03356281295418739
being O 0 0.03269222006201744
evaluated O 0 0.057942237704992294
. O 0 0.038325924426317215

Currently O 0 0.04858030751347542
, O 0 0.025204544886946678
the O 0 0.02020357921719551
most O 0 0.015750201418995857
useful O 0 0.01964743621647358
role O 0 0.021798105910420418
for O 0 0.012818624265491962
this O 0 0.010364394634962082
test O 0 0.017696503549814224
is O 0 0.009720968082547188
in O 0 0.007691722363233566
the O 0 0.013427597470581532
detection O 0 0.04091937467455864
of O 0 0.041099388152360916
hemochromatosis B-Disease 1 1.0
in O 0 0.017801837995648384
the O 0 0.017641594633460045
family O 0 0.022246867418289185
members O 0 0.015470023266971111
of O 0 0.018530843779444695
patients O 1 0.9729932546615601
with O 0 0.014322199858725071
a O 0 0.02254505641758442
proven O 0 0.06130301207304001
case O 0 0.022857002913951874
of O 0 0.02669510990381241
the O 1 0.9644864201545715
disease O 1 0.999998927116394
. O 0 0.06744765490293503

It O 0 0.024923212826251984
is O 0 0.01922779344022274
crucial O 0 0.03172938898205757
to O 0 0.034727271646261215
diagnose O 1 0.9999996423721313
hemochromatosis B-Disease 1 1.0
before O 1 0.9999922513961792
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999997615814209
because O 1 0.9996867179870605
phlebotomy O 1 1.0
therapy O 1 0.9999986886978149
can O 0 0.04948928952217102
avert O 1 0.9999996423721313
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.999904990196228
can O 0 0.0245954766869545
even O 0 0.015817560255527496
lead O 0 0.02526579424738884
to O 0 0.01884879171848297
normal O 0 0.03131471201777458
life O 0 0.05931061506271362
expectancy O 1 0.9898432493209839
. O 0 0.030431006103754044
. O 0 0.038084324449300766

Prevalence O 1 0.6470126509666443
of O 0 0.03673521429300308
the O 0 0.05557950586080551
I1307K O 1 0.9999935626983643
APC B-Disease 1 0.9999947547912598
gene O 0 0.044931285083293915
variant O 0 0.03195719048380852
in O 0 0.012766456231474876
Israeli O 0 0.025803137570619583
Jews O 0 0.02389947697520256
of O 0 0.014399216510355473
differing O 0 0.014107106253504753
ethnic O 0 0.018980788066983223
origin O 0 0.015446481294929981
and O 0 0.021100526675581932
risk O 1 0.9991769194602966
for O 1 0.9999313354492188
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9944105744361877

BACKGROUND O 0 0.2530052065849304
& O 1 0.7432003021240234
AIMS O 0 0.07760165631771088
Israeli O 0 0.0361214242875576
Jews O 0 0.02911221794784069
of O 0 0.018063247203826904
European O 0 0.02534393221139908
birth O 1 0.9527632594108582
, O 0 0.022480282932519913
i O 0 0.0265143271535635
. O 0 0.014875084161758423
e O 0 0.03266194090247154
. O 0 0.011457023210823536
, O 0 0.015386088751256466
Ashkenazim O 0 0.22507552802562714
, O 0 0.011686277575790882
have O 0 0.006457328796386719
the O 0 0.019919462502002716
highest O 1 0.9999988079071045
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 1.0
of O 1 0.9667038917541504
any O 0 0.03753740340471268
Israeli O 0 0.2506329119205475
ethnic O 0 0.05041816830635071
group O 0 0.05838440731167793
. O 0 0.040902815759181976

The O 0 0.07655096799135208
I1307K O 1 0.9997708201408386
APC B-Disease 1 0.9999934434890747
gene O 0 0.06579717248678207
variant O 0 0.053718212991952896
was O 0 0.03048820234835148
found O 0 0.01874004676938057
in O 0 0.02060137502849102
6 O 0 0.05069735646247864
. O 0 0.04042009264230728

1 O 0 0.04664125666022301
% O 0 0.020039420574903488
of O 0 0.01683984510600567
American O 0 0.026857461780309677
Jews O 0 0.030243467539548874
, O 0 0.013507739640772343
28 O 0 0.016196129843592644
% O 0 0.010049370117485523
of O 0 0.01505214162170887
their O 0 0.05191808566451073
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9999948740005493
, O 1 0.8046721816062927
but O 0 0.01159648597240448
not O 0 0.008549628779292107
in O 0 0.011646746657788754
non O 1 0.9085984826087952
- O 1 0.9999071359634399
Jews O 0 0.06535174697637558
. O 0 0.0399661548435688

We O 0 0.03362758830189705
assessed O 0 0.04303764924407005
the O 0 0.03834017366170883
I1307K O 1 0.9985945820808411
prevalence O 1 0.9937883019447327
in O 0 0.01911040022969246
Israeli O 0 0.03264840319752693
Jews O 0 0.03119221143424511
of O 0 0.0163242407143116
differing O 0 0.01550725195556879
ethnic O 0 0.020066892728209496
origin O 0 0.017257433384656906
and O 0 0.020469289273023605
risk O 1 0.9991298317909241
for O 1 0.9999785423278809
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9966371059417725

METHODS O 0 0.050875063985586166
DNA O 0 0.032647356390953064
samples O 0 0.020205438137054443
from O 0 0.013500879518687725
500 O 0 0.026163244619965553
unrelated O 0 0.024858446791768074
Jews O 0 0.022420711815357208
of O 0 0.016314901411533356
European O 0 0.020514464005827904
or O 0 0.018232312053442
non O 1 0.8235893249511719
- O 1 0.9991418123245239
European O 0 0.017004365101456642
origin O 0 0.011643464677035809
, O 0 0.010270457714796066
with O 0 0.009514110162854195
or O 0 0.009266108274459839
without O 0 0.009849014692008495
a O 0 0.016404755413532257
personal O 0 0.1114087700843811
and O 0 0.030866393819451332
/ O 1 0.9999128580093384
or O 0 0.014231039211153984
family O 0 0.019432302564382553
history O 0 0.019247783347964287
of O 1 0.8033366799354553
neoplasia B-Disease 1 1.0
, O 0 0.01947714202105999
were O 0 0.010569690726697445
examined O 0 0.021843232214450836
for O 0 0.011875856667757034
the O 0 0.020349593833088875
I1307K O 1 0.9966521859169006
variant O 0 0.029456129297614098
by O 0 0.013951918110251427
the O 0 0.020808113738894463
allele O 0 0.10958864539861679
- O 1 0.9973006844520569
specific O 0 0.02686353400349617
oligonucleotide O 1 0.9643011689186096
( O 0 0.05773228406906128
ASO O 1 0.9999510049819946
) O 0 0.04313526675105095
method O 0 0.041972383856773376
. O 0 0.03878111392259598

RESULTS O 0 0.033470068126916885
In O 0 0.01653454825282097
persons O 0 0.020326882600784302
at O 0 0.019184740260243416
average O 0 0.025933437049388885
risk O 1 0.7546759247779846
for O 1 0.9988780617713928
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9998934268951416
I1307K O 1 0.9999982118606567
was O 0 0.32806265354156494
found O 0 0.017348818480968475
in O 0 0.018521206453442574
5 O 0 0.036531828343868256
. O 0 0.0374872200191021

0 O 0 0.062454164028167725
% O 0 0.02569846250116825
of O 0 0.02200055867433548
120 O 0 0.03589633107185364
European O 0 0.029569333419203758
and O 0 0.028123676776885986
1 O 0 0.047392092645168304
. O 0 0.04216250032186508

6 O 0 0.045226000249385834
% O 0 0.019771365448832512
of O 0 0.021411407738924026
188 O 0 0.0704498440027237
non O 0 0.2745801508426666
- O 1 0.9944882988929749
European O 0 0.024752363562583923
Jews O 0 0.0472378246486187
( O 0 0.03777182847261429
P O 1 0.9990384578704834
= O 0 0.06339394301176071
0 O 0 0.04518573358654976
. O 0 0.025740737095475197
08 O 0 0.12968577444553375
) O 0 0.033928871154785156
. O 0 0.03656678646802902

It O 0 0.03503958880901337
occurred O 0 0.04163791984319687
in O 0 0.025125209242105484
15 O 0 0.04394061863422394
. O 0 0.04683227092027664

4 O 0 0.044309984892606735
% O 0 0.01992456428706646
of O 0 0.019223324954509735
52 O 0 0.04236016422510147
Ashkenazi O 0 0.3538009822368622
Israelis O 0 0.04305044934153557
with O 0 0.03843352571129799
familial O 1 0.9999998807907104
cancer B-Disease 1 1.0
( O 1 0.9921850562095642
P O 1 0.9999748468399048
= O 0 0.1288202702999115
0 O 0 0.04009199142456055
. O 0 0.022852253168821335
02 O 1 0.9965193271636963
) O 0 0.019132796674966812
and O 0 0.014015785418450832
was O 0 0.0175738837569952
not O 0 0.009709539823234081
detected O 0 0.017918696627020836
in O 0 0.009803135879337788
51 O 0 0.030229484662413597
non O 0 0.047351736575365067
- O 1 0.9707946181297302
European O 0 0.020643096417188644
Jews O 0 0.03650164604187012
at O 0 0.04673824459314346
increased O 1 0.9383363723754883
cancer B-Disease 1 0.9999996423721313
risk O 1 0.9993281364440918
. O 0 0.06020930036902428

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999990463256836
occurred O 0 0.4598510265350342
personally O 1 0.823697030544281
or O 0 0.019510775804519653
in O 0 0.012445250526070595
the O 0 0.01483217254281044
families O 0 0.015543532557785511
of O 0 0.01329178549349308
13 O 0 0.01775333657860756
of O 0 0.015822675079107285
20 O 0 0.025877032428979874
Ashkenazi O 1 0.9978785514831543
I1307K O 1 0.9994372725486755
carriers O 0 0.04524184390902519
, O 0 0.015482599847018719
8 O 0 0.01761527918279171
of O 0 0.014680903404951096
whom O 0 0.023517165333032608
also O 0 0.012975613586604595
had O 0 0.014631321653723717
a O 0 0.01859470270574093
personal O 0 0.02792719379067421
or O 0 0.016364311799407005
family O 0 0.024104036390781403
history O 0 0.028631655499339104
of O 0 0.058300506323575974
noncolonic O 1 0.9999934434890747
neoplasia B-Disease 1 0.9999963045120239
. O 0 0.07843486219644547

CONCLUSIONS O 0 0.0783124715089798
The O 0 0.06021454930305481
I1307K O 1 0.9998526573181152
APC O 1 0.9999877214431763
variant O 0 0.0644783154129982
may O 0 0.017639324069023132
represent O 0 0.015614179894328117
a O 0 0.02525872178375721
susceptibility O 1 0.9875348806381226
gene O 0 0.039303846657276154
for O 0 0.04111461713910103
colorectal B-Disease 1 1.0
, I-Disease 0 0.0391976460814476
or I-Disease 0 0.018245955929160118
other I-Disease 0 0.012405159883201122
, I-Disease 0 0.02274463139474392
cancers I-Disease 1 0.9988273978233337
in O 0 0.0192274022847414
Ashkenazi O 1 0.9998396635055542
Jews O 0 0.3402714133262634
, O 0 0.017811652272939682
and O 0 0.015188842080533504
partially O 0 0.032086681574583054
explains O 0 0.022012248635292053
the O 0 0.014139685779809952
higher O 0 0.0218410175293684
incidence O 1 0.9999960660934448
of O 1 0.9999990463256836
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.951296329498291
European O 0 0.254072368144989
Israelis O 0 0.09363077580928802
. O 0 0.045074645429849625

Systematic O 0 0.07724998146295547
analysis O 0 0.025411171838641167
of O 0 0.036212578415870667
coproporphyrinogen O 1 0.9999860525131226
oxidase O 1 0.9999971389770508
gene O 1 0.6019517183303833
defects O 1 0.998441755771637
in O 0 0.037619199603796005
hereditary B-Disease 1 0.9999995231628418
coproporphyria I-Disease 1 0.9999985694885254
and O 1 0.766459584236145
mutation O 1 0.9511145949363708
update O 0 0.10281425714492798
. O 0 0.051421746611595154

Hereditary B-Disease 1 0.9999889135360718
coproporphyria I-Disease 1 0.9999805688858032
( O 0 0.42083540558815
HC B-Disease 1 0.9999996423721313
) O 0 0.0308050736784935
is O 0 0.021701302379369736
an O 0 0.466706246137619
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999470710754395
autosomal O 1 1.0
dominant O 1 0.9999998807907104
inheritance O 1 0.9999985694885254
caused O 1 0.9999293088912964
by O 0 0.45598235726356506
deficient B-Disease 1 0.9999473094940186
activity I-Disease 0 0.028293365612626076
of I-Disease 0 0.03999368101358414
coproporphyrinogen I-Disease 1 0.9999982118606567
III I-Disease 1 0.9999998807907104
oxidase I-Disease 1 0.999998927116394
( O 0 0.24249714612960815
CPO O 1 0.9977414608001709
) O 0 0.04583936184644699
. O 0 0.041642073541879654

Clinical O 1 0.942574143409729
manifestations O 1 0.9984158277511597
of O 0 0.41985008120536804
the O 1 0.9993730187416077
disease O 1 0.9999998807907104
are O 0 0.014324118383228779
characterized O 1 0.9123848676681519
by O 0 0.11274083703756332
acute O 1 1.0
attacks O 1 0.9998704195022583
of O 1 0.9999988079071045
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9956516623497009
precipitated O 1 0.9999988079071045
by O 0 0.05163184925913811
drugs O 1 0.9779312014579773
, O 0 0.028575604781508446
fasting O 1 0.9972363710403442
, O 0 0.04836266115307808
cyclical O 1 0.9999823570251465
hormonal O 1 0.9999954700469971
changes O 0 0.03134583681821823
, O 0 0.3682926595211029
or O 1 0.9991316199302673
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 1 0.9567505717277527

Skin O 1 1.0
photosensitivity O 1 0.9999998807907104
may O 0 0.3102301359176636
also O 0 0.02753600664436817
be O 0 0.021440548822283745
present O 0 0.03425978124141693
. O 0 0.042484257370233536

The O 0 0.03824084252119064
seven O 0 0.03387291356921196
exons O 0 0.06177514046430588
, O 0 0.02301499992609024
the O 0 0.03379431739449501
exon O 1 0.9922986626625061
/ O 1 0.9982339143753052
intron O 1 0.9775002598762512
boundaries O 0 0.026489758864045143
and O 0 0.01589639112353325
part O 0 0.018744632601737976
of O 0 0.019319096580147743
3 O 0 0.02953460067510605
noncoding O 0 0.05663878843188286
sequence O 0 0.015510368160903454
of O 0 0.015897421166300774
the O 0 0.02837619185447693
CPO O 1 0.9958105087280273
gene O 0 0.027841530740261078
were O 0 0.012654679827392101
systematically O 0 0.02920687571167946
analyzed O 0 0.015520092099905014
by O 0 0.012143702246248722
an O 0 0.018141411244869232
exon O 0 0.2254919707775116
- O 1 0.9008795022964478
by O 0 0.02843666635453701
- O 1 0.992473840713501
exon O 0 0.3975020945072174
denaturing O 1 0.9968760013580322
gradient O 1 0.9910095930099487
gel O 1 0.9997856020927429
electrophoresis O 1 0.9945652484893799
( O 0 0.056228600442409515
DGGE O 1 0.9998958110809326
) O 0 0.02576090581715107
strategy O 0 0.026219913735985756
followed O 0 0.018328994512557983
by O 0 0.01278009545058012
direct O 0 0.01979861967265606
sequencing O 0 0.02103663980960846
in O 0 0.01064454298466444
seven O 0 0.021064752712845802
unrelated O 0 0.05159800872206688
heterozygous O 1 0.8987922668457031
HC B-Disease 1 0.9999998807907104
patients O 1 0.9998689889907837
from O 0 0.036731135100126266
France O 1 0.9489474296569824
, O 0 0.04011889174580574
Holland O 1 0.9688652753829956
, O 0 0.026711340993642807
and O 0 0.02643025480210781
Czech O 0 0.12180158495903015
Republic O 0 0.08458501100540161
. O 0 0.05364491418004036

Seven O 0 0.058618806302547455
novel O 0 0.07273043692111969
mutations O 0 0.03798500820994377
and O 0 0.017940988764166832
two O 0 0.016619553789496422
new O 0 0.03486570715904236
polymorphisms O 0 0.08514989912509918
were O 0 0.02632863074541092
detected O 0 0.05731499195098877
. O 0 0.04212164878845215

Among O 0 0.045283243060112
these O 0 0.017963871359825134
mutations O 0 0.022003382444381714
two O 0 0.010498622432351112
are O 0 0.011365191079676151
missense O 0 0.09288039803504944
( O 0 0.03532911464571953
G197W O 1 0.9997945427894592
, O 0 0.03819592669606209
W427R O 1 0.9996204376220703
) O 0 0.017243392765522003
, O 0 0.009966716170310974
two O 0 0.007525239139795303
are O 0 0.007938449271023273
nonsense O 0 0.07071443647146225
( O 0 0.028918299823999405
Q306X O 1 0.9967556595802307
, O 0 0.032548729330301285
Q385X O 1 0.9986248016357422
) O 0 0.018530530855059624
, O 0 0.010965398512780666
two O 0 0.007166438270360231
are O 0 0.006389904301613569
small O 0 0.016377808526158333
deletions O 0 0.05363638326525688
( O 0 0.03439774364233017
662de14bp O 1 0.9982779026031494
; O 0 0.027044283226132393
1168del3bp O 1 0.8323258757591248
removing O 0 0.053627051413059235
a O 0 0.027735833078622818
glycine O 0 0.06667778640985489
at O 0 0.022854698821902275
position O 0 0.02755930833518505
390 O 0 0.1687287986278534
) O 0 0.018901290372014046
, O 0 0.012460955418646336
and O 0 0.009754547849297523
one O 0 0.009582243859767914
is O 0 0.010244017466902733
a O 0 0.017373817041516304
splicing O 0 0.036027561873197556
mutation O 0 0.03183137997984886
( O 0 0.02477896958589554
IVS1 O 1 0.9993958473205566
- O 1 0.999861478805542
15c O 1 0.9998551607131958
- O 1 0.9999991655349731
- O 1 0.9999983310699463
> O 1 0.9974501729011536
g O 0 0.09099037945270538
) O 0 0.017295626923441887
which O 0 0.011367437429726124
creates O 0 0.026898059993982315
a O 0 0.02291627787053585
new O 0 0.03672285005450249
acceptor O 1 0.9349564909934998
splice O 0 0.356216698884964
site O 0 0.060805924236774445
. O 0 0.039990175515413284

The O 0 0.05398721247911453
pathological O 0 0.13215401768684387
significance O 0 0.03135225176811218
of O 0 0.019903281703591347
the O 0 0.021291641518473625
point O 0 0.03419099375605583
mutations O 0 0.040479909628629684
G197W O 1 0.998233437538147
, O 0 0.02656235359609127
W427R O 1 0.9862686991691589
, O 0 0.014728966169059277
and O 0 0.009761730208992958
the O 0 0.013564362190663815
in O 0 0.016860144212841988
- O 1 0.9999794960021973
frame O 1 0.7557730078697205
deletion O 1 0.590040922164917
390delGly O 1 0.9887540340423584
were O 0 0.013789131306111813
assessed O 0 0.020074957981705666
by O 0 0.01034332625567913
their O 0 0.009647528640925884
respective O 0 0.018957804888486862
expression O 0 0.01898987405002117
in O 0 0.012016834691166878
a O 0 0.02177351713180542
prokaryotic O 0 0.04647544398903847
system O 0 0.025426974520087242
using O 0 0.018373319879174232
site O 0 0.04704795777797699
- O 1 0.9701542854309082
directed O 0 0.06329528242349625
mutagenesis O 0 0.12440018355846405
. O 0 0.05305354669690132

These O 0 0.03133995458483696
mutations O 0 0.039930231869220734
resulted O 0 0.02631094865500927
in O 0 0.015109722502529621
the O 0 0.02187359519302845
absence O 0 0.4534171223640442
or O 0 0.019710436463356018
a O 0 0.027262164279818535
dramatic O 0 0.045286472886800766
decrease O 0 0.04989410564303398
of O 0 0.05600754916667938
CPO O 1 0.9999382495880127
activity O 0 0.0635746642947197
. O 0 0.04559778422117233

The O 0 0.03990405052900314
two O 0 0.025725597515702248
polymorphisms O 0 0.06132720410823822
were O 0 0.01756068505346775
localized O 0 0.04293745756149292
in O 0 0.015543946996331215
noncoding O 0 0.05805819854140282
part O 0 0.01770445518195629
of O 0 0.014455052092671394
the O 0 0.020122384652495384
gene O 0 0.023170487955212593
1 O 0 0.020951833575963974
) O 0 0.016287200152873993
a O 0 0.027732476592063904
C O 1 0.998615026473999
/ O 1 0.9994903802871704
G O 1 0.7642276883125305
polymorphism O 0 0.04711391404271126
in O 0 0.016308505088090897
the O 0 0.028546610847115517
promotor O 1 0.999906063079834
region O 0 0.04465344175696373
, O 0 0.026914862915873528
142 O 0 0.06719489395618439
bp O 0 0.05480833724141121
upstream O 0 0.028204580768942833
from O 0 0.01079411432147026
the O 0 0.015357141382992268
transcriptional O 0 0.05067450925707817
initiation O 0 0.1041586771607399
site O 0 0.029139846563339233
( O 0 0.029065415263175964
- O 1 0.999955415725708
142C O 1 0.9999722242355347
/ O 1 0.9999872446060181
G O 1 0.9985615611076355
) O 0 0.02021992765367031
, O 0 0.012813031673431396
and O 0 0.012529896572232246
2 O 0 0.02068912796676159
) O 0 0.013764486648142338
a O 0 0.016443932428956032
6 O 0 0.0313069112598896
bp O 0 0.04994824528694153
deletion O 0 0.04573250189423561
polymorphism O 0 0.0370141975581646
in O 0 0.012825149111449718
the O 0 0.017292411997914314
3 O 0 0.02536562830209732
noncoding O 0 0.050387416034936905
part O 0 0.01887138932943344
of O 0 0.016489945352077484
the O 0 0.029159901663661003
CPO O 1 0.9998244643211365
gene O 0 0.037967558950185776
, O 0 0.025035982951521873
574 O 1 0.7770547866821289
bp O 0 0.05532044544816017
downstream O 0 0.03032338060438633
of O 0 0.013765386305749416
the O 0 0.01580442674458027
last O 0 0.018467549234628677
base O 0 0.022819142788648605
of O 0 0.013526191003620625
the O 0 0.02066032961010933
normal O 0 0.035537973046302795
termination O 1 0.9947038292884827
codon O 1 0.8416003584861755
( O 0 0.05535614863038063
+ O 1 0.6211314797401428
574 O 1 0.9953629970550537
delATTCTT O 1 0.9974736571311951
) O 0 0.05311491712927818
. O 0 0.044900380074977875

Five O 0 0.0617687851190567
intragenic O 1 0.9994723200798035
dimorphisms O 1 0.9987106323242188
are O 0 0.01568872481584549
now O 0 0.020106444135308266
well O 0 0.01757149025797844
characterized O 0 0.030863342806696892
and O 0 0.014547557570040226
the O 0 0.0168424341827631
high O 0 0.027570217847824097
degree O 0 0.022936290130019188
of O 0 0.027894150465726852
allelic O 1 0.9996238946914673
heterogeneity O 1 0.998969554901123
in O 0 0.037459276616573334
HC B-Disease 1 0.9999998807907104
is O 0 0.025554783642292023
demonstrated O 0 0.023858703672885895
with O 0 0.011221325024962425
seven O 0 0.013391121290624142
new O 0 0.01481714192777872
different O 0 0.007407068274915218
mutations O 0 0.015253260731697083
making O 0 0.010711610317230225
a O 0 0.011797078885138035
total O 0 0.011763720773160458
of O 0 0.019522428512573242
nineteen O 1 0.9662635326385498
CPO O 1 0.9999986886978149
gene B-Disease 1 0.9948623776435852
defects I-Disease 1 0.9998310804367065
reported O 0 0.03411184251308441
so O 0 0.021581385284662247
far O 0 0.02347635291516781
. O 0 0.023559531196951866
. O 0 0.033961448818445206

Coincidence O 0 0.06595879793167114
of O 0 0.02487066201865673
two O 0 0.018091468140482903
novel O 0 0.0501626692712307
arylsulfatase O 1 0.9827887415885925
A O 0 0.05015162006020546
alleles O 0 0.04961727559566498
and O 0 0.02737475000321865
mutation O 0 0.23028609156608582
459 O 1 0.9999518394470215
+ O 1 0.9998766183853149
1G O 1 0.9999915361404419
> O 0 0.20600876212120056
A O 0 0.028439879417419434
within O 0 0.015467002056539059
a O 0 0.021578297019004822
family O 0 0.03585531562566757
with O 0 0.04064645990729332
metachromatic B-Disease 1 0.9999991655349731
leukodystrophy I-Disease 1 0.9999997615814209
: O 0 0.05172502249479294
molecular O 0 0.03208271041512489
basis O 0 0.020183974876999855
of O 0 0.030799074098467827
phenotypic O 0 0.10648485273122787
heterogeneity O 1 0.8910239338874817
. O 0 0.06742420792579651

In O 0 0.029406486079096794
a O 0 0.0318453274667263
family O 0 0.02996484935283661
with O 0 0.01593911461532116
three O 0 0.01711803674697876
siblings O 0 0.06692130863666534
, O 0 0.0179160013794899
one O 0 0.014723694883286953
developed O 0 0.022174187004566193
classical O 0 0.026770062744617462
late O 0 0.14294567704200745
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9999383687973022
MLD B-Disease 1 1.0
) O 0 0.037400782108306885
, O 0 0.02485251985490322
fatal O 1 0.9984990358352661
at O 0 0.02385280281305313
age O 0 0.022441983222961426
5 O 0 0.016719426959753036
years O 0 0.012745572254061699
, O 0 0.012687299400568008
with O 0 0.017321566119790077
deficient O 1 0.9999474287033081
arylsulfatase O 1 0.999967098236084
A O 1 0.986172616481781
( O 0 0.24212834239006042
ARSA O 1 0.9999986886978149
) O 0 0.023693960160017014
activity O 0 0.019302137196063995
and O 0 0.015587654896080494
increased O 0 0.035850416868925095
galactosylsulfatide O 1 0.9999914169311523
( O 1 0.9658018350601196
GS O 1 0.9999998807907104
) O 0 0.0645299181342125
excretion O 1 0.9664945006370544
. O 0 0.05930424481630325

The O 0 0.03318805247545242
two O 0 0.017483990639448166
other O 0 0.016413960605859756
siblings O 0 0.054067425429821014
, O 0 0.021384896710515022
apparently O 0 0.027492942288517952
healthy O 0 0.04375218227505684
at O 0 0.01874123141169548
12 O 0 0.021190546452999115
( O 0 0.020070113241672516
1 O 0 0.03387754037976265
/ O 1 0.9946013689041138
2 O 0 0.023225752636790276
) O 0 0.01261806022375822
and O 0 0.010431163012981415
15 O 0 0.01503060944378376
years O 0 0.013574822805821896
, O 0 0.013284996151924133
respectively O 0 0.016057344153523445
, O 0 0.01177599560469389
and O 0 0.009981987997889519
their O 0 0.012118182145059109
father O 1 0.7481710910797119
, O 0 0.020042503252625465
apparently O 0 0.0242144875228405
healthy O 0 0.03893261030316353
as O 0 0.013907111249864101
well O 0 0.012965111993253231
, O 0 0.017698846757411957
presented O 0 0.041533783078193665
ARSA O 1 0.9999961853027344
and O 0 0.05004813149571419
GS O 1 0.9999971389770508
values O 0 0.022491153329610825
within O 0 0.0139538599178195
the O 0 0.01840958558022976
range O 0 0.0283570047467947
of O 0 0.4158760905265808
MLD B-Disease 1 1.0
patients O 1 0.9999853372573853
. O 0 0.07180576771497726

Mutation O 0 0.16394305229187012
screening O 0 0.07930772751569748
and O 0 0.024875745177268982
sequence O 0 0.01934167556464672
analysis O 0 0.013248092494904995
disclosed O 0 0.023739084601402283
the O 0 0.01372116431593895
involvement O 0 0.027266673743724823
of O 0 0.01442661415785551
three O 0 0.013804526999592781
different O 0 0.01662518084049225
ARSA O 1 0.9999948740005493
mutations O 0 0.03195091336965561
being O 0 0.01765003427863121
the O 0 0.018124939873814583
molecular O 0 0.022250384092330933
basis O 0 0.018097450956702232
of O 0 0.0322338305413723
intrafamilial O 1 0.9996153116226196
phenotypic O 1 0.5563130378723145
heterogeneity O 1 0.9329121708869934
. O 0 0.06847119331359863

The O 0 0.05761924386024475
late O 0 0.4171160161495209
infantile O 1 0.9999998807907104
patient O 1 0.9999972581863403
inherited O 1 0.9998981952667236
from O 0 0.027873164042830467
his O 0 0.04161570221185684
mother O 1 0.6605836749076843
the O 0 0.022725649178028107
frequent O 0 0.05016842111945152
0 O 0 0.05181381106376648
- O 1 0.9990485310554504
type O 0 0.04181427136063576
mutation O 0 0.05297747626900673
459 O 1 0.9983086585998535
+ O 1 0.9995023012161255
1G O 1 0.9999903440475464
> O 1 0.945751428604126
A O 0 0.038980599492788315
, O 0 0.016728200018405914
and O 0 0.012562386691570282
from O 0 0.012516800314188004
his O 0 0.02231789007782936
father O 0 0.0577046163380146
a O 0 0.02506449446082115
novel O 0 0.03681492432951927
, O 0 0.019145086407661438
single O 0 0.03455551713705063
basepair O 1 0.9853672981262207
microdeletion O 1 0.9154964685440063
of O 0 0.030440112575888634
guanine O 0 0.06871497631072998
at O 0 0.023375848308205605
nucleotide O 0 0.027798976749181747
7 O 0 0.01884380355477333
in O 0 0.015598488040268421
exon O 0 0.09635180979967117
1 O 0 0.050105370581150055
( O 0 0.044195566326379776
7delG O 1 0.985504686832428
) O 0 0.042717237025499344
. O 0 0.04103358834981918

The O 0 0.04606080800294876
two O 0 0.03533872216939926
clinically O 1 0.9826357364654541
unaffected O 1 0.597517192363739
siblings O 0 0.062426310032606125
carried O 0 0.030149955302476883
the O 0 0.02769607864320278
maternal O 1 0.998392641544342
mutation O 1 0.9592150449752808
459 O 1 0.9999854564666748
+ O 1 0.9999709129333496
1G O 1 0.9999982118606567
> O 1 0.9699739217758179
A O 0 0.03585556522011757
and O 0 0.017516644671559334
, O 0 0.013540388084948063
on O 0 0.011114186607301235
their O 0 0.014274618588387966
paternal O 1 0.8478928208351135
allele O 0 0.05698626488447189
, O 0 0.02011062763631344
a O 0 0.024906981736421585
novel O 0 0.04670507833361626
cytosine O 0 0.07419857382774353
to O 0 0.027432987466454506
thymidine O 0 0.10527908056974411
transition O 0 0.04697761684656143
at O 0 0.0339495949447155
nucleotide O 0 0.056239284574985504
2435 O 1 0.9738744497299194
in O 0 0.025452742353081703
exon O 0 0.0897584781050682
8 O 0 0.03187108412384987
, O 0 0.018178164958953857
resulting O 0 0.018350079655647278
in O 0 0.014946172013878822
substitution O 0 0.037021148949861526
of O 0 0.03131229802966118
alanine O 1 0.9943300485610962
464 O 1 0.9982725381851196
by O 0 0.061899323016405106
valine O 1 0.999876856803894
( O 0 0.08274249732494354
A464V O 1 0.9984046816825867
) O 0 0.05032825842499733
. O 0 0.04621409997344017

The O 0 0.06914971768856049
fathers O 0 0.13253383338451385
genotype O 0 0.14716368913650513
thus O 0 0.04140416160225868
was O 0 0.07148810476064682
7delG O 1 0.9998642206192017
/ O 1 0.9997755885124207
A464V O 1 0.9961064457893372
. O 0 0.06995657831430435

Mutation O 0 0.4421778917312622
A464V O 1 0.9690185785293579
was O 0 0.036161214113235474
not O 0 0.012006467208266258
found O 0 0.011085527949035168
in O 0 0.012997143901884556
18 O 0 0.03793942555785179
unrelated O 1 0.9989941716194153
MLD B-Disease 1 1.0
patients O 1 0.9999707937240601
and O 0 0.04073621705174446
50 O 0 0.052302613854408264
controls O 0 0.07684587687253952
. O 0 0.04617549479007721

A464V O 1 0.8439149260520935
, O 0 0.034870248287916183
although O 0 0.02151540294289589
clearly O 0 0.032850299030542374
modifying O 0 0.13191555440425873
ARSA O 1 0.9999980926513672
and O 1 0.840492844581604
GS O 1 1.0
levels O 0 0.05862986296415329
, O 0 0.02322390303015709
apparently O 0 0.024726353585720062
bears O 0 0.02249867096543312
little O 0 0.019406814128160477
significance O 0 0.021330777555704117
for O 0 0.015969466418027878
clinical O 1 0.938622772693634
manifestation O 1 0.9999908208847046
of O 1 0.9970269799232483
MLD B-Disease 1 1.0
, O 0 0.05191601812839508
mimicking O 1 0.6252452731132507
the O 0 0.041882313787937164
frequent O 1 0.880907416343689
ARSA O 1 0.9999984502792358
pseudodeficiency O 1 0.999944806098938
allele O 0 0.3263634443283081
. O 0 0.062042076140642166

Our O 0 0.05137990787625313
results O 0 0.02563958428800106
demonstrate O 0 0.02635660022497177
that O 0 0.008648844435811043
in O 0 0.009302904829382896
certain O 0 0.014125959947705269
genetic O 0 0.026997247710824013
conditions O 1 0.7567294836044312
MLD B-Disease 1 1.0
- O 1 0.9999997615814209
like O 1 0.7195045948028564
ARSA O 1 0.9999997615814209
and O 0 0.3844766318798065
GS O 1 0.9999996423721313
values O 0 0.028122449293732643
need O 0 0.016681542620062828
not O 0 0.008565613068640232
be O 0 0.008779860101640224
paralleled O 0 0.0401836559176445
by O 0 0.029541559517383575
clinical O 1 0.9999967813491821
disease O 1 0.9999996423721313
, O 0 0.03018398955464363
a O 0 0.02728436514735222
finding O 0 0.03272445127367973
with O 0 0.027574662119150162
serious O 1 0.9998345375061035
diagnostic O 1 0.9999573230743408
and O 1 0.7213714718818665
prognostic O 1 0.9999986886978149
implications O 1 0.9890822172164917
. O 0 0.0639018565416336

Moreover O 0 0.0764603316783905
, O 0 0.03648419678211212
further O 0 0.043471381068229675
ARSA O 1 0.9999560117721558
alleles O 0 0.11827234923839569
functionally O 0 0.08058103919029236
similar O 0 0.021590786054730415
to O 0 0.026535790413618088
A464V O 1 0.99885094165802
might O 0 0.02044263295829296
exist O 0 0.01144199725240469
which O 0 0.007998809218406677
, O 0 0.008503522723913193
together O 0 0.009135766886174679
with O 0 0.012331982143223286
0 O 0 0.06496471911668777
- O 1 0.9999918937683105
type O 1 0.636135458946228
mutations O 0 0.026726707816123962
, O 0 0.016458826139569283
may O 0 0.020543893799185753
cause O 1 0.8723369836807251
pathological O 1 0.9999945163726807
ARSA O 1 1.0
and O 1 0.9991050362586975
GS O 1 1.0
levels O 0 0.04194672778248787
, O 0 0.016036052256822586
but O 0 0.010630711913108826
not O 0 0.011550715193152428
clinical O 1 0.6675037741661072
outbreak O 1 0.999481737613678
of O 1 0.6777923703193665
the O 1 0.9997677206993103
disease O 1 1.0
. O 0 0.06006034463644028
. O 0 0.04457417130470276

Human O 1 0.9493283629417419
MLH1 O 1 0.9999991655349731
deficiency O 1 1.0
predisposes O 1 0.9999881982803345
to O 1 0.9512665271759033
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 1 0.9999765157699585
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999110698699951
1 I-Disease 0 0.08923497796058655
. O 0 0.05142688378691673

Heterozygous O 1 0.645409107208252
germ O 1 0.9999833106994629
- O 1 0.999890923500061
line O 0 0.04867548868060112
mutations O 0 0.02582019753754139
in O 0 0.011446711607277393
the O 0 0.021291304379701614
DNA O 0 0.04123659431934357
mismatch O 1 0.998936116695404
repair O 1 0.9822010397911072
genes O 0 0.023344876244664192
lead O 0 0.03282064571976662
to O 0 0.03869955986738205
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.991033136844635

The O 1 0.8702141642570496
disease O 1 0.999998927116394
susceptibility O 1 0.9997912049293518
of O 0 0.09683431684970856
individuals O 0 0.03565249219536781
who O 0 0.05871465057134628
constitutionally O 1 0.7093770503997803
lack O 0 0.030340073630213737
both O 0 0.01936968043446541
wild O 0 0.07832753658294678
- O 1 0.9999953508377075
type O 1 0.930743396282196
alleles O 0 0.06271278113126755
is O 0 0.029065480455756187
unknown O 0 0.04417961463332176
. O 0 0.037154119461774826

We O 0 0.024447565898299217
have O 0 0.01032065786421299
identified O 0 0.014015113934874535
three O 0 0.009256483986973763
offspring O 0 0.023475924506783485
in O 0 0.011380143463611603
a O 0 0.03018740564584732
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999862909317017
who O 1 0.9981095790863037
developed O 1 0.9982917904853821
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 0.39804527163505554
a O 0 0.024460218846797943
very O 0 0.013935331255197525
early O 0 0.018039539456367493
age O 0 0.02714061178267002
, O 0 0.01422435138374567
and O 0 0.010905037634074688
at O 0 0.012675991281867027
least O 0 0.007222547195851803
two O 0 0.006018017418682575
of O 0 0.009780199266970158
them O 0 0.009753967635333538
displayed O 0 0.021695394068956375
signs O 0 0.034396663308143616
of O 0 0.2624342739582062
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9998816251754761
1 I-Disease 1 0.63361656665802
( O 0 0.06405360996723175
NF1 B-Disease 1 0.9998863935470581
) O 0 0.04141323268413544
. O 0 0.04069671034812927

DNA O 0 0.04745127633213997
sequence O 0 0.020580722019076347
analysis O 0 0.014688278548419476
and O 0 0.019556714221835136
allele O 0 0.06624194234609604
- O 1 0.9781268835067749
specific O 0 0.01881576143205166
amplification O 0 0.03774968907237053
in O 0 0.010198536328971386
two O 0 0.011039596050977707
siblings O 0 0.03777351975440979
revealed O 0 0.025426646694540977
a O 0 0.026479285210371017
homozygous O 0 0.10139666497707367
MLH1 O 1 0.9999769926071167
mutation O 0 0.2393752783536911
( O 0 0.04394349455833435
C676T O 1 0.9999362230300903
- O 1 0.9999994039535522
- O 1 0.9999983310699463
> O 1 0.9991624355316162
Arg226Stop O 1 0.999206006526947
) O 0 0.04379739612340927
. O 0 0.038984265178442

Thus O 0 0.03909805789589882
, O 0 0.022321324795484543
a O 0 0.029696211218833923
homozygous O 0 0.10297825187444687
germ O 1 0.9999513626098633
- O 1 0.9999589920043945
line O 0 0.1312437355518341
MLH1 O 1 0.9999661445617676
mutation O 0 0.061083775013685226
and O 0 0.0348992720246315
consequent O 1 0.999996542930603
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.026860717684030533
in O 0 0.01774999499320984
a O 0 0.03808514401316643
mutator O 1 0.9999910593032837
phenotype O 1 0.9734954237937927
characterized O 0 0.22493858635425568
by O 0 0.12160523980855942
leukemia B-Disease 1 1.0
and O 1 0.9997274279594421
/ O 1 1.0
or O 1 0.9998856782913208
lymphoma B-Disease 1 1.0
associated O 1 0.9850244522094727
with O 1 0.9988276362419128
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9995830655097961
1 I-Disease 0 0.05970025807619095
. O 0 0.02958686463534832
. O 0 0.03415260836482048

Missense O 1 0.7857244610786438
mutations O 0 0.04558254033327103
in O 0 0.015388544648885727
the O 0 0.016308709979057312
most O 0 0.013605493120849133
ancient O 0 0.02063894085586071
residues O 0 0.0253510270267725
of O 0 0.018763376399874687
the O 0 0.035016488283872604
PAX6 O 1 0.9999992847442627
paired O 1 0.681515097618103
domain O 0 0.043956831097602844
underlie O 0 0.07440434396266937
a O 0 0.025437766686081886
spectrum O 0 0.04482296481728554
of O 1 0.6029317378997803
human O 1 0.9999983310699463
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9941429495811462

Mutations O 0 0.049103785306215286
of O 0 0.021198924630880356
the O 0 0.02589181624352932
human O 0 0.05346211791038513
PAX6 O 1 0.9999985694885254
gene O 1 0.7240909934043884
underlie O 1 0.999983549118042
aniridia B-Disease 1 1.0
( O 1 0.9997262358665466
congenital B-Disease 1 1.0
absence I-Disease 1 0.9984356760978699
of I-Disease 1 0.6950996518135071
the I-Disease 1 0.9951685667037964
iris I-Disease 1 0.9999985694885254
) O 0 0.020455852150917053
, O 0 0.014487484470009804
a O 0 0.01867740973830223
rare O 0 0.043878618627786636
dominant O 1 0.9996341466903687
malformation B-Disease 1 0.9999996423721313
of I-Disease 1 0.7624224424362183
the I-Disease 1 0.9816727638244629
eye I-Disease 1 0.9999904632568359
. O 0 0.060293205082416534

The O 0 0.04406706616282463
spectrum O 0 0.05971869081258774
of O 0 0.044943977147340775
PAX6 O 1 0.999998927116394
mutations O 0 0.2926863133907318
in O 0 0.040020667016506195
aniridia B-Disease 1 1.0
patients O 1 0.9999903440475464
is O 0 0.027266673743724823
highly O 0 0.03435828536748886
biased O 0 0.03709525614976883
, O 0 0.01339785847812891
with O 0 0.011432094499468803
92 O 0 0.0363781675696373
% O 0 0.013974443078041077
of O 0 0.01251336932182312
all O 0 0.012047000229358673
reported O 0 0.020606793463230133
mutations O 0 0.022367266938090324
leading O 0 0.026419062167406082
to O 0 0.018144996836781502
premature O 1 0.8830151557922363
truncation O 0 0.0867295190691948
of O 0 0.020549219101667404
the O 0 0.03300144895911217
protein O 0 0.03147902339696884
( O 0 0.02046053484082222
nonsense O 0 0.0538255013525486
, O 0 0.02220744453370571
splicing O 0 0.03724358230829239
, O 0 0.018771909177303314
insertions O 0 0.06473932415246964
and O 0 0.0240443367511034
deletions O 0 0.14342957735061646
) O 0 0.01945706643164158
and O 0 0.013362922705709934
just O 0 0.016996212303638458
2 O 0 0.01974920928478241
% O 0 0.014623844996094704
leading O 0 0.021548015996813774
to O 0 0.013885856606066227
substitution O 0 0.025603968650102615
of O 0 0.01491221971809864
one O 0 0.018866054713726044
amino O 0 0.029932115226984024
acid O 0 0.03417474403977394
by O 0 0.01873662695288658
another O 0 0.03519807010889053
( O 0 0.04091426357626915
missense O 1 0.6157084703445435
) O 0 0.03944288194179535
. O 0 0.038467295467853546

The O 0 0.04125596210360527
extraordinary O 0 0.046617403626441956
conservation O 0 0.03763183206319809
of O 0 0.023083176463842392
the O 0 0.037089213728904724
PAX6 O 1 0.9999984502792358
protein O 0 0.03300873935222626
at O 0 0.019587920978665352
the O 0 0.022251227870583534
amino O 0 0.0333036370575428
acid O 0 0.03970954939723015
level O 0 0.02553148753941059
amongst O 0 0.03891328349709511
vertebrates O 0 0.053988438099622726
predicts O 0 0.05486605688929558
that O 0 0.017192460596561432
pathological O 1 0.9977098703384399
missense O 1 0.9959222078323364
mutations O 0 0.033515844494104385
should O 0 0.013926436193287373
in O 0 0.01180714275687933
fact O 0 0.014261110685765743
be O 0 0.010196158662438393
common O 0 0.0137599753215909
even O 0 0.010482520796358585
though O 0 0.010276470333337784
they O 0 0.007027336861938238
are O 0 0.006656250450760126
hardly O 0 0.024215923622250557
ever O 0 0.022785482928156853
seen O 0 0.028229176998138428
in O 0 0.03367776796221733
aniridia B-Disease 1 0.9999960660934448
patients O 1 0.9996647834777832
. O 0 0.061085134744644165

This O 0 0.029962021857500076
indicates O 0 0.03356001526117325
that O 0 0.011169043369591236
there O 0 0.01097362395375967
is O 0 0.013635610230267048
a O 0 0.022433117032051086
heavy O 0 0.341884970664978
ascertainment O 1 0.9999244213104248
bias O 0 0.05366683006286621
in O 0 0.013129904866218567
the O 0 0.015652505680918694
selection O 0 0.022709283977746964
of O 0 0.023279402405023575
patients O 1 0.9990800619125366
for O 0 0.3895576000213623
PAX6 O 1 1.0
mutation O 1 0.576368510723114
analysis O 0 0.015426324680447578
and O 0 0.011118956841528416
that O 0 0.008849415928125381
the O 0 0.02012508176267147
missing O 0 0.05837195739150047
PAX6 O 1 0.9999872446060181
missense O 1 0.9950507283210754
mutations O 0 0.06675989925861359
frequently O 0 0.03696989640593529
may O 0 0.03305169567465782
underlie O 1 0.9313222765922546
phenotypes O 0 0.13804008066654205
distinct O 0 0.03835621103644371
from O 0 0.043146368116140366
textbook O 1 0.9994145631790161
aniridia B-Disease 1 0.9999819993972778
. O 0 0.08071217685937881

Here O 0 0.037733323872089386
we O 0 0.016391880810260773
present O 0 0.018539195880293846
four O 0 0.022017819806933403
novel O 0 0.07616276293992996
PAX6 O 1 0.9999947547912598
missense O 1 0.9970518350601196
mutations O 0 0.042664140462875366
, O 0 0.01627568155527115
two O 0 0.009956694208085537
in O 0 0.011963228695094585
association O 0 0.02423679456114769
with O 0 0.024443229660391808
atypical O 1 0.9999886751174927
phenotypes O 1 0.9999350309371948
ectopia B-Disease 1 0.999997615814209
pupillae I-Disease 1 0.9999969005584717
( O 0 0.04450660198926926
displaced B-Disease 1 0.822678804397583
pupils I-Disease 1 0.9913791418075562
) O 0 0.04228774458169937
and O 1 0.9425989985466003
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 1 0.9474426507949829
searching B-Disease 1 0.9398553967475891
gaze I-Disease 1 0.9997996687889099
) O 0 0.020873574540019035
, O 0 0.013413367792963982
and O 0 0.010055405087769032
two O 0 0.008520725183188915
in O 0 0.011708812788128853
association O 0 0.020958703011274338
with O 0 0.015341171063482761
more O 0 0.019619103521108627
recognizable O 1 0.9948615431785583
aniridia B-Disease 1 0.9999905824661255
phenotypes O 1 0.9829915165901184
. O 0 0.05837468057870865

Strikingly O 0 0.10370954126119614
, O 0 0.027059823274612427
all O 0 0.014207765460014343
four O 0 0.01904163509607315
mutations O 0 0.022655431181192398
are O 0 0.007355095352977514
located O 0 0.018537990748882294
within O 0 0.014342657290399075
the O 0 0.02946419082581997
PAX6 O 1 0.9999967813491821
paired O 0 0.4475727081298828
domain O 0 0.04072234779596329
and O 0 0.020314494147896767
affect O 0 0.02905532345175743
amino O 0 0.031155409291386604
acids O 0 0.020462971180677414
which O 0 0.009150250814855099
are O 0 0.00673489598557353
highly O 0 0.018808895722031593
conserved O 0 0.019908366724848747
in O 0 0.010338022373616695
all O 0 0.01487609650939703
known O 0 0.037080828100442886
paired O 0 0.35943591594696045
domain O 0 0.05982111021876335
proteins O 0 0.041326530277729034
. O 0 0.03716479614377022

Our O 0 0.043820325285196304
results O 0 0.020299134775996208
support O 0 0.02275734581053257
the O 0 0.01803470030426979
hypothesis O 0 0.024698147550225258
that O 0 0.00762876495718956
the O 0 0.012704961933195591
under O 0 0.021195057779550552
- O 1 0.6894350051879883
representation O 0 0.019931351765990257
of O 0 0.023432860150933266
missense O 1 0.9931754469871521
mutations O 0 0.0400201715528965
is O 0 0.020397277548909187
caused O 0 0.04344768822193146
by O 0 0.03332964703440666
ascertainment O 1 0.9999991655349731
bias O 1 0.9788358807563782
and O 0 0.020723463967442513
suggest O 0 0.015665730461478233
that O 0 0.0071192542091012
a O 0 0.012175009585916996
substantial O 0 0.017249146476387978
burden O 1 0.736103355884552
of O 1 0.9405965805053711
PAX6 B-Disease 1 1.0
- I-Disease 1 1.0
related I-Disease 1 0.9998917579650879
disease I-Disease 1 0.9999997615814209
remains O 1 0.9573522806167603
to O 0 0.0228132214397192
be O 0 0.017978867515921593
uncovered O 0 0.04934441298246384
. O 0 0.02338501438498497
. O 0 0.032200299203395844

The O 0 0.058086808770895004
chromosomal O 0 0.09385711699724197
order O 0 0.028981812298297882
of O 0 0.024754799902439117
genes O 0 0.023961801081895828
controlling O 0 0.04095675051212311
the O 0 0.028005460277199745
major O 1 0.9302096366882324
histocompatibility O 1 0.9999998807907104
complex O 0 0.19535832107067108
, O 0 0.0292816124856472
properdin O 1 0.9999326467514038
factor O 1 0.9965938925743103
B O 1 0.999988317489624
, O 0 0.033021826297044754
and O 0 0.09558635205030441
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.029470372945070267
the I-Disease 0 0.0567353181540966
second I-Disease 1 0.6449712514877319
component I-Disease 0 0.35542717576026917
of I-Disease 0 0.03569677472114563
complement I-Disease 0 0.09534981101751328
. O 0 0.049177031964063644

The O 0 0.0443011038005352
relationship O 0 0.03674595057964325
of O 0 0.022915193811058998
the O 0 0.02852417714893818
genes O 0 0.029724180698394775
coding O 0 0.044650085270404816
for O 0 0.027049768716096878
HLA O 1 0.999987006187439
to O 0 0.023171482607722282
those O 0 0.015774015337228775
coding O 0 0.033526331186294556
for O 0 0.019405009225010872
properdin O 1 0.9931500554084778
Factor O 0 0.475835382938385
B O 1 0.9990110397338867
allotypes O 1 0.9933159947395325
and O 0 0.025783244520425797
for O 0 0.03439360484480858
deficiency B-Disease 1 0.9999997615814209
of I-Disease 0 0.021465081721544266
the I-Disease 0 0.022361449897289276
second I-Disease 0 0.039210256189107895
component I-Disease 0 0.11018753796815872
of I-Disease 0 0.024051573127508163
complement I-Disease 1 0.9955859184265137
( O 1 0.8259679079055786
C2 O 1 0.9999996423721313
) O 0 0.017673572525382042
was O 0 0.01722782664000988
studied O 0 0.013506279326975346
in O 0 0.009282776154577732
families O 0 0.015319159254431725
of O 0 0.026795679703354836
patients O 1 0.9999797344207764
with O 1 0.9999673366546631
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9972150325775146

Patients O 1 0.990695595741272
were O 0 0.022138938307762146
selected O 0 0.025890769436955452
because O 0 0.015209225937724113
they O 0 0.00913231074810028
were O 0 0.012241481803357601
heterozygous O 0 0.04531213641166687
or O 0 0.027703573927283287
homozygous O 1 0.7535654306411743
for O 1 0.9839670062065125
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.8932359218597412

12 O 0 0.0459340363740921
families O 0 0.031239913776516914
with O 0 0.020487472414970398
15 O 0 0.03378035128116608
matings O 0 0.23654676973819733
informative O 0 0.2895854711532593
for O 1 0.9959638118743896
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.05797827988862991
found O 0 0.038939133286476135
. O 0 0.046303439885377884

Of O 0 0.05926236882805824
57 O 0 0.09631875157356262
informative O 0 0.1056431457400322
meioses O 1 0.9546940326690674
, O 0 0.02379355952143669
two O 0 0.01416380051523447
crossovers O 0 0.04043453186750412
were O 0 0.009250140748918056
noted O 0 0.014595890417695045
between O 0 0.018417291343212128
the O 1 0.727595865726471
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.04609634727239609
and O 0 0.02099144458770752
the O 0 0.25504380464553833
HLA O 1 1.0
- O 1 0.9999998807907104
B O 1 0.9999377727508545
gene O 0 0.023347312584519386
, O 0 0.011252261698246002
with O 0 0.010969623923301697
a O 0 0.02252042666077614
recombinant O 0 0.0626518577337265
fraction O 0 0.03831982985138893
of O 0 0.03259943425655365
0 O 0 0.06438668072223663
. O 0 0.04472782835364342

035 O 1 0.9645637273788452
. O 0 0.10555756837129593

A O 0 0.10097625851631165
lod O 1 0.9409140348434448
score O 0 0.03233210742473602
of O 0 0.02177398093044758
13 O 0 0.023640310391783714
was O 0 0.021071571856737137
calculated O 0 0.01775740273296833
for O 0 0.01412024162709713
linkage O 0 0.11068448424339294
between O 1 0.5707271695137024
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.999994158744812
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999171495437622
at O 0 0.021571911871433258
a O 0 0.018611887469887733
maximum O 0 0.021464956924319267
likelihood O 0 0.02257854864001274
value O 0 0.011145474389195442
of O 0 0.012978947721421719
the O 0 0.021263739094138145
recombinant O 0 0.060366250574588776
fraction O 0 0.038704656064510345
of O 0 0.033736225217580795
0 O 0 0.06468559056520462
. O 0 0.04661184921860695

04 O 1 0.956927478313446
. O 0 0.09730934351682663

18 O 0 0.051299527287483215
families O 0 0.03527005389332771
with O 0 0.023814454674720764
21 O 0 0.04135272279381752
informative O 0 0.05680127069354057
matings O 0 0.07448115944862366
for O 0 0.01968618482351303
both O 0 0.01969650201499462
properdin O 1 0.9819507598876953
Factor O 0 0.23692922294139862
B O 1 0.9989118576049805
allotype O 1 0.999559223651886
and O 1 0.7470040917396545
HLA O 1 1.0
- O 1 0.9999998807907104
B O 1 0.9999217987060547
were O 0 0.022240815684199333
found O 0 0.023202115669846535
. O 0 0.031439218670129776

Of O 0 0.056800588965415955
72 O 0 0.09116476774215698
informative O 0 0.08999605476856232
meioses O 1 0.9000678658485413
, O 0 0.025965506210923195
three O 0 0.02002943493425846
recombinants O 1 0.9619255065917969
were O 0 0.015174156986176968
found O 0 0.012893500737845898
, O 0 0.01254605408757925
giving O 0 0.018752044066786766
a O 0 0.023224562406539917
recombinant O 0 0.06244039908051491
fraction O 0 0.04011901840567589
of O 0 0.03488301485776901
0 O 0 0.06858789920806885
. O 0 0.04909493774175644

042 O 1 0.8620619177818298
. O 0 0.10800222307443619

A O 0 0.08416340500116348
lod O 1 0.6321407556533813
score O 0 0.02595660835504532
of O 0 0.018628058955073357
16 O 0 0.027260301634669304
between O 0 0.03577137738466263
HLA O 1 1.0
- O 1 0.9999990463256836
B O 1 0.9997327923774719
and O 0 0.027136635035276413
Factor O 1 0.9529617428779602
B O 1 0.999947190284729
allotypes O 1 0.9986670017242432
was O 0 0.0288524366915226
calculated O 0 0.018924888223409653
at O 0 0.014235547743737698
a O 0 0.01584494486451149
maximum O 0 0.018812963739037514
likelihood O 0 0.02292361855506897
value O 0 0.009803885594010353
of O 0 0.012981091625988483
the O 0 0.02045377530157566
recombinant O 0 0.06153646111488342
fraction O 0 0.03903058171272278
of O 0 0.03252056613564491
0 O 0 0.06434875726699829
. O 0 0.04368002340197563

04 O 1 0.8624839782714844
. O 0 0.09559579193592072

A O 0 0.0832730308175087
crossover O 0 0.12605255842208862
was O 0 0.03658146783709526
shown O 0 0.018787596374750137
to O 0 0.01259947381913662
have O 0 0.008355229161679745
occurred O 0 0.015352237969636917
between O 0 0.01229917537420988
genes O 0 0.011703666299581528
for O 0 0.012245697900652885
Factor O 0 0.0396193265914917
B O 1 0.9968382120132446
and O 0 0.10365532338619232
HLA O 1 1.0
- O 1 0.9999996423721313
D O 1 0.999708354473114
, O 0 0.013784612528979778
in O 0 0.010316149331629276
which O 0 0.017580803483724594
HLA O 1 0.9999998807907104
- O 1 0.9999954700469971
D O 1 0.9998185038566589
segregared O 1 0.9945494532585144
with O 0 0.06621197611093521
HLA O 1 1.0
- O 1 0.999993085861206
A O 0 0.19378580152988434
and O 0 0.04064835608005524
B O 1 0.9967209696769714
. O 0 0.050802767276763916

These O 0 0.025832241401076317
studies O 0 0.020978061482310295
suggest O 0 0.014255496673285961
that O 0 0.00740475207567215
the O 0 0.011496162973344326
genes O 0 0.01206170953810215
for O 0 0.013787556439638138
Factor O 1 0.8130806684494019
B O 1 0.9999984502792358
and O 1 0.999864935874939
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.017242293804883957
located O 0 0.029082968831062317
outside O 0 0.019698090851306915
those O 0 0.01228525210171938
for O 0 0.024048402905464172
HLA O 1 0.9999998807907104
, O 0 0.015582243911921978
that O 0 0.0067666321992874146
the O 0 0.009153265506029129
order O 0 0.01124708354473114
of O 0 0.015758277848362923
genese O 1 0.9998286962509155
is O 0 0.047886740416288376
HLA O 1 1.0
- O 1 0.9996615648269653
A O 0 0.02944675087928772
, O 0 0.02046017162501812
- O 1 0.9994868040084839
B O 1 0.9975583553314209
, O 0 0.024165520444512367
- O 1 0.9999243021011353
D O 1 0.9959111213684082
, O 0 0.018575696274638176
Factor O 0 0.046654652804136276
B O 1 0.9997552037239075
allotype O 1 0.9999973773956299
, O 1 0.9998732805252075
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.02444903552532196
that O 0 0.00968394335359335
the O 0 0.014715638943016529
genes O 0 0.018793361261487007
coding O 0 0.04168226197361946
for O 0 0.21507540345191956
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9803615808486938
Factor O 1 0.9999687671661377
B O 1 0.9999656677246094
allotypes O 1 0.9406255483627319
are O 0 0.007648230064660311
approximately O 0 0.01279426459223032
3 O 0 0.026067759841680527
- O 1 0.9979174733161926
- O 1 0.9296228289604187
5 O 0 0.020639954134821892
centimorgans O 0 0.053021982312202454
from O 0 0.011776178143918514
the O 0 0.024469904601573944
HLA O 1 0.9999998807907104
- O 1 0.9994126558303833
A O 0 0.044141314923763275
and O 0 0.20374250411987305
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999979734420776
loci O 0 0.2536494731903076
, O 0 0.0162865798920393
and O 0 0.010994820855557919
that O 0 0.007994133047759533
the O 0 0.014026951044797897
apparent O 0 0.03642791137099266
lack O 0 0.02369210682809353
of O 0 0.02024342305958271
recombinants O 1 0.9877611398696899
between O 0 0.016046153381466866
the O 0 0.018843062222003937
Factor O 0 0.27260294556617737
B O 1 0.9996852874755859
gene O 0 0.05517243593931198
and O 1 0.989884614944458
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 1 0.9621280431747437
suggests O 0 0.02685043402016163
that O 0 0.009828217327594757
these O 0 0.007416796870529652
two O 0 0.011711743660271168
genes O 0 0.01835724525153637
lie O 0 0.030818305909633636
in O 0 0.014451193623244762
close O 0 0.022888625040650368
proximity O 0 0.03473523259162903
to O 0 0.01743210107088089
one O 0 0.023079263046383858
another O 0 0.03842909261584282
. O 0 0.03920505940914154

Distribution O 0 0.05245920643210411
of O 0 0.04334135726094246
emerin O 1 0.9979448914527893
and O 0 0.03774723783135414
lamins O 1 0.9980226755142212
in O 0 0.02259763516485691
the O 0 0.03133923187851906
heart O 1 0.9999263286590576
and O 0 0.02239045314490795
implications O 0 0.03515290468931198
for O 0 0.0263065192848444
Emery B-Disease 1 0.9999985694885254
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.8659862875938416

Emerin O 1 0.9227177500724792
is O 0 0.030809076502919197
a O 0 0.03419417887926102
nuclear O 0 0.05958905443549156
membrane O 0 0.2822132110595703
protein O 0 0.02188909985125065
which O 0 0.009934879839420319
is O 0 0.011168873868882656
missing O 0 0.020806297659873962
or O 0 0.014326710253953934
defective O 0 0.149863600730896
in O 0 0.02202076092362404
Emery B-Disease 1 0.9999849796295166
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999947190284729
EDMD B-Disease 1 0.9999998807907104
) O 0 0.06242584064602852
. O 0 0.04739715903997421

It O 0 0.02323136106133461
is O 0 0.014959460124373436
one O 0 0.01125988271087408
member O 0 0.016917536035180092
of O 0 0.01184849813580513
a O 0 0.016928112134337425
family O 0 0.02513064071536064
of O 0 0.055971480906009674
lamina O 1 1.0
- O 1 0.9999991655349731
associated O 0 0.025420313701033592
proteins O 0 0.016220614314079285
which O 0 0.009668363258242607
includes O 0 0.020170873031020164
LAP1 O 1 0.999233603477478
, O 0 0.030487772077322006
LAP2 O 1 0.9997119307518005
and O 0 0.050329193472862244
lamin O 1 0.9999991655349731
B O 1 0.9999990463256836
receptor O 1 0.9998102784156799
( O 0 0.08111180365085602
LBR O 1 0.9998143315315247
) O 0 0.05013914033770561
. O 0 0.04608190059661865

A O 0 0.05210363119840622
panel O 0 0.03902844712138176
of O 0 0.026155643165111542
16 O 0 0.052175894379615784
monoclonal O 1 0.9997661709785461
antibodies O 1 0.9998204112052917
( O 0 0.31919029355049133
mAbs O 1 0.9998424053192139
) O 0 0.02507649175822735
has O 0 0.014596788212656975
been O 0 0.014138082042336464
mapped O 0 0.02470031939446926
to O 0 0.01108920481055975
six O 0 0.013187169097363949
specific O 0 0.008962067775428295
sites O 0 0.012798373587429523
throughout O 0 0.01169438287615776
the O 0 0.019576964899897575
emerin O 1 0.9487547874450684
molecule O 0 0.03900040313601494
using O 0 0.01939469389617443
phage O 1 0.9993712306022644
- O 1 0.9996792078018188
displayed O 0 0.046174682676792145
peptide O 0 0.05812538042664528
libraries O 0 0.025801025331020355
and O 0 0.016088640317320824
has O 0 0.01427102368324995
been O 0 0.012419270351529121
used O 0 0.009816331788897514
to O 0 0.017325617372989655
localize O 1 0.9116929173469543
emerin O 1 0.9857746362686157
in O 0 0.022634359076619148
human O 0 0.03424091637134552
and O 0 0.0619020015001297
rabbit O 1 0.9999845027923584
heart O 1 0.9999951124191284
. O 0 0.06344617158174515

Several O 0 0.04911210760474205
mAbs O 0 0.1715485006570816
against O 0 0.04220607504248619
different O 0 0.02268793433904648
emerin O 1 0.997775137424469
epitopes O 1 0.9394553303718567
did O 0 0.023404233157634735
not O 0 0.015520491637289524
recognize O 0 0.038215506821870804
intercalated O 1 0.9994150400161743
discs O 0 0.053854379802942276
in O 0 0.018784018233418465
the O 0 0.036104701459407806
heart O 1 0.9999730587005615
, O 0 0.018117915838956833
though O 0 0.012030668556690216
they O 0 0.008974019438028336
recognized O 0 0.028984561562538147
cardiomyocyte O 1 0.9999767541885376
nuclei O 0 0.17087599635124207
strongly O 0 0.024620437994599342
, O 0 0.013672632165253162
both O 0 0.01028341706842184
at O 0 0.01697959378361702
the O 0 0.021156849339604378
rim O 0 0.4288228154182434
and O 0 0.018125873059034348
in O 0 0.02273014560341835
intranuclear O 1 0.9999293088912964
spots O 0 0.26370251178741455
or O 0 0.030896028503775597
channels O 0 0.040271081030368805
. O 0 0.03869713842868805

A O 0 0.1498355269432068
polyclonal O 1 0.9985297918319702
rabbit O 1 0.9936779141426086
antiserum O 1 0.9884175658226013
against O 0 0.07900065183639526
emerin O 1 0.9989879727363586
did O 0 0.026474548503756523
recognize O 0 0.030918071046471596
both O 0 0.019923048093914986
nuclear O 0 0.052798014134168625
membrane O 0 0.08650024980306625
and O 0 0.029876170679926872
intercalated O 1 0.9982168078422546
discs O 0 0.05203980207443237
but O 0 0.014660457149147987
, O 0 0.014830115251243114
after O 0 0.022983331233263016
affinity O 0 0.04077012091875076
purification O 0 0.3236316442489624
against O 0 0.024086643010377884
a O 0 0.028539180755615234
pure O 1 0.7457137107849121
- O 1 0.9999680519104004
emerin O 1 0.993415355682373
band O 0 0.036047741770744324
on O 0 0.015065119601786137
a O 0 0.017712878063321114
western O 0 0.028412088751792908
blot O 1 0.9447977542877197
, O 0 0.02304229699075222
it O 0 0.01643187738955021
stained O 1 0.9974145889282227
only O 0 0.017479969188570976
the O 0 0.030226927250623703
nuclear O 0 0.06446836143732071
membrane O 0 0.07975519448518753
. O 0 0.040292199701070786

These O 0 0.023339908570051193
results O 0 0.01806311309337616
would O 0 0.011964632198214531
not O 0 0.008963000029325485
be O 0 0.008097654208540916
expected O 0 0.014993761666119099
if O 0 0.018903765827417374
immunostaining O 1 0.9891140460968018
at O 0 0.04523036256432533
intercalated O 1 0.9998664855957031
discs O 0 0.05304389074444771
were O 0 0.012254595756530762
due O 0 0.013838988728821278
to O 0 0.011625467799603939
a O 0 0.013909146189689636
product O 0 0.01386368740350008
of O 0 0.012589915655553341
the O 0 0.025392908602952957
emerin O 1 0.9999797344207764
gene O 0 0.037493981420993805
and O 0 0.017519280314445496
, O 0 0.016253380104899406
therefore O 0 0.014102424494922161
, O 0 0.01215865183621645
cast O 0 0.01438637264072895
some O 0 0.007631249260157347
doubt O 0 0.017437150701880455
upon O 0 0.013483325019478798
the O 0 0.016964128240942955
hypothesis O 0 0.03708566352725029
that O 0 0.025556281208992004
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999994039535522
in O 1 0.6862406134605408
EDMD B-Disease 1 1.0
are O 0 0.015672944486141205
caused O 0 0.030371112748980522
by O 0 0.01880224607884884
absence O 0 0.08670302480459213
of O 0 0.05229450762271881
emerin O 1 0.9999842643737793
from O 0 0.06730546057224274
intercalated O 1 0.9998794794082642
discs O 0 0.23598477244377136
. O 0 0.05763592943549156

Although O 0 0.052256662398576736
emerin O 1 0.9324747323989868
was O 0 0.0350598469376564
abundant O 0 0.031806252896785736
in O 0 0.014377773739397526
the O 0 0.020723184570670128
membranes O 0 0.15408582985401154
of O 0 0.036478620022535324
cardiomyocyte O 1 0.9999972581863403
nuclei O 1 0.9361018538475037
, O 0 0.01730506308376789
it O 0 0.009300618432462215
was O 0 0.018242232501506805
absent O 0 0.024135276675224304
from O 0 0.009802141226828098
many O 0 0.01119876280426979
non O 1 0.9827422499656677
- O 1 0.9999995231628418
myocyte O 1 0.9999985694885254
cells O 0 0.046695124357938766
in O 0 0.022724971175193787
the O 0 0.043682049959897995
heart O 1 0.999870777130127
. O 0 0.057924073189496994

This O 0 0.022913243621587753
distribution O 0 0.02423769421875477
of O 0 0.025356845930218697
emerin O 1 0.999157190322876
was O 0 0.027235211804509163
similar O 0 0.010742897167801857
to O 0 0.009893834590911865
that O 0 0.008192705921828747
of O 0 0.017268653959035873
lamin O 1 0.9998829364776611
A O 0 0.03652476519346237
, O 0 0.01514490321278572
a O 0 0.017816735431551933
candidate O 0 0.026636658236384392
gene O 0 0.01749475672841072
for O 0 0.011995755136013031
an O 0 0.021278016269207
autosomal O 1 0.9984387755393982
form O 0 0.04734904691576958
of O 1 0.9565910696983337
EDMD B-Disease 1 0.9999998807907104
. O 0 0.09795314073562622

In O 0 0.03692779690027237
contrast O 0 0.05460292845964432
, O 0 0.0533393956720829
lamin O 1 0.9999921321868896
B1 O 1 0.9999994039535522
was O 0 0.057324908673763275
absent O 0 0.0637308731675148
from O 0 0.028134137392044067
cardiomyocyte O 1 0.9985583424568176
nuclei O 0 0.0754307210445404
, O 0 0.020484430715441704
showing O 0 0.03103111870586872
that O 0 0.025993043556809425
lamin O 1 0.9999982118606567
B1 O 1 0.9999998807907104
is O 0 0.024771468713879585
not O 0 0.013614654541015625
essential O 0 0.021944735199213028
for O 0 0.015186009928584099
localization O 0 0.052342984825372696
of O 0 0.027025897055864334
emerin O 1 0.9651985168457031
to O 0 0.02691623754799366
the O 0 0.03680993244051933
nuclear O 0 0.181556835770607
lamina O 1 0.9998148083686829
. O 0 0.06231997162103653

Lamin O 1 0.9999947547912598
B1 O 1 0.9999985694885254
is O 0 0.036531828343868256
also O 0 0.018739379942417145
almost O 0 0.017942575737833977
completely O 0 0.03812645003199577
absent O 1 0.5232484936714172
from O 0 0.10346051305532455
skeletal O 1 0.9999992847442627
muscle O 1 0.999992847442627
nuclei O 1 0.9942418932914734
. O 0 0.06615713238716125

In O 0 0.060712460428476334
EDMD B-Disease 1 0.9998877048492432
, O 0 0.026810338720679283
the O 0 0.01891251467168331
additional O 0 0.015877077355980873
absence O 0 0.03368702903389931
of O 0 0.04194078966975212
lamin O 1 0.9999997615814209
B1 O 1 1.0
from O 1 0.6857807040214539
heart O 1 0.9999996423721313
and O 1 0.9985173344612122
skeletal O 1 1.0
muscle O 1 0.9999997615814209
nuclei O 1 0.9976363182067871
which O 0 0.020024247467517853
already O 0 0.024740062654018402
lack O 0 0.06335426867008209
emerin O 1 0.999880313873291
may O 0 0.019422199577093124
offer O 0 0.016782121732831
an O 0 0.012254380621016026
alternative O 0 0.018003609031438828
explanation O 0 0.017003925517201424
of O 0 0.01573275960981846
why O 0 0.024555960670113564
these O 0 0.013901052996516228
tissues O 1 0.6879276037216187
are O 0 0.013105078600347042
particularly O 0 0.03271738812327385
affected O 0 0.042648639529943466
. O 0 0.028720296919345856
. O 0 0.04035010561347008

Genetic O 0 0.06057170405983925
mapping O 0 0.03799857199192047
of O 0 0.02664921060204506
the O 0 0.04235045611858368
copper B-Disease 1 0.9991022348403931
toxicosis I-Disease 1 0.9999591112136841
locus O 0 0.4628811776638031
in O 0 0.03248688951134682
Bedlington O 1 0.998610258102417
terriers O 1 0.5952356457710266
to O 0 0.03315959870815277
dog O 1 0.9249467849731445
chromosome O 0 0.041579678654670715
10 O 0 0.015229236334562302
, O 0 0.011832780204713345
in O 0 0.009399695321917534
a O 0 0.017751241102814674
region O 0 0.029641617089509964
syntenic O 1 0.8542126417160034
to O 0 0.021234162151813507
human O 0 0.03054286725819111
chromosome O 0 0.05914103612303734
region O 0 0.06157057359814644
2p13 O 1 0.9999432563781738
- O 1 0.9999690055847168
p16 O 1 0.9754189848899841
. O 0 0.056970760226249695

Abnormal O 1 0.9999948740005493
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999910593032837
accumulation I-Disease 1 0.9998830556869507
is O 0 0.02046916075050831
recognized O 0 0.02119162492454052
as O 0 0.017281822860240936
an O 0 0.299064576625824
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.8067906498908997
man O 1 0.999957799911499
, O 0 0.4442967474460602
mouse O 1 0.9897347688674927
, O 0 0.04693814739584923
rat O 1 0.9995771050453186
and O 0 0.03509380668401718
dog O 1 0.5811465978622437
. O 0 0.0461813360452652

The O 0 0.04332634061574936
major O 0 0.0467306487262249
cause O 1 0.9898971319198608
of O 1 0.9997943043708801
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999997615814209
accumulation I-Disease 1 0.9999041557312012
in O 0 0.01779104396700859
man O 0 0.03496532514691353
is O 0 0.011779390275478363
a O 0 0.019656123593449593
dysfunctional O 1 0.9999130964279175
ATP7B O 1 0.9999980926513672
gene O 0 0.042193058878183365
, O 0 0.026219921186566353
causing O 1 0.9988188147544861
Wilson B-Disease 1 0.9999988079071045
disease I-Disease 1 1.0
( O 1 0.9996273517608643
WD B-Disease 1 0.9999997615814209
) O 0 0.05655008926987648
. O 0 0.04521103948354721

Mutations O 0 0.052642859518527985
in O 0 0.021005112677812576
the O 0 0.032206613570451736
ATP7B O 1 0.9999964237213135
genes O 0 0.024880023673176765
have O 0 0.009577303193509579
also O 0 0.010796691291034222
been O 0 0.012454374693334103
demonstrated O 0 0.022595517337322235
in O 0 0.020695067942142487
mouse O 0 0.1552894413471222
and O 0 0.04391155019402504
rat O 1 0.9974259734153748
. O 0 0.05622400715947151

The O 0 0.0753498375415802
ATP7B O 1 0.9999719858169556
gene O 0 0.04582986235618591
has O 0 0.018143298104405403
been O 0 0.014074712060391903
excluded O 0 0.02524377405643463
in O 0 0.009447957389056683
the O 0 0.013423656113445759
much O 0 0.01683683693408966
rarer O 1 0.9047375321388245
human O 0 0.1390068233013153
copper B-Disease 1 0.9999880790710449
overload I-Disease 1 0.9999998807907104
disease O 1 0.9999998807907104
non B-Disease 1 0.9999716281890869
- I-Disease 1 0.9999997615814209
Indian I-Disease 1 0.9982115030288696
childhood I-Disease 1 0.9999998807907104
cirrhosis I-Disease 1 1.0
, O 1 0.9686541557312012
indicating O 1 0.6744188070297241
genetic O 0 0.06669718772172928
heterogeneity O 1 0.928124189376831
. O 0 0.058084823191165924

By O 0 0.030371714383363724
investigating O 0 0.040268946439027786
the O 0 0.029687058180570602
common O 0 0.056596361100673676
autosomal O 1 0.9999934434890747
recessive O 1 0.9999998807907104
copper B-Disease 1 0.9999998807907104
toxicosis I-Disease 1 1.0
( O 1 0.9992148876190186
CT B-Disease 1 0.9999970197677612
) O 0 0.025589516386389732
in O 0 0.021907245740294456
Bedlington O 1 0.9998352527618408
terriers O 1 0.949265718460083
, O 0 0.019769370555877686
we O 0 0.0096179423853755
have O 0 0.006043886300176382
identified O 0 0.010114687494933605
a O 0 0.01188999880105257
new O 0 0.01748550683259964
locus O 0 0.05718294158577919
involved O 0 0.02590467594563961
in O 0 0.0557202585041523
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9945000410079956

We O 0 0.030370881780982018
examined O 0 0.03766465559601784
whether O 0 0.021208416670560837
the O 0 0.03344336152076721
WD B-Disease 1 0.999990701675415
gene O 0 0.06456441432237625
ATP7B O 1 0.9997268319129944
was O 0 0.0414615124464035
also O 0 0.024778736755251884
causative O 1 0.8365393877029419
for O 0 0.02340380847454071
CT B-Disease 1 0.9964544773101807
by O 0 0.016010506078600883
investigating O 0 0.023591015487909317
the O 0 0.02438771165907383
chromosomal O 1 0.9890461564064026
co O 1 0.9974077343940735
- O 1 0.999910831451416
localization O 0 0.12518389523029327
of O 0 0.03377199545502663
ATP7B O 1 0.9999778270721436
and O 0 0.03494151309132576
C04107 O 1 0.993470311164856
, O 0 0.021430348977446556
using O 0 0.01540500670671463
fluorescence O 0 0.04360170289874077
in O 0 0.024526026099920273
situ O 1 0.9894786477088928
hybridization O 0 0.07217373698949814
( O 0 0.03955035284161568
FISH O 0 0.05017215758562088
) O 0 0.03418878838419914
. O 0 0.036269962787628174

C04107 O 1 0.9343299865722656
is O 0 0.03591436892747879
an O 0 0.029933635145425797
anonymous O 0 0.06978148967027664
microsatellite O 1 0.9402816295623779
marker O 1 0.6561538577079773
closely O 0 0.041373711079359055
linked O 0 0.06255701184272766
to O 0 0.04552953317761421
CT B-Disease 1 0.9998169541358948
. O 0 0.06066957116127014

However O 0 0.04740282893180847
, O 0 0.05124364048242569
BAC O 1 0.999744713306427
clones O 1 0.7799153327941895
containing O 0 0.059250589460134506
ATP7B O 1 0.9991493225097656
and O 0 0.03676511347293854
C04107 O 0 0.43409624695777893
mapped O 0 0.038054488599300385
to O 0 0.016801686957478523
the O 0 0.026637829840183258
canine O 1 0.9997592568397522
chromosome O 0 0.08977749198675156
regions O 0 0.029477933421730995
CFA22q11 O 1 0.9997081160545349
and O 0 0.02987607568502426
CFA10q26 O 1 0.9999204874038696
, O 0 0.021011214703321457
respectively O 0 0.019955918192863464
, O 0 0.016340773552656174
demonstrating O 0 0.030799074098467827
that O 0 0.020233096554875374
WD B-Disease 1 0.9999980926513672
cannot O 0 0.026509756222367287
be O 0 0.01821100153028965
homologous O 0 0.06365198642015457
to O 0 0.04392857104539871
CT B-Disease 1 0.9996680021286011
. O 0 0.05674383044242859

The O 0 0.059859149158000946
copper O 0 0.4950622022151947
transport O 0 0.0643187165260315
genes O 0 0.04438956826925278
CTR1 O 1 0.9999645948410034
and O 0 0.032604724168777466
CTR2 O 1 0.9999040365219116
were O 0 0.014890560880303383
also O 0 0.013858185149729252
excluded O 0 0.026557669043540955
as O 0 0.01407053042203188
candidate O 0 0.026338139548897743
genes O 0 0.018786249682307243
for O 0 0.02221408300101757
CT B-Disease 1 0.9999516010284424
since O 0 0.018928198143839836
they O 0 0.008380008861422539
both O 0 0.011506056413054466
mapped O 0 0.035284604877233505
to O 0 0.028216347098350525
canine O 1 0.9997218251228333
chromosome O 0 0.1753026843070984
region O 0 0.07473219186067581
CFA11q22 O 1 0.9974992871284485
. O 0 0.06466873735189438

2 O 0 0.11416073888540268
- O 1 0.9932796359062195
22 O 0 0.07324165105819702
. O 0 0.05395586043596268

5 O 0 0.10972166061401367
. O 0 0.07422488927841187

A O 0 0.07332824915647507
transcribed O 0 0.05550698563456535
sequence O 0 0.019069943577051163
identified O 0 0.01619785465300083
from O 0 0.011275931261479855
the O 0 0.02175140380859375
C04107 O 1 0.9993947744369507
- O 1 0.9999544620513916
containing O 0 0.05558198317885399
BAC O 1 0.9998705387115479
was O 0 0.02880912460386753
found O 0 0.013330935500562191
to O 0 0.012428408488631248
be O 0 0.011023219674825668
homologous O 0 0.027637386694550514
to O 0 0.01321903895586729
a O 0 0.017350852489471436
gene O 0 0.01702023297548294
expressed O 0 0.013686091639101505
from O 0 0.012228579260408878
human O 0 0.024486886337399483
chromosome O 0 0.37214621901512146
2p13 O 1 0.9999773502349854
- O 1 0.9999979734420776
p16 O 1 0.9857386350631714
, O 0 0.021047253161668777
a O 0 0.021547701209783554
region O 0 0.02611732669174671
devoid O 0 0.0403994657099247
of O 0 0.019696880131959915
any O 0 0.02421463653445244
positional O 1 0.8205309510231018
candidate O 0 0.0714121013879776
genes O 0 0.03960079699754715
. O 0 0.03667721524834633

Molecular O 0 0.052026525139808655
analysis O 0 0.01746189594268799
of O 0 0.019505174830555916
the O 0 0.030529895797371864
APC B-Disease 1 0.9995438456535339
gene O 0 0.028432397171854973
in O 0 0.014292381703853607
205 O 0 0.05042276903986931
families O 0 0.025951746851205826
: O 0 0.02310657501220703
extended O 0 0.042237721383571625
genotype O 1 0.9991317391395569
- O 1 0.9999815225601196
phenotype O 1 0.8522617816925049
correlations O 0 0.060499437153339386
in O 0 0.029557939618825912
FAP B-Disease 1 0.9999998807907104
and O 0 0.017906539142131805
evidence O 0 0.011776837520301342
for O 0 0.00869991909712553
the O 0 0.010960635729134083
role O 0 0.02319392003118992
of O 0 0.02571066841483116
APC B-Disease 1 0.9999943971633911
amino O 0 0.03788825497031212
acid O 0 0.04648376256227493
changes O 0 0.024322673678398132
in O 1 0.9731847047805786
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 1 0.9512434601783752

BACKGROUND O 0 0.3666819930076599
/ O 1 0.9285951256752014
AIMS O 0 0.05708446353673935
The O 0 0.023360611870884895
development O 0 0.047054171562194824
of O 1 0.9999722242355347
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9655139446258545
a O 0 0.2978459596633911
variable O 0 0.02447427436709404
range O 0 0.014202884398400784
of O 0 0.019077498465776443
extracolonic O 1 0.9988113641738892
manifestations O 1 0.9990189075469971
in O 0 0.17122206091880798
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999996423721313
FAP B-Disease 1 1.0
) O 0 0.03277280926704407
is O 0 0.013264909386634827
the O 0 0.011531932279467583
result O 0 0.008661935105919838
of O 0 0.010303226299583912
the O 0 0.015573344193398952
dominant O 0 0.07981453835964203
inheritance O 1 0.8054934144020081
of O 1 0.9984663724899292
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9998936653137207
APC B-Disease 1 0.9999995231628418
) O 0 0.0490838959813118
gene O 0 0.05201750248670578
mutations O 0 0.049144044518470764
. O 0 0.040140558034181595

In O 0 0.027533380314707756
this O 0 0.017215004190802574
study O 0 0.019309015944600105
, O 0 0.016435783356428146
direct O 0 0.02144303359091282
mutation O 0 0.024838794022798538
analysis O 0 0.008750183507800102
of O 0 0.012503474950790405
the O 0 0.02570420503616333
APC B-Disease 1 0.9999822378158569
gene O 0 0.02970685437321663
was O 0 0.021706877276301384
performed O 0 0.02180890552699566
to O 0 0.0146171934902668
determine O 0 0.022695953026413918
genotype O 1 0.9763277173042297
- O 1 0.9995338916778564
phenotype O 0 0.06360079348087311
correlations O 0 0.03667496517300606
for O 0 0.015929576009511948
nine O 0 0.034573402255773544
extracolonic O 1 0.9999011754989624
manifestations O 1 0.9992687106132507
and O 0 0.01840188354253769
to O 0 0.01484987884759903
investigate O 0 0.03100487031042576
the O 0 0.020404702052474022
incidence O 1 0.9987689852714539
of O 0 0.04909898340702057
APC B-Disease 1 0.9999924898147583
mutations O 0 0.030546734109520912
in O 0 0.01920161582529545
non O 1 0.9998940229415894
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9335578083992004

METHODS O 0 0.048745445907115936
The O 0 0.04300859197974205
APC B-Disease 1 0.9999606609344482
gene O 0 0.03293246403336525
was O 0 0.02422887459397316
analysed O 0 0.02919241227209568
in O 0 0.013128559105098248
190 O 0 0.03874003142118454
unrelated O 0 0.042758580297231674
FAP B-Disease 1 0.9999810457229614
and O 0 0.020575789734721184
15 O 0 0.03058168850839138
non O 1 0.9995762705802917
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999990463256836
using O 0 0.049812376499176025
denaturing O 1 0.9999845027923584
gradient O 1 0.9998927116394043
gel O 1 0.9999589920043945
electrophoresis O 1 0.8683313727378845
, O 0 0.02296093851327896
the O 0 0.025296272709965706
protein O 0 0.03214037045836449
truncation O 0 0.07170254737138748
test O 0 0.03443321958184242
, O 0 0.02243945188820362
and O 0 0.02170080877840519
direct O 0 0.038625944405794144
sequencing O 0 0.05631723254919052
. O 0 0.042452819645404816

RESULTS O 0 0.0714714303612709
Chain O 0 0.12154694646596909
terminating O 0 0.10731440782546997
signals O 0 0.030857369303703308
were O 0 0.011211373843252659
only O 0 0.010458756238222122
identified O 0 0.01834874600172043
in O 0 0.014122557826340199
patients O 0 0.06581971794366837
belonging O 0 0.027527684345841408
to O 0 0.01790100708603859
the O 0 0.03850457817316055
FAP B-Disease 1 1.0
group O 1 0.8550779223442078
( O 0 0.042146191000938416
105 O 1 0.7527533173561096
patients O 1 0.9979155659675598
) O 0 0.043464113026857376
. O 0 0.04196896404027939

Amino O 0 0.10044095665216446
acid O 0 0.06473416090011597
changes O 0 0.016879886388778687
were O 0 0.010815468616783619
identified O 0 0.016207380220294
in O 0 0.010944938287138939
four O 0 0.019176876172423363
patients O 1 0.8359688520431519
, O 0 0.01458603236824274
three O 0 0.010673124343156815
of O 0 0.01501497346907854
whom O 0 0.0248394925147295
belonged O 0 0.027798863127827644
to O 0 0.01128410454839468
the O 0 0.016525696963071823
non O 1 0.9541763663291931
- O 1 0.9999980926513672
FAP O 1 0.9999998807907104
group O 1 0.9878389835357666
of O 1 0.9999475479125977
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 1 0.6988701224327087

Genotype O 1 0.9992374181747437
- O 1 0.999976634979248
phenotype O 1 0.9655472636222839
correlations O 0 0.07347045838832855
identified O 0 0.03014960326254368
significant O 0 0.016684798523783684
differences O 0 0.01482157688587904
in O 0 0.011275914497673512
the O 0 0.01349043007940054
nature O 0 0.01624837890267372
of O 0 0.015460635535418987
certain O 0 0.02076714299619198
extracolonic O 1 0.9999746084213257
manifestations O 1 0.9999939203262329
in O 1 0.9859399795532227
FAP B-Disease 1 1.0
patients O 1 0.9999797344207764
belonging O 0 0.05427313596010208
to O 0 0.022902416065335274
three O 0 0.028469882905483246
mutation O 0 0.14487263560295105
subgroups O 0 0.1923574060201645
. O 0 0.051810409873723984

CONCLUSIONS O 0 0.08380221575498581
Extended O 0 0.08927591145038605
genotype O 1 0.9989199638366699
- O 1 0.9999830722808838
phenotype O 1 0.9686427712440491
correlations O 0 0.04615422710776329
made O 0 0.01668541692197323
in O 0 0.011712891049683094
this O 0 0.010375860147178173
study O 0 0.015373221598565578
may O 0 0.010524128563702106
have O 0 0.006334823090583086
the O 0 0.010648329742252827
potential O 0 0.01584472320973873
to O 0 0.01038738340139389
determine O 0 0.010941615328192711
the O 0 0.01085633598268032
most O 0 0.010177570395171642
appropriate O 0 0.02123069018125534
surveillance O 0 0.03951093554496765
and O 0 0.03022933565080166
prophylactic O 1 0.9999996423721313
treatment O 1 0.9999998807907104
regimens O 1 0.9999992847442627
for O 0 0.03512486815452576
those O 0 0.022764071822166443
patients O 1 0.999729573726654
with O 0 0.028439583256840706
mutations O 0 0.33280864357948303
associated O 0 0.02606740966439247
with O 0 0.02536368928849697
life O 1 0.8957524299621582
threatening O 1 0.9992393255233765
conditions O 1 0.7630123496055603
. O 0 0.053166382014751434

This O 0 0.03164135292172432
study O 0 0.025349099189043045
also O 0 0.016955193132162094
provided O 0 0.016122490167617798
evidence O 0 0.013008124195039272
for O 0 0.01190206129103899
the O 0 0.021039929240942
pathological O 1 0.9707689881324768
nature O 0 0.028371185064315796
of O 0 0.030864747241139412
amino O 0 0.04587940871715546
acid O 0 0.050879720598459244
changes O 0 0.013575437478721142
in O 0 0.015457320027053356
APC O 1 0.9995114803314209
associated O 0 0.016815118491649628
with O 0 0.011397751979529858
both O 0 0.016239488497376442
FAP B-Disease 1 0.9999991655349731
and O 0 0.03742813318967819
non O 1 0.999997615814209
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.4178237318992615
. O 0 0.054212361574172974

Inherited B-Disease 1 0.9999997615814209
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999973773956299
cancer B-Disease 1 1.0
risk O 1 0.9998987913131714
of O 1 0.5177448987960815
the O 1 0.9925864338874817
APC O 1 0.9999988079071045
I1307K O 1 0.999893069267273
polymorphism O 0 0.18183089792728424
. O 0 0.05547827109694481

Germ O 1 0.9999771118164062
- O 1 0.9997945427894592
line O 0 0.05968837812542915
and O 0 0.031050071120262146
somatic O 0 0.2118842899799347
truncating O 1 0.8799713253974915
mutations O 0 0.034561023116111755
of O 0 0.020976996049284935
the O 0 0.03654281049966812
APC B-Disease 1 0.9999840259552002
gene O 0 0.024954024702310562
are O 0 0.006541644223034382
thought O 0 0.013999255374073982
to O 0 0.017635291442275047
initiate O 1 0.9962452054023743
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999998807907104
formation O 1 0.9966980218887329
in O 1 0.6285066604614258
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999991655349731
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.997934103012085
respectively O 0 0.07675721496343613
. O 0 0.050562404096126556

Recently O 0 0.05880467966198921
, O 0 0.026971977204084396
an O 0 0.03073144145309925
isoleucine O 1 0.9998750686645508
- O 1 0.9999979734420776
- O 1 0.9999886751174927
> O 1 0.9687947630882263
lysine O 0 0.09764198213815689
polymorphism O 0 0.05824542045593262
at O 0 0.032517243176698685
codon O 0 0.09504129737615585
1307 O 1 0.936014711856842
( O 0 0.03406267240643501
I1307K O 0 0.2046528309583664
) O 0 0.015367044135928154
of O 0 0.016168393194675446
the O 0 0.03183085098862648
APC B-Disease 1 0.9999978542327881
gene O 0 0.02747604250907898
has O 0 0.013264010660350323
been O 0 0.010167814791202545
identified O 0 0.011180882342159748
in O 0 0.009420845657587051
6 O 0 0.02352239564061165
% O 0 0.02176097221672535
- O 1 0.9500867128372192
7 O 0 0.022852929309010506
% O 0 0.012684181332588196
of O 0 0.013315447606146336
the O 0 0.026420818641781807
Ashkenazi O 1 0.985077440738678
Jewish O 0 0.0657513216137886
population O 0 0.03590083867311478
. O 0 0.041699137538671494

To O 0 0.03792702034115791
assess O 0 0.04841382056474686
the O 0 0.024038055911660194
risk O 0 0.028554299846291542
of O 0 0.015429404564201832
this O 0 0.013187950477004051
common O 0 0.027543537318706512
APC B-Disease 1 0.9999918937683105
allelic O 1 0.9997473359107971
variant O 1 0.9303885102272034
in O 1 0.7208433747291565
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.03636816516518593
we O 0 0.012840468436479568
have O 0 0.007163724862039089
analyzed O 0 0.011767375282943249
a O 0 0.012485995888710022
large O 0 0.01563717983663082
cohort O 0 0.15222568809986115
of O 0 0.029724756255745888
unselected O 1 0.988734245300293
Ashkenazi O 1 0.9774301052093506
Jewish O 0 0.05180151015520096
subjects O 0 0.03855273872613907
with O 0 0.04018843546509743
adenomatous B-Disease 1 1.0
polyps I-Disease 1 0.9999997615814209
and O 0 0.09667607396841049
. O 0 0.244646817445755
or O 1 0.9999828338623047
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 1 0.6592211127281189
for O 0 0.02547035552561283
the O 0 0.10137280821800232
APC O 1 0.9999960660934448
I1307K O 1 0.9996273517608643
polymorphism O 0 0.16140492260456085
. O 0 0.055563535541296005

The O 0 0.07641936093568802
APC O 1 0.9998300075531006
I1307K O 1 0.9988632202148438
allele O 0 0.10663484781980515
was O 0 0.03187150880694389
identified O 0 0.02187047153711319
in O 0 0.013523666188120842
48 O 0 0.02793131209909916
( O 0 0.018339376896619797
10 O 0 0.014886505901813507
. O 0 0.011674354784190655
1 O 0 0.020836535841226578
% O 0 0.017213769257068634
) O 0 0.019029028713703156
of O 0 0.030123746022582054
476 O 1 0.9994856119155884
patients O 1 0.9996521472930908
. O 0 0.06717057526111603

Compared O 0 0.035677991807460785
with O 0 0.018344305455684662
the O 0 0.019106851890683174
frequency O 0 0.016844196245074272
in O 0 0.008595552295446396
two O 0 0.0071265618316829205
separate O 0 0.011383120901882648
population O 0 0.011884717270731926
control O 0 0.017634928226470947
groups O 0 0.011727157048881054
, O 0 0.012386713176965714
the O 0 0.02270238660275936
APC O 1 0.9999971389770508
I1307K O 1 0.9999880790710449
allele O 0 0.43580713868141174
is O 0 0.01624331995844841
associated O 0 0.014277617447078228
with O 0 0.010772050358355045
an O 0 0.015130003914237022
estimated O 0 0.020772384479641914
relative O 0 0.03305114433169365
risk O 0 0.04770345240831375
of O 0 0.028710221871733665
1 O 0 0.05530960485339165
. O 0 0.04354292154312134

5 O 0 0.10860925167798996
- O 1 0.9960525035858154
1 O 0 0.07959750294685364
. O 0 0.0559387132525444

7 O 0 0.07646723091602325
for O 0 0.1442130208015442
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999998807907104
( O 0 0.07939780503511429
both O 0 0.04128936678171158
P O 1 0.9999405145645142
= O 1 0.6088787913322449
. O 0 0.035777512937784195
01 O 1 0.9988998174667358
) O 0 0.044118717312812805
. O 0 0.04101205989718437

Furthermore O 0 0.06429963558912277
, O 0 0.02437863126397133
compared O 0 0.0204240120947361
with O 0 0.022816484794020653
noncarriers O 1 0.9997889399528503
, O 0 0.05467076227068901
APC O 1 0.9999953508377075
I1307K O 1 0.9994125366210938
carriers O 0 0.045856278389692307
had O 0 0.014808583073318005
increased O 0 0.013438118621706963
numbers O 0 0.010495229624211788
of O 0 0.024275926873087883
adenomas B-Disease 1 0.9999996423721313
and O 1 0.9977317452430725
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
per O 0 0.0587376207113266
patient O 1 0.9999951124191284
( O 1 0.7713437676429749
P O 1 0.9999803304672241
= O 0 0.4133542478084564
. O 0 0.020456578582525253
03 O 1 0.9704473614692688
) O 0 0.01706543006002903
, O 0 0.011992289684712887
as O 0 0.00983619224280119
well O 0 0.009631035849452019
as O 0 0.010912354104220867
a O 0 0.020861400291323662
younger O 0 0.47387972474098206
age O 0 0.15106070041656494
at O 1 0.959070086479187
diagnosis O 1 0.9999964237213135
. O 0 0.05363228917121887

We O 0 0.03176727518439293
conclude O 0 0.03753642365336418
that O 0 0.013705027289688587
the O 0 0.029341470450162888
APC O 1 0.9996638298034668
I1307K O 1 0.9981774091720581
variant O 0 0.06411920487880707
leads O 0 0.04417867586016655
to O 0 0.02964850887656212
increased O 1 0.9166958928108215
adenoma B-Disease 1 1.0
formation O 1 0.9862293004989624
and O 0 0.02660694345831871
directly O 0 0.021265685558319092
contributes O 0 0.029054030776023865
to O 0 0.014299786649644375
3 O 0 0.021778715774416924
% O 0 0.019207404926419258
- O 1 0.5191206336021423
4 O 0 0.018143832683563232
% O 0 0.009402613155543804
of O 0 0.011487754993140697
all O 0 0.01922740787267685
Ashkenazi O 1 0.9999285936355591
Jewish O 1 0.9999923706054688
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9629969596862793

The O 0 0.046723898500204086
estimated O 0 0.04114796966314316
relative O 0 0.05148336663842201
risk O 0 0.17546507716178894
for O 0 0.02574644237756729
carriers O 0 0.12023375183343887
may O 0 0.025092411786317825
justify O 0 0.04111253842711449
specific O 0 0.01927846670150757
clinical O 1 0.6489551067352295
screening O 0 0.13234172761440277
for O 0 0.01711008884012699
the O 0 0.02237033285200596
360 O 0 0.04776264354586601
, O 0 0.019451754167675972
000 O 0 0.030560752376914024
Americans O 0 0.01787140592932701
expected O 0 0.015502017922699451
to O 0 0.015486430376768112
harbor O 0 0.0664750337600708
this O 0 0.01591731607913971
allele O 0 0.044797006994485855
, O 0 0.01790444366633892
and O 0 0.015759792178869247
genetic O 0 0.01830967515707016
testing O 0 0.016047373414039612
in O 0 0.008616093546152115
the O 0 0.011217745020985603
setting O 0 0.017132602632045746
of O 0 0.01452084630727768
long O 0 0.03700515627861023
- O 1 0.9999191761016846
term O 0 0.12078703194856644
- O 1 0.9993461966514587
outcome O 0 0.019838504493236542
studies O 0 0.01164916716516018
may O 0 0.010877694003283978
impact O 0 0.016501449048519135
significantly O 0 0.025784911587834358
on O 1 0.9771661758422852
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 1.0
in O 0 0.10263462364673615
this O 0 0.020089419558644295
population O 0 0.023967109620571136
. O 0 0.03466924652457237

Localization O 0 0.10734888166189194
of O 0 0.03741459175944328
human O 0 0.05032394081354141
BRCA1 O 1 0.99944669008255
and O 0 0.017906222492456436
its O 0 0.015781767666339874
loss O 0 0.021645408123731613
in O 0 0.013203025795519352
high O 1 0.6078465580940247
- O 1 0.9999760389328003
grade O 1 0.8770412802696228
, O 0 0.023131441324949265
non B-Disease 1 0.9922877550125122
- I-Disease 1 0.9999997615814209
inherited I-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.3045572340488434

Although O 0 0.025673210620880127
the O 0 0.02044603042304516
link O 0 0.02769835852086544
between O 0 0.015256734564900398
the O 0 0.03478609398007393
BRCA1 O 1 0.9999996423721313
tumour B-Disease 1 1.0
- O 1 0.9999998807907104
suppressor O 1 0.9999808073043823
gene O 0 0.034742821007966995
and O 0 0.02483769692480564
hereditary B-Disease 1 0.9999997615814209
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.9600793719291687
established O 0 0.09187085926532745
, O 0 0.013938045129179955
the O 0 0.014029247686266899
role O 0 0.025874245911836624
, O 0 0.011541142128407955
if O 0 0.008166921325027943
any O 0 0.008018075488507748
, O 0 0.00940657127648592
of O 0 0.015108234249055386
BRCA1 O 1 0.9963855743408203
in O 0 0.023787612095475197
non B-Disease 1 0.9999692440032959
- I-Disease 1 1.0
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 0.07195507735013962
unclear O 0 0.04886787384748459
. O 0 0.03853985667228699

BRCA1 O 1 0.9999313354492188
mutations O 0 0.049004655331373215
are O 0 0.012791024520993233
rare O 0 0.025192642584443092
in O 0 0.023047158494591713
sporadic B-Disease 1 0.9999126195907593
cancers I-Disease 1 0.9999991655349731
, O 0 0.02230447717010975
but O 0 0.013584238477051258
loss O 0 0.028570014983415604
of O 0 0.03513544052839279
BRCA1 O 1 0.9999405145645142
resulting O 0 0.03128262609243393
from O 0 0.01888355240225792
reduced O 0 0.03143157809972763
expression O 0 0.026209499686956406
or O 0 0.018200496211647987
incorrect O 0 0.03988974913954735
subcellular O 0 0.49831974506378174
localization O 0 0.15301793813705444
is O 0 0.02020840346813202
postulated O 0 0.033196136355400085
to O 0 0.010935765691101551
be O 0 0.006430103909224272
important O 0 0.007223648484796286
in O 0 0.010802794247865677
non B-Disease 1 0.9238943457603455
- I-Disease 1 0.9999998807907104
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9856736063957214

Epigenetic O 1 0.8559918403625488
loss O 1 0.668418824672699
, O 0 0.029266487807035446
however O 0 0.016001133248209953
, O 0 0.014608597382903099
has O 0 0.012345713563263416
not O 0 0.009418637491762638
received O 0 0.018697915598750114
general O 0 0.02815224975347519
acceptance O 0 0.11158633977174759
due O 0 0.022155754268169403
to O 0 0.016969330608844757
controversy O 0 0.030011991038918495
regarding O 0 0.018613575026392937
the O 0 0.01993297040462494
subcellular O 0 0.06670110672712326
localization O 0 0.07534558326005936
of O 0 0.04434647038578987
BRCA1 O 1 0.9999959468841553
proteins O 0 0.027098629623651505
, O 0 0.015248363837599754
reports O 0 0.013667488470673561
of O 0 0.013813254423439503
which O 0 0.011511094868183136
have O 0 0.009288878180086613
ranged O 0 0.024648325517773628
from O 0 0.013831390999257565
exclusively O 0 0.02362673543393612
nuclear O 0 0.028124520555138588
, O 0 0.013757128268480301
to O 0 0.013731797225773335
conditionally O 0 0.05878394469618797
nuclear O 0 0.025953536853194237
, O 0 0.012088017538189888
to O 0 0.013684090226888657
the O 0 0.03725710138678551
ER O 1 0.9999998807907104
/ O 1 0.9999943971633911
golgi O 1 0.9997598528862
, O 0 0.027634337544441223
to O 0 0.027515629306435585
cytoplasmic O 0 0.3553045988082886
invaginations O 1 0.751044511795044
into O 0 0.029062755405902863
the O 0 0.03981468826532364
nucleus O 0 0.10330116003751755
. O 0 0.050394248217344284

In O 0 0.03363852947950363
an O 0 0.023813048377633095
attempt O 0 0.037367530167102814
to O 0 0.0204678475856781
resolve O 0 0.04715709015727043
this O 0 0.014481200836598873
issue O 0 0.02076398767530918
, O 0 0.013975197449326515
we O 0 0.009835375472903252
have O 0 0.00896585825830698
comprehensively O 0 0.06201643496751785
characterized O 0 0.04292575269937515
19 O 0 0.052767883986234665
anti O 1 0.9999432563781738
- O 1 0.9999997615814209
BRCA1 O 1 0.9999713897705078
antibodies O 1 0.8942865133285522
. O 0 0.056989699602127075

These O 0 0.03809994086623192
reagents O 0 0.08184841275215149
detect O 0 0.04539674147963524
a O 0 0.03225288540124893
220 O 0 0.07558125257492065
- O 1 0.9999701976776123
kD O 1 0.9998582601547241
protein O 0 0.039722129702568054
localized O 0 0.039241112768650055
in O 0 0.01494421437382698
discrete O 0 0.0296632070094347
nuclear O 0 0.03984301537275314
foci O 0 0.11490543931722641
in O 0 0.01780759170651436
all O 0 0.023773586377501488
epithelial O 1 0.9999775886535645
cell O 1 0.6212747097015381
lines O 0 0.027800505980849266
, O 0 0.01516107190400362
including O 0 0.011940536089241505
those O 0 0.013473154045641422
derived O 0 0.028756937012076378
from O 0 0.04565642774105072
breast B-Disease 1 0.9999995231628418
malignancies I-Disease 1 0.9999963045120239
. O 0 0.09131094068288803

Immunohistochemical O 1 0.99950110912323
staining O 1 0.9974512457847595
of O 0 0.06324613839387894
human O 1 0.9767063856124878
breast O 1 0.9999996423721313
specimens O 0 0.045489560812711716
also O 0 0.023877356201410294
revealed O 0 0.041536252945661545
BRCA1 O 1 0.9783849716186523
nuclear O 0 0.04687800258398056
foci O 1 0.9230979084968567
in O 0 0.03364904224872589
benign O 1 0.9999997615814209
breast O 1 1.0
, O 1 0.9987297654151917
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
and O 1 0.8445675373077393
low B-Disease 1 0.9999903440475464
- I-Disease 1 1.0
grade I-Disease 1 0.9999994039535522
ductal I-Disease 1 1.0
carcinomas I-Disease 1 0.9999997615814209
. O 0 0.09336742013692856

Conversely O 0 0.4523911476135254
, O 0 0.051797203719615936
BRCA1 O 1 0.9992339611053467
expression O 0 0.039273280650377274
was O 0 0.034581057727336884
reduced O 0 0.031133968383073807
or O 0 0.020814266055822372
undetectable O 1 0.9736517071723938
in O 0 0.010807186365127563
the O 0 0.010514926165342331
majority O 0 0.011862518265843391
of O 0 0.01422862522304058
high O 1 0.9270257949829102
- O 1 0.9999996423721313
grade O 1 0.9999892711639404
, O 1 0.9720678329467773
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.03212706744670868
suggesting O 0 0.022316642105579376
that O 0 0.010791538283228874
absence O 0 0.036551740020513535
of O 0 0.17323671281337738
BRCA1 O 1 0.999993085861206
may O 0 0.023901792243123055
contribute O 0 0.022316334769129753
to O 0 0.014675287529826164
the O 0 0.021051760762929916
pathogenesis O 1 0.9999220371246338
of O 0 0.015861326828598976
a O 0 0.01613396778702736
significant O 0 0.012796672992408276
percentage O 0 0.019540971145033836
of O 0 0.032537791877985
sporadic B-Disease 1 0.9999984502792358
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.1637527048587799
. O 0 0.05303185060620308

